Psyllid ID: psy10459
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | 2.2.26 [Sep-21-2011] | |||||||
| Q9D411 | 328 | Testis-specific serine/th | yes | N/A | 0.835 | 0.853 | 0.486 | 4e-74 | |
| Q6SA08 | 328 | Testis-specific serine/th | yes | N/A | 0.835 | 0.853 | 0.472 | 7e-70 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.820 | 0.749 | 0.470 | 6e-69 | |
| Q3SZW1 | 367 | Testis-specific serine/th | no | N/A | 0.794 | 0.724 | 0.477 | 5e-68 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.794 | 0.728 | 0.474 | 1e-67 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.794 | 0.743 | 0.455 | 1e-65 | |
| Q96PF2 | 358 | Testis-specific serine/th | no | N/A | 0.794 | 0.743 | 0.448 | 5e-65 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.773 | 0.966 | 0.413 | 8e-61 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.773 | 0.966 | 0.406 | 1e-59 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.773 | 0.948 | 0.422 | 5e-59 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 278 bits (711), Expect = 4e-74, Method: Compositional matrix adjust.
Identities = 141/290 (48%), Positives = 187/290 (64%), Gaps = 10/290 (3%)
Query: 32 SDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI 91
D +E T SV+E +GY +G ++G GSY TV A + VA+KIISK +A
Sbjct: 4 GDTSETASATPAYRSVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASE 63
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 151
DYL KFLPREI+V+K L+H LI F QAIETT RVYII+E A+ G +LE I++ E
Sbjct: 64 DYLNKFLPREIQVMKVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAET 123
Query: 152 KGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV-----NNT 206
+WFSQ+A I Y H K +VHRD+K ENLLLD + N+K+SDFGFA+ ++
Sbjct: 124 LAGKWFSQMALGIAYLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSP 183
Query: 207 DYKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y+Q +LS+T+CGS+AYA PEIL G+PY P SD WSMGV+L+ +V RLPFDDTN
Sbjct: 184 SYRQMNSLSHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTN 243
Query: 262 YSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
+LL++ QK V FP + +S CK LI +L R + D+ +DPW+
Sbjct: 244 LKKLLRETQKEVTFPANLTISQECKNLILQLLRQSTKRATILDVLRDPWM 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 7e-70, Method: Compositional matrix adjust.
Identities = 137/290 (47%), Positives = 183/290 (63%), Gaps = 10/290 (3%)
Query: 32 SDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI 91
D E T S+++ +GY +G +G GSY +V A + VA+KIISK +A
Sbjct: 4 GDVLEAAPTTTAYHSLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASD 63
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 151
DYL KFLPREI+V+K L+H LI F +AIE+T RVYII+E A+ G +LE I++ E
Sbjct: 64 DYLNKFLPREIQVMKVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEP 123
Query: 152 KGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN-----NT 206
+WFSQL I Y H KS+VHRD+K ENLLLD N+K+SDFGFA+ N +
Sbjct: 124 LAGKWFSQLTLGIAYLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSP 183
Query: 207 DYKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y+Q +LS+T+CGS+AYA PEIL+G+PY P SD WSMGV+L+ +V LPFDDTN
Sbjct: 184 SYRQVNCFSHLSQTYCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTN 243
Query: 262 YSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
+LL++ QK V FP + +S CK LI +L R + DI +D W+
Sbjct: 244 LKKLLRETQKEVTFPANHTISQECKNLILQMLRQATKRATILDIIKDSWV 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 134/285 (47%), Positives = 194/285 (68%), Gaps = 10/285 (3%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY LG +G GSYA VK A S R +VAIKII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++I+ + ET+H +VYI+ME A G LLE+I+ + ED+ R+ F QL+ AI
Sbjct: 65 AMLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KC+NLLLD +NIKLSDF F+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKR-CLRDDSGRMALSKTFCGSPAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 327
CK LI ++L P V R+ +++I W++ K++ +P V
Sbjct: 244 ECKDLIYHMLQPDVNRRLHIDEILSHCWMQP------KARGSPSV 282
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 129/270 (47%), Positives = 184/270 (68%), Gaps = 4/270 (1%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++I+ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLTLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
CK LI +L P V R+ +++I W++
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 256 bits (654), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 128/270 (47%), Positives = 184/270 (68%), Gaps = 4/270 (1%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPSDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++++ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLILSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
CK LI +L P V R+ +++I W++
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILNHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 249 bits (637), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 123/270 (45%), Positives = 182/270 (67%), Gaps = 4/270 (1%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL GY +G +G GSYA VK A S R +VA+KII + + P D++++FLPRE++++
Sbjct: 5 AVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
+ H ++I+ + ET+ R+YI+ME G LLE I+ + ED R+ F QL+ A+
Sbjct: 65 ATVNHRSIIKTYEIFETSDGRIYIVMELGVQGDLLEFIKCRGALHEDVARKMFRQLSSAV 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDGSGRIVLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQKEHRVDFPRSKNLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
CK LI IL P V R+ +++I WL+
Sbjct: 244 ECKDLIYRILQPDVNRRLHIDEILSHSWLQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 121/270 (44%), Positives = 184/270 (68%), Gaps = 4/270 (1%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL GY +G +G GSYA VK A S R +VA+KII + + P D++++FLPRE++++
Sbjct: 5 TVLRKKGYIVGINLGKGSYAKVKSAYSERLKFNVAVKIIDRKKTPTDFVERFLPREMDIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
+ H ++I+ + ET+ R+YIIME G LLE I+ + + ED R+ F QL+ A+
Sbjct: 65 ATVNHGSIIKTYEIFETSDGRIYIIMELGVQGDLLEFIKCQGALHEDVARKMFRQLSSAV 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + +++ + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDSNGRIILSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+ +PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRIQKEHRVDFPRSKNLTC 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
CK LI +L P V R+ +++I WL+
Sbjct: 244 ECKDLIYRMLQPDVSQRLHIDEILSHSWLQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (596), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 110/266 (41%), Positives = 176/266 (66%), Gaps = 7/266 (2%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
L ++GY LG +G G+Y+ VK A S +H + VAIKII K+ P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKIIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 108 LKHPNLIRFLQAIETT-HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
L H N+I+ + +E+ ++Y++ME A+ G + + + + E + + F Q+ +AI Y
Sbjct: 65 LDHKNIIQVYEMLESADGKIYLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
CH V HRD+KCEN LL +N+KL+DFGFA+ + ++ LS+TFCGS AYA+PE
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKS----RRELSQTFCGSTAYAAPE 179
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286
+L+G+P+ ++ D+WSMGVVL+ M+ LPFDDT+ ++L Q QK V FP +S+ C+
Sbjct: 180 VLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLGISTECQ 239
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWL 311
L+ +L P + R +E++ PWL
Sbjct: 240 DLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (587), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 108/266 (40%), Positives = 175/266 (65%), Gaps = 7/266 (2%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
L ++GY LG +G G+Y+ VK A S +H + VAIK+I K+ P +++++FLPRE+++V+
Sbjct: 5 LLSNGYQLGKTIGEGTYSKVKEAFSKKHQRKVAIKVIDKMGGPEEFIQRFLPRELQIVRT 64
Query: 108 LKHPNLIRFLQAIETT-HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
L H N+I+ + +E+ ++ ++ME A+ G + + + + E + + F Q+ +AI Y
Sbjct: 65 LDHKNIIQVYEMLESADGKICLVMELAEGGDVFDCVLNGGPLPESRAKALFRQMVEAIRY 124
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
CH V HRD+KCEN LL +N+KL+DFGFA+ ++ + LS+TFCGS AYA+PE
Sbjct: 125 CHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKSH----RELSQTFCGSTAYAAPE 179
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286
+L+G+P+ ++ D+WSMGVVL+ M+ LPFDDT+ ++L Q QK V FP +S+ C+
Sbjct: 180 VLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQKGVSFPTHLSISADCQ 239
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWL 311
L+ +L P + R +E++ PWL
Sbjct: 240 DLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 114/270 (42%), Positives = 179/270 (66%), Gaps = 11/270 (4%)
Query: 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK 106
+L GY LG +G GSY+ VK+ATS ++ VAIK++ + +AP D++ KFLPRE+ +++
Sbjct: 6 LLSELGYKLGRTIGEGSYSKVKVATSKKYKGTVAIKVVDRRRAPPDFVNKFLPRELSILR 65
Query: 107 GLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
G++HP+++ + IE + ++YI+ME A LL+ +++ I + R F+Q+A A+
Sbjct: 66 GVRHPHIVHVFEFIEVCNGKLYIVMEAAAT-DLLQAVQRNGRIPGVQARDLFAQIAGAVR 124
Query: 166 YCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y H +VHRD+KCEN+LL D+ +KL+DFGF R+ +LS T+CGS AYAS
Sbjct: 125 YLHDHHLVHRDLKCENVLLSPDERRVKLTDFGFGRQ-----AHGYPDLSTTYCGSAAYAS 179
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
PE+L G+PY P++ D+WSMGVVL+ MV G +PFDD++ + L ++ ++ V++PE LS
Sbjct: 180 PEVLLGIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAGLPRRQKRGVLYPEGLELSER 239
Query: 285 CKALISNIL--SPVKFRIQMEDIRQDPWLK 312
CKALI+ +L SP R + ++ WL+
Sbjct: 240 CKALIAELLQFSP-SARPSAGQVARNCWLR 268
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| 357614817 | 329 | putative cAMP-dependent protein kinase c | 0.850 | 0.866 | 0.680 | 1e-114 | |
| 383852844 | 364 | PREDICTED: testis-specific serine/threon | 0.886 | 0.815 | 0.650 | 1e-114 | |
| 380027639 | 345 | PREDICTED: testis-specific serine/threon | 0.826 | 0.802 | 0.694 | 1e-114 | |
| 242016558 | 386 | cAMP-dependent protein kinase catalytic | 0.904 | 0.784 | 0.648 | 1e-114 | |
| 91087563 | 340 | PREDICTED: similar to CG9222 CG9222-PA [ | 0.814 | 0.802 | 0.700 | 1e-113 | |
| 270010686 | 327 | hypothetical protein TcasGA2_TC010125 [T | 0.814 | 0.834 | 0.700 | 1e-113 | |
| 328776257 | 351 | PREDICTED: testis-specific serine/threon | 0.811 | 0.774 | 0.699 | 1e-113 | |
| 350401037 | 363 | PREDICTED: testis-specific serine/threon | 0.823 | 0.760 | 0.685 | 1e-112 | |
| 340709608 | 363 | PREDICTED: testis-specific serine/threon | 0.823 | 0.760 | 0.682 | 1e-111 | |
| 332019401 | 361 | Testis-specific serine/threonine-protein | 0.859 | 0.797 | 0.634 | 1e-109 |
| >gi|357614817|gb|EHJ69292.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 202/297 (68%), Positives = 237/297 (79%), Gaps = 12/297 (4%)
Query: 41 TERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR 100
T+RKL+VLETHGY LG +G GSYATVK+ATS RH+ VAIKIISK QAP DYLKKFLPR
Sbjct: 17 TDRKLTVLETHGYILGRTIGSGSYATVKVATSERHNCQVAIKIISKFQAPGDYLKKFLPR 76
Query: 101 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL 160
EIEVVKGLKH NLIRFLQAIETTHRVYI+MEYA+NGSLL++IRK+++IDE +GRRWF QL
Sbjct: 77 EIEVVKGLKHENLIRFLQAIETTHRVYIVMEYAENGSLLDIIRKDQHIDEQRGRRWFKQL 136
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-SVNNTDYKQNLSETFCGS 219
+A+DYCH++ VVHRDIKCENLL+D NIKLSDFGFAR + N Y LSETFCGS
Sbjct: 137 VEAVDYCHERGVVHRDIKCENLLMDHGLNIKLSDFGFARGHMKPKNGVYA--LSETFCGS 194
Query: 220 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
YAYASPEILKGVPY PQ SDIWSMGVVL+A+VYGRLPFDDTNY++LLKQVQ +V FP P
Sbjct: 195 YAYASPEILKGVPYRPQDSDIWSMGVVLYAIVYGRLPFDDTNYTQLLKQVQNKVSFPREP 254
Query: 280 RLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE---------DSNPVGKSKSAPEV 327
++S+ C+ LI+ IL+P+K R ++ I DPWL D+NP S E+
Sbjct: 255 KVSTECRKLITKILAPLKLRSKIPQILADPWLSPSAPTKDEELDTNPDNAQASKEEI 311
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852844|ref|XP_003701935.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 197/303 (65%), Positives = 240/303 (79%), Gaps = 6/303 (1%)
Query: 32 SDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI 91
S NE D+ T++KL+VLE+HGY+LG +G GSYATVK+A S RH VAIKI+SK QAP
Sbjct: 17 SADNEHDEKTDKKLTVLESHGYNLGKTIGSGSYATVKIAKSCRHDCQVAIKIVSKFQAPG 76
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 151
+YLKKFLPREIEVVKGL+HPNLIRFLQAIETTHRVYIIMEYA+NGSLL++IR++ +IDE
Sbjct: 77 EYLKKFLPREIEVVKGLRHPNLIRFLQAIETTHRVYIIMEYAQNGSLLDIIRRDTFIDEV 136
Query: 152 KGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211
+ RRWF QL +AIDYCH + VVHRD+KCENLL+D +N+KLSDFGFAR + +
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDVKCENLLMDSNFNVKLSDFGFARG-QMKPKNGINP 195
Query: 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
LSETFCGSYAYASPEILKG+PY PQ SD+WSMGVVL+AMVYGRLPFDDTNY++LLKQVQ
Sbjct: 196 LSETFCGSYAYASPEILKGIPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYNQLLKQVQS 255
Query: 272 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKS-----APE 326
R+ FP+ P++S SC++LIS IL P + R+ ++ IR D WL V S + AP
Sbjct: 256 RITFPKDPKVSQSCRSLISRILVPQRTRLHIDRIRNDVWLSASLVTVQTSTTDTLMNAPY 315
Query: 327 VIP 329
+P
Sbjct: 316 TLP 318
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027639|ref|XP_003697528.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1074), Expect = e-114, Method: Compositional matrix adjust.
Identities = 193/278 (69%), Positives = 232/278 (83%), Gaps = 1/278 (0%)
Query: 36 EQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLK 95
+++ +E+KL++LE+HGY+LG +G GSYATVK+A S RH VA+KI+SK QAP DYLK
Sbjct: 20 DKNDKSEKKLTILESHGYTLGKTIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLK 79
Query: 96 KFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRR 155
KFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSLL++IR++ +IDE + RR
Sbjct: 80 KFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDEFRSRR 139
Query: 156 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215
WF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + LSET
Sbjct: 140 WFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKPKNGTNPLSET 198
Query: 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275
FCGSYAYASPEILKGVPY PQ SDIWSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ +VVF
Sbjct: 199 FCGSYAYASPEILKGVPYLPQLSDIWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVF 258
Query: 276 PESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE 313
P+ P +S +C++LIS IL P + R+ +++IR D WL E
Sbjct: 259 PKEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWLAE 296
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242016558|ref|XP_002428853.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513589|gb|EEB16115.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 199/307 (64%), Positives = 246/307 (80%), Gaps = 4/307 (1%)
Query: 20 ERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDV 79
E++H K + D E+ E+KL+VLETHGY+LG +G GSYATVK+A S RH V
Sbjct: 21 EKNH-PKPGVKSKDETEEKLQPEKKLTVLETHGYTLGKTIGTGSYATVKVARSERHDCLV 79
Query: 80 AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLL 139
A+KI+SK QAP DYLKKFLPREIEVVKGLKH NLIRFLQAIETTHRVYIIMEYA+NGSLL
Sbjct: 80 AVKIVSKFQAPADYLKKFLPREIEVVKGLKHINLIRFLQAIETTHRVYIIMEYAENGSLL 139
Query: 140 EVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199
+VIRK++YIDE + R++F QL DA+DYCH++ VVHRDIKCENLL+D N+KLSDFGFAR
Sbjct: 140 DVIRKDQYIDEVRARKYFRQLIDAVDYCHERGVVHRDIKCENLLMDHDNNVKLSDFGFAR 199
Query: 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
+ + + LS+TFCGSYAYASPEILKGVPY PQ SDIWS GVVL+A+VYGRLPFDD
Sbjct: 200 GH-MRIKNGVAPLSDTFCGSYAYASPEILKGVPYQPQLSDIWSTGVVLYAIVYGRLPFDD 258
Query: 260 TNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVG 319
TNY++LLKQVQ ++ FP+ P++S++CK+LI+ IL+PVKFR+++ IR DPW + P
Sbjct: 259 TNYNQLLKQVQSKISFPKEPKISANCKSLITKILAPVKFRLKIPAIRSDPWFVQ--GPSD 316
Query: 320 KSKSAPE 326
S + P+
Sbjct: 317 SSANGPQ 323
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91087563|ref|XP_971036.1| PREDICTED: similar to CG9222 CG9222-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1065), Expect = e-113, Method: Compositional matrix adjust.
Identities = 192/274 (70%), Positives = 231/274 (84%), Gaps = 1/274 (0%)
Query: 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI 102
+K +VLE+HGY LG +G GSYATV++A S RH+ +VA+KI+SK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 103 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLAD 162
EVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+NGSLLE+IRK+ YIDE + R+WF QL D
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
A+DYCH++ VVHRDIKCENLLL+ +Y IKLSDFGFAR + + + + LSETFCGSYAY
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGH-MKIKNGQAPLSETFCGSYAY 205
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282
ASPEILKG+PY PQ SDIWSMGVVLFAMVYGRLPFDDTNY +L+KQV +VVFP+ P++S
Sbjct: 206 ASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKVS 265
Query: 283 SSCKALISNILSPVKFRIQMEDIRQDPWLKEDSN 316
CKALI+ IL+P+K RI++ I+ DPW ++N
Sbjct: 266 LMCKALINKILAPLKARIRIPGIKTDPWYTYNTN 299
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010686|gb|EFA07134.1| hypothetical protein TcasGA2_TC010125 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1063), Expect = e-113, Method: Compositional matrix adjust.
Identities = 192/274 (70%), Positives = 231/274 (84%), Gaps = 1/274 (0%)
Query: 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI 102
+K +VLE+HGY LG +G GSYATV++A S RH+ +VA+KI+SK AP DYLKKFLPREI
Sbjct: 27 KKQTVLESHGYILGKTIGSGSYATVRMAHSERHNMNVAVKIVSKFSAPADYLKKFLPREI 86
Query: 103 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLAD 162
EVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+NGSLLE+IRK+ YIDE + R+WF QL D
Sbjct: 87 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAENGSLLEIIRKDSYIDEIRSRKWFRQLVD 146
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
A+DYCH++ VVHRDIKCENLLL+ +Y IKLSDFGFAR + + + + LSETFCGSYAY
Sbjct: 147 AVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGH-MKIKNGQAPLSETFCGSYAY 205
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282
ASPEILKG+PY PQ SDIWSMGVVLFAMVYGRLPFDDTNY +L+KQV +VVFP+ P++S
Sbjct: 206 ASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTNKVVFPKEPKVS 265
Query: 283 SSCKALISNILSPVKFRIQMEDIRQDPWLKEDSN 316
CKALI+ IL+P+K RI++ I+ DPW ++N
Sbjct: 266 LMCKALINKILAPLKARIRIPGIKTDPWYTYNTN 299
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776257|ref|XP_395246.3| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 191/273 (69%), Positives = 228/273 (83%), Gaps = 1/273 (0%)
Query: 41 TERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR 100
+E+ L++LE+HGY+LG +G GSYATVK+A S RH VA+KI+SK QAP DYLKKFLPR
Sbjct: 31 SEKXLTILESHGYTLGKPIGAGSYATVKIAKSDRHDCQVAVKIVSKFQAPGDYLKKFLPR 90
Query: 101 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL 160
EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSLL++IR++ +IDE + RRWF QL
Sbjct: 91 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDIIRRDTFIDELRSRRWFRQL 150
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
+AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + LSETFCGSY
Sbjct: 151 LEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKAKNGINPLSETFCGSY 209
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280
AYASPEILKGVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ +VVFP+ P
Sbjct: 210 AYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVVFPKEPN 269
Query: 281 LSSSCKALISNILSPVKFRIQMEDIRQDPWLKE 313
+S +C++LIS IL P + R+ +++IR D WL E
Sbjct: 270 VSQACRSLISRILVPQRIRMNIDNIRNDTWLAE 302
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401037|ref|XP_003486034.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1059), Expect = e-112, Method: Compositional matrix adjust.
Identities = 190/277 (68%), Positives = 229/277 (82%), Gaps = 1/277 (0%)
Query: 35 NEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL 94
+ D+ E+KL++LE+HGY+LG +G GSYATVK+A S RH VA+KI+SK QAP DYL
Sbjct: 20 GKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPGDYL 79
Query: 95 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR 154
KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSLL++IR++ +IDE + R
Sbjct: 80 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYARCGSLLDMIRRDTFIDEFRSR 139
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214
RWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + + LSE
Sbjct: 140 RWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKSKNGIAPLSE 198
Query: 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274
TFCGSYAYASPEILKGVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ +V+
Sbjct: 199 TFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVI 258
Query: 275 FPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
FP+ P +S +C++LIS IL + R+ ++ IR D WL
Sbjct: 259 FPKEPNVSQACRSLISRILVSQRIRLHIDHIRNDVWL 295
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709608|ref|XP_003393396.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1051), Expect = e-111, Method: Compositional matrix adjust.
Identities = 189/277 (68%), Positives = 228/277 (82%), Gaps = 1/277 (0%)
Query: 35 NEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL 94
+ D+ E+KL++LE+HGY+LG +G GSYATVK+A S RH VA+KI+SK QAP DYL
Sbjct: 20 GKNDEKLEKKLTILESHGYTLGKTIGTGSYATVKIAKSNRHDCQVAVKIVSKFQAPGDYL 79
Query: 95 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR 154
KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA+ GSLL++IR++ +IDE + R
Sbjct: 80 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAQCGSLLDMIRRDTFIDEFRSR 139
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214
RWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + + LSE
Sbjct: 140 RWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKSKNGIAPLSE 198
Query: 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274
TFCGSYAYASPEIL GVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ +V+
Sbjct: 199 TFCGSYAYASPEILMGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQNKVI 258
Query: 275 FPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
FP+ P +S +C++LIS IL + R+ ++ IR D WL
Sbjct: 259 FPKEPNVSQACRSLISRILVSQRIRLDIDHIRNDVWL 295
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019401|gb|EGI59887.1| Testis-specific serine/threonine-protein kinase 4 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1025), Expect = e-109, Method: Compositional matrix adjust.
Identities = 186/293 (63%), Positives = 237/293 (80%), Gaps = 5/293 (1%)
Query: 23 HSAKTNAEGSDPNEQ--DKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVA 80
+++K G +Q + +E+KL+VLE+HGY+LG +G GSYATVK+A S R+ VA
Sbjct: 9 YTSKEQQAGMKLTDQKNGEKSEKKLTVLESHGYTLGKTIGAGSYATVKVAKSDRYGYQVA 68
Query: 81 IKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLE 140
+KI+SK QAP +YL KFLPREIEVVKGLKHPNLI FLQAIETTHRVYIIMEYA+NGSLL+
Sbjct: 69 VKIVSKFQAPGEYLTKFLPREIEVVKGLKHPNLIHFLQAIETTHRVYIIMEYAQNGSLLD 128
Query: 141 VIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR- 199
+IR++ YIDE + RRWF QL +AI+YCH+ +VHRD+KCENLL+D ++NIKLSDFGFAR
Sbjct: 129 IIRRDTYIDELRSRRWFRQLLEAIEYCHEHGIVHRDVKCENLLMDFRFNIKLSDFGFARG 188
Query: 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
+ + N ++ LS T+CGSYAYASPEIL+G+PY PQ SDIWSMGVVL+AMV+GRLPFDD
Sbjct: 189 QMKLKNGEWP--LSTTYCGSYAYASPEILRGIPYQPQLSDIWSMGVVLYAMVHGRLPFDD 246
Query: 260 TNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLK 312
TNY++LLKQVQ RVVFP+ P++S C++LIS IL P R+++ I+ D WL+
Sbjct: 247 TNYAQLLKQVQNRVVFPKHPKVSQPCRSLISRILVPQFARLRINSIKNDAWLE 299
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| FB|FBgn0031784 | 337 | CG9222 [Drosophila melanogaste | 0.832 | 0.827 | 0.553 | 8.2e-83 | |
| UNIPROTKB|D4A7Q4 | 339 | D4A7Q4 "Uncharacterized protei | 0.498 | 0.492 | 0.497 | 3.7e-74 | |
| UNIPROTKB|F6RLA2 | 326 | TSSK4 "Uncharacterized protein | 0.794 | 0.815 | 0.521 | 4.4e-68 | |
| MGI|MGI:1918349 | 328 | Tssk4 "testis-specific serine | 0.832 | 0.850 | 0.491 | 1.9e-67 | |
| UNIPROTKB|Q9BXA7 | 367 | TSSK1B "Testis-specific serine | 0.820 | 0.749 | 0.473 | 2.9e-64 | |
| UNIPROTKB|Q6SA08 | 328 | TSSK4 "Testis-specific serine/ | 0.794 | 0.810 | 0.485 | 4.7e-64 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.823 | 0.752 | 0.468 | 1.6e-63 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.823 | 0.752 | 0.468 | 1.6e-63 | |
| UNIPROTKB|F1RK80 | 364 | TSSK1B "Uncharacterized protei | 0.823 | 0.758 | 0.457 | 2e-63 | |
| RGD|1307352 | 365 | Tssk1b "testis-specific serine | 0.794 | 0.728 | 0.474 | 2e-63 |
| FB|FBgn0031784 CG9222 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 155/280 (55%), Positives = 208/280 (74%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP 90
G P + D ++ + ++LE HG LG V+G G+YA VK+ S + + VA+KIISKV+AP
Sbjct: 54 GVVPVKADDKSKPQKTILEEHGIILGKVIGTGNYAKVKIGFSEEYGKRVAVKIISKVKAP 113
Query: 91 IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDE 150
+Y +KFLPREIE VKGL H NLI F Q+IET+HRVY+IM+ A+NG+LL+ +R+ +++DE
Sbjct: 114 SEYTQKFLPREIEAVKGLHHENLITFYQSIETSHRVYLIMQLAENGTLLDYVRERKFLDE 173
Query: 151 DKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
+ R F QL A++Y H K VVHRDIKCENLLLD+ +N+KL DFGFARK +D +
Sbjct: 174 PQSRTLFKQLVSAVEYIHSKGVVHRDIKCENLLLDENWNLKLIDFGFARK-DTRTSDNQV 232
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 270
LS+TFCGSYAYASPEILKGV Y P SDIW+ GVV +AMV+GRLP+D +N LLK++
Sbjct: 233 ILSKTFCGSYAYASPEILKGVAYDPFMSDIWACGVVCYAMVFGRLPYDGSNVHILLKRIN 292
Query: 271 KRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPW 310
+ +VFP+SP SS CK +I +IL+PVK R + +++DPW
Sbjct: 293 QSLVFPKSPSASSECKHMIMHILAPVKIRYNIPQVKEDPW 332
|
|
| UNIPROTKB|D4A7Q4 D4A7Q4 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 3.7e-74, Sum P(2) = 3.7e-74
Identities = 88/177 (49%), Positives = 112/177 (63%)
Query: 33 DPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID 92
D +E T SV+E +GY +G V+G GSY TV A + VA+KIISK +A D
Sbjct: 5 DTSETASATPAYRSVMEEYGYEVGKVIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASED 64
Query: 93 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 152
YL KFLPREI+V+K L+H LI F QAIETT RVYII+E A+ G +LE I++ E
Sbjct: 65 YLNKFLPREIQVMKVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSETL 124
Query: 153 GRRWFSQLADAIDYCHKKSVVHR----------DIKCENLLLDDKYNIKLSDFGFAR 199
+WFSQ+A I Y H K +VHR D+K ENLLLD + N+K+SDFGFA+
Sbjct: 125 AGKWFSQMALGIAYLHSKGIVHRLTPSLSAAGRDLKLENLLLDKRENVKISDFGFAK 181
|
|
| UNIPROTKB|F6RLA2 TSSK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
Identities = 144/276 (52%), Positives = 183/276 (66%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
SV+E +GY +G V+G GSY TV A + VA+KIISK +A DYL KFLPREI+V+
Sbjct: 16 SVMEEYGYEVGKVIGNGSYGTVYEAYYTKQKVMVAVKIISKKKASEDYLNKFLPREIQVM 75
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
K L+H LI F QAIETT RVYII+E A+ G +LE I++ E +WFSQL I
Sbjct: 76 KVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 135
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR----KYSVNNT-DYKQ-----NLSET 215
Y H K +VHRD+K ENLLLD + N+K+SDFGFA+ SV N+ Y+Q +LS+T
Sbjct: 136 YLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSNQSVRNSPSYRQMNCFSHLSQT 195
Query: 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275
+CGS+AYA PEIL G+PY P SD WSMGV+L+ +V RLPFDDTN +LLK+ QK V F
Sbjct: 196 YCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNLKKLLKETQKEVTF 255
Query: 276 PESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
P + +S CK LI L R + DI +DPW+
Sbjct: 256 PPNYAISQECKNLILQTLRQAPKRATILDIIKDPWV 291
|
|
| MGI|MGI:1918349 Tssk4 "testis-specific serine kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
Identities = 142/289 (49%), Positives = 189/289 (65%)
Query: 33 DPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID 92
D +E T SV+E +GY +G ++G GSY TV A + VA+KIISK +A D
Sbjct: 5 DTSETASATPAYRSVMEEYGYEVGKIIGHGSYGTVYEAYYTKQKVMVAVKIISKKKASED 64
Query: 93 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 152
YL KFLPREI+V+K L+H LI F QAIETT RVYII+E A+ G +LE I++ E
Sbjct: 65 YLNKFLPREIQVMKVLRHKYLINFYQAIETTSRVYIILELAQGGDVLEWIQRYGACAETL 124
Query: 153 GRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR----KYSVNNT-D 207
+WFSQ+A I Y H K +VHRD+K ENLLLD + N+K+SDFGFA+ V+++
Sbjct: 125 AGKWFSQMALGIAYLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPS 184
Query: 208 YKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
Y+Q +LS+T+CGS+AYA PEIL G+PY P SD WSMGV+L+ +V RLPFDDTN
Sbjct: 185 YRQMNSLSHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNL 244
Query: 263 SELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
+LL++ QK V FP + +S CK LI +L R + D+ +DPW+
Sbjct: 245 KKLLRETQKEVTFPANLTISQECKNLILQLLRQSTKRATILDVLRDPWM 293
|
|
| UNIPROTKB|Q9BXA7 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
Identities = 135/285 (47%), Positives = 195/285 (68%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY LG +G GSYA VK A S R +VAIKII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYLLGINLGEGSYAKVKSAYSERLKFNVAIKIIDRKKAPADFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++I+ + ET+H +VYI+ME A G LLE+I+ + ED+ R+ F QL+ AI
Sbjct: 65 AMLNHCSIIKTYEIFETSHGKVYIVMELAVQGDLLELIKTRGALHEDEARKKFHQLSLAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KC+NLLLD +NIKLSDF F+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKR-CLRDDSGRMALSKTFCGSPAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 327
CK LI ++L P V R+ +++I W++ P K++ +P V
Sbjct: 244 ECKDLIYHMLQPDVNRRLHIDEILSHCWMQ----P--KARGSPSV 282
|
|
| UNIPROTKB|Q6SA08 TSSK4 "Testis-specific serine/threonine-protein kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 134/276 (48%), Positives = 180/276 (65%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
S+++ +GY +G +G GSY +V A + VA+KIISK +A DYL KFLPREI+V+
Sbjct: 18 SLMDEYGYEVGKAIGHGSYGSVYEAFYTKQKVMVAVKIISKKKASDDYLNKFLPREIQVM 77
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
K L+H LI F +AIE+T RVYII+E A+ G +LE I++ E +WFSQL I
Sbjct: 78 KVLRHKYLINFYRAIESTSRVYIILELAQGGDVLEWIQRYGACSEPLAGKWFSQLTLGIA 137
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN-----NTDYKQ-----NLSET 215
Y H KS+VHRD+K ENLLLD N+K+SDFGFA+ N + Y+Q +LS+T
Sbjct: 138 YLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPSYRQVNCFSHLSQT 197
Query: 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275
+CGS+AYA PEIL+G+PY P SD WSMGV+L+ +V LPFDDTN +LL++ QK V F
Sbjct: 198 YCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNLKKLLRETQKEVTF 257
Query: 276 PESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 311
P + +S CK LI +L R + DI +D W+
Sbjct: 258 PANHTISQECKNLILQMLRQATKRATILDIIKDSWV 293
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 648 (233.2 bits), Expect = 1.6e-63, P = 1.6e-63
Identities = 132/282 (46%), Positives = 189/282 (67%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++I+ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLTLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 324
CK LI +L P V R+ +++I W++ + G S +A
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKAR--GLSSAA 283
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 648 (233.2 bits), Expect = 1.6e-63, P = 1.6e-63
Identities = 132/282 (46%), Positives = 189/282 (67%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++I+ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIIKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLTLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 324
CK LI +L P V R+ +++I W++ + G S +A
Sbjct: 244 ECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKAR--GLSSAA 283
|
|
| UNIPROTKB|F1RK80 TSSK1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 2.0e-63, P = 2.0e-63
Identities = 129/282 (45%), Positives = 189/282 (67%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++++ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDMDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLTLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 324
CK LI +L P V R+ ++++ W++ + G S +A
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEVLSHCWVQPKAR--GLSSAA 283
|
|
| RGD|1307352 Tssk1b "testis-specific serine kinase 1B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 2.0e-63, P = 2.0e-63
Identities = 128/270 (47%), Positives = 184/270 (68%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
+VL+ GY +G +G GSYA VK A S R +VA+KII + +AP D+L+KFLPREIE++
Sbjct: 5 AVLKRRGYIMGINLGEGSYAKVKSAYSERLKFNVAVKIIDRKKAPTDFLEKFLPREIEIL 64
Query: 106 KGLKHPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
L H ++++ + ET+ +VYI+ME G LLE I+ + ED R+ F QL+ AI
Sbjct: 65 AMLNHRSIVKTYEIFETSDGKVYIVMELGVQGDLLEFIKTRGALQEDDARKKFHQLSSAI 124
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + + LS+TFCGS AYA+
Sbjct: 125 KYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRLTLSKTFCGSAAYAA 183
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQKRVVFPESPRLSS 283
PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q + RV FP S L+
Sbjct: 184 PEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQKEHRVNFPRSKHLTG 243
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
CK LI +L P V R+ +++I W++
Sbjct: 244 ECKDLIYRMLQPDVNRRLHIDEILSHCWVQ 273
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6SA08 | TSSK4_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4724 | 0.8358 | 0.8536 | yes | N/A |
| Q9D411 | TSSK4_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4862 | 0.8358 | 0.8536 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 335 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-60 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-53 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-49 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-44 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-38 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-37 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-36 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-34 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-34 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-32 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-32 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-32 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-32 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-32 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-31 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-31 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-30 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-28 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-28 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-27 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-27 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-27 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-27 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-26 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-23 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-23 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-23 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-22 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-22 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 2e-83
Identities = 91/263 (34%), Positives = 147/263 (55%), Gaps = 13/263 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G GS+ V LA + + VAIK+I K + I ++ + REI+++K LKHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKK--IKKDRERILREIKILKKLKHPN 58
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R E ++Y++MEY + G L ++++K + ED+ R + Q+ A++Y H K +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD+K EN+LLD+ ++KL+DFG AR+ TF G+ Y +PE+L G
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT------TFVGTPEYMAPEVLLGKG 172
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKR--VVFPESPRLSSSCKALI 289
Y DIWS+GV+L+ ++ G+ PF D EL K++ K P +S K LI
Sbjct: 173 YGK-AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 290 SNILSP-VKFRIQMEDIRQDPWL 311
+L + R+ E+ Q P+
Sbjct: 232 RKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 1e-75
Identities = 82/267 (30%), Positives = 139/267 (52%), Gaps = 15/267 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L +G GS+ TV A + VA+KI+ K + REI +++ L HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R + A E +Y++MEY + G L + + + + ED+ ++ Q+ ++Y H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K EN+LLD+ +K++DFG A+K +++ TF G+ Y +PE+L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-----TFVGTPWYMAPEVLLGGN 174
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR------VVFPESPRLSSSCK 286
+ D+WS+GV+L+ ++ G+ PF N + L+ +++ P+ S K
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 287 ALISNILS--PVKFRIQMEDIRQDPWL 311
LI L+ P K R E+I Q PW
Sbjct: 235 DLIKKCLNKDPSK-RPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-60
Identities = 72/194 (37%), Positives = 118/194 (60%), Gaps = 9/194 (4%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + TV LA + + VAIKII K + L + L REIE++K L HPN+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 119 AIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
E + +Y++MEY + GSL +++ E + ED+ R Q+ + ++Y H ++HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 178 KCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
K EN+LLD D +KL+DFG ++ + + +L +T G+ AY +PE+L G Y +
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDK-----SLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 237 QSDIWSMGVVLFAM 250
+SDIWS+GV+L+ +
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-60
Identities = 80/262 (30%), Positives = 133/262 (50%), Gaps = 12/262 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G GS+ V L + +K I + L E++++K L HPN
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-NEVKILKKLNHPN 60
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCH 168
+I++ ++ E ++ I+MEYA G L + I+K+ + E++ WF QL A+ Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+ ++HRDIK +N+ L +KL DFG ++ S + D + T G+ Y SPE+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAK----TVVGTPYYLSPELC 175
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288
+ PY +SDIWS+G VL+ + + PF+ N EL ++ K P + SS + L
Sbjct: 176 QNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 289 ISNILSPV-KFRIQMEDIRQDP 309
+S++L + R + I Q P
Sbjct: 235 VSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 78/262 (29%), Positives = 140/262 (53%), Gaps = 23/262 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G GS+ V L + A+K++ K + +++ E ++ + HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL----TERNILSRINHPFIV 56
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ A +T ++Y+++EYA G L + KE E++ R + +++ A++Y H +++
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RD+K EN+LLD +IKL+DFG A++ S + TFCG+ Y +PE+L G Y
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-----TFCGTPEYLAPEVLLGKGYG 171
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL 293
D WS+GV+L+ M+ G+ PF + E+ +++ + + FPE LS + LIS +L
Sbjct: 172 K-AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF--LSPEARDLISGLL 228
Query: 294 --SPVKFRIQ---MEDIRQDPW 310
P K R+ E+I+ P+
Sbjct: 229 QKDPTK-RLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 86/282 (30%), Positives = 143/282 (50%), Gaps = 29/282 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK--FLPREIEVVKGLK- 109
+ G ++G GS++TV LA +++ AIKI+ K Q + KK ++ E EV+ L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--LIKEKKVKYVKIEKEVLTRLNG 60
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HP +I+ + +Y ++EYA NG LL+ IRK +DE R + +++ A++Y H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR------KYSVNNTDYKQNLSE--------- 214
K ++HRD+K EN+LLD +IK++DFG A+ N D S+
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-V 273
+F G+ Y SPE+L P SD+W++G +++ M+ G+ PF +N +++ K
Sbjct: 181 SFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 274 VFPESPRLSSSCKALISNIL--SPVK---FRIQMEDIRQDPW 310
FP P K LI +L P ++++ P+
Sbjct: 240 SFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 8e-49
Identities = 72/264 (27%), Positives = 135/264 (51%), Gaps = 10/264 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
++ G+++G GS+ +V LA + +A+K + + L+ REI ++ L+HPN
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-REIRILSSLQHPN 60
Query: 113 LIRFL--QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
++R+ + E + + I +EY GSL +++K + E R++ Q+ + + Y H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+VHRDIK N+L+D +KL+DFG A++ + + + + + G+ + +PE+++G
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIET-GEGTGSVRGTPYWMAPEVIRG 177
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPESP-RLSSSCKAL 288
Y +DIWS+G + M G+ P+ + L ++ PE P LS K
Sbjct: 178 EEYGR-AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 289 ISNILSP-VKFRIQMEDIRQDPWL 311
+ L K R +++ Q P+L
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-45
Identities = 84/266 (31%), Positives = 135/266 (50%), Gaps = 14/266 (5%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
G+ +G G++ V A + + +A+K I ++Q K + E++V++ LKHPNL+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 115 RFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +E HR VYI MEY G+L E++ R +DE R + QL + + Y H +
Sbjct: 63 KYY-GVEV-HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRDIK N+ LD IKL DFG A K N T + + ++ G+ AY +PE++ G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV-QSLAGTPAYMAPEVITGGK 179
Query: 233 YTPQQ--SDIWSMGVVLFAMVYGRLPFD--DTNYSELLKQVQK-RVVFPESPRLSSSCKA 287
+DIWS+G V+ M G+ P+ D + + + P+S +LS K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239
Query: 288 LISNILS--PVKFRIQMEDIRQDPWL 311
+ L P K R ++ Q P++
Sbjct: 240 FLDRCLESDPKK-RPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-44
Identities = 79/258 (30%), Positives = 131/258 (50%), Gaps = 30/258 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL------KKFLPREIEVVK 106
Y + + +G GS+ TV+ R D I V IDY K+ L E+ +++
Sbjct: 2 YEVLETIGKGSFGTVRKV---RRKSDGKIL----VWKEIDYGNMTEKEKQQLVSEVNILR 54
Query: 107 GLKHPNLIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQL 160
LKHPN++R+ I + +YI+MEY + G L ++I+K + YI+E+ R +QL
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 161 ADAIDYCH-----KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215
A+ CH +V+HRD+K N+ LD N+KL DFG A+ + + ++T
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-----ILGHDSSFAKT 169
Query: 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275
+ G+ Y SPE L + Y +SDIWS+G +++ + PF N +L ++++
Sbjct: 170 YVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228
Query: 276 PESPRLSSSCKALISNIL 293
R SS +I ++L
Sbjct: 229 RIPYRYSSELNEVIKSML 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 6e-43
Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 9/260 (3%)
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121
G+Y V LA AIK+I K + E +++ + P +++ + +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181
+Y++MEY G L ++ +DED R + +++ A++Y H ++HRD+K +N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS---ETFCGSYAYASPEILKGVPYTPQQS 238
+L+D ++KL+DFG ++ V + + G+ Y +PE++ G ++
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK-TV 182
Query: 239 DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNILSP-V 296
D WS+G +L+ + G PF E+ + + + +PE +S LIS +L P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 297 KFRIQM---EDIRQDPWLKE 313
+ R+ E+I+ P+ K
Sbjct: 243 EKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 63/226 (27%), Positives = 115/226 (50%), Gaps = 14/226 (6%)
Query: 54 SLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
+LG +G G++ V T +VA+K + K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYC 167
HPN+++ L + I+MEY G LL+ +RK + + + Q+A ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
K+ +HRD+ N L+ + +K+SDFG +R + + DY + + +PE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYKVKGGKL--PIRWMAPES 175
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 272
LK +T +SD+WS GV+L+ + G P+ + +E+L+ ++K
Sbjct: 176 LKEGKFTS-KSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG 220
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 60/235 (25%), Positives = 113/235 (48%), Gaps = 26/235 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + + +G G + V A R ++VAIK+I K+ + EI+++K KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHPN 58
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLA-------DAI 164
++++ + ++I+ME+ GSL ++++ + + E SQ+A +
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-------SQIAYVCKELLKGL 111
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
+Y H ++HRDIK N+LL +KL DFG + + S T G+ + +
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARNTMVGTPYWMA 165
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
PE++ G PY ++DIWS+G+ + G+ P+ + + L ++ P
Sbjct: 166 PEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLR 218
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 24/265 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G+G + V+L ++ A+K + K ++ + E E+++ HP +++ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ +Y++MEY G L ++R DE R + + + A +Y H + +++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
ENLLLD +KL DFGFA+K + TFCG+ Y +PEI+ Y
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTW------TFCGTPEYVAPEIILNKGYD-FSV 173
Query: 239 DIWSMGVVLFAMVYGRLPF--DDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNI 292
D WS+G++L+ ++ GR PF DD + Y+++LK K + FP + + K LI +
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-LEFP--NYIDKAAKDLIKQL 230
Query: 293 LS--PVKFRIQM-----EDIRQDPW 310
L P + R+ +DI++ W
Sbjct: 231 LRRNPEE-RLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 3e-41
Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 11/266 (4%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y + +G GS+ V LA R + VA+K+++K + REI+++ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 112 -NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY---IDEDKGRRWFSQLADAIDYC 167
N+++ + +Y++MEY GSL ++++K + E + +Q+ A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 168 HKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQN-LSETFCGSYAYASP 225
H K ++HRDIK EN+LLD +KL DFG A+ + L T G+ Y +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 226 EILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283
E+L G + Y SDIWS+G+ L+ ++ G PF+ S Q K ++ +P L+S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 284 SCKALISNILSPVKFRIQMEDIRQDP 309
++S + + + +DP
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDP 263
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 79/266 (29%), Positives = 137/266 (51%), Gaps = 20/266 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y LGD++G G++ V + VAIK IS + + LK + +EI+++K LKHPN
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPN 60
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++++ +IET+ +YII+EYA+NGSL ++I+K E + Q+ + Y H++ V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK N+L +KL+DFG A K + + D + G+ + +PE+++
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DASVVGTPYWMAPEVIEMSG 175
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--RVVFPESPRLSSSCKALIS 290
+ SDIWS+G + ++ G P+ D L + R+V + P L +
Sbjct: 176 AS-TASDIWSLGCTVIELLTGNPPYYD------LNPMAALFRIVQDDHPPLPEGISPELK 228
Query: 291 NILSP-----VKFRIQMEDIRQDPWL 311
+ L R + + + PW+
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-41
Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 21/236 (8%)
Query: 57 DVVGMGSYATVKLAT---SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+G G++ V + +VA+K + + A + K FL +E V+K L HPN+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE-DASEEERKDFL-KEARVMKKLGHPNV 58
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------QLADAI 164
+R L +Y+++EY + G LL+ +RK R + + S Q+A +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
+Y K VHRD+ N L+ + +K+SDFG +R V + DY + + + +
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKL-PIRWMA 175
Query: 225 PEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK--RVVFPE 277
PE LK +T +SD+WS GV+L+ G P+ + E+L+ ++K R+ PE
Sbjct: 176 PESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE 230
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-41
Identities = 77/246 (31%), Positives = 126/246 (51%), Gaps = 16/246 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLK--KFLPREIEVVKGLKH 110
+ +G GS+ V L + A+KI+SK A I LK + + E +++ ++H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK--AKIVKLKQVEHVLNEKRILQSIRH 60
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P L+ + + +Y++MEY G L +RK E R + +Q+ A++Y H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+V+RD+K ENLLLD IK++DFGFA K T T CG+ Y +PEI+
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFA-KRVKGRT-------YTLCGTPEYLAPEIILS 172
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKALI 289
Y + D W++G++++ M+ G PF D N ++ ++ ++ +V FP S K LI
Sbjct: 173 KGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF--FSPDAKDLI 229
Query: 290 SNILSP 295
N+L
Sbjct: 230 RNLLQV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-40
Identities = 63/225 (28%), Positives = 114/225 (50%), Gaps = 13/225 (5%)
Query: 54 SLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
+LG +G G++ V + +VA+K + K A +++FL RE +++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFL-REARIMRKLD 59
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCH 168
HPN+++ L +YI+MEY + G LL +RK R + + Q+A ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K+ +HRD+ N L+ + +K+SDFG +R + + DY + + +PE L
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGGKL--PIRWMAPESL 175
Query: 229 KGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 272
K +T +SD+WS GV+L+ + G P+ + E+L+ ++
Sbjct: 176 KEGKFTS-KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG 219
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 12/224 (5%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
LG +G G++ V T VA+K + K A + ++FL E ++K L H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFL-EEASIMKKLSH 60
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
PN++R L +YI+ EY G LL+ +RK + + Q+A ++Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
K+ VHRD+ N L+ + +K+SDFG +R + DY + + +PE LK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKRGGGKL-PIKWMAPESLK 177
Query: 230 GVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 272
+T +SD+WS GV+L+ + G P+ + E+L+ ++
Sbjct: 178 DGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 18/235 (7%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLK-KFLPREIEVVKGLKHPNLIR 115
V+G GS V + A+K I D K L RE++ ++ + P +++
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS-VVH 174
A + I++EY GSL ++++K I E Q+ +DY H K ++H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RDIK NLL++ K +K++DFG ++ + NT + N TF G+ Y SPE ++G Y
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCN---TFVGTVTYMSPERIQGESY- 177
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRVVFPESPRLSSSCK 286
+DIWS+G+ L G+ PF + EL++ + P L +
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPPPSLPAEEF 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 82/264 (31%), Positives = 145/264 (54%), Gaps = 13/264 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G GS+ + LA + S+ IK I + P+ K+ +E+ ++ +KHPN
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHPN 60
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI--DEDKGRRWFSQLADAIDYCHKK 170
++ F + + R++I+MEY G L++ I ++R + ED+ WF Q++ + + H +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 171 SVVHRDIKCENLLLDDKYNI-KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
++HRDIK +N+ L + KL DFG AR +N++ L+ T G+ Y SPEI +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDS---MELAYTCVGTPYYLSPEICQ 175
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289
PY ++DIWS+G VL+ + + PF+ N +L+ ++ + P SP S ++LI
Sbjct: 176 NRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234
Query: 290 SNI--LSPVKFRIQMEDIRQDPWL 311
S + +SP + R + I + P+L
Sbjct: 235 SQLFKVSP-RDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-38
Identities = 85/257 (33%), Positives = 131/257 (50%), Gaps = 14/257 (5%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VVG G++ V L + V IK I Q D + E +V+K L HPN+I +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYY 65
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+ + I+MEYA G+L E I+K +DED +F Q+ A+ + H K ++HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 176 DIKCENLLLDDKYNI-KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
D+K +N+LLD + K+ DFG ++ S + Y T G+ Y SPE+ +G PY
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY------TVVGTPCYISPELCEGKPYN 179
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS 294
Q+SDIW++G VL+ + + F+ N L+ ++ P S R S + LI ++L+
Sbjct: 180 -QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238
Query: 295 --PVKFRIQMEDIRQDP 309
P K R Q+ I P
Sbjct: 239 LDPSK-RPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 6e-37
Identities = 85/287 (29%), Positives = 144/287 (50%), Gaps = 18/287 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDV-AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+VG G + V++ + + D+ A+K++ K F E +++ P + +
Sbjct: 8 LVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
A + +Y++MEY G LL ++ R E DED + + ++L AI H+ VHR
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
DIK EN+L+D +IKL+DFG A + + N K S+ G+ Y +PE+L +
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTAN----KMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 236 QQS-----DIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKA 287
+ + D WS+GV+ + M+YGR PF + ++ + Q+ + FPE P++SS
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242
Query: 288 LISNILSPVKFRIQMEDIRQDPWLKE-DSNPVGKSKSAPEVIPFKKS 333
LI ++L K R+ E + P+ + D N + S P +P KS
Sbjct: 243 LIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKS 287
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 77/239 (32%), Positives = 130/239 (54%), Gaps = 13/239 (5%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
++G G++ V L + A+KI+ K V D + L E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTAL 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +T R+ +MEYA G L + +ER ED+ R + +++ A+ Y H VV+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 177 IKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
+K ENL+LD +IK++DFG ++ S T +TFCG+ Y +PE+L+ Y
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGAT------MKTFCGTPEYLAPEVLEDNDYG- 173
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL 293
+ D W +GVV++ M+ GRLPF + ++ +L + + + + FP LS K+L++ +L
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 76/238 (31%), Positives = 131/238 (55%), Gaps = 11/238 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
++G G++ V L + A+KI+ K V D + + E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTAL 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A +T R+ +MEYA G L + +ER E++ R + +++ A++Y H + VV+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK ENL+LD +IK++DFG ++ + K TFCG+ Y +PE+L+ Y +
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMK-----TFCGTPEYLAPEVLEDNDYG-R 174
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL 293
D W +GVV++ M+ GRLPF + ++ L + + + + FP + LS K+L++ +L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 51/296 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y + +G G+Y V A + + VA+K I +D ++ +P REI ++K L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
KHPN+++ L I T ++Y++ EY L+ + + + QL + Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAY 113
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
CH ++HRD+K +N+L++ +KL+DFG AR + + Y T Y +PE
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-VVTLW----YRAPE 168
Query: 227 ILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPF-------------------DDTNYSELL 266
IL G Y+ DIWS+G + M+ G+ F + ++ +
Sbjct: 169 ILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227
Query: 267 KQVQKRVVFPES---------PRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 311
K + FP+ PRL L+S +L P K RI ++ + P+
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 74/264 (28%), Positives = 130/264 (49%), Gaps = 16/264 (6%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
+ + +G GSY +V +Q A+K + + + ++ EI ++ + HP
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYC 167
N+I + +A +++ I+MEYA G L + I K + I E + R F QL +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H++ ++HRD+K N+LL +K+ D G ++ K+N+++T G+ Y +PE+
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV-------LKKNMAKTQIGTPHYMAPEV 172
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287
KG PY+ +SDIWS+G +L+ M PF+ + +L +VQ+ P P S +
Sbjct: 173 WKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231
Query: 288 LISNIL--SPVKFRIQMEDIRQDP 309
I ++L P R + I P
Sbjct: 232 FIRSMLQVKPKL-RPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 80/298 (26%), Positives = 144/298 (48%), Gaps = 49/298 (16%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDV-AIKIISKVQAPIDYLKK----FLPREIEVVKG 107
+ + V+G G++ V L + + V A+K++ K D +K+ + E +++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRD-KDTGQVYAMKVLRKS----DMIKRNQIAHVRAERDILAD 57
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDY 166
P +++ + + +Y++MEY G L+ +IRK+ E+ R + ++L A+D
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDS 116
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-SVNNTDYKQN-------------- 211
HK +HRDIK +N+L+D +IKL+DFG +K + +Y N
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 212 ---------LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
+ + G+ Y +PE+L+G PY + D WS+GV+L+ M+YG PF Y
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPF----Y 231
Query: 263 SELLKQVQKRV-------VFPESPRLSSSCKALISNILSPVKFRI-QMEDIRQDPWLK 312
S+ L++ ++ FP P +S LI +L + R+ E+I+ P+ K
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 80/294 (27%), Positives = 147/294 (50%), Gaps = 33/294 (11%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK--------VQAPIDYLKKF-LPREIEVVKGL 108
V+G GS+ V LA + A+K++ K V+ + + L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-------- 53
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
KHP L + +T R++ +MEY G L+ I++ DE + R + +++ + + H
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
++ +++RD+K +N+LLD + +IK++DFG ++ + + TFCG+ Y +PEIL
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-----VTTSTFCGTPDYIAPEIL 168
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKA 287
PY P D W++GV+L+ M+ G+ PF+ + EL + + + V +P LS K+
Sbjct: 169 SYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW--LSKEAKS 225
Query: 288 LISNILS--PVK----FRIQMEDIRQDPWLKE-DSNPVGKSKSAPEVIPFKKSR 334
++ + L+ P K +DI+ P+ +E D + + + + P P K R
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGR 279
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 77/238 (32%), Positives = 131/238 (55%), Gaps = 11/238 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
++G G++ V L + A+KI+ K V D + L E V+K +HP L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSL 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +T R+ +MEY G L + +ER ED+ R + +++ A+DY H +V+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K ENL+LD +IK++DFG ++ + K TFCG+ Y +PE+L+ Y +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMK-----TFCGTPEYLAPEVLEDNDYG-R 174
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL 293
D W +GVV++ M+ GRLPF + ++ +L + + + + FP + LS+ K+L+S +L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT--LSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 75/239 (31%), Positives = 125/239 (52%), Gaps = 13/239 (5%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKII--SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G GS+ L S + IK I SK+ ++ +E+ V+ +KHPN++++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQY 64
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYI--DEDKGRRWFSQLADAIDYCHKKSVVH 174
++ E +YI+M+Y + G L + I +R + ED+ WF Q+ A+ + H + ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RDIK +N+ L IKL DFG AR +N+T L+ T G+ Y SPEI + PY
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIAR--VLNST---VELARTCIGTPYYLSPEICENRPYN 179
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293
+SDIW++G VL+ M + F+ N L+ ++ + P S S + L+S +
Sbjct: 180 -NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VVG G+Y V + + VAIK K + +KK RE++V++ L+H N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+A R+Y++ EY + +LLE++ + D R + QL AI YCH +++HRD
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPEILKG-V 231
IK EN+L+ + +KL DFGFAR Y Y +PE+L G
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRARPASP--------LTDYVATRWYRAPELLVGDT 177
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
Y D+W++G ++ ++ G F + + L +QK
Sbjct: 178 NYGK-PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 72/248 (29%), Positives = 130/248 (52%), Gaps = 10/248 (4%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIK--IISKVQAPIDYLKK----FLPREIEVVKGLK 109
G ++G GS+ +V L +A + +A+K + V A K+ L REI ++K L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
H N++++L + + I +EY GS+ ++ +E R + Q+ ++Y H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-TFCGSYAYASPEIL 228
+ ++HRDIK N+L+D+K IK+SDFG ++K N+ K N + + GS + +PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP-RLSSSCKA 287
K YT ++DIWS+G ++ M+ G+ PF D + + ++ + PE P +SS
Sbjct: 185 KQTSYTR-KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS-PEIPSNISSEAID 242
Query: 288 LISNILSP 295
+
Sbjct: 243 FLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-33
Identities = 70/212 (33%), Positives = 112/212 (52%), Gaps = 16/212 (7%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWF 157
E V+ L +IR+ ++ ++ I+MEYA+NG L ++++ + R + ED+ R+F
Sbjct: 48 DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF 107
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
Q+ + + H K ++HRDIK NL LD N+K+ D G A+ S N N + T
Sbjct: 108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-----NFANTIV 162
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 277
G+ Y SPE+ + PY ++SD+W++GVVL+ G+ PFD N L+ ++ + V P
Sbjct: 163 GTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221
Query: 278 SPRLSSSCKALISNILSPVKFRIQMEDIRQDP 309
S S LI L+ +D RQ P
Sbjct: 222 SQMYSQQLAQLIDQCLT--------KDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 72/245 (29%), Positives = 127/245 (51%), Gaps = 23/245 (9%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR-------EIEVVKGLKH 110
V+G G++ AT R ++D ++ + +V L + + EI ++ L+H
Sbjct: 7 VLGKGAFGE---ATLYRRTEDDSLVVWKEVN-----LTRLSEKERRDALNEIVILSLLQH 58
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKGRRWFSQLADAIDYCH 168
PN+I + + + I MEYA G+L + I +K + +E+ + Q+ A+ Y H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K ++HRDIK N+ L IKL DFG ++ ++Y +++ET G+ Y SPE+
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEY--SMAETVVGTPYYMSPELC 173
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288
+GV Y +SDIW++G VL+ ++ + FD TN L+ ++ + P SS +L
Sbjct: 174 QGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISL 232
Query: 289 ISNIL 293
+ ++L
Sbjct: 233 VHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 69/222 (31%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGLKHPNLI 114
+G G+Y V A + + + VA+K I PI + REI++++ L+HPN++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-----REIKLLQKLRHPNIV 61
Query: 115 RFLQAIETTHR---VYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
R L+ I T+ +Y++ EY + LL+ E E + + + QL + + Y H
Sbjct: 62 R-LKEIVTSKGKGSIYMVFEYMDHDLTGLLD--SPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-SVNNTDYKQNLSETFCGSYAYASPEIL 228
++HRDIK N+L+++ +KL+DFG AR Y N+ DY N T Y PE+L
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRVITLW----YRPPELL 173
Query: 229 KG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
G Y P + D+WS+G +L + G+ F + E L+++
Sbjct: 174 LGATRYGP-EVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 72/237 (30%), Positives = 129/237 (54%), Gaps = 8/237 (3%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRF 116
V+G GS+ V LA + A+K++ K +K + E V+ K +KHP L+
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +T ++Y +++Y G L +++ER E + R + +++A A+ Y H ++V+RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K EN+LLD + +I L+DFG ++ +N + TFCG+ Y +PE+L PY +
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHN-----GTTSTFCGTPEYLAPEVLHKQPYD-R 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293
D W +G VL+ M+YG PF N +E+ + + + P +++S + L+ +L
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 69/221 (31%), Positives = 120/221 (54%), Gaps = 8/221 (3%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G GS+ V LA + A+K++ K V D ++ + + + HP L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R++ +ME+ G L+ I+K R DE + R + +++ A+ + H K +++RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD + + KL+DFG ++ N + TFCG+ Y +PEIL+ + Y P
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGK-----TTSTFCGTPDYIAPEILQEMLYGP- 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFP 276
D W+MGV+L+ M+ G PF+ N +L + + VV+P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 73/241 (30%), Positives = 132/241 (54%), Gaps = 16/241 (6%)
Query: 58 VVGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNL 113
V+G GS+ V LA +H D A+K++ K +K + E V +K +KHP L
Sbjct: 2 VIGKGSFGKVLLA---KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+ + +T ++Y +++Y G L +++ER E + R + +++A A+ Y H +++
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
+RD+K EN+LLD + ++ L+DFG ++ ++ + S TFCG+ Y +PE+L+ PY
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE----GIEHSKTTS-TFCGTPEYLAPEVLRKQPY 173
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNI 292
+ D W +G VL+ M+YG PF + +E+ + K + P +S S + L+ +
Sbjct: 174 D-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGL 230
Query: 293 L 293
L
Sbjct: 231 L 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 74/236 (31%), Positives = 130/236 (55%), Gaps = 19/236 (8%)
Query: 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF--LPRE 101
KLS E +G+ +G GS+ V++A + AIK + K + I +K+ + +E
Sbjct: 16 KLSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE--ILKMKQVQHVAQE 68
Query: 102 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLA 161
++ L HP ++ + + + +RVY ++E+ G L +RK D + + ++L
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
A +Y H K +++RD+K ENLLLD+K ++K++DFGFA+K V + + T CG+
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK--VPDRTF------TLCGTPE 180
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVVFP 276
Y +PE+++ + + D W+MGV+L+ + G PF DDT + K + R+ FP
Sbjct: 181 YLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 67/233 (28%), Positives = 118/233 (50%), Gaps = 17/233 (7%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-YLKKFLPREIEVVKGLKHPNLIR 115
+G G+ V + +A+K I + I+ ++K + RE++++ P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKK-SV 172
F A + I MEY GSL + I KE I E + + + Y H+K +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+L++ + IKL DFG + + VN +L++TF G+ +Y +PE ++G
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN------SLAKTFVGTSSYMAPERIQGND 175
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPESPRLSSS 284
Y+ +SDIWS+G+ L + GR P+ N + + ++ + +V PRL S
Sbjct: 176 YS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 73/244 (29%), Positives = 122/244 (50%), Gaps = 12/244 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR-EIEVVKGLKHP 111
Y++ VVG GS+ L Q A+K +++ P R E ++ +KHP
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMK---EIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHK 169
N++ F ++ E +YI+MEY G L++ I+ +R ED +WF Q+ + + H+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
K V+HRDIK +N+ L +KL DFG AR + + T+ G+ Y PEI +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-----SPGAYACTYVGTPYYVPPEIWE 173
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289
+PY +SDIWS+G +L+ + + PF ++ L+ +V + P S ++LI
Sbjct: 174 NMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232
Query: 290 SNIL 293
+
Sbjct: 233 KQMF 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 10/206 (4%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIIS-KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G+Y V A + VAIK I + ++ K REI+++K L HPN+I+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGI--PKTALREIKLLKELNHPNIIKLL 64
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+Y++ E+ L ++I+ + + E + + QL + +CH ++HRD
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K ENLL++ + +KL+DFG AR + Y + + Y +PE+L G
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPELLLGDKGYST 178
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNY 262
DIWS+G + ++ R F +
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-32
Identities = 79/239 (33%), Positives = 134/239 (56%), Gaps = 12/239 (5%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
++G G++ V L + A+KI+ K V D + L E V++ +HP L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTAL 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-KKSVVHR 175
+ +T R+ +MEYA G L + +ER ED+ R + +++ A+DY H +K+VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+K ENL+LD +IK++DFG ++ + K TFCG+ Y +PE+L+ Y
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-----TFCGTPEYLAPEVLEDNDYG- 174
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL 293
+ D W +GVV++ M+ GRLPF + ++ +L + + + + FP + LS K+L+S +L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLSGLL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 67/262 (25%), Positives = 128/262 (48%), Gaps = 24/262 (9%)
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF----LPREIEVVKGLKHPNLIRFL 117
G++ +V LA AIK++ K + + + R I +++G P + +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQGES-PYVAKLY 63
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
+ ++ +Y++MEY G +I+ + ED +++ +++ ++ H++ ++HRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
K ENLL+D ++KL+DFG +R N + F G+ Y +PE + GV +
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLEN---------KKFVGTPDYLAPETILGVGDD-KM 173
Query: 238 SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKA--LISNILS 294
SD WS+G V+F ++G PF + + R + +PE + S +A LI+ +L
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233
Query: 295 P-VKFRIQ---MEDIRQDPWLK 312
R+ ++I+ P+ K
Sbjct: 234 MDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 68/221 (30%), Positives = 121/221 (54%), Gaps = 8/221 (3%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G GS+ V LA + AIK++ K V D + + + + KHP L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R++ +MEY G L+ I++ R DE + R + +++ A+ + H+ V++RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD + + KL+DFG ++ +N + TFCG+ Y +PEIL+ + Y P
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNG-----VTTTTFCGTPDYIAPEILQELEYGP- 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFP 276
D W++GV+++ M+ G+ PF+ N +L + + V++P
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 9/241 (3%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLK--KFLPREIEVVKGLKHPNL 113
G+++G GS+ +V + A+K +S + K L +EI ++ L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+++L +YI +E GSL ++++K E R + Q+ ++Y H ++ V
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRDIK N+L+D +KL+DFG A++ + + +++F GS + +PE++
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVV------EFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP-RLSSSCKALISNI 292
+DIWS+G + M G+ P+ + ++ + P P LS K I
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 293 L 293
L
Sbjct: 239 L 239
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 65/214 (30%), Positives = 120/214 (56%), Gaps = 9/214 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRF 116
V+G GS+ V LA + A+K++ K +K + E V+ K +KHP L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +TT ++Y ++++ G L +++ER E + R + +++A A+ Y H ++V+RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
+K EN+LLD + ++ L+DFG ++ + ++T + TFCG+ Y +PE+++ PY
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDT------TTTFCGTPEYLAPEVIRKQPYD- 174
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
D W +G VL+ M+YG PF + +E+ +
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 67/234 (28%), Positives = 123/234 (52%), Gaps = 7/234 (2%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRF 116
V+G GS+ V LA A+K++ K + + E V+ K LKHP L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +T ++Y +++Y G L +++ER E + R + +++A AI Y H ++++RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K EN+LLD + ++ L+DFG ++ + + TFCG+ Y +PE+L+ PY +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGV-----EPEETTSTFCGTPEYLAPEVLRKEPYD-R 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290
D W +G VL+ M+YG PF + S++ + + + + ++C L+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVG 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 83/289 (28%), Positives = 138/289 (47%), Gaps = 39/289 (13%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK--FLPREIEVVKGLKHPNLIRF 116
VG G++ V L A+K+++ + I LK+ + E V+K + HP +IR
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMA-IPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+Y++MEY G L +R G + S++ A++Y H K +V+RD
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL------KG 230
+K EN+LLD + +IKL+DFGFA+K + + T CG+ Y +PE++ K
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAKKLR--------DRTWTLCGTPEYLAPEVIQSKGHNKA 178
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKALI 289
V D W++G++++ M+ G PF D N + K + ++ FP L K LI
Sbjct: 179 V-------DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLI 229
Query: 290 SNILSPVKFRIQ--------MEDIRQDPWLKE-DSNPVGKSKSAPEVIP 329
+L V R + +D++ W K D + V + K P ++P
Sbjct: 230 KKLL--VVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 72/232 (31%), Positives = 128/232 (55%), Gaps = 17/232 (7%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK-GLKHPNLIRF 116
V+G GSYA V L + + A+K+I K D ++ E V + HP L+
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R++ ++E+ G L+ ++++R + E+ R + ++++ A+++ H++ +++RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD + +IKL+D+G K + D + TFCG+ Y +PEIL+G Y
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMC-KEGIRPGD----TTSTFCGTPNYIAPEILRGEDYG-F 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFD--------DTNYSELLKQV--QKRVVFPES 278
D W++GV++F M+ GR PFD D N + L QV +K++ P S
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS 227
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 72/236 (30%), Positives = 131/236 (55%), Gaps = 15/236 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRF 116
V+G GSYA V L ++ Q A+K++ K D ++ E V + +P L+
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+TT R+++++EY G L+ ++++R + E+ R + +++ A+++ H++ +++RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD +IKL+D+G ++ + D + TFCG+ Y +PEIL+G Y
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKE-GLGPGD----TTSTFCGTPNYIAPEILRGEEYG-F 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFD------DTNYSELLKQV--QKRVVFPESPRLSSS 284
D W++GV++F M+ GR PFD D N + L QV +K + P + +S
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS 231
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 60/271 (22%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK----FLPREIEVVKG 107
+ L V+G G++ V + + A+K ++K ++K + E +++
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ----KCVEKGSVRNVLNERRILQE 56
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
L HP L+ + + +Y++++ G L + ++ E++ + W ++ A++Y
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H K ++HRDIK +N+LLD++ ++ ++DF A K + L+ + G+ Y +PE+
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT------PDTLTTSTSGTPGYMAPEV 170
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF---DDTNYSELL-KQVQKRVVFPESPRLSS 283
L Y+ D WS+GV + + G+ P+ T ++ KQ V++P S+
Sbjct: 171 LCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--ATWST 227
Query: 284 SCKALISNILSP---VKFRIQMEDIRQDPWL 311
I+ +L + ++D++ P+
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 80/262 (30%), Positives = 132/262 (50%), Gaps = 16/262 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
V+G GS+ V LA ++ AIK + K V D + R + + +HP L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLTH 60
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+T ++ +MEY G L+ I+ DE + R + +++ + + HKK +++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+K +N+LLD +IK++DFG ++ + + TFCG+ Y +PEILKG Y
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKE-----NMNGEGKASTFCGTPDYIAPEILKGQKYN- 174
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR-LSSSCKALISNIL- 293
+ D WS GV+L+ M+ G+ PF + EL + P PR +S K +S +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWISKEAKDCLSKLFE 232
Query: 294 -SPVKFRIQME-DIRQDPWLKE 313
P K R+ ++ DIRQ P+ +
Sbjct: 233 RDPTK-RLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 72/232 (31%), Positives = 129/232 (55%), Gaps = 17/232 (7%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRF 116
V+G GSYA V L + + A+K++ K D ++ E V + HP L+
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R++ ++EY G L+ ++++R + E+ R + ++++ A++Y H++ +++RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD + +IKL+D+G ++ + D + TFCG+ Y +PEIL+G Y
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD----TTSTFCGTPNYIAPEILRGEDYG-F 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFD--------DTNYSELLKQV--QKRVVFPES 278
D W++GV++F M+ GR PFD D N + L QV +K++ P S
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 76/263 (28%), Positives = 135/263 (51%), Gaps = 13/263 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ + +G G+ TV A Q+VAIK ++ Q P K+ + EI V++ KHPN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPN 77
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +L + ++++MEY GSL +V+ E +DE + + A+++ H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESPRLSSSCKALIS 290
Y P + DIWS+G++ MV G P+ + N + L +LS+ + ++
Sbjct: 192 YGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250
Query: 291 NILS-PVKFRIQMEDIRQDPWLK 312
L V+ R +++ Q P+LK
Sbjct: 251 RCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 57/208 (27%), Positives = 112/208 (53%), Gaps = 12/208 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + + +G GSY +V A Q VAIK++ V+ + + K EI ++K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIK----EISILKQCDSPY 59
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKS 171
++++ + ++I+MEY GS+ ++++ + + E++ Q ++Y H
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRDIK N+LL+++ KL+DFG + + + +T K+N T G+ + +PE+++ +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRN---TVIGTPFWMAPEVIQEI 174
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
Y ++DIWS+G+ M G+ P+ D
Sbjct: 175 GYN-NKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-28
Identities = 72/229 (31%), Positives = 123/229 (53%), Gaps = 15/229 (6%)
Query: 38 DKDTERKLSVLETHG-----YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID 92
D++ KL + + G Y+ + +G G+ TV A Q+VAIK I+ + P
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-- 58
Query: 93 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 152
K+ + EI V+K LK+PN++ FL + ++++MEY GSL +V+ E +DE +
Sbjct: 59 -KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQ 116
Query: 153 GRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
+ A+++ H V+HRDIK +N+LL ++KL+DFGF + + +Q+
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-----EQSK 171
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
T G+ + +PE++ Y P + DIWS+G++ MV G P+ + N
Sbjct: 172 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 73/238 (30%), Positives = 135/238 (56%), Gaps = 15/238 (6%)
Query: 58 VVGMGSYATVKLA---TSARHSQDVAIKIISKVQAPI-DYLKKFLPREIEVVKGLKHPNL 113
V+G GS+ V L T Q A+K++ K + D ++ + R+I + HP +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVNHPFI 60
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
++ A +T ++Y+I+++ + G L + KE E+ + + ++LA A+D+ H ++
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
+RD+K EN+LLD++ +IKL+DFG + K S+++ + + +FCG+ Y +PE++ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS-KESIDH----EKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPE--SPRLSSSCKAL 288
T Q +D WS GV++F M+ G LPF + E + + K ++ P+ SP S +AL
Sbjct: 176 T-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRAL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 54/208 (25%), Positives = 108/208 (51%), Gaps = 6/208 (2%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L +V+G+G+ A V A +++ VAIK I + L +E++ + HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNHPN 60
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR---KERYIDEDKGRRWFSQLADAIDYCHK 169
++++ + ++++M Y GSLL++++ +DE ++ ++Y H
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+HRDIK N+LL + ++K++DFG + + + D + + +TF G+ + +PE+++
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLA-DGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
V ++DIWS G+ + G P+
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 69/271 (25%), Positives = 129/271 (47%), Gaps = 28/271 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G G+ V AT ++VAIK + + + + EI ++K KHPN
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPN 76
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLA-------DAI 164
++ + + ++++MEY GSL ++I ++E Q+A +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-------PQIAYVCREVLQGL 129
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
+Y H ++V+HRDIK +N+LL ++KL+DFGFA + + +++ + G+ + +
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-----EKSKRNSVVGTPYWMA 184
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLS 282
PE++K Y P + DIWS+G++ M G P+ L + + + + S
Sbjct: 185 PEVIKRKDYGP-KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS 243
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLK 312
K ++ L + R E++ Q P+LK
Sbjct: 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 28/247 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIK-IISKVQAPIDYLKKFLPREIEVVKGLK-H 110
Y + +G G++ +V LA + + VAIK + K + + + RE++ ++ L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEH 57
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKGRRWFSQLADAIDYCH 168
PN+++ + +Y + EY G+L +++ RK + E R Q+ + + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN----TDYKQNLSETFCGSYAYAS 224
K HRD+K ENLL+ +K++DFG AR + + TDY + Y +
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDY--------VSTRWYRA 166
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQ-----KRVVFPES 278
PEIL DIW++G ++ + R F ++ +L K + +PE
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 279 PRLSSSC 285
+L+S
Sbjct: 227 YKLASKL 233
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 59 VGMGSYATVKLATSARHSQDVAIK-IISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G GSY V + Q VAIK + P+ +KK REI ++K LKHPNL+ +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNLI 66
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
+ +++++ EY + L E+ + R + E ++ Q A+++CHK + +HRD+
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG-VPYTPQ 236
K EN+L+ + IKL DFGFAR + DY + + Y +PE+L G Y P
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTD-----YVATRWYRAPELLVGDTQYGP- 180
Query: 237 QSDIWSMGVVLFAMVYG 253
D+W++G V ++ G
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 80/282 (28%), Positives = 141/282 (50%), Gaps = 17/282 (6%)
Query: 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI 102
RKL ++ Y + V+G G++ V+L + A+K++SK + F E
Sbjct: 36 RKLQ-MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 103 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLAD 162
+++ P +++ A + +Y++MEY G L+ ++ + E + + +++
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVL 153
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
A+D H ++HRD+K +N+LLD ++KL+DFG K +T G+ Y
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR----CDTAVGTPDY 209
Query: 223 ASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYSELLKQVQKRVVF 275
SPE+LK G Y ++ D WS+GV LF M+ G PF D+ YS+++ + + F
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH-KNSLNF 268
Query: 276 PESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 314
PE +S K LI L+ + R+ +E+I+Q P+ K D
Sbjct: 269 PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 69/233 (29%), Positives = 115/233 (49%), Gaps = 22/233 (9%)
Query: 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKII-----SKVQAPIDYLKKFLPREIEV 104
+ + +G G ++ V A + VA+K + +A D LK EI++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-----EIDL 55
Query: 105 VKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQL 160
+K L HPN+I++L + + + I++E A G L +I+ +R I E ++F QL
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
A+++ H K ++HRDIK N+ + +KL D G R +S T + + G+
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-----AHSLVGTP 170
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQK 271
Y SPE + Y +SDIWS+G +L+ M + PF D N L K+++K
Sbjct: 171 YYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
LG+ G GS +L A+K I+ P L+K + RE+E+ K K P +
Sbjct: 8 RLGEGAG-GSVTKCRLK---NTGMIFALKTITT--DPNPDLQKQILRELEINKSCKSPYI 61
Query: 114 IRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI----DYC 167
+++ A E++ + I MEY + GSL + +K + G + ++A+++ Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H + ++HRDIK N+LL K +KL DFG + + VN +L+ TF G+ Y +PE
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VN------SLAGTFTGTSFYMAPER 174
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
++G PY+ SD+WS+G+ L + R PF
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 75/291 (25%), Positives = 133/291 (45%), Gaps = 41/291 (14%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQA-PIDYLKKFLPREIEVVKGLKHPNLIRF 116
++G G V L + A+K++ K + + +K+ L E E++ L HP L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPTL 66
Query: 117 LQAIETTHRVYIIMEYAKNG---SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+ +T + ++M+Y G LL+ + + + E+ R + +++ A++Y H +V
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 174 HRDIKCENLLLDDKYNIKLSDF----------GFARKYSVNNTDYKQNLSET-------- 215
+RD+K EN+LL + +I LSDF K + S
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 216 ------FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
F G+ Y +PE++ G + D W++G++L+ M+YG PF +N E +
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244
Query: 270 QKR-VVFPESPRLSSSCKALISNILSPVK-------FRIQMEDIRQDPWLK 312
K+ V FP SP +SSS + LI +L VK + +I+Q P+ +
Sbjct: 245 LKKEVTFPGSPPVSSSARDLIRKLL--VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 77/274 (28%), Positives = 139/274 (50%), Gaps = 33/274 (12%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH---PNL 113
+++G G+Y V + VA+KII+ + P D + + RE+ ++ L+ PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSD-IQREVALLSQLRQSQPPNI 64
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHK 169
++ + R++IIMEYA+ GS+ +++ E+YI ++ A+ Y HK
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYIHK 119
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
V+HRDIK N+L+ + N+KL DFG A +N K++ TF G+ + +PE++
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAA--LLNQNSSKRS---TFVGTPYWMAPEVIT 174
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--PRL-----S 282
Y ++DIWS+G+ ++ M G P+ D + + + + P+S PRL S
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDV---DAFRAMM---LIPKSKPPRLEDNGYS 228
Query: 283 SSCKALISNILSPV-KFRIQMEDIRQDPWLKEDS 315
+ ++ L K R+ E++ + W+K S
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 9/220 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L +G G+Y V A R + VAIK IS V + K+ L REI++++ L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHEN 60
Query: 113 LIRFL-----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+I L + E + VYI+ E + L +VI+ + + +D + + Q+ + Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H +V+HRD+K N+L++ ++K+ DFG AR + D K L+E + Y +PE+
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARG-VDPDEDEKGFLTEYVVTRW-YRAPEL 177
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
L + DIWS+G + ++ + F +Y + L
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 61/220 (27%), Positives = 111/220 (50%), Gaps = 18/220 (8%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
LG +G G + V L Q VA+K + FL E V+ L+HPNL+
Sbjct: 10 LGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQ---AFLA-EASVMTTLRHPNLV 63
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFS-QLADAIDYCHKKSV 172
+ L + + +YI+ EY GSL++ +R + R + + F+ + + ++Y +K+
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD+ N+L+ + K+SDFG A++ S K + T +PE L+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------APEALREKK 175
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+WS G++L+ + +GR+P+ +++ V+K
Sbjct: 176 FS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 13/213 (6%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIK-------IISKVQAPIDYLKKFLPREIEVVKGL 108
G+++G G+Y V LA + + +A+K I + + + K L EIE +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
H N++++L T + I +EY GS+ +R +E R + Q+ + + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI- 227
K ++HRD+K +NLL+D K+SDFG ++K S + D QN+S GS + +PE+
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQ--GSVFWMAPEVI 182
Query: 228 -LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
Y+ + DIWS+G V+ M GR P+ D
Sbjct: 183 HSYSQGYS-AKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 67/237 (28%), Positives = 123/237 (51%), Gaps = 9/237 (3%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS+ V + A+K I K E V+ + P ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ ++ ++Y+++ + G L +++E D + R + ++L A++ HK +V++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
EN+LLD + +I L DFG K ++ + D + TFCG+ Y +PE+L G YT +
Sbjct: 121 PENILLDYQGHIALCDFGLC-KLNMKDDDK----TNTFCGTPEYLAPELLLGHGYT-KAV 174
Query: 239 DIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNILS 294
D W++GV+L+ M+ G PF D N +E+ +++ Q+ + FP+ K L+ +LS
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG--FDRDAKDLLIGLLS 229
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-YLKKFLPREIEVVKGLKHPNLIRF 116
+VG GSY V Q VAIK +++ D +KK REI ++K L+H NL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
++ R+Y++ E+ + L ++ + +DE + R++ Q+ I++CH +++HRD
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK EN+L+ +KL DFGFAR + Y + + Y +PE+L G +
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD-----YVATRWYRAPELLVGDTKYGR 180
Query: 237 QSDIWSMGVVLFAMVYG 253
DIW++G ++ M+ G
Sbjct: 181 AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 75/265 (28%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VG G Y V LA + VA+K + K + ++ ++ L E +++ K L++ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL-TERDILTTTKSEWLVKLL 67
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
A + +Y+ MEY G ++ + ED R + +++ +A+D H+ +HRD+
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
K EN L+D +IKL+DFG ++ + + GS Y +PE+L+G Y
Sbjct: 128 KPENFLIDASGHIKLTDFGLSKGIV--------TYANSVVGSPDYMAPEVLRGKGYD-FT 178
Query: 238 SDIWSMGVVLFAMVYGRLPFDDTNYSELL------KQVQKRVVFPESPRLSSSCKA--LI 289
D WS+G +L+ + G PF + +E K+ +R V+ + PR + S +A LI
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY-DDPRFNLSDEAWDLI 237
Query: 290 SNILSPVKFRIQ-MEDIRQDPWLKE 313
+ +++ R +EDI+ P+ KE
Sbjct: 238 TKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ + +G G+ TV A Q+VAIK ++ Q P K+ + EI V++ K+PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPN 77
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +L + ++++MEY GSL +V+ E +DE + + A+D+ H V
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ + +PE++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALI 289
Y P + DIWS+G++ MV G P+ + N L + PE RLS+ + +
Sbjct: 192 YGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAVFRDFL 249
Query: 290 SNILS-PVKFRIQMEDIRQDPWLK 312
+ L V R +++ Q P+LK
Sbjct: 250 NRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 57/233 (24%), Positives = 113/233 (48%), Gaps = 6/233 (2%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQ---APIDYLKKFLPREIEVVKGLKHPN 112
G +G G++++ A + +A+K ++ V+ + + + + L +EI ++ L HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+IR L A + +E+ GS+ ++ K E + QL + Y H+ +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 173 VHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD+K NLL+D ++++DFG A + + T + G+ A+ +PE+L+G
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE-FQGQLLGTIAFMAPEVLRGE 183
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
Y + D+WS+G V+ M + P++ +S L + K +P +
Sbjct: 184 QYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G+Y V + + Q VA+K I ++++ + + REI ++K L+HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 119 AIETTHRVYIIMEYAKNG--SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ R+Y+I E+ L+ + K +Y+D + + + Q+ I +CH + V+HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +NLL+D+K IKL+DFG AR + + Y + + Y +PE+L G P
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-----YRAPEVLLGSPRYST 181
Query: 237 QSDIWSMGVVLFAMV 251
DIWS+G + M
Sbjct: 182 PVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 76/271 (28%), Positives = 135/271 (49%), Gaps = 24/271 (8%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK----FLPREIEVVKGLKHPNL 113
V+G G++ V+L Q A+K++SK + +K+ F E +++ +
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSK----FEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
++ A + +Y++MEY G L+ ++ I E R + +++ A+D H +
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK---G 230
HRD+K +N+LLD ++KL+DFG K N +T G+ Y SPE+LK G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAVGTPDYISPEVLKSQGG 220
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYSELLKQVQKRVVFPESPRLSSSCK 286
Y ++ D WS+GV L+ M+ G PF D+ YS+++ + + FP+ +S K
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KNSLTFPDDIEISKQAK 279
Query: 287 ALISNILSPVKFRI---QMEDIRQDPWLKED 314
LI L+ + R+ +++I+ P+ K D
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII--SKVQAPIDYLKKFLPREIEVVKGLKH 110
Y G +G G+YA V A + VAIK I + + D + REI++++ LKH
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG--RRWFSQLADAIDYCH 168
PN+I L + ++ E+ + LE + K++ I + + ++Y H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM--ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
++HRD+K NLL+ +KL+DFG AR + N + + Y +PE+L
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELL 174
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
G + D+WS+G + FA + R+PF
Sbjct: 175 FGARHYGVGVDMWSVGCI-FAELLLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 73/275 (26%), Positives = 136/275 (49%), Gaps = 30/275 (10%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
LGD G++ V A A KII ++++ + L+ F+ EI+++ KHPN++
Sbjct: 13 LGD----GAFGKVYKAQHKETGLFAAAKII-QIESE-EELEDFMV-EIDILSECKHPNIV 65
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+A ++++I++E+ G+L ++ + ER + E + R Q+ +A+++ H V+
Sbjct: 66 GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL----- 228
HRD+K N+LL ++KL+DFG + K N Q TF G+ + +PE++
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAK----NKSTLQKRD-TFIGTPYWMAPEVVACETF 180
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK-- 286
K PY ++DIWS+G+ L + P + N +L ++ K E P L K
Sbjct: 181 KDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS----EPPTLDQPSKWS 235
Query: 287 -----ALISNILSPVKFRIQMEDIRQDPWLKEDSN 316
L S ++ R ++ + P++ + S+
Sbjct: 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 67/268 (25%), Positives = 131/268 (48%), Gaps = 25/268 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKI--ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G GS V +AT + VA+K + K Q ++ L E+ +++ +HPN++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHPNIVEM 81
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ ++++ME+ + G+L +++ R ++E++ + A+ + H + V+HRD
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGVIHRD 140
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK +++LL +KLSDFGF + S K + G+ + +PE++ +PY
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK-----SLVGTPYWMAPEVISRLPYGT- 194
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL------SSSCKALIS 290
+ DIWS+G+++ MV G P+ ++E Q KR+ P+L S ++ +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY----FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNP 317
+L R ++ P+L + P
Sbjct: 251 RMLVRDPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 70/238 (29%), Positives = 124/238 (52%), Gaps = 12/238 (5%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
V+G GS+ V LA + AIKI+ K V D + + + + G K P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQ 65
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+T R+Y +MEY G L+ I++ E + +++A + + H K +++R
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+K +N++LD + +IK++DFG ++ + K TFCG+ Y +PEI+ PY
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-----TFCGTPDYIAPEIIAYQPYG- 179
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPE--SPRLSSSCKALIS 290
+ D W+ GV+L+ M+ G+ PF+ + EL + + + V +P+ S + CK L++
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 69/237 (29%), Positives = 128/237 (54%), Gaps = 10/237 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G GS+ V LA + AIKI+ K V D ++ + + + K P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R+Y +MEY G L+ I++ E + + ++++ + + H++ +++RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N++LD + +IK++DFG +++ V+ + TFCG+ Y +PEI+ PY +
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGV-----TTRTFCGTPDYIAPEIIAYQPYG-K 180
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPE--SPRLSSSCKALIS 290
D W+ GV+L+ M+ G+ PFD + EL + + + V +P+ S S CK L++
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 72/239 (30%), Positives = 125/239 (52%), Gaps = 14/239 (5%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G GS+ V LA + AIKI+ K V D ++ + + + K P L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R+Y +MEY G L+ I++ E + +++A + + H K +++RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N++LD + +IK++DFG ++ + TFCG+ Y +PEI+ PY +
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR-----TFCGTPDYIAPEIIAYQPYG-K 180
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLS----SSCKALIS 290
D W+ GV+L+ M+ G+ PFD + EL + + + V +P+S LS S CK L++
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLLT 237
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIK------IISKVQAPIDYLKKFLPREIEVVKGLKHP 111
V+G G + V LA + + AIK II++ + +K R E +HP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK---RIFETANSERHP 62
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
L+ +T V +MEYA G L+ I + + E + + + + + Y H+
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-SEPRAVFYAACVVLGLQYLHENK 121
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+V+RD+K +NLLLD + +K++DFG ++ + S TFCG+ + +PE+L
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKE----GMGFGDRTS-TFCGTPEFLAPEVLTET 176
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPF--DD 259
YT + D W +GV+++ M+ G PF DD
Sbjct: 177 SYT-RAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 65/220 (29%), Positives = 106/220 (48%), Gaps = 12/220 (5%)
Query: 59 VGMGSYATVKLA---TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G GS+ V+ TS VA+K + + D + FL +E ++ L H NLIR
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFL-KEAAIMHSLDHENLIR 60
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRW-FS-QLADAIDYCHKKSVV 173
L + TH + ++ E A GSLL+ +RK+ ++ Q+A+ + Y K +
Sbjct: 61 -LYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRD+ N+LL +K+ DFG R N Y +A+ +PE L+ +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTF 177
Query: 234 TPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKR 272
+ SD+W GV L+ M YG P+ + S++LK++ K
Sbjct: 178 S-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 84/283 (29%), Positives = 138/283 (48%), Gaps = 13/283 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK-GLKHPNLIRF 116
++G GS+ V LA +Q AIK + K +D + E V+ +HP L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T ++ +MEY G L+ I+ D + + +++ + + H K +V+RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N+LLD +IK++DFG ++ + D K TFCG+ Y +PEIL G Y
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC---TFCGTPDYIAPEILLGQKYN-T 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR-LSSSCKALISNIL-- 293
D WS GV+L+ M+ G+ PF + EL + + R+ P PR L+ K ++ +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--RMDNPCYPRWLTREAKDILVKLFVR 233
Query: 294 SPVKFRIQMEDIRQDPWLKE-DSNPVGKSKSAPEVIPFKKSRN 335
P + DIRQ P+ +E D + + + + P P KS N
Sbjct: 234 EPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSAN 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 80/290 (27%), Positives = 145/290 (50%), Gaps = 22/290 (7%)
Query: 39 KDTERKLSVL--ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK 96
KDT K+ L + Y + V+G G++ V+L + A+K++SK +
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 97 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRW 156
F E +++ P +++ A + +Y++MEY G L+ ++ + E R +
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFY 147
Query: 157 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL--SE 214
+++ A+D H +HRD+K +N+LLD ++KL+DFG K + K+ + +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN------KEGMVRCD 201
Query: 215 TFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYSELLK 267
T G+ Y SPE+LK G Y ++ D WS+GV L+ M+ G PF D+ YS+++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261
Query: 268 QVQKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 314
+ + FP+ +S K LI L+ + R+ +E+I++ + K D
Sbjct: 262 H-KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 10/208 (4%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIKII-----SKVQAPIDYLKKFLPREIEVVKGLKH 110
G+V+G G+Y TV + + Q +A+K + + + A +Y K L E++++K LKH
Sbjct: 5 GEVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEK--LQEEVDLLKSLKH 61
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
N++++L + + I ME+ GS+ ++ + + E ++ Q+ D + Y H
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQNLSETFCGSYAYASPEILK 229
VVHRDIK N++L IKL DFG AR+ + V N+ ++ G+ + +PE++
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
Y ++SDIWS+G +F M G+ P
Sbjct: 182 ESGYG-RKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 8/215 (3%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VVG G+Y V + VAIK + + +K+ RE+++++ LK N++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELK 66
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
+A ++Y++ EY + L + + +K R + QL AI +CHK +VHRDI
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSV-NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
K ENLL+ +KL DFGFAR S +N +Y + + + Y SPE+L G PY +
Sbjct: 127 KPENLLISHNDVLKLCDFGFARNLSEGSNANYTE-----YVATRWYRSPELLLGAPYG-K 180
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
D+WS+G +L + G+ F + + L +QK
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 69/256 (26%), Positives = 128/256 (50%), Gaps = 40/256 (15%)
Query: 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV 104
V + G G + M +K AT R+ +D A +A E +
Sbjct: 13 FQVRKVTGADTGKIFAM---KVLKKATIVRNQKDTA-----HTKA-----------ERNI 53
Query: 105 VKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
++ +KHP ++ + A +T ++Y+I+EY G L + +E ED + S+++ A+
Sbjct: 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
++ H++ +++RD+K EN+LLD + ++KL+DFG ++ T ++ TFCG+ Y +
Sbjct: 114 EHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-----VTHTFCGTIEYMA 168
Query: 225 PEIL------KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPE 277
PEIL K V D WS+G +++ M+ G PF N + + ++ K ++ P
Sbjct: 169 PEILMRSGHGKAV-------DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP- 220
Query: 278 SPRLSSSCKALISNIL 293
P L+ + L+ +L
Sbjct: 221 -PYLTPEARDLLKKLL 235
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 64/248 (25%), Positives = 129/248 (52%), Gaps = 19/248 (7%)
Query: 58 VVGMGSYATVKLATSA-RHSQD--VAIKIISKVQAPIDYLKKFLPR---EIEVVKGLKH- 110
V+G G+Y V L H A+K++ K A I K E +V++ ++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKK--ATIVQKAKTAEHTRTERQVLEAVRRC 64
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P L+ A +T ++++I++Y G L + + + E + R + +++ A+D+ H+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+++RDIK EN+LLD + ++ L+DFG ++++ + + +FCG+ Y +PE+++G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEVIRG 180
Query: 231 VPYTPQQS-DIWSMGVVLFAMVYGRLPF----DDTNYSELLKQVQKRVVFPESPRLSSSC 285
++ D WS+GV+ F ++ G PF + + SE+ +++ K P +S+
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP-PFPKTMSAEA 239
Query: 286 KALISNIL 293
+ I +L
Sbjct: 240 RDFIQKLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLI 114
+G G+Y V A + VA+K I ++ + +P REI ++K L HPN++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRK-------ERYIDEDKGRRWFSQLADAIDYC 167
R L + + +++Y++ E+ L++ K +D + + QL I YC
Sbjct: 62 RLLDVVHSENKLYLVFEF------LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H V+HRD+K +NLL+D + +KL+DFG AR + V Y + + Y +PEI
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEI 170
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGR 254
L G DIWS+G + MV R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 63/241 (26%), Positives = 116/241 (48%), Gaps = 29/241 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L +G G+Y V A + VAIK+I K++ D+ + + +EI ++K +HPN
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHPN 61
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLA-------DAI 164
++ + + +++I+MEY GSL ++ + + E Q+A +
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------QIAYVCRETLKGL 114
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y H+ +HRDIK N+LL + ++KL+DFG + + + T K+ +F G+ + +
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRK---SFIGTPYWMA 169
Query: 225 PEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
PE+ + Y + DIW++G+ + + P D + L + K P P+L
Sbjct: 170 PEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PKL 226
Query: 282 S 282
Sbjct: 227 K 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 13/213 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGLKH 110
Y + +G G++ V A + VA+K KV + REI+ ++ +H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQH 58
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHK 169
P +++ L ++MEY L EV+R ER + E + + + L + Y H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
++HRD+K NLL+ +K++DFG AR + + + + S + Y +PE+L
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLAR---LFSEEEPRLYSHQ-VATRWYRAPELLY 173
Query: 230 GVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
G Y P D+W++G + ++ G F N
Sbjct: 174 GARKYDP-GVDLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G+Y V A + + VA+K I ++ + + REI ++K L HPN+++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG--------RRWFSQLADAIDYCHKK 170
I T +++Y++ E+ + L ++++D + + QL + +CH
Sbjct: 67 VIHTENKLYLVFEFL-HQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
V+HRD+K +NLL++ + IKL+DFG AR + V Y + + Y +PEIL G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLG 174
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPF 257
Y DIWS+G + MV R F
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 57/249 (22%), Positives = 118/249 (47%), Gaps = 16/249 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK-------FLPREIEVV 105
+ G ++G G++ V L +++A+K Q P D L EI+++
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVK-----QVPFDPDSPETKKEVNALECEIQLL 58
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
K L+H ++++ + + I MEY GS+ + ++ + E R++ Q+ + ++
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
Y H +VHRDIK N+L D N+KL DFG +++ + ++ G+ + SP
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR--LQTICSSGTGMKSVTGTPYWMSP 176
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP-RLSSS 284
E++ G Y +++D+WS+G + M+ + P+ + + ++ + P+ P +S
Sbjct: 177 EVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPD 235
Query: 285 CKALISNIL 293
+ +
Sbjct: 236 ARNFLRRTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 69/248 (27%), Positives = 125/248 (50%), Gaps = 14/248 (5%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV--QAPIDYLKKFLPREIEVVKGLK 109
Y VVG GSY V L RH D +I K+ + +K +E +++ LK
Sbjct: 1 AYCFVRVVGKGSYGEVSLV---RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 110 HPNLIRFLQAIETTH-RVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDY 166
HPN++ + ++ E +YI+M + + G L +++++ + E++ WF Q+A A+ Y
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
H+K ++HRD+K +N+ L IK+ D G AR +++ T G+ Y SPE
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-----DMASTLIGTPYYMSPE 172
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286
+ PY +SD+W++G ++ M + F+ + + L+ ++ + + P S
Sbjct: 173 LFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231
Query: 287 ALISNILS 294
LI+ +LS
Sbjct: 232 ELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-25
Identities = 63/209 (30%), Positives = 114/209 (54%), Gaps = 10/209 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ + +G G+ TV A Q+VAI+ ++ Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPN 78
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +L + ++++MEY GSL +V+ E +DE + + A+++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y P + DIWS+G++ M+ G P+ + N
Sbjct: 193 YGP-KVDIWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 78/265 (29%), Positives = 124/265 (46%), Gaps = 22/265 (8%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP--REIEVVKGLKHPNLIR 115
V+G G+Y V A +AIK I P + P EI + LKH N+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHKKSV 172
+L + I ME GSL ++R + +E + Q+ + + Y H +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 173 VHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-K 229
VHRDIK +N+L+ + Y+ +K+SDFG +++ + N +ETF G+ Y +PE++ K
Sbjct: 130 VHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEVIDK 183
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPESPR-LSSSCKA 287
G +DIWS+G + M G+ PF + + +V + PE P LS+ K
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243
Query: 288 LISNILSP-VKFRIQMEDIRQDPWL 311
I P R D+ QDP+L
Sbjct: 244 FILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 70/245 (28%), Positives = 125/245 (51%), Gaps = 15/245 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G ++ V AT + VA+K + + ++ +EI+++K L HPN+I++L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 119 AIETTHRVYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ + + I++E A G L ++I +++R I E ++F QL A+++ H + V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RDIK N+ + +KL D G R +S T + + G+ Y SPE + Y
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPERIHENGYN 184
Query: 235 PQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQKRVVFPESPR--LSSSCKALIS 290
+SDIWS+G +L+ M + PF D N L +++++ +P P S + L+S
Sbjct: 185 -FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPTEHYSEKLRELVS 242
Query: 291 NILSP 295
+ P
Sbjct: 243 MCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 66/224 (29%), Positives = 115/224 (51%), Gaps = 9/224 (4%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK-GLKHPNLIRF 116
V+G GS+ V LA + A+K + K ID + E V+ ++P L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T ++ +ME+ G L+ I+ + D + + +++ + + H K +++RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K +N++LD +IK++DFG ++ + N + TFCG+ Y +PEIL+G+ YT
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKE-----NVFGDNRASTFCGTPDYIAPEILQGLKYT-F 175
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280
D WS GV+L+ M+ G+ PF + EL + + RV P PR
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 101 EIEVVK-GLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI-----RKERYIDEDKGR 154
E+ ++K L+HPN++R+ + R+YI+M+ + L E +K+R+ +E R
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE---R 114
Query: 155 RW--FSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211
W F Q+ A+ Y HK K +VHRD+ N++L + + ++DFG A++ +
Sbjct: 115 IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----- 169
Query: 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
+ G+ Y+ PEI+K PY +++D+W+ G +L+ M + PF TN L ++ +
Sbjct: 170 -LTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 272 RVVFP-ESPRLSSSCKALISNILSP 295
V P S +I++ L+P
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 21/246 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
++L +G G + V + VAIKI+ + + F +E++ +K L+H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILK--SDDLLKQQDFQ-KEVQALKRLRHKH 63
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWFSQLADAIDYCHKK 170
LI VYII E + GSLL +R + + + Q+A+ + Y ++
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFAR--KYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+ +HRD+ N+L+ + K++DFG AR K V + K+ Y + +PE
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTAPEAA 176
Query: 229 KGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287
++ +SD+WS G++L+ M YG++P+ N E+ Q+ P + C
Sbjct: 177 SHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK----CPQ 231
Query: 288 LISNIL 293
I I+
Sbjct: 232 EIYKIM 237
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-24
Identities = 62/209 (29%), Positives = 115/209 (55%), Gaps = 13/209 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKH 110
++L + +G GS+ V A R +Q VAIK+I +A I+ + +EI+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE----DIQQEIQFLSQCRS 58
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P + ++ + +++IIMEY GS L+++ K +DE ++ ++Y H++
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+HRDIK N+LL ++ ++KL+DFG + + +T K+N TF G+ + +PE++K
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRN---TFVGTPFWMAPEVIKQ 172
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
Y +++DIWS+G+ + G P D
Sbjct: 173 SGYD-EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 70/223 (31%), Positives = 117/223 (52%), Gaps = 18/223 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKH-PNLIR 115
+G G++ V + A+K++SK + A + R I V L P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+ +T +Y++ +Y G L ++KE ED+ + + ++L A+++ HK +V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL---KGVP 232
D+K EN+LLD +I L DFG ++ N TD K + TFCG+ Y +PE+L KG
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK---ANLTDNK--TTNTFCGTTEYLAPEVLLDEKG-- 173
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275
YT + D WS+GV++F M G PF Y+E +Q+ + + F
Sbjct: 174 YT-KHVDFWSLGVLVFEMCCGWSPF----YAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 69/277 (24%), Positives = 136/277 (49%), Gaps = 22/277 (7%)
Query: 53 YSLGDVVGMGSYATVKL---ATSARHSQDVAIKIISK---VQAPIDYLKKFLPREI-EVV 105
+ L V+G G+Y V L T + A+K++ K VQ R + E V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
+ + P L+ A +T ++++I++Y G + + + ED+ R + ++ A++
Sbjct: 62 R--QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
+ HK +V+RDIK EN+LLD + ++ L+DFG ++++ ++ + +FCG+ Y +P
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEKERTYSFCGTIEYMAP 175
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285
EI++G + D WS+G+++F ++ G PF +V +R++ C
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL---------KC 226
Query: 286 KALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSK 322
+ + P + + +R+DP + + P G S+
Sbjct: 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 26/202 (12%)
Query: 126 VYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184
+Y++M+Y G LL ++ K E + ED R + +++ AID H+ VHRDIK +N+LL
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP-----YTPQQSD 239
D +I+L+DFG + + T S G+ Y SPEIL+ + Y P + D
Sbjct: 136 DKNGHIRLADFGSCLRLLADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGP-ECD 190
Query: 240 IWSMGVVLFAMVYGRLPFDDTNYSELLKQV-------QKRVVFP-ESPRLSSSCKALISN 291
WS+GV ++ M+YG PF Y+E L + ++ FP + +S K LI
Sbjct: 191 WWSLGVCMYEMLYGETPF----YAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR 246
Query: 292 ILSPVKFRI---QMEDIRQDPW 310
++ + R+ ++D + P+
Sbjct: 247 LICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L +G G + V + T + VA+K + +P +L+ E +++K L+H
Sbjct: 9 KLERKLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEAFLQ-----EAQIMKKLRHDK 62
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRR--------WFSQLADAI 164
L++ +YI+ EY GSLL+ ++ +G++ +Q+A+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y ++ +HRD+ N+L+ + K++DFG AR + +Y F + +
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKF--PIKWTA 172
Query: 225 PE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
PE G +T +SD+WS G++L +V YGR+P+ E+L+QV++
Sbjct: 173 PEAANYGR-FT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 40/225 (17%)
Query: 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186
Y+IMEY G ++ ++ K+ E++ R + ++ AID HK +HRDIK +NLLLD
Sbjct: 77 YLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136
Query: 187 KYNIKLSDFG------------FAR---KYSVNN---------------TDYKQN---LS 213
K +IKLSDFG F R +N +K+N L+
Sbjct: 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA 196
Query: 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---Q 270
+ G+ Y +PE+ Y ++ D WS+GV+++ M+ G PF N E +++ +
Sbjct: 197 YSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWK 255
Query: 271 KRVVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLK 312
+ + FP+ LS K LI + + R+ + +I+ P+ K
Sbjct: 256 ETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 58/204 (28%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
Y + +G G+++ V A S + + AIK + K ++ + REI+ ++ L HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHP 58
Query: 112 NLIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCH 168
N++R ++ + T R+ ++ E + +L E+I+ + + E + + + QL ++D+ H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE-I 227
+ + HRDIK EN+L+ D +KL+DFG S K +E + + Y +PE +
Sbjct: 118 RNGIFHRDIKPENILIKD-DILKLADFG-----SCRGIYSKPPYTE-YISTRWYRAPECL 170
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMV 251
L Y P+ DIW++G V F ++
Sbjct: 171 LTDGYYGPKM-DIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 15/216 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKII---SKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G G+YATV + + VA+K I ++ P + REI ++K LKH N++R
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62
Query: 116 FLQAIETTHRVYIIMEYAKNG--SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
I T +++ ++ EY ++ +D + + + QL I +CH+ V+
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRD+K +NLL++ + +KL+DFG AR + + + + + Y +P++L G
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW-----YRAPDVLLGSRT 177
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
DIWS+G ++ M+ GR F TN + L ++
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 56/222 (25%), Positives = 110/222 (49%), Gaps = 24/222 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHP 111
+ L +V+G G+Y V A + Q VAIKI+ I+ ++ + E +++ HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNHP 63
Query: 112 NLIRF----LQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS----QLA 161
N+ F ++ + ++++ME GS+ ++++ R + W + +
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
+ Y H+ V+HRDIK +N+LL +KL DFG + + +++T ++N TF G+
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRN---TFIGTPY 178
Query: 222 YASPEIL----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
+ +PE++ + +SD+WS+G+ + G+ P D
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-23
Identities = 80/310 (25%), Positives = 146/310 (47%), Gaps = 41/310 (13%)
Query: 17 LKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHS 76
LK + H K + +P ++K + + T +G GS+ V LAT
Sbjct: 4 LKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRT--------LGTGSFGRVILATYKNED 55
Query: 77 -QDVAIKIISKV----QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131
VAIK K Q +D++ F R+I + + HP + + + +Y+++E
Sbjct: 56 FPPVAIKRFEKSKIIKQKQVDHV--FSERKI--LNYINHPFCVNLYGSFKDESYLYLVLE 111
Query: 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191
+ G +R+ + D G + +Q+ +Y ++V+RD+K ENLLLD IK
Sbjct: 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171
Query: 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 251
++DFGFA+ V+ Y T CG+ Y +PEIL V + + +D W++G+ ++ ++
Sbjct: 172 MTDFGFAK--VVDTRTY------TLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEIL 222
Query: 252 YGRLPFDDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNILSP------VKFRIQ 301
G PF Y ++L+ + + FP+ L ++CK L+ +LS +
Sbjct: 223 VGCPPFYANEPLLIYQKILEGI---IYFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKG 277
Query: 302 MEDIRQDPWL 311
+++++ PW
Sbjct: 278 AQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQ---APIDYLKKFLPREIEVVKGLKHPNL 113
D +G GSYATV S Q VA+K I AP + RE ++K LKH N+
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANI 65
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+ I T + ++ EY + + R + QL + YCH++ V+
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRD+K +NLL+ ++ +KL+DFG AR SV + Y + + Y P++L G
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW-----YRPPDVLLGSTE 180
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPF 257
D+W +G + + M GR F
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 75/267 (28%), Positives = 131/267 (49%), Gaps = 18/267 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
V+G G++ V + + A+KI++K + E +V+ + +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A + + +Y++M+Y G LL ++ K E + ED R + +++ AID H+ VHRD
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP---- 232
IK +N+L+D +I+L+DFG K + T S G+ Y SPEIL+ +
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ----SSVAVGTPDYISPEILQAMEDGKG 183
Query: 233 -YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFP-ESPRLSSSCKA 287
Y P + D WS+GV ++ M+YG PF + E ++ ++R FP + +S K
Sbjct: 184 KYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242
Query: 288 LISNILSPVKFRI---QMEDIRQDPWL 311
LI ++ + R+ +ED +Q P+
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 72/269 (26%), Positives = 131/269 (48%), Gaps = 27/269 (10%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS V +AT + VA+K K+ ++ L E+ +++ H N++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ ++++ME+ + G+L +++ R +E S L A+ Y H + V+HRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR-ALSYLHNQGVIHRDIK 145
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
+++LL IKLSDFGF + S K + G+ + +PE++ +PY +
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGTPYWMAPEVISRLPYG-TEV 199
Query: 239 DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL----- 293
DIWS+G+++ M+ G P+ ++E Q +R+ PR+ S K +S++L
Sbjct: 200 DIWSLGIMVIEMIDGEPPY----FNEPPLQAMRRIRDNLPPRVKDSHK--VSSVLRGFLD 253
Query: 294 -----SPVKFRIQMEDIRQDPWLKEDSNP 317
P + R +++ Q P+LK P
Sbjct: 254 LMLVREPSQ-RATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 66/237 (27%), Positives = 118/237 (49%), Gaps = 23/237 (9%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G G + V L R DVAIK+I + + D+++ E +V+ L HPN
Sbjct: 7 TFLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-----EAKVMMKLSHPN 60
Query: 113 LIRFLQAIETTHR-VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWF----SQLADAIDYC 167
L++ L + T R ++I+ EY NG LL +R+ + G W S + +A++Y
Sbjct: 61 LVQ-LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKL---GTEWLLDMCSDVCEAMEYL 116
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
+HRD+ N L+ + +K+SDFG AR V + Y + F +A PE+
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--YVLDDQYTSSQGTKF--PVKWAPPEV 172
Query: 228 LKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283
++ +SD+WS GV+++ + G++P++ + SE+++ V P+L+
Sbjct: 173 FDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 24/193 (12%)
Query: 62 GSYATVKLATSARHSQDVAIK--IISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFL 117
G+Y V A + + VA+K + K + PI L REI ++ L+HPN++ +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-----REINILLKLQHPNIVT-V 69
Query: 118 QAI---ETTHRVYIIMEYAKNG--SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+ + ++Y++MEY ++ SL+E +++ E K QL + + H +
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC--LMLQLLSGVAHLHDNWI 127
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K NLLL+++ +K+ DFG AR+Y Y Q + + Y +PE+L G
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW-----YRAPELLLGAK 182
Query: 233 -YTPQQSDIWSMG 244
Y+ D+WS+G
Sbjct: 183 EYST-AIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 15/222 (6%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIIS---KVQAPIDYLKKFLPREIEV 104
LET Y D +G G+YATV S VA+K I + AP + RE+ +
Sbjct: 5 LET--YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-----REVSL 57
Query: 105 VKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
+K LKH N++ I T + ++ EY + I+ + + QL +
Sbjct: 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
+YCH++ V+HRD+K +NLL++++ +KL+DFG AR S+ Y + + Y
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW-----YRP 172
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266
P+IL G Q D+W +G + + M GR F + E L
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 66/268 (24%), Positives = 133/268 (49%), Gaps = 25/268 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIIS--KVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G GS V +A + VA+K++ K Q ++ L E+ +++ +H N++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-----RELLFNEVVIMRDYQHQNVVEM 83
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
++ ++++ME+ + G+L +++ + R ++E++ + A+ Y H + V+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK +++LL +KLSDFGF + S + K + G+ + +PE++ PY
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-----SLVGTPYWMAPEVISRTPYG-T 196
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA-------LI 289
+ DIWS+G+++ MV G P+ +S+ Q KR+ P+L ++ K L
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252
Query: 290 SNILSPVKFRIQMEDIRQDPWLKEDSNP 317
+ + R +++ P+L + P
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 22/239 (9%)
Query: 24 SAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKI 83
S+ +++ S + + LS LE + +G G+ TV + A+K+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELER-----VNRIGSGAGGTVYKVIHRPTGRLYALKV 106
Query: 84 ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV-I 142
I D +++ + REIE+++ + HPN+++ + + +++E+ GSL I
Sbjct: 107 IYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 143 RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202
E+++ D R Q+ I Y H++ +VHRDIK NLL++ N+K++DFG +R
Sbjct: 165 ADEQFL-ADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR--I 217
Query: 203 VNNTDYKQNLSETFCGSYAYASPEI----LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+ T N S G+ AY SPE L Y DIWS+GV + GR PF
Sbjct: 218 LAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 7/219 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G G+Y V A R + VAIK I K+ L RE+++++ KH N
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDN 65
Query: 113 LIRFLQAIETTHR----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
+I + VY++M+ ++ L +I ++ + E+ R + QL + Y H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+V+HRD+K NLL+++ +++ DFG AR S + T++K ++E + + Y +PE+L
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE-YVATRWYRAPELL 183
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
+P D+WS+G + M+ R F NY LK
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 69/245 (28%), Positives = 121/245 (49%), Gaps = 15/245 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G ++ V AT VA+K + + +EI+++K L HPN+I++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ + + I++E A G L +I+ ++R I E ++F QL A+++ H + V+H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RDIK N+ + +KL D G R +S T + + G+ Y SPE + Y
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPERIHENGYN 184
Query: 235 PQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQKRVVFPESP--RLSSSCKALIS 290
+SDIWS+G +L+ M + PF D N L K++++ +P P S + L++
Sbjct: 185 -FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSDHYSEELRQLVN 242
Query: 291 NILSP 295
++P
Sbjct: 243 MCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 53/302 (17%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK----FLPREIEVVKGLKHPNLI 114
+G+G++ V L + A+K + K D L + + E +++ + ++
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKA----DVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ + + +Y +M+Y G ++ ++ + +ED R + ++L AI+ HK +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH 124
Query: 175 RDIKCENLLLDDKYNIKLSDFGFA--------RKYSVNNTDYKQN--------------- 211
RDIK +N+L+D +IKL+DFG KY ++Q+
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184
Query: 212 ---------------LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 256
L+ + G+ Y +PE+L YT Q D WS+GV+L+ M+ G+ P
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPP 243
Query: 257 FDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPW 310
F +E +V + + P +LS LI + + R+ ++I+ P+
Sbjct: 244 FLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPF 303
Query: 311 LK 312
K
Sbjct: 304 FK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-22
Identities = 74/276 (26%), Positives = 132/276 (47%), Gaps = 34/276 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI-------EVV 105
Y L +G GS+ TV L + + +K++ ++ P+ L P E +++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEI--PVGELN---PNETVQANQEAQLL 56
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLA 161
L HP +++F + II EY + L + + + + E++ WF QL
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNI-KLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
+ Y H++ ++HRD+K +N+ L K N+ K+ DFG +R + + D L+ TF G+
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSR-LLMGSCD----LATTFTGTP 169
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280
Y SPE LK Y +SDIWS+G +L+ M F+ N+ V R+V +P
Sbjct: 170 YYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRIVEGPTPS 224
Query: 281 L----SSSCKALISNILSP-VKFRIQMEDIRQDPWL 311
L S +++ ++L+ R +I ++P++
Sbjct: 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-22
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 16/220 (7%)
Query: 59 VGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G G++ +V S +VA+K + + I KK RE V+ L HP ++R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCIVR 60
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
L + + ++ME A G LL+ ++K R I + Q+A + Y K VHR
Sbjct: 61 -LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA---YASPEILKGVP 232
D+ N+LL +++ K+SDFG +R + Y+ + T G + YA PE +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---ATT-AGRWPLKWYA-PECINYGK 174
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+WS GV L+ YG P+ + +E++ ++
Sbjct: 175 FS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-22
Identities = 66/264 (25%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF--LPREIEVVKGLKH 110
+ LG ++G G++ V L A +++A+K + + K+ L EI+++K L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 111 PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
++++ + + I ME+ GS+ + ++ + E+ R++ Q+ + + Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQNLSETFCGSYAYASP 225
+VHRDIK N+L D N+KL DFG +++ ++ T K + G+ + SP
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-----SVTGTPYWMSP 178
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL---- 281
E++ G Y +++DIWS+G + M+ + P+ + E + + K P +P L
Sbjct: 179 EVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEF---EAMAAIFKIATQPTNPVLPPHV 234
Query: 282 SSSCKALISNILSPVKFRIQMEDI 305
S C+ + I K R +++
Sbjct: 235 SDHCRDFLKRIFVEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-22
Identities = 64/207 (30%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+ +G GS+ V R + VAIKII +A D ++ + +EI V+ P + R+
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIED-IQQEITVLSQCDSPYITRY 67
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+ +++IIMEY GS L++++ +E YI ++ +DY H +
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSERK 122
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK N+LL ++ ++KL+DFG A + + +T K+N TF G+ + +PE++K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRN---TFVGTPFWMAPEVIKQSA 177
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDD 259
Y ++DIWS+G+ + G P D
Sbjct: 178 YD-FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-22
Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 9/215 (4%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+ +G GS+ V R Q VAIKII +A D ++ + +EI V+ P + ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIED-IQQEITVLSQCDSPYVTKY 67
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ +++IIMEY GS L+++R + DE + ++ +DY H + +HRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-DEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK N+LL ++ ++KL+DFG A + + +T K+N TF G+ + +PE+++ Y
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRN---TFVGTPFWMAPEVIQQSAYD-S 180
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
++DIWS+G+ + G P D + +L + K
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-22
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 22/231 (9%)
Query: 55 LGDVVGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
L +G GS+ V + + VAIK ++ A + +FL E V+K
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFL-NEASVMKEFN 67
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR----------RWFSQ 159
+++R L + T ++ME G L +R R E+ + ++
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+AD + Y K VHRD+ N ++ + +K+ DFG R + TDY + +
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL-P 184
Query: 220 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 269
+ +PE LK +T +SD+WS GVVL+ M P+ + E+LK V
Sbjct: 185 VRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-22
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIIS---KVQAPIDYLKKFLPREIEV 104
LET Y D +G G+YATV S VA+K I + AP + RE+ +
Sbjct: 4 LET--YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSL 56
Query: 105 VKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDE-------DKGRRWF 157
+K LKH N++ I T + ++ EY + ++Y+D + +
Sbjct: 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDSDL-------KQYLDNCGNLMSMHNVKIFM 109
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
QL + YCHK+ ++HRD+K +NLL+++K +KL+DFG AR SV Y + +
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW- 168
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266
Y P++L G D+W +G +L+ M GR F + E L
Sbjct: 169 ----YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 7e-22
Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 13/216 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G G+Y V AT VAIK IS + + ++ L REI++++ KH N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTL-REIKILRRFKHEN 64
Query: 113 LIRFL-----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+I L + E+ + VYI+ E + L ++I+ + + D + + Q+ + Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSN-DHIQYFLYQILRGLKYI 122
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H +V+HRD+K NLLL+ ++K+ DFG AR + D+ L+E + + Y +PEI
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTE-YVATRWYRAPEI 180
Query: 228 -LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
L YT + DIWS+G +L M+ R F +Y
Sbjct: 181 MLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
+ + +G G+Y V A + VA+K KV+ +D K+ P REI++++ L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVR--LDNEKEGFPITAIREIKILRQL 63
Query: 109 KHPNLIRFLQAI----------ETTHRVYIIMEYAKNG--SLLEVIRKERYIDEDKGRRW 156
H N++ + + + Y++ EY + LLE + ED + +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE--SGLVHFSEDHIKSF 121
Query: 157 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216
QL + ++YCHKK+ +HRDIKC N+LL++K IKL+DFG AR Y+ + N T
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 217 CGSYAYASPEILKGVP-YTPQQSDIWSMGVVL 247
Y PE+L G Y P D+WS G +L
Sbjct: 182 W----YRPPELLLGEERYGP-AIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 69/262 (26%), Positives = 126/262 (48%), Gaps = 33/262 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKI----------ISKVQAPI------DYLKK 96
Y + V+G G+ TV A + A+K+ ++ QA + D+
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 97 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE----RYIDEDK 152
E K ++P E + ++++YA G L + I+ R E +
Sbjct: 94 VKCHEDFAKKDPRNP---------ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144
Query: 153 GRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
F Q+ A+ + H K ++HRDIK N+LL +KL DFGF++ Y+ +D ++
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD---DV 201
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 272
TFCG+ Y +PEI + PY+ +++D++S+GV+L+ ++ + PFD N E++ +
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260
Query: 273 VVFPESPRLSSSCKALISNILS 294
P P +S + +++ +LS
Sbjct: 261 RYDPLPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 69/249 (27%), Positives = 124/249 (49%), Gaps = 12/249 (4%)
Query: 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLK 109
H Y L +VG +AT D K+++K V + + E+ +
Sbjct: 67 HMYVLTTLVGRNPTTAAFVAT---RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR---KERY-IDEDKGRRWFSQLADAID 165
H +++ ++ ++ +IMEY G L + I+ KE E + F Q+ A+D
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
H + ++HRD+K N+ L IKL DFGF+++YS +++ +FCG+ Y +P
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS---DSVSLDVASSFCGTPYYLAP 240
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285
E+ + Y+ +++D+WS+GV+L+ ++ PF + E+++QV P +SS
Sbjct: 241 ELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299
Query: 286 KALISNILS 294
KAL+ +LS
Sbjct: 300 KALLDPLLS 308
|
Length = 478 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 69/273 (25%), Positives = 130/273 (47%), Gaps = 30/273 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK-------FLPREIEVV 105
+ LG ++G G++ V L A +++A+K Q P D + L EI+++
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVK-----QVPFDPDSQETSKEVNALECEIQLL 58
Query: 106 KGLKHPNLIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADA 163
K L+H ++++ + ++ I +EY GS+ + ++ + E+ RR+ Q+
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQNLSETFCGSY 220
+ Y H +VHRDIK N+L D N+KL DFG +++ ++ T K + G+
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-----SVTGTP 173
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280
+ SPE++ G Y +++D+WS+ + M+ + P+ + E + + K P P
Sbjct: 174 YWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEY---EAMAAIFKIATQPTKPM 229
Query: 281 L----SSSCKALISNILSPVKFRIQMEDIRQDP 309
L S +C+ + I K R E + + P
Sbjct: 230 LPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 59 VGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G G + V+L + VA+K + + F REIE+++ L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDF-EREIEILRTLDHENIV 69
Query: 115 RFLQAIETTHR--VYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKS 171
++ E + +IMEY +GSL + +++ R I+ + + SQ+ +DY +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-QNLSETFCGSYAYASPEILKG 230
+HRD+ N+L++ + +K+SDFG A+ + Y + E+ YA PE L+
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA---PECLRT 186
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGR 254
++ SD+WS GV L+ + YG
Sbjct: 187 SKFS-SASDVWSFGVTLYELFTYGD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 27/205 (13%)
Query: 82 KIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAKNGSLLE 140
KII K F E V + +K +PN I+ ++ T +IM+Y K+G L +
Sbjct: 47 KIIKA--------KNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98
Query: 141 VIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFAR 199
+++KE + E + ++ QL +A++ HK +++H DIK EN+L D K I L D+G +
Sbjct: 99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
Query: 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS-DIWSMGVVLFAMVYGRLPFD 258
+ G+ Y SPE +KG Y S D W++GV+ + ++ G+ PF
Sbjct: 159 ---------IIGTPSCYDGTLDYFSPEKIKGHNY--DVSFDWWAVGVLTYELLTGKHPFK 207
Query: 259 DT-----NYSELLKQVQKRVVFPES 278
+ + LLK+ QK++ F ++
Sbjct: 208 EDEDEELDLESLLKRQQKKLPFIKN 232
|
Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 28/247 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--- 109
Y +G G+Y TV A + VA+K + +V + + REI ++K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 110 HPNLIRFLQ--AIETTHR---VYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLAD 162
HPN++R L T R + ++ E+ L + K + + + + QL
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC-GSYA 221
+D+ H +VHRD+K +N+L+ +K++DFG AR YS ++ T +
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-------EMALTSVVVTLW 171
Query: 222 YASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQKRVVFP--- 276
Y +PE+L Y TP D+WS+G + FA ++ R P F T+ ++ L ++ + P
Sbjct: 172 YRAPEVLLQSSYATP--VDMWSVGCI-FAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228
Query: 277 ESPRLSS 283
E PR S
Sbjct: 229 EWPRNVS 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-21
Identities = 60/216 (27%), Positives = 113/216 (52%), Gaps = 15/216 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G Y V ++S VA+K + + +++FL +E V+K +KHPNL++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL-KEAAVMKEIKHPNLVQLLG 69
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
YII E+ G+LL+ +R+ + ++ +Q++ A++Y KK+ +HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+ N L+ + + +K++DFG +R + Y + F + +PE L ++
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS-I 184
Query: 237 QSDIWSMGVVLFAM-VYGRLPF---DDTNYSELLKQ 268
+SD+W+ GV+L+ + YG P+ D + ELL++
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-21
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
A + + +Y++M+Y G LL ++ K E + ED R + +++ AI H+ VHRDI
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-----P 232
K +N+LLD +I+L+DFG K + + T S G+ Y SPEIL+ +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ----SSVAVGTPDYISPEILQAMEDGMGK 184
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPES-PRLSSSCKAL 288
Y P + D WS+GV ++ M+YG PF + E ++ ++R FP +S K L
Sbjct: 185 YGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDL 243
Query: 289 ISNILSPVKFRI---QMEDIRQDPWLK 312
I ++ + R+ +ED ++ + +
Sbjct: 244 IQRLICSRERRLGQNGIEDFKKHAFFE 270
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-21
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 11/214 (5%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIIS-KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G GSYATV S + Q VA+K+IS K + + + RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI---REASLLKGLKHANIVLLH 69
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
I T + + EY +I+ + R + QL + Y H + ++HRD+
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
K +NLL+ +KL+DFG AR S+ + Y + + Y P++L G
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW-----YRPPDVLLGATDYSSA 184
Query: 238 SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
DIW G + M+ G+ F S++ +Q++K
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGV--SDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 13/222 (5%)
Query: 56 GDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
V+G G++ TV + VAIK++ + +P K+ L E V+ + HP
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEIL-DEAYVMASVDHP 69
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKK 170
+++R L I + +V +I + G LL+ +R + I W Q+A + Y +K
Sbjct: 70 HVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+VHRD+ N+L+ ++K++DFG A+ V+ +Y + + + E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV---PIKWMALESILH 185
Query: 231 VPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQK 271
YT +SD+WS GV ++ M +G P++ E+ ++K
Sbjct: 186 RIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLI 114
+G G+Y V A + VA+K KV+ +D + +P REI ++ L+HPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK---KVR--MDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 115 RFLQAIETTH--RVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
+ + H ++++MEY + SLL+ + + K QL + Y H+
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC--LMLQLLRGLQYLHEN 127
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
++HRD+K NLLL DK +K++DFG AR Y + + + Y +PE+L G
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW-----YRAPELLLG 182
Query: 231 VPYTPQQSDIWSMGVVL 247
D+W++G +L
Sbjct: 183 CTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 75/295 (25%), Positives = 137/295 (46%), Gaps = 45/295 (15%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK----FLPREIEVVKGLKHPNL 113
V+G G++ V+L A+KI+ K D L+K + E +++ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKA----DMLEKEQVAHIRAERDILVEADGAWV 63
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
++ + + +Y+IME+ G ++ ++ K+ + E+ + + ++ AID H+ +
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 174 HRDIKCENLLLDDKYNIKLSDFG------------FARK--------YSVNNTDYKQ--- 210
HRDIK +NLLLD K ++KLSDFG F R +S N + K+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 211 -------NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 263
L+ + G+ Y +PE+ Y + D WS+GV+++ M+ G PF
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 264 ELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLK 312
E ++V ++ +VFP +S K LI + + RI +E+I+ P+ +
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 59/227 (25%), Positives = 115/227 (50%), Gaps = 25/227 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + V + +S VA+K + + + FL E ++K L+H L+R
Sbjct: 14 LGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSV---QAFL-EEANLMKTLQHDKLVRLYA 68
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRR--------WFSQLADAIDYCHKK 170
+ +YII EY GSLL+ ++ D+G + + +Q+A+ + Y +K
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLD------FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ +HRD++ N+L+ + K++DFG AR + + +Y F + +PE +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKF--PIKWTAPEAINF 178
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 276
+T +SD+WS G++L+ +V YG++P+ + S+++ +Q+ P
Sbjct: 179 GSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 61/229 (26%), Positives = 120/229 (52%), Gaps = 26/229 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + V +AT +H++ VA+K + ++ FL E V+K L+H L++ L
Sbjct: 14 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFL-AEANVMKTLQHDKLVK-LH 67
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRR--------WFSQLADAIDYCHKK 170
A+ T +YII E+ GSLL+ ++ D+G + + +Q+A+ + + ++
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ +HRD++ N+L+ K++DFG AR + + +Y F + +PE +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKF--PIKWTAPEAINF 177
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPES 278
+T +SD+WS G++L +V YGR+P+ + E+++ +++ P
Sbjct: 178 GSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 69/247 (27%), Positives = 123/247 (49%), Gaps = 19/247 (7%)
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPI---DYLKKFLPREIEVVKGLKHPNLIRFLQ 118
G+Y V L Q A+K I+K Q I + F+ R+I + ++P ++
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINK-QNLILRNQIQQVFVERDI--LTFAENPFVVSMFC 68
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ ET + ++MEY + G +++ + D R +F++ A++Y H +VHRD+K
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNT----------DYKQNLSETFCGSYAYASPEIL 228
+NLL+ +IKL+DFG ++ ++ T D ++ L + CG+ Y +PE++
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPR-LSSSCK 286
Y + D W+MG++L+ + G +PF EL QV + +PE L + +
Sbjct: 189 LRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQ 247
Query: 287 ALISNIL 293
LIS +L
Sbjct: 248 DLISRLL 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIIS---KVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+ +G G+YATV S VA+K I + AP + RE+ ++K LKH N+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANI 66
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDE-------DKGRRWFSQLADAIDY 166
+ + T + ++ EY ++Y+D+ + + Q+ + Y
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDKDL-------KQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
CH++ V+HRD+K +NLL++++ +KL+DFG AR SV Y + + Y P+
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW-----YRPPD 174
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+L G Q D+W +G + F M GR F
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 71/267 (26%), Positives = 131/267 (49%), Gaps = 18/267 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G++ V A + A K+I + L+ ++ EI+++ HPN+++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMV-EIDILASCDHPNIVKLLD 69
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
A + ++I++E+ G++ V+ + ER + E + R Q +A++Y H+ ++HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-----KGVP 232
K N+L +IKL+DFG + K NT Q ++F G+ + +PE++ K P
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAK----NTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALIS 290
Y ++D+WS+G+ L M P + N +L ++ K + R SS K +
Sbjct: 185 YD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243
Query: 291 NILSP-VKFRIQMEDIRQDPWLKEDSN 316
L V R + Q P++ +SN
Sbjct: 244 KCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-20
Identities = 66/220 (30%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + VK R DVAIK+I + D +F+ E +V+ L H L++
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMKLSHEKLVQLYG 66
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADAIDYCHKKS 171
+YI+ EY NG LL Y+ E R SQL + + Y K
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLN------YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD+ N L+DD+ +K+SDFG +R V + +Y ++ F ++ PE+L
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSSVGSKF--PVRWSPPEVLLYS 176
Query: 232 PYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQV 269
++ +SD+W+ GV+++ VY G++P++ N SE +++V
Sbjct: 177 KFS-SKSDVWAFGVLMWE-VYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 64/230 (27%), Positives = 113/230 (49%), Gaps = 17/230 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL- 117
VG G+Y +V A + VA+K +S+ I + K+ RE+ ++K +KH N+I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 118 -----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++E + VY++ G+ L I K + + +D + Q+ + Y H +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K NL +++ +K+ DFG AR T Y + Y +PEI+
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY--------VATRWYRAPEIMLNWM 193
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282
+ Q DIWS+G ++ ++ GR F T++ + LK + + V P + L
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQ---APIDYLKKFLPREIEVVKGLKHPNLIR 115
+G GSYATV S + + VA+K+I + P + RE ++KGLKH N++
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-----REASLLKGLKHANIVL 67
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
I T + ++ EY + + + + + + QL + Y H++ ++HR
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+K +NLL+ D +KL+DFG AR SV + Y + + Y P++L G
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW-----YRPPDVLLGSTEYS 182
Query: 236 QQSDIWSMGVVLFAMVYGRLPF 257
D+W +G + M+ G F
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-20
Identities = 64/224 (28%), Positives = 121/224 (54%), Gaps = 16/224 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + V + H++ VAIK + + + FL E ++K L+HP L+R L
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPE---AFL-AEANLMKQLQHPRLVR-LY 67
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDE--DKGRRWFSQLADAIDYCHKKSVVHRD 176
A+ T +YII EY +NGSL++ ++ I +K +Q+A+ + + +K+ +HRD
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
++ N+L+ + K++DFG AR + + +Y F + +PE + +T
Sbjct: 128 LRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKF--PIKWTAPEAINYGTFTI- 182
Query: 237 QSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK--RVVFPE 277
+SD+WS G++L +V YGR+P+ E+++ +++ R+ P+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS V +AT + VA+K K+ ++ L E+ +++ +H N++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ ++++ME+ + G+L +++ R +E + L A+ H + V+HRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVL-KALSVLHAQGVIHRDIK 143
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
+++LL +KLSDFGF + S K + G+ + +PE++ +PY P +
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLVGTPYWMAPELISRLPYGP-EV 197
Query: 239 DIWSMGVVLFAMVYGRLPF 257
DIWS+G+++ MV G P+
Sbjct: 198 DIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 79 VAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYIIMEYAKNG 136
VA+K + P D+L E +++K L+HP LI+ L A+ T +YI+ E K G
Sbjct: 33 VAVKTLKPGTMDPKDFL-----AEAQIMKKLRHPKLIQ-LYAVCTLEEPIYIVTELMKYG 86
Query: 137 SLLEVIRKERYIDEDKGRR--------WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY 188
SLLE Y+ GR +Q+A + Y ++ +HRD+ N+L+ +
Sbjct: 87 SLLE------YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN 140
Query: 189 NIKLSDFGFARKYSVNNTDYKQNLSETFCGS---YAYASPEILKGVPYTPQQSDIWSMGV 245
K++DFG AR K+++ E G+ + +PE ++ +SD+WS G+
Sbjct: 141 ICKVADFGLARV-------IKEDIYEAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGI 192
Query: 246 VLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESP 279
+L +V YGR+P+ +E+L+QV + P P
Sbjct: 193 LLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 63/213 (29%), Positives = 112/213 (52%), Gaps = 9/213 (4%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS+ V R + VAIKII +A D ++ + +EI V+ P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIED-IQQEITVLSQCDSPYVTKYYG 69
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ +++IIMEY GS L+++ +DE + ++ +DY H + +HRDIK
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
N+LL + +KL+DFG A + + +T K+N TF G+ + +PE++K Y ++
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQ--LTDTQIKRN---TFVGTPFWMAPEVIKQSAYD-SKA 182
Query: 239 DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
DIWS+G+ + G P + + ++L + K
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPK 215
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 64/230 (27%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VG G+Y +V A R Q VA+K +S+ Q+ I + + RE+ ++K +KH N+I L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRLLKHMKHENVIGLL 80
Query: 118 Q------AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+IE + VY++ G+ L I K + + ++ + QL + Y H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
++HRD+K N+ +++ +++ DFG AR+ T Y + Y +PEI+
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY--------VATRWYRAPEIMLNW 190
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
+ Q DIWS+G ++ ++ G+ F +Y + LK++ + V P L
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 65/237 (27%), Positives = 118/237 (49%), Gaps = 16/237 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G + V + T ++ VAIK + +P +L+ E +V+K L+H L++ L
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-----EAQVMKKLRHEKLVQ-L 66
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
A+ + +YI+ EY GSLL+ ++ E +Y+ + +Q+A + Y + + VHR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D++ N+L+ + K++DFG AR + + +Y F + +PE +T
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 236 QQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291
+SD+WS G++L + GR+P+ E+L QV++ P P S L+
Sbjct: 183 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 49/191 (25%), Positives = 107/191 (56%), Gaps = 12/191 (6%)
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
+ P L+ A +T ++++I++Y G L + + E + + + ++ A+++ H
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K +++RDIK EN+LLD ++ L+DFG ++++ + + + +FCG+ Y +P+I+
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER----AYSFCGTIEYMAPDIV 178
Query: 229 KGVPYTPQQS-DIWSMGVVLFAMVYGRLPF----DDTNYSELLKQVQKRVVFPESPR-LS 282
+G ++ D WSMGV+++ ++ G PF + + +E+ +++ K P P+ +S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMS 236
Query: 283 SSCKALISNIL 293
+ K +I +L
Sbjct: 237 ALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 20/220 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VG G+Y +V A R + VAIK +S+ Q+ I + + RE+ ++K ++H N+I L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHENVIGLL 80
Query: 118 QAIETT------HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+ Y++M Y + L+ I EDK + Q+ + Y H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPL-SEDKVQYLVYQMLCGLKYIHSAG 137
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
++HRD+K NL +++ +K+ DFG AR T Y + Y +PE++
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--------VVTRWYRAPEVILNW 189
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
+ Q DIWS+G ++ M+ G+ F +Y + L Q+ K
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 70/205 (34%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIK-IISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRF 116
+G G+Y V A R + VA+K I + D + F REI ++ L HPN+++
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDHPNIVKL 72
Query: 117 LQAI--ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRW-FSQLADAIDYCHKKSVV 173
L I E +Y++ EY + L VIR I ED +R+ QL A+ Y H +V+
Sbjct: 73 LNVIKAENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVI 129
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPEILK 229
HRD+K N+LL+ +KL+DFG AR S + +N T Y Y +PEIL
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLT---DYVATRWYRAPEILL 185
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGR 254
G + D+WS+G +L M+ G+
Sbjct: 186 GSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G+Y V A ++ +A+K I +++ + + REI ++K ++H N++R
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 119 AIETTHRVYIIMEY------AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+ + R+Y++ EY S + + R I + + Q+ I YCH V
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-----KTYLYQILRGIAYCHSHRV 123
Query: 173 VHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD+K +NLL+D + N +KL+DFG AR + + + + + Y +PEIL G
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW-----YRAPEILLGS 178
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLK 267
+ DIWS+G + MV + F D+ EL K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-19
Identities = 67/269 (24%), Positives = 124/269 (46%), Gaps = 42/269 (15%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK----FLPREIEVVKGLKHPNL 113
V+G G++ V+L A+KI+ K D L+K + E +++ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKA----DMLEKEQVGHIRAERDILVEADSLWV 63
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
++ + + +Y+IME+ G ++ ++ K+ + E++ + + ++ AID H+ +
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQNLSETF---------------- 216
HRDIK +NLLLD K ++KLSDFG + T++ +NL+ +
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 217 -------------CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 263
G+ Y +PE+ Y + D WS+GV+++ M+ G PF
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 264 ELLKQV---QKRVVFPESPRLSSSCKALI 289
E K+V ++ ++FP +S K LI
Sbjct: 243 ETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLI 114
+G G+Y TV A + + VA+K + +D + +P REI ++K LKH N++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG-------RRWFSQLADAIDYC 167
R + + ++ ++ EY ++Y D G + + QL + +C
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQDL-------KKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H +V+HRD+K +NLL++ +KL+DFG AR + + Y + + Y P++
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-----YRPPDV 170
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQK 271
L G D+WS G + + P F + + LK++ +
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 54/167 (32%), Positives = 88/167 (52%), Gaps = 9/167 (5%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQ 159
RE++V+ P ++ F A + + I ME+ GSL +V++K I E +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA 111
Query: 160 LADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+ + Y +K ++HRD+K N+L++ + IKL DFG + + +++ +F G
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 164
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
+ +Y SPE L+G Y+ QSDIWSMG+ L M GR P + EL
Sbjct: 165 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGLKHPNLIRF 116
VG G+Y TV A R VAIK K+ P + K RE+ ++K +KH N+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 117 L------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
L +++ H Y++M + G+ L + K + ED+ + Q+ + Y H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE-ILK 229
++HRD+K NL +++ +K+ DFG AR+ T Y + Y +PE IL
Sbjct: 138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY--------VVTRWYRAPEVILN 189
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
+ YT Q DIWS+G ++ M+ G+ F ++ + L ++ K
Sbjct: 190 WMHYT-QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED-KGRRWFS 158
RE++V+ P ++ F A + + I ME+ GSL +V+++ + I E+ G+ +
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
L K ++HRD+K N+L++ + IKL DFG + + +++ +F G
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 164
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
+ +Y SPE L+G Y+ QSDIWSMG+ L + GR P + EL
Sbjct: 165 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-19
Identities = 63/266 (23%), Positives = 128/266 (48%), Gaps = 20/266 (7%)
Query: 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF--LPREIEVVKGLKHPNL 113
G ++G G++ V L +++A K + + K+ L EI+++K L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 114 IRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+++ + + I MEY GS+ + ++ + E R++ Q+ + + Y H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQNLSETFCGSYAYASPEIL 228
+VHRDIK N+L D N+KL DFG +++ ++ T + + G+ + SPE++
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-----SVTGTPYWMSPEVI 181
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL----SSS 284
G Y +++D+WS+G + M+ + P+ + E + + K P +P+L S
Sbjct: 182 SGEGYG-RKADVWSLGCTVVEMLTEKPPWAEY---EAMAAIFKIATQPTNPQLPSHISEH 237
Query: 285 CKALISNILSPVKFRIQMEDIRQDPW 310
+ + I + R E++ + P+
Sbjct: 238 ARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-19
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQ 159
RE++V+ P ++ F A + + I ME+ GSL +V++K I E+ +
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 160 LADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+ + Y +K ++HRD+K N+L++ + IKL DFG + + +++ +F G
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 160
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
+ +Y SPE L+G YT QSDIWS+G+ L M GR P + EL
Sbjct: 161 TRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
VG G+Y V A + + VAIK +S+ Q+ I + + RE+ ++K + H N+I L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHENVIGLL 80
Query: 118 ------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
++E VY++ G+ L I K + + +D + Q+ + Y H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG 138
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI-LKG 230
++HRD+K N+ +++ +K+ DFG AR T Y + Y +PEI L
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY--------VATRWYRAPEIMLNW 190
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
+ Y Q DIWS+G ++ ++ G+ F +++ + LK++
Sbjct: 191 MHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 55 LGDVVGMGSYATVKLATSARHS-----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
LG +G G + V AT+ R VA+K++ + + + L E ++K +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLKQVN 61
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-----YIDEDKGRRWFS------ 158
HP++I+ A + +I+EYAK GSL +R+ R Y+ D R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 159 -------------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205
Q++ + Y + +VHRD+ N+L+ + +K+SDFG +R +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 251
+ K++ + + E L YT QSD+WS GV+L+ +V
Sbjct: 182 SYVKRSKGRI---PVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 22/222 (9%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+LG+++G G + V Q VA+K I D + E V+ L H NL
Sbjct: 9 TLGEIIGEGEFGAV--LQGEYTGQKVAVKNIK-----CDVTAQAFLEETAVMTKLHHKNL 61
Query: 114 IRFLQAIETTHR-VYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFS-QLADAIDYCHKK 170
+R L I H +YI+ME G+L+ +R + R + FS +A+ ++Y K
Sbjct: 62 VRLLGVI--LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+VHRD+ N+L+ + K+SDFG AR S+ + K + T +PE LK
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------APEALKH 171
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+WS GV+L+ + YGR P+ + E+ + V+K
Sbjct: 172 KKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
H Y L VG G+Y V A + + A+KII K++ D+ + +EI +VK KH
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDF--SLIQQEIFMVKECKH 65
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
N++ + + + +++I MEY GSL ++ + E + + + Y H K
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-- 228
+HRDIK N+LL D ++KL+DFG A K + K +F G+ + +PE+
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK-----SFIGTPYWMAPEVAAV 180
Query: 229 -KGVPYTPQQSDIWSMGV 245
K Y Q DIW++G+
Sbjct: 181 EKNGGYN-QLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 27/243 (11%)
Query: 58 VVGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+G G++ V L + VA+K + K A D K F RE E++ +H N
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFE-REAELLTNFQHEN 69
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE-------RYIDEDKGRRWFSQL----- 160
+++F ++ EY ++G L + +R + D G SQL
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 161 --ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
A + Y + VHRD+ N L+ +K+ DFG +R V TDY + T
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTML- 186
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFPE 277
+ PE + +T +SD+WS GVVL+ + YG+ P+ + E+++ + + + +
Sbjct: 187 PIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL-Q 244
Query: 278 SPR 280
PR
Sbjct: 245 RPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 61/244 (25%), Positives = 117/244 (47%), Gaps = 11/244 (4%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G++ V T R + VA+K + V + K+ RE++++ KH N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 119 AIETTH-----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
++ H +Y++ E ++ L ++I + + D + + Q+ + Y H ++
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRDIK NLL++ +K+ DFG AR V D +++++ Y Y +PEIL G +
Sbjct: 126 HRDIKPGNLLVNSNCVLKICDFGLAR---VEEPDESKHMTQEVVTQY-YRAPEILMGSRH 181
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293
DIWS+G + ++ R+ F + + L + + P + S+C+ ++IL
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241
Query: 294 SPVK 297
Sbjct: 242 RGPH 245
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 78 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 137
+VA+K + P D +KFL +E E++K HPN+++ + +YI+ME GS
Sbjct: 21 EVAVKT-CRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78
Query: 138 LLEVIRKERYIDEDKGRRWFSQLADA---IDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194
LL +RK++ + ++ DA ++Y K+ +HRD+ N L+ + +K+SD
Sbjct: 79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISD 136
Query: 195 FGFARK-----YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249
FG +R+ Y+V++ KQ + +PE L YT +SD+WS G++L+
Sbjct: 137 FGMSREEEGGIYTVSD-GLKQI-------PIKWTAPEALNYGRYT-SESDVWSYGILLWE 187
Query: 250 MV-YGRLPFDDTNYSELLKQVQK--RVVFPES 278
G P+ + + ++++ R+ P+
Sbjct: 188 TFSLGDTPYPGMSNQQTRERIESGYRMPAPQL 219
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 16/192 (8%)
Query: 101 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQ 159
EIE++ HP +++ L A +++I++E+ G++ ++ + +R + E + + Q
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+ +A+ Y H ++HRD+K N+LL +IKL+DFG + K N Q ++F G+
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK----NVKTLQR-RDSFIGT 173
Query: 220 YAYASPEI-----LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274
+ +PE+ +K PY ++DIWS+G+ L M P + N +L ++ K
Sbjct: 174 PYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-- 230
Query: 275 FPESPRLSSSCK 286
E P LS K
Sbjct: 231 --EPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-18
Identities = 61/222 (27%), Positives = 116/222 (52%), Gaps = 16/222 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G + V + T +++ VA+K + +P +L+ E +++K L+H L++ L
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE-----EAQIMKKLRHDKLVQ-L 66
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
A+ + +YI+ EY GSLL+ ++ + R + +Q+A + Y + + +HR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D++ N+L+ D K++DFG AR + + +Y F + +PE +T
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI 182
Query: 236 QQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276
+SD+WS G++L +V GR+P+ N E+L+QV++ P
Sbjct: 183 -KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G+ V A Q+VAIK +S+ + + K+ RE+ ++K + H N+I L
Sbjct: 23 PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLL 81
Query: 118 QA------IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+E VY++ME + +L +VI+ + +D ++ Q+ I + H
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG 138
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGSYAYASPEILK 229
++HRD+K N+++ +K+ DFG AR + T Y Y Y +PE++
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-------VVTRY-YRAPEVIL 190
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
G+ Y + DIWS+G ++ M+ G + F T++
Sbjct: 191 GMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDH 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G+Y V A ++ ++ VAIK I+ ID + REI++++ L H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL--REIKLLRHLDHENVIAIK 70
Query: 118 QAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+ HR VYI+ E + L ++IR + + +D + + QL + Y H +V
Sbjct: 71 DIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K NLLL+ ++K+ DFG AR S ++E + A +L
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG----DFMTEYVVTRWYRAPELLLNCSE 185
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLK 267
YT D+WS+G + FA + GR P F +Y LK
Sbjct: 186 YT-TAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 66/231 (28%), Positives = 115/231 (49%), Gaps = 23/231 (9%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDY---LKKFLPREIEVVKGLKHPNL 113
+++G G+ TV A + +A+K+I P+D L+K + E+E++ P +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVI-----PLDITVELQKQIMSELEILYKCDSPYI 61
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
I F A +R+ I E+ GSL +V RK I E R + + Y ++
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLKIL 117
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRD+K N+L++ + +KL DFG + + VN ++++T+ G+ AY +PE + G Y
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL-VN------SIAKTYVGTNAYMAPERISGEQY 170
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLK-QVQKRVVFPESPRL 281
SD+WS+G+ + GR P+ N L+ Q+ + +V + P L
Sbjct: 171 G-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 94 LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED-K 152
++K + RE++++ + P ++ F A + + + ME+ GSL + +K I +
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEIL 105
Query: 153 GRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
G+ + + + ++HRDIK N+L++ + IKL DFG + + +N ++
Sbjct: 106 GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-IN------SI 158
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--------- 263
++TF G+ Y SPE ++G YT +SD+WS+G+ + + G+ PF +N
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217
Query: 264 --ELLKQVQKRVVFPESPRLSSS 284
+LL+Q +V PRL SS
Sbjct: 218 ILDLLQQ----IVQEPPPRLPSS 236
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 39/228 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII----SKVQAPIDYLKKFLPREIEVVKGL 108
Y + +G G++ V A + + VA+K I K PI L REI+++K L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-----REIKILKKL 64
Query: 109 KHPNLIRFLQAI-----ETTHR---VYIIMEYAK---NGSLLEVIRKERYIDEDKGRRWF 157
KHPN++ + ++ + VY++ Y +G LLE + + E + + +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-LLENPSVK--LTESQIKCYM 121
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
QL + I+Y H+ ++HRDIK N+L+D++ +K++DFG AR Y N
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY----DGPPPNPKGGGG 177
Query: 218 GSYA----------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
G Y PE+L G YT DIW +G V M R
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTT-AVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 26/232 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS V A + + VA+K I +K L REI++++ L H N+++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHAL-REIKIIRRLDHDNIVKVYE 69
Query: 119 AIETTHR--------------VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
+ + VYI+ EY + L + ++ + E+ R + QL +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGL 127
Query: 165 DYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYA 221
Y H +V+HRD+K N+ ++ + +K+ DFG AR + + Y K LSE +
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEGLVTKW- 183
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273
Y SP +L + D+W+ G + M+ G+ F + E ++ + + V
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 76 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIMEYAK 134
+VAIK++ ++ + RE + L HPN++ L + E ++ + EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIK 191
+L EV+ + + + R Q+ DA+ H + +VHRD+K +N+++ + + K
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 192 LSDFGFARKYSVNNTDYKQNLSET--FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249
+ DFG L+ T G+ Y +PE L+G P TP SD+++ G++
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP-NSDLYAWGLIFLE 181
Query: 250 MVYGRLPFDDTNYSELLKQ 268
+ G+ + +E+L Q
Sbjct: 182 CLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 16/180 (8%)
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A ET + ++M G L I E E + + +Q+ +++ H++ +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+K EN+LLDD N+++SD G A + + G+ Y +PE+L+G Y
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELK------GGKKIKGRAGTPGYMAPEVLQGEVYD-F 173
Query: 237 QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-----FPE--SPRLSSSCKALI 289
D +++G L+ M+ GR PF +++++R + +P+ SP C+AL+
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 30/244 (12%)
Query: 57 DVVGMGSYATVKLATSARH--SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNL 113
DV+G G++ V A + D AIK + + + D+ + E+EV+ L HPN+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNI 58
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG----------------RRWF 157
I L A E +Y+ +EYA +G+LL+ +RK R ++ D +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
+ +A +DY +K +HRD+ N+L+ + Y K++DFG +R V K+ +
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRL-- 173
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 276
+ + E L YT SD+WS GV+L+ +V G P+ +EL +++ +
Sbjct: 174 -PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL- 230
Query: 277 ESPR 280
E P
Sbjct: 231 EKPL 234
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 32/222 (14%)
Query: 54 SLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
+LG +G G++ V A + + VA+K++ K A L + E+E++K +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLV-SEMEMMKMI 72
Query: 109 -KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED---------------K 152
KH N+I L +Y+++EYA +G+L + +R R E K
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 153 GRRWFS-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211
F+ Q+A +++ K +HRD+ N+L+ + + +K++DFG AR +++ DY +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRK 190
Query: 212 LSETFCGS--YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 251
+ G + +PE L YT QSD+WS GV+L+ +
Sbjct: 191 TTN---GRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 49/265 (18%)
Query: 11 RPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLA 70
D+ ++ER H+ NA + E+ D + S Y LG+++G GS+ V A
Sbjct: 30 MNDKKLDEEERSHN--NNAGEDEDEEKMIDNDINRS--PNKSYKLGNIIGNGSFGVVYEA 85
Query: 71 TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY--- 127
S+ VAIK + +Q P ++ RE+ ++K L H N+I FL+ T
Sbjct: 86 ICIDTSEKVAIKKV--LQDP-----QYKNRELLIMKNLNHINII-FLKDYYYTECFKKNE 137
Query: 128 ------IIME------------YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
++ME YA+N L + + Y QL A+ Y H
Sbjct: 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS---------YQLCRALAYIHS 188
Query: 170 KSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K + HRD+K +NLL+D + +KL DFG A+ N Q C + Y +PE++
Sbjct: 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLAGQRSVSYICSRF-YRAPELM 242
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYG 253
G D+WS+G ++ M+ G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 57 DVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNL 113
DV+G G++ V A + + AIK++ + + D+ + E+EV+ L HPN+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNI 65
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG----------------RRWF 157
I L A E +YI +EYA G+LL+ +RK R ++ D ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
S +A + Y +K +HRD+ N+L+ + K++DFG +R V K+ +
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRL-- 180
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 269
+ + E L YT +SD+WS GV+L+ +V G P+ +EL +++
Sbjct: 181 -PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 19/230 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS+ V AT++ ++ VA+K +S + + + +E++ ++ LKHPN I +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 119 AIETTHRVYIIMEY--AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
H +++MEY LLEV +K + E + + Y H +++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP--YT 234
IK N+LL + +KL+DFG A K S N +F G+ + +PE++ +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPAN---------SFVGTPYWMAPEVILAMDEGQY 197
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
+ D+WS+G+ + + P + N L + + +SP L S+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQSN 243
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 60/221 (27%), Positives = 114/221 (51%), Gaps = 14/221 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G + V + T + VAIK + P + + +E +++K L+H L+ L
Sbjct: 14 LGQGCFGEVWMGT-WNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVP-LY 67
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A+ + +YI+ E+ GSLL+ +++ +Y+ + +Q+AD + Y + + +HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
++ N+L+ D K++DFG AR + + +Y F + +PE +T
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKF--PIKWTAPEAALYGRFTI- 182
Query: 237 QSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276
+SD+WS G++L +V GR+P+ E+L+QV++ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 75 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134
+ VAIK + K A ++F +E E++ L+HPN++ L ++ EY
Sbjct: 34 SATSVAIKTL-KENAEPKVQQEFR-QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 135 NGSLLE-VIRK--------ERYIDEDKGRRWFS-------QLADAIDYCHKKSVVHRDIK 178
+G L E ++R E + K S Q+A ++Y VHRD+
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLA 151
Query: 179 CENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFCGSYAYASPE-ILKGVPYTPQ 236
N L+ + +K+SDFG +R YS DY + S++ + PE IL G +T
Sbjct: 152 ARNCLVGEGLTVKISDFGLSRDIYS---ADYYRVQSKSLL-PVRWMPPEAILYG-KFTT- 205
Query: 237 QSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 276
+SDIWS GVVL+ + YG P+ + E+++ ++ R + P
Sbjct: 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-17
Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 26/276 (9%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLK-KFLPREIEVVKGLKHPNLIR 115
D +G G+Y +V H + +++ +D K + E++++ P ++
Sbjct: 7 DELGKGNYGSV---YKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVI---RKERYIDEDKGRRWFSQLADAIDYCHKK-S 171
F A VY+ MEY GSL ++ I ED RR + + + ++ +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG- 230
++HRD+K N+L++ +KL DFG + + +L++T G +Y +PE +K
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS-------GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 231 ----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL----S 282
P QSD+WS+G+ + M GR P+ Y+ + Q+ +V + P L S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-IVDGDPPTLPSGYS 235
Query: 283 SSCKALISNILSPV-KFRIQMEDIRQDPWLKEDSNP 317
+ ++ L+ + R + + PWL + N
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 46/276 (16%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G+G++ V LA A+K + K + + E +++ + ++R
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ + +Y +M+Y G ++ ++ + ED R + ++L A++ HK +HRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128
Query: 179 CENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQN-------------------------- 211
+N+L+D +IKL+DFG + +++ Y Q+
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188
Query: 212 ---------------LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 256
L+ + G+ Y +PE+L YT Q D WS+GV+L+ M+ G+ P
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPP 247
Query: 257 FDDTNYSELLKQV---QKRVVFPESPRLSSSCKALI 289
F E +V Q + P +LS LI
Sbjct: 248 FLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 63/239 (26%), Positives = 114/239 (47%), Gaps = 17/239 (7%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+LG +G G + V + VA+K K +KFL +E +++ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVREKFL-QEAYIMRQFDH 66
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
P++++ L + T + V+I+ME A G L ++ +Y +D + QL+ A+ Y
Sbjct: 67 PHIVK-LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
K VHRDI N+L+ +KL DFG +R Y + + YK + + + +PE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKL---PIKWMAPESIN 181
Query: 230 GVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQK--RVVFPES--PRLSS 283
+T SD+W GV ++ ++ G PF ++++ +++ R+ P + P L S
Sbjct: 182 FRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 58 VVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
V+G G + V L S A+K ++++ ++ +++FL +E ++K HPN++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFL-KEGIIMKDFSHPNVL 59
Query: 115 RFLQ-AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS-QLADAIDYCHKKSV 172
L + + +++ Y K+G L IR E + K F Q+A ++Y K
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARK------YSVNN-TDYKQNLSETFCGSYAYASP 225
VHRD+ N +LD+ + +K++DFG AR YSV+N T K + + +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--------WMAL 171
Query: 226 EILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTN 261
E L+ +T +SD+WS GV+L+ M G P+ D +
Sbjct: 172 ESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 31/236 (13%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIIS-----KVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+G GS+ V A R ++ VAIK +S + D +K E+ ++ L+HPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHPNT 77
Query: 114 IRFLQAIETTHRVYIIMEY--AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
I + H +++MEY +LEV +K + E + + Y H
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHE 135
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRDIK N+LL + +KL+DFG A S N +F G+ + +PE++ +
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---------SFVGTPYWMAPEVILAM 186
Query: 232 ---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
Y + D+WS+G+ + + P + N L + + +SP LSS+
Sbjct: 187 DEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLSSN 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 71/306 (23%), Positives = 131/306 (42%), Gaps = 55/306 (17%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR---EIEVVKGLKHPNLI 114
V+G G++ V+L + A+K + K + + K L E +V+ P ++
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM---FKKDQLAHVKAERDVLAESDSPWVV 64
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ + +Y+IME+ G L+ ++ K ED R + ++ AI+ HK +H
Sbjct: 65 SLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKY----------------SVNNTDYKQN------- 211
RDIK +N+L+D +IKLSDFG + + S N +N
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 212 -------------------LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY 252
++ + G+ Y +PEI Y Q+ D WS+G ++F +
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMFECLI 243
Query: 253 GRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIR 306
G PF N E +++ ++ + FP+ LS + LI +++ + R+ +I+
Sbjct: 244 GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIK 303
Query: 307 QDPWLK 312
P+ +
Sbjct: 304 SHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS+ V A R ++ VAIK +S + + + +E++ ++ +KHPN I +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 119 AIETTHRVYIIMEY--AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
H +++MEY LLEV +K + E + + Y H +++HRD
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP--YT 234
IK N+LL + +KL+DFG A S N +F G+ + +PE++ +
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPAN---------SFVGTPYWMAPEVILAMDEGQY 201
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
+ D+WS+G+ + + P + N L + + ESP L S+
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQSN 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 29/243 (11%)
Query: 47 VLETHGYSLGDVVGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEV 104
VLE + DV+G G++ V A + D AIK + + + D+ + E+EV
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEV 60
Query: 105 VKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG---------- 153
+ L HPN+I L A E +Y+ +EYA +G+LL+ +RK R ++ D
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 154 ------RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207
+ + +A +DY +K +HRD+ N+L+ + Y K++DFG +R V
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--- 177
Query: 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 266
K+ + + + E L YT SD+WS GV+L+ +V G P+ +EL
Sbjct: 178 VKKTMGRL---PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233
Query: 267 KQV 269
+++
Sbjct: 234 EKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 60/224 (26%), Positives = 114/224 (50%), Gaps = 17/224 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL- 117
+G G+ V A A ++VAIK +S+ + K+ RE+ ++K + H N+I L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLN 90
Query: 118 -----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++E VYI+ME + +L +VI+ E +D ++ Q+ I + H +
Sbjct: 91 VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGI 147
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+++ +K+ DFG AR T + + + Y +PE++ G+
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 276
Y + DIWS+G ++ M+ G + F T++ + +V +++ P
Sbjct: 202 YK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 46 SVLE-THGYSLGDVVGMGSYATVKLATSARHSQDVAIK-IISKVQAPIDYLKKFLPREIE 103
+V E T+ Y VGMG++ V A Q+VAIK I+ P+ L K RE++
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV--LAKRTYRELK 61
Query: 104 VVKGLKHPNLIR----FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQ 159
++K L+H N+I F+ +E +Y + E G+ L + R +++ + + Q
Sbjct: 62 LLKHLRHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQ 116
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+ + Y H VVHRD+K N+L+++ ++K+ DFG AR T Y +
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY--------VST 168
Query: 220 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
Y +PEI+ + DIWS G + M+ G+ F
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G + V L + VAIK I++ + D+++ E +V+ L HP L++
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIE-----EAKVMMKLSHPKLVQLY 65
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+YI+ E+ +NG LL +R+ + + +D + + ++Y + S +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+ N L+ +K+SDFG R V + +Y + F ++ PE+ Y+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYS-S 180
Query: 237 QSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 271
+SD+WS GV+++ + G++PF+ + E+++ + +
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
++ V+G G + V +L + DVAIK + K + FL E ++ H
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFL-TEASIMGQFDH 64
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADA 163
PN+IR + + V II EY +NGSL ++++ E+ G+ QL A
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSL------DKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG--SYA 221
+ Y + + VHRD+ N+L++ K+SDFG +R+ + Y T G
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-----TTKGGKIPIR 173
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
+ +PE + +T SD+WS G+V++ M YG P+ D + +++K V+
Sbjct: 174 WTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 54 SLGDVVGMGSYATVKLATS-------ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK 106
+LG +G G + V +A + + + VA+K++ D L E+E++K
Sbjct: 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 75
Query: 107 GL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI------------DEDKG 153
+ KH N+I L A +Y+I+EYA G+L E +R R DE
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 154 RRWFS----QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
+ Q+A ++Y + +HRD+ N+L+ + +K++DFG AR VNN DY
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYY 193
Query: 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQ 268
+ + + +PE L YT QSD+WS GV+++ + G P+ EL K
Sbjct: 194 KKTTNGRL-PVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 269 VQK 271
+++
Sbjct: 252 LKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 77 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136
VA+K + K A K+FL +E ++ HPN+++ L YIIME + G
Sbjct: 27 IRVAVKTLRK-GATDQEKKEFL-KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG 84
Query: 137 SLLEVIRKERYIDEDKGRRWFSQLAD-AID------YCHKKSVVHRDIKCENLLLDDKYN 189
LL +R R +L D +D Y + +HRD+ N L+ +K
Sbjct: 85 DLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY 144
Query: 190 -----IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244
+K+ DFG AR + +DY + E + +PE L +T QSD+WS G
Sbjct: 145 DADRVVKIGDFGLAR--DIYKSDYYRKEGEGLL-PVRWMAPESLLDGKFT-TQSDVWSFG 200
Query: 245 VVLFA-MVYGRLPFDDTNYSELLKQVQ 270
V+++ + G+ P+ N E+L+ V
Sbjct: 201 VLMWEILTLGQQPYPALNNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-16
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIR 115
+G+G+Y TV A VA+K + +VQ D L RE+ ++K L+ HPN++R
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 116 FLQAIETTH-----RVYIIMEYAKNGSLLEVIRKERYIDE--------DKGRRWFSQLAD 162
+ T+ +V ++ E+ Y+D+ + + Q
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDL-------RTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
+D+ H +VHRD+K EN+L+ +KL+DFG AR YS + L+ + Y
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-----CQMALTPVVVTLW-Y 173
Query: 223 ASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPF 257
+PE+L Y TP D+WS+G + FA ++ R P
Sbjct: 174 RAPEVLLQSTYATP--VDMWSVGCI-FAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 63/234 (26%), Positives = 115/234 (49%), Gaps = 30/234 (12%)
Query: 43 RKLSVLETHGY-SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPRE 101
++L +L+T G GDV+ +G Y K+A IK + QA + E
Sbjct: 6 KELKLLQTIGKGEFGDVM-LGDYRGNKVAVKC-------IKNDATAQAFL--------AE 49
Query: 102 IEVVKGLKHPNLIRFLQAI-ETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFS 158
V+ L+H NL++ L I E +YI+ EY GSL++ +R + D ++
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+ +A++Y + VHRD+ N+L+ + K+SDFG ++ S K + T
Sbjct: 110 DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--- 166
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+PE L+ ++ +SD+WS G++L+ + +GR+P+ +++ +V+K
Sbjct: 167 -----APEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 16/232 (6%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G G+Y V A + + AIK+I K++ D+ + +EI ++K KH N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDF--AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ +++I ME+ GSL ++ + E + + + Y H K +HRDIK
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL----KGVPYT 234
N+LL D ++KL+DFG + + + K +F G+ + +PE+ KG Y
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRK-----SFIGTPYWMAPEVAAVERKG-GYN 187
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286
Q DIW++G+ + + P D + L + K P P+L K
Sbjct: 188 -QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP--PKLKDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 62/244 (25%), Positives = 116/244 (47%), Gaps = 19/244 (7%)
Query: 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPR 100
L +L+ + V+G G++ TV + VAIK + + +P K +
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILD 58
Query: 101 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRR----W 156
E V+ + +P++ R L I T V +I + G LL+ +R+ + ++ G + W
Sbjct: 59 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNW 114
Query: 157 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216
Q+A ++Y ++ +VHRD+ N+L+ ++K++DFG A+ + +Y +
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV- 173
Query: 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQKRVVF 275
+ + E + YT QSD+WS GV ++ M +G P+D SE+ ++K
Sbjct: 174 --PIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 230
Query: 276 PESP 279
P+ P
Sbjct: 231 PQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 59 VGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G G++ V S R D VA+K + P D KFL +E ++K HPN++R
Sbjct: 3 IGRGNFGEV---FSGRLRADNTPVAVKSCRETLPP-DLKAKFL-QEARILKQYSHPNIVR 57
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ +YI+ME + G L +R E + + + A ++Y K +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RD+ N L+ +K +K+SDFG +R+ + + + +PE L Y+
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI---PVKWTAPEALNYGRYS 174
Query: 235 PQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK--RVVFPE 277
+SD+WS G++L+ A G +P+ + + + + +++ R+ PE
Sbjct: 175 -SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 69/303 (22%), Positives = 127/303 (41%), Gaps = 49/303 (16%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G+G++ V LA A+K + K + E +++ + +++
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ + +Y +M+Y G ++ ++ + E R + ++L AI+ HK +HRDIK
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128
Query: 179 CENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQN-------------------------- 211
+N+L+D +IKL+DFG + +N+ Y Q
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 212 ---------------LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 256
L+ + G+ Y +PE+L YT Q D WS+GV+LF M+ G+ P
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPP 247
Query: 257 FDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPW 310
F +E +V + + P +LS LI+ + + R+ +DI+ P+
Sbjct: 248 FLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 311 LKE 313
E
Sbjct: 308 FSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 56/216 (25%), Positives = 111/216 (51%), Gaps = 8/216 (3%)
Query: 59 VGMGSYATVK--LATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G++ TVK + + + VA+KI+ K LK L RE V++ L +P ++R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ E + ++ME A+ G L + ++K +++ E Q++ + Y + + VHRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+ N+LL ++ K+SDFG ++ + YK + + +PE + ++
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW--PVKWYAPECMNYYKFS-S 177
Query: 237 QSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
+SD+WS GV+++ A YG+ P+ +E+ + ++
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 60/250 (24%), Positives = 112/250 (44%), Gaps = 32/250 (12%)
Query: 57 DVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+V+G G + V +L + VAIK + K + FL E ++ HPN+
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNI 67
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADAIDY 166
I + + V II E+ +NG+L + ++ ++ G+ QL A + Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----- 221
+ + VHRD+ N+L++ K+SDFG +R + +D T+ S
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------PTYTSSLGGKIPI 175
Query: 222 -YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
+ +PE + +T SD+WS G+V++ M YG P+ D + +++ +++ P
Sbjct: 176 RWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234
Query: 280 RLSSSCKALI 289
++ L+
Sbjct: 235 DCPTALHQLM 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 55/231 (23%), Positives = 112/231 (48%), Gaps = 19/231 (8%)
Query: 58 VVGMGSYATVKLATSARHSQDV----AIKIISKVQAP---IDYLKKFLPREIEVVKGLKH 110
V+G G++ TV + V AIKI+++ P ++++ + L ++ + H
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-----IMASMDH 68
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHK 169
P+L+R L + + + ++ + +G LL+ + + + I W Q+A + Y +
Sbjct: 69 PHLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE 127
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+ +VHRD+ N+L+ ++K++DFG AR + +Y + + + + E +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM---PIKWMALECIH 184
Query: 230 GVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
+T QSD+WS GV ++ M +G P+D E+ ++K P+ P
Sbjct: 185 YRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 78/318 (24%), Positives = 143/318 (44%), Gaps = 61/318 (19%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL- 117
+G G+ V A A ++VAIK +S+ + K+ RE+ ++K + H N+I L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 83
Query: 118 -----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++E VY++ME + +L +VI+ E +D ++ Q+ I + H +
Sbjct: 84 VFTPQKSLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+++ +K+ DFG AR T + + + Y +PE++ G+
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------------SELLKQVQKRV---- 273
Y + DIWS+G ++ MV ++ F +Y E +K++Q V
Sbjct: 195 YK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 274 -------------VFPES--PRLS-------SSCKALISNIL--SPVKFRIQMEDIRQDP 309
+FP+S P S S + L+S +L P K RI +++ Q P
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK-RISVDEALQHP 312
Query: 310 WLKEDSNPVGKSKSAPEV 327
++ +P P++
Sbjct: 313 YINVWYDPAEVEAPPPQI 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 68/230 (29%), Positives = 116/230 (50%), Gaps = 20/230 (8%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQD--VAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
Y L +G G+Y V A +A S++ VAIK I+ V + K+ L RE+++++ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFR 59
Query: 110 -HPNL-------IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLA 161
H N+ I F + +ME L ++IR + + + + + Q+
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
+ Y H +V+HRD+K NLL++ +K+ DFG AR +S N + ++E + +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVATRW 174
Query: 222 YASPEI-LKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQV 269
Y +PEI L YT + D+WS+G +L A + GR P F +Y + L Q+
Sbjct: 175 YRAPEIMLSFQSYT-KAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
+G GS+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN I++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 119 AIETTHRVYIIMEY--AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
H +++MEY LLEV +K + E + + Y H +++HRD
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP--YT 234
+K N+LL + +KL DFG A + N F G+ + +PE++ +
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPAN---------XFVGTPYWMAPEVILAMDEGQY 191
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
+ D+WS+G+ + + P + N L + + ESP L S
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQSG 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 101 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFS 158
E E+++ + P ++ A E+ + ++M G L I ER ++ ++ + +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+ I + H +V+RD+K EN+LLDD+ N +LSD G A + T ++ G
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR------AG 156
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
+ Y +PEILK PY+ D ++MG ++ MV GR PF D
Sbjct: 157 TNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 38/142 (26%), Positives = 82/142 (57%), Gaps = 8/142 (5%)
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL----KHPNLIRFL 117
G++ V L +S+ A+K++ K D + K + +++ + K P ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKA----DMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
++++ + VY++MEY G + ++ Y DE+ ++ S++A A+DY H+ ++HRD+
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 178 KCENLLLDDKYNIKLSDFGFAR 199
K +N+L+ ++ +IKL+DFG ++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 20/220 (9%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +V+G GSY V A + VAIK I+ V + + L REI++++ L+HP+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL-REIKLLRLLRHPD 60
Query: 113 LIRFLQAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
++ + R +Y++ E ++ L +VI+ + + + + QL A+ Y
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YA 223
H +V HRD+K +N+L + +K+ DFG AR + N+T + F Y Y
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTP-----TAIFWTDYVATRWYR 173
Query: 224 SPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
+PE+ YTP DIWS+G + ++ G+ F N
Sbjct: 174 APELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 62/224 (27%), Positives = 107/224 (47%), Gaps = 24/224 (10%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+++G G++ V T + VA+K K P + KFL E ++K HPN+++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKT-CKEDLPQELKIKFL-SEARILKQYDHPNIVKL 57
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADA---IDYCHKKSVV 173
+ +YI+ME G L +RK++ DE K ++ DA + Y K+ +
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARK-----YSVNNTDYKQNLSETFCGSYAYASPEIL 228
HRD+ N L+ + +K+SDFG +R+ YS ++ KQ + +PE L
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--SSGLKQI-------PIKWTAPEAL 166
Query: 229 KGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
Y+ +SD+WS G++L+ G P+ + +QV+K
Sbjct: 167 NYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 57/224 (25%), Positives = 111/224 (49%), Gaps = 17/224 (7%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL- 117
+G G+ V A +VA+K +S+ + K+ RE+ ++K + H N+I L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87
Query: 118 -----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++E VY++ME + +L +VI E +D ++ Q+ I + H +
Sbjct: 88 VFTPQKSLEEFQDVYLVMELM-DANLCQVIHME--LDHERMSYLLYQMLCGIKHLHSAGI 144
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+++ +K+ DFG AR N + + + Y +PE++ G+
Sbjct: 145 IHRDLKPSNIVVKSDCTLKILDFGLARTACTN------FMMTPYVVTRYYRAPEVILGMG 198
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 276
Y + DIWS+G ++ +V G + F T++ + +V +++ P
Sbjct: 199 YK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 68/243 (27%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQD-------VAIKIISKVQAPIDYLKKFLPREIEVVK 106
+LG +G G + V +A + +D VA+K++ D L E+E++K
Sbjct: 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD--LVSEMEMMK 72
Query: 107 GL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG------------ 153
+ KH N+I L A +Y+++EYA G+L E +R R D
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 154 -RRWFS---QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
+ S Q+A ++Y + +HRD+ N+L+ + +K++DFG AR V+N DY
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYY 190
Query: 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQ 268
+ + + +PE L YT QSD+WS GV+L+ + G P+ EL K
Sbjct: 191 KKTTNGRL-PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
Query: 269 VQK 271
+++
Sbjct: 249 LKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 32/223 (14%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
+G G + V L + VAIK I + + D+++ E +V+ L HP L++
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFIE-----EAQVMMKLSHPKLVQLY 65
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQ---------LADAIDYCH 168
+ ++ E+ ++G L + +R +R FSQ + + + Y
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMCLDVCEGMAYLE 117
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+V+HRD+ N L+ + +K+SDFG R V + Y + F ++SPE+
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSSTGTKF--PVKWSSPEVF 173
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQV 269
Y+ +SD+WS GV+++ V+ G+ P+++ + SE+++ +
Sbjct: 174 SFSKYS-SKSDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 58 VVGMGSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
V+G G++ TV ++ VAIK++ + +P K + E V+ G+ P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYV 71
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR-------RWFSQLADAIDY 166
R L I T V ++ + G LL+ Y+ E+K R W Q+A + Y
Sbjct: 72 CRLL-GICLTSTVQLVTQLMPYGCLLD------YVRENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
+ +VHRD+ N+L+ ++K++DFG AR ++ T+Y + + + + E
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV---PIKWMALE 181
Query: 227 ILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
+ +T QSD+WS GV ++ M +G P+D E+ ++K P+ P
Sbjct: 182 SILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 31/242 (12%)
Query: 55 LGDVVGMGSYATVKLATSARHSQD-------VAIKIISKVQAPIDYLKKFLPREIEVVKG 107
LG +G G + V +A + ++ VA+K++ D L E+E++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKM 79
Query: 108 L-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-------YIDEDKGRRWFS- 158
+ KH N+I L A +Y+I+EYA G+L E +R R Y S
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 159 --------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR +++ DY +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 197
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV 269
+ + +PE L YT QSD+WS GV+L+ + G P+ EL K +
Sbjct: 198 KTTNGRL-PVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 270 QK 271
++
Sbjct: 256 KE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGR 154
REI+++K + H +I + A V ++M K V R E+ I +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRR- 193
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214
L +A+ Y H + ++HRD+K EN+ LD+ N L DFG A K + D Q
Sbjct: 194 -----LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYG- 246
Query: 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+ G+ SPE+L PY ++DIWS G+VLF M +
Sbjct: 247 -WSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 60/231 (25%), Positives = 112/231 (48%), Gaps = 28/231 (12%)
Query: 75 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134
H+Q VAIK + + P + + +E ++ L HPN++ L + V ++ EY
Sbjct: 33 HAQLVAIKTLKDINNPQQWGE--FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 135 NGSLLE-VIRKERYID-----EDKGRRWFS-----------QLADAIDYCHKKSVVHRDI 177
G L E +I + + D ++ G S Q+A ++Y VH+D+
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDL 150
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
N+L+ ++ ++K+SD G +R+ + + DY + ++ + PE + ++
Sbjct: 151 AARNILIGEQLHVKISDLGLSRE--IYSADYYRVQPKSLL-PIRWMPPEAIMYGKFS-SD 206
Query: 238 SDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPES----PRLSS 283
SDIWS GVVL+ + +G P+ + E+++ V+KR + P S PR+ S
Sbjct: 207 SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 58 VVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
V+G G + V +L + VAIK + K + FL E ++ HPN+I
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASIMGQFDHPNII 68
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADAIDYC 167
+ + V I+ EY +NGSL +RK G+ QL A + Y
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASGMKYL 122
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA--YASP 225
VHRD+ N+L++ K+SDFG +R D + T G + +P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEAAYTTRGGKIPIRWTAP 178
Query: 226 EILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFP 276
E + +T SD+WS G+V++ M YG P+ + + +++K +++ P
Sbjct: 179 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 26/227 (11%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPN 112
+ +G G+Y V A + VA+K K + +D ++ +P REI +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMD--EEGIPPTALREISLLQMLSESI 61
Query: 113 LIRFLQAIETTHR------VYIIMEYAKNG--SLLEVIRKE--RYIDEDKGRRWFSQLAD 162
I L +E +Y++ EY + ++ + R + + + QL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
+ +CHK V+HRD+K +NLL+D + +K++D G R +S+ Y + +
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW----- 176
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLK 267
Y +PE+L G + DIWS+G + M + F D+ +LL
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 20/224 (8%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQ-DVAIKIISKVQAPIDYL--KKFLPREIEVVKGL-K 109
S G +G G++ V AT+ S+ D +K+ K+ P + ++ L E++++ L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYC 167
H N++ L A + +I EY G LL +R++R ++ + + Q+A + +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASP 225
K+ +HRD+ N+LL +K+ DFG AR +N+++Y K N A
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGN---ARLPVKWMAPE 213
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMV------YGRLPFDDTNYS 263
I V YT +SD+WS G++L+ + Y +P D Y
Sbjct: 214 SIFNCV-YT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 29/188 (15%)
Query: 83 IISKVQAPID------YLKKFLPREIEVVKGLKH------PNLIRFLQAIETTHRVYIIM 130
+I KV +D ++ K L + E + PN++ + I + V++++
Sbjct: 5 VIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVL 64
Query: 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI 190
++A+ G L I K I E+ +RW +++ A+D H++ +V RD+ N+LLDD+ +I
Sbjct: 65 QHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI 124
Query: 191 KLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPEILKGVPYTPQQSDIWSMGVV 246
+L+ F + E C A Y +PE+ G+ + D WS+G +
Sbjct: 125 QLTYFSRWSEV------------EDSCDGEAVENMYCAPEV-GGISEETEACDWWSLGAI 171
Query: 247 LFAMVYGR 254
LF ++ G+
Sbjct: 172 LFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 56/175 (32%), Positives = 96/175 (54%), Gaps = 13/175 (7%)
Query: 79 VAIKIISKVQ-APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKN 135
VA+K K+Q + ++L+ F REIE++K L+H N++++ + R + ++MEY
Sbjct: 36 VAVK---KLQHSTAEHLRDF-EREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91
Query: 136 GSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194
GSL + ++K R +D K + SQ+ ++Y K VHRD+ N+L++ + +K+ D
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGD 151
Query: 195 FGFARKYSVNNTDYK-QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
FG + + YK + E+ YA PE L ++ SD+WS GVVL+
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYA---PESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 59 VGMGSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G+Y V A + ++ AIK + + + REI +++ LKH N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 117 LQAI--ETTHRVYIIMEYAKNGSLLEVIR-----KERYIDEDKGRRWFSQLADAIDYCHK 169
++ VY++ +YA++ L ++I+ K I + Q+ + + Y H
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 170 KSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSY 220
V+HRD+K N+L+ ++ +K+ D G AR + N K T
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLADLDPVVVTIW--- 180
Query: 221 AYASPEILKGVP-YTPQQSDIWSMGVVLFA 249
Y +PE+L G YT DIW++G + FA
Sbjct: 181 -YRAPELLLGARHYTK-AIDIWAIGCI-FA 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 31/238 (13%)
Query: 55 LGDVVGMGSYATVKLATS-------ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
LG +G G + V A + + VA+K++ D L E+E++K
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD--LISEMELMKL 73
Query: 108 L-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED---------KGRRWF 157
+ KH N+I L +Y+I+EYA G+L E +R R D + + F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 158 S-------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
Q+A ++Y + +HRD+ N+L+ + +K++DFG AR V++ DY +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYK 191
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLK 267
S + +PE L YT QSD+WS G++++ + G P+ EL K
Sbjct: 192 KTSNGRL-PVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG---FARKYSVNNTDYKQNLSET 215
QL AIDY H + ++HRDIK EN+L++ +I L DFG FAR Y
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG------ 321
Query: 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
G+ +PE+L G PYTP DIWS G+V+F
Sbjct: 322 IAGTVDTNAPEVLAGDPYTP-SVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 33/270 (12%)
Query: 32 SDPNEQDKDT-----ERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISK 86
S+ ++ D D ++ V+ + GY++ + GS V +AT V +KI K
Sbjct: 42 SESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK 101
Query: 87 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 146
I+ + +++ + HP++IR + + +++ + + + ++ R
Sbjct: 102 GTTLIEAM---------LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR 152
Query: 147 YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206
+ D+ Q+ + + Y H + ++HRD+K EN+ ++D + + D G A+ V
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212
Query: 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD------ 259
G+ +PE+L Y ++DIWS G+VLF M+ Y F+D
Sbjct: 213 FLG------LAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
Query: 260 ----TNYSELLKQVQKRVVFPES-PRLSSS 284
+ +S LLK + V PE PR S
Sbjct: 266 EYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295
|
Length = 357 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 62/250 (24%), Positives = 117/250 (46%), Gaps = 23/250 (9%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVV 105
++ H L +G G++ V LA QD + + ++ D +K RE E++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE-------------RYIDEDK 152
L+H ++++F + ++ EY K+G L + +R + + +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 153 GRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
Q+A + Y + VHRD+ N L+ + +K+ DFG +R V +TDY +
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVG 179
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-Q 270
T + PE + +T +SD+WS+GVVL+ + YG+ P+ + +E+++ + Q
Sbjct: 180 GHTML-PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237
Query: 271 KRVVFPESPR 280
RV+ + PR
Sbjct: 238 GRVL--QRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 58 VVGMGSYATV---KLATSARHSQDVAIKIIS---KVQAPIDYLKKFLPREIEVVKGLKHP 111
V+G G + V L R VAIK + + D+L E ++ H
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-----EASIMGQFSHH 66
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADAI 164
N+IR + II EY +NG+L ++Y+ + G QL A +
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL------DKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA--Y 222
Y + VHRD+ N+L++ K+SDFG +R D + T G +
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE----DDPEGTYTTSGGKIPIRW 176
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFP 276
+PE + +T SD+WS G+V++ M +G P+ D + E++K + P
Sbjct: 177 TAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 43/149 (28%), Positives = 84/149 (56%), Gaps = 13/149 (8%)
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
E + + +Q+ +++ H++ +++RD+K EN+LLD+ N+++SD G A V D
Sbjct: 95 PEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA----VELKD- 149
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 268
Q+ ++ + G+ + +PE+L+G Y D +++GV L+ M+ R PF K+
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208
Query: 269 VQKR-----VVFPE--SPRLSSSCKALIS 290
+++R V +P+ SP S C+AL++
Sbjct: 209 LKQRILNDSVTYPDKFSPASKSFCEALLA 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 55/231 (23%), Positives = 108/231 (46%), Gaps = 22/231 (9%)
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P ++ A T ++ I++ G L + + E + R + +++ +++ H +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-K 229
VV+RD+K N+LLD+ ++++SD G A D+ + G++ Y +PE+L K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL----SSSC 285
GV Y +D +S+G +LF ++ G PF + K R+ + L S
Sbjct: 170 GVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPDSFSPEL 226
Query: 286 KALISNILS-PVKFRI-----QMEDIRQDPWLKE-DSNPVGKSKSAPEVIP 329
++L+ +L V R+ +++++ P+ + D V K P +IP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 58/221 (26%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L +VVG G+Y V + Q AIK++ + + +K EI ++K H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL----EINMLKKYSHHR 73
Query: 113 LIR-----FLQAIETTH--RVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADA 163
I F++ H +++++ME+ GS+ ++++ + + ED ++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223
+ + H V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF G+ +
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFIGTPYWM 188
Query: 224 SPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYGRLPFDD 259
+PE++ P +SDIWS+G+ M G P D
Sbjct: 189 APEVI-ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 71 TSARHSQDVAIKIIS-KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129
+Q VAIK + K + P L++ E + L+HPN++ L + + +I
Sbjct: 30 APGEQTQAVAIKTLKDKAEGP---LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86
Query: 130 MEYAKNGSLLE--VIRKERY----IDEDKGRR----------WFSQLADAIDYCHKKSVV 173
Y + L E V+R D+DK + +Q+A +++ VV
Sbjct: 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
H+D+ N+L+ DK N+K+SD G R+ V DY + + + + SPE + +
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFRE--VYAADYYKLMGNSLL-PIRWMSPEAIMYGKF 203
Query: 234 TPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 276
+ SDIWS GVVL+ + YG P+ + ++++ ++ R V P
Sbjct: 204 S-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 50/229 (21%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKII----SKVQAPIDYLKKFLPREIEVVK 106
L D++ G++ + ++V +K + S++Q + L + E ++
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQ----ESCLLY 63
Query: 107 GLKHPNLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR--------RWF 157
GL H N++ L IE +++ Y G+L +++ R + + +
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
Q+A + Y HK+ V+H+DI N ++D++ +K++D +R + DY L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDY-HCLGDNEN 180
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSEL 265
+ + E L Y+ SD+WS GV+L+ ++ G+ P+ + + E+
Sbjct: 181 RPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 50/227 (22%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----------LPREIE 103
G +G G+Y V+ A + VAIK + ++ D K RE++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 104 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADA 163
++ +KH N++ + + ++M+ L +V+ ++ + E + + Q+ +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG----- 218
++ HK +HRD+ N+ ++ K K++DFG AR+Y + ET
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 219 ----SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
+ Y +PE+L G D+WS+G + ++ G+ F N
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 48/278 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G G + V L R + K IS + + K L E+ V++ LKH N
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAIS-YRGLKEREKSQLVIEVNVMRELKHKN 73
Query: 113 LIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRK--------ERYIDEDKGRRWFSQLAD 162
++R++ + ++YI+ME+ G L I+K E + D R QL
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR----QLLH 129
Query: 163 AIDYCHK-------KSVVHRDIKCENLLL-----------------DDKYNIKLSDFGFA 198
A+ YCH + V+HRD+K +N+ L + + K+ DFG +
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 199 RKYSVNNTDYKQNLSETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+ + ++++ + G+ Y SPE+L +SD+W++G +++ + G+ PF
Sbjct: 190 KNIGI------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 258 DDT-NYSELLKQVQKRVVFPESPRLSSSCKALISNILS 294
N+S+L+ ++++ P + S LI N+L+
Sbjct: 244 HKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLN 280
|
Length = 1021 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 21/237 (8%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNL 113
LG++ G G+ V + +A+K + + + K+ L +++VV K P +
Sbjct: 20 LGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRIL-MDLDVVLKSHDCPYI 76
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKK- 170
++ T V+I ME + L+ + K I ED + + A+ Y +K
Sbjct: 77 VKCYGYFITDSDVFICME--LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
V+HRD+K N+LLD N+KL DFG + + D K C AY +PE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKTRSAGCA--AYMAPERIDP 188
Query: 231 VPYTPQ---QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
P+ ++D+WS+G+ L + G+ P+ + +E +V +++ E P L +
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-TEF--EVLTKILQEEPPSLPPN 242
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
AI Y H+ ++HRDIK EN+ ++ ++ L DFG A + V D N + G+ A
Sbjct: 194 AIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPV---DINANKYYGWAGTIAT 249
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
+PE+L PY P DIWS G+VLF M
Sbjct: 250 NAPELLARDPYGP-AVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 23/236 (9%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFL 117
+G G++ TV +A+K I + +K L +++VV + P +++F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 118 QAIETTHRVYIIMEYA----KNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SV 172
A+ +I ME + I E+ + A++Y ++ +
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI 129
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+LLD NIKL DFG + V++ ++ G Y +PE + P
Sbjct: 130 IHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSIAKTRD-----AGCRPYMAPERID--P 181
Query: 233 YTPQ----QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
+SD+WS+G+ L+ + G+ P+ N + Q+ + VV + P LS+S
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQ-VVKGDPPILSNS 234
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 47/174 (27%), Positives = 91/174 (52%), Gaps = 16/174 (9%)
Query: 98 LPREIEVVKGLKHPNLIRF--LQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGR 154
L +EIE+++ L H N++++ + + + + +IME+ +GSL E + R + I+ +
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNL 212
++ Q+ +DY + VHRD+ N+L++ ++ +K+ DFG + + Y K +L
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 213 -SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
S F + +PE L + SD+WS GV L+ + L + D+ S +
Sbjct: 173 DSPVF-----WYAPECLIQSKFY-IASDVWSFGVTLYEL----LTYCDSESSPM 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 61/251 (24%), Positives = 117/251 (46%), Gaps = 40/251 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII-------SKVQAPIDYLKKFLPREIEVV 105
+ L ++VG G+Y V + Q AIK++ +++ I+ LKK+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS------- 60
Query: 106 KGLKHPNLIRFLQAIETTH------RVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWF 157
H N+ + A + +++++ME+ GS+ ++I+ K + E+
Sbjct: 61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
++ + + H+ V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFI 172
Query: 218 GSYAYASPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 272
G+ + +PE++ P +SD+WS+G+ M G P D + L + +
Sbjct: 173 GTPYWMAPEVI-ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231
Query: 273 VVFPESPRLSS 283
+PRL S
Sbjct: 232 ----PAPRLKS 238
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 26/243 (10%)
Query: 59 VGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G++ V LA S +D + + ++ P +K RE E++ L+H ++++F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKER-----YID----EDKGRRWFSQL------- 160
+ ++ EY K+G L + +R +D + KG SQ+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
A + Y + VHRD+ N L+ +K+ DFG +R V +TDY + T
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTML-PI 189
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-QKRVVFPES 278
+ PE + +T +SD+WS GV+L+ + YG+ P+ + +E+++ + Q RV+ E
Sbjct: 190 RWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ER 246
Query: 279 PRL 281
PR+
Sbjct: 247 PRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 45/175 (25%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
DE++ + +++ ++ H++ +V+RD+K EN+LLDD +I++SD G A + T
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 267
+ G+ Y +PE++K YT D W +G +++ M+ G+ PF E +K
Sbjct: 160 GR------VGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPF--RQRKEKVKR 210
Query: 268 -QVQKRVVFPE---SPRLSSSCKALISNILSP-VKFRI-----QMEDIRQDPWLK 312
+V++RV + S + S + +++ +L+ FR+ E+++ P+ +
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
+E + + +++ ++ H++ +V+RD+K EN+LLDD +I++SD G A T
Sbjct: 100 EEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-------TN 261
+ G+ Y +PE++K YT D W++G +L+ M+ G+ PF
Sbjct: 160 GR------VGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 262 YSELLKQVQKRVVFPESPRLSSSCKALI 289
L+K+VQ+ SP S CK L+
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 9e-13
Identities = 51/230 (22%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 78 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR----FLQAIETTHRVYIIMEYA 133
+V I+ K L EI+ ++ + N+++ + ++ R+ +I+EY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 134 KNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC------HKK-SVVHRDIKCENLLLDD 186
G L EV+ KE+ + + ++L AID C +K + ++++ + L+ +
Sbjct: 105 TRGYLREVLDKEKDLS------FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158
Query: 187 KYNIKLSDFGFARKYSVNNTDYKQ-NLSETFCGSYAYASPEILKGV--PYTPQQSDIWSM 243
Y +K+ G + S + +K N Y S ++L + YT + DI+S+
Sbjct: 159 NYKLKIICHGLEKILS--SPPFKNVNFM-------VYFSYKMLNDIFSEYT-IKDDIYSL 208
Query: 244 GVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293
GVVL+ + G++PF++ E+ + + S +L C I I+
Sbjct: 209 GVVLWEIFTGKIPFENLTTKEIYDLIINKNN---SLKLPLDCPLEIKCIV 255
|
Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 59 VGMGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
VG G+Y V A + +D A+K I + REI +++ LKHPN+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELKHPNVIS- 62
Query: 117 LQAIETTH---RVYIIMEYAKNGSLLEVIRKERYIDEDKG---------RRWFSQLADAI 164
LQ + +H +V+++ +YA++ L +I+ R +K + Q+ D I
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 165 DYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLS-ETFCGS 219
Y H V+HRD+K N+L+ ++ +K++D GFAR + N+ K + +
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVVT 178
Query: 220 YAYASPEILKGVPYTPQQSDIWSMGVVL 247
+ Y +PE+L G + + DIW++G +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 40/149 (26%), Positives = 77/149 (51%), Gaps = 10/149 (6%)
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
+E++ + +++ ++ H+++ V+RD+K EN+LLDD +I++SD G A K
Sbjct: 100 EEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP------ 153
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 268
+ G+ Y +PE+L YT D W +G +++ M+ G+ PF ++
Sbjct: 154 EGESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 269 VQKRVVFPE---SPRLSSSCKALISNILS 294
V +RV+ E S + S K++ +L+
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLT 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 59 VGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLI 114
+G G+Y V A ++ + VA+K + +VQ + + RE+ V++ L+ HPN++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 115 RFLQAIETTH-----RVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYC 167
R + ++ ++ E+ + L + K E + + + QL +D+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H VVHRD+K +N+L+ IKL+DFG AR YS Q + + Y +PE+
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF------QMALTSVVVTLWYRAPEV 180
Query: 228 LKGVPY-TPQQSDIWSMGVVLFAMVYGRLPF 257
L Y TP D+WS+G + FA ++ R P
Sbjct: 181 LLQSSYATP--VDLWSVGCI-FAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 79 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138
VA+K +++ A + +FL E V+KG +++R L + ++ME +G L
Sbjct: 39 VAVKTVNE-SASLRERIEFL-NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 139 LEVIRKERYIDED-KGR---------RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY 188
+R R E+ GR + +++AD + Y + K VHRD+ N ++ +
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156
Query: 189 NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
+K+ DFG R + TDY + + + +PE LK +T SD+WS GVVL+
Sbjct: 157 TVKIGDFGMTR--DIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTT-SSDMWSFGVVLW 212
Query: 249 AMV-YGRLPFDDTNYSELLKQV 269
+ P+ + ++LK V
Sbjct: 213 EITSLAEQPYQGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + ++G G V LA S+ VA+K I + + LKK RE ++ L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSL---------LEVIRKERYIDEDKGR--RWFSQLA 161
++ VY M Y + +L E + KE G F ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR------------KYSVNNTDYK 209
I+Y H K V+HRD+K +N+LL + + D+G A N Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 210 Q-NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+ G+ Y +PE L GVP + + +DI+++GV+L+ M+ P+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 65/277 (23%), Positives = 124/277 (44%), Gaps = 33/277 (11%)
Query: 54 SLGDVVGMGSYATVK--LATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
+LG +G G + +V VA+K + ++ FL E +K HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 112 NLIRFLQA-IETTHR-----VYIIMEYAKNGSLLEVIRKER------YIDEDKGRRWFSQ 159
N++R + ++T +I+ + K+G L + R Y+ ++ +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+A ++Y KS +HRD+ N +L++ N+ ++DFG ++K + N DY + G
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK--IYNGDYYRQ------GR 172
Query: 220 YA-----YASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRV 273
A + + E L YT +SD+WS GV ++ + G+ P+ SE+ +++
Sbjct: 173 IAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
Query: 274 VFPESPRLSSSCKALISN--ILSPVKFRIQMEDIRQD 308
+ P +L+S+ +L+P K R E +R +
Sbjct: 232 RLKQPPDCLDGLYSLMSSCWLLNP-KDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 23/190 (12%)
Query: 72 SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131
+A VA+K++ + A + + FL +E++++ L PN+ R L + +IME
Sbjct: 42 NADAPVLVAVKVL-RPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCMIME 99
Query: 132 YAKNGSLLEVIRKERYIDEDKGRRWFS-------------QLADAIDYCHKKSVVHRDIK 178
Y +NG L + ++K ++ E G S Q+A + Y + VHRD+
Sbjct: 100 YMENGDLNQFLQK--HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157
Query: 179 CENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
N L+ Y IK++DFG +R YS +DY + A +L G +T +
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYS---SDYYRVQGRAPLPIRWMAWESVLLG-KFT-TK 212
Query: 238 SDIWSMGVVL 247
SD+W+ GV L
Sbjct: 213 SDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P ++ A T ++ I++ G L + + E + R + +++ +++ H +
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-K 229
VV+RD+K N+LLD+ ++++SD G A D+ + G++ Y +PE+L K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEVLQK 169
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
G Y +D +S+G +LF ++ G PF
Sbjct: 170 GTAYD-SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDY 166
L H ++R L I + ++ + + GSLL+ +R+ R +D + W Q+A + Y
Sbjct: 66 LDHAYIVRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
+ +VHR++ N+LL ++++DFG A ++ Y + +T A S
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES-- 182
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285
IL G YT QSD+WS GV ++ M+ YG P+ E+ ++K RL+
Sbjct: 183 ILFG-RYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK------GERLAQPQ 234
Query: 286 KALISNILSPVKFRIQMEDIRQDPWLKEDSN 316
I + VK + E++R P KE +N
Sbjct: 235 ICTIDVYMVMVKCWMIDENVR--PTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/244 (24%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 59 VGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+G G++ V LA + VA+K + + + ++ RE E++ L+H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE----RYIDEDKGR-----------RWFS 158
+RF + ++ EY ++G L +R + + + S
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A + Y VHRD+ N L+ +K+ DFG +R + +TDY + T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML- 186
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-QKRVVFP 276
+ PE + +T +SDIWS GVVL+ + YG+ P+ + +E ++ + Q R +
Sbjct: 187 PIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL-- 243
Query: 277 ESPR 280
E PR
Sbjct: 244 ERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 41/154 (26%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 100 REIEVVKGLKHPNLIRFLQAIETT--HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWF 157
+EI ++K L H N++++ + +IMEY GSL + + K + ++ + +
Sbjct: 55 KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFA 113
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
Q+ + + Y H + +HRD+ N+LLD+ +K+ DFG A+ + Y+ + E
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGD 171
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 251
+ + E LK ++ SD+WS GV L+ ++
Sbjct: 172 SPVFWYAVECLKENKFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDE 150
D+LK EI+++ LK+PN+IR L + + +I EY +NG L + + ++E
Sbjct: 63 DFLK-----EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117
Query: 151 DKGRRWFS-----------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199
S Q+A + Y + VHRD+ N L+ + Y IK++DFG +R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 250
++ + DY + A IL G T SD+W+ GV L+ M
Sbjct: 178 --NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA--SDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 94 LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED-- 151
L EI + L H N+++ + + + Y+I + + L + E + +D
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ-KYDFDLYSFMYDEAFDWKDRP 264
Query: 152 ---KGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
+ R QL A++Y H K ++HRDIK EN+ L+ I L DFG A +
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE----KE 320
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTN---YSE 264
++ + G+ A SPEIL G Y + +DIWS G++L M+ + P D +
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379
Query: 265 LLKQVQKRVV----FPESP 279
LLK + V FP+ P
Sbjct: 380 LLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 59 VGMGSYATVKLA--TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
VG G+Y V A + ++ A+K I + REI +++ LKHPN+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC-----REIALLRELKHPNVIA- 62
Query: 117 LQAIETTH---RVYIIMEYAKNGSLLEVIRKERYIDEDKG---------RRWFSQLADAI 164
LQ + +H +V+++ +YA++ L +I+ R +K + Q+ D I
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 165 DYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLS-ETFCGS 219
Y H V+HRD+K N+L+ ++ +K++D GFAR + N+ K + +
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADLDPVVVT 178
Query: 220 YAYASPEILKGVPYTPQQSDIWSMGVVL 247
+ Y +PE+L G + + DIW++G +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 26/183 (14%)
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSL----LEVIRKERYIDEDK-GRRWFSQLADAID 165
P + F A+ V+I ME SL +V K I ED G+ S + A++
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117
Query: 166 YCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF-CGSYAYA 223
Y H K SV+HRD+K N+L++ +KL DFG + Y V+ ++++T G Y
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVD------SVAKTIDAGCKPYM 170
Query: 224 SPEILKGVPYTPQQ-----SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278
+PE + P Q+ SD+WS+G+ + + GR P+D ++ +Q+ K+VV S
Sbjct: 171 APERIN--PELNQKGYDVKSDVWSLGITMIELATGRFPYD--SWKTPFQQL-KQVVEEPS 225
Query: 279 PRL 281
P+L
Sbjct: 226 PQL 228
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 59 VGMGSYATVKLATSARHSQD-----VAIKIISK---VQAPIDYLKKFLPREIEVVKGLKH 110
+G GS+ V + +D VAIK +++ ++ I++L E V+K
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN-----EASVMKEFNC 68
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED----------KGRRWFSQL 160
+++R L + +IME G L +R R E+ K + ++
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
AD + Y + VHRD+ N ++ + + +K+ DFG R + TDY + +
Sbjct: 129 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLL-PV 185
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 271
+ SPE LK +T SD+WS GVVL+ + P+ + ++L+ V +
Sbjct: 186 RWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 41/151 (27%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
DE + + ++L ++ ++ +V+RD+K EN+LLDD+ +I++SD G A + T
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 267
+ G+ Y +PE++ YT D W +G +++ M+ G+ PF E +K
Sbjct: 160 GR------VGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPF--RKRKERVKR 210
Query: 268 -QVQKRVVFPE---SPRLSSSCKALISNILS 294
+V +RV + S + S K++ +L+
Sbjct: 211 EEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKII----SKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G G++ V A + Q VA+K + K PI L REI++++ LKH N++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL-----REIKILQLLKHENVV 74
Query: 115 RFLQAIETTHR--------VYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAI 164
++ T Y++ E+ ++ LL + + E K + L + +
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK--KVMKMLLNGL 132
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y H+ ++HRD+K N+L+ +KL+DFG AR +S++ K N + Y
Sbjct: 133 YYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS-KPNRYTNRVVTLWYRP 191
Query: 225 PEILKG-VPYTPQQSDIWSMGVVLFAM 250
PE+L G Y P D+W G ++ M
Sbjct: 192 PELLLGERDYGP-PIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 51/226 (22%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
+ + + +G G+Y V + ++ A+KI+ PI + + + E ++K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALSDHP 75
Query: 112 NLIRFL-----QAIETTHRVYIIMEYAKNGSLLEVI-----RKERYIDEDKGRRWFSQLA 161
N+++F + ++ ++++++E GS+ +++ R ER ++E +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEAL 134
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
+ + H +HRD+K N+LL + +KL DFG + + + +T ++N S G+
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS---VGTPF 189
Query: 222 YASPEILKGVPYTPQQ--------SDIWSMGVVLFAMVYGRLPFDD 259
+ +PE++ QQ D+WS+G+ + G P D
Sbjct: 190 WMAPEVIA----CEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 55/226 (24%), Positives = 109/226 (48%), Gaps = 12/226 (5%)
Query: 59 VGMGSYATVKLATSARHSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G++ VK + DVAIK++ + + RE E++ L +P ++R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV--RDEMMREAEIMHQLDNPYIVRM 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+ E + ++ME A G L + + K+ I Q++ + Y K+ VHR
Sbjct: 61 IGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+ N+LL +++ K+SDFG ++ +++ YK + + + +PE + ++
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW--PLKWYAPECINFRKFS- 176
Query: 236 QQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQ--KRVVFPES 278
+SD+WS G+ ++ A YG+ P+ E++ ++ KR+ P
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE 222
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 50/224 (22%), Positives = 105/224 (46%), Gaps = 23/224 (10%)
Query: 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL- 108
T + + + +G G+Y V T+ + A+KI+ PI + + + E +++ L
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVDEEIEAEYNILQSLP 76
Query: 109 KHPNLIRFLQAIETTHR-----VYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQ 159
HPN+++F + +++++E GS+ E++ + +DE
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+ + H ++HRD+K N+LL + +KL DFG + + + +T ++N S G+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS---VGT 191
Query: 220 YAYASPEIL---KGVPYT-PQQSDIWSMGVVLFAMVYGRLPFDD 259
+ +PE++ + Y+ + D+WS+G+ + G P D
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 37/268 (13%)
Query: 49 ETHGYSLGDVVGMGSYATVKLATSARHSQD--VAIKII---SKVQAPIDYLKKFLPREIE 103
E H L + GM + + +Q VA+K++ + A D+LK EI+
Sbjct: 20 EVH---LCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK-----EIK 71
Query: 104 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY----IDEDKGRRWFS- 158
++ LK PN+IR L T+ + +I EY +NG L + + + D +S
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 159 ------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
Q+A + Y + VHRD+ N L+ Y IK++DFG +R ++ + DY +
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYSGDYYRIQ 189
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-------YGRLPFDDT--NYS 263
+ IL G T SD+W+ GV L+ ++ Y +L + N
Sbjct: 190 GRAVLPIRWMSWESILLGKFTT--ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 264 ELLKQVQKRVVFPESPRLSSSCKALISN 291
E + ++V P+ S L+ +
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLMLS 275
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-11
Identities = 47/225 (20%), Positives = 101/225 (44%), Gaps = 31/225 (13%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
LG ++G G + +V +L+ VA+K + +++FL E +K H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDH 60
Query: 111 PNLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKER------YIDEDKGRRWFS 158
PN+++ + +++ + +I+ + K+G L + R + ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+A ++Y ++ +HRD+ N +L + + ++DFG ++K + + DY + G
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGDYYRQ------G 172
Query: 219 SYA-----YASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPF 257
A + + E L YT +SD+W+ GV ++ G+ P+
Sbjct: 173 RIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 30/199 (15%)
Query: 79 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138
VA+K I+ + LK L +EI + L+HPN++ ++ + +Y++ GS
Sbjct: 28 VAVKKINLDSCSKEDLK-LLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS- 85
Query: 139 LEVIRKERYIDEDKGRRWFSQLA---------DAIDYCHKKSVVHRDIKCENLLLDDKYN 189
E + K + + +LA +A+DY H K +HR +K ++LL
Sbjct: 86 CEDLLKTHFPEG------LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK 139
Query: 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPEILK----GVPYTPQQSDIW 241
+ LS ++ S+ +Q + F S + SPE+L+ G Y +SDI+
Sbjct: 140 VVLSGLRYSV--SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG--YNE-KSDIY 194
Query: 242 SMGVVLFAMVYGRLPFDDT 260
S+G+ + G +PF D
Sbjct: 195 SVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 61/235 (25%), Positives = 114/235 (48%), Gaps = 33/235 (14%)
Query: 53 YSLGDVVGMGSYATVK---LATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGL 108
++LG ++G G + +V+ L + Q VA+K++ + + + D +++FL RE +K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFL-REAACMKEF 58
Query: 109 KHPNLIRFLQAIETTHRV-------YIIMEYAKNGSLLEVIRKERYIDE------DKGRR 155
HPN+I+ L + R +I+ + K+G L + R +E R
Sbjct: 59 DHPNVIK-LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 156 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSE 214
+ +A ++Y K+ +HRD+ N +L++ + ++DFG ++K YS + Y+Q
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY--YRQG--- 172
Query: 215 TFCGS---YAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSEL 265
C S + + E L YT SD+W+ GV ++ M G+ P+ SE+
Sbjct: 173 --CASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 79 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138
VA+K++ K +A D F RE ++ HPN+++ L + ++ EY G L
Sbjct: 38 VAVKML-KEEASADMQADFQ-REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 139 LEVIR-------------KERYIDEDKGRRWFS---------QLADAIDYCHKKSVVHRD 176
E +R S Q+A + Y ++ VHRD
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD 155
Query: 177 IKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
+ N L+ + +K++DFG +R YS DY + SE + PE + YT
Sbjct: 156 LATRNCLVGENMVVKIADFGLSRNIYS---ADYYK-ASENDAIPIRWMPPESIFYNRYT- 210
Query: 236 QQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQ 270
+SD+W+ GVVL+ + YG P+ + E++ V+
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 43/237 (18%)
Query: 75 HSQDVAIKII---SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131
VA+KI+ + A D+LK E++++ LK PN+IR L + +I E
Sbjct: 45 RPLLVAVKILRPDANKNARNDFLK-----EVKILSRLKDPNIIRLLGVCVDEDPLCMITE 99
Query: 132 YAKNGSLLEVIRKERYIDEDKGR--------------------RWFSQLADAIDYCHKKS 171
Y +NG L + + ++D+ + Q+A + Y +
Sbjct: 100 YMENGDLNQFL-SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
VHRD+ N L+ + IK++DFG +R DY + A IL G
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAG--DYYRIQGRAVLPIRWMAWECILMGK 216
Query: 232 PYTPQQSDIWSMGVVLFAMV-------YGRLPFDDT--NYSELLKQVQKRVVFPESP 279
T SD+W+ GV L+ ++ YG L + N E + Q R V+ P
Sbjct: 217 FTT--ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD-QGRQVYLFRP 270
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 79 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138
V +K + K + L+ RE+++ + L H N++R L Y+I+EY G L
Sbjct: 38 VLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 139 LEVIRKERYIDEDKGRRWFS---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189
+ +R + DE S Q+A +D+ VHRD+ N L+ +
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155
Query: 190 IKLSDFGFAR-KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
+K+S ++ Y+ + L + +PE ++ ++ +SD+WS GV+++
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPL-----RWLAPEAVQEDDFS-TKSDVWSFGVLMW 209
Query: 249 AMV-YGRLPFDDTNYSELLKQVQ 270
+ G LPF + E+L ++Q
Sbjct: 210 EVFTQGELPFYGLSDEEVLNRLQ 232
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------AD 162
H N++R I + + I+ EY NG+L +RK +G+ QL A
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH------EGQLVAGQLMGMLPGLAS 118
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA- 221
+ Y + VH+ + +L++ K+S F ++ D + + T G
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE------DKSEAIYTTMSGKSPV 172
Query: 222 -YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
+A+PE ++ ++ SD+WS G+V++ M YG P+ D + +++K V+ P +P
Sbjct: 173 LWAAPEAIQYHHFSS-ASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-AP 230
Query: 280 R 280
R
Sbjct: 231 R 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 29/232 (12%)
Query: 57 DVVGMGSYATVKL--ATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
D +G G + V L A V +K + P + L FL +E++ + L HPN++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FL-QEVQPYRELNHPNVL 58
Query: 115 RFL-QAIETTHRVYIIMEYAKNGSLLEVIRKERYI-----DEDKGRRWFSQLADAIDYCH 168
+ L Q IE+ + +++E+ G L +R R + +D +R ++A + + H
Sbjct: 59 QCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET---FCGSYAYASP 225
+ +H D+ N L ++K+ D+G A Y ++ T + +P
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA------LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 226 EI-------LKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 269
E+ L T ++S+IWS+GV ++ + P+ D + ++LKQV
Sbjct: 172 ELVEIRGQDLLPKDQT-KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 14/228 (6%)
Query: 60 GMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119
G + +V LA V ++I ++LK L E+ + +HPN++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA-LQNEVVLSHFFRHPNIMTSWTV 67
Query: 120 IETTHRVYII---MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
T +++I M Y SLL+ E + G F L ++Y H+ +HR+
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALR-GLNYLHQNGYIHRN 126
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF----CGSYAYASPEILKGVP 232
IK ++L+ + LS G + YS+ K + F + SPE+L+
Sbjct: 127 IKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDL 184
Query: 233 YTPQ-QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP 279
Y +SDI+S+G+ + GR+PF D +++L +QK P SP
Sbjct: 185 YGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 54/236 (22%), Positives = 91/236 (38%), Gaps = 30/236 (12%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQD-----VAIKII---SKVQAPIDYLKKFLPREIEVV 105
+L +G G++ V D VA+K + Q D+L + L ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-----IM 63
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL----- 160
H N++R + +I++E G L +R+ R E L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 161 --ADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSET 215
A Y + +HRDI N LL K K++DFG AR + Y +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRA 181
Query: 216 FCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQV 269
+ PE L G+ + ++D+WS GV+L+ G +P+ E+++ V
Sbjct: 182 ML-PIKWMPPEAFLDGIFTS--KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNL 212
R+ SQ+A +D+ K+ +HRD+ N+LL D K+ DFG AR +N+++Y K N
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNA 274
Query: 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF 257
+ +PE + YT QSD+WS G++L+ + G+ P+
Sbjct: 275 RLPV----KWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 46/195 (23%), Positives = 91/195 (46%), Gaps = 27/195 (13%)
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFL-QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDE 150
++L++ P I L+HPN+++ L Q +E ++ EY + G L + +E++
Sbjct: 41 EFLQQGDPYRI-----LQHPNILQCLGQCVEAI-PYLLVFEYCELGDLKSYLSQEQWHRR 94
Query: 151 DKG----RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206
+ +R ++A + + HK + +H D+ N L +K+ D+G + +
Sbjct: 95 NSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG------IGPS 148
Query: 207 DYKQNLSET---FCGSYAYASPEI---LKGVPYTPQQ---SDIWSMGVVLFAMV-YGRLP 256
YK++ ET C + +PE+ G T +Q S++W++GV L+ + P
Sbjct: 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
Query: 257 FDDTNYSELLKQVQK 271
+ + E+L V K
Sbjct: 209 YSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 24/221 (10%)
Query: 60 GMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119
G TV LA + V ++ I+ ++A + + FL E+ V K HPN++ +
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 120 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLA---------DAIDYCHKK 170
+ ++++ + GS ++I ++D S+LA A+DY H
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLI-CTHFMDG------MSELAIAYILQGVLKALDYIHHM 120
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPE 226
VHR +K ++L+ + LS G S+ N + + F + SPE
Sbjct: 121 GYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE 178
Query: 227 ILK-GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266
+L+ + +SDI+S+G+ + G +PF D +++L
Sbjct: 179 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY +
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARL-- 243
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
+ +PE + YT QSD+WS GV+L+
Sbjct: 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY +
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARL-- 237
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
+ +PE + YT QSD+WS GV+L+
Sbjct: 238 PLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY + S
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARL-- 238
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 248
+ +PE + YT QSD+WS GV+L+
Sbjct: 239 PLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 32/203 (15%)
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWF----SQLADA 163
L H +L++ L + ++ EY K G L + +E+ + W QLA A
Sbjct: 58 LSHKHLVK-LYGVCVRDENIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASA 113
Query: 164 IDYCHKKSVVHRDIKCENLLL----DDKYN---IKLSDFGFARKYSVNNTDYKQNLSETF 216
+ Y K +VH ++ +N+L+ ++ IKLSD G +V + + +
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI--- 168
Query: 217 CGSYAYASPEILKGVPYTPQQ-SDIWSMGVVLFAMVY-GRLPFDDTNYSELLK--QVQKR 272
+ +PE ++ + +D WS G L + G P + SE + Q Q R
Sbjct: 169 ----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 273 VVFPESPRLSSSCKALISNILSP 295
+ P+ L+ LI+ +
Sbjct: 225 LPMPDCAELA----NLINQCWTY 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A+ +++ K+ VHRD+ N+L+ + +K+ DFG AR + +++Y S TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGS-TFL- 303
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKR 272
+ +PE + YT SD+WS G++L+ + G P+ + +E KR
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 59 VGMGSYATVKLA--TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G + V L S V +K + +V A + KFL E + + L+H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFL-EEAQPYRSLQHSNLLQC 60
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYI-----DEDKGRRWFSQLADAIDYCHKKS 171
L ++ME+ G L +R R D +R ++A + + HK +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA---YASPEIL 228
+H D+ N LL +K+ D+G + + YK++ T + + +PE++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLS------HNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 229 KGVPYT------PQQSDIWSMGVVLFAMV-YGRLPF 257
V ++S++WS+GV ++ + G P+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 157 FS-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLS 213
FS Q+A + + K+ +HRD+ N+LL K+ DFG AR N+++Y K N
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNAR 277
Query: 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV------YGRLPFDDTNY 262
+ +PE + YT +SD+WS G++L+ + Y +P D Y
Sbjct: 278 LPV----KWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A +++ K+ VHRD+ N+LL +K+ DFG AR +++++Y S TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVSKGS-TFL- 301
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 250
+ +PE + YT SD+WS G++L+ +
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 3/110 (2%)
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGSYA 221
++Y H+ + H DIK EN+++D + D+G A + ++ + +Y + + G+
Sbjct: 139 LEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
YA + G T ++ D+ S+G + +LP+ ++ L K
Sbjct: 199 YAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 48/190 (25%)
Query: 128 IIMEYAKNGSLLEVIRKERYIDEDKGR---RW----FSQLADAIDYCHKKSVVHRDIKCE 180
++ E+ ++G L +RKE KGR W QLA A+ Y K++VH ++ +
Sbjct: 93 MVEEFVEHGPLDVCLRKE------KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAK 146
Query: 181 NLLLDDK-------YNIKLSDFG-----FARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
N+LL IKLSD G +R+ V + +PE +
Sbjct: 147 NILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--------------PWIAPECV 192
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK- 286
G +D WS G L + + G +P + SE + +K+ PE SCK
Sbjct: 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE-----PSCKE 247
Query: 287 --ALISNILS 294
LIS L+
Sbjct: 248 LATLISQCLT 257
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 40/169 (23%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 99 PREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS 158
EI + L+HPN+++ + + Y+I EY + +L EV+R + ++ R+
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW---ERRRKIAI 787
Query: 159 QLADAIDYCH---KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215
+A A+ + H +VV ++ E +++D K L + +L
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----------------RLSLPGL 831
Query: 216 FC------GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 258
C S AY +PE + T ++SDI+ G++L ++ G+ P D
Sbjct: 832 LCTDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 16/57 (28%), Positives = 29/57 (50%), Gaps = 6/57 (10%)
Query: 143 RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFA 198
R+ + I + Q+ A+D H +VHRD+K +N++ + + K+ D G A
Sbjct: 252 RENKII-----QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 53/246 (21%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-------QAPIDYLKKFLPREI 102
T + + ++G G++ V A + + A+KI+ V + I +++K R+
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV--RQA 185
Query: 103 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLAD 162
+ + R+ Q ET H ++ +Y LL+ I K + Q
Sbjct: 186 DPADRFPLMKIQRYFQN-ETGHMCIVMPKYGP--CLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 163 AIDYCHKK-SVVHRDIKCENLLLD----------------DKYNIKLSDFGFARKYSVNN 205
A+DY H + ++H D+K EN+L++ D +++ D G
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-------GC 295
Query: 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
D + + + + Y SPE++ G+ + +D+WSMG +++ + G+L +D + E
Sbjct: 296 CDERHSRT-AIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 266 LKQVQK 271
L ++K
Sbjct: 354 LHLMEK 359
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG1024|consensus | 563 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1345|consensus | 378 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1163|consensus | 341 | 99.97 | ||
| KOG1164|consensus | 322 | 99.96 | ||
| KOG1165|consensus | 449 | 99.96 | ||
| KOG0590|consensus | 601 | 99.96 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1240|consensus | 1431 | 99.94 | ||
| KOG0603|consensus | 612 | 99.93 | ||
| KOG0195|consensus | 448 | 99.93 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG4158|consensus | 598 | 99.91 | ||
| KOG1166|consensus | 974 | 99.9 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606|consensus | 1205 | 99.9 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.83 | |
| KOG1023|consensus | 484 | 99.82 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG0590|consensus | 601 | 99.81 | ||
| KOG1033|consensus | 516 | 99.81 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0601|consensus | 524 | 99.75 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1243|consensus | 690 | 99.69 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG0606|consensus | 1205 | 99.63 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.6 | |
| KOG1266|consensus | 458 | 99.58 | ||
| KOG0601|consensus | 524 | 99.55 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.54 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.5 | |
| KOG3741|consensus | 655 | 99.49 | ||
| KOG3087|consensus | 229 | 99.45 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG2137|consensus | 700 | 99.29 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.29 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.21 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.0 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.91 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.82 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.67 | |
| KOG1035|consensus | 1351 | 98.6 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.58 | |
| KOG1235|consensus | 538 | 98.57 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.56 | |
| KOG0576|consensus | 829 | 98.53 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.44 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.35 | |
| KOG2268|consensus | 465 | 98.24 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 98.23 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| KOG2270|consensus | 520 | 98.06 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| KOG1093|consensus | 725 | 97.74 | ||
| KOG1826|consensus | 2724 | 97.67 | ||
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.15 | |
| KOG1236|consensus | 565 | 97.14 | ||
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.73 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.7 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.69 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.51 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.3 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.28 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.08 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.92 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.79 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-60 Score=424.08 Aligned_cols=270 Identities=28% Similarity=0.570 Sum_probs=246.8
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+.+....+|...+.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.+.|+|||||+++++|++.+
T Consensus 12 i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 12 IEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred eecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 33334467999999999999999999999999999999999876666677888999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++|||+|+|..++|..++++.+.++|.+++.++.||+.||.|||+.+|+|||||..|+|++++.++||+|||+|..+..+
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988644
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 283 (335)
.. ...+.|||+.|.|||++....++ ..+||||+||++|-||.|++||+..+..+.+..|+. .+.+|. .++.
T Consensus 172 ~E-----rk~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~ 243 (592)
T KOG0575|consen 172 GE-----RKKTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSA 243 (592)
T ss_pred cc-----ccceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCH
Confidence 32 24578999999999999988888 789999999999999999999999999999999976 566665 6999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKSK 322 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~ 322 (335)
+.++||.+|| .+|.+|||+++||+|+||+....|.+...
T Consensus 244 ~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 244 EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPS 283 (592)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence 9999999999 99999999999999999987777666433
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-61 Score=410.86 Aligned_cols=261 Identities=33% Similarity=0.581 Sum_probs=229.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH----HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
..+.|.+.+.||+|+||.|.+|..+.+|+.||||++.+...... .....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45679999999999999999999999999999999987554331 12334679999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEecccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKY 201 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~~~~~ 201 (335)
..||||||+.||.|.+.+-.++.+.+...+.+++|++.|+.|||+.||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999877 67999999999877
Q ss_pred ccCCcccccccccccccccccccccccCCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHccc---cC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQKRV---VF 275 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~-~~~~i~~~~---~~ 275 (335)
+.. .+..+.|||+.|.|||++.+.. +++.+.|+|||||++|-+++|.+||.+...+. ..++|.++- ..
T Consensus 330 g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 330 GEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred ccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 532 3356789999999999997654 44468899999999999999999999876665 777776642 33
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+.+..++.+..+||.+|| .||++|||++|+|+||||+...
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 456789999999999999 9999999999999999999654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-59 Score=394.95 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=231.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-eE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-RV 126 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 126 (335)
+..++.+.++.||+|..|+||+|+++.+++.+|+|++.... ....++++.+|+++++.++||+||.+++.|..+. ..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 44457888999999999999999999999999999994332 3445788889999999999999999999999998 49
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.|+||||+||+|.+++...+.++|..+..++.++++||.|||. .+|+||||||+|||++..|.+||||||.+..+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999998999999999999999999999996 89999999999999999999999999999776432
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHccccCCCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~ 280 (335)
...+++||..|||||.+.+..|+ .++||||||++++|+++|+.||... +..++...|..+.....+..
T Consensus 233 ------~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 233 ------IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred ------hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 45678999999999999999999 7899999999999999999999874 66677777776544433444
Q ss_pred -CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 281 -LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 281 -~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+|+++++||..|| +||.+||++.|+++|||+++...
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999 99999999999999999998654
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-59 Score=393.27 Aligned_cols=281 Identities=26% Similarity=0.514 Sum_probs=251.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
....++|+++++||+|+||+||.++.+++++.||+|++++..............|..+|..++||.||.++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678899999999999999999999999999999999987665555577788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|+|+||+.||.|...+++.+.|++..+..++..|+.||.|||+.|||||||||+|||++..|+++|+|||+++.....+
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998543322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
..+.++|||+.|||||++.+..|+ ..+|.||||+++|+|++|..||.+.+....+++|...........++.+.+
T Consensus 180 ----~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 180 ----DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred ----CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 234568999999999999999999 889999999999999999999999999999999988763333345999999
Q ss_pred HHHHHhc-CCCCCCC----CHHHHhcCCCcCCC-CCCCCCCCCCCcccccCCC
Q psy10459 287 ALISNIL-SPVKFRI----QMEDIRQDPWLKED-SNPVGKSKSAPEVIPFKKS 333 (335)
Q Consensus 287 ~li~~~L-~~p~~Rp----s~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~~ 333 (335)
+||+++| .||++|. .+++|.+||||..- ++........|.++|...+
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 9999999 9999995 89999999999874 4555567777877776654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-58 Score=401.42 Aligned_cols=265 Identities=30% Similarity=0.576 Sum_probs=239.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
....++|.+++.||+|+|++|++|+++.+++.||||++.+.....+.....+..|-.+|.+| .||+|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45677899999999999999999999999999999999887666666667788999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||++.+++++|+|||.++.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999886533
Q ss_pred cc-----cc---cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCC
Q psy10459 206 TD-----YK---QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFP 276 (335)
Q Consensus 206 ~~-----~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~ 276 (335)
.. .. ......++||..|.+||++.....+ ..+|+|+|||++|+|+.|.+||.+.+.-.++++|.. .+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 22 11 1112458999999999999988777 789999999999999999999999999999998876 45555
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+++++..++||+++| .||++|+++++|.+||||.+-
T Consensus 308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 --EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred --CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 569999999999999 999999999999999999874
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=398.27 Aligned_cols=284 Identities=27% Similarity=0.500 Sum_probs=247.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|+++++||+|+||.||+|+.+.+|..+|+|++++..........-+..|..+|....+++||+++..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 35678899999999999999999999999999999999988766555556667889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+||||||++||++..++.+.+.+++..+..++.+++.|+..||+.|+|||||||+|+|||..|++||+|||++..+....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999996443211
Q ss_pred c--------------------ccc----------------------cccccccccccccccccccCCCCCCCCchhHHHH
Q psy10459 206 T--------------------DYK----------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSM 243 (335)
Q Consensus 206 ~--------------------~~~----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl 243 (335)
. ... .......+||+.|+|||++.+..|. ..+|.|||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSL 374 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSL 374 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHH
Confidence 0 000 0011225799999999999999988 88999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCC-CC
Q psy10459 244 GVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED-SN 316 (335)
Q Consensus 244 G~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~-~~ 316 (335)
|||+||||.|.+||.+.++.+++.+|.. .+.+|....++.+.+|||.+||.||++|. .++||.+||||++- ++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999999988854 78899988999999999999999999999 69999999999874 33
Q ss_pred CCCCCCCCCcccccCC
Q psy10459 317 PVGKSKSAPEVIPFKK 332 (335)
Q Consensus 317 ~~~~~~~~~~~~~~~~ 332 (335)
.... ..++++|..+
T Consensus 455 ~l~~--~~apfvP~v~ 468 (550)
T KOG0605|consen 455 HLRE--MPAPFVPQVN 468 (550)
T ss_pred hhhc--CCCCCCCCCC
Confidence 3333 3466766554
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=363.06 Aligned_cols=271 Identities=30% Similarity=0.553 Sum_probs=242.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++++.||.|+||.|.+++++.+|..+|+|++.+...-.-...+-..+|..+|+.+.||.++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66788999999999999999999999999999999998765544444566779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++||.|..++++.++|++..++.++.||+.||+|||+++|++||+||+|||+|.+|.+||+|||+++.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~ 286 (335)
+.+.|||+.|+|||++...++. .++|.||||+++|||+.|..||.+.+...++++|.. .+.+|. .++.+++
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~--~fs~~~k 269 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS--YFSSDAK 269 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc--ccCHHHH
Confidence 4577999999999999999999 889999999999999999999999999999999987 456664 4999999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC-CCCCCCCCCCCcccc
Q psy10459 287 ALISNIL-SPVKFRI-----QMEDIRQDPWLKED-SNPVGKSKSAPEVIP 329 (335)
Q Consensus 287 ~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~-~~~~~~~~~~~~~~~ 329 (335)
+||+++| .|-.+|. ..++|..||||+.- +.....+.-.++++|
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 9999999 9988883 67899999999864 344444555555554
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=371.83 Aligned_cols=260 Identities=34% Similarity=0.628 Sum_probs=233.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+.... ....+.+..|+.+|+.++|||||.+++++...+.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 45799999999999999999999999999999999876653 34467788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC------CCEEEecccccccccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK------YNIKLSDFGFARKYSV 203 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~------~~~~l~Dfg~~~~~~~ 203 (335)
||||.||+|.+++++.+.+++..++.++.||+.||++||+++||||||||.|||++.. ..+||.|||+++.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999875 4589999999998863
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC--CCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--SPRL 281 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~~ 281 (335)
. ....+.||++.|||||++....|+ .|+|+||+|+++|+|++|+.||...+..++...+.++..... ...+
T Consensus 168 ~------~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 168 G------SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred h------hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 3 345678999999999999999998 899999999999999999999999999999998887543332 2356
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
+..+.+|+..+| .+|..|.+..+-+.|+++..+...
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQD 277 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence 777889999999 999999999999999999876533
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-54 Score=381.25 Aligned_cols=261 Identities=40% Similarity=0.766 Sum_probs=233.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-h-HHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-I-DYLKKFLPREIEVVKGLK-HPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 123 (335)
.....+|.+++.||+|+||.|++|.+..+|..||+|++.+.... . ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35567899999999999999999999999999999987764222 1 234566778999999998 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~ 202 (335)
..+|+||||+.||+|.+++...+++.+..+..++.|++.|++|+|+.||+||||||+|||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999998899999999999999999999999999999999999999999 999999999998763
Q ss_pred cCCcccccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPR 280 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~ 280 (335)
. ........|||+.|+|||++.+.. |...++||||+|+++|.|++|..||.+.+...+...+..+ +.+|....
T Consensus 173 ~-----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 173 G-----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred C-----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence 1 122355779999999999999988 8889999999999999999999999999988888887664 56665533
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+.++++|+.+|| .||.+|+++.+|+.||||+.
T Consensus 248 -S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 -SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999 99999999999999999998
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-54 Score=364.67 Aligned_cols=286 Identities=28% Similarity=0.447 Sum_probs=251.6
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
+...+..+.|++++.||.|.-|+||+|....++..+|+|++.+..........+++.|.++|..++||.++++|..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44567788999999999999999999999999999999999987776666677888999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+..|++||||+||+|..+.+++ +.|++..+..++..++.||+|||..|||+|||||+||||.++|++.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999875 46999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCc------------------------------ccc---------------------cccccccccccccccccccCC
Q psy10459 202 SVNNT------------------------------DYK---------------------QNLSETFCGSYAYASPEILKG 230 (335)
Q Consensus 202 ~~~~~------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~ 230 (335)
..... ... ...+..++||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 21000 000 012234689999999999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-ccccCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHH
Q psy10459 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ-KRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----MED 304 (335)
Q Consensus 231 ~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps----~~~ 304 (335)
.... .+.|.|+||+++|||+.|..||.+.+..+.+.+|. +...+|..+.++..++|||+++| +||.+|.. |.|
T Consensus 310 ~GHg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGHG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCCC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 9999 89999999999999999999999999888877775 47788888899999999999999 99999998 999
Q ss_pred HhcCCCcCCCCCCCCCCCCCCcccccC
Q psy10459 305 IRQDPWLKEDSNPVGKSKSAPEVIPFK 331 (335)
Q Consensus 305 ll~hp~~~~~~~~~~~~~~~~~~~~~~ 331 (335)
|.+||||++-+=. -.++..|+.||..
T Consensus 389 IK~HpFF~gVnWa-Lir~~~PP~iP~~ 414 (459)
T KOG0610|consen 389 IKRHPFFEGVNWA-LIRCARPPEIPKP 414 (459)
T ss_pred hhcCccccCCChh-heeccCCCcCCCc
Confidence 9999999986554 5677888888764
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=356.12 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=221.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|+.+.++|+|+||.||+|+++.+|+.||||.+.... ......+-..+|+.+|++++|+|+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 57899999999999999999999999999999986543 33455777789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+. ++.+-+.+ ...+++..+.++++|++.|+.|+|+.+++||||||+||||+.+|.+||||||+|+.+...+..+
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y- 158 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY- 158 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh-
Confidence 99987 55555544 4568999999999999999999999999999999999999999999999999999887654443
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK------------------ 271 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~------------------ 271 (335)
..++.|.+|+|||.+.+...+....|||++||++.||++|.+.|.+.+.-+..-.|..
T Consensus 159 ----TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 159 ----TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred ----hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 3456799999999999865555889999999999999999999998876666555532
Q ss_pred --cccCCCC----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 272 --RVVFPES----------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 272 --~~~~~~~----------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+..+|.. +.++..+.+|++.|| .||.+|++-+++|.||||.+..+
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 2222221 457788999999999 99999999999999999966543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-55 Score=376.09 Aligned_cols=259 Identities=24% Similarity=0.405 Sum_probs=226.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCC-e
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH-R 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~ 125 (335)
+..++|.++++||.|+||.||+|+.+.+|..||||.+++.....++.. -.+|+..|++|+ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456789999999999999999999999999999999987666555333 348999999998 999999999998887 9
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+|+|||||+. +|+++++.+ +.|++..+..|+.||++||+|+|.+|++|||+||+|||+..+..+||+|||+|+.+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999976 999999765 56999999999999999999999999999999999999998889999999999876432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES------ 278 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 278 (335)
+....++.|.+|+|||++....+++.+.|+|++|||++|+.+-++.|.+.+.-+.+-+|...+..|..
T Consensus 164 ------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 164 ------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 23456678999999999988877779999999999999999999999999888877777543332211
Q ss_pred -----------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 279 -----------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 279 -----------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+..+.++.+||.+|| -||.+||||.++|+||||+...
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 347889999999999 9999999999999999998763
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-54 Score=384.21 Aligned_cols=262 Identities=39% Similarity=0.643 Sum_probs=240.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.-|++++.||.|+-|.|.+|++..+|+.+|||++.+.....+.....+++|+.+++.+.|||++.++++|+....+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 35999999999999999999999999999999998775545555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++||.|.+++-+.+++++.++..++.||+.|+.|+|..+|+|||+||+|+|+|..+++||+|||+|.....+
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g------ 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG------ 165 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999765432
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
....+.||++.|.|||++.+.+|...++||||.|+|+|.||+|.+||++.+...++.+++++. |..+..+|.++++||+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLR 244 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHH
Confidence 345677999999999999999999999999999999999999999999999999999999864 3444679999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+|| .||++|.|.+||++|||+.++.....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 999 99999999999999999998755443
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-55 Score=353.36 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=218.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeece-eEEeCCe-E
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ-AIETTHR-V 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~ 126 (335)
...+|+++++||+|+||+||+++...+|+.+|.|.+.-... .....+.+..|+.+|++|+|||||++++ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34569999999999999999999999999999999974333 3445777889999999999999999998 5555555 8
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHK--KS--VVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~--~~--i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
+||||+|.+|+|...++. .+.++|..+|+++.|++.||..+|. .. |+||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999864 3569999999999999999999998 44 999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
+.+.... ......+||+.||+||.+.+.+|+ .+|||||+||++|||+....||.+.+..++.++|..+-..|.+
T Consensus 176 r~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 176 RFLSSKT-----TFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hHhcchh-----HHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 9886532 235577899999999999999999 8999999999999999999999999999999999987443344
Q ss_pred -CCCCHHHHHHHHHhc-CCCCCCCCH
Q psy10459 279 -PRLSSSCKALISNIL-SPVKFRIQM 302 (335)
Q Consensus 279 -~~~~~~l~~li~~~L-~~p~~Rps~ 302 (335)
..+|.++..||..|+ .||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 468999999999999 999999985
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=339.60 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=225.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|...++||+|.||.||+|++..+|+.||+|.++...... .......+|+..|+.++|+||+.++++|...+.+-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47889999999999999999999999999999998764432 22344559999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||++. +|+..++.. ..++..+++.++.++++||+|||.+.|+||||||+|+||+++|.+||.|||+++.++..+....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99975 999999765 4589999999999999999999999999999999999999999999999999999887655432
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC-----------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES----------- 278 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----------- 278 (335)
..+-|.+|+|||.+.+...+....|+||.||++.||+.|.+-|.+.+.-+....|-+.+..|..
T Consensus 160 -----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 160 -----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred -----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 2256999999999988776668899999999999999999999998888887777554333311
Q ss_pred ----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 279 ----------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 279 ----------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
+..+.+..+|+..|+ .||.+|+++.|+|+|+||+....+.
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 335678899999999 9999999999999999999754433
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=361.76 Aligned_cols=262 Identities=30% Similarity=0.535 Sum_probs=219.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC--eEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--RVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~ 127 (335)
..++..++.||+|+||+||++.+.++|...|||.+....... .+.+.+|+.+|.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456889999999999999999999999999999987653322 566889999999999999999999744433 699
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~ 205 (335)
|+|||+++|+|.+++.+.+ .++++.+..++.||++||.|||++|++|+||||+|||++. ++.+||+|||++.......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 7999999999998765411
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHccccCC-CCCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFP-ESPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~ 283 (335)
. .........||+.|||||++........++|||||||++.||+||..||.. .......-.+......| .+..+|.
T Consensus 173 ~--~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 173 T--KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred c--cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 1 112233567999999999999633332489999999999999999999997 44444444444333333 3346999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+.++||.+|+ .+|+.||||+++|+|||.+++..
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999 99999999999999999988765
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=356.83 Aligned_cols=272 Identities=25% Similarity=0.438 Sum_probs=233.9
Q ss_pred hhhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 42 ERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
......+....|++..+||.|..++||+|+....++.||||++....-..+ ...+++|+..+..++||||++++..|.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 344456778899999999999999999999999999999999987655444 678889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.++.+|+||.+|.+|++.++++.. ..++|..+..|++++++||.|||.+|.||||||+.||||+.+|.++|+|||.+.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999999999764 349999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccccccccccccccccccccc-CC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc---
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEIL-KG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--- 274 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~-~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--- 274 (335)
.+...+....... ..++|+++|||||++ .. ..|+ .|+||||||++..||.+|..||....+..++.....+-.
T Consensus 175 ~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 175 SLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eecccCceeeEee-ccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 7766553322222 778999999999994 33 3455 899999999999999999999999887776655444321
Q ss_pred ------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 275 ------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 275 ------~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
......++.+++.+|..|| +||.+|||++++|+|+||++.+..
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 1122457889999999999 999999999999999999986543
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-53 Score=372.65 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=231.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
..|...++||+|+.|.||.|....+++.||+|.+....... ++.+.+|+.+++..+|+|||.+++.|...+.+|.||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 36888899999999999999999999999999998766544 566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++||+|.+.+.... ++|.++..|+.++++||+|||..||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 350 Eym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 9999999999996644 89999999999999999999999999999999999999999999999999988765433
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
.+...+||+.|||||+.....|. .+.||||||++++||+-|.+||-..++-..+..|.... .+.....+|+++++|
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred -ccccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 35677899999999999999999 79999999999999999999999888877777776543 233446799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+.+|| .|+++|+++.|||+||||+.....++
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p~ss 534 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKPESS 534 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCCHHH
Confidence 99999 99999999999999999966554443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-52 Score=361.92 Aligned_cols=254 Identities=27% Similarity=0.484 Sum_probs=222.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46999999999999999999999999999999997543322233556789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
....+|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+.....+.+.... ......++..+++||+
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIK 230 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHH
Confidence 1234689999999999887776 78999999999999999999999998888877776543 2222457899999999
Q ss_pred Hhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
+|| .||.+|++ ++++++||||+..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 999 99999995 9999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-52 Score=373.46 Aligned_cols=280 Identities=26% Similarity=0.479 Sum_probs=247.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 124 (335)
..+..++|.++++||+|+||.|+++..+.+++.+|||++++...-.++..+..+.|..++.... ||.++.++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678889999999999999999999999999999999999987766666778889999998885 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++|+||||+.||++. .+...+.|++..+..++..++.||.|||++|||+||||.+|||+|.+|.+||+|||+++....
T Consensus 443 ~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 999999999999933 334456799999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 283 (335)
....+.++|||+.|+|||++.+..|+ .+.|.||||+++|||+.|..||.+.+.+++.+.|.. ...+|. .+|.
T Consensus 521 ----~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~--~ls~ 593 (694)
T KOG0694|consen 521 ----QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSK 593 (694)
T ss_pred ----CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--cccH
Confidence 23357789999999999999999999 899999999999999999999999999999999976 445554 4999
Q ss_pred HHHHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC-CCCCCCCCCCCcccccCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQ-----MEDIRQDPWLKED-SNPVGKSKSAPEVIPFKKSR 334 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~~~ 334 (335)
+..+++++|| .+|++|.- +++|..||||+.- +..-..+.-+|+++|.-+++
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 9999999999 99999993 7999999999873 34444577788888876653
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-53 Score=334.78 Aligned_cols=260 Identities=32% Similarity=0.616 Sum_probs=238.8
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
......++|++++.||+|-||.||+|+.++++-.||+|++.+.+........++.+|+++-..|+||||++++++|.+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 34567788999999999999999999999999999999998877766667888999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..|+++||...|+++..+. ..+.+++...+.++.|++.||.|+|..+|+||||||+|+|++..+.++|+|||.+..-.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999999998 56779999999999999999999999999999999999999999999999999986543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 281 (335)
. ....+.|||..|.+||...+..++ ...|+|++|++.||++.|..||......+.++.|.+ .+.+| ..+
T Consensus 176 ~-------~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~i 245 (281)
T KOG0580|consen 176 S-------NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STI 245 (281)
T ss_pred C-------CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--ccc
Confidence 1 224578999999999999999999 789999999999999999999999999999999977 44455 679
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+.+..+||.+|| .+|.+|.+..|++.|||+..+
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999 999999999999999999764
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=368.53 Aligned_cols=259 Identities=30% Similarity=0.534 Sum_probs=233.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....... ...+.+|+++++.++||||+.++++|+....+|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~-l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE-LKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH-HHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5788999999999999999999999999999999887665433 556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+.| +|..++...+.++|+.+..++.+++.||.|||+.+|+|||+||.|||++.+|.+|+||||+++....+.
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99977 999999999999999999999999999999999999999999999999999999999999998776532
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....+.||+.|||||...+.+|+ ..+|+|||||++|||+.|++||......+..+.|...-..+. ...+.++.+|++
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p-~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP-STASSSFVNFLQ 232 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-ccccHHHHHHHH
Confidence 234566799999999999999999 889999999999999999999999988888888876433222 379999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
.+| +||.+|.+..+++.|||.++...-.
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~~~~~ 261 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGKINIA 261 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhhhhhh
Confidence 999 9999999999999999998765433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=368.59 Aligned_cols=263 Identities=25% Similarity=0.444 Sum_probs=224.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||+||+|.+..+++.||+|+++............+..|+.++..++|+||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997644333334566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc---
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--- 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--- 207 (335)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998754321100
Q ss_pred ---------------------------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy10459 208 ---------------------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 260 (335)
Q Consensus 208 ---------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~ 260 (335)
.........+||..|+|||++.+..++ .++|+|||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000011245799999999999888877 7899999999999999999999998
Q ss_pred CHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCC---CCCCCHHHHhcCCCcCCC
Q psy10459 261 NYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPV---KFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 261 ~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p---~~Rps~~~ll~hp~~~~~ 314 (335)
+..+....+.. ...+|....++.++++||.+|+.+| ..||+++||++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence 88888877764 3445555568999999999988443 456899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=365.64 Aligned_cols=259 Identities=26% Similarity=0.509 Sum_probs=227.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++.+..++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34556789999999999999999999999999999999976433222335567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.|++|||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
....+|++.|+|||++.+..++ .++|||||||++|+|++|..||.+.......+.+.... .+....++..+
T Consensus 172 -------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~ 242 (329)
T PTZ00263 172 -------TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRA 242 (329)
T ss_pred -------cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHH
Confidence 1234689999999999888777 78999999999999999999999988888877776542 22234588999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 286 KALISNIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
++||++|| .||.+|++ +++++.||||++.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999 99999996 7999999999873
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=359.32 Aligned_cols=266 Identities=29% Similarity=0.592 Sum_probs=227.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH-----------HHHhhHHHHHHHHHcCCCCCeeeec
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-----------YLKKFLPREIEVVKGLKHPNLIRFL 117 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~ 117 (335)
..+.|.+.+.||+|.||.|.+|++..+++.||||++.+...... .-.+...+|+.++++|.|+|||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45689999999999999999999999999999999975432211 0135788999999999999999999
Q ss_pred eeEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecc
Q psy10459 118 QAIET--THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 195 (335)
Q Consensus 118 ~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Df 195 (335)
++..+ .+.+|||+|||..|.+...-.....+++.++++++.+++.||+|||.+||+||||||+|+|++++|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99876 4689999999998887655433333899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK- 271 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~- 271 (335)
|.+..+...............+||+.|+|||...+ ..+..++.||||+|+++|.|+.|..||.+....+++.+|..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 99986633321111111223689999999999876 45666889999999999999999999999999999998876
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+.+|..+.+..++++||.+|| +||+.|+++.+|..|||....
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 6778888889999999999999 999999999999999999887
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=359.26 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=223.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 126 (335)
..+.|+.+++||+|.||.||+|++..+|+.||+|.++........ .....+|+.+|++|+||||+++.+..... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-hHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 455799999999999999999999999999999999876544333 44556999999999999999999988765 689
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
|+|+|||+. +|.-++... -.|++.+++.+++||+.||+|+|.+||+|||||.+|||||.+|.+||+|||+|+.+....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999987 999988764 369999999999999999999999999999999999999999999999999999876544
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-----------c
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-----------V 274 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-----------~ 274 (335)
.. .....+-|.+|+|||.+.+...++.+.|+||.|||+.||++|++.|.+.+..+.++.|.+.. .
T Consensus 273 ~~----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 273 SA----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred Cc----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 32 12344569999999999988766689999999999999999999999999888888875421 1
Q ss_pred CCC-----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 275 FPE-----------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 275 ~~~-----------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+|. ...++....+|+..|| .||.+|.||.++|+|+||...
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 110 0347889999999999 999999999999999999443
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=347.46 Aligned_cols=267 Identities=27% Similarity=0.459 Sum_probs=226.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-----CC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----TH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 124 (335)
...|...+.||+|+||.|+.+.+..+|+.||+|.+.......- ..++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~-~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQI-DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchH-HHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456667999999999999999999999999999875433322 25566699999999999999999998754 35
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+|+|+|+| +.+|...++.+..+++..+..+++||+.||.|+|+.+|+|||+||.|++++.+..+||+|||+|+.....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 789999999 4599999998888999999999999999999999999999999999999999999999999999987643
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES------ 278 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------ 278 (335)
.....-..++.|.+|+|||++.....++.+.||||+||++.||++|+..|.+.+.-+.++.|......|..
T Consensus 179 ---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 179 ---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred ---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 12223346678999999999877665558999999999999999999999998877776666443333311
Q ss_pred ------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCC
Q psy10459 279 ------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKS 321 (335)
Q Consensus 279 ------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 321 (335)
++.++...+|+.+|| .||.+|+|++|+|+||||.....+....
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 568899999999999 9999999999999999999988777643
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=342.00 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=222.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 127 (335)
.+.|+.+.+|++|+||.||+|+++.+++.||+|.++........-... .+|+.+|.+++|||||.+-++... -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIts-LREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITS-LREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchh-HHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 456999999999999999999999999999999997654322221222 389999999999999999887654 45799
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||||+. +|..++...+ +|...+++.++.|++.|++|||...|+||||||+|+|+...|.+||+|||+|+.++..-.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 99999987 9999998765 799999999999999999999999999999999999999999999999999998876533
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC--------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-------- 278 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------- 278 (335)
.+ ...+-|.+|+|||.+.+...++.+.|+||+|||+.||+++.+.|.+....+.+.+|-+.+..|..
T Consensus 233 ~~-----T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 233 PY-----TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cC-----cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 32 34456999999999988776668899999999999999999999999888888777543322211
Q ss_pred -----------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 279 -----------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 279 -----------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
..++..-.+|+..+| .||.+|.||++.|+|+||.+-..+.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P 373 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP 373 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence 114578889999999 999999999999999999996555554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=364.00 Aligned_cols=259 Identities=24% Similarity=0.485 Sum_probs=225.3
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCC-CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
..+..++|.+.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.++..++||||+++++++..++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456778999999999999999999876554 689999987543322333556778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.....+.+...... ....++..
T Consensus 185 --------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~ 254 (340)
T PTZ00426 185 --------TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY-FPKFLDNN 254 (340)
T ss_pred --------cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCHH
Confidence 2245689999999999887777 7899999999999999999999999888888777765322 23458999
Q ss_pred HHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 285 CKALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
+.++|++|| .||.+|+ +++++++||||++.
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999 9999995 89999999999863
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=367.85 Aligned_cols=263 Identities=27% Similarity=0.485 Sum_probs=225.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||+||+|.+..+|+.||||++.............+.+|+.++..++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997643333333556778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc--
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY-- 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-- 208 (335)
||+.+++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543211100
Q ss_pred -------------------------------ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy10459 209 -------------------------------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257 (335)
Q Consensus 209 -------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~ 257 (335)
........+||+.|+|||++....++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 00011234699999999999888777 7899999999999999999999
Q ss_pred CCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCC
Q psy10459 258 DDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKED 314 (335)
Q Consensus 258 ~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rps---~~~ll~hp~~~~~ 314 (335)
.+.+..+....+.. ...++....+++++.+||++||.+|.+|++ ++++++||||++.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCC
Confidence 99888777776654 334455556899999999999988889997 9999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-52 Score=352.47 Aligned_cols=256 Identities=38% Similarity=0.710 Sum_probs=238.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|++.+.||+|.||.|-+|.+..+|+.||||.+++.....+...-.+++|++++..|+||||+.++++|+..+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 45789999999999999999999999999999999999888777667778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||..+|.|++|+...+.+++.++..++.||+.|+.|+|..+++|||||.+|||+|.|+++||.|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~---- 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK---- 206 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999776543
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.+..++||++.|.+||+..+.+|.....|.||||+++|-|..|..||++.+...++.+|..+..+. +.-|.+...|
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gL 282 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGL 282 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHH
Confidence 235678999999999999999999889999999999999999999999999999999999876544 2367788999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
|++|| .+|++|.|+++|..|.|.+
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheee
Confidence 99999 9999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=366.84 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=221.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|.+++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+...+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58999999999999999999999999999999976544434445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc----
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD---- 207 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---- 207 (335)
|++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999997543210000
Q ss_pred --------------------------------------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHH
Q psy10459 208 --------------------------------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249 (335)
Q Consensus 208 --------------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~ 249 (335)
.........+||..|+|||++.+..++ .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 000011245799999999999887777 78999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhc-C--CCCCCCCHHHHhcCCCcCCC
Q psy10459 250 MVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-S--PVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 250 l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L-~--~p~~Rps~~~ll~hp~~~~~ 314 (335)
|++|..||...+..+....+.. ....|....++.++.+||.+|| . ++..|++++++++||||++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998887766655543 3445555578999999999976 4 45559999999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=361.39 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=217.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..++||||+++++.+...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643322333455678999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccc
Q psy10459 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 137 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-----cccce
Confidence 9999998888899999999999999999999999999999999999999999999999999865322111 12345
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CC
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SP 295 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~ 295 (335)
+||..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... ......++.++.+||++|| .|
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCC
Confidence 789999999999888777 78999999999999999999999988877777665432 2223468999999999999 99
Q ss_pred CCCCC-----CHHHHhcCCCcCCC
Q psy10459 296 VKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 296 p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
|++|| ++.++++||||...
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999 89999999999773
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=368.56 Aligned_cols=262 Identities=25% Similarity=0.455 Sum_probs=224.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.++++||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999976443333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc-----
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT----- 206 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----- 206 (335)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999753311000
Q ss_pred -------------------------------------ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHH
Q psy10459 207 -------------------------------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249 (335)
Q Consensus 207 -------------------------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~ 249 (335)
..........+||..|+|||++.+..++ .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHH
Confidence 0000111235799999999999888887 78999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCC
Q psy10459 250 MVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKED 314 (335)
Q Consensus 250 l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rps---~~~ll~hp~~~~~ 314 (335)
|++|..||.+.+..+....+.. ....|....+++++.++|.+|+.+|.+|++ ++++++||||++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999998887776666653 344555567899999999998889999997 9999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=361.14 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=223.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999997643332233556778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++|++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875532
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCC----CCCCH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPES----PRLSS 283 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~----~~~~~ 283 (335)
.....+|+..|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+... ...|.. ..++.
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 12345689999999999888777 7899999999999999999999998888877666542 222222 25689
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++.+||.+|| .+|.+||+++++++||||++.
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999 889999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=336.58 Aligned_cols=260 Identities=30% Similarity=0.551 Sum_probs=229.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..+.|++.++||+|.|+.|+++.+..+|+.+|+|++........ ..+.+.+|+.+-+.|+||||+++.+.+......
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4556789999999999999999999999999999999865443322 366788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEecccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSV 203 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~~~~~~ 203 (335)
|+|+|++.|++|..-+-....++|..+-..+.||+++|.|+|.+||+|||+||+|+++-+ ..-+||+|||++..+..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999999999765544456789999999999999999999999999999999999964 34589999999988762
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccC--CCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVF--PESPR 280 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~--~~~~~ 280 (335)
........||+.|+|||++...+|+ ..+|||+-|+++|-|+.|++||.+.+...+++.|..+ +.+ |.++.
T Consensus 166 ------g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 166 ------GEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred ------ccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 2235567899999999999999999 7899999999999999999999999999999999874 333 45788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++++.++||++|| .||.+|+|+.|+|+|||+.+.
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999 999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=351.79 Aligned_cols=272 Identities=21% Similarity=0.332 Sum_probs=223.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.++..++|++|+++++.+...+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999876543333334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 99999999887543 3589999999999999999999999999999999999999999999999999876532211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCK 286 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~ 286 (335)
.....|+..|+|||++.+..++ .++|||||||++|+|++|..||...........+.. .........++.++.
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 1234689999999999988877 789999999999999999999987654332222222 222223346899999
Q ss_pred HHHHHhc-CCCCCCCC-----HHHHhcCCCcCCCC-CCCCCCCCCCccccc
Q psy10459 287 ALISNIL-SPVKFRIQ-----MEDIRQDPWLKEDS-NPVGKSKSAPEVIPF 330 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~~-~~~~~~~~~~~~~~~ 330 (335)
+||++|| .||.+||+ ++++++||||.+.. .....+...|.+.|.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 9999999 99999997 99999999998863 233345666666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=363.61 Aligned_cols=263 Identities=27% Similarity=0.537 Sum_probs=227.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||+||+|.+..+|+.||+|++.............+..|+.++..++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997643322233566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc----
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT---- 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 206 (335)
||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999976644320
Q ss_pred --------------------ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy10459 207 --------------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266 (335)
Q Consensus 207 --------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~ 266 (335)
...........||..|+|||++.+..++ .++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0001122345689999999999988777 7899999999999999999999998877777
Q ss_pred HHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCCC-HHHHhcCCCcCCC
Q psy10459 267 KQVQK---RVVFPESPRLSSSCKALISNILSPVKFRIQ-MEDIRQDPWLKED 314 (335)
Q Consensus 267 ~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rps-~~~ll~hp~~~~~ 314 (335)
..+.. ....|....+++++.+||.+||.||.+|++ ++++++||||++.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCC
Confidence 76654 445555566899999999999989999999 9999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=367.24 Aligned_cols=263 Identities=24% Similarity=0.462 Sum_probs=223.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999987543222223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc----
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT---- 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 206 (335)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999753321000
Q ss_pred ----------------------------------ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh
Q psy10459 207 ----------------------------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY 252 (335)
Q Consensus 207 ----------------------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~ 252 (335)
..........+||..|+|||++.+..++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0000111235799999999999888877 78999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCC
Q psy10459 253 GRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 314 (335)
Q Consensus 253 g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~ 314 (335)
|..||.+....+....+.. ....+....++.++.++|.+|+.+|.+|+ ++.++++||||++.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999887776666543 33445555789999999999889999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=362.56 Aligned_cols=263 Identities=27% Similarity=0.474 Sum_probs=224.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45667899999999999999999999999999999999754332223345577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|+||||++||+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999999998654 589999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPR 280 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~ 280 (335)
......+||+.|+|||++.+.. ..+.++|+|||||++|+|++|..||.+.+.......+... ..+|....
T Consensus 198 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 198 ----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred ----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 1123457899999999986532 2337899999999999999999999999888887777643 44555567
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
+|.++.+||++|| .+|.+ |++++++++||||++.
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 8999999999999 88887 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=347.86 Aligned_cols=254 Identities=29% Similarity=0.460 Sum_probs=211.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.++||.|+||.||+|.+..++..||+|+++...... ....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 467999999999999999999999999999999987543221 134566899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 999975 9999886644 478999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------------- 274 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-------------- 274 (335)
......++..|+|||++.+....+.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 ---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred ---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 122346789999999987644334889999999999999999999998877666555432111
Q ss_pred ------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 ------FPE---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 ------~~~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++. .+.++.++.+||++|| .||.+|||++|+|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111 1346889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=364.36 Aligned_cols=263 Identities=25% Similarity=0.453 Sum_probs=221.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987643323333566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc---
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--- 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--- 207 (335)
||++|++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211000
Q ss_pred --------cc-------------------------------cccccccccccccccccccCCCCCCCCchhHHHHHHHHH
Q psy10459 208 --------YK-------------------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 248 (335)
Q Consensus 208 --------~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~ 248 (335)
.. .......+||..|+|||++.+..++ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 00 0001124689999999999888777 7899999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCC---CCCHHHHhcCCCcCCC
Q psy10459 249 AMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKF---RIQMEDIRQDPWLKED 314 (335)
Q Consensus 249 ~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~---Rps~~~ll~hp~~~~~ 314 (335)
+|++|..||.+....+....+.. ...+|....++.++.+||.+||.+|.+ |+++.++++||||++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999998888777766653 344555557899999999999955444 5699999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=351.98 Aligned_cols=253 Identities=28% Similarity=0.505 Sum_probs=219.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCe-EEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQD-VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
..+......+.+.||.|+||+||+|.+. |.. ||+|++......... ...|.+|+.+|..++|||||+++|++..+.
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3455566777788999999999999975 556 999999876555444 778999999999999999999999998887
Q ss_pred -eEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEeecCCC-CEEEecccccc
Q psy10459 125 -RVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKS-VVHRDIKCENLLLDDKY-NIKLSDFGFAR 199 (335)
Q Consensus 125 -~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~-i~H~dikp~Nili~~~~-~~~l~Dfg~~~ 199 (335)
.++|||||+++|+|.+++.. ...++...+..|+.||+.||.|||+.+ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999987 577999999999999999999999999 99999999999999997 99999999997
Q ss_pred ccccCCcccccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILK--GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
....... ......||..|||||++. ...++ .++||||||+++|||+||..||.+....++...+......|.
T Consensus 193 ~~~~~~~-----~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 193 EKVISKT-----SMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred eeccccc-----cccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 6653221 122257899999999999 45666 899999999999999999999999998888877776555555
Q ss_pred -CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 278 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 278 -~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+++.+..||.+|| .||..||+..+++.
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 3459999999999999 99999999998874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=353.70 Aligned_cols=249 Identities=26% Similarity=0.475 Sum_probs=216.4
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||+|+||.||+|.+..+++.||+|++.............+..|+.++..++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999754332233345667899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccccc
Q psy10459 139 LEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218 (335)
Q Consensus 139 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g 218 (335)
.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........ .....+|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----KTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-----ccccccC
Confidence 99998888899999999999999999999999999999999999999999999999999875432211 1234578
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCC
Q psy10459 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVK 297 (335)
Q Consensus 219 ~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~ 297 (335)
|..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ......++.++.+||.+|| .||.
T Consensus 156 t~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHH
Confidence 9999999999888777 78999999999999999999999988888777766532 2223468999999999999 9999
Q ss_pred CCC---CHHHHhcCCCcCCC
Q psy10459 298 FRI---QMEDIRQDPWLKED 314 (335)
Q Consensus 298 ~Rp---s~~~ll~hp~~~~~ 314 (335)
+|| ++.++|+||||.+.
T Consensus 234 ~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 234 RRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCHHHHHcCCCcCCC
Confidence 997 58999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=354.80 Aligned_cols=251 Identities=29% Similarity=0.519 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+++.||+|++.......+.....+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999764322222344556788888776 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-----~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-----KTTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-----Ccccc
Confidence 9999999888889999999999999999999999999999999999999999999999999986532211 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.....+.+..... .....++.++.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHccc
Confidence 5789999999999887777 789999999999999999999999998888888765432 223458999999999999 9
Q ss_pred CCCCCCCH------HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM------EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~------~~ll~hp~~~~~ 314 (335)
||.+||++ +++++||||++.
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=352.77 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=233.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 125 (335)
.-....|.+.+.||.|.||.||+|+.+.+|+.+|+|++.+...........+.+|+.+|+++. ||||+.++++|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345568999999999999999999999999999999998876654444577889999999998 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC----CCEEEecccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKY 201 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~----~~~~l~Dfg~~~~~ 201 (335)
+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+... +.++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999776 49999999999999999999999999999999999999743 47999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPES 278 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~ 278 (335)
... ......+||+.|+|||++...+|. ..+|+||+|+++|.|++|..||.+.........+..+ +..+.+
T Consensus 190 ~~~------~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 190 KPG------ERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred cCC------ceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 541 234567999999999999998988 7899999999999999999999999988888888774 344566
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+.++...++||+.|| .||..|+++.++|+|||++..
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 789999999999999 999999999999999999875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=357.04 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=228.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
...|...++||+|+||.||+|.+..+++.||+|++.......+ ...+++|+.+|.+++++||.++++.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3458888999999999999999999999999999987655443 66788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||||.||++.+.++.+..+.+..+..++.+++.||.|||..+.+|||||+.|||+..+|.++|+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---- 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---- 165 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh----
Confidence 9999999999999988878999999999999999999999999999999999999999999999999997664322
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
....+++||+.|||||++....|+ .++||||||++++||++|.+||....+..+...|.+.........+++.+++||
T Consensus 166 -~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 166 -KRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred -hccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 223678999999999999988888 899999999999999999999999888666655555443333346899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..|| .+|+.||+|.++|+|+|++..
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 9999 999999999999999999983
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=360.47 Aligned_cols=263 Identities=25% Similarity=0.471 Sum_probs=224.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+..|+.++..++|++|+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997543333333566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc---
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--- 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--- 207 (335)
||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998754321100
Q ss_pred ---------------------------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy10459 208 ---------------------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 260 (335)
Q Consensus 208 ---------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~ 260 (335)
.........+||..|+|||++.+..++ .++|+|||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 000111245799999999999888887 7899999999999999999999998
Q ss_pred CHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCC
Q psy10459 261 NYSELLKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 314 (335)
Q Consensus 261 ~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~ 314 (335)
+.......+.. ...+|....++.++++||.+|+.+|.+|+ +++++++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCC
Confidence 88887777654 33455555689999999999878898888 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=351.77 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=219.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC-CCeeeeceeEEeCCeEEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~iv~ 130 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|++.......+.....+..|..++..+.| ++|+.+++.+...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999976433222334556788999999976 46888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864322111
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....+|+..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+.... ......++.++.++|+
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICK 233 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence 12345789999999999988877 78999999999999999999999998888887776532 2223468999999999
Q ss_pred Hhc-CCCCCCCCH-----HHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRIQM-----EDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rps~-----~~ll~hp~~~~~ 314 (335)
+|| .||.+|++. +++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999 999999976 899999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=352.44 Aligned_cols=250 Identities=30% Similarity=0.547 Sum_probs=216.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643322233455668999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccc
Q psy10459 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 137 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
+|..++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........ .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----ccccc
Confidence 9999998888899999999999999999999999999999999999999999999999999865322211 12245
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
+|+..|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+... ..+| ..+++++.+||.+|| .
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHccC
Confidence 689999999999888777 7899999999999999999999988888777766543 2233 468999999999999 9
Q ss_pred CCCCCC-----CHHHHhcCCCcCCC
Q psy10459 295 PVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
||.+|+ ++.++++||||.+.
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=353.15 Aligned_cols=251 Identities=29% Similarity=0.517 Sum_probs=216.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997644333333556778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccc
Q psy10459 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 137 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
+|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-----~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-----TMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----ccccc
Confidence 9999998888899999999999999999999999999999999999999999999999999865322111 12345
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CC
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SP 295 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~ 295 (335)
+|+..|+|||++.+..++ .++|||||||++|+|++|..||...+.....+.+.... .+....++.++.+||++|| .|
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCC
Confidence 789999999999887777 78999999999999999999999888877766664322 2223468999999999999 99
Q ss_pred CCCCC-----CHHHHhcCCCcCCC
Q psy10459 296 VKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 296 p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
|.+|+ ++.++++||||...
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=358.04 Aligned_cols=263 Identities=28% Similarity=0.484 Sum_probs=222.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+..++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999754332233345677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 9999999999999999654 589999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPR 280 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~ 280 (335)
......+||..|+|||++.+.. +.+.++|+|||||++|+|++|..||.+.+.......+... ..+|....
T Consensus 198 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 198 ----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred ----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 1123457899999999986543 2337899999999999999999999998887777777642 34555557
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
++..++++|..|| .++.+ |++++++++||||+..
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 8999999999999 55543 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=344.51 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=212.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||+||+|++..+++.||+|++...... +.....+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999764332 223456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+.++.+..+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99998777666555567999999999999999999999999999999999999999999999999999765432211
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc------------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR------------------ 272 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~------------------ 272 (335)
......|+..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 -NYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -cccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 12234688999999999887776 7899999999999999999999887654443332211
Q ss_pred --ccCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 273 --VVFPE-----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 273 --~~~~~-----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...+. ...+|.++.+||++|| .||++|||++++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01111 0236888999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=355.96 Aligned_cols=259 Identities=29% Similarity=0.501 Sum_probs=224.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998654433334667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999876 67999999999999999999999999999999999999999999999999999766433221
Q ss_pred cccccccccccccccccccCC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCCCC
Q psy10459 210 QNLSETFCGSYAYASPEILKG------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPR 280 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~ 280 (335)
......||..|+|||++.. ..++ .++|||||||++|+|++|..||...........+... ..+|..+.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 159 --NSKLPVGTPDYIAPEVLTTMNGDGKGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred --eeecccCCccccCHHHhccccccccCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCC
Confidence 1223468999999999863 3344 7899999999999999999999988887777776543 34555567
Q ss_pred CCHHHHHHHHHhcCCCCCCCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNILSPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++.++.+||+.||.+|.+||+++++++||||.+.
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCC
Confidence 8999999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=347.28 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........ ...+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4689999999999999999999998999999999875432211 33456899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+. ++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99996 5888877654 5689999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccccCC-----------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFP----------- 276 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~----------- 276 (335)
......++..|+|||++.+....+.++|+|||||++|+|++|..||.+... .+..+.+......+
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 ---TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ---cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 122346789999999987655444789999999999999999999987532 23333222111000
Q ss_pred --------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 --------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 --------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....++.++.+||++|| .||++|||++++|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00124578999999999 999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=350.81 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=216.4
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||.||+|.+..+++.||+|++.......+.....+..|..++..+ +||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999764332233345566788888766 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-----TTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-----cccc
Confidence 99999998888899999999999999999999999999999999999999999999999999875432211 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|+|||||++|+|++|..||...+.....+.+...... ....++.++.++|.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-YPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHHhcc
Confidence 5689999999999887777 7899999999999999999999999988888887664322 22358999999999999 9
Q ss_pred CCCCCC-------CHHHHhcCCCcCCC
Q psy10459 295 PVKFRI-------QMEDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rp-------s~~~ll~hp~~~~~ 314 (335)
||++|+ +++++++||||...
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999 99999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=350.34 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=213.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
....+|..++.||+|+||+||+|.+..+++.||+|++..... +.....+.+|+.+++.++|+||+++++++...+.++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 345678899999999999999999999999999999865432 334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+++|... ...++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..+.....
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99999999998653 2356788899999999999999999999999999999999999999999999876532211
Q ss_pred cccccccccccccccccccccCC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHccccCCCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKG----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQKRVVFPESPR 280 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~ 280 (335)
......|+..|+|||++.. ..+...++|||||||++|+|++|..||...... .....+...........
T Consensus 224 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 224 ----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred ----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 1223468999999998753 233346899999999999999999999744322 22223332333333456
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
++.++.+||.+|| .||++||++.|+++||||.+.......
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~~ 340 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQ 340 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCccccc
Confidence 8999999999999 999999999999999999997655443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=347.61 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=219.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||.||++++..+|..||+|++..... ......+.+|+.+++.++|+||+++++++..++..+
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 456789999999999999999999999999999999875422 234567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999998888899999999999999999999986 6999999999999999999999999998755322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-------------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------------- 273 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~------------- 273 (335)
......|+..|+|||++.+..++ .++|+|||||++|+|++|+.||...+..+....+....
T Consensus 158 -----~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 -----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred -----ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 12234689999999999887777 78999999999999999999998766554433221100
Q ss_pred --------------------------------cCC--CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 274 --------------------------------VFP--ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 274 --------------------------------~~~--~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
..+ ....++.++++||.+|| .||++|||+++|++||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 001 11247889999999999 9999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=354.06 Aligned_cols=264 Identities=27% Similarity=0.465 Sum_probs=223.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34566899999999999999999999999999999999975433223334567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+++||||++|++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999999998664 48999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESP 279 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~ 279 (335)
.. .....+||+.|+|||++.... ..+.++|||||||++|+|++|..||.+.+.......+... ..+|...
T Consensus 197 ~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 197 MV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred cc----cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 11 123457899999999986543 2337899999999999999999999999888888777653 3455556
Q ss_pred CCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
.++.++++||..|| .++.+ |++++++++||||++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 79999999999999 54443 8899999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.84 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=211.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----CeE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----HRV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 126 (335)
+|++.++||+|+||.||+|.+..+|..||+|.+........ ....+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch-hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58999999999999999999999999999999865322222 234567899999999999999999987543 258
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 69999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred ccccccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-----------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV----------- 273 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~----------- 273 (335)
.. .......|+..|+|||++.+ ..++ .++|||||||++|+|++|..||.+.+.......+....
T Consensus 159 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 159 TA--IFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred cc--ccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 11 11234568999999999865 4455 78999999999999999999998766543332221110
Q ss_pred ----------------cCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 274 ----------------VFP---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 274 ----------------~~~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
..+ ..+.++.++.++|.+|| .||++||+++++|+||||++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 000 11357788999999999 9999999999999999998765533
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=332.21 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=224.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC-eeeeceeEEeCC----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTH---- 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~---- 124 (335)
...|..+++||+|+||+||+|+++.+|+.||+|.++..... +..-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688889999999999999999999999999999865442 112334458999999999999 999999998877
Q ss_pred --eEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
.+++|+||++. +|..++.... .++...++.++.||+.||+|||+.+|+||||||.||||+++|.+||+|||++
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999997654 4778899999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
+.+..+... ...-++|.+|+|||++.+...++...||||+||+++||++++..|.+....+....|-+....|..
T Consensus 168 ra~~ip~~~-----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIPMRT-----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCCccc-----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 977644433 234467999999999998865557899999999999999999999999888887777553333311
Q ss_pred -----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCC
Q psy10459 279 -----------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKS 321 (335)
Q Consensus 279 -----------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 321 (335)
+..+++..+++.+|| .+|.+|.|++.+|.||||.....+.+..
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~ 315 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQL 315 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhh
Confidence 223458899999999 9999999999999999999987776653
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=336.33 Aligned_cols=266 Identities=27% Similarity=0.440 Sum_probs=222.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----eE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 126 (335)
.|.-.+++|.|+||.||.|....+++.||||.+-..... -.+|+.+|+.++|||||+++.+|.... ++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 488899999999999999999999999999988654332 227999999999999999998885422 45
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEecccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKY 201 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~ 201 (335)
.+||||++. +|..+++. +..++.-.++-+.+||++||.|||..||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 689999975 99999974 4668888999999999999999999999999999999999976 88999999999988
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC----
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---- 277 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 277 (335)
..+.. ...+..|..|+|||.+.+...++.+.||||.||++.||+.|++.|.+.+..+....|.+.+..|.
T Consensus 177 ~~~ep------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGEP------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCCC------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 65433 23445688999999999887777899999999999999999999999888777777754333221
Q ss_pred ------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC---CCCCCcccc
Q psy10459 278 ------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK---SKSAPEVIP 329 (335)
Q Consensus 278 ------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~---~~~~~~~~~ 329 (335)
....+++..+|+.++| .+|.+|.++.|+|.||||.....+-.. +...|++-+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~ 330 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFN 330 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccC
Confidence 1347899999999999 999999999999999999998877443 335555555
Q ss_pred cC
Q psy10459 330 FK 331 (335)
Q Consensus 330 ~~ 331 (335)
|+
T Consensus 331 f~ 332 (364)
T KOG0658|consen 331 FK 332 (364)
T ss_pred ch
Confidence 54
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=349.35 Aligned_cols=250 Identities=28% Similarity=0.538 Sum_probs=210.2
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
++||+|+||.||+|.+..+++.||+|+++............+..|..++..+ +||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865443333455677899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-----~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-----DTTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-----Ccccc
Confidence 9999999888889999999999999999999999999999999999999999999999999986422111 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---------YSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.+||..|+|||++.+..++ .++|+|||||++|+|++|..||.... .....+.+.. ........++.++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CCCCCCCCCCHHHH
Confidence 5789999999999888777 78999999999999999999996321 1222333332 22223346899999
Q ss_pred HHHHHhc-CCCCCCCC------HHHHhcCCCcCC
Q psy10459 287 ALISNIL-SPVKFRIQ------MEDIRQDPWLKE 313 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps------~~~ll~hp~~~~ 313 (335)
++|++|| .||.+|++ ++++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999 99999997 799999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=351.12 Aligned_cols=258 Identities=28% Similarity=0.548 Sum_probs=237.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe-EEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~i 128 (335)
.++|..++++|+|+||.+++++++.+++.||+|.+......... +....+|+.++.+++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 46799999999999999999999999999999999876554333 4466799999999999999999999998888 999
Q ss_pred EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 129 IMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||+||+||++.+.+.+.+ .|+++.+..|+.|++.|+.|||++.|+|||||+.|||++.++.++|+|||+++.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999999997654 59999999999999999999999999999999999999999999999999999886543
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
......+||+.|++||++.+.+|. .++|||||||++|||++-+.+|.+.+...++.++......|.+..++.+++
T Consensus 161 ----~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 161 ----SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELR 235 (426)
T ss_pred ----hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHH
Confidence 235677899999999999999999 899999999999999999999999999999999999998888889999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+|+.|| .+|+.||++.++|.+|.+...
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 9999999 999999999999999988744
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=346.86 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=219.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+.....+.....+..|..++..+ +|++|+.+++.+...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999864433233344556777888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++|+|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999865332111
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....+|++.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.......+.... ......++.++.+++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 233 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK 233 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHH
Confidence 12345789999999999988877 78999999999999999999999998888887776532 2223468999999999
Q ss_pred Hhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
+|| .+|.+|++ ..++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999 99999997 4899999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=347.23 Aligned_cols=254 Identities=26% Similarity=0.466 Sum_probs=215.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHH---HcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV---KGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
|++.+.||+|+||.||+|.+..+|+.||+|++.............+..|..++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999764322222244556666655 466799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+.+++|..++.. +.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 999999999988865 468999999999999999999999999999999999999999999999999986432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
......+|+..|+|||.+.+..++ .++|+|||||++|+|++|..||.+.+..+....+...... ....++.++.++|
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~~~li 232 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSREAISIM 232 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCCCHHHHHHH
Confidence 112345789999999999887777 7899999999999999999999999888887777654322 2245899999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
++|| .||.+|| ++.++++||||++.
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999 9999999 79999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=326.97 Aligned_cols=257 Identities=27% Similarity=0.514 Sum_probs=226.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCC-----CChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ-----APIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 123 (335)
.++|...+.||.|..++|.+|..+.+|..+|+|++.... .......+.-..|+.+|+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346888999999999999999999999999999986422 22344566677899999999 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..+|+|+|.|+.|.|.+++.+.-.+++.....|+.|+++|++|||..+|+||||||+|||++++.+++|+|||++..+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999988764
Q ss_pred CCcccccccccccccccccccccccCC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---cc
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKG------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VV 274 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~ 274 (335)
.. .....|||++|.|||.+.. ..|+ ...|+|++|+++|-|+.|.+||....+.-.+..|..+ +.
T Consensus 176 Ge------kLrelCGTPgYLAPEtikC~m~e~~pGYs-~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 176 GE------KLRELCGTPGYLAPETIKCSMYENHPGYS-KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred ch------hHHHhcCCCcccChhheeeecccCCCCcc-chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 32 2446799999999998742 2344 7799999999999999999999998888777777653 34
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 275 FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 275 ~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
-|.+..++...++||++|| .||.+|.|++|+|.||||++
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 5677889999999999999 99999999999999999954
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=350.83 Aligned_cols=251 Identities=31% Similarity=0.526 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..++|+||+++++.+...+..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997643332333455668999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 137 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
+|..++...+.+++..+..++.||+.||.|||+ .|++||||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-----cccc
Confidence 999999888889999999999999999999997 7999999999999999999999999999865322111 1224
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... ......+++++.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 5689999999999888777 78999999999999999999999888877776665432 2223458999999999999 9
Q ss_pred CCCCCC-----CHHHHhcCCCcCCC
Q psy10459 295 PVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
||.+|+ ++.++++||||.+.
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999997 99999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=380.41 Aligned_cols=280 Identities=29% Similarity=0.479 Sum_probs=247.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|.++++||+|+||.|.+++.+.+++.||+|++.+-..........|..|..++..-+.+.|+.++.+|++++++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45679999999999999999999999999999999998733322233677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++||+|..++.+...+++..+..++..|+.||..||+.|+|||||||+|||+|..|+++|.|||.+..+..++.-
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999887655432
Q ss_pred cccccccccccccccccccccC----C-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILK----G-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESP 279 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~ 279 (335)
.....+|||.|.+||++. + +.|. ..+|.||+|+++|||+.|..||......+.+.+|-. .+.||...
T Consensus 232 ----~s~~aVGTPDYISPEvLqs~~~~~g~yG-~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 232 ----RSSVAVGTPDYISPEVLQSQGDGKGEYG-RECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred ----EeccccCCCCccCHHHHHhhcCCccccC-CccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 244568999999999984 2 3455 789999999999999999999999999999988854 68888777
Q ss_pred CCCHHHHHHHHHhcCCCCCCCC---HHHHhcCCCcCCCCCCCCCCCCCCcccccCCC
Q psy10459 280 RLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKS 333 (335)
Q Consensus 280 ~~~~~l~~li~~~L~~p~~Rps---~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~ 333 (335)
.+|.+.++||++++.+|+.|.. ++++..||||.+..= ...+-+.|+++|-..|
T Consensus 307 ~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W-~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDW-DNIRESVPPVVPEVSS 362 (1317)
T ss_pred ccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCCh-hhhhhcCCCCCCcCCC
Confidence 8999999999999999999998 999999999988533 4457788888886544
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=345.93 Aligned_cols=251 Identities=30% Similarity=0.505 Sum_probs=212.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
++||+|+||.||+|.+..+++.||+|+++......+.....+..|..++..+ +||||+++++.+...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764322222234445666666654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-----~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-----GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----Ccccc
Confidence 9999999888889999999999999999999999999999999999999999999999999987543221 12234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+||..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+..... .....++.++.+||.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-HFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHccC
Confidence 5789999999999888777 789999999999999999999999988888877765322 223458999999999999 9
Q ss_pred CCCCCCCH-HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM-EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~-~~ll~hp~~~~~ 314 (335)
+|.+||++ .++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=345.38 Aligned_cols=251 Identities=27% Similarity=0.491 Sum_probs=213.3
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||.||+|.+..+|+.||+|+++......+.....+..|..++..+ +|+||+++++.+...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999764322222244455677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++.....+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-----NRAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-----Cceec
Confidence 9999999888889999999999999999999999999999999999999999999999999986432111 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+.....+.+..... .....++.++++||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-HYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHccC
Confidence 5789999999999988777 789999999999999999999999888888777765322 122358899999999999 9
Q ss_pred CCCCCCCH-HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM-EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~-~~ll~hp~~~~~ 314 (335)
||++||++ +++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=344.14 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=213.0
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHc-CCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG-LKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+++.||+|+++......+........|..++.. ++||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976432212223445567777775 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-----KTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-----ceee
Confidence 99999998877899999999999999999999999999999999999999999999999999865322111 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+||..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+..+.+...... ....++.++.+||.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC-YPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccCCHHHHHHHHHHhcc
Confidence 5689999999999887777 7899999999999999999999998888877777653221 22358899999999999 9
Q ss_pred CCCCCCCHH-HHhcCCCcCCC
Q psy10459 295 PVKFRIQME-DIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~~-~ll~hp~~~~~ 314 (335)
||.+||++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 99999999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=345.26 Aligned_cols=251 Identities=29% Similarity=0.527 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+++.||+|++.............+..|..++..+ +||||+++++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999864332223345566888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-----TTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-----cccc
Confidence 99999998888899999999999999999999999999999999999999999999999999864322111 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.......+..... .....++.++.+||++|| .
T Consensus 156 ~~g~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccC
Confidence 5689999999999888877 789999999999999999999999888887777655322 222458999999999999 9
Q ss_pred CCCCCCCH-----HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM-----EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~-----~~ll~hp~~~~~ 314 (335)
||.+||++ .++++||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=347.63 Aligned_cols=258 Identities=26% Similarity=0.477 Sum_probs=213.5
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCC-ChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQA-PIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (335)
+|++++.||+|+||.||+|.+. .+++.||+|++.+... ........+..|+.++..+ +|++|+++++.+..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 4688999999975322 1122345577899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876533221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHccccCCCCCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~----~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
. .....+||..|+|||++.+....+.++|||||||++|+|++|..||... ........+.. ...+....++
T Consensus 161 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (332)
T cd05614 161 E----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIG 235 (332)
T ss_pred C----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCC
Confidence 1 1234578999999999987553347899999999999999999999643 23333333332 2223335689
Q ss_pred HHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
..+.+||.+|| .||++|| +++++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999 9999999 89999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=350.89 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=210.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999996532 2356899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++++|++. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 99999995 6999998887789999999999999999999999999999999999999999999999999986432211
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHc--------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-------YSELLKQVQK-------- 271 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-------~~~~~~~i~~-------- 271 (335)
.......+||..|+|||++.+..++ .++|||||||++|+|++|..||.... .......+..
T Consensus 237 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 237 ---ANKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ---ccccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 1112345789999999999888777 78999999999999999998875321 1111111110
Q ss_pred ------------------c-ccCCC-------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 272 ------------------R-VVFPE-------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 272 ------------------~-~~~~~-------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
. ...+. ...++.++.+||.+|| .||.+|||++|+|+||||+....+.+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 387 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence 0 00000 0135678999999999 99999999999999999988655543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=345.53 Aligned_cols=252 Identities=26% Similarity=0.501 Sum_probs=215.6
Q ss_pred eeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 56 GDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
++.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 46889999999754321 11223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence 999999999998888899999999999999999999999999999999999999999999999999864322211
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 291 (335)
.....+|+..|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... .+....++.++.+||++
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence 12345689999999999887776 78999999999999999999999988887777776542 23335689999999999
Q ss_pred hc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 292 IL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 292 ~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
|| .+|++|| +++++++||||+..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99 9999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=346.48 Aligned_cols=251 Identities=28% Similarity=0.550 Sum_probs=212.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH-HHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+|+.||+|++.............+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997643222222333444544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-----KTTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-----Ccccc
Confidence 9999999888889999999999999999999999999999999999999999999999999986432211 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+..+.+.... ....+.++.++.++|++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 5789999999999888777 78999999999999999999999988888877776542 2233568999999999999 9
Q ss_pred CCCCCCCH----HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM----EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~----~~ll~hp~~~~~ 314 (335)
||.+||++ .++++||||...
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=338.50 Aligned_cols=249 Identities=20% Similarity=0.350 Sum_probs=207.4
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.++|+||+++.+++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998764433332345567899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 139 LEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 139 ~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
..++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-----~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-----KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----ccc
Confidence 887743 34589999999999999999999999999999999999999999999999999876543221 122
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE----LLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
...|+..|+|||++.+..++ .++|+|||||++|+|++|..||....... ....+... .......++.++.+++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHH
Confidence 34688999999999988877 78999999999999999999998654322 22222211 11223468999999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
+|| .||++|| +++++++||||++.
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999 9999999 88999999999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=337.54 Aligned_cols=256 Identities=21% Similarity=0.375 Sum_probs=215.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|++.++||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999988999999999976443333334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999888653 3589999999999999999999999999999999999999999999999999876532211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCK 286 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~ 286 (335)
....+|+..|+|||++.+..++ .++|+||+|+++|+|++|..||.+.......+.+.. .........++..+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 1234688999999999887777 789999999999999999999988765444333322 112222345899999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 287 ALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 287 ~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
+||.+|| .||.+|| +++++++||||.+.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999 9999999 99999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=354.04 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=207.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC---
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--- 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 123 (335)
.....+|.++++||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|+||+++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 345668999999999999999999999999999999885432 2234799999999999999998876432
Q ss_pred -----CeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEe
Q psy10459 124 -----HRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLS 193 (335)
Q Consensus 124 -----~~~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~ 193 (335)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 257799999975 7877664 345689999999999999999999999999999999999999665 69999
Q ss_pred ccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc
Q psy10459 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273 (335)
Q Consensus 194 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~ 273 (335)
|||++..+..... .....|+..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....
T Consensus 214 DFGla~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 214 DFGSAKNLLAGQR------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred ccccchhccCCCC------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999986543221 2234679999999998765433378999999999999999999999887665554443211
Q ss_pred ------------------cCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 274 ------------------VFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 274 ------------------~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
.++. ....+.++.+||.+|| .||.+|||+.|+|+||||.+...+
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 1111 1236789999999999 999999999999999999876554
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=344.97 Aligned_cols=251 Identities=29% Similarity=0.534 Sum_probs=209.3
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999865433333355677888888776 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-----~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-----cccc
Confidence 99999998888899999999999999999999999999999999999999999999999999864322111 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------NYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---------~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.+||..|+|||++.+..++ .++|+|||||++|+|++|..||... ......+.+.. .....+..++..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~ 233 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAA 233 (329)
T ss_pred ccCCccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHH
Confidence 5789999999999988777 7899999999999999999999521 12223333332 22222346889999
Q ss_pred HHHHHhc-CCCCCCCC------HHHHhcCCCcCCC
Q psy10459 287 ALISNIL-SPVKFRIQ------MEDIRQDPWLKED 314 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps------~~~ll~hp~~~~~ 314 (335)
+||++|| .||.+||+ +.++++||||++.
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999 99999998 5899999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=341.40 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=218.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+|++.+.||+|+||+||+|.+..+|+.||+|++.......+.....+..|..++..+. |++|+++++.+...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999997643322223455667888888885 577888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....+||..|+|||++.+..++ .++|+|||||++|+|++|..||.+.......+.+.... ......++.++.+++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICK 233 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHH
Confidence 12345689999999999887777 78999999999999999999999998888877776532 2223458999999999
Q ss_pred Hhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
+|| .+|.+|++ .+++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999 99999997 5899999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=342.72 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=216.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|..++..++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997533322333556778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 456899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccCC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCC-CCCC
Q psy10459 210 QNLSETFCGSYAYASPEILKG----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPE-SPRL 281 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~-~~~~ 281 (335)
.....+||..|+|||++.. ....+.++|+|||||++|+|++|..||.+....+....+... ..++. ...+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 159 --QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred --cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 1123468999999999863 222337899999999999999999999988877777666542 22222 2358
Q ss_pred CHHHHHHHHHhc-CCCC--CCCCHHHHhcCCCcCCC
Q psy10459 282 SSSCKALISNIL-SPVK--FRIQMEDIRQDPWLKED 314 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~--~Rps~~~ll~hp~~~~~ 314 (335)
+.++++||++|| .++. .|++++++++||||.+.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999999 5443 38899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=344.32 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=221.8
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
....+....+..++.||+|-||.||.|.+.. ...||+|.+...... .+.+.+|++++++|+|++||++++++..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 3344556667788999999999999999753 448999999875443 34566999999999999999999999998
Q ss_pred CeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+.+||||||++.|+|.++++. +..+...+.+.++.||++|++||+++++|||||-..||||+++..+||+|||+++..
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 899999999999999999987 456899999999999999999999999999999999999999999999999999944
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
..+. +... ....-...|.|||.+....++ .+|||||||++||||+| |+.||.+....++++.+.+++++|.+..
T Consensus 354 ~d~~--Y~~~--~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 354 GDDE--YTAS--EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG 428 (468)
T ss_pred CCCc--eeec--CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC
Confidence 3322 2111 111225579999999999988 89999999999999998 9999999999999999999999999999
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll 306 (335)
+|.++.+++..|| .+|++|||.+.+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999 9999999999765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=347.43 Aligned_cols=251 Identities=24% Similarity=0.446 Sum_probs=210.3
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
||+|+||+||+|.+..+++.||+|++................|..++..+ .||||+++++.+...+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999754322222223334566666554 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-----~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-----TTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-----CccC
Confidence 99999998888899999999999999999999999999999999999999999999999999865432211 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...........++.++.+||++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 578999999999876543347899999999999999999999998888887777654322223458999999999999 9
Q ss_pred CCCCCC----CHHHHhcCCCcCCC
Q psy10459 295 PVKFRI----QMEDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rp----s~~~ll~hp~~~~~ 314 (335)
||.+|| +++++++||||.+.
T Consensus 236 ~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CHHHCCCCCCCHHHHhcCccccCC
Confidence 999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=340.79 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=216.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||.||++.+..++..+|+|++..... +.....+.+|+.+++.++|+||+++++++...+..+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 456789999999999999999999999999999999875432 233566789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++..+...
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999998888899999999999999999999975 7999999999999999999999999998655321
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ---------------- 270 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~---------------- 270 (335)
......|+..|+|||++.+..++ .++|+|||||++|+|++|..||...........+.
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 158 -----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred -----ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 12234688999999999887776 78999999999999999999998665443322110
Q ss_pred ----------------------------ccccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 271 ----------------------------KRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 271 ----------------------------~~~~~~-~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
...... ....++.++++||.+|| .||++|||+++++.||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000000 01236789999999999 9999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=337.36 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=213.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|.+.+.||+|+||+||+|.+..+++.||+|.++....... ...+.+|+.+++.++|+||+++++++..++..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 34679999999999999999999999999999999875433211 3345689999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9999975 888887654 45889999999999999999999999999999999999999999999999998754322211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--------------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-------------- 273 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-------------- 273 (335)
.....++..|+|||++.+....+.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 161 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 161 -----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred -----cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 1233578899999998765444478999999999999999999998877665554443211
Q ss_pred ------cCC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 274 ------VFP---------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 274 ------~~~---------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.++ ..+.++.++++||.+|| .||.+|||++|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 111 11357889999999999 9999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=343.53 Aligned_cols=251 Identities=27% Similarity=0.540 Sum_probs=212.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH-HHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+|+.||+|++.............+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997643322222334445554 56778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-----~~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-----DTTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-----CCccc
Confidence 9999999888889999999999999999999999999999999999999999999999999986432111 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+.... ....+.++..+.++|++|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhcc
Confidence 5789999999999988877 78999999999999999999999988888777776532 2233468999999999999 9
Q ss_pred CCCCCCCH----HHHhcCCCcCCC
Q psy10459 295 PVKFRIQM----EDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~----~~ll~hp~~~~~ 314 (335)
+|.+||++ .++++||||+..
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999976 599999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=341.00 Aligned_cols=251 Identities=28% Similarity=0.516 Sum_probs=210.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+++.||+|++.............+.+|..++..+ +|++|+.+++.+...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999875443344456677899998888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|..++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-----DTTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-----Cceec
Confidence 9999999888889999999999999999999999999999999999999999999999999986432211 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-------NYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-------~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.+|+..|+|||++.+..++ .++|+|||||++|+|++|..||... ........+.. ...+....++..+.++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~l 233 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHV 233 (327)
T ss_pred ccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHH
Confidence 5789999999999888777 7899999999999999999999532 12223333332 2233334689999999
Q ss_pred HHHhc-CCCCCCCC------HHHHhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQ------MEDIRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps------~~~ll~hp~~~~~ 314 (335)
|++|| .||.+|++ ++++++||||+.-
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999 99999997 5799999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=354.34 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=225.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC---
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--- 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 124 (335)
....+|.+.+.||+|+||+||+|.+..+|+.||||++........ ....+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA-DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH-HHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345699999999999999999999999999999999976554333 3456778999999999999999987764432
Q ss_pred -----eEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecc
Q psy10459 125 -----RVYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 195 (335)
Q Consensus 125 -----~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Df 195 (335)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999998642 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
|+++.+...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 188 Gls~~~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 188 GFSKMYAATVSD---DVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred ccCeeccccccc---cccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 998765432111 123356789999999999988877 7899999999999999999999999988888887776555
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+....+++++.++|.+|| .||.+||++.++++|||++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 556679999999999999 999999999999999998764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=333.44 Aligned_cols=272 Identities=22% Similarity=0.351 Sum_probs=221.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+.+++.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876544333334556689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999999988543 3589999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHccccCCCCCCCCHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.....|+..|+|||++.+..++ .++|+||||+++|+|++|..||...... .................++.++.
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDAR 233 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHH
Confidence 1233689999999999887777 7899999999999999999999865432 22222222222222345889999
Q ss_pred HHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC-CCCCCCCCCCCccccc
Q psy10459 287 ALISNIL-SPVKFRIQ-----MEDIRQDPWLKED-SNPVGKSKSAPEVIPF 330 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~ 330 (335)
+||++|| .||++||| ++++++||||++. ...+......|.++|.
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 9999999 99999999 9999999999863 3434445566666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=333.52 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=205.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcC-CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEE-----
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIE----- 121 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~----- 121 (335)
.+|++.+.||+|+||.||+|.+.. ++..||+|+++........ ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 4688999998754332211 22344677766655 6999999999875
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
....++++|||+. ++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2456899999996 5999988653 348999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC--
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-- 277 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-- 277 (335)
..... .......|+..|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+......+.
T Consensus 159 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 159 IYSFQ------MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred eccCC------cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 65432 112345689999999999887777 789999999999999999999998887777666654221110
Q ss_pred ------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 ------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 ------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+.++..+.+||.+|| .||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1347788999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.52 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=214.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----eE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 126 (335)
+|++.+.||+|+||.||+|.+..+|+.||+|.+........ ....+.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV-SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH-HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999865433222 2456778999999999999999999998766 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|+|+||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 58999888878899999999999999999999999999999999999999999999999999876533221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc------------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------ 274 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~------------ 274 (335)
. ......++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 159 K----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred c----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 1 122335788999999998755444789999999999999999999998877666555432111
Q ss_pred ------------C-------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 ------------F-------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 ------------~-------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
. ......+.++.+||.+|| .||.+|||+.++|+||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 111346789999999999 9999999999999999999853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=341.01 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=209.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 124 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3578999999999999999999999999999999997543322 22455668999999999999999999886443
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..|+||||+.+ +|...+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 67766643 47899999999999999999999999999999999999999999999999986543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------- 274 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-------- 274 (335)
... ......||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.....
T Consensus 175 ~~~------~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 175 TNF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cCc------cCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 211 12334678999999999888877 789999999999999999999987765443332221110
Q ss_pred ---------------C--------------CC----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 275 ---------------F--------------PE----SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 275 ---------------~--------------~~----~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
. +. ....+.++++||.+|| .||++|||+.|+|+||||+....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~ 326 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE 326 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccc
Confidence 0 00 0124678999999999 99999999999999999986544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=346.97 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=212.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-C-----CCeeeeceeEEeCCe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-H-----PNLIRFLQAIETTHR 125 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~ 125 (335)
+|.+.+.||+|+||+|.+|.+..+++.||||++++...- ..+...|+.+|..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 799999999999999999999999999999999875332 344557999999986 3 489999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC--CEEEecccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKY 201 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~--~~~l~Dfg~~~~~ 201 (335)
+|||+|.+. .+|+++++.++ .++...++.++.||+.||.+||..||||+||||+|||+.+-+ .+||+|||.+...
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999995 59999998764 589999999999999999999999999999999999997543 6999999998765
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC---
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--- 278 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 278 (335)
... ...++-+..|+|||++.+.+|. .+.||||||||++||++|.+.|.+.+..+.+..|.+.+..|..
T Consensus 342 ~q~--------vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 342 SQR--------VYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred CCc--------ceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432 2255678899999999999999 7899999999999999999999999888887777432222210
Q ss_pred -----------------------------------------------C------------CCCHHHHHHHHHhc-CCCCC
Q psy10459 279 -----------------------------------------------P------------RLSSSCKALISNIL-SPVKF 298 (335)
Q Consensus 279 -----------------------------------------------~------------~~~~~l~~li~~~L-~~p~~ 298 (335)
+ .-...+.+||++|| -||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 1 12347899999999 99999
Q ss_pred CCCHHHHhcCCCcCCC
Q psy10459 299 RIQMEDIRQDPWLKED 314 (335)
Q Consensus 299 Rps~~~ll~hp~~~~~ 314 (335)
|+|+.++|+||||.+.
T Consensus 493 R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGT 508 (586)
T ss_pred cCCHHHHhcCcccccc
Confidence 9999999999999954
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=339.81 Aligned_cols=250 Identities=27% Similarity=0.521 Sum_probs=211.3
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHH-HHHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI-EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
++||+|+||.||+|.+..+++.||+|++.............+..|. .+++.++|+||+++++.+...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999764332222233344454 467889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|...+.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-----ETTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----Ccccc
Confidence 9999999888889999999999999999999999999999999999999999999999999986432211 11234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+.... ....+..+.++.++|.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 5789999999999887777 78999999999999999999999998888777776542 2333468899999999999 9
Q ss_pred CCCCCCCH----HHHhcCCCcCC
Q psy10459 295 PVKFRIQM----EDIRQDPWLKE 313 (335)
Q Consensus 295 ~p~~Rps~----~~ll~hp~~~~ 313 (335)
||.+|+++ .++++|+||..
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=340.20 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=217.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.++||+|+||+||++.+..+++.||+|++.+...........+.+|+.++..++|++|+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999996533222333455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++..+......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-- 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence 99999999999976 456899999999999999999999999999999999999999999999999998755332211
Q ss_pred cccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCCC-CC
Q psy10459 210 QNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPES-PR 280 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~-~~ 280 (335)
.....+||..|+|||++.. ..++ .++|+|||||++|+|++|..||...+..+....+.... .+|.. ..
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 159 --QSSVAVGTPDYISPEILQAMEDGKGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred --eecccccCccccCHHHHhccccCCCCCC-CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 1223568999999999863 2344 78999999999999999999999998888887776532 23322 35
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
++.++++||++|| .++.+ |++++++++||||.+.
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 8999999999999 65443 7899999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=341.90 Aligned_cols=251 Identities=27% Similarity=0.511 Sum_probs=214.6
Q ss_pred eeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 56 GDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
++.||+|+||.||++.+. .+|+.||+|++........ ....+..|+.++.+++||||+++++.+..++..|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999998763 5789999999976433221 234566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+.+++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-----~ 154 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-----K 154 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-----c
Confidence 99999999998888899999999999999999999999999999999999999999999999999875433211 1
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHh
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 292 (335)
....+|+..|+|||++.+..++ .++|+|||||++|+|++|..||...+..+....+.... ......++.++.+||++|
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred eecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHH
Confidence 2345689999999999887776 78999999999999999999999988887777765532 222345899999999999
Q ss_pred c-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 293 L-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 293 L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
| .||++||+ ++++++||||...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9 99999999 7889999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=340.00 Aligned_cols=251 Identities=29% Similarity=0.554 Sum_probs=211.6
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHH-HHHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI-EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||+|+||+||+|.+..+++.||+|++.............+..|. .+++.++|+||+++++.+...+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999754322121222333444 456788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-----~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-----TTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-----Cccc
Confidence 99999998888899999999999999999999999999999999999999999999999999865422111 1234
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
.+|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ....+.++..+.++|.+|| .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHccc
Confidence 5789999999999888777 78999999999999999999999988888777765432 2233568999999999999 9
Q ss_pred CCCCCCCHH----HHhcCCCcCCC
Q psy10459 295 PVKFRIQME----DIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps~~----~ll~hp~~~~~ 314 (335)
+|.+|+++. ++++|+||...
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCCC
Confidence 999999876 89999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.87 Aligned_cols=278 Identities=27% Similarity=0.483 Sum_probs=231.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|++|+||+|.+..+++.||+|.+.............+..|++++..++|+||+++++.+...+..|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46999999999999999999998899999999998765544344667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 131 EYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 468999999999999999999999999999999999999999999999999987553321110
Q ss_pred c------------------------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy10459 209 K------------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264 (335)
Q Consensus 209 ~------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~ 264 (335)
. ........|+..|+|||++.+..++ .++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0 0111234678899999999887776 78999999999999999999998888776
Q ss_pred HHHHHHc-cccCCCCCCCCHHHHHHHHHhc-CCCCCCCC----HHHHhcCCCcCCCCCCCCCCCCCCccccc
Q psy10459 265 LLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQ----MEDIRQDPWLKEDSNPVGKSKSAPEVIPF 330 (335)
Q Consensus 265 ~~~~i~~-~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps----~~~ll~hp~~~~~~~~~~~~~~~~~~~~~ 330 (335)
....+.. ...++....++..+.++|.+|| .+|.+||+ ++++|+||||++.. ....+...++.+|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~-~~~~~~~~~~~~~~ 310 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN-WALIRHTTPPIIPR 310 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC-hhhcccCCCCCCCC
Confidence 6665553 3444444457999999999999 99999999 99999999998743 33345555555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=329.70 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=205.0
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||+|+||.||++.+..+|+.||+|.+.............+..|+++++.++||||+++++.+......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998653332222244455799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccc
Q psy10459 139 LEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 139 ~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------eecc
Confidence 98886543 488999999999999999999999999999999999999999999999999876543211 1234
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHccccCCCCCCCCHHHHHHHHHh
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVFPESPRLSSSCKALISNI 292 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 292 (335)
.|+..|+|||++.+..++ .++|+|||||++|+|++|..||..... .+................++.++++||++|
T Consensus 155 ~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 578899999999888766 789999999999999999999976533 222222222111112246899999999999
Q ss_pred c-CCCCCCCCH----HHHhcCCCcCCC
Q psy10459 293 L-SPVKFRIQM----EDIRQDPWLKED 314 (335)
Q Consensus 293 L-~~p~~Rps~----~~ll~hp~~~~~ 314 (335)
| .||.+||++ ++++.||||+.-
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCC
Confidence 9 999999999 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=338.89 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=216.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||+||++.+..+++.||+|++.............+.+|..++..++|++|+.+++.+...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997533222333455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999977 467899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCC-CCC
Q psy10459 210 QNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPE-SPR 280 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~-~~~ 280 (335)
.....+|+..|+|||++.+ ..++ .++|+||||+++|+|++|..||...+..+....+.... .+|. ...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 159 --QSSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred --eeccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcccc
Confidence 1223568999999999865 3344 78999999999999999999999988877777765432 2222 235
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
++.+++++|.+|| .++.+ |++++++++||||+..
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 7899999999999 55443 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=336.50 Aligned_cols=254 Identities=37% Similarity=0.677 Sum_probs=226.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
-|.+.+.||+|-|+.|.+|++.-+|+.||||++.+.....- ....+.+|+..++.++|||||++|++...+..+|+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 48899999999999999999999999999999988776533 35566799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-CCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
.-++|+|.+||.++ ..+.+..+.+++.||+.|+.|+|+..+|||||||+||.+- .-|-+||+|||++..+.+...
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--- 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--- 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---
Confidence 99999999999765 4599999999999999999999999999999999998765 567899999999977754332
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKAL 288 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~l 288 (335)
..+.||+..|.|||++.+..|...+.||||||+++|.|.+|+.||...+..+.+-.|-. .+..| ..++.++++|
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP--shvS~eCrdL 249 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP--SHVSKECRDL 249 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc--hhhhHHHHHH
Confidence 34679999999999999999998899999999999999999999998888887766655 34444 4699999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|..|| .||.+|.+.++|..|+|++..
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccCC
Confidence 99999 999999999999999999874
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.23 Aligned_cols=263 Identities=28% Similarity=0.456 Sum_probs=216.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|.+.+.||.|+||.||+|.+..+++.||+|.+........ ...+.+|+.+++.++|+||+++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 34679999999999999999999998999999999875433221 3345689999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 999997 5898888653 46899999999999999999999999999999999999999999999999998754322211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-------------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------- 274 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 274 (335)
.....++..|+|||++.+....+.++||||||+++|+|++|..||...+..+....+.....
T Consensus 161 -----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 161 -----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 12234688999999987655444789999999999999999999998876655544332111
Q ss_pred -------CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 275 -------FPE---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 275 -------~~~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+. ...++.++++||.+|| .||.+|||++++|+||||+...+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~ 297 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence 111 1347889999999999 99999999999999999998776544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=350.11 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=221.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...|.+.+.||+|++|.||+|.+..+ +..||+|.+.... ......+.+|+.++..++||||+++++.+..++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998777 7789999764332 2224567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 129 IMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..+...+....++.+
T Consensus 223 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 223 VS---LDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred cc---cccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 21 1123456789999999999887777 7899999999999999999999998888888777665544444568999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+.+||.+|| .+|.+||++++++.|+|++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999 99999999999999999864
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=322.28 Aligned_cols=258 Identities=21% Similarity=0.419 Sum_probs=218.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH--HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID--YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
++|.+.+.||+|++|.||.|.+..+++.||+|++........ .....+.+|+.+++.++|+||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 469999999999999999999988999999999875433222 224567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~- 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS- 160 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998765332111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~ 287 (335)
........++..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+... ........++..+.+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 161 -GTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred -cccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1111234578899999999887766 8899999999999999999999887665555444433 222233468899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+|++|| .+|.+||++.++++||||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999 999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=328.04 Aligned_cols=255 Identities=29% Similarity=0.523 Sum_probs=222.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|++|.||++.+..+++.||+|++.............+.+|+++++.+.||||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999999999997644333333566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....++..|+|||.+.+...+ .++|+||||+++|+|++|..||...+.....+.+... ..+....++..++++|+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIR 230 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHH
Confidence 2234678899999999877666 7899999999999999999999988877766666543 22333457899999999
Q ss_pred Hhc-CCCCCCC-----CHHHHhcCCCcCCCC
Q psy10459 291 NIL-SPVKFRI-----QMEDIRQDPWLKEDS 315 (335)
Q Consensus 291 ~~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 315 (335)
+|| .+|.+|+ +++++++||||+...
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 999 9999999 999999999997754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=327.36 Aligned_cols=272 Identities=21% Similarity=0.349 Sum_probs=224.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+.+.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876543333334556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence 99999999888653 3589999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCCCCCCCHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCK 286 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~ 286 (335)
.....|+..|+|||.+.+..++ .++|+||||+++|+|++|..||.+.........+.... .......++.++.
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 1234689999999999887777 78999999999999999999998876654444443321 1122346889999
Q ss_pred HHHHHhc-CCCCCCCC-----HHHHhcCCCcCCCCCCC-CCCCCCCccccc
Q psy10459 287 ALISNIL-SPVKFRIQ-----MEDIRQDPWLKEDSNPV-GKSKSAPEVIPF 330 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~~~~~-~~~~~~~~~~~~ 330 (335)
+|+..|| .||.+||+ +.+++.|+||+...... ......+.++|.
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 9999999 99999999 89999999999874433 345566666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.46 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=210.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH-HHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35689999999999999999999988999999999876443322 245566899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
...+++|||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 77777654 47899999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------- 274 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-------- 274 (335)
... ......|+..|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 171 ~~~------~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 171 TSF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred Ccc------ccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 221 12334689999999999888777 789999999999999999999988765544333221110
Q ss_pred -----------------------------CC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 275 -----------------------------FP----ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 275 -----------------------------~~----~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
++ .....+.++++||.+|| .||++|||+.|+|+||||.....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~ 322 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAE 322 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhh
Confidence 00 01124567899999999 99999999999999999986654433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=337.46 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=212.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|.+.+.||+|+||.||+|.+..+++.||||++........ ....+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch-hHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 35789999999999999999999999999999999875433222 245566899999999999999999887543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999965 78777754 37889999999999999999999999999999999999999999999999997653
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----- 277 (335)
... ......|+..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 178 ~~~------~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 178 TSF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CCC------cccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 221 12334689999999999888777 789999999999999999999998876665555433211110
Q ss_pred ------------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 ------------------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 ------------------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
....+..+++||.+|| .||.+|||++++|+||||.....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 329 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE 329 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence 0113467899999999 99999999999999999986544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=329.05 Aligned_cols=252 Identities=35% Similarity=0.638 Sum_probs=210.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|++++.||+|+||+||++.+..+++.||+|++......... .....+|+.+++.++|+||+++++++...+..+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999876443322 22334699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+.+++|.+++.....+++..+..++.|+++||.+||+.|++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-----~~ 154 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-----EN 154 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-----SE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cc
Confidence 9999999999977889999999999999999999999999999999999999999999999999987541111 12
Q ss_pred ccccccccccccccccC-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc----c--CCCCCCCCHHH
Q psy10459 213 SETFCGSYAYASPEILK-GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV----V--FPESPRLSSSC 285 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~-~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~----~--~~~~~~~~~~l 285 (335)
.....++..|+|||++. +...+ .++|+||||+++|+|++|..||...........+.... . .......+..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYT-RKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBS-THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 33456789999999998 55555 89999999999999999999999874333333332211 1 11111234899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++|.+|| .||++||+++++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 99999999 999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=322.69 Aligned_cols=259 Identities=26% Similarity=0.492 Sum_probs=219.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh------HHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI------DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
+|.+...||.|++|.||+|.+..+++.||+|.+....... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999998889999999986543321 1234568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.+++|||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987664322
Q ss_pred cccc-cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYK-QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.... ........|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+...........++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1111 1111234578899999999887776 7899999999999999999999887766665555554333333468899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+.++|++|| .+|.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999999 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=348.38 Aligned_cols=254 Identities=21% Similarity=0.351 Sum_probs=203.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC------CCCeeeeceeEEe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK------HPNLIRFLQAIET 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~ 122 (335)
...+|++.++||+|+||+||+|.+..+++.||||+++.... .......|+.++..++ |.+++.+++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999965321 1233445777766664 4458888888866
Q ss_pred C-CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCC------------
Q psy10459 123 T-HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKY------------ 188 (335)
Q Consensus 123 ~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~------------ 188 (335)
+ ..+|+||+++ |++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 77999999888889999999999999999999998 5999999999999998765
Q ss_pred ----CEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy10459 189 ----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264 (335)
Q Consensus 189 ----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~ 264 (335)
.+||+|||.+..... .....+||..|+|||++.+..++ .++|||||||++|||++|+.||.+.+..+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH--------SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCceEEECCCCccccCcc--------ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998753221 12345789999999999988887 78999999999999999999998877655
Q ss_pred HHHHHHcccc-CC------------------------C----------------CCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy10459 265 LLKQVQKRVV-FP------------------------E----------------SPRLSSSCKALISNIL-SPVKFRIQM 302 (335)
Q Consensus 265 ~~~~i~~~~~-~~------------------------~----------------~~~~~~~l~~li~~~L-~~p~~Rps~ 302 (335)
....+..... +| . ....+..+.+||.+|| .||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 5444432110 00 0 0011356789999999 999999999
Q ss_pred HHHhcCCCcCCCCC
Q psy10459 303 EDIRQDPWLKEDSN 316 (335)
Q Consensus 303 ~~ll~hp~~~~~~~ 316 (335)
+|+|+||||++...
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999988543
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=323.06 Aligned_cols=279 Identities=29% Similarity=0.507 Sum_probs=242.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|..+++||+|.||.|.+|+.+.+|+.||+|++++.-........--..|-.+|+..+||.+..+...|+..+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 44567789999999999999999999999999999999987655433334445578899999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||..||.|.-.+.+...|++.....+...|+.||.|||+.+||+||||.+|.|+|.+|++||+|||+++.-...+
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999997543322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 284 (335)
....++|||+.|+|||++....|. .+.|.|.+|+++|||++|++||...+.+.+++.|.. .+.+|. .++++
T Consensus 323 -----~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr--~ls~e 394 (516)
T KOG0690|consen 323 -----DTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR--TLSPE 394 (516)
T ss_pred -----ceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--cCCHH
Confidence 235678999999999999999999 899999999999999999999999999998888865 566664 59999
Q ss_pred HHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC-CCCCCCCCCCCcccccCC
Q psy10459 285 CKALISNIL-SPVKFRI-----QMEDIRQDPWLKED-SNPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~ 332 (335)
.+.|+..+| +||.+|. .+.||.+|+||..- ++..-..+..|++.|..-
T Consensus 395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred HHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 999999999 9999998 78999999999764 333333555666666543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=318.31 Aligned_cols=253 Identities=27% Similarity=0.524 Sum_probs=216.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-CCeEEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIM 130 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~ 130 (335)
+|++.+.||+|++|.||++.+..+++.||+|.+....... .....+.+|+.+++.++|+|++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999899999999987543322 224567789999999999999999988764 44689999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 131 EYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||+++++|.+++... ..+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 999999999998763 4589999999999999999999999999999999999999999999999999876533221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
......++..|+|||++.+..++ .++|+||||+++++|++|..||...+.......+......+....++..+.++
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd08223 158 ---MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233 (257)
T ss_pred ---ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHH
Confidence 12344678899999999887777 78999999999999999999999888777766665554433445688999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
|.+|| .+|++||++.+++.||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 99999 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=337.36 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=210.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 123 (335)
.++|.+.+.||.|+||+||+|.+..+++.||+|.+....... .....+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 468999999999999999999999999999999986543222 2234566899999999999999999877532
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3578999998 7799888754 4599999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------- 276 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 276 (335)
. .....|+..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 171 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 171 E--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred C--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 1 2234689999999999775444488999999999999999999998877655554443211100
Q ss_pred -----------------C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 277 -----------------E------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 277 -----------------~------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
. ....++.+.+||.+|| .||.+|||+.++|+||||.+...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 0 1235677899999999 9999999999999999999865544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=318.22 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=220.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||+|++|.||+|.+..+++.|++|.+........ ....+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH-HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 48899999999999999999999999999999876444333 35667799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999999999764 56899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
.....|+..|+|||+..+..++ .++|+||||+++++|++|..||...+.......+......+....++..+.++|
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08529 158 ---ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233 (256)
T ss_pred ---hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 2234578899999999887776 789999999999999999999998887777777666543333346889999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+|| .+|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 9999 999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=326.79 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=203.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEEe-----C
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIET-----T 123 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~ 123 (335)
+|++.+.||+|+||+||+|.+..+|+.||+|.++....... ....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875322211 122334566666555 79999999998754 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...+++||++.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 898888664 34899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-----
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----- 276 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----- 276 (335)
..... .....|+..|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+......+
T Consensus 159 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 159 SCQMA------LTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccc------CCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 42211 1234578899999999887777 78999999999999999999998877766655553311100
Q ss_pred ---------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 277 ---------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 277 ---------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+.++..+.+||.+|| .||.+|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01357888999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=323.16 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=221.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||.|++|.||+|.+..++..||+|++....... ....+.+|+.+++.++|+||+++++.+..+...++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch--HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999987543222 2455778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++... .+++..++.++.|++.||.+||+.+++|+||+|+||++++++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999999765 689999999999999999999999999999999999999999999999999977653321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCC-CCHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR-LSSSCKALI 289 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-~~~~l~~li 289 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+........... ++.++.+++
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred -ccccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 12234578889999999887766 889999999999999999999988777766666655433222223 789999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+|| .+|++||+++++++||||++...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999 99999999999999999988544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=334.17 Aligned_cols=255 Identities=21% Similarity=0.371 Sum_probs=206.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++.++||+|+||.||+|.+. .+++.||+|++...... .....+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 466788999999999999999999752 34578999998653322 2245677999999999 899999999988
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q psy10459 121 ETT-HRVYIIMEYAKNGSLLEVIRKE------------------------------------------------------ 145 (335)
Q Consensus 121 ~~~-~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------ 145 (335)
... +.++++|||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 4689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccc
Q psy10459 146 --------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217 (335)
Q Consensus 146 --------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~ 217 (335)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......... ......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~---~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh---cccCCC
Confidence 236778889999999999999999999999999999999999999999999997653221110 112234
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHccccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 218 g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.... .....+..+........++.++.++|.+|| .
T Consensus 238 ~~~~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CCccccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 56789999999887777 78999999999999997 99999876543 344444444444444568899999999999 9
Q ss_pred CCCCCCCHHHHhc
Q psy10459 295 PVKFRIQMEDIRQ 307 (335)
Q Consensus 295 ~p~~Rps~~~ll~ 307 (335)
||.+|||+.++++
T Consensus 317 dp~~RPs~~el~~ 329 (338)
T cd05102 317 DPKERPTFSALVE 329 (338)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=326.82 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=214.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||.||++.+..++..+|+|.+..... ......+.+|++++..++||||+++++.+..++.++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 369999999999999999999999999999999865322 233556778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 999999999999888889999999999999999999997 59999999999999999999999999988654321
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc---------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------- 274 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--------------- 274 (335)
......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 12344678999999998877666 789999999999999999999976654444333321100
Q ss_pred --------------------CCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 --------------------FPE--SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 --------------------~~~--~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.|. ...++.++++||.+|| .+|++||+++++++||||.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 000 0136788999999999 9999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=315.12 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=219.0
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
.+.||+|+|+.|--|+...+|..||||++.+.. ...+.++.+|++++.+++ |+||+.++++|+++..+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 478999999999999999999999999998753 334777889999999995 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEeccccccccccCCcc--cc
Q psy10459 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTD--YK 209 (335)
Q Consensus 135 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~~--~~ 209 (335)
||+|...|+..+.|++.++..+.++|+.||.|||.+||.|||+||+|||-..... +|||||.+.......+.. ..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999976543 799999987654322211 11
Q ss_pred cccccccccccccccccccC----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILK----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------------NYSELLKQVQ 270 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---------------~~~~~~~~i~ 270 (335)
.+-..+.+|+..|||||+.. ...++..++|+||||+++|-|++|++||.+. -+..+++.|+
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 12234578999999999863 3344448899999999999999999999752 2566777777
Q ss_pred cc-ccCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 271 KR-VVFPE--SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 271 ~~-~~~~~--~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++ +.||+ +..+|.+.++||+.+| .|+.+|.++.++++|||++.....
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 74 44553 5679999999999999 999999999999999999876443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=324.80 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=217.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC--hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
+|.+.+.||+|++|.||+|.+..+|+.||+|.+...... .+.....+..|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999889999999999765432 122345567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+ +++|.+++.... .+++..+..++.||++||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 889999998765 7999999999999999999999999999999999999999999999999999766443211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------ 276 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------ 276 (335)
.....++..|+|||.+.+....+.++|+|||||++|+|++|..+|.+....+....+......+
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 159 ----MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred ----ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 1222457789999998654444478999999999999999988888776655554443321111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 277 ---------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 277 ---------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
.....+..+.++|.+|| .+|++|||+.++++||||++...+-++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 01235788999999999 999999999999999999997666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=324.70 Aligned_cols=254 Identities=27% Similarity=0.480 Sum_probs=215.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|.+.+.||.|++|.||+|.+..++..||+|.+....... ...+.+|+.+++.+.|+||+++++.+..+...++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999998999999999987644432 355678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--- 172 (296)
T cd06654 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172 (296)
T ss_pred cccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc---
Confidence 999999999998653 5889999999999999999999999999999999999999999999999998754322111
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
.....++..|+|||.+.+..++ .++|+|||||++|+|++|..||...........+.... ..+....++..+.++
T Consensus 173 --~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 173 --RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred --cCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHH
Confidence 1234578899999999887776 78999999999999999999998877654443333222 112234688999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|.+|| .+|.+||+++++++||||...
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999 999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=333.18 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+...+|.+++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|+||+++++++...+..
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 34566899999999999999999999989999999975432 223689999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|+|++. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||.+......
T Consensus 133 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 133 CMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred EEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 99999995 588888754 456899999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCH----------HHHHHHHHccc-
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNY----------SELLKQVQKRV- 273 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~-~~~~~----------~~~~~~i~~~~- 273 (335)
.......||..|+|||++.+..++ .++|+|||||++|+|+++..++ ..... ..+...+....
T Consensus 211 -----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 211 -----PAFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred -----cccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 112234689999999999888877 7899999999999999855444 32111 11111111100
Q ss_pred ---cCC----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 274 ---VFP----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 274 ---~~~----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
.++ ....++.++.+||.+|| .||.+|||++|+|+||||++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 011 01245677888999999 99999999999999999986
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=321.23 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=206.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||+|++|.||+|.+..++..||+|.+...... +.....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999889999999998654322 1223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+. ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 5898888643 4589999999999999999999999999999999999999999999999999875543221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------- 273 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--------------- 273 (335)
......++..|+|||++.+....+.++|+|||||++|+|++|+.||.+.........+....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 ---VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ---cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 11223568889999998765543478999999999999999999998766543332221100
Q ss_pred ----cC---------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 274 ----VF---------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 274 ----~~---------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+ .....++.++.++|++|| .||.+|||+++|+.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 012347899999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=324.08 Aligned_cols=253 Identities=26% Similarity=0.475 Sum_probs=206.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++|+||+++++.+.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 589999999999999999999999999999998754322 1223456689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|+.+ +|.+++.. .+.+++..++.++.||++||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--- 155 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC---
Confidence 9964 88887765 466899999999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcccc---------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVV--------------- 274 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~-~~~~~~~~~~~i~~~~~--------------- 274 (335)
.....++..|+|||.+.+....+.++|+|||||++|+|++|..|+ .+.+..+....+.+...
T Consensus 156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 122356889999999877554447899999999999999988885 44444444333321110
Q ss_pred ---CC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 ---FP----------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 ---~~----------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+ ..+.++.++.+||++|| .||.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 11347889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=320.82 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=213.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|++|.||+|.+..+|+.||+|++....... .....+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999998899999999997654322 234567799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 45689999999999999999999999999999999999999999999999999876644321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-------------- 276 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 276 (335)
.......++..|+|||.+.+....+.++||||||+++|+|++|..||.+.........+......+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 112234678899999998765544478999999999999999998888776655554443321111
Q ss_pred ------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 277 ------E---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 277 ------~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
. .+..+.++.+||++|| .+|++||+++++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 1346789999999999 9999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=315.41 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=220.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|+||.||++.+..+|+.||+|.+........ ....+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChH-HHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433322 24567799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+.+++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-- 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--
Confidence 999999999987543 4789999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
.....|+..|+|||++.+...+ .++|+||||+++++|++|..||...+..+....+..+...+....++.++.++|
T Consensus 158 ---~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08218 158 ---ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233 (256)
T ss_pred ---hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence 1233578889999999887766 789999999999999999999998888888777766655445567899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+|| .+|.+||++.++++||||
T Consensus 234 ~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 234 SQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHhhCChhhCcCHHHHhhCcCC
Confidence 9999 999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=320.46 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=212.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++|+|++++++.+...+..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4799999999999999999999989999999998654321 122455678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999888888777677999999999999999999999999999999999999999999999999999766443221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc------------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR------------------ 272 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~------------------ 272 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+....+....+...
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 123346788999999876443347899999999999999999999887765544443221
Q ss_pred --ccCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 273 --VVFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 273 --~~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...+. .+.++..+.+||.+|| .+|++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111 1346889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=320.42 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=218.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|++.+.||.|++|.||+|.+..+|+.||+|.+....... ...+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 356999999999999999999999999999999987543322 45677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+||+++++|..++... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 9999999999988654 589999999999999999999999999999999999999999999999999876533221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKA 287 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~ 287 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.... .......++..+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 12234578899999999887776 78999999999999999999999887766555444322 12233468899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
||++|| .||.+||++.++++||||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 999999 9999999999999999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=321.95 Aligned_cols=263 Identities=25% Similarity=0.446 Sum_probs=221.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987654333333556778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc----
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT---- 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 206 (335)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998863211100
Q ss_pred ------ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCCCC-
Q psy10459 207 ------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPES- 278 (335)
Q Consensus 207 ------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~- 278 (335)
...........++..|+|||.+....++ .++|+|||||++|+|++|..||.+....+....+.... ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0000111234578889999999877776 78999999999999999999999888887777765532 23322
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCC---HHHHhcCCCcCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQ---MEDIRQDPWLKED 314 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps---~~~ll~hp~~~~~ 314 (335)
..++.++.++|++|| .+|++||+ +.++|+||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 358899999999999 99999997 8999999999663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=318.97 Aligned_cols=252 Identities=21% Similarity=0.436 Sum_probs=217.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|++++++++||||+++++.+...+..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999976544333345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+.|++|.+++.....+++..+..++.|+++||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998877899999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.....|+..|+|||.+.+..++ .++|+||||+++|+|++|..||.... .......... ........++..+.++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDA 232 (258)
T ss_pred -ccccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHH
Confidence 1234578899999999877766 78999999999999999999998877 3444433332 2233345688999999
Q ss_pred HHHhc-CCCCCCCCH--HHHhcCCCc
Q psy10459 289 ISNIL-SPVKFRIQM--EDIRQDPWL 311 (335)
Q Consensus 289 i~~~L-~~p~~Rps~--~~ll~hp~~ 311 (335)
|++|| .||.+||++ .++++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999 999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=335.72 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=206.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc--CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
...+|.+++.||+|+||.||+|... ..++.||+|.+... ....+|+.+++.++|+||+++++.+...+..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999754 34678999988642 2345799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|++||++. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 58999997777899999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHccc----------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQKRV---------- 273 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---~~~~~i~~~~---------- 273 (335)
. .......||..|+|||++.+..++ .++|||||||++|+|++|..||.+.... ..+..+.+..
T Consensus 241 ~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 241 T---PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred c---ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1 112345789999999999888877 7899999999999999999999764321 1111111100
Q ss_pred --------------------cCCC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 274 --------------------VFPE---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 274 --------------------~~~~---~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
..+. ...++.++.+||++|| .||.+||++.++|.||||++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0000 0235678999999999 99999999999999999976
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=318.54 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=209.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.++||+|+||.||+|.+..++..||+|++..... ......+.+|+.++.+++||||+++++.+...+..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368899999999999999999999999999999875432 223456779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------ 148 (279)
T cd06619 79 EFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------ 148 (279)
T ss_pred ecCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence 999999986542 4788999999999999999999999999999999999999999999999998765322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcccc-CCCCCCCC
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-------SELLKQVQKRVV-FPESPRLS 282 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-------~~~~~~i~~~~~-~~~~~~~~ 282 (335)
.....+|+..|+|||.+.+..++ .++|+||||+++|+|++|..||..... ......+..... ......++
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 12234688999999999887776 789999999999999999999965322 122222222111 11123578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.++.++|.+|| .+|.+||+++++++||||+....
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 89999999999 99999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=317.47 Aligned_cols=253 Identities=19% Similarity=0.321 Sum_probs=215.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
++..+|++.+.||+|+||.||+|.+. ..+..||+|.++.... ......+.+|+.++..++||||+++++.+..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45678999999999999999999765 3456899999876433 222456779999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 4689999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
... .......++..|+|||.+.+..++ .++|||||||++|++++ |..||.+....+..+.+......+....++
T Consensus 160 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05064 160 EAI----YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCP 234 (266)
T ss_pred cch----hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 111 111123346789999999887777 78999999999999775 999999999888888888777667777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+.+++.+|| .+|.+||++++|++
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=327.67 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=206.4
Q ss_pred Eeeeeccc--CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 55 LGDVVGMG--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 55 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
++++||+| +|++||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7889999999999999999998765433 23356778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc--c
Q psy10459 133 AKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--Y 208 (335)
Q Consensus 133 ~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~ 208 (335)
+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++++||+........... .
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999653 45899999999999999999999999999999999999999999999999875443221111 0
Q ss_pred ccccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------ 274 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~------------ 274 (335)
.........++..|+|||++.+. .++ .++|||||||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred cccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01111223467789999998763 355 789999999999999999999987654443322221100
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 275 ---------------------------------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 275 ---------------------------------~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+....+++.+.+||.+|| .||++|||++++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0011235778999999999 999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=321.87 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=218.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++|+||+++++.+..++..++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 356999999999999999999998889999999986432 22245677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998764 5689999999999999999999999999999999999999999999999998765433221
Q ss_pred ccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCC
Q psy10459 209 KQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRL 281 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~ 281 (335)
......++..|+|||.+.. ..++ .++|+||||+++|+|++|..||...+.......+..... ......+
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (280)
T cd06611 159 ---KRDTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKW 234 (280)
T ss_pred ---ccceeecchhhcCHHHHhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccC
Confidence 1223457889999999753 2333 689999999999999999999998887776666665432 2223468
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+.++.++|.+|| .+|.+||+++++++||||.+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 899999999999 9999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=314.51 Aligned_cols=259 Identities=23% Similarity=0.460 Sum_probs=214.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (335)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+..... ........+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864322 122234677889999999999999999998865 3568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+++|||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877789999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-CCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l 285 (335)
. ........|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+......+. ...++..+
T Consensus 162 ~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 162 S--GTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred c--ccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 1 0112234578899999999877766 789999999999999999999987765555554443332222 23577889
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCcC
Q psy10459 286 KALISNILSPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 286 ~~li~~~L~~p~~Rps~~~ll~hp~~~ 312 (335)
.++|++|+.+|.+||+++++++|||+.
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 999999998899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.38 Aligned_cols=262 Identities=27% Similarity=0.456 Sum_probs=215.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--TH 124 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 124 (335)
....++|.+++.||.|+||+||+|.+..++..||+|++........ ....+..|+.++..++||||++++++|.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~-~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH-HHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3456789999999999999999999999999999999976544333 35567799999999999999999998854 45
Q ss_pred eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCEeecCC------
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKK-------SVVHRDIKCENLLLDDK------ 187 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~-------~i~H~dikp~Nili~~~------ 187 (335)
.+||||||+++++|.+++.. ...+++..++.|+.||+.||.|||+. +|+|+||||+||||+..
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 78999999999999999865 25699999999999999999999985 49999999999999642
Q ss_pred -----------CCEEEeccccccccccCCcccccccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCC
Q psy10459 188 -----------YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGR 254 (335)
Q Consensus 188 -----------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~ 254 (335)
+.++|+|||++..+.... .....+||+.|+|||++.+. .++ .++|||||||++|+|++|.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s-~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCC-chhHHHHHHHHHHHHHHCC
Confidence 348999999997654321 12344689999999998643 344 7899999999999999999
Q ss_pred CCCCCCCH-HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 255 LPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 255 ~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
.||..... ......+......+ ...++.++.+||..|| .+|.+||++.++|.||||+....+
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 99976543 44444444433332 2457899999999999 999999999999999999876555
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=311.95 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=221.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||.|+||.||.+.+..++..+++|.+......... ...+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH-HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999998755433332 4556799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
......++..|.|||...+..++ .++|+||||+++|+|++|..||......+....+......+....++.++.++|
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHH
Confidence 12344678999999999877766 789999999999999999999999888887777766544444467899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+|| .+|.+||+++++++|||+
T Consensus 234 ~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 234 HSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHcccCcccCCCHHHHhhCcCC
Confidence 9999 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=320.31 Aligned_cols=240 Identities=18% Similarity=0.273 Sum_probs=206.5
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----CCeEEEEEec
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THRVYIIMEY 132 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~iv~e~ 132 (335)
..||+|++|.||+|.. +|+.||||+++..........+.+.+|+.++.+++||||+++++++.+ ...++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999996 689999999987655444445678899999999999999999999876 3578999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+++|+|.+++...+.+++.....++.+++.||.+||+. +++||||||+||+++.++.++|+|||++..+....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 99999999998888899999999999999999999984 99999999999999999999999999987653221
Q ss_pred cccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKAL 288 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l 288 (335)
....|+..|+|||++.+ ..++ .++|||||||++|+|++|..||.+.+..+....+... ...+....++.++.+|
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~l 254 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCI 254 (283)
T ss_pred --ccccCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHH
Confidence 12357889999999976 4555 8999999999999999999999998888877777543 3333334689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhc
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~ 307 (335)
|.+|| .||++|||+.++++
T Consensus 255 i~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 255 VEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHhcCCcccCcCHHHHHH
Confidence 99999 99999999999985
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=335.91 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=219.6
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
..+.+..+...++..||+|+||+||+|.|.. .||||++.......+ ..+.|.+|+.+|++-+|.||+-+.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 6677788889999999999999999999864 599999976655544 688899999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.. .||+.+|.|.+|+.+++-. ..|.....+.|+.||++|+.|||.++|||+|||.+|||+.+++.|+|+|||++..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 66 8999999999999999653 358999999999999999999999999999999999999999999999999986432
Q ss_pred cCCcccccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC-
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES- 278 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~- 278 (335)
.-. ...-.....|...|||||+++. .+|+ ..+|||||||++|||++|.+||.....++++-.+-+++..|+.
T Consensus 540 ~w~---g~~q~~qp~gsilwmAPEvIRmqd~nPfS-~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 540 RWS---GEQQLEQPHGSLLWMAPEVIRMQDDNPFS-FQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eec---cccccCCCccchhhhcHHHHhhcccCCCC-cccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 211 1111234457889999999853 3455 8899999999999999999999988889988888888777764
Q ss_pred ---CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 279 ---PRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 279 ---~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+++++++|+..|| .++++||.+.+||.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 357789999999999 99999999999987
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=315.68 Aligned_cols=258 Identities=24% Similarity=0.435 Sum_probs=217.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+..++.++|+||+++++.+...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987544433 3567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 131 EYAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
|++++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45899999999999999999999999999999999999999999999999998776543322
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCC---CCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPE---SPRLS 282 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~---~~~~~ 282 (335)
.. .......|+..|+|||.+......+.++|+||||+++|+|++|..||...+............. .+. ...++
T Consensus 159 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 159 TR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred cc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 11 1223446788999999987763344889999999999999999999988776655555544321 111 13578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+.+++.+|| .+|++||++++|++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999 999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=328.51 Aligned_cols=277 Identities=21% Similarity=0.371 Sum_probs=237.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..+.|+.-++||+|+||.||-|+...+|+.||+|.+.+.............+|..+|..++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 44567789999999999999999999999999999999877666555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+|+|+..|+||+|.-+|...+ .|++..+..++.+|+.||++||+.+||+||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999998886655 699999999999999999999999999999999999999999999999999987764
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----cccCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-----RVVFPES 278 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~ 278 (335)
... ....+||.+|||||++.+..|+ ...|.|||||++|+|+.|..||.......-.+.+.+ ...++
T Consensus 340 g~~------~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~-- 410 (591)
T KOG0986|consen 340 GKP------IRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS-- 410 (591)
T ss_pred CCc------cccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--
Confidence 332 2233799999999999999988 789999999999999999999976554333333332 22233
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC-CCCCCCCCCCCcccccC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED-SNPVGKSKSAPEVIPFK 331 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~ 331 (335)
..+|++.++|.+.+| .||++|. .+.++.+||||++- +.....+...|+++|-+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 579999999999999 9999987 78899999999984 33334577888888754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=315.53 Aligned_cols=258 Identities=22% Similarity=0.435 Sum_probs=213.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC--hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (335)
.+|.+.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++|+||+++++.+.. .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999999999999999998754322 22234567889999999999999999998865 3678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++++||+++++|.+++...+.+++...+.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999876532111
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-CCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l 285 (335)
.. .......++..|+|||.+.+..++ .++|+|||||++|+|++|..||..................+. ...++..+
T Consensus 162 ~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 162 SG--TGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred cC--CccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 10 111234578899999999887766 789999999999999999999988766655555444332232 23468889
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
+++| +|| .+|.+||++++|++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9999 566 9999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=322.55 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=217.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|.+.+.||.|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 67999999999999999999998899999999987544322 355678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||.+........
T Consensus 96 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 170 (297)
T cd06656 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 170 (297)
T ss_pred cccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----
Confidence 999999999998653 478999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~l 288 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||.+.+.......+..... ......++..+.+|
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 11234578899999999887776 789999999999999999999987665443332222211 11224578899999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
|.+|| .+|.+||+++++++||||+.......
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 99999 99999999999999999988665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=317.28 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=214.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC---hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP---IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
+|++.+.||+|++|.||+|.+..+++.||+|++...... .......+.+|+.+++.++|+||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999999999999999999754322 12235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 207 (335)
|+||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5899999998766433211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HccccCC-CCCCCCH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFP-ESPRLSS 283 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i---~~~~~~~-~~~~~~~ 283 (335)
.........++..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+ ......+ ....++.
T Consensus 161 -~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 -AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred -CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11112344678899999999877766 7899999999999999999999755432222222 2222222 2235789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
++.+++.+|| .+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999 9999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=318.38 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=211.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|.+.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.+++.++||||+++++.+...+..++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 345799999999999999999999999999999998754321 13456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
+|||+.+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-- 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875532211
Q ss_pred ccccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCC---CCCC
Q psy10459 209 KQNLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPE---SPRL 281 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~---~~~~ 281 (335)
......|+..|+|||.+. ...+. .++|+|||||++|+|++|..||.............. ....+. ...+
T Consensus 162 ---~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 162 ---KRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred ---ccccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 122346889999999974 33344 789999999999999999999976655444333322 222111 2257
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPW 310 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~ 310 (335)
+..+.++|.+|| .+|++||+++++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 889999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=314.63 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=214.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC---hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP---IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
+|.+.+.||.|+||+||+|.+ .++..+|+|.+...... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478899999999999999986 57889999998754321 12234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc-
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD- 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 207 (335)
++||+++++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988778999999999999999999999999999999999999999999999999998765321111
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc--ccCCCCCCCCHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSC 285 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~l 285 (335)
..........|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+... ...+....++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 011112334678899999999887776 7899999999999999999999876655444443332 1122334689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++|++|| .+|.+||++.++|+||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999 999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=324.89 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=191.8
Q ss_pred eeeecccCceEEEEEEEc--CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEEEEEe
Q psy10459 56 GDVVGMGSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYIIME 131 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e 131 (335)
+.+||+|+||+||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++.+.. +...+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999965 3678999999865433 2335689999999999999999998854 456899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee----cCCCCEEEeccccc
Q psy10459 132 YAKNGSLLEVIRKE---------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFA 198 (335)
Q Consensus 132 ~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili----~~~~~~~l~Dfg~~ 198 (335)
|+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888887532 248899999999999999999999999999999999999 45678999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------SELLKQV 269 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~---------~~~~~~i 269 (335)
..+...... ........||..|+|||++.+....+.++|+||+||++|+|++|..||..... ......+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 160 RLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eccCCCCcc--ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 765432211 11123456899999999998755444889999999999999999999964321 1111111
Q ss_pred HccccCC-------------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 270 QKRVVFP-------------------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 270 ~~~~~~~-------------------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
......+ .....+.++.+||++|| .||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100000 01123567889999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=316.62 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=210.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.++..++|+||+++++.+...+..++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 4567999999999999999999999999999999986543221 3456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 999999999999998878899999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCC---CCCCC
Q psy10459 209 KQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFP---ESPRL 281 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~---~~~~~ 281 (335)
......|+..|+|||.+.. ..++ .++|+|||||++|+|++|..||...........+.. ....+ ....+
T Consensus 162 ---~~~~~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 162 ---KRKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred ---ccCccccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 1123457889999998753 2344 789999999999999999999976654443333222 11211 12357
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPW 310 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~ 310 (335)
+..+.+||++|| .+|++||++++||+|+|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 899999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=320.44 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=216.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...+.|++++.||.|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++.+..++..+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34467999999999999999999999999999999986532 223556778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|..++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999999888754 45689999999999999999999999999999999999999999999999998865432111
Q ss_pred ccccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESP 279 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~ 279 (335)
......++..|+|||++.+ ..++ .++|+|||||++|+|++|..||...+.......+..... .....
T Consensus 166 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06644 166 -----RRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS 239 (292)
T ss_pred -----ccceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence 1123457889999999853 2334 689999999999999999999988777666655544322 12234
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
.++.++.++|.+|| .+|++||+++++++||||......
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 67889999999999 999999999999999999764433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=311.39 Aligned_cols=252 Identities=33% Similarity=0.517 Sum_probs=218.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|++|.||+|.+..++..+|+|.+........ ....+.+|+.+++.++|+|++++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH-HHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976544333 35678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+++++|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999763 3489999999999999999999999999999999999998654 579999999976643221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.....++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+......+....++.++.++
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 232 (256)
T cd08220 158 ----AYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQL 232 (256)
T ss_pred ----ccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHH
Confidence 2234578899999999877666 78999999999999999999999888877777776655444455689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
|.+|| .+|.+|||++++++||||
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 99999 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=314.67 Aligned_cols=249 Identities=28% Similarity=0.544 Sum_probs=214.6
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||.|++|.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999888999999999765544344466788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccccc
Q psy10459 139 LEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218 (335)
Q Consensus 139 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g 218 (335)
.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------ccccccC
Confidence 9999888789999999999999999999999999999999999999999999999999987664332 1223467
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcc-ccCCCCCCCCHHHHHHHHHhc-C
Q psy10459 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKR-VVFPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 219 ~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~--~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~L-~ 294 (335)
+..|+|||.+....++ .++|+||||+++|+|++|..||.... .......+... .........+.++.++|.+|| .
T Consensus 155 ~~~~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 8899999998877766 78999999999999999999998776 66666665532 222222345899999999999 9
Q ss_pred CCCCCCC-----HHHHhcCCCcCCC
Q psy10459 295 PVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 295 ~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
+|.+||+ ++|+++||||++.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCC
Confidence 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=317.38 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=202.2
Q ss_pred eecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHH---cCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK---GLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
.||+|+||.||++.+..+++.||+|.+...............+|..++. ...|++|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654432222333334544443 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 135 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
+++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-------~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-------cc
Confidence 99999999888889999999999999999999999999999999999999999999999999986553221 12
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHccccCCCCCCCCHHHHHHHHHh
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--ELLKQVQKRVVFPESPRLSSSCKALISNI 292 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 292 (335)
...|+..|+|||.+.+....+.++|+||+||++|+|++|..||...... .................++.++.++|++|
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence 3458999999999865333337899999999999999999999754321 12222222222223346899999999999
Q ss_pred c-CCCCCCC-----CHHHHhcCCCcCCCC
Q psy10459 293 L-SPVKFRI-----QMEDIRQDPWLKEDS 315 (335)
Q Consensus 293 L-~~p~~Rp-----s~~~ll~hp~~~~~~ 315 (335)
| .||.+|+ ++.++++||||++..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 9 9999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=317.56 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=213.3
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 678899999999999999999899999999985432 22245567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988765 45689999999999999999999999999999999999999999999999999865432111
Q ss_pred cccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHH
Q psy10459 212 LSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSS 284 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 284 (335)
......++..|+|||++. +..++ .++|+|||||++|+|++|..||...+.......+.... ..+....++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 122345788999999974 22344 68999999999999999999999887766665554432 12233458899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+.+||.+|| .+|.+||+++++++||||+..
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999 999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=312.48 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=214.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||.|+||.||+|.+..+++.+|+|++...... ....+.+|+.+++.++|+||+++++.+...+.++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 36799999999999999999999888999999999754332 356778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999999776 6799999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccC---CCCCCC
Q psy10459 209 KQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVF---PESPRL 281 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~---~~~~~~ 281 (335)
......++..|+|||.+.+. .++ .++|+||||+++|+|++|..||...........+... +.. .....+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 157 ---KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred ---ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 12234578889999998765 555 7899999999999999999999887766555544433 111 112346
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPW 310 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~ 310 (335)
+.++.++|++|| .+|.+||++.+++.|+|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 789999999999 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=284.96 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=220.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.-.++||+|.||+||+|+...+++.||+|.++....... .-....+|+-+++.++|.|||++++....++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46678899999999999999999999999999986543322 23345589999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||.. +|..+..+ ++.++.+.+..++.|++.||.++|+.++.|||+||.|.+|+.||.+||.|||+++.++..-..+..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 9965 89888866 567999999999999999999999999999999999999999999999999999988766554433
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCC-----------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPES----------- 278 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~----------- 278 (335)
. +-|.+|++|.++.+...++...|+||-||++.|+.. |++.|.+.+.++..+.|-..+..|..
T Consensus 161 e-----vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 161 E-----VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-----eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 358999999999988877688999999999999986 88999999999998888653322211
Q ss_pred -----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 279 -----------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 279 -----------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+.++..-++|++++| .+|.+|++++++++||||.+..
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 334556789999999 9999999999999999998743
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=319.93 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=212.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+++++.++|+||+++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46999999999999999999998889999999986543322 23456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|..+......+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--- 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc---
Confidence 99999889888776667999999999999999999999999999999999999999999999999998765433221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK------------------- 271 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~------------------- 271 (335)
.....++..|+|||++.+....+.++|+||||+++|+|++|..||......+....+..
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22345788999999987655444789999999999999999999987665443333221
Q ss_pred -cccCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 272 -RVVFP----------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 272 -~~~~~----------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
....+ ..+.++..+.+|+++|| .+|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00111 12357889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=335.25 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=203.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++|+||+++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 3557999999999999999999999999999999642 2234589999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+|+++. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 999995 6888888654 4699999999999999999999999999999999999999999999999999976533211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHccc----cC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--------NYSELLKQVQKRV----VF 275 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~--------~~~~~~~~i~~~~----~~ 275 (335)
........||..|+|||++.+..++ .++|||||||++|||++|..++... ...++...+.... .+
T Consensus 316 --~~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 316 --TPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred --cccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1122345789999999999888877 7899999999999999887655322 1223333222210 00
Q ss_pred C-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 276 P-----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 276 ~-----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+ ....++.++.+||.+|| .||.+|||+.|||+||||+.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 00135668999999999 99999999999999999964
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=312.73 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=222.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+..+..++|+||+++++.+...+..++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765432 33567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+++++|.+++.....+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999887889999999999999999999999 99999999999999999999999999998766432221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHccccCCCCCC-CCHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESPR-LSSSC 285 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~-~~~~l 285 (335)
.....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+....+......+.... ++..+
T Consensus 157 ---~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 157 ---CNTFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred ---ccceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 1234578899999999887666 7899999999999999999999877 45555666555444444444 88999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++|++|| .+|.+||+++++++||||+..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999 999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=316.82 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=214.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+++++.++|+||+++++.+...+.+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 3688899999999999999999999999999998765432 33566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||+.+++|.+++... ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999999876 778999999999999999999999 9999999999999999999999999999865532211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHccccCCCCCC-CC
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQKRVVFPESPR-LS 282 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~-~~ 282 (335)
....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+..+.+........... ++
T Consensus 157 -----~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06605 157 -----KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS 230 (265)
T ss_pred -----hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 114578899999999887776 7899999999999999999999764 23333333333222111122 78
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++.++|.+|| .+|.+||++.+++.||||+++
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 89999999999 999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=324.04 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=210.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 124 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 4689999999999999999999999999999999864322 22245566899999999999999999876543 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..++++||+.+ +|..++.. ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 57999999964 88888754 45899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-------- 276 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 276 (335)
.... .......|+..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+......+
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 160 HDHT--GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccc--CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 2111 112345678999999987654333478999999999999999999998766544333222111000
Q ss_pred ----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 ----------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 ----------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
..+.++.++.++|.+|| .+|++||++.++++||||+....+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 01346788999999999 99999999999999999998876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=319.83 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=215.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 126 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++....... ....+.+|+.+++.++|+||+++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45789999999999999999999999999999999875432211 122345799999999999999999998654 568
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 88888865 3568999999999999999999999999999999999999999999999999987664332
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC---------
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------- 276 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 276 (335)
.. .....++..|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+.+..+......+
T Consensus 163 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 KP-----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CC-----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 11 1122357789999998765444478999999999999999999999888777766665421110
Q ss_pred -----------C---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 -----------E---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 -----------~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
. ...++.++.+||++|| .||++|||+++++.||||++-..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 0 0125788999999999 99999999999999999998666633
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=318.26 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=214.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||.||+|.+..+|..||+|.+..... +.....+.+|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 468899999999999999999998999999999865322 222456779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 131 EYAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||+++++|..++... ..+++..+..++.|++.||.|||. .|++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999998763 368999999999999999999997 59999999999999999999999999998655322
Q ss_pred ccccccccccccccccccccccCCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPY-----TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPES 278 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~ 278 (335)
......++..|+|||.+.+... .+.++|+|||||++|+|++|..||...........+.. .......
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd06622 157 -----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP 231 (286)
T ss_pred -----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC
Confidence 1223457888999999854432 23789999999999999999999987665554444332 2222233
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
..++.++.+||.+|| .+|.+||++++++.||||......
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 458999999999999 999999999999999999886544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=314.51 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=208.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC-----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT----- 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 123 (335)
...|.+.+.||+|+||.||+|.+..+++.||+|++...... ...+.+|+.++..+ +|+||+++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 34688999999999999999999999999999998754332 34566899999988 699999999998652
Q ss_pred -CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
...+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999998763 3589999999999999999999999999999999999999999999999999875
Q ss_pred cccCCcccccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-c
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-V 274 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~ 274 (335)
...... ......|+..|+|||++.. ..++ .++|+|||||++|+|++|..||...........+.... .
T Consensus 161 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 161 LDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred cccccc-----cCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 532211 1234568889999999863 2344 68999999999999999999998776655554443322 1
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 ~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
......++.++.+||.+|| .+|.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2222457899999999999 999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=316.57 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=208.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||.|++|.||+|.+..+|+.||+|.+...... ......+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999988654322 1223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+. ++|..++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 996 5899888653 45899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------- 276 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 276 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+......+
T Consensus 157 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 ---YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ---cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1223467889999998765544478999999999999999999998776554443332211110
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 277 ---------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 277 ---------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+.++.+++++|.+|| .||.+||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01347889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=320.81 Aligned_cols=259 Identities=24% Similarity=0.448 Sum_probs=219.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|.....||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555678999999999999998899999999986432 2235567799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----- 173 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----- 173 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-----
Confidence 9999999998854 4589999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCCCCCHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALI 289 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li 289 (335)
......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+...... +....++..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 12234578899999999877777 7899999999999999999999988777666665543322 23345789999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
.+|| .||.+|||++++++||||+....+++.
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~ 284 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPPSCI 284 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCcccc
Confidence 9999 999999999999999999998888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=310.27 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=217.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~iv 129 (335)
+|++.+.||.|+||.||+|.+..++..||+|++....... ...+.+.+|+.+++.++|+||+++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5889999999999999999999999999999987654433 335667789999999999999999987753 4568999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 130 MEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCH-----KKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH-----~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
|||+++++|.+++.. ...+++..++.++.||+.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 356899999999999999999999 88999999999999999999999999999887
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
....... .....++..|+|||.+.+..++ .++|+||||+++++|++|..||...+.....+.+......+....
T Consensus 160 ~~~~~~~-----~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd08217 160 LGHDSSF-----AKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYR 233 (265)
T ss_pred ccCCccc-----ccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccc
Confidence 6433211 2234578899999999887766 789999999999999999999999887777777776554444457
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++..+.+++.+|| .+|.+||++++|++|||+
T Consensus 234 ~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 234 YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 8899999999999 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=310.25 Aligned_cols=253 Identities=26% Similarity=0.460 Sum_probs=215.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++.+...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999875432 2233356678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKA 287 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~ 287 (335)
......|+..|+|||.+.... ++ .++|+||||+++|+|++|..||...........+......+ ....++.++.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 122345788999999987665 55 78999999999999999999998776555554444422222 23457899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++.+|| .+|.+||+++++++|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999 999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=317.28 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=217.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCC-----CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHS-----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+...+|++.+.||+|+||.||+|.+...+ ..||+|.+..... ......+.+|+.++..++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34567999999999999999999876554 6799998864432 3335668899999999999999999999998
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~ 186 (335)
.+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 88999999999999999999764 34788899999999999999999999999999999999999
Q ss_pred CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy10459 187 KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSEL 265 (335)
Q Consensus 187 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~ 265 (335)
++.++|+|||++......... .......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+....+.
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999998755332211 112233567889999999887777 78999999999999998 9999999998888
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+......+....++.++.+|+.+|| .+|.+||++.+|+++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8888776666656679999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=316.00 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=218.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
..|+..+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.+.|+||+++++.+..++..++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3578889999999999999999888999999998754332 22566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++.. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 99999999999865 4589999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+...........++..+.++|.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred -ccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 12234578889999999877766 7899999999999999999999988777766665544333333457889999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+|| .+|.+||+++++++||||.+..
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHcccCcccCcCHHHHHhChHhhhcc
Confidence 999 9999999999999999997743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=317.35 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=216.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||+||++.+..+|+.||+|++..... ......+.+|+++++.++|+||+++++.+...+.++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 456789999999999999999999998999999999865432 223567789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999999999888889999999999999999999997 599999999999999999999999999886542211
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHccccC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-----------ELLKQVQKRVVF 275 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-----------~~~~~i~~~~~~ 275 (335)
.....|+..|+|||++.+..++ .++|+|||||++|+|++|..||...... .....+......
T Consensus 159 ------~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 159 ------ADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred ------cCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 1234688999999998877666 7899999999999999999999865542 222222221111
Q ss_pred C-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 276 P-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 276 ~-~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
. ....++.++.+||.+|| .||.+||+++|+++|+||.+...
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 1 11237889999999999 99999999999999999977543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=330.83 Aligned_cols=252 Identities=29% Similarity=0.540 Sum_probs=219.2
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
.++||.|.||+||-|.+.++|+.||||++.+...+... ...+++|+.+|+.++||+||.+...|+..+..|.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 47999999999999999999999999999987776543 57789999999999999999999999999999999999965
Q ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEeccccccccccCCccccc
Q psy10459 136 GSLLEVIR--KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 136 ~sL~~~l~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+..+.|- ..+++++...+.++.||+.||.|||.++|+|.||||+|||+.+. .++||||||+++..+...
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----- 721 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence 6666553 34679999999999999999999999999999999999999764 469999999999887543
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
+....+||+.|+|||++....|. ..-|+||+|+++|--++|..||.. .+..+.+++-.-.+....+.+++.+..+||
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred -hhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 35677899999999999999998 789999999999999999999964 334444444333444445678999999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
..+| ..-++|-|.+..|+|||++++++
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcchH
Confidence 9999 99999999999999999999854
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=314.97 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=214.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCeEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~i 128 (335)
.|++.+.||.|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++ |+|++++++.+......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788999999999999999999999999999986543322 2455778999999886 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
+|||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..+......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 99999999999998664 6899999999999999999999999999999999999999999999999998766543211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-CCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~ 287 (335)
.....|+..|+|||.+.+....+.++|+||||+++|+|++|..||...........+........ ...++.++.+
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 158 ----RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ----cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 22345788999999987654434789999999999999999999988776665544433311111 1237889999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++.+|| .||.+||++.+++.|+||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999 9999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=309.21 Aligned_cols=250 Identities=27% Similarity=0.493 Sum_probs=209.6
Q ss_pred cCCeEEe-eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe----C
Q psy10459 50 THGYSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET----T 123 (335)
Q Consensus 50 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~ 123 (335)
.++|.+. ++||-|-.|.|..|.++.+|+.+|+|++.. ....++|++.--.. .|+|||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4456654 689999999999999999999999999865 34456888865555 69999999998754 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFA 198 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~ 198 (335)
.++.+|||.++||.|...++.++. |+|.++..|+.||..|+.|||+.+|.||||||+|+|+.. |..+||+|||++
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 678899999999999999987654 999999999999999999999999999999999999975 456899999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc---
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQK--- 271 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~--- 271 (335)
+.-... ....+.|-|+.|.|||++....|+ ..+|+||+|+++|-|++|.+||....- .....+|..
T Consensus 212 K~t~~~------~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 212 KETQEP------GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cccCCC------ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 754321 223456789999999999998888 789999999999999999999976543 222333333
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+..|.+..+|++.+++|+.|| .+|.+|.|++++++|||+.+.
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 3344566789999999999999 999999999999999999875
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=314.34 Aligned_cols=254 Identities=21% Similarity=0.403 Sum_probs=210.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC-----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT----- 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----- 123 (335)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++...... ...+.+|+.+++.+ +|+|++++++.+...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 57899999999999999999999999999999998653221 34566889999988 799999999988653
Q ss_pred CeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+..++||||+++++|.++++. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 368999999999999998853 4568999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccccccccccccccccccccCCCCC----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY----TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV- 274 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~----~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~- 274 (335)
........ .....|+..|+|||.+..... .+.++|+|||||++|+|++|+.||...........+.....
T Consensus 177 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 177 QLTSTRLR-----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred hccccccc-----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 65432211 123457889999999764321 23789999999999999999999988877666555544322
Q ss_pred -CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 275 -FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 275 -~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
......++.++.+||.+|| .+|.+||++.++++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1223357789999999999 9999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=311.06 Aligned_cols=251 Identities=23% Similarity=0.452 Sum_probs=214.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||.|+||.||+|.+..++..||+|.+..... .+.+.+|+.+++.++|+||+++++.+......|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999988899999999865321 56788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999975 45689999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCK 286 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~ 286 (335)
......++..|+|||++.+..++ .++|+||||+++|+|++|..||...........+.... .......++.++.
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHH
Confidence 12233468899999999887776 78999999999999999999998776655444433221 1122235788999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++|.+|| .+|.+||+++++|+||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=324.39 Aligned_cols=270 Identities=28% Similarity=0.477 Sum_probs=218.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----CCeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 126 (335)
++|++.+.||.|++|.||+|.+..+|+.||+|++........ ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc-chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875432222 24556689999999999999999988753 3578
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++||||+. ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 59999998777899999999999999999999999999999999999999999999999999876543322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc------------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------ 274 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~------------ 274 (335)
. .........|+..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+.....
T Consensus 163 ~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 E-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred C-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1 111123456888999999986644344789999999999999999999987765443332221100
Q ss_pred ---------CC---C------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCCCC
Q psy10459 275 ---------FP---E------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKSKS 323 (335)
Q Consensus 275 ---------~~---~------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 323 (335)
++ . .+.++.++.++|++|| .+|.+||++++++.||||++...+......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~ 309 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTC 309 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccC
Confidence 00 0 1346899999999999 999999999999999999988877765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=314.66 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=207.7
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||+|+||+||+|.+..+|+.||+|++.............+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999998754333333345566899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccc
Q psy10459 139 LEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 139 ~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
.+++...+ .+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------cccc
Confidence 99997655 689999999999999999999999999999999999999999999999999875532111 1223
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhc
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL 293 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L 293 (335)
.++..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+.. .........+++.+.++|.+||
T Consensus 155 ~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred cCCCCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence 467889999999877766 789999999999999999999987654222222211 1222233457999999999999
Q ss_pred -CCCCCCC-----CHHHHhcCCCcCCCCC
Q psy10459 294 -SPVKFRI-----QMEDIRQDPWLKEDSN 316 (335)
Q Consensus 294 -~~p~~Rp-----s~~~ll~hp~~~~~~~ 316 (335)
.+|.+|| ++.++++||||++..-
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 9999999 8999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=309.25 Aligned_cols=249 Identities=29% Similarity=0.519 Sum_probs=216.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||.|+||.||++.+..++..||+|.++..... ...+.+.+|+.+++.++|+||+++++.+...+.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 588999999999999999999999999999998754332 225567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+..+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998865 34589999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
......|+..|+|||++.+..++ .++|+||||+++|+|++|..||...+.......+..+...+....++..+.+||
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLI 232 (255)
T ss_pred --ccccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence 12234578899999999887766 789999999999999999999999888877777766555455556899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~h 308 (335)
.+|| .||.+||++.+++.-
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhCCcccCCCHHHHhhc
Confidence 9999 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=318.45 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=220.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
-|.++++||+|+||.||+|.++.+|..+|+|.+.... ..+.+..|+.++++++.+++|++++.|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3778999999999999999999999999999775432 26667799999999999999999999988889999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||-.|++.++++- ++++++.++..++...+.||+|||...-+|||||..|||++.+|..||.|||.+-.+.. ..
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-----TM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-----TM 183 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-----hH
Confidence 9999999999864 57899999999999999999999999999999999999999999999999999866532 22
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
....+..||+.|||||++..-.|. .++||||||++..||..|++||.+..+...+..|.... .|..+..+|.++.+|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 335677899999999999999998 78999999999999999999999877765554443211 111223588999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
|++|| +.|++|-|+.++++|||+++....
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 99999 999999999999999999886543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=309.89 Aligned_cols=253 Identities=31% Similarity=0.591 Sum_probs=217.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+........ ....+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876433222 24567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC-EEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~-~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999987643 4789999999999999999999999999999999999998864 69999999876543221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
......|+..|+|||++.+..++ .++|+||||+++++|++|..||...+.......+......+..+.++.++.++
T Consensus 158 ---~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (257)
T cd08225 158 ---LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233 (257)
T ss_pred ---cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHH
Confidence 12234578899999998877766 78999999999999999999999888777777666655445556789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
|.+|| .+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 99999 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=318.69 Aligned_cols=258 Identities=22% Similarity=0.453 Sum_probs=218.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|.....||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++..+.||||+++++.+..++..++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 44556899999999999999889999999998653322 245567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+++++|..++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~----- 173 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----- 173 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-----
Confidence 999999998755 45899999999999999999999999999999999999999999999999998654332211
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHHHH
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALIS 290 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~li~ 290 (335)
.....|+..|+|||.+.+..++ .++|+|||||++|+|++|..||...........+.... .......++..+.++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence 2234678999999999887776 78999999999999999999998877766666554422 11223457899999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
+|| .+|.+||+++++++||||.+...+.+.
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~ 283 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTGLPECL 283 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCCCcccc
Confidence 999 999999999999999999998877774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=318.84 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=216.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|+..+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 477888999999999999999888999999998654322 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 9999999998865 45899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 291 (335)
.....++..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+...........++.++.++|.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 158 -RNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred -hhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHH
Confidence 1234578899999999887776 78999999999999999999998776666655554443322234578899999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 292 IL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 292 ~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
|| .+|.+||++.++++||||++..
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HccCCcccCcCHHHHHHhHHHHHHh
Confidence 99 9999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.38 Aligned_cols=259 Identities=31% Similarity=0.595 Sum_probs=221.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv 129 (335)
++|.+.+.||.|+||.||+|.+..+|..||+|++.............+.+|+.++..+. |+||+++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999899999999997644433344567778999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||++.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999876654332100
Q ss_pred ---------------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 210 ---------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 210 ---------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
........++..|+|||......++ .++|+||||++++++++|..||...........+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-E 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-C
Confidence 0122334678899999998877666 7899999999999999999999988766665555432 2
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCH----HHHhcCCCc
Q psy10459 275 FPESPRLSSSCKALISNIL-SPVKFRIQM----EDIRQDPWL 311 (335)
Q Consensus 275 ~~~~~~~~~~l~~li~~~L-~~p~~Rps~----~~ll~hp~~ 311 (335)
......++..+.+||++|| .+|.+||++ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2333568999999999999 999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.59 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=209.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEE-----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++.+.||+|+||.||+|.+ ..++..||||+++...... ..+.+.+|+.++..+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34566899999999999999999974 3456789999986543322 245677899999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhcC------------------------------------------------------
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKER------------------------------------------------------ 146 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~~------------------------------------------------------ 146 (335)
...+..++||||+++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 147 ---------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 147 ---------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 36778899999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHccccCCCCCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNY-SELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.. .......++..|+|||++.+..++ .++|+|||||++|+|++ |..||..... ....+.+............+.
T Consensus 269 ~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (375)
T cd05104 269 NY---VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS 344 (375)
T ss_pred cc---cccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence 11 111223346679999999888777 78999999999999998 8999987654 344455555544444445789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.+||.+|| .||++||++.+|++.
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=315.07 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=206.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCe----
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHR---- 125 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---- 125 (335)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.+. |+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986543221 12345668999999995 6999999998877665
Q ss_pred -EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccc
Q psy10459 126 -VYIIMEYAKNGSLLEVIRKE-----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFA 198 (335)
Q Consensus 126 -~~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~ 198 (335)
.|++|||+.+ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887542 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-- 276 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-- 276 (335)
..+...... .....++..|+|||++.+....+.++|+||||+++|+|++|..||.+.+.......+......+
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 159 RAFSIPVKS-----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred eecCCCccc-----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 765432211 1123467889999988664443478999999999999999999998876655444433211110
Q ss_pred -------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 277 -------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 277 -------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
..+.++.++.+||.+|| .+|.+||++++++.||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01357899999999999 9999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=311.24 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=211.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... .....+.+..|+.+++.++|+|++++++.+...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999999889999999988642211 1122356778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccccccccccccccccCCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCC--
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPE-- 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~-- 277 (335)
.. ........|+..|+|||.+.... ++ .++|+||||+++|+|++|..||...........+.... .++.
T Consensus 162 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 162 YD---NDQNMSMQGSVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred cc---ccccccccCCccccCHHHhccccCCCC-ccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 11 11123345788999999987654 44 78999999999999999999997666554443332211 1111
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...++.++.++|.+|| .+|.+||+++++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2357899999999999 999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=313.67 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=208.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||.|++|.||+|.+..+|+.||+|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 5899999999999999999999999999999987543321 13455689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+..+......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 9975 898888654 35899999999999999999999999999999999999999999999999998755432111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------- 277 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 277 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+....+......|.
T Consensus 157 ----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 157 ----FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ----cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 12234678899999987654444789999999999999999999988776665554432211110
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 -----------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 -----------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+.++..+.++|.+|| .||.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1245788999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=312.45 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=217.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
-|++.+.||.|+||.||+|.+..++..||+|++...... .....+.+|+.++..++|+||+++++.+..++..++|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 377889999999999999999889999999998654332 224567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh----
Confidence 9999999999865 45899999999999999999999999999999999999999999999999998765432111
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 291 (335)
.....++..|+|||.+.+...+ .++|+||||+++|+|++|..||...........+...........++.++.++|.+
T Consensus 158 -~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred -hccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 1234578889999999876666 78999999999999999999998877766666665443322334578999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 292 IL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 292 ~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
|| .+|.+||++.++++||||.+..
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhhh
Confidence 99 9999999999999999998853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=322.00 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=210.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
...+|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT-HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh-HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35789999999999999999999999999999999865433222 234566899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
...|+||||+.+ +|.+.+... +++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999964 888888654 8999999999999999999999999999999999999999999999999997653
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------ 276 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------ 276 (335)
.... .....++..|+|||.+.+..++ .++|+|||||++|+|++|..||...+.......+......|
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 170 TSFM------MTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCC------CCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 3211 2234578899999999888777 78999999999999999999998776554444432211110
Q ss_pred -------------------------------C-----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 -------------------------------E-----SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 -------------------------------~-----~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
. ....+..++++|.+|| .||++|||+.++|+||||+.-..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 0 1134667899999999 99999999999999999986544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=313.14 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=204.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 467999999999999999999998899999999987543221 123355899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 999975 999988664 45899999999999999999999999999999999999999999999999998654322111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHccccC------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVF------------ 275 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~~~~~------------ 275 (335)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|..||.... ..+....+......
T Consensus 160 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 160 ----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred ----ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122457889999998764433378999999999999999999997665 33333322211000
Q ss_pred --------C---------CCCCCC--HHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 276 --------P---------ESPRLS--SSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 276 --------~---------~~~~~~--~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+ ....++ .++.++|.+|| .+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 001244 78899999999 999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=311.87 Aligned_cols=256 Identities=23% Similarity=0.457 Sum_probs=217.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|.-.+.||+|++|.||++.+..+++.+|+|++..... .....+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 35556799999999999999988999999998864322 224456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.. ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999977 5689999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCCCCCHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALI 289 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li 289 (335)
......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+...... .....++..+.++|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 12234578899999999887766 7899999999999999999999888877777666654211 12234789999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++|| .+|++||++.++++||||++...+
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCCc
Confidence 9999 999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.67 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=205.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC----------------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR----------------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 111 (335)
+..++|++.++||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.++..++|+
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 345689999999999999999998532 334799999875432 33356788999999999999
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-------------------YIDEDKGRRWFSQLADAIDYCHKKSV 172 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-------------------~~~~~~~~~i~~~i~~~L~~LH~~~i 172 (335)
||+++++++...+..+++|||+.+++|.+++.... .+++..++.++.||+.||.|||+.|+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986532 35678889999999999999999999
Q ss_pred eeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh
Q psy10459 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY 252 (335)
Q Consensus 173 ~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~ 252 (335)
+|+||||+|||++.++.++|+|||++..+...... .......++..|+|||++....++ .++||||||+++|+|++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILM 235 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHH
Confidence 99999999999999999999999998765432211 112233457789999999877777 78999999999999986
Q ss_pred --CCCCCCCCCHHHHHHHHHcc-------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 253 --GRLPFDDTNYSELLKQVQKR-------VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 253 --g~~p~~~~~~~~~~~~i~~~-------~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..||......+....+... ......+.++..+.+||.+|| .||.+|||+++|.+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 67889887776665554321 111223467899999999999 99999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=305.83 Aligned_cols=253 Identities=31% Similarity=0.547 Sum_probs=221.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||.|++|.||++.+..++..||+|++...... ......+.+|+++++.++|+|++++.+.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999999765443 2235567799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 132 YAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 132 ~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
++++++|.+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 679999999999999999999999999999999999999999999999999987664432
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
.......|+..|+|||......++ .++|+||+|+++++|++|..||...+..............+....++..+.+
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd08215 158 ---DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRN 233 (258)
T ss_pred ---ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 122334678899999998877766 7899999999999999999999988888877777665544444578899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++.+|| .+|.+||+++++|+||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.37 Aligned_cols=257 Identities=31% Similarity=0.509 Sum_probs=215.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++.+...+.+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999889999999999765443 3346778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||++++++.++|+|||.+........... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-~ 158 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-E 158 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc-c
Confidence 999999999998877789999999999999999999999999999999999999999999999999877654332211 1
Q ss_pred cccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHc--cccCCCCCCCCHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQK--RVVFPESPRLSSSC 285 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~-~~~~i~~--~~~~~~~~~~~~~l 285 (335)
......++..|+|||.+.+.. .. .++|+||||+++|+|++|..||....... ....+.. ....|....++..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 012345788999999987655 44 78999999999999999999997654322 2222222 22334444568999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++|++|| .+|.+||++++++.|||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=308.47 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=216.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+...+|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++|+||+++++.+..++..+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 455679999999999999999999998999999999865322 1445778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++++++.++|+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999999654 358899999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+......+....++.+
T Consensus 159 ~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd05052 159 YT----AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK 233 (263)
T ss_pred ee----ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 11 11122335679999999887777 78999999999999998 99999998888888888777666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++|.+|| .+|++||++.++++.
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHH
Confidence 999999999 999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=330.50 Aligned_cols=288 Identities=23% Similarity=0.418 Sum_probs=244.9
Q ss_pred hhhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 42 ERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
..+...++..-|-.++.||-|+||.|.++...++...||+|.+++..........-+..|..+|....++.||+++..|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34555677788999999999999999999999999999999998866655555666778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+.+.+|+||+|++||++-.++-+.+-|+|..+..++..+..|+++.|+.|+|||||||+|||||.+|++||+|||++.-+
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999643
Q ss_pred c--c------CCcc-----------------------------cccccccccccccccccccccCCCCCCCCchhHHHHH
Q psy10459 202 S--V------NNTD-----------------------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244 (335)
Q Consensus 202 ~--~------~~~~-----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG 244 (335)
. . .+.. .........+||..|+|||++....++ ..+|.||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhh
Confidence 1 0 0000 001112235799999999999998888 889999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHH---HHHccccCCCCCCCCHHHHHHHHHhcCCCCCCC---CHHHHhcCCCcCCCCCCC
Q psy10459 245 VVLFAMVYGRLPFDDTNYSELLK---QVQKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 245 ~~~~~l~~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~~l~~li~~~L~~p~~Rp---s~~~ll~hp~~~~~~~~~ 318 (335)
+|+|||+.|+.||-...+.+... ++...+.++....++.++.+||.+++.+++.|. -+++|..||||+. +..+
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkg-IDfs 937 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKG-IDFS 937 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccc-cchH
Confidence 99999999999998877665544 445577788888999999999999998888888 6778999999986 4555
Q ss_pred CCCCCCCcccccC
Q psy10459 319 GKSKSAPEVIPFK 331 (335)
Q Consensus 319 ~~~~~~~~~~~~~ 331 (335)
..++....+||.-
T Consensus 938 slRkq~ApYIP~I 950 (1034)
T KOG0608|consen 938 SLRKQRAPYIPRI 950 (1034)
T ss_pred hhhhccCCcCccc
Confidence 5777887788764
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=333.72 Aligned_cols=254 Identities=23% Similarity=0.414 Sum_probs=220.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+-|.|+..||.|+||.||+|..+.++...|.|++..... .....+.-|+++|..+.||+||++++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 357888999999999999999998888899999865332 22566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||.||.+..++-. ...+.+.++..+++|++.||.|||+.+|||||||..|||++-+|.++|.|||.+..... .
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-----t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-----T 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-----H
Confidence 99999999887754 55699999999999999999999999999999999999999999999999999854321 2
Q ss_pred cccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--CCCCCC
Q psy10459 210 QNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--ESPRLS 282 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~ 282 (335)
......+.||+.|||||+.. ..+|+ .++||||||+++.+|..+.+|....++..++-+|.+..... .+..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 22345678999999999974 34566 89999999999999999999999999999988887643221 234689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
..+.||+.+|| .+|..||++.++|+||||++
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 99999999999 99999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=312.13 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=203.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeC--CeEEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETT--HRVYII 129 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~iv 129 (335)
|++.+.||+|+||.||+|.+..+++.||+|.+........ .....+|+..+..+. |+|++++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999875433222 222347888888885 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 999975 888887653 56899999999999999999999999999999999999999 9999999999876543221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------- 273 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--------------- 273 (335)
.....++..|+|||.+......+.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1123568899999987654444478999999999999999999998877665554443211
Q ss_pred ----cCCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 274 ----VFPE---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 274 ----~~~~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++. ...++.++.++|.+|| .+|++||+++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 1246899999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=319.43 Aligned_cols=271 Identities=22% Similarity=0.367 Sum_probs=217.8
Q ss_pred CCeEE-eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHH-----------HHhhHHHHHHHHHcCCCCCeeeece
Q psy10459 51 HGYSL-GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDY-----------LKKFLPREIEVVKGLKHPNLIRFLQ 118 (335)
Q Consensus 51 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~ 118 (335)
++|.. .+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 57799999999999999999999999998754332110 0124668999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
++...+..+++|||+. ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 599999988778999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy10459 199 RKYSVNNTD---------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269 (335)
Q Consensus 199 ~~~~~~~~~---------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i 269 (335)
......... ..........++..|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 766421110 00111122346788999999876554448899999999999999999999988876665554
Q ss_pred HccccCCC---------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCC
Q psy10459 270 QKRVVFPE---------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKS 321 (335)
Q Consensus 270 ~~~~~~~~---------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 321 (335)
......+. ....+.++.++|.+|| .+|++||+++++|.||||+....+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~~ 326 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPS 326 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCcc
Confidence 33111010 1235788999999999 9999999999999999999887775544
Q ss_pred C
Q psy10459 322 K 322 (335)
Q Consensus 322 ~ 322 (335)
.
T Consensus 327 ~ 327 (335)
T PTZ00024 327 Q 327 (335)
T ss_pred c
Confidence 3
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=310.03 Aligned_cols=254 Identities=25% Similarity=0.506 Sum_probs=216.6
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++|+||+++++.+...+..|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999888999999999765443334466788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc---ccccccc
Q psy10459 139 LEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY---KQNLSET 215 (335)
Q Consensus 139 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~ 215 (335)
.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.......... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887789999999999999999999999999999999999999999999999999987543321100 0011233
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCCCHHHHHHHHHhc-
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL- 293 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~L- 293 (335)
..++..|+|||.......+ .++|+||||+++|+|++|..||...........+.. ...++....++..+.++|++||
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 4578899999999877765 789999999999999999999998888887777765 2333333345899999999999
Q ss_pred CCCCCCCCH---HHHhcCCCcCC
Q psy10459 294 SPVKFRIQM---EDIRQDPWLKE 313 (335)
Q Consensus 294 ~~p~~Rps~---~~ll~hp~~~~ 313 (335)
.+|.+||++ .++|+||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=317.60 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=190.8
Q ss_pred eeeecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEEEEEe
Q psy10459 56 GDVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYIIME 131 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e 131 (335)
+.+||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999654 567899999865433 2345689999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee----cCCCCEEEeccccc
Q psy10459 132 YAKNGSLLEVIRKE---------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFA 198 (335)
Q Consensus 132 ~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili----~~~~~~~l~Dfg~~ 198 (335)
|+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9964 888877421 247899999999999999999999999999999999999 45678999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHH
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------ELLKQV 269 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---------~~~~~i 269 (335)
......... ........||..|+|||++.+....+.++|||||||++|+|++|..||.....+ .....+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 160 RLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 766432211 111234568999999999877554447899999999999999999999653321 111111
Q ss_pred HccccC-------------------------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 270 QKRVVF-------------------------------------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 270 ~~~~~~-------------------------------------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...... ......+..+.+||.+|| .||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 001124567889999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=310.79 Aligned_cols=250 Identities=21% Similarity=0.369 Sum_probs=202.3
Q ss_pred eecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH---HHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE---VVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
.||+|+||.||+|.+..+++.||+|.+................|.. .+....|++|+.+++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999998899999999987644322221222333433 3444579999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 135 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
|++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..+.... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-------~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-------Cc
Confidence 99999999888889999999999999999999999999999999999999999999999999987553221 22
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHccccCCCCCCCCHHHHHHHHH
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESPRLSSSCKALISN 291 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 291 (335)
...|+..|+|||.+.+....+.++|+||+|+++|+|++|..||... ......... ..........++.++.+++.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHH
Confidence 3468999999999875533337899999999999999999999876 333332222 222223334578999999999
Q ss_pred hc-CCCCCCC-----CHHHHhcCCCcCCCC
Q psy10459 292 IL-SPVKFRI-----QMEDIRQDPWLKEDS 315 (335)
Q Consensus 292 ~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 315 (335)
|| .+|.+|| ++.++++||||+...
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 99 9999999 999999999998853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=311.93 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=202.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|.+.+.||+|+||.||+|.+..+|..||+|++....... ....+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999999899999999986543221 133456899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
+||+. +++.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 99996 577776654 345788889999999999999999999999999999999999999999999998654322111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHccccC------------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVF------------ 275 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~~~~------------ 275 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...... +....+......
T Consensus 160 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 160 ----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred ----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 123346889999999876543337899999999999999999999765432 222222110000
Q ss_pred C--------C-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 276 P--------E-----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 276 ~--------~-----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+ . ....+.++.+++.+|| .||++|||+++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 0113578999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=317.49 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=215.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCe----EEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|++.+.||+|+||.||+|.+..++.. ||+|++..... ......+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 45677899999999999999999998666654 89998864322 2235567789999999999999999998876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
. ..+++++|+++|+|.+++... ..++...++.++.||+.||+|||+.|++||||||+|||++.++.++|+|||++..+
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4 567999999999999999764 45889999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
........ .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+....+....+......+....
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd05108 160 GADEKEYH---AEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 235 (316)
T ss_pred cCCCccee---ccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 54322211 1122346689999999888777 78999999999999997 9999998888777777776666666677
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.++.+++.+|| .+|.+||++.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=308.02 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=217.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..++|.+.+.||+|+||.||+|.+..+ ...||+|.+..... +.....+.+|+.++..++|+||+++++.+...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 456799999999999999999998644 45799998865432 2335567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+++|||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999664 46899999999999999999999999999999999999999999999999999877522
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
..... .....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...........+......+....++.
T Consensus 160 ~~~~~---~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05033 160 EATYT---TKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPS 235 (266)
T ss_pred cccee---ccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 22111 1122346789999999887777 78999999999999998 9999998888888888887766666667899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+++.+|| .+|++||++++++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=326.53 Aligned_cols=261 Identities=39% Similarity=0.691 Sum_probs=236.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
-....|.+.+.||+|.|+.|.++++..++..||+|.+.+.........+ +.+|++++..++|||||+++.+...+..+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3456799999999999999999999999999999999988777665444 789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+|.+.+++.+.+...+..+..++.|++.|++|||+++|+|||||++|||++.+.+++|+|||++..+...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--- 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--- 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887632
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 286 (335)
......||++.|.|||++.+..|....+|+||+|+++|-|+.|.+||++.+..+....+..+ +..| --++.++.
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp--~~ms~dce 283 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP--FYMSCDCE 283 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc--ceeechhH
Confidence 33567899999999999999999989999999999999999999999999887777766653 3333 34889999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++|++|| .+|.+|++.+++..|.|+......
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999 999999999999999999876544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=325.91 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|.+.+.||+|+||.||+|++... +..||+|++...... .....+.+|+.+++.+ +|+||+++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 46677899999999999999999986443 357999999754332 2255677999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc-------------------------------------------------------
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE------------------------------------------------------- 145 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------- 145 (335)
...+..++||||+++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999988542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 146 ---------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 146 ---------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
.++++..++.++.||+.||.|||+.|++||||||+|||+++++.++|+|||++..+......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--- 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--- 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence 13678889999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHccccCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.......++..|+|||++.+..++ .++|||||||++|+|++ |..||......... ..+......+....++.++.++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 111223346679999999887777 78999999999999997 99999876554433 3333344444444578999999
Q ss_pred HHHhc-CCCCCCCCHHHHhc
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~ 307 (335)
|.+|| .||.+||+++++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=338.04 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=213.8
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeecee-EE
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQA-IE 121 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~ 121 (335)
..-.++.+++++.++|.+|||+.||+|++...|..||+|++-.. .+...+.+.+|+.+++.|+ |+|||.+++. ..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 44557788999999999999999999999888899999987544 3444788889999999997 9999999993 21
Q ss_pred e------CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCEE
Q psy10459 122 T------THRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 122 ~------~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~~ 191 (335)
. .-.++|+||||.||.|-++++. ...|++.++++|+.|+++|+.+||..+ |||||||-+||||+.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1357899999999999999974 345999999999999999999999997 99999999999999999999
Q ss_pred EeccccccccccCCc-cccc-cc--cccccccccccccccc---CCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy10459 192 LSDFGFARKYSVNNT-DYKQ-NL--SETFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~-~~~~-~~--~~~~~g~~~y~aPE~~---~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~ 264 (335)
|||||.+........ .... .. ......|+.|+|||++ .+.+.+ .|+|||+|||+||-|+....||+......
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 999999864332221 0000 00 0113469999999986 466666 89999999999999999999998764433
Q ss_pred HHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 265 LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
+ +...+.+|..+.++..+++||+.|| .+|.+||++-+++.+-
T Consensus 266 I---lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 266 I---LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred E---EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 2 3346888988999999999999999 9999999999998654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=311.05 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=203.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH-HHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+. .++.++|+||+++++.+..++..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 469999999999999999999999999999999876433222 223334555 46677899999999999999999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 130 MEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 588887754 24589999999999999999999997 9999999999999999999999999998765321
Q ss_pred CcccccccccccccccccccccccCCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHccccCC-CC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGV----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVFP-ES 278 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~~~~~~-~~ 278 (335)
. ......++..|+|||.+.+. .++ .++|+|||||++|+|++|..||.... ..+....+....... ..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd06617 158 V------AKTIDAGCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230 (283)
T ss_pred c------ccccccCCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc
Confidence 1 11223578889999988652 234 78999999999999999999997532 222223332222111 12
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
..+|.++.++|.+|| .+|.+||+++++++||||++..
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 358899999999999 9999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=315.37 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=209.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYI 128 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~i 128 (335)
++|++.+.||.|+||.||+|.+..+++.+|+|.++..... +.....+.+|+.+++.++||||+++++++... +..|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999989999999999754332 22233456899999999999999999998877 89999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999975 9999887643 5899999999999999999999999999999999999999999999999998766543211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-----------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------- 276 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 276 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+......+
T Consensus 163 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 163 -----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred -----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 1223467889999998765544478999999999999999999998877666555443211100
Q ss_pred ------------------CCCC--CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 277 ------------------ESPR--LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 277 ------------------~~~~--~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+. ++..+.++|++|| .+|++|||++|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0111 5888999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=311.03 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=214.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|++.+.||+|+||.||+|.... .+..||+|.+....... ....+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999997542 35589999886443222 23456789999999999999999999998
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEE
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER----------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKL 192 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l 192 (335)
.+..+++|||+++|+|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 899999999999999999997532 2456788999999999999999999999999999999999999999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~ 271 (335)
+|||+++......... ......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+....+....+..
T Consensus 161 ~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYYR---KGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCcccccccccccc---ccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 9999987553322110 01122346779999999887777 78999999999999998 8999999888887777765
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc------CCCcCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ------DPWLKE 313 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~------hp~~~~ 313 (335)
....+....++..+.+++.+|| .+|++||++.++++ ||||++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 5444444567899999999999 99999999999997 999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=307.36 Aligned_cols=249 Identities=25% Similarity=0.464 Sum_probs=207.7
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHH-HHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
+.||.|+||.||+|.+..+|+.||+|++.............+..|..+ ....+|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999988999999999875433222222233345444 4455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---------ccc
Confidence 99999998888899999999999999999999999999999999999999999999999998865432 123
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCC--CCCCCCHHHHHHHHHh
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFP--ESPRLSSSCKALISNI 292 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~l~~li~~~ 292 (335)
..++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.... .++ ....++.++.++|.+|
T Consensus 153 ~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 153 FVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 3578889999999877655 78999999999999999999999888877776665432 222 2235799999999999
Q ss_pred c-CCCCCCC---CHHHHhcCCCcCCCC
Q psy10459 293 L-SPVKFRI---QMEDIRQDPWLKEDS 315 (335)
Q Consensus 293 L-~~p~~Rp---s~~~ll~hp~~~~~~ 315 (335)
| .+|.+|| +++|++.||||++..
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 9 9999999 558999999997743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=302.97 Aligned_cols=253 Identities=30% Similarity=0.514 Sum_probs=219.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|++|.||++.+..+++.||+|.+....... .....+.+|++++..++|+|++++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 5889999999999999999998899999999997765432 335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
++++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988888999999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 291 (335)
.....++..|+|||...+.... .++|+||||+++|+|++|..||..................+....++..+.++|.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 1234578899999998877655 78999999999999999999998777655555544433333445688999999999
Q ss_pred hc-CCCCCCCCHHHHhcCCCc
Q psy10459 292 IL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 292 ~L-~~p~~Rps~~~ll~hp~~ 311 (335)
|| .+|++||++++++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 99 999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=310.34 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=214.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
+..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.++|+||+++++.+...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 34567999999999999999999853 3567899999875332 22345678899999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~ 186 (335)
+..|++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 23678889999999999999999999999999999999999
Q ss_pred CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy10459 187 KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSEL 265 (335)
Q Consensus 187 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~ 265 (335)
++.++|+|||++......... .......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999765432211 112233456789999999877776 78999999999999998 9999998888888
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+......+....++..+.+++.+|| .+|.+||++.+|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 8777776666666678999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=314.26 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=215.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|.+.+.||+|+||.||++.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.+...+..++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999998888999999998643322 245577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-- 171 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence 9999999999998754 4789999999999999999999999999999999999999999999999988655432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc--ccCCCCCCCCHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKA 287 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~~l~~ 287 (335)
.....++..|+|||.+....++ .++|+||||+++|++++|..||...+.......+... ..++....++..+.+
T Consensus 172 ---~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 172 ---RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ---cccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2234578889999999877766 7899999999999999999999877655443333221 122233457889999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+|++|| .+|.+||++++++.|+||+...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999 9999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=310.80 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=207.3
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|++.+.||.|++|.||+|.+..+|+.||+|++....... .....+.+|+.+++.++|+|++++++++...+..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987543221 1234566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 133 AKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 133 ~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+. ++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--- 155 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--- 155 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence 95 69999997765 6899999999999999999999999999999999999999999999999998755332111
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc----------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---------------- 274 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~---------------- 274 (335)
.....++..|+|||++.+....+.++|+||||+++|+|++|..||...+.......+.+...
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 12234578899999886654333789999999999999999999987766544333322110
Q ss_pred ---CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 ---FP---------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 ---~~---------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++ ..+.++..+.++|.+|| .+|.+||+++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 12457789999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=318.67 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=213.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 124 (335)
..+|.+.+.||+|+||+||+|.+..+++.||+|.+......... ...+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch-hHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45799999999999999999999999999999998653222222 34556899999999999999999987644 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..|+++||+. ++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 4799999995 699999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc----------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---------- 274 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~---------- 274 (335)
.. ......++..|+|||.+......+.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 162 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 162 GD-----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cc-----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 11 122345788999999887543334789999999999999999999987654433332221000
Q ss_pred --------------C------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 275 --------------F------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 275 --------------~------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
. ...+.++.++.+||++|| .+|++|||++++++||||.....+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 0 012457899999999999 999999999999999999887665553
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=309.58 Aligned_cols=253 Identities=25% Similarity=0.444 Sum_probs=209.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~---- 124 (335)
.++|++.+.||.|++|.||+|.+..+++.+++|++..... ....+.+|+.+++.+ .|+||+++++.+....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4789999999999999999999988899999999875432 245677999999999 6999999999986544
Q ss_pred --eEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999998865 346899999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
........ ......|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+.....
T Consensus 161 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 161 AQLDSTLG-----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred eecccchh-----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 75532211 122345788999999875422 223689999999999999999999987766655555554322
Q ss_pred --CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 --FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 --~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
......++.++.+||++|| .||++|||+.++++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1122347889999999999 999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=319.09 Aligned_cols=281 Identities=27% Similarity=0.444 Sum_probs=221.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC--Ce
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT--HR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 125 (335)
..++|.+.+.||+|+||.||+|.+..+|+.+|+|.+......... ...+.+|+.++.++ +|+||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh-hhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 356799999999999999999999888999999988643222222 34566899999999 999999999988653 36
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.++||||+. ++|..++... .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999997 4999988765 68899999999999999999999999999999999999999999999999998765433
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC----------
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---------- 275 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------- 275 (335)
............|+..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 2211122334568899999998866544447899999999999999999999876655444333221100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC-CCCCCcccccCC
Q psy10459 276 --------------------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK-SKSAPEVIPFKK 332 (335)
Q Consensus 276 --------------------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~-~~~~~~~~~~~~ 332 (335)
...+.++.++.++|.+|| .+|.+|||+.++++||||++...+... ....+...|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDD 320 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCccc
Confidence 011347889999999999 999999999999999999998766553 444444555553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=310.90 Aligned_cols=256 Identities=29% Similarity=0.489 Sum_probs=211.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+++++.++|+||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 3699999999999999999999989999999988653322 223566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++++.+..+......+++..++.++.|++.||.|||..|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999877776666666799999999999999999999999999999999999999999999999999876654322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-----------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV----------------- 273 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~----------------- 273 (335)
.......++..|+|||++.+....+.++|+||||+++|+|++|..||.+....+....+....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 112234678889999999887334489999999999999999999998765544333322100
Q ss_pred ---cCCC-----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 274 ---VFPE-----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 274 ---~~~~-----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++. ...++.++.+||++|| .+|++||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 1134889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=327.84 Aligned_cols=248 Identities=29% Similarity=0.489 Sum_probs=216.6
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
..+.+-.+...-++-||.|+.|.||+|+. .++.||||.++.. -+.+++-|++|+|+||+.+.++|...
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 34444455556678899999999999994 4789999987542 22688999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..+|||||||..|.|+.+++....+....+..|.++|+.|+.|||...|||||||.-||||+.+..+||+|||.++.+..
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987754
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-ccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ-KRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 282 (335)
... .-.++||-.|||||++.+.+.. .|.||||||+++|||+||..||.+.+...++--+- ..+..|.+..+|
T Consensus 265 ~ST------kMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 265 KST------KMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhh------hhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence 432 2356899999999999999999 89999999999999999999999877766554443 245566667899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPW 310 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~ 310 (335)
..++-||+.|| ..|.+||++.+||.|-=
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 99999999999 99999999999999963
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=316.70 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=203.7
Q ss_pred CeEEeeeecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVY 127 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 127 (335)
+|.+.+.||+|++|.||+|.+.. ++..||+|.+.......+.....+.+|+.++..++||||+++++++... +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999764322222245566899999999999999999999888 8899
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC----CCCEEEeccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD----KYNIKLSDFGFA 198 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~----~~~~~l~Dfg~~ 198 (335)
+||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.+++|+||||+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 777776432 25899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE---------LLKQV 269 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~---------~~~~i 269 (335)
..+...... ........++..|+|||++.+....+.++|+||||+++|+|++|..||.+..... ....+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 160 RLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 766433221 1112334678899999988765433478999999999999999999997654322 11111
Q ss_pred Hc------------------------cccCCCC------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 270 QK------------------------RVVFPES------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 270 ~~------------------------~~~~~~~------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.. ....... ...+..+.++|.+|| .||++|||+.++++||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 0000001 146778999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.54 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=208.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|++|+||+|.+..+|+.||+|.+...... +.....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 5799999999999999999999989999999998654322 122455678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccccccccCCcc
Q psy10459 131 EYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||+. ++|.+++..... +++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9996 588888765433 578889999999999999999999999999999999985 457899999998765432111
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-----------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------- 276 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------- 276 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||......+....+......+
T Consensus 160 -----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 160 -----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred -----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1233568899999998765443478999999999999999999998776655544432211100
Q ss_pred -----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 -----------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 -----------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+.++.++.++|.+|| .+|++||+++++++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 01357889999999999 999999999999999999873
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=310.56 Aligned_cols=253 Identities=20% Similarity=0.398 Sum_probs=206.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEE-----e
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE-----T 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~ 122 (335)
..++|++.+.||+|+||.||+|.+..+++.+|+|++...... ...+.+|+.+++.+ +|+||+++++.+. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 456899999999999999999999999999999987643221 34566899999999 6999999999873 3
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4578999999999999998753 345889999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~ 273 (335)
........ ......|+..|+|||++.. ..++ .++|+|||||++|+|++|..||...........+....
T Consensus 172 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 172 AQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred eecccCCC-----ccccccCCCcccChhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 76543211 1223457899999999753 2344 78999999999999999999998776555444433321
Q ss_pred c--CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 274 V--FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 274 ~--~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
. ......++..+.+||.+|| .||.+||++.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1 1122346789999999999 999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.18 Aligned_cols=251 Identities=23% Similarity=0.422 Sum_probs=215.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356778999999999999999999864 567899998764322 145677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+++|||+++++|.+++... ..++...+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999999653 45888999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... ......++..|+|||.+....++ .++|+||||+++|+|++ |..||...........+......+....++.
T Consensus 157 ~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (261)
T cd05072 157 EYT----AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD 231 (261)
T ss_pred cee----ccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 211 11122356789999999877776 78999999999999998 9999999888888888887777666677899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.+++.+|| .+|++||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=312.11 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=213.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
...|.+.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++.+.+...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999889999999998755443344456678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
+||+.| ++.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 999974 77777654 456899999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSS 284 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 284 (335)
....++..|+|||++.+ ..++ .++||||||+++|+|++|..||...+.......+....... ....++..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDY 242 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHH
Confidence 22356788999998742 3344 78999999999999999999998887766655554332111 12347889
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+.++|.+|| .+|.+||++.+++.||||....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999 9999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.29 Aligned_cols=248 Identities=21% Similarity=0.391 Sum_probs=211.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|.+.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 456899999999999999999864 4668999988644332 34567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+++++|.+++... +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 9999999999998753 45899999999999999999999999999999999999999999999999998765322111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..+....+............+..+.+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05114 157 ---SSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYE 232 (256)
T ss_pred ---ccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 01122345679999999877776 78999999999999999 99999999888888888776555445567899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.+|| .+|.+||+++++++
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=310.78 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=207.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEE------e
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE------T 122 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~ 122 (335)
...|++.+.||.|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ +|+||+++++.+. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4579999999999999999999999999999999865321 234567889999888 6999999999884 2
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
.+..|++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46789999999999999999653 3488889999999999999999999999999999999999999999999999875
Q ss_pred cccCCcccccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
...... ......|+..|+|||.+.. ..++ .++|+||||+++|+|++|..||...........+......
T Consensus 171 ~~~~~~-----~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 171 LDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred hhcccc-----CCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 432111 1223467889999999753 2344 6899999999999999999999877655544444333221
Q ss_pred -CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 276 -PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 276 -~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.....++.++.+||++|| .||.+||++.+||+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 122358899999999999 999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.82 Aligned_cols=255 Identities=19% Similarity=0.281 Sum_probs=212.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|.+.+.||+|++|.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 445779999999999999999999876 677899998864332 2224557789999999999999999999988
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---CEEE
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER-------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKL 192 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---~~~l 192 (335)
.+..+++|||+++++|.+++...+ .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++ .++|
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 889999999999999999997643 488999999999999999999999999999999999998765 5899
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~ 271 (335)
+|||++.......... .......+..|+|||++.+..++ .++|||||||++|+|++ |..||...........+..
T Consensus 161 ~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999987653221110 01122235679999999887777 78999999999999997 9999998888887777766
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.........++..+.+++.+|| .+|.+||++.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5554545678999999999999 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.76 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=211.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999887544433444566778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 131 EYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 34488999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHccccCCCC-CCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPES-PRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~-~~~~~ 283 (335)
......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||.... .......+......+.. ..++.
T Consensus 162 -----~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 162 -----AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred -----HHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCH
Confidence 11234578899999999877766 78999999999999999999997653 34444554443322221 35788
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.++|.+|| .+|.+||+++++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999 999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=325.27 Aligned_cols=283 Identities=23% Similarity=0.449 Sum_probs=248.7
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..+.....++.++..||-|+||.|-++..+.....+|+|++++.........+-+..|..++..++.|.||++|..|.+
T Consensus 412 ~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 412 EEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred hhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 35556677788999999999999999998766666699999988776666666777899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+.++|++||-|-||.|+..++..+.|++.....++..+++|++|||++|||+|||||+|.+++.+|-+||.|||+++.+.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-CCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~ 281 (335)
..... -++|||+.|.|||++.+...+ .+.|.||||+++|||++|.+||.+.++...+..|.+++..-. +..+
T Consensus 572 ~g~KT------wTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 572 SGRKT------WTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred cCCce------eeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccccc
Confidence 65543 367999999999999999888 889999999999999999999999999999999988764332 2579
Q ss_pred CHHHHHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC-CCCCCCCCCCCcccccCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQ-----MEDIRQDPWLKED-SNPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~ 332 (335)
+....+||++++ .+|.+|.. +.+|.+|.||.+. ++--......|+++|-.+
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va 702 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA 702 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence 999999999999 88999984 9999999999886 333334556666666543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=310.18 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=214.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
...+|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+++++.++|+||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45678999999999999999998743 357899999865433 22356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER--------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~ 189 (335)
...+++|||+++++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997542 3788899999999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy10459 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQ 268 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~ 268 (335)
++|+|||.+......... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+....
T Consensus 161 ~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred EEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999998754322110 111223456789999999888877 78999999999999998 9999998888888888
Q ss_pred HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 269 VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 269 i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..+...+....++..+.+++++|| .+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8766555545678999999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.46 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=211.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|++.+.||+|+||.||+|.+. .++..||+|++...... .....+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999864 23567999988643322 224457789999999999999999999998
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEE
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER----------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKL 192 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l 192 (335)
....++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+||++++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 899999999999999999996532 2567788999999999999999999999999999999999999999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~ 271 (335)
+|||++.......... ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+.........+..
T Consensus 161 ~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999987554322111 11123456789999999887777 78999999999999998 7999998888888777766
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
....+....++..+.+++.+|| .+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5544445678899999999999 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=314.10 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=210.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeE--EEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDV--AIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 123 (335)
.+..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .......+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 456778999999999999999999988777654 666654322 233356677899999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~ 187 (335)
+..+++|||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997542 47889999999999999999999999999999999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL 266 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~ 266 (335)
+.++|+|||++....... ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CcEEeCccccCcccchhh------hcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999985321110 01111235679999998777766 78999999999999998 99999988888877
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.+......+....++.++.+||.+|| .+|.+||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777665544444568899999999999 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.44 Aligned_cols=253 Identities=22% Similarity=0.402 Sum_probs=214.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|.+.+.||+|+||.||++.+. .++..+|+|.+.... ......+.+|+.++..++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45678999999999999999999852 345678999886432 2335567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER-------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~ 189 (335)
.+..+++|||+++++|.+++...+ .+++..++.++.|++.||+|||+.|++||||||+||++++++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997543 3899999999999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy10459 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQ 268 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~ 268 (335)
++|+|||++......... .......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||...........
T Consensus 159 ~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred EEeccCCccccccCCcee---ecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999998755332211 111233457789999999887777 78999999999999998 9999999888888888
Q ss_pred HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 269 VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 269 i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..+...+....++.++.+|+.+|| .+|.+|||+.++++
T Consensus 235 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8776555555568999999999999 99999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=303.56 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=214.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|++|.||+|.+. +++.||+|.++..... .+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999964 4678999998654332 345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 68999999999999999999999999999999999999999999999999998765321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. .......+..|+|||...+..++ .++|+||||+++|+|++ |..||.+.........+......+....++..
T Consensus 158 ~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 158 YE----AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232 (261)
T ss_pred cc----ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 11 01112234579999999887776 78999999999999999 99999998888888888777666656678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+++.+|| .+|.+||+++++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.17 Aligned_cols=245 Identities=26% Similarity=0.482 Sum_probs=201.0
Q ss_pred CCeEEeeee--cccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEE
Q psy10459 51 HGYSLGDVV--GMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 51 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (335)
++|.+.+.+ |+|+||.||++.+..++..+|+|++....... .|......+ +|+||+++++.+...+..+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666666 99999999999999999999999987543211 122222222 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998877899999999999999999999999999999999999999998 9999999998765322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHc--cccCCCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL-LKQVQK--RVVFPESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~-~~~i~~--~~~~~~~~~~~~ 283 (335)
....++..|+|||++.+..++ .++|+||||+++|+|++|..||........ ...+.. ....+....++.
T Consensus 164 -------~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T PHA03390 164 -------SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSK 235 (267)
T ss_pred -------ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCH
Confidence 123578899999999887777 789999999999999999999986543321 111111 222233346899
Q ss_pred HHHHHHHHhc-CCCCCCCC-HHHHhcCCCcCC
Q psy10459 284 SCKALISNIL-SPVKFRIQ-MEDIRQDPWLKE 313 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps-~~~ll~hp~~~~ 313 (335)
.+.+||.+|| .+|.+||+ ++++|+||||++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999 99999996 699999999974
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.50 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=215.5
Q ss_pred eeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+..+..++|+||+++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999998766 8899999997654432 3567789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 134 KNGSLLEVIRKE---------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 134 ~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.. ........++..|+|||.+....++ .++|+||||+++|+|++ |..||......+..+.+......+....++.
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 159 DY---YRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred cc---cccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 21 1112334568899999999887666 78999999999999999 6999999999888888887666666677899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.+++.+|| .+|.+|||+++++++
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=316.84 Aligned_cols=264 Identities=27% Similarity=0.459 Sum_probs=219.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----eE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 126 (335)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 589999999999999999999888999999998754321 222456778999999999999999999987765 78
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|++|+|+. ++|.+++.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 48999998877899999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------- 277 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 277 (335)
. ........++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+....+......+.
T Consensus 159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 159 E--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred c--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 1 01122345788999999998873334889999999999999999999998887766655544221111
Q ss_pred ---------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 ---------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 ---------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.++.++.++|.+|| .+|.+||+++++++||||++...+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 1346889999999999 99999999999999999998777654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=303.06 Aligned_cols=245 Identities=22% Similarity=0.390 Sum_probs=206.5
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+++++.++|+||+++++++...+..++||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 469999999999999988999999998864322 233566789999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 137 SLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 137 sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
+|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... .....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~ 155 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA---STGGM 155 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc---ccCCC
Confidence 999999764 45899999999999999999999999999999999999999999999999998754321110 00111
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 293 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L- 293 (335)
..++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...........+......+....++..+.+|+.+||
T Consensus 156 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 1234569999999887776 78999999999999997 99999888877777777665555555678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy10459 294 SPVKFRIQMEDIRQ 307 (335)
Q Consensus 294 ~~p~~Rps~~~ll~ 307 (335)
.+|.+||++.++++
T Consensus 235 ~~p~~Rps~~~~~~ 248 (252)
T cd05084 235 YDPGQRPSFSTVHQ 248 (252)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=304.99 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=204.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
+.+.+.....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34445556789999999999999988999999998865322 224567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccccccccC
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYI--DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~--~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~ 204 (335)
++||+++++|.+++... ..+ ++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999764 445 78889999999999999999999999999999999976 678999999998755322
Q ss_pred CcccccccccccccccccccccccCCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH-ccccCCCCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QVQ-KRVVFPESPR 280 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~-~i~-~~~~~~~~~~ 280 (335)
... .....|+..|+|||.+.... ++ .++|+||||+++|+|++|..||.......... ... ..........
T Consensus 163 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 163 NPC-----TETFTGTLQYMAPEVIDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred CCc-----cccCCCCccccChhhhccccccCC-chhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 211 12234688999999986543 44 78999999999999999999997644322211 111 1111112245
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++.++.+|+++|| .+|.+||++.+++.||||
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 8899999999999 999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.90 Aligned_cols=259 Identities=21% Similarity=0.339 Sum_probs=205.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 124 (335)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-chhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3579999999999999999999999999999999865432211 1234457999999999999999999876543
Q ss_pred ---eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 125 ---RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 125 ---~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
..++||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999964 888887654 3689999999999999999999999999999999999999999999999999976
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-------
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------- 273 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~------- 273 (335)
+....... ........++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.......+....
T Consensus 169 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 64332211 1112234578889999988765433378999999999999999999998877655444333211
Q ss_pred -------------cCCCC-----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 274 -------------VFPES-----------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 274 -------------~~~~~-----------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+.. ...+..+.+||.+|| .||.+|||++++|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00100 113567889999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=303.02 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=211.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|.+.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++..++||||+++++++...+..++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 3457999999999999999999864 3556999988654332 3456789999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+|||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999999764 46899999999999999999999999999999999999999999999999998765332111
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...........+......+.....+..+.
T Consensus 157 ----~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 157 ----SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred ----ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 01122346679999999877776 78999999999999998 9999998888888777777665555556789999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+++.+|| .+|.+||++.+|+.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999 999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=302.13 Aligned_cols=246 Identities=30% Similarity=0.555 Sum_probs=214.7
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||.|+||.||++.+..+++.+|+|++.............+..|+.+++.++|+||+++++.+..++..+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999776544333456778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccccc
Q psy10459 139 LEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218 (335)
Q Consensus 139 ~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g 218 (335)
.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........ ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-----RTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-----cccCCcC
Confidence 99998887899999999999999999999999999999999999999999999999999876543221 1233457
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCC
Q psy10459 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVK 297 (335)
Q Consensus 219 ~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~ 297 (335)
+..|+|||...+...+ .++|+||||+++|+|++|..||...+.......+.. ...+....++..+.++|++|| .||.
T Consensus 156 ~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 8899999999877666 789999999999999999999988887666666655 334444567999999999999 9999
Q ss_pred CCCCH---HHHhcCCCc
Q psy10459 298 FRIQM---EDIRQDPWL 311 (335)
Q Consensus 298 ~Rps~---~~ll~hp~~ 311 (335)
+||++ +++++||||
T Consensus 234 ~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hCCCcccHHHHHhCCCC
Confidence 99999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=301.92 Aligned_cols=258 Identities=23% Similarity=0.449 Sum_probs=214.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCC--CChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ--APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 126 (335)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++|+||+++++.+... +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875422 11223356788999999999999999999988653 468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++++||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998877799999999999999999999999999999999999999999999999999976532111
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l 285 (335)
. ........++..|+|||.+.+...+ .++|+|||||++|+|++|..||...........+......+ ....++..+
T Consensus 162 ~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 162 S--GTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred c--CccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 1 1111234578899999999887666 78999999999999999999998876665555544322222 235688999
Q ss_pred HHHHHHhcCCCCCCCCHHHHhcCCCc
Q psy10459 286 KALISNILSPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 286 ~~li~~~L~~p~~Rps~~~ll~hp~~ 311 (335)
.++|++||.+|..||++.+++.|||.
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcCCCC
Confidence 99999999778999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=301.04 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=215.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~iv 129 (335)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+..++.++|+||+++++.+... +..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 488899999999999999999889999999998765432 23366788999999999999999999999888 899999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988778999999999999999999999999999999999999999999999999998776543321
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc-cccCCCCCCCCHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK-RVVFPESPRLSSSCKA 287 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~-~~~~~~~~~~~~~l~~ 287 (335)
.......++..|+|||.......+ .++|+||||+++++|++|..||.... .......+.. .........++..+.+
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred -ccccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 012234578899999999877766 78999999999999999999998776 3333333332 1222223457899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+|.+|| .+|.+||++.++++||||
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999 999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=305.81 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=208.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYI 128 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~i 128 (335)
++|...+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+++++.++|+||+++++.+.. .+.+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4689999999999999999999889999999998754332 335667799999999999999999998855 347899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 129 IMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 345889999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHccc--cCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQKRV--VFPE 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-----~~~~~~~~i~~~~--~~~~ 277 (335)
. .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+....+.... ..+.
T Consensus 159 ~-------~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 159 L-------AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred c-------cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhcc
Confidence 1 1133568889999999887777 7899999999999999999999865 2233333333211 1111
Q ss_pred C----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 278 S----PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 278 ~----~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
. ..+++.+.++|.+|| .+|++|||+.|+++||||++..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 1 235678999999999 9999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=308.21 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=209.7
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--CeEEEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRVYIIM 130 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~iv~ 130 (335)
|.+.+.||.|++|.||+|.+..+++.+|+|++.... ..+.....+.+|+.+++.++|+|++++++.+... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999899999999998654 1222245567899999999999999999999887 8999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99975 899888665 57999999999999999999999999999999999999999999999999999766543211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------ 277 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------ 277 (335)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+......+.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 --DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred --cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 112234578899999876544334789999999999999999999998887666655543211110
Q ss_pred -----------------CCC-CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 -----------------SPR-LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 -----------------~~~-~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
... ++..+.++|++|| .+|.+||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 3889999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.54 Aligned_cols=249 Identities=22% Similarity=0.396 Sum_probs=211.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
..+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++|+||+++++.+...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346889999999999999999875 5678999998654332 23466899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999998765322111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||......+....+......+....++..+.+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT 232 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 01111234579999999887777 78999999999999998 89999988888888888777666666678999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.+|| .+|++|||++++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 999999 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=325.05 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=219.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|.-++.||.|+||.||.|++..+.+.||||.+.-.........+.+..|+.+|++++|||++.+-++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47778999999999999999999999999999987666556667888899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||- |+-.+++.- .+++-+..+..|+.+.+.||+|||+.+.||||||..|||+++.|.|||.|||.+....+
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------- 178 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc-------
Confidence 996 488888854 45689999999999999999999999999999999999999999999999999865543
Q ss_pred ccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCCCCCCCCHHHH
Q psy10459 211 NLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPESPRLSSSCK 286 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~ 286 (335)
...++||+.|||||++. .+.|+ -++||||||++..||.-.++|+...+....+-.|-.+. ..-....+|..++
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred --hhcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 45678999999999973 44555 78999999999999999999998877766665555432 2223457899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+||..|| +-|.+|||.+++|.|+|...
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 9999999 89999999999999999865
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=310.40 Aligned_cols=281 Identities=28% Similarity=0.473 Sum_probs=240.5
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 122 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 122 (335)
+...+...+|..+.+||+|+||.|.++..+.+.+.||||++++.-...+...+--..|-.+|... +-|.+++++..|+.
T Consensus 342 ~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 342 KRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred cccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 34456777899999999999999999999999999999999876554444345555777888776 46788999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
-+.+|+||||+.||+|-..++.-+.+-++.+..++..|+-||-+||++||++||||.+|||++.+|++||.|||+++.-.
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999986433
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 281 (335)
.. ...+.++|||+.|+|||++.-.+|. .+.|.||+|+++|||+.|+.||++.+.+++...|.. ...+| ..+
T Consensus 502 ~~-----~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP--Ksl 573 (683)
T KOG0696|consen 502 FD-----GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP--KSL 573 (683)
T ss_pred cC-----CcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc--ccc
Confidence 22 2345688999999999999999999 789999999999999999999999999999999876 44555 459
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC-CCCCCCCCCCCcccccCC
Q psy10459 282 SSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED-SNPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~ 332 (335)
|.+..++++.+| +.|.+|. .-.+|..||||+.- ++....+--.|++.|..|
T Consensus 574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k 631 (683)
T KOG0696|consen 574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK 631 (683)
T ss_pred cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence 999999999999 9999998 34789999999863 444445556666666654
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=328.09 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=212.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
-+||+|.||+||.|+|..+....|||.+..... ...+-+..|+.+-++|+|.|||+++|.+..++.+-|.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 489999999999999999999999998854332 22566779999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccccccccCCccccccc
Q psy10459 137 SLLEVIRK-ERYI--DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 137 sL~~~l~~-~~~~--~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+|.++++. .+++ .+..+..+.+||++||.|||...|||||||-+||||+. .|.+||+|||.++.+..-+ +.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-----P~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-----PC 732 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-----cc
Confidence 99999976 4677 78899999999999999999999999999999999975 6789999999998875433 34
Q ss_pred ccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 213 SETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
+.++.||..|||||++..+ .|. .++|||||||++.||.||++||......+....-...+ ..|.+..++.+.++|
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG-~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYG-KAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCC-chhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 6678899999999999654 355 78999999999999999999997665444433322222 223334688899999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
|.+|. .||.+||++.++|.+||++....
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccCCC
Confidence 99999 99999999999999999998733
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.90 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=219.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..+.|++...||+|++|.||+|.+..++..||+|++..... ....+.+|+..++.++|+|++++++.+...+..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34568999999999999999999988899999999975433 24567789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998876 799999999999999999999999999999999999999999999999998865533211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSC 285 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l 285 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+..... .+....++.++
T Consensus 172 ----~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (286)
T cd06614 172 ----KRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF 246 (286)
T ss_pred ----hhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHH
Confidence 11233467889999999877776 789999999999999999999998877665555543222 22223488999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++|.+|| .+|.+||++.+++.|+||++.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 99999999 999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=304.64 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=214.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
..+|++.+.||+|+||.||+|.+..+++ .||+|++..... +.....+..|+.+++.++||||+++++.+..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4568999999999999999999877665 599999865322 33356788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+++|||+.+++|.+++... +.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999763 568999999999999999999999999999999999999999999999999987554322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.............+..|+|||.+....++ .++|+|||||++|+|++ |..||...+..+....+......+....++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 11110001111124579999999887777 78999999999999886 99999998888888888777666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.+++.+|| .+|.+||++++|++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=305.53 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=214.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|++.++||+|+||+||+|.+..+|. .||+|++..... ......+.+|+.++..+.|+||+++++.+..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 4567889999999999999999999877776 479998865433 2235567789999999999999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...+++++|+++|+|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++..+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4567999999999999999764 46899999999999999999999999999999999999999999999999998766
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
........ .....++..|+|||...+..++ .++|||||||++|||++ |..||...........+......+....
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05109 160 DIDETEYH---ADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccccceee---cCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCcc
Confidence 43222111 1122346689999999887777 78999999999999998 9999998888877777777666666667
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.++.++|.+|| .||++||++.++++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999 999999999999953
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=331.98 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=194.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC-CeEEEEE--------------EecCCCChHHHHhhHHHHHHHHHcCCCCCee
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHS-QDVAIKI--------------ISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 114 (335)
..+|++++.||+|+||+||+|...... ..++.|. +.+...........+.+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764322 2222221 1111111122345678999999999999999
Q ss_pred eeceeEEeCCeEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC
Q psy10459 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKE-----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 115 ~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~ 189 (335)
++++++...+..|++++++. ++|.+++... .......+..++.||+.||.|||+.||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 5788777442 22345677889999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCC--HHHHH
Q psy10459 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTN--YSELL 266 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p-~~~~~--~~~~~ 266 (335)
++|+|||++..+...... .....+|+..|+|||++.+..++ .++|||||||++|+|++|..+ |.... ....+
T Consensus 306 vkL~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREA----FDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred EEEEeCCCceecCccccc----ccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999766432211 12345789999999999988877 789999999999999998754 43221 21222
Q ss_pred HHHHccc-----cCCC--------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 267 KQVQKRV-----VFPE--------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 267 ~~i~~~~-----~~~~--------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+.... .+|. ...++.++.++|.+|| .||.+|||+.|+|+||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1111110 0000 1235678889999999 999999999999999999774
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=298.53 Aligned_cols=249 Identities=25% Similarity=0.497 Sum_probs=213.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976443 235677799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 132 YAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 132 ~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|+++++|.+++... ..+++..+..++.|++.||.+||..|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999999776 5789999999999999999999999999999999999999999999999999876643321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
.....++..|+|||.+.+...+ .++|+||||+++|+|++|..||...+............ ..+....++..+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHH
Confidence 2234578899999999877665 78999999999999999999998876555554444321 122223358999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPW 310 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~ 310 (335)
|.+|| .||.+|||+.++++|||
T Consensus 231 i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHccCChhhCCCHHHHhcCCC
Confidence 99999 99999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=303.67 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=214.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
...+|++.+.||+|+||.||+|.+..++. .+|+|.+..... +.....+.+|+.++..++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45689999999999999999998765443 689998865332 2235677899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+++|||+++++|.+++... +.++...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 45899999999999999999999999999999999999999999999999999866433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.... .......++..|+|||.+.+..++ .++|+||||+++|++++ |..||......+....+......+....++.
T Consensus 160 ~~~~--~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 160 PEAA--YTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred ccee--eecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCH
Confidence 2111 111122235679999999887776 78999999999999886 9999998888888888887766666667899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+.+++.+|| .+|.+||++.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=311.82 Aligned_cols=276 Identities=25% Similarity=0.398 Sum_probs=217.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCC--CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe----CC
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARH--SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET----TH 124 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~ 124 (335)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+.+|+.+++.+ .|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999877 889999998653222 22244566899999999 59999999986533 24
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..+++++++. ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||.+..+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999985 599999988888999999999999999999999999999999999999999999999999999866433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC---------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--------- 275 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 275 (335)
.... ........|+..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+......
T Consensus 159 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 159 PGEN-AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred cccc-cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 111234568999999998766433337899999999999999999999877654444333221100
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC-CCCCCCccccc
Q psy10459 276 ---------------------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG-KSKSAPEVIPF 330 (335)
Q Consensus 276 ---------------------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~-~~~~~~~~~~~ 330 (335)
...+.++..+.+|+.+|| .+|.+||++.+++.||||++...+.. ..+.+++-.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSF 315 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCc
Confidence 011346789999999999 99999999999999999988766644 35666665554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=300.58 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=218.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+|++.+.||+|++|.||++.+..+++.+|+|.+........ ....+.+|+.+++.++|+||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999876443322 24566789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 132 YAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 132 ~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
|+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999866 356899999999999999999999999999999999999999999999999998766433
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+......+....++.++.+
T Consensus 157 ----~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd08530 157 ----MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQN 231 (256)
T ss_pred ----CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHH
Confidence 12233578899999999887776 7899999999999999999999998888777777665544444578899999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++.+|| .+|.+||++.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999 999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=300.94 Aligned_cols=245 Identities=23% Similarity=0.391 Sum_probs=207.7
Q ss_pred eeecccCceEEEEEEEcCCC---CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
++||+|+||.||+|.+...+ ..+|+|.+...... .....+.+|+.+++.+.|+||+++++++. .+..+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999875544 78999998765443 23566778999999999999999999876 45679999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccc
Q psy10459 134 KNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213 (335)
Q Consensus 134 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 213 (335)
++++|.+++.....+++..+..++.|++.||.+||..|++|+||||+||+++.++.++|+|||.+............ .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~--~ 155 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--T 155 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc--c
Confidence 99999999988778999999999999999999999999999999999999999999999999999866443322111 1
Q ss_pred cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHh
Q psy10459 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292 (335)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 292 (335)
....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..+....+......+....++..+.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 112234679999999887777 78999999999999998 9999999888888888877666566667899999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10459 293 L-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 293 L-~~p~~Rps~~~ll~ 307 (335)
| .+|++||++.++++
T Consensus 235 l~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 235 WKYRPEDRPTFSELES 250 (257)
T ss_pred hcCChhhCcCHHHHHH
Confidence 9 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=313.52 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=207.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 123 (335)
..+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ....+.+|+.+++.++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 36899999999999999999999999999999998654432 245567899999999999999998766543
Q ss_pred --------CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEec
Q psy10459 124 --------HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSD 194 (335)
Q Consensus 124 --------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~D 194 (335)
...+++|||+. ++|.+++.. ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 589888864 45899999999999999999999999999999999999985 55789999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
||.+..+...... ........++..|+|||.+......+.++|+|||||++|+|++|..||...+.......+.....
T Consensus 159 fg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred cccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9998765321111 11112235688899999876544344789999999999999999999987765554444332111
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 275 FP-----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 275 ~~-----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
.+ ..+.++.++.+||.+|| .||.+|||++++++||||+....|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 00 01357889999999999 999999999999999999875444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=307.72 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=209.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (335)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ....+.+.+|+.++.++ +||||+++++.+...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 468887763222 22245677899999999 7999999999999989999
Q ss_pred EEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 128 IIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
+++||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478889999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQ 270 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~ 270 (335)
|+|||++........ ......+..|+|||.+.+..++ .++|||||||++|+|++ |..||......+....+.
T Consensus 160 l~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 160 IADFGLSRGEEVYVK------KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred ECCcCCCccccceec------cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 999999853321100 1111234579999999887777 78999999999999997 999999999888888887
Q ss_pred ccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 271 KRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.....+....++.++.+||.+|| .+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76665555678999999999999 999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=307.01 Aligned_cols=248 Identities=26% Similarity=0.473 Sum_probs=207.1
Q ss_pred EEeeeecccCceEEEEEEEc----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 54 SLGDVVGMGSYATVKLATSA----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.+.+.||.|+||.||+|.+. ..+..|+||++... .. ......+.+|++.++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~-~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SS-EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SS-HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cc-cccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 34568999999542 22 22366778999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 130 MEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||+++|+|.+++... ..++...+..|+.||+.||.|||+.+++|+||+++||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999999766221111
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.......+...|+|||.+....++ .++||||||+++||+++ |..||...+..+....+......+....++..+.
T Consensus 160 ---~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 160 ---KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp ---EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ---cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence 112233457789999999877766 89999999999999999 7899999999999999988777766677999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++|..|| .+|.+||++.+|++
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHh
Confidence 9999999 99999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=315.21 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=214.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe---
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--- 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 125 (335)
..++|.+...||+|++|.||+|.+..++..||+|++....... .....+.+|+.+++.++|+||+++++.+...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567999999999999999999999999999999886532222 224556689999999999999999988765544
Q ss_pred ---EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 126 ---VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 126 ---~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6699998875 458999999999999999999999999999999999999999999999999987653
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----- 277 (335)
.. .....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.......+......+.
T Consensus 170 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 170 DE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 32 12335688899999986643444789999999999999999999988776665555433221110
Q ss_pred -------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 -------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 -------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
...++..+.+||.+|| .+|.+|||+.+|++||||++...+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~ 309 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED 309 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence 1246889999999999 99999999999999999998766644
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=291.50 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=207.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe---
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--- 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 122 (335)
..+...+|++.+.||+|||+.||++....++..||+|.+..... ...+..++|++..++++|||+++++++...
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 45778899999999999999999999999999999999865542 225667799999999999999999877533
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCEEEec
Q psy10459 123 --THRVYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 123 --~~~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~~l~D 194 (335)
....||+++|...|||.+.+... ..+++.+++.|+.++.+||++||... ++||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 34599999999999999988642 36999999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCcccc----cccccccccccccccccccCCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Q psy10459 195 FGFARKYSVNNTDYK----QNLSETFCGSYAYASPEILKGVPYT--PQQSDIWSMGVVLFAMVYGRLPFDDTNY--SELL 266 (335)
Q Consensus 195 fg~~~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~--~~~~Di~slG~~~~~l~~g~~p~~~~~~--~~~~ 266 (335)
||.+......-.... ..-...-..|..|+|||.+.-.... +.++|||||||++|.|+.|..||+..-. ..+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 999865432111000 0000112358899999998543322 3789999999999999999999964211 0111
Q ss_pred HHH-HccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 267 KQV-QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 267 ~~i-~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
-.+ ...+.+|....+|..+.++|++|| .||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111 225677887889999999999999 999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=300.87 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=210.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.+++.++|+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999998899999999987544333334667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 131 EYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||+++++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 24489999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHccccCCCCC-CCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESP-RLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~-~~~~ 283 (335)
. .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||.... ..+..+.+......+... .++.
T Consensus 162 ~-----~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 162 A-----AHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred c-----cceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCH
Confidence 1 1234578889999999877776 78999999999999999999996543 334444544443333322 6788
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+.++|.+|| .+|.+||++.+|++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=300.77 Aligned_cols=245 Identities=23% Similarity=0.382 Sum_probs=206.4
Q ss_pred eecccCceEEEEEEE--cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 58 VVGMGSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
.||+|+||.||+|.+ ..++..+|+|+++..... ....+.+.+|+.++..+.|+||+++++++. .+..+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 456789999998654332 334566789999999999999999999875 4567899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 136 ~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
++|.+++.....+++..+..++.|++.||.+||+.|++|+||||.||+++.++.++|+|||++............ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~~ 157 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA--KTH 157 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee--cCC
Confidence 999999988778999999999999999999999999999999999999999999999999999766433221111 112
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 293 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L- 293 (335)
..++..|+|||.+....++ .++|+|||||++|+|++ |..||.+....+..+.+......+....++.++.++|.+||
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence 2345789999998776666 78999999999999998 99999998888888888776555555678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy10459 294 SPVKFRIQMEDIRQ 307 (335)
Q Consensus 294 ~~p~~Rps~~~ll~ 307 (335)
.||.+||++.+|..
T Consensus 237 ~~p~~Rp~~~~i~~ 250 (257)
T cd05116 237 YGVDERPGFAVVEL 250 (257)
T ss_pred cCchhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=301.60 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=209.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+...+|++.++||+|+||.||+|.+..+ ..||+|.+...... ...+.+|+.+++.++|+||+++++.+. .+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4556799999999999999999987655 46999998753332 345678999999999999999998774 45679
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999763 347899999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||...+..++ .++|+|||||++|+|++ |..||.+.........+......+....++..
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd05071 157 YT----ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 231 (262)
T ss_pred cc----cccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHH
Confidence 11 11123356789999999877776 78999999999999999 89999988888887777766656666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.++|.+|| .+|.+||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=308.12 Aligned_cols=257 Identities=23% Similarity=0.437 Sum_probs=216.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|....+||+|+||.||++....+|..||+|.+..... .....+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 3345789999999999999989999999998854322 2355677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~----- 172 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----- 172 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-----
Confidence 999999998754 45899999999999999999999999999999999999999999999999988655332111
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCHHHHHHHH
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALIS 290 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~ 290 (335)
.....|+..|+|||.+.+..++ .++|+||+|+++|+|++|..||.+.........+..... ......++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHH
Confidence 1234578899999998876666 789999999999999999999998877766666554332 2233467899999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+|| .+|.+||++.++++||||.+...+.+
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~ 281 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGPPSC 281 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence 999 99999999999999999999876554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=336.27 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=206.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|++.++||+|+||.||+|.+..+|+.||+|++.......+.....+.+|+.++..++||||+++++.+...+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997654444445667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 131 EYAKNGSLLEVIRKE-----------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
||++|++|.+++... ...+...+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 224566788999999999999999999999999999999999999999999997
Q ss_pred ccccCCcc-------------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy10459 200 KYSVNNTD-------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266 (335)
Q Consensus 200 ~~~~~~~~-------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~ 266 (335)
........ .........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 66221100 001112235799999999999888777 7899999999999999999999876544332
Q ss_pred HHHH--ccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy10459 267 KQVQ--KRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 267 ~~i~--~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll 306 (335)
.... ..........++..+.+++.+|| .||++|++..+.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2211 11112223468899999999999 9999998655544
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.68 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=215.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++.+.||+|+||.||++.+... ...+|+|.+....... ....+.+|+.++..+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH--HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45667899999999999999999987643 3689999987543322 245577899999999 799999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili 184 (335)
...+.++++|||+++++|..++... ..+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 357899999999999999999999999999999999999
Q ss_pred cCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy10459 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS 263 (335)
Q Consensus 185 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~ 263 (335)
+.++.++|+|||.+..+...... . ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~-~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY-R--KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCccccccccccccce-e--ccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999765432211 0 01112345679999998887777 78999999999999997 99999999988
Q ss_pred HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 264 ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+....+......+....++.++.+|+.+|| .+|++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 888888777665555678899999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=303.57 Aligned_cols=254 Identities=20% Similarity=0.329 Sum_probs=209.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCe----EEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|++.+.||+|+||+||+|.+..++.. +++|.+..... ......+..|+..+..+.|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 35567899999999999999999998777764 66666643221 2223456678888999999999999998754
Q ss_pred CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...++++||+++++|.+++.. .+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+..+
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 457889999999999999976 456899999999999999999999999999999999999999999999999999766
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
...... .......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+.......+.+..+...+....
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 160 YPDDKK---YFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235 (279)
T ss_pred cCCCcc---cccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCC
Confidence 433221 112234467789999999887777 78999999999999998 9999998888777776766555555556
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.++.+++.+|| .+|.+||++.++++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7889999999999 99999999999987
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=308.24 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=212.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeece
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQ 118 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 118 (335)
.+..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+....... ....+..|+.+++.+ +|+||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH--HHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3445789999999999999999998643 23469999987543222 245577899999999 7999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
.+...+..++||||+.+++|.+++...+ .++...++.++.|++.||+|||+.|++|+||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 378889999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
+++.++.++|+|||.+.......... ......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYK---KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhh---ccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999987553221110 01112235689999999887776 78999999999999998 999999988
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+....+......+....++.++.+||.+|| .+|.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88888877776655555678999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=303.46 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=213.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|.+.+.||+|+||.||+|.+... +..||+|.+...... .....+.+|+.++..++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5567899999999999999999987643 378999998644322 224556789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEE
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER----------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKL 192 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~----------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l 192 (335)
.+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999986432 3677889999999999999999999999999999999999999999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~ 271 (335)
+|||++......... .......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||...+.....+.+..
T Consensus 161 ~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 161 GDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 999998765432211 011233457789999999877766 78999999999999998 9999999888888888776
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
....+....++..+.++|.+|| .+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5544455568999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=303.33 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=214.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|.+.+.||.|+||.||+|.+.. +..+|+|++...... ....+..|+.+++.++|+||+++++++...+..+++|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 468999999999999999999876 889999998654321 2445778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 131 EYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999999753 45899999999999999999999999999999999999999999999999998765332111
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
.....++..|+|||......+. .++|+||||+++|+|++ |..||......+....+......+....++..+.+
T Consensus 161 ----~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 161 ----SSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYK 235 (261)
T ss_pred ----ccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHH
Confidence 1122346689999999877776 78999999999999998 89999998888888888877777777789999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhc
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~ 307 (335)
+|.+|| .+|.+|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=303.06 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=209.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+.+.||.|++|.||+|.+..+++.+|||.+.............+.+|+.+++.++|+||+++++.+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46889999999999999999998899999999887644433444567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 131 EYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 131 e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 34589999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHccccCCC-CCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY--SELLKQVQKRVVFPE-SPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~--~~~~~~i~~~~~~~~-~~~~~~ 283 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||.+... ......+......+. ...++.
T Consensus 162 -----~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 162 -----AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred -----ccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence 12234678899999999887776 789999999999999999999976543 333344433222221 235788
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+.++|.+|| .+|.+|||+.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999 99999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=305.98 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=212.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999853 345668888875432 22245678999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~ 187 (335)
+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997542 37889999999999999999999999999999999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL 266 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~ 266 (335)
+.++|+|||++......... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||......+..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred CcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999998755432211 112234467889999999887777 78999999999999998 99999988888888
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+...........++..+.+++.+|| .+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 236 ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 877766555445568899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.97 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=210.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|...+.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.++|+|++++++.+...+..+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999999889999999999765443333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+. +++.+++.. ...+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 478777754 45689999999999999999999999999999999999999999999999998754221
Q ss_pred cccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-CCCCCCCCHHHHH
Q psy10459 212 LSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKA 287 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~ 287 (335)
.....|+..|+|||++. ...++ .++|+||||+++|+|++|..||...+.......+..... ......++..+++
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCccccccccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 12346788999999984 23344 789999999999999999999988776665555543322 1122457889999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
||.+|| .+|.+||++.++++||||+..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999 999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.07 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=214.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+...+|++.+.||+|+||.||+|.+.. .+..||+|++..... ......+.+|+.++..++|+||+++++.+..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 345568899999999999999998754 357899999875432 2335667899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~ 186 (335)
.+..++++||+.+++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||++++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 24788889999999999999999999999999999999999
Q ss_pred CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy10459 187 KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSEL 265 (335)
Q Consensus 187 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~ 265 (335)
++.++|+|||++......... .......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+....+.
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999998765432211 112233457789999999877776 78999999999999998 9999999888888
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+......+....++..+.+|+..|| .+|.+||++.+|++.
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 8888776655555679999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.15 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=205.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++.+.||+|+||.||+|.+.. +++.||+|+++..... .....+..|+.++..+ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3456689999999999999999997533 4578999998653322 2245567899999999 799999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q psy10459 121 ET-THRVYIIMEYAKNGSLLEVIRKE------------------------------------------------------ 145 (335)
Q Consensus 121 ~~-~~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------ 145 (335)
.. +..++++|||+++++|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 45788999999999999988542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccccc
Q psy10459 146 -------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218 (335)
Q Consensus 146 -------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g 218 (335)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....... ......+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---hccCCCC
Confidence 257889999999999999999999999999999999999999999999999998664322111 1122345
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHccccCCCCCCCCHHHHHHHHHhc-CC
Q psy10459 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SP 295 (335)
Q Consensus 219 ~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~ 295 (335)
+..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+ ....+...........++.++.+++.+|| .+
T Consensus 238 ~~~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 238 PLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred CccccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCC
Confidence 6789999999888877 78999999999999997 999998755433 33444444433334567899999999999 99
Q ss_pred CCCCCCHHHHhcC
Q psy10459 296 VKFRIQMEDIRQD 308 (335)
Q Consensus 296 p~~Rps~~~ll~h 308 (335)
|.+||+++++++|
T Consensus 317 p~~RPs~~ell~~ 329 (337)
T cd05054 317 PEDRPTFSELVEI 329 (337)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.25 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=215.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+..++|...+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.++..++|+||+++.+++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 455679999999999999999999876654 689998865432 222556778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..+++|||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999999764 5689999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
...... .......+..|+|||.+....++ .++|+|||||++|+|++ |..||......+....+......+....++
T Consensus 160 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 236 (268)
T cd05063 160 DPEGTY--TTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236 (268)
T ss_pred ccccce--eccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 221110 01112234579999999877766 78999999999999997 999999888888888888776666666789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.++.+++.+|| .+|.+||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=317.53 Aligned_cols=257 Identities=22% Similarity=0.355 Sum_probs=209.8
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeece
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQ 118 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~ 118 (335)
...+..++|.+++.||+|+||.||+|.+... +..||+|++..... ....+.+.+|+.++..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445677899999999999999999986432 34699999865432 223566789999999996 999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKE----------------------------------------------------- 145 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------------------------------------------- 145 (335)
++...+..|+||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 146 -------------------------------------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 146 -------------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
..+++..+..++.|++.||.|||+.+++|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367788899999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
|++.++.++|+|||++..+...... .......++..|+|||.+.+..++ .++|||||||++|+|++ |..||....
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999998765432211 112233467789999999887777 78999999999999997 999998765
Q ss_pred HH-HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 262 YS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 262 ~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.. .....+......+....++.++.++|.+|| .+|++||++.+|.+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 345 VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 43 344555555555555678999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=322.32 Aligned_cols=255 Identities=24% Similarity=0.473 Sum_probs=219.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC-ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe--EEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA-PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYII 129 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~iv 129 (335)
.+...+||+|+|-+||+|.|..+|..||.-.++.... ......++|..|+.+|+.|+|+||++++..|.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3456799999999999999999999998665543221 122236789999999999999999999999987654 7889
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEeecCC-CCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK--SVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~ 206 (335)
+|.+..|+|..|+++.+.++...++.|+.||++||.|||++ .|+|||||-+||||+.+ |.+||+|+|+|......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 99999999999999999999999999999999999999998 59999999999999864 78999999999876432
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHccccCCCCCCC-CHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQKRVVFPESPRL-SSS 284 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~-~~~ 284 (335)
......||+.|||||+.. ..|. ...||||||++++||+|+..||. ..++.++++++..+........+ .++
T Consensus 200 -----~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe 272 (632)
T KOG0584|consen 200 -----HAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE 272 (632)
T ss_pred -----ccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence 234468999999999998 5677 88999999999999999999995 67899999999998766554444 589
Q ss_pred HHHHHHHhcCCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 285 CKALISNILSPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 285 l~~li~~~L~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+++||.+||...++|+|+.|+|.||||.....
T Consensus 273 vr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 273 VREFIEKCLATKSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred HHHHHHHHhcCchhccCHHHHhhChhhccccc
Confidence 99999999933999999999999999998744
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=308.16 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=208.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 124 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++..... +.....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456799999999999999999999989999999999754321 112345668999999999999999999886654
Q ss_pred ------eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 125 ------RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 125 ------~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
.+++++||+++ ++..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999976 777777654 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP- 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~- 276 (335)
+..+...... ......++..|+|||.+.+....+.++|+|||||++|+|++|+.||...+.......+......+
T Consensus 163 ~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 163 ARLYNSEESR----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccCCccc----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 8766433211 11122457789999988654433478999999999999999999998877666555544321110
Q ss_pred ----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 277 ----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 277 ----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
....++..+.++|..|| .+|.+||++++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11247899999999999 999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=306.33 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=211.4
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC--CC----Ceeeec
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HP----NLIRFL 117 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~~~ 117 (335)
...+....+|.+++.+|+|.||.|..+.+..++..||||+++.. +.+.+...-|+++|.++. .| -++.+.
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 34556688999999999999999999999999999999999764 444666778999999993 22 378888
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---------
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--------- 186 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--------- 186 (335)
++|+..+..|||+|.+ |.|+.+++..++ +++..++..+++|+++++.+||+.+++|.||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999999 779999998764 5889999999999999999999999999999999999942
Q ss_pred -----------CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy10459 187 -----------KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRL 255 (335)
Q Consensus 187 -----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~ 255 (335)
+..++++|||.++..... ....+.|..|+|||++.+-+++ .++||||+|||++|+.+|..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGET 307 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccce
Confidence 345899999998754322 2455679999999999999999 88999999999999999999
Q ss_pred CCCCCCHHHHHHHHHccc----------------------cCCCC-----------------------CCCCHHHHHHHH
Q psy10459 256 PFDDTNYSELLKQVQKRV----------------------VFPES-----------------------PRLSSSCKALIS 290 (335)
Q Consensus 256 p~~~~~~~~~~~~i~~~~----------------------~~~~~-----------------------~~~~~~l~~li~ 290 (335)
.|...+..+....+...+ .+++. ..--..+.+||+
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 998766544333332111 11110 001236889999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+|| .||.+|+|+.|+|+||||+...
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcCC
Confidence 999 9999999999999999998643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.28 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=208.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 123 (335)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++...... +.....+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 45899999999999999999999889999999998654322 22234567899999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..+++++||+.. +|..+. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 346899999964 777665 33589999999999999999999999999999999999999999999999999865422
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-------- 275 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------- 275 (335)
. .....++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+.......+......
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 170 E--------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred C--------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 1 123456888999999876443347899999999999999999999987765554443321110
Q ss_pred ----------------CC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 276 ----------------PE------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 276 ----------------~~------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+. .+..+.++.+||.+|| .||.+||++.+++.||||+.......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 00 1346788999999999 99999999999999999999865443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.79 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=227.1
Q ss_pred cchhhhhhccccccCCeEEeeeecccCceEEEEEEEcCCCC---e-EEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC
Q psy10459 37 QDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ---D-VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112 (335)
Q Consensus 37 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 112 (335)
...+.....+.+..++-.+.++||+|+||.||+|.....+. . ||+|...............+.+|++++++++|||
T Consensus 143 L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 143 LKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred ecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence 34455566677888888899999999999999998765422 3 8999887544334455777889999999999999
Q ss_pred eeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 113 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
||+++|+...+..+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+|
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999999998876 499999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQV- 269 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i- 269 (335)
|+|||++..-. .+.... ....-...|+|||.+....++ .++||||||+++||+++ |..||.+....++...+
T Consensus 303 ISDFGLs~~~~----~~~~~~-~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~ 376 (474)
T KOG0194|consen 303 ISDFGLSRAGS----QYVMKK-FLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV 376 (474)
T ss_pred eCccccccCCc----ceeecc-ccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence 99999986432 111100 011235689999999998777 89999999999999998 89999999999999999
Q ss_pred HccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 270 QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..++..+.....|.++..++.+|+ .+|++||++.++.+
T Consensus 377 ~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 377 KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 668888888889999999999999 99999999998864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.26 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=211.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 124 (335)
..++|.+.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++|+||+++++.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35679999999999999999999999999999999864322 2233456778999999999999999999886543
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+++||+++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 458999999 7799888864 468999999999999999999999999999999999999999999999999987543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------- 274 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-------- 274 (335)
.. .....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 170 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 170 SE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 21 12335688899999987644344789999999999999999999987765444333221100
Q ss_pred -------------CC---------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 275 -------------FP---------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 275 -------------~~---------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+ ....++.++.++|.+|| .||.+|||+.+++.||||+....+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 00 11357888999999999 99999999999999999998755433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=298.22 Aligned_cols=250 Identities=23% Similarity=0.419 Sum_probs=215.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|.+.+.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.+++.++|+||+++++.+......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56788999999999999999999965 5678999998754332 345778999999999999999999999888999
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+++++|.+++... ..++...+..++.+++.||.|||+.|++|+||+|+||++++++.++|+|||.+..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999999764 358999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||.+.+...+ .++|+||||+++|+|++ |+.||.+.........+......+.....+.+
T Consensus 158 ~~----~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 158 YT----AREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232 (261)
T ss_pred hh----hhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 01112235679999999877766 78999999999999998 99999998888888888877766666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+++.+|| .+|.+||+++++++
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.66 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=212.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++|+||+++++.+. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 4567899999999999999999985 46788999998754433 345678999999999999999998864 45789
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 358899999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||.+....++ .++|+||||+++|+|++ |..||.+.+..+....+......+....++.+
T Consensus 157 ~~----~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05067 157 YT----AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231 (260)
T ss_pred cc----cccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 11223356789999999877776 78999999999999998 99999998888888888777666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.++|.+|| .+|++||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.28 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=210.6
Q ss_pred CeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
+|++.+.||+|+||.||+|.+.. ....+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998743 2356888888654332 2245677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 127 YIIMEYAKNGSLLEVIRKE------------------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2367889999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
++++++.++|+|||++........... .....++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVK---RSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhc---ccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999876533221110 1223446789999998877766 78999999999999998 999999998
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+.+.+......+....++.++.+++.+|| .+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 88888888777666666678999999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=297.29 Aligned_cols=245 Identities=24% Similarity=0.466 Sum_probs=213.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999985 478999999875432 2556778999999999999999999999889999
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 68999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
. ...++..|+|||.+....+. .++|+||||+++|+|++ |..||......+....+...........++..
T Consensus 157 ~--------~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05039 157 D--------SGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227 (256)
T ss_pred c--------cCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHH
Confidence 1 12235679999999877766 78999999999999997 99999999888888777776555455678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.++|.+|| .+|.+||++++++.
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.67 Aligned_cols=251 Identities=18% Similarity=0.328 Sum_probs=208.7
Q ss_pred eEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe----
Q psy10459 53 YSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 125 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 125 (335)
|.+++.||+|+||.||+|....+ +..||+|.+........ ....+.+|+..++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56889999999999999987653 37899999876443322 24567799999999999999999998765443
Q ss_pred --EEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 126 --VYIIMEYAKNGSLLEVIRKE------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 126 --~~iv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988442 2588999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 276 (335)
+........... .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+..+.+......+
T Consensus 160 ~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 160 SKKIYSGDYYRQ---GRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred eeeccccccccc---cccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 876543322111 1112345679999999877776 78999999999999999 999999988888888887765555
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
....++..+.+++.+|| .||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=308.48 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=206.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------ 123 (335)
.++|.+.+.||.|+||.||+|.+..+++.||+|++........ ....+.+|+++++.++|+||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999999999999999999999999865432211 123456899999999999999999877443
Q ss_pred --CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 124 --HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 124 --~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
..++++++|+.+ +|...+.. ...+++..+..++.|+++||.|||+.|++|+||+|+||++++++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999965 77777654 45699999999999999999999999999999999999999999999999999976
Q ss_pred cccCCcccc------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 201 YSVNNTDYK------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 201 ~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
......... ........++..|+|||.+.+....+.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 543222111 01112345688899999886654334789999999999999999999988777665555433111
Q ss_pred CC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 FP-----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 ~~-----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+ ....++.++.++|.+|| .+|.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 00234578999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.65 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=210.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++|+|++++++.+. .+..+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 44568999999999999999999865 5667999998764433 345778999999999999999998875 45678
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+.+++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||++++++.++|+|||.+..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999753 358999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.....+..
T Consensus 157 ~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05070 157 YT----ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231 (260)
T ss_pred cc----cccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 11 11122345679999998877766 78999999999999999 99999998888888888776666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+|+.+|| .+|.+|||+.++++
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 99999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.00 Aligned_cols=244 Identities=24% Similarity=0.440 Sum_probs=208.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE-eCCeE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHRV 126 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 126 (335)
+...+|.+.+.||+|+||.||++.. .|..||+|.++.... .+.+.+|+.+++.++|+|++++++.+. ..+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4567899999999999999999975 478899999864322 445778999999999999999998754 45678
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+++|||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997643 3789999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
. ....++..|+|||++.+..++ .++|+|||||++|+|++ |..||......+....+...........++.
T Consensus 156 ~--------~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05082 156 Q--------DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226 (256)
T ss_pred C--------CCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 1 122345679999999887776 78999999999999997 9999998888888888877665555567899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+.++|.+|| .+|++|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.13 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=214.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|+|++++++++...+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34889999999999999999998899999999987654443344556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+.| +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 77777754 45689999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC-CCCCCCCHHH
Q psy10459 210 QNLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-PESPRLSSSC 285 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l 285 (335)
.....|+..|+|||.+. ...++ .++|+||||+++|+|++|..||...........+...... .....++..+
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHH
Confidence 12335788899999974 23344 7899999999999999999999887776666666554332 2334678899
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.++|.+|| .+|.+||++.++++|+|+.....
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 99999999 99999999999999999976544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=305.80 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~i 128 (335)
.++|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 34677888999999999999999999999999998754333 23556778999999996 9999999999998889999
Q ss_pred EEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 129 IMEYAKNGSLLEVIR-----KERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 129 v~e~~~~~sL~~~l~-----~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+|||+.. ++.++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 6655432 235689999999999999999999975 99999999999999999999999999987553
Q ss_pred cCCcccccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccc--cC-
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRV--VF- 275 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~--~~- 275 (335)
.... .....|+..|+|||++.+. .++ .++|+||||+++|+|++|..||..... .+....+.... ..
T Consensus 160 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 160 DSIA------KTRDAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred cCCc------cccccCccCccCHHHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 3211 1223578889999998776 344 789999999999999999999976542 11112221111 11
Q ss_pred -CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 276 -PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 276 -~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.....++.++.+||.+|| .+|.+|||+++|+.||||++.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 111348899999999999 999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.42 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=212.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+...+|...++||+|+||.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34567899999999999999999742 346688999876432 2335678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER---------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~ 187 (335)
.+..+++|||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997643 37889999999999999999999999999999999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL 266 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~ 266 (335)
+.++|+|||++......... .......++..|+|||.+.+..++ .++|+|||||++|+|++ |..||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 99999999998755322111 011222346789999999887777 78999999999999998 99999888888877
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+...........++..+.++|.+|| .||.+||++++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 777776555555678999999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.40 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=214.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-------CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeece
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSA-------RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQ 118 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 118 (335)
.+..++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.+++.+ +|+||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 466788999999999999999999752 2345799998864322 22245677999999999 7999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
.+...+..+++|||+.+++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999753 2367788999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
+++.++.++|+|||.+.......... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYK---KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccc---cccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999997664322111 11122346789999999887777 78999999999999998 899999999
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+..+.+...........++.++.+||.+|| .+|.+||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88888888776655555678999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=289.52 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=210.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv 129 (335)
++...+..||.|+.|+|+++....+|...|||.+.+.....+ .+++...+.++... .+|+||+.+|+|..+..++|.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 345667899999999999999999999999999987655433 55566677766655 499999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||.|. ..+..++++ .++++|..+-++...++.||.||-. +||+|||+||+|||+|+.|++||||||++-.+..+...
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 99994 477777755 4679999999999999999999975 49999999999999999999999999999776543322
Q ss_pred cccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcccc--CCCCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVV--FPESPRL 281 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~~~~--~~~~~~~ 281 (335)
....|-+.|||||.+... .|. .++||||||++++||.||..||.+.+ ..++.-++..... .+...++
T Consensus 249 ------trsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 249 ------TRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred ------ccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 223577889999998643 445 78999999999999999999999854 3455555554332 2233459
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
|+.+.+|+..|| +|+.+||.+.++|+|||+..+..
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 999999999999 99999999999999999987643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.67 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=209.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++|+||+++++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 3578999999999999999999998899999999986533222 2244566899999999999999999887543
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..+++++++ +++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3467888887 77998888654 58999999999999999999999999999999999999999999999999987543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------- 274 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-------- 274 (335)
.. .....++..|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+.....
T Consensus 172 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 172 DE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cc--------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 21 12345788999999987643333789999999999999999999987765554443322111
Q ss_pred ----------------CCC------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 275 ----------------FPE------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 275 ----------------~~~------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+. ....+.++.+||.+|| .||.+||++.++++||||++...+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence 000 1135788999999999 99999999999999999998655543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=330.21 Aligned_cols=150 Identities=25% Similarity=0.503 Sum_probs=138.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.++++||+|+||+||+|.+..+++.||||++.............+..|+.++..++|+||+++++.+...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999765544444567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
|||+.|++|.+++...+.+++..++.++.||+.||.|||..||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=300.68 Aligned_cols=254 Identities=18% Similarity=0.328 Sum_probs=213.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET- 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 122 (335)
+..++|.+.+.||+|+||.||+|.+.. ++..|++|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS--EIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 567789999999999999999999865 357899998864322 2235667789999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEec
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE--------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~D 194 (335)
+...+++++|+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999998653 3488999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccc
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRV 273 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~ 273 (335)
||+++.+....... ......++..|+|||.+.+..++ .++||||||+++|++++ |..||...+..+....+....
T Consensus 161 ~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 161 NALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred CCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 99997654322111 11122356679999999887776 78999999999999998 999999988888888777776
Q ss_pred cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 274 VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+....++.++.+++.+|| .+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66655678999999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=299.80 Aligned_cols=251 Identities=22% Similarity=0.384 Sum_probs=207.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC------C
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------H 124 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~ 124 (335)
|.+.+.||+|+||.||+|.+..++. .||+|.++..... ......+..|+.+++.++|+||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3577899999999999999877665 6899988654332 23356677899999999999999999876431 2
Q ss_pred eEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK------ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
..+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 46899999999999988742 234789999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
.......... ......++..|+|||...+..++ .++|+|||||++|+|++ |..||.+.......+.+......+.
T Consensus 160 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 160 KKIYNGDYYR---QGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred cccCccccee---cCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 7664322110 11222356789999999887777 78999999999999999 8999998888888888877665555
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...++..+.++|.+|| .+|.+|||+.+|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6678999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.30 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=208.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|++.+.||+|++|.||+|.+..+ ..+|+|.+...... ...+.+|+.+++.++|+|++++++.+. .+..++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 446799999999999999999987544 46999987653322 345678999999999999999998875 456789
Q ss_pred EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 129 IMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999764 3478999999999999999999999999999999999999999999999999876533221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
. ......++..|+|||...+...+ .++|+||||+++|+|++ |..||.+....+....+......+....++..+
T Consensus 158 ~----~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05069 158 T----ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232 (260)
T ss_pred c----ccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 1 11122356789999998877766 78999999999999999 999999988888887777766555556789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+++++|| .+|.+||+++++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=303.93 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=210.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|.+.+.||+|+||.||++.+. .++..||+|+++.... ......+.+|+.+++.+ +|+||+++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4466778999999999999999999752 3455899998865433 22356678999999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
+...+..+++|||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHccccC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVF 275 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~-~~i~~~~~~ 275 (335)
+..+....... ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||......+.. ..+......
T Consensus 188 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 188 ARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred cccccCCCcee---ecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 87654322110 11223456789999999887777 78999999999999998 99999877655444 333444444
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.....+..+.+++.+|| .+|++||++.++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 444567899999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=296.46 Aligned_cols=244 Identities=21% Similarity=0.391 Sum_probs=203.8
Q ss_pred eecccCceEEEEEEEc--CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 58 VVGMGSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
.||+|+||.||+|.+. ..+..||+|++..... ....+.+.+|+.+++.++|+||+++++.+. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999764 3455799999865432 333566889999999999999999999875 4578999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 136 GSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 136 ~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+........ ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~ 156 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARS 156 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee--ccC
Confidence 999999875 45689999999999999999999999999999999999999999999999999876543322111 111
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L 293 (335)
...++..|+|||.+....++ .++|+||||+++|+|++ |..||......+....+..+...+....++.++.++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence 12235689999998877766 78999999999999996 99999998888888888776665555678999999999999
Q ss_pred -CCCCCCCCHHHHhc
Q psy10459 294 -SPVKFRIQMEDIRQ 307 (335)
Q Consensus 294 -~~p~~Rps~~~ll~ 307 (335)
.+|++||++.+|++
T Consensus 236 ~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 236 IYKWEDRPNFAKVEE 250 (257)
T ss_pred CCChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=312.10 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=204.6
Q ss_pred eeeccc--CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMG--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
..||.| +||+||++.+..+|+.||+|++....... ...+.+.+|+.+++.++|+||+++++++..++..++++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987654433 335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc--c
Q psy10459 135 NGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK--Q 210 (335)
Q Consensus 135 ~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~--~ 210 (335)
+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++||+.+........... .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998764 3489999999999999999999999999999999999999999999999986543322111100 0
Q ss_pred ccccccccccccccccccCCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------- 273 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--------------- 273 (335)
.......++..|+|||++.+.. ++ .++|+|||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0011123456799999987642 44 78999999999999999999998766544433322110
Q ss_pred -------------------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 274 -------------------------------VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 274 -------------------------------~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
..+....++..+.+||++|| .||++|||++++|+||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112235678999999999 999999999999999999886654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=301.18 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=206.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEEeCCe----
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETTHR---- 125 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~---- 125 (335)
|++.+.||.|+||.||+|.+..+++.||+|++...... +.....+.+|+.+++.+ +|+|++++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 67899999999999999999888999999999754332 22234455677776655 69999999999988776
Q ss_pred -EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 126 -VYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 126 -~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+++|||+.+ +|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+..+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8998887643 48999999999999999999999999999999999999999999999999987664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----- 277 (335)
.... .....++..|+|||.+.+..++ .++|+|||||++|+|++|..||.+....+....+......+.
T Consensus 159 ~~~~------~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 159 FEMA------LTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CCcc------cccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 3221 1123468889999999887776 789999999999999999999998887776666644221110
Q ss_pred ---------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 ---------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 ---------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+.++..+.++|++|| .||.+||+++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0235678899999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=299.41 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=215.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|++.+.||+|+||.||+|.+..+|. .+|+|+...... ......+.+|+.++..++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3566789999999999999999999876665 589998765443 2335567789999999999999999999877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999999764 46899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
........ .....++..|+|||.+....++ .++|+||||+++|++++ |..||.+....++.+.+......+....
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 160 DVDEKEYH---AEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235 (279)
T ss_pred cCccccee---cCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 53322111 1112235679999998877776 78999999999999998 9999999998888888887766666667
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+..+.+++.+|| .+|..||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 8899999999999 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=305.07 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=211.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeece
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQ 118 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 118 (335)
.+..++|.+.+.||+|+||.||+|.+.. .+..||+|.+...... .....+.+|+.+++.+ .|+||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456789999999999999999997532 3457999988754332 2245577899999999 6999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
++...+..+++|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999889999999999999999999653 2478889999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
+++.++.++|+|||.+.......... ......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+..
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK---KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc---ccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999997654221110 01112234579999999887776 78999999999999998 999999988
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+....+...........++.++.++|.+|| .+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 88888887776544444568899999999999 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=302.31 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=211.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.++..+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345689999999999999999998743 578899999865332 2335668889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER----------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCE 180 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~ 180 (335)
.+..++++||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 899999999999999999997432 3678889999999999999999999999999999
Q ss_pred CEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy10459 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDD 259 (335)
Q Consensus 181 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~ 259 (335)
||+++.++.++|+|||.+......... ........+..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998754322110 001112335679999998877777 78999999999999997 8899998
Q ss_pred CCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 260 TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 260 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....+....+......+....++.++.+||.+|| .+|.+||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8888888777766555545568899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.80 Aligned_cols=252 Identities=28% Similarity=0.483 Sum_probs=209.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|+..+.||+|++|.||+|....+++.||+|++...... +.....+..|+.+++.++|+|++++++.+...+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 67789999999999999999989999999999765322 22245566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+. ++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 97 5999999876 57999999999999999999999999999999999999999999999999998765432221
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-----------------
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV----------------- 274 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~----------------- 274 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12234567899999987763334789999999999999999999988776655544432111
Q ss_pred --CCC---------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 275 --FPE---------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 275 --~~~---------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++. .+.++..+.++|++|| .+|++||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111 1235788999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.64 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=209.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC--hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
+|.+.+.||+|+||.||++.+...+..+++|+++..... .......+..|+.+++.++||||+++++.+...+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999998877777777776543221 111133455789999999999999999999988899999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 130 MEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 346899999999999999999999999999999999999975 569999999987654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
. ......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+...........++.++
T Consensus 160 ~-----~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd08222 160 D-----LATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233 (260)
T ss_pred c-----cccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHH
Confidence 1 12234578889999998777766 68999999999999999999998877776666665543333334688999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.++|.+|| .+|.+||+++++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=302.83 Aligned_cols=254 Identities=20% Similarity=0.355 Sum_probs=209.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCC----------------CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHS----------------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 111 (335)
+...+|++++.||+|+||.||+|.+...+ ..||+|.+...... .....+.+|+.++..++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence 34568999999999999999999876533 46899998754332 3356778999999999999
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-----------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCE 180 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~ 180 (335)
||+++++++..++..+++||++.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999899999999999999999997765 6899999999999999999999999999999999
Q ss_pred CEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q psy10459 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFD 258 (335)
Q Consensus 181 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~p~~ 258 (335)
||+++.++.++|+|||.+......... .......++..|+|||.+.+..++ .++|||||||++|+|++ +..||.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred ceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999998765332211 112233457789999998876666 78999999999999998 788998
Q ss_pred CCCHHHHHHHHHcc-------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 259 DTNYSELLKQVQKR-------VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 259 ~~~~~~~~~~i~~~-------~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.....+.+...... ...+....++.++.++|.+|| .||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 87777766665432 112233457899999999999 99999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=300.48 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=205.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEEe
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e 131 (335)
|.+.+.||.|++|+||+|.+..+++.||+|.+.......+ .....+|+..++.++ |+|++++++.+..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6789999999999999999988899999999865433222 223447899999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|+ +++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 779999887654 689999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------ 277 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------ 277 (335)
.....++..|+|||++......+.++|+||||+++++|++|..||......+....+......+.
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 12235688899999886554444789999999999999999999987766555443332111100
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 -----------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 -----------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
.+..+.++.++|++|| .+|++||+++|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1123688999999999 999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=304.49 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=210.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-CCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 127 (335)
..++|.+.+.||.|+||.||+|.+..+++.||+|.+...... ......+..|+.+++.++||||+++++++.. .+..+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 567899999999999999999999999999999988653322 2224556789999999999999999998865 56789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+++||+ +++|..++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+......
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 5689888864 45788899999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--------------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-------------- 273 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-------------- 273 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.+..
T Consensus 162 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 -----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred -----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 1223567889999998664333488999999999999999999998766533322221100
Q ss_pred -------------cCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 274 -------------VFP---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 274 -------------~~~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
..+ ..+.++..+.++|++|| .+|++||++++++.||||.....+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~ 299 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence 001 11347889999999999 99999999999999999988776644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=326.47 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=224.2
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeece
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 118 (335)
....+...+....+.||+|+||.||+|.-.. ....||||.++.... ...+++|++|++++..++|||||+++|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3344666778889999999999999997532 345799999876544 334889999999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER--------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili 184 (335)
+|...+.+|+|+|||..|+|.+|+.... +++..+.+.|+.||+.|++||-+..+|||||-..|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999996421 27889999999999999999999999999999999999
Q ss_pred cCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy10459 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS 263 (335)
Q Consensus 185 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~ 263 (335)
.++..|||+|||+++....... -. ....-.-..+|||||.+..+.++ .+|||||+|+++||+++ |..||.+...+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDY--Yk-~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDY--YK-VRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred ccceEEEecccccchhhhhhhh--hc-ccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999999999987654322 11 11122346799999999999999 68999999999999998 99999999999
Q ss_pred HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy10459 264 ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll 306 (335)
++++.+..+-..+.+..+|.++..|+..|| ..|.+||++.||-
T Consensus 713 EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 713 EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999998888888899999999999999 9999999999984
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=304.16 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=212.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
...|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++.++|+|++++++++...+..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999999989999999998754333333345667899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+. +++.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 99996 588777754 456899999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSS 284 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 284 (335)
....++..|+|||.+.+ ...+ .++|||||||++|+|++|..||...+.......+....... ....++..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence 23357889999999752 2344 78999999999999999999998877665555554433222 23468899
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+.+||++|| .+|.+||++++++.|||+.+..-
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999 99999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=293.87 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=212.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|.+.+.||.|+||.||+|.+. ++..+|+|.+...... ...+.+|+++++.++|+|++++++.+......++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3457999999999999999999875 4678999988654332 3356789999999999999999999999899999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+|||+.+++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998764 45899999999999999999999999999999999999999999999999998765332111
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.........+.+............+..+.
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 01122345689999999877766 78999999999999998 9999998888888888877655544456789999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+|+.+|| .+|.+||++.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 9999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=307.06 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=214.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCC-------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeec
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARH-------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 117 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 117 (335)
..+...+|.+++.||+|+||.||+|.+... +..||+|++..... +.....+.+|+.+++++ +|+||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 345566899999999999999999986432 23689998864322 22355677899999999 799999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+.+...+..++++||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999997532 36778889999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
|+++.++.++|+|||+++......... ......++..|+|||++.+..++ .++|+||||+++|+|++ |..||.+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYK---KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccc---cccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999987654321110 11122335679999999887777 78999999999999998 89999999
Q ss_pred CHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 261 NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
+..+....+......+....++.++.++|.+|| .+|.+||++.+++.+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 888888888776655555678899999999999 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=301.48 Aligned_cols=259 Identities=25% Similarity=0.491 Sum_probs=210.9
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (335)
+|++.+.||.|+||.||+|.+. .+|+.||+|++...... .......+.+|+.++..+ +|+||+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47899999998753221 112245567899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHccccCCCCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~ 281 (335)
. ......|+..|+|||.+.... ..+.++|+||||+++|+|++|..||..... ......+... ..+....+
T Consensus 161 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (290)
T cd05613 161 E----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEM 235 (290)
T ss_pred c----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCccC
Confidence 1 122346788999999987532 223789999999999999999999974332 2333332222 22233458
Q ss_pred CHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKEDS 315 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~ 315 (335)
+..+.+++++|| .+|.+|| ++++++.||||++..
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 899999999999 9999997 899999999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.31 Aligned_cols=266 Identities=25% Similarity=0.412 Sum_probs=208.2
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEe
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 122 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 122 (335)
.+-.+....|+++++||.||.+.||++... +...||+|.+...... +....-+.+|+..|.+|+ |.+|+.++++-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 444566778999999999999999999953 4456777766544333 233566779999999995 8999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
++.+|+||||-+. +|..+++.... .+.-.++.+..||+.|+.++|..||||.||||.|+|+..+ .+||+|||+|...
T Consensus 432 d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG-RLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee-eEEeeeechhccc
Confidence 9999999999964 99999987654 3435888999999999999999999999999999999764 7999999999887
Q ss_pred ccCCcccccccccccccccccccccccCCCCC----------CCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPY----------TPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQ 270 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~----------~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~ 270 (335)
..+..... ....+||..||+||.+..... ...++|||||||++|+|+.|+.||.... ...-+..|.
T Consensus 510 ~~DTTsI~---kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 510 QPDTTSIV---KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred Ccccccee---eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 66554432 345689999999998742211 1368999999999999999999997543 222222332
Q ss_pred c---cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 271 K---RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 271 ~---~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
. .+.+|..+.. .++.++++.|| .||.+||++.++|+|||++-+-.+
T Consensus 587 ~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 587 DPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred CCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 2 1233333222 34999999999 999999999999999999774433
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.07 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=209.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|.+.+.||.|++|.||+|.+..+|+.+++|.+....... .....+.+|+.+++.++|+||+++++.+..++..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677899999999999999998899999999987644331 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+.+ +|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~---- 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---- 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc----
Confidence 975 88888766 357899999999999999999999999999999999999999999999999998766543211
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC---------------
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------- 276 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 276 (335)
.....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 155 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 -YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred -ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 1223467889999998876334488999999999999999999998877666554443221111
Q ss_pred --------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 277 --------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 277 --------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+.++.++.++|.+|| .||.+||++++++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01246789999999999 999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=294.39 Aligned_cols=245 Identities=25% Similarity=0.422 Sum_probs=206.1
Q ss_pred eeecccCceEEEEEEEcC-CCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSAR-HSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
+.||+|++|.||+|.+.. .++ .||+|.+...... ...+.+.+|+.+++.++|+||+++++.+.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6899998765543 446678899999999999999999999888 8899999999
Q ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 134 KNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 134 ~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......+..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~- 156 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM- 156 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec-
Confidence 9999999997654 6899999999999999999999999999999999999999999999999999876543322111
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc-cccCCCCCCCCHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALI 289 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li 289 (335)
.....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||......+....+.. ....+....++..+.+++
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 157 -EEHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred -ccCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 1234467789999999877777 78999999999999998 9999988888777776664 233333446789999999
Q ss_pred HHhc-CCCCCCCCHHHHhc
Q psy10459 290 SNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~ 307 (335)
.+|| .+|.+||++.++++
T Consensus 235 ~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 235 LQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHCCCCcccCCCHHHHHH
Confidence 9999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=301.90 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=206.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC--------------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARH--------------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 113 (335)
+..++|++.+.||+|+||.||+|.+... ...||+|.++.... ......+.+|++++..++|+|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 3456899999999999999999986542 23589999875432 2335668899999999999999
Q ss_pred eeeceeEEeCCeEEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 114 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+++++++...+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999986432 36788899999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDD 259 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~p~~~ 259 (335)
|+++.++.++|+|||++..+...... .......++..|+|||+..+..++ .++|+||||+++|+|++ +..||..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999998765432211 111223456789999998877776 78999999999999988 7789988
Q ss_pred CCHHHHHHHHHcc-------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 260 TNYSELLKQVQKR-------VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 260 ~~~~~~~~~i~~~-------~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....+....+... ......+.++..+.+||.+|| .+|.+||++++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7777666554321 112223457899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=293.96 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=213.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCC----CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
+.+.+.||.|+||.||+|.+...+ ..||+|++....... ....+..|+.++..++|+||+++++.+...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357789999999999999998766 899999996543321 35677899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 129 IMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+|||+++++|.+++..... +++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999876654321
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
.. .....++..|+|||.+.+..++ .++|+||||+++++|++ |..||...+.....+.+......+....++.++
T Consensus 159 ~~----~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T smart00219 159 YK----KKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI 233 (258)
T ss_pred cc----cccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence 11 1112257889999999766666 78999999999999998 899999988888888888776666666789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+++.+|| .+|++|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999 99999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=297.75 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=198.3
Q ss_pred eEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeE
Q psy10459 53 YSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRV 126 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (335)
|.+.+.||+|+||+||++. ...++..||+|++..... +.....+.+|+.+++.++|+||+++++++.. ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4899999999999998764 345678999999875432 2234567789999999999999999998765 3468
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+++|||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999999765 489999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHc
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------------ELLKQVQK 271 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---------------~~~~~i~~ 271 (335)
.. .......++..|+|||.+.+..++ .++||||||+++|+|++|..||...... ...+.+..
T Consensus 163 ~~--~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 163 YY--RVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred hh--ccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 11 111222356679999999877776 7899999999999999999998643211 11112222
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....+....++..+.+++.+|| .+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2233334567899999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=346.17 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=221.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
++.-...||.|.||.||-|.+..+|+..|+|-+...... ......+.+|..++..++|||+|+++++-.+.+..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 567778999999999999999999999999988755443 4445667799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
||.+|+|.+++..++-.++.....+..|++.|+.|||+.|||||||||.||+++.+|-+|++|||.+..+........ .
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~-~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP-G 1393 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC-H
Confidence 999999999999888788888888899999999999999999999999999999999999999999988765432222 2
Q ss_pred cccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-CCCCCHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSCKA 287 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~l~~ 287 (335)
-.....||+.|||||++.+.. .. .++|||||||++.||+||+.||...+.+-.+..-......|. +..++++-++
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~-~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHG-GAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCC-cchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 223568999999999996543 33 689999999999999999999988776665555544443333 3469999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
||..|| .||+.|.++.|||+|-|=+..
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999 999999999999999976543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=299.65 Aligned_cols=255 Identities=20% Similarity=0.378 Sum_probs=205.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEE----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATS----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 123 (335)
+..-|.+++.||+|+||.||+|.. ..++..||+|.+..... ......+.+|+.+++.+.|+||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 445689999999999999999974 45688999999865432 22345688999999999999999999988765
Q ss_pred -CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...+++|||++|++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 5789999999999999999764 35899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHH
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------------NYSELL 266 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---------------~~~~~~ 266 (335)
....... .......++..|+|||.+.+..++ .++|+||||+++|+|+++..|+... ......
T Consensus 160 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 160 ETDKEYY--TVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccCccce--eecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 4332211 112234567789999999877776 7899999999999999977664321 112223
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+......+....++..+.+||.+|| .+|.+||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 333344444555678999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.42 Aligned_cols=256 Identities=20% Similarity=0.360 Sum_probs=204.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEE-----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++.+.||+|+||.||+|.+ ..+++.||||+++..... .....+.+|+.++..+ +|+||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 35567899999999999999999985 346789999999754322 2245677899999999 689999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q psy10459 121 ET-THRVYIIMEYAKNGSLLEVIRKE------------------------------------------------------ 145 (335)
Q Consensus 121 ~~-~~~~~iv~e~~~~~sL~~~l~~~------------------------------------------------------ 145 (335)
.. ....+++|||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 45678999999999999998642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 146 -------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 146 -------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
..++...+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---R 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh---h
Confidence 125777888999999999999999999999999999999999999999999987653222111 1
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...... .....+..+...+....+++++.+++.
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 316 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 1122346679999999887777 78999999999999997 99999875533 344444444444444457889999999
Q ss_pred Hhc-CCCCCCCCHHHHhcC
Q psy10459 291 NIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~h 308 (335)
.|| .+|.+||++.+|++|
T Consensus 317 ~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 999 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.05 Aligned_cols=244 Identities=22% Similarity=0.388 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+.||+|+||.||+|.. .++..+|+|++..... ......+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4789999999999985 4688999999865432 223446778999999999999999999999999999999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 137 SLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 137 sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
+|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~~~ 153 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS----SSGL 153 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc----cCCC
Confidence 999998654 45789999999999999999999999999999999999999999999999998654321111 0111
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 293 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L- 293 (335)
..++..|+|||++.+..++ .++|+||||+++|++++ |..||...........+...........++..+.+++.+||
T Consensus 154 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred CCCcccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 2335679999999877766 78999999999999998 99999988888887777776555555678999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q psy10459 294 SPVKFRIQMEDIRQD 308 (335)
Q Consensus 294 ~~p~~Rps~~~ll~h 308 (335)
.+|.+||++.++++.
T Consensus 233 ~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 233 YKPENRPKFSELQKE 247 (250)
T ss_pred cCcccCCCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.22 Aligned_cols=259 Identities=22% Similarity=0.381 Sum_probs=207.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 124 (335)
..+..++|.+.+.||+|++|.||+|.+..+++.||||.+........ ...+..|+.++... .|+||+++++++....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH--HHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34667889999999999999999999988899999999976433222 34445677666666 4999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..|++|||+. +++.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999995 478877755 4568999999999999999999997 599999999999999999999999999987653
Q ss_pred cCCcccccccccccccccccccccccCCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccc--cC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRV--VF 275 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~--~~ 275 (335)
.... .....++..|+|||.+.+.. ++ .++|+||||+++|+|++|..||..... .+....+.... ..
T Consensus 167 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 167 DSKA------KTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred CCCc------ccCCCCCccccCHhhcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 2211 11234678899999987553 44 789999999999999999999976433 23333333221 22
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+....++.++.+||.+|| .||.+||+++++++||||+..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 222357899999999999 999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.00 Aligned_cols=253 Identities=21% Similarity=0.392 Sum_probs=211.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+..++|.+.+.||+|+||.||+|.+... ...||+|.+..... ....+.+.+|+.+++.+.|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987543 34689998864432 2235577899999999999999999998865 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5789999999999999997643 589999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... ......++..|+|||.+....++ .++|+||||+++|+|++ |..||......+....+......+....++
T Consensus 160 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05056 160 ESYY----KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234 (270)
T ss_pred ccce----ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 3211 01122345679999998877766 78999999999999986 999999888888777777766666667889
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+.++|.+|+ .+|.+|||+.++++.
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.97 Aligned_cols=249 Identities=23% Similarity=0.418 Sum_probs=210.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||.||++.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999854 566799998864322 24567789999999999999999998877 7789
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 357888999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||.+....++ .++|+||||+++|++++ |..||.+.+.......+......+....++.+
T Consensus 157 ~~----~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd05073 157 YT----AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 231 (260)
T ss_pred cc----cccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHH
Confidence 11 11122345679999999877666 78999999999999998 99999998888888888777666666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+++.+|| .+|++||++.++++
T Consensus 232 ~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 232 LYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 99999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=298.40 Aligned_cols=259 Identities=25% Similarity=0.491 Sum_probs=209.8
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (335)
+|.+.+.||+|++|.||++.+. .+++.||+|++...... .......+.+|+.++..+ +|+||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46789999998753221 122345677899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++||||+.+++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777799999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHccccCCCCCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~ 281 (335)
. ......|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+..+.+... ..+....+
T Consensus 161 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (288)
T cd05583 161 E----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTM 235 (288)
T ss_pred c----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCccc
Confidence 1 122345788999999987654 22378999999999999999999996432 22223333222 23334458
Q ss_pred CHHHHHHHHHhc-CCCCCCCC---HHHHhcCCCcCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQ---MEDIRQDPWLKEDS 315 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps---~~~ll~hp~~~~~~ 315 (335)
+.++.++|.+|| .+|++||| +.++|+||||+.-.
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 899999999999 99999998 57789999997753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=294.53 Aligned_cols=242 Identities=27% Similarity=0.436 Sum_probs=202.0
Q ss_pred eeecccCceEEEEEEEcCCCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSARHSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
+.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.++..+ +||||+++++.+...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999888776 458887764322 22345677899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 134 KNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 134 ~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997532 378899999999999999999999999999999999999999999999998
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 276 (335)
+....... .......+..|+|||++....++ .++|+||||+++|+|++ |..||.+.+..+....+......+
T Consensus 159 ~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 159 SRGQEVYV------KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231 (270)
T ss_pred ccccchhh------hccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC
Confidence 75322110 01112235679999999877766 78999999999999997 999999888888888777765555
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....++.++.+++.+|| .+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 55568899999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.26 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=205.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC----------------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR----------------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 111 (335)
+..++|++.+.||+|+||.||++.+.. ++..||+|++..... ......+.+|+.+++.++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCC
Confidence 345679999999999999999985432 345789999865432 23356778999999999999
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-----------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCE 180 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~ 180 (335)
||+++++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999999999999997642 3667789999999999999999999999999999
Q ss_pred CEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh--CCCCCC
Q psy10459 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFD 258 (335)
Q Consensus 181 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~p~~ 258 (335)
||+++.++.++|+|||++..+...... .......++..|+|||......++ .++|+|||||++|+|++ |..||.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999998765432211 111223346789999988877776 78999999999999998 789998
Q ss_pred CCCHHHHHHHHHc-------cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 259 DTNYSELLKQVQK-------RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 259 ~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.....+....... ....+....++..+.+|+.+|| .||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7776665544322 2223444568899999999999 99999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=309.97 Aligned_cols=257 Identities=21% Similarity=0.387 Sum_probs=209.3
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~ 119 (335)
..+..++|.+.+.||+|+||.||+|.+. .+++.||+|++....... ....+.+|+.++..+. |+||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566678999999999999999999863 345689999997543322 2446779999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKER----------------------------------------------------- 146 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------------------------------------------- 146 (335)
+...+..++||||+.+|+|.+++...+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 147 ---------------------------------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 147 ---------------------------------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
.++...+..++.||+.||.|||+.+++|+||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
||++.++.++|+|||++......... .......++..|+|||.+.+..+. .++|+||||+++|+|++ |..||...
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999998765322211 011223467889999999887776 78999999999999998 89999876
Q ss_pred CHHHH-HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 261 NYSEL-LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 261 ~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+. ...+..+...+....++.++.+|+.+|| .+|.+||++.+|++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54443 3444555444445568999999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.00 Aligned_cols=253 Identities=21% Similarity=0.361 Sum_probs=211.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
...+|++.+.||+|+||.||+|.... +.+.|++|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34679999999999999999999653 346799998865332 23356678999999999999999999999888
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEec
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER---------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~---------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~D 194 (335)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 89999999999999999997655 689999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc-c
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK-R 272 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~-~ 272 (335)
||++........ .......++..|+|||.+.+.... .++|+||||+++|+|++ |..||...........+.. .
T Consensus 161 ~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccCcccc----cccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 999865432111 112233457789999998877666 78999999999999998 8999988777777766653 3
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 273 VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..++....++..+.+++.+|| .+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 334444568999999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=290.04 Aligned_cols=244 Identities=23% Similarity=0.394 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++|+||+++++++...+..+++|||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999998765443 23566789999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccc
Q psy10459 137 SLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 215 (335)
Q Consensus 137 sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 215 (335)
+|.+++.. ...+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......... ....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~---~~~~ 154 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV---SDGL 154 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee---cccc
Confidence 99999965 3468899999999999999999999999999999999999999999999999987553211110 0111
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-
Q psy10459 216 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 293 (335)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L- 293 (335)
..++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...........+......+....++..+.+++.+||
T Consensus 155 ~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 2235679999998877766 78999999999999998 89999988887777777766555555678999999999999
Q ss_pred CCCCCCCCHHHHhc
Q psy10459 294 SPVKFRIQMEDIRQ 307 (335)
Q Consensus 294 ~~p~~Rps~~~ll~ 307 (335)
.+|.+||+++++++
T Consensus 234 ~~p~~Rp~~~ell~ 247 (251)
T cd05041 234 YDPENRPSFSEIYN 247 (251)
T ss_pred cChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.32 Aligned_cols=255 Identities=22% Similarity=0.415 Sum_probs=212.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|++.+.||+|+||.||+|.+..+|. .||+|.+...... .....+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 3566789999999999999999999877776 4688877644332 223457789999999999999999998865
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
. ..+++++|+++|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 4679999999999999987654 5899999999999999999999999999999999999999999999999999866
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
....... ......++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.........+......+....
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd05110 160 EGDEKEY---NADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI 235 (303)
T ss_pred cCccccc---ccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 4322211 11223456789999999877776 78999999999999997 9999998887777777776666666667
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++..+.+++..|| .+|++||+++++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999 999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.41 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=202.4
Q ss_pred ccCCeEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 122 (335)
+..+|++.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.++..++|+||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 45689999999999999999997 34578899999986432 2234567899999999999999999987644
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...+++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 34689999999999999999764 45899999999999999999999999999999999999999999999999999866
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS----------------EL 265 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~----------------~~ 265 (335)
........ ......++..|+|||.+.+..++ .++|+||||+++|+|++|..++...... ..
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYK--VREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCccee--ecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 43322111 11112234569999999877776 7899999999999999987776433211 11
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+......+....++.++.+||.+|| .+|++|||+.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 2223334444555678999999999999 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.79 Aligned_cols=242 Identities=26% Similarity=0.444 Sum_probs=206.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|.+.+.||+|+||.||++. .+++.||+|.++... ....+.+|+.+++.++|+|++++++.+..+ ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 44679999999999999999987 468899999986432 134577899999999999999999988654 5789
Q ss_pred EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 129 IMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+|||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999997643 47899999999999999999999999999999999999999999999999986542211
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
.....+..|+|||.+.+..++ .++|+||||+++|+|++ |..||......+....+......+....++..+
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADV 226 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHH
Confidence 112235679999999877777 78999999999999997 999999998888888887776555556789999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+++++|| .+|..||++++++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=305.54 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=195.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-eEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-RVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 127 (335)
.+++|.-..+||+|+||.||+|.. .+|..||||++....... ...|.+|+.++..++|||+|+++|+|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 457899999999999999999995 456899999876644431 233889999999999999999999999888 599
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKS---VVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~---i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+|+||+++|+|.+++.... .+++..+.+|+.+++.||+|||... |+|||||++|||+|.++++||+|||++....
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997654 7899999999999999999999853 9999999999999999999999999995543
Q ss_pred c-CCccccccccccc-ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHH-HHHHcc-
Q psy10459 203 V-NNTDYKQNLSETF-CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN------YSELL-KQVQKR- 272 (335)
Q Consensus 203 ~-~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~------~~~~~-~~i~~~- 272 (335)
. ... .... .||.+|+|||+......+ .++||||||+++.||++|+.+.+... ..+.. ..+...
T Consensus 229 ~~~~~------~~~~~~gt~gY~~PEy~~~g~lt-~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 229 EGDTS------VSTTVMGTFGYLAPEYASTGKLT-EKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred ccccc------eeeecCCCCccCChhhhccCCcC-cccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2 111 1111 689999999999886666 89999999999999999998887432 11111 112111
Q ss_pred ---ccCCCC--CCCC--HH---HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 273 ---VVFPES--PRLS--SS---CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 273 ---~~~~~~--~~~~--~~---l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+..|.. ..++ .+ +..+...|+ .+|..||++.++.+.
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111111 2233 33 445556899 899999999997543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.01 Aligned_cols=251 Identities=21% Similarity=0.368 Sum_probs=196.5
Q ss_pred CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHHH
Q psy10459 63 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI 142 (335)
Q Consensus 63 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l 142 (335)
++|.||.+....+++.||+|++........ ....+.+|+.+++.++|+||+++++.+...+..+++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKE-DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchh-HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445566666667899999999976533322 3567889999999999999999999999999999999999999999999
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc--ccccccccccc
Q psy10459 143 RKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--YKQNLSETFCG 218 (335)
Q Consensus 143 ~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~g 218 (335)
... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+..+...... ..........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 45889999999999999999999999999999999999999999999999988655322211 00111123446
Q ss_pred ccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcccc---------------------
Q psy10459 219 SYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQVQKRVV--------------------- 274 (335)
Q Consensus 219 ~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~-~~i~~~~~--------------------- 274 (335)
+..|+|||++... .++ .++|+|||||++|+|++|..||......... +.+.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 7789999998763 345 7899999999999999999999876543332 22211100
Q ss_pred -----------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 -----------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 -----------~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.+....++.++.+||.+|| .||.+|||++++|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000123567899999999 9999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=287.52 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=210.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC----CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-CC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-TH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 124 (335)
...|+....||+|.||.||+|...+++ +.+|+|.++...... ......-+|+.+++.++|+|++.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 346999999999999999999655443 378999887653322 223345589999999999999999999877 78
Q ss_pred eEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC----CCEEEecc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDF 195 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~----~~~~l~Df 195 (335)
.+++++||.+. +|+.+|+- .+.++...++.|+.||+.|+.|||++=|+||||||.|||+..+ |.+||.||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 99998853 2458999999999999999999999999999999999999887 89999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHH
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---------YSELL 266 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---------~~~~~ 266 (335)
|+++.+...-... ......+-|.+|+|||.+.+...++.+.|+|++||++.||++..+.|.+.. ..+..
T Consensus 181 GlaR~~~~plkpl--~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 181 GLARLFNNPLKPL--ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cHHHHhhcccccc--ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999875432211 123345679999999999998887799999999999999999988886532 22333
Q ss_pred HHHHccccCCCC------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 267 KQVQKRVVFPES------------------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 267 ~~i~~~~~~~~~------------------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
..|-..+..|.. ..-++...+|+.+|| .||.+|.|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 333322222211 112345779999999 9999999999999999
Q ss_pred CcCCCCCCCC
Q psy10459 310 WLKEDSNPVG 319 (335)
Q Consensus 310 ~~~~~~~~~~ 319 (335)
||.....+..
T Consensus 339 yF~~d~lpp~ 348 (438)
T KOG0666|consen 339 YFTEDPLPPL 348 (438)
T ss_pred ccccCCCCCC
Confidence 9999876633
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.62 Aligned_cols=228 Identities=24% Similarity=0.373 Sum_probs=189.5
Q ss_pred cCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHH
Q psy10459 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV 141 (335)
Q Consensus 62 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~ 141 (335)
|.+|.||+|.+..+++.||+|.+.... ....|...+....||||+++++.+...+..+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999999999999999986532 122455555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccc
Q psy10459 142 IRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221 (335)
Q Consensus 142 l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~ 221 (335)
+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||.+..+.... ....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--------DGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--------ccCCcCcc
Confidence 9887779999999999999999999999999999999999999999999999999876543211 12245677
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCC
Q psy10459 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI 300 (335)
Q Consensus 222 y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rp 300 (335)
|+|||......++ .++|+||+|+++|+|++|..|+...... +...........++..++++|.+|| .||.+||
T Consensus 148 y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 148 YCAPEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred ccCCcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999998877776 7899999999999999999887643221 1111111222458899999999999 9999999
Q ss_pred CH-----HHHhcCCCc
Q psy10459 301 QM-----EDIRQDPWL 311 (335)
Q Consensus 301 s~-----~~ll~hp~~ 311 (335)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=289.33 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=198.7
Q ss_pred eeecccCceEEEEEEEcC---CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE-eCCeEEEEEec
Q psy10459 57 DVVGMGSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHRVYIIMEY 132 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~iv~e~ 132 (335)
+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++.+. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998643 345799998754322 122456778999999999999999999765 45568899999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+.+++|.+++... ...+...+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||++......... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-SVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-eec
Confidence 9999999999764 34677888999999999999999999999999999999999999999999998755322110 001
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+..+....+......+....++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 11223456789999999877776 78999999999999999 57778887777777777665444444567899999999
Q ss_pred Hhc-CCCCCCCCHHHHhcC
Q psy10459 291 NIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~h 308 (335)
+|| .+|++||++.++++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHcCCChhhCCCHHHHHHH
Confidence 999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.87 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred eeecccCceEEEEEEEcCCC------CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 57 DVVGMGSYATVKLATSARHS------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+.||+|+||.||+|.+.... +.+|+|.+...... .....+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876433 68999988653221 22456778999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-----CEEEeccccc
Q psy10459 131 EYAKNGSLLEVIRKE-------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKLSDFGFA 198 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-----~~~l~Dfg~~ 198 (335)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 2378899999999999999999999999999999999999887 8999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
......... .......++..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..+....+........
T Consensus 159 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 159 RDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccccc---ccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 755322111 011222456789999999887776 78999999999999998 9999998888887777776655555
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+|..+.++|.+|| .+|.+||+++++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5678999999999999 99999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=289.89 Aligned_cols=238 Identities=17% Similarity=0.256 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEEcCC------------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 57 DVVGMGSYATVKLATSARH------------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+.||+|+||.||+|..... ...||+|++.... ......+.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985322 2358888875432 223456778899999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC-------EEEeccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-------IKLSDFG 196 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~-------~~l~Dfg 196 (335)
..+++|||+++++|..++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999988753 56899999999999999999999999999999999999987664 8999999
Q ss_pred cccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHccccC
Q psy10459 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~-~g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
.+...... ....++..|+|||.+......+.++|||||||++|+|+ .|..||......+.........
T Consensus 158 ~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-- 226 (262)
T cd05077 158 IPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC-- 226 (262)
T ss_pred CCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc--
Confidence 88654321 12346788999999874443347899999999999997 5899988766555433322222
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
......+.++.+||.+|| .||.+||++.+|+++
T Consensus 227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222335688999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=290.15 Aligned_cols=246 Identities=20% Similarity=0.360 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
+.||+|+||.||+|.... ....+|+|.+..... ......+.+|+..++.++|+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996533 345688887654322 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 135 NGSLLEVIRKER-----YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 135 ~~sL~~~l~~~~-----~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+++|.+++.... ..++..+..++.||+.||+|||+.|++||||||+|||++.++.++|+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999997643 24677889999999999999999999999999999999999999999999986543221110
Q ss_pred cccccccccccccccccccCCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcccc--CCC---
Q psy10459 210 QNLSETFCGSYAYASPEILKGV------PYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVV--FPE--- 277 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~--~~~--- 277 (335)
......++..|+|||++... ...+.++|+|||||++|+|++ |..||......+.......... .+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 158 --TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred --ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 01223456779999987431 222378999999999999998 8899988776666555443322 111
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCHHHHhc
Q psy10459 278 SPRLSSSCKALISNILSPVKFRIQMEDIRQ 307 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L~~p~~Rps~~~ll~ 307 (335)
...++..+.+++..|+.||.+||++++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 236 DLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred cccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 235788899999998899999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=290.60 Aligned_cols=237 Identities=22% Similarity=0.266 Sum_probs=190.5
Q ss_pred eecccCceEEEEEEEcCC------------------------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe
Q psy10459 58 VVGMGSYATVKLATSARH------------------------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 113 (335)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975321 2358888875432 2234556788999999999999
Q ss_pred eeeceeEEeCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----
Q psy10459 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---- 188 (335)
Q Consensus 114 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---- 188 (335)
+++++++...+..++||||+++++|..++.. .+.+++..+..++.||+.||.|||+.|++||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 45689999999999999999999999999999999999998643
Q ss_pred ---CEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHH
Q psy10459 189 ---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 264 (335)
Q Consensus 189 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~-~g~~p~~~~~~~~ 264 (335)
.++++|||.+...... ....++..|+|||.+.+....+.++|+||||+++|+|+ +|..||......+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987543211 11245778999998876443348899999999999985 6999998877666
Q ss_pred HHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 265 LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...........+. ..+..+.++|.+|| .+|.+||+++++|++
T Consensus 230 ~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5444444333332 35678999999999 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.97 Aligned_cols=238 Identities=21% Similarity=0.317 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEEcCCCC-------eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 57 DVVGMGSYATVKLATSARHSQ-------DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
+.||.|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.+.||||+++++.+...+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 479999999999998765443 48888775322 22345677899999999999999999999998899999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC--------EEEeccccccc
Q psy10459 130 MEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--------IKLSDFGFARK 200 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~--------~~l~Dfg~~~~ 200 (335)
|||+++++|..++...+ .+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 58999998765
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHccccCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~ 279 (335)
... .....++..|+|||++.+....+.++|+||||+++|+|++| ..||..................| .
T Consensus 158 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (258)
T cd05078 158 VLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP--A 226 (258)
T ss_pred cCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCC--C
Confidence 432 12235678899999998754334789999999999999998 57777666655544444333333 3
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+.++.+||.+|| .+|.+|||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 46688999999999 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=307.51 Aligned_cols=242 Identities=32% Similarity=0.563 Sum_probs=206.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~i 128 (335)
.+.|.+...+|.|+|+.|..+.+..+++..++|++.+.... ..+|+.++... +|+||+++.+.+.+....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 56789999999999999999999999999999999875222 22567655555 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee-cCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL-DDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili-~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
|||.+.|+-+.+.+...+.+. .++..|+.+|+.|+.|||.+|++|||+||+|||+ ++.++++|+|||.+......
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999998888887766555 7788999999999999999999999999999999 58889999999998765433
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
....|-|..|.|||+.....|+ .++|+||||+++|+|++|+.||...... ++...+... .+ ...+|.+.+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~-~~--s~~vS~~AK 540 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP-KF--SECVSDEAK 540 (612)
T ss_pred -----hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC-cc--ccccCHHHH
Confidence 2234568899999999988888 8999999999999999999999876665 333333322 12 256999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
+||+.|| .||.+|+++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 9999999 999999999999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=292.49 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=207.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSAR----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-- 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 122 (335)
....|++.+.||+|+||.||+|.... +++.||+|++...... .....+.+|+.+++.+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 34578899999999999999998643 4789999999765443 335678899999999999999999998877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
....+++|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 567899999999999999997654 5899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------HHHH
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------------SELL 266 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~---------------~~~~ 266 (335)
........ ......++..|+|||...+..++ .++|+||||+++|+|++|..|+..... ....
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYY--VKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCccee--ccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 53222111 11122345679999999877766 789999999999999999999865432 2233
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+......+....++.++.+++.+|| .+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 344444455555668899999999999 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=286.95 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=213.1
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEE
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 121 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 121 (335)
...-.|..++.+-+..||.|+||+|++..++.+|+..|||.++......+ +.++..|.+...+- ++||||+++|+..
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 44455777788888999999999999999999999999999987655333 66677888765555 7999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEecc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDF 195 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Df 195 (335)
.++.+||.||.|+ .||..+.+. ...++|+.+..|....+.||.||-.. .|+||||||+|||++..|.+|||||
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence 9999999999995 487766542 34689999999999999999999764 8999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR- 272 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~- 272 (335)
|++-.+..+-. ...-.|-..|+|||.+... .|. .+||+||||+++||+.||+.||..-+. +++++..-
T Consensus 213 GIcGqLv~SiA------kT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv 283 (361)
T KOG1006|consen 213 GICGQLVDSIA------KTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVV 283 (361)
T ss_pred cchHhHHHHHH------hhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHH
Confidence 99976543221 1223466789999998643 355 889999999999999999999976443 44444321
Q ss_pred -ccCC------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 273 -VVFP------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 273 -~~~~------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
...| ....++..+..+|..|| +|-+.||...+++.+||++.+.+.-.
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~ 338 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGP 338 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCC
Confidence 1111 12358999999999999 99999999999999999998865443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.51 Aligned_cols=246 Identities=19% Similarity=0.320 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
+.||+|+||.||+|.+.. ++..+|+|.++...... ....+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998643 45679999886544322 23467789999999999999999999988889999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 135 NGSLLEVIRKER-----YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 135 ~~sL~~~l~~~~-----~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
+++|.+++.... ..++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999999986532 3567788899999999999999999999999999999999999999999998654322111
Q ss_pred cccccccccccccccccccCCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcc--ccCCCC--
Q psy10459 210 QNLSETFCGSYAYASPEILKGVP------YTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR--VVFPES-- 278 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~--~~~~~~-- 278 (335)
.......++..|+|||++.... ..+.++|+||||+++|+|++ |..||......+........ ...+..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 157 -VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred -ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 1122345678899999986421 12368999999999999996 99999877766554433322 112211
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCHHHHhc
Q psy10459 279 -PRLSSSCKALISNILSPVKFRIQMEDIRQ 307 (335)
Q Consensus 279 -~~~~~~l~~li~~~L~~p~~Rps~~~ll~ 307 (335)
...+..+.++++.|+.+|.+|||+++|+.
T Consensus 236 ~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 24678899999999977999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.59 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=208.3
Q ss_pred CeEEeeeecccCceEEEEEEEcC-CCCeEEEEEEecCCC-------ChHHHHhhHHHHHHHHHc-CCCCCeeeeceeEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQA-------PIDYLKKFLPREIEVVKG-LKHPNLIRFLQAIET 122 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 122 (335)
+|.+.+.||+|+||.||+|.+.. .++.+|+|.+..... ..+.....+.+|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 678999998864321 112223445678887764 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3458999999999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
+....... ......|+..|+|||.+.+..++ .++|+||||+++|+|++|..||...........+......+.
T Consensus 161 ~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 161 AKQKQPES------KLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred eeeccccc------ccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 87654322 12234578899999999887766 789999999999999999999998888777777766544443
Q ss_pred CC-CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 278 SP-RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 278 ~~-~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.. .++.++.++|.+|| .||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 33 67899999999999 999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=289.71 Aligned_cols=259 Identities=14% Similarity=0.248 Sum_probs=195.2
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHH--------HhhHHHHHHHHHcCCCCCe
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYL--------KKFLPREIEVVKGLKHPNL 113 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i 113 (335)
...+...+|.+.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+.|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3446667899999999999999999998777 6678888654332221100 0111123344556789999
Q ss_pred eeeceeEEeCC----eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC
Q psy10459 114 IRFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 114 v~~~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~ 189 (335)
+.+++.+.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+.+++||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 99998765443 4478888884 478777776666788999999999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCccc--ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHH-
Q psy10459 190 IKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SEL- 265 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~- 265 (335)
++|+|||+++.+....... .........||..|+|||++.+..++ .++|||||||++|+|++|..||.+... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999998764332211 11122334689999999999888877 899999999999999999999987632 222
Q ss_pred -------HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 266 -------LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 266 -------~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+..... ....++..+.++++.|+ .+|++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222222211 12457899999999999 99999999999975
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=320.38 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=219.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-CC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARH-SQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+..........||+|.||.||.|..... |. .||+|.+.+... ......|.+|..++..++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4466788899999999999999986443 22 388888766544 3447788899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 195 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Df 195 (335)
....+|++|||.||+|..++++. ..++...++.++.||++|+.||+++++|||||...|+|++....+||.||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 24889999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcccc
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
|+|+.+..... +... . ...-...|||||.+....++ .|+||||||+++||+++ |..||.+.+..++...+..+.+
T Consensus 847 GlArDiy~~~y-yr~~-~-~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 847 GLARDIYDKDY-YRKH-G-EAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR 922 (1025)
T ss_pred chhHhhhhchh-eecc-C-ccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc
Confidence 99995543221 1111 1 11224579999999998888 79999999999999998 9999999999999998888778
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 275 FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 275 ~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.+.+..+|..+.++|..|| .+|++||++..|+.
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 8888999999999999999 99999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.59 Aligned_cols=234 Identities=21% Similarity=0.280 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEcCCC----------CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 57 DVVGMGSYATVKLATSARHS----------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++|+||+++++.+.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47899999999999987766 34777776543221 4567789999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-------CEEEeccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-------NIKLSDFGFA 198 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-------~~~l~Dfg~~ 198 (335)
++||||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 689999999999999999999999999999999999999887 7999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
...... ....++..|+|||++... .++ .++|+||||+++|+|++ |..||..................
T Consensus 156 ~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 225 (259)
T cd05037 156 ITVLSR---------EERVERIPWIAPECIRNGQASLT-IAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL 225 (259)
T ss_pred cccccc---------cccccCCCccChhhhcCCCCCcc-hhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCC
Confidence 765431 122456789999998776 444 78999999999999999 68888777654444443332222
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+. .....+.++|.+|| .+|.+||++.++++
T Consensus 226 ~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PM--PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC--CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 12378999999999 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.62 Aligned_cols=251 Identities=21% Similarity=0.377 Sum_probs=204.8
Q ss_pred eEEeeeecccCceEEEEEEEcC---CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----
Q psy10459 53 YSLGDVVGMGSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 124 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 124 (335)
|.+.+.||+|+||.||+|.+.. ++..||+|++........ ..+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998643 468899999965443322 3556778999999999999999999875432
Q ss_pred -eEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 125 -RVYIIMEYAKNGSLLEVIRKE------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 125 -~~~iv~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
..+++++|+.+++|.+++... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999999999887432 1478899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 276 (335)
+.......... ......++..|++||.+....++ .++|||||||++|+|++ |..||...+.......+.......
T Consensus 160 ~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 160 SKKIYSGDYYR---QGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccCCccee---cCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 87654322110 11122345679999999887777 78999999999999999 999999888877777776655555
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.....+..+.+++.+|| .+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45668899999999999 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=283.66 Aligned_cols=260 Identities=28% Similarity=0.531 Sum_probs=223.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 124 (335)
+.+...+|.++.+||+|+|+.|.+++.+++.+.||+|++++.-...+......+.|-.+..+. +||.+|.++..|+.+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 456788999999999999999999999999999999999887666665577788899888877 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+++|.||.+||+|--.++++..++++.+..+...|..||.|||+.||++||+|.+|||++..|++||+|+|+++.-..+
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999998643221
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CC-HHHHHHHHHc-cccC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-------TN-YSELLKQVQK-RVVF 275 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-------~~-~~~~~~~i~~-~~~~ 275 (335)
...+.++|||+.|.|||++.+..|. +..|.|+||++++||+.|+.||.- .+ .+.+++-|.+ .+..
T Consensus 405 -----gd~tstfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 405 -----GDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred -----CcccccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 2346788999999999999999999 889999999999999999999951 22 3333443332 3344
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCC------CHHHHhcCCCcCC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRI------QMEDIRQDPWLKE 313 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rp------s~~~ll~hp~~~~ 313 (335)
| ..+|-....+++..| +||.+|. ...++..|+||+.
T Consensus 479 p--rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 479 P--RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred c--ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 4 346666777889999 9999886 6789999999984
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.82 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=229.9
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 119 (335)
+-...++.....|.++||.|.||.|++|+.+..|+ .||||.++.... +..+..|..|+.++-++.||||+.+.|+
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 34456778889999999999999999999877664 699999976544 3347778899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
........||+|||++|+|..|++.+ +.|+..++.-++..|+.|+.||-+.|+|||||...|||++.+-.+|++|||++
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999999999764 67999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
+.+..+.... .......-..+|.|||.+....++ .++||||+|++|||.++ |..||.+....++++.|.+++..|.
T Consensus 779 Rvledd~~~~--ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 779 RVLEDDPEAA--YTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred eecccCCCcc--ccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 9775544221 111222235689999999999988 78999999999999876 9999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+..+|..+.+|+..|| +|-.+||.+.+|..+
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999 999999999888753
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.09 Aligned_cols=256 Identities=25% Similarity=0.467 Sum_probs=199.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE---------
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--------- 121 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------- 121 (335)
.+|+.++.||+||||.||+|+++-+|..||||.+.... .+.....+.+|+.+|.+|+|||||+++..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 35888999999999999999999999999999997654 3444666779999999999999999983220
Q ss_pred ---------------------------------------------------------------------e----------
Q psy10459 122 ---------------------------------------------------------------------T---------- 122 (335)
Q Consensus 122 ---------------------------------------------------------------------~---------- 122 (335)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CeEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q psy10459 123 -----------------------T--------HRVYIIMEYAKNGSLLEVIRKERYI-DEDKGRRWFSQLADAIDYCHKK 170 (335)
Q Consensus 123 -----------------------~--------~~~~iv~e~~~~~sL~~~l~~~~~~-~~~~~~~i~~~i~~~L~~LH~~ 170 (335)
+ ..+||-||||+..++.+++.++... .....|.++.+|++||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 1368999999987777777766544 4778999999999999999999
Q ss_pred CceeccCCCCCEeecCCCCEEEecccccccccc-------CCc-----c-cccccccccccccccccccccCCCC--CCC
Q psy10459 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV-------NNT-----D-YKQNLSETFCGSYAYASPEILKGVP--YTP 235 (335)
Q Consensus 171 ~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~-------~~~-----~-~~~~~~~~~~g~~~y~aPE~~~~~~--~~~ 235 (335)
|+|||||||.||++++++.+||+|||++..+.. ... . .........+||.-|+|||++.+.. .++
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 999999999999999999999999999987220 000 0 0111234568999999999997765 334
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHccccCCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 236 QQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPES----PRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 236 ~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
.|+|+||||++++||+ .||.. .....++..+.+ ...|.. ..--+.-..+|++|| .||.+||||.|+|++.
T Consensus 797 ~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~-g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK-GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc-CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 8999999999999999 45543 233344455553 333332 112245568999999 8999999999999999
Q ss_pred CcC
Q psy10459 310 WLK 312 (335)
Q Consensus 310 ~~~ 312 (335)
||-
T Consensus 873 llp 875 (1351)
T KOG1035|consen 873 LLP 875 (1351)
T ss_pred CCC
Confidence 996
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=277.94 Aligned_cols=268 Identities=21% Similarity=0.346 Sum_probs=215.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-----
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----- 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 122 (335)
.+...|+-+.+||+|.||.||+|+...+|+.||+|.+--.......-.. ..+|+.+|..++|+|++.+++.|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpit-alreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHH-HHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 4566788899999999999999999999999999876432211111122 3389999999999999999887643
Q ss_pred ---CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 123 ---THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 123 ---~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
...+|+|+++|.. +|..++... ..++..++..++.+++.||.|+|+..|+|||+|+.|+||+.+|.++|.|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2358999999976 888888655 56999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---c--
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---V-- 273 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~-- 273 (335)
+.+....... .+.....+-|.+|++||.+.+...+..+.|+|.-||++.+|+++.+-+.+......+..|..- .
T Consensus 172 r~fs~~~n~~-kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVV-KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred cceecccccC-CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 8886654332 223344566999999999988766668899999999999999999999998877777666431 0
Q ss_pred -cCCCC----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 274 -VFPES----------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 274 -~~~~~----------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
-+|.- -.-+++..+|+..|| .||.+|+.++++|.|.||.+...+.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pq 325 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQ 325 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcch
Confidence 01100 001347779999999 9999999999999999998876663
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=289.32 Aligned_cols=284 Identities=25% Similarity=0.432 Sum_probs=231.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh----HHHHhhHHHHHHHHHcCCCCCeeeeceeEE-eC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI----DYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 123 (335)
..++|.+++.||+|||+.||+|-|....+.||||+-....... +.+.+-..+|..+-+.|.||.||+++++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4568999999999999999999999999999999875543332 233445668999999999999999999985 56
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEeecCC---CCEEEeccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK--SVVHRDIKCENLLLDDK---YNIKLSDFGFA 198 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--~i~H~dikp~Nili~~~---~~~~l~Dfg~~ 198 (335)
+.+|.|+|||+|.+|.-+++..+.+++.++..|+.||+.||.||... .|||.||||.|||+.+. |.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 78899999999999999999999999999999999999999999976 69999999999999754 67999999999
Q ss_pred cccccCCcc--cccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH---
Q psy10459 199 RKYSVNNTD--YKQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQV--- 269 (335)
Q Consensus 199 ~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i--- 269 (335)
+....++.. ....++....||.+|++||.+.- .+..+.+.||||+|+++|.++.|+.||...-. .++++.-
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 988665533 23456677889999999999742 33445899999999999999999999986543 3333221
Q ss_pred -HccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC-CCCCCCcccccCC
Q psy10459 270 -QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG-KSKSAPEVIPFKK 332 (335)
Q Consensus 270 -~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~-~~~~~~~~~~~~~ 332 (335)
.....||..+.++.+.++||++|| ..-++|....++..||+|.-....+. .+.....-|+..+
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~~a~i~~sp 766 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPAGAAIASSP 766 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCccccccCCC
Confidence 135788888999999999999999 88999999999999999976533332 2334444454443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=278.31 Aligned_cols=246 Identities=18% Similarity=0.309 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEEcCCC--CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
+.||+|+||.||+|....++ ..+++|.+..... ......+.+|+.+++.++||||+++++.+......+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999754332 3456666654332 2235677899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 135 NGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 135 ~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++........ .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---I 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh---h
Confidence 99999999753 2356778889999999999999999999999999999999999999999998754321111 0
Q ss_pred ccccccccccccccccccCCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccC----C-CC
Q psy10459 211 NLSETFCGSYAYASPEILKGVP------YTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVF----P-ES 278 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~------~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~----~-~~ 278 (335)
......+++..|+|||++.... ..+.++|+||||+++|+|++ |..||......+....+...... + ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1122346788999999975321 12368999999999999996 67899887776666654332211 1 12
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCHHHHhc
Q psy10459 279 PRLSSSCKALISNILSPVKFRIQMEDIRQ 307 (335)
Q Consensus 279 ~~~~~~l~~li~~~L~~p~~Rps~~~ll~ 307 (335)
..++..+.+++..|+.+|.+||++++|++
T Consensus 236 ~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 35788999999999977999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=301.10 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=219.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe----
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET---- 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---- 122 (335)
.-.+.|++.++||.|.+|.||++..+.+++.+|+|+....... ...++.|.++|+.+ .|||++.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3456799999999999999999999999999999998654433 34456789999888 59999999999853
Q ss_pred -CCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 123 -THRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 123 -~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
++.+|+|||||.|||..++++. +..+.|+.+..|+..++.||.+||+..++|||||=.|||++.++.+||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 5789999999999999999976 3568999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccccccccccccccCCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGV-----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
.+.. ....+.+..||+.|||||++... .|+ ..+|+||||++..||.-|.+|+.+..+....-.|.++-.
T Consensus 172 Qlds-----T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP 245 (953)
T KOG0587|consen 172 QLDS-----TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 245 (953)
T ss_pred eeec-----ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC
Confidence 7643 22345677899999999998532 344 679999999999999999999998888777666655322
Q ss_pred CC--CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 FP--ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 ~~--~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.. .+...+.++.+||..|| +|-.+||+..++|+|||++.+.
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 11 12457899999999999 9999999999999999999654
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.10 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=231.6
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcC-CCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSAR-HSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 119 (335)
.....|-.++..+.+.||+|+||.|++|.|.. +|+ .||||.++...... ....|.+|+.++..|+|+|++++||+
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeee
Confidence 33445666778889999999999999999865 344 68999998765543 46778899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
..+ ....+|+|.+++|+|.+.+++. ..|....+..++.||+.||.||..+++|||||-..|+++-....+||+|||+
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 887 6788999999999999999773 3478888999999999999999999999999999999999988999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~ 276 (335)
.+.++.+...|.. .....-...|+|||.+....++ .++|+|++|+++|||++ |..||.+....++++++.++...+
T Consensus 259 mRaLg~ned~Yvm--~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 259 MRALGENEDMYVM--APQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP 335 (1039)
T ss_pred eeccCCCCcceEe--cCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC
Confidence 9999887766643 2222335679999999999999 89999999999999998 999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+.++.++.+++..|| ..|.+||++..|...-+....
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 98999999999999999 999999999999765555443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=303.41 Aligned_cols=259 Identities=18% Similarity=0.298 Sum_probs=179.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCC----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee--
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARH----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA-- 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-- 119 (335)
..+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ....+ .+....+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhh
Confidence 445678999999999999999999999888 8999999876432211 11111 1122222222222221
Q ss_pred ----EEeCCeEEEEEeccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy10459 120 ----IETTHRVYIIMEYAKNGSLLEVIRKERY--------------------IDEDKGRRWFSQLADAIDYCHKKSVVHR 175 (335)
Q Consensus 120 ----~~~~~~~~iv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~i~~~i~~~L~~LH~~~i~H~ 175 (335)
.......++|+||+.+++|.+++..... .....+..++.||+.||.|||+.||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2345678999999999999999865421 1133466899999999999999999999
Q ss_pred cCCCCCEeecC-CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCC--------------------
Q psy10459 176 DIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT-------------------- 234 (335)
Q Consensus 176 dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-------------------- 234 (335)
||||+|||++. ++.++|+|||++..+..... ......++++.|+|||.+......
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999999986 57899999999976533211 123356789999999976432211
Q ss_pred -CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-c------------cC-------CCCCCCCHHHHHHHHHhc
Q psy10459 235 -PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-V------------VF-------PESPRLSSSCKALISNIL 293 (335)
Q Consensus 235 -~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~------------~~-------~~~~~~~~~l~~li~~~L 293 (335)
+.++|||||||++|+|+++..++... .......+... . .. ..........++||.+||
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 14569999999999999977665432 11111111110 0 00 000112334568999999
Q ss_pred -CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 294 -SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 294 -~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.||++|||++++|+||||++...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999999987544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.57 Aligned_cols=240 Identities=35% Similarity=0.658 Sum_probs=206.6
Q ss_pred CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHHH
Q psy10459 63 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI 142 (335)
Q Consensus 63 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l 142 (335)
+||.||+|.+..+|+.+|+|++........ ...+.+|+..++.++|+||+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999876543321 467789999999999999999999999989999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccccccccccc
Q psy10459 143 RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222 (335)
Q Consensus 143 ~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y 222 (335)
.....++...++.++.+++.++.+||+.+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~ 152 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTTFVGTPEY 152 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc------ccccccCCcCC
Confidence 877668999999999999999999999999999999999999999999999999997765432 12234578889
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHccccCCCCCC--CCHHHHHHHHHhc-CCCCC
Q psy10459 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPR--LSSSCKALISNIL-SPVKF 298 (335)
Q Consensus 223 ~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~--~~~~l~~li~~~L-~~p~~ 298 (335)
++||......++ .++|+||||+++++|++|..||.. .......+.+........... ++.++.+++.+|| .+|++
T Consensus 153 ~~pE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 231 (244)
T smart00220 153 MAPEVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEK 231 (244)
T ss_pred CCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchh
Confidence 999999877777 689999999999999999999988 666666666655443332222 8899999999999 99999
Q ss_pred CCCHHHHhcCCCc
Q psy10459 299 RIQMEDIRQDPWL 311 (335)
Q Consensus 299 Rps~~~ll~hp~~ 311 (335)
||++.++++||||
T Consensus 232 Rp~~~~~~~~~~~ 244 (244)
T smart00220 232 RLTAEEALQHPFF 244 (244)
T ss_pred ccCHHHHhhCCCC
Confidence 9999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=289.63 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=217.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
...+-.....++++||+|-||.|.+|.. ..+..||||.++.... ...+..|..|+++|.+|+||||+.++++|..++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 3456667788999999999999999994 4468999999976543 334788999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+++++||+++|+|.+++..+. .........|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-+.
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999999998763 34556678899999999999999999999999999999999999999999998665
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHccccCC----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV--YGRLPFDDTNYSELLKQVQKRVVFP---- 276 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~--~g~~p~~~~~~~~~~~~i~~~~~~~---- 276 (335)
..... ......+-..+|||+|.+....++ .++|+|+||+++||++ +...||.....+++.++....+..+
T Consensus 689 sg~yy---~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 689 SGDYY---RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cCCce---eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 43321 112334457899999999988888 7899999999999986 5899999999999988886644333
Q ss_pred ---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 277 ---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 277 ---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.++.++.++.++|.+|+ .|-++||+.+++-.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 33568999999999999 99999999999854
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.49 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=223.2
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
+.++..+...-++||-|.||.||.|.|++..-.||||.++....+ ...|..|+.+++.++|||+|+++++|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 445556677789999999999999999999999999998765443 5667899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+|||+|||..|+|.+|++... .++.-.++.++.||..|++||..+++|||||-..|.|+.++..+|+.|||+++....
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999998754 367778899999999999999999999999999999999999999999999987754
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
+... ... ...-.+-|.|||-+.-..++ .++|||+||+++||+.| |-.||.+.+..+++..+.+++.+....++|
T Consensus 418 DTYT--AHA--GAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 418 DTYT--AHA--GAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred Ccee--ccc--CccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 3321 111 11225679999999988888 89999999999999998 999999999999999999999999989999
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+..|++.|| -.|.+||++.|+-+
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999 88999999988743
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.50 Aligned_cols=132 Identities=23% Similarity=0.421 Sum_probs=116.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC--------CCCeeeecee
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--------HPNLIRFLQA 119 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~ 119 (335)
|...+|-+.++||-|-|++||+|.|..+.+.||+|+++... .+.+....|+.+|++++ ..+||++++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 45589999999999999999999999999999999997653 33556679999999883 2479999999
Q ss_pred EEe----CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEee
Q psy10459 120 IET----THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLL 184 (335)
Q Consensus 120 ~~~----~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili 184 (335)
|.. +.++|+|+|++ |.+|..+|... +.++...+++|++||+.||.|||.. ||||.||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 965 45899999999 77999999765 4599999999999999999999975 99999999999999
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.25 Aligned_cols=246 Identities=23% Similarity=0.413 Sum_probs=213.3
Q ss_pred eEEeeeecccCceEEEEEEEcCC--C--CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARH--S--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..+.++||.|-||.||.|....- | -.||||..+....+.+ .+.|..|..+++.++||||++++|++.. ...||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34457999999999999987432 2 3689999987666544 7778899999999999999999999865 47899
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
|||.++.|.|..|++..+ .++...+..++.||..||.|||+..+|||||-..|||+.+...+||+|||+++.+..+..
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y- 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY- 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch-
Confidence 999999999999998764 589999999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
+.. ....-..-|||||.+.-..++ .++|||.||+++||++. |..||.+....+++..+..+.+.|.++.+|+.+.
T Consensus 547 Yka---S~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 547 YKA---SRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred hhc---cccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 111 122235679999999888888 78999999999999986 9999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHh
Q psy10459 287 ALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll 306 (335)
.|+.+|| .+|.+||...+|.
T Consensus 623 slmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhccCcccCCcHHHHH
Confidence 9999999 9999999876654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=288.79 Aligned_cols=262 Identities=17% Similarity=0.191 Sum_probs=188.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc----------------CCCCeEEEEEEecCCCChH-----------HHHhhHHH
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA----------------RHSQDVAIKIISKVQAPID-----------YLKKFLPR 100 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~~~~-----------~~~~~~~~ 100 (335)
+..++|.+.++||+|+||+||+|.+. ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 46779999999999999999999752 2456799999864322110 01122334
Q ss_pred HHHHHHcCCCCCe-----eeeceeEEe--------CCeEEEEEeccCCCCHHHHHHhcC---------------------
Q psy10459 101 EIEVVKGLKHPNL-----IRFLQAIET--------THRVYIIMEYAKNGSLLEVIRKER--------------------- 146 (335)
Q Consensus 101 E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~--------------------- 146 (335)
|+.++..++|.++ +.+++++.. .+..++||||+.+++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766544 566666542 346899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccc
Q psy10459 147 ---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223 (335)
Q Consensus 147 ---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~ 223 (335)
.+++..++.++.|++.+|.|||+.+++||||||+|||++.++.++|+|||++......... ......+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~----~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF----NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc----CccccCCCccee
Confidence 1345678889999999999999999999999999999999999999999998654322110 111223478999
Q ss_pred cccccCCCCC--------------------C-CCchhHHHHHHHHHHHHhCCC-CCCCCCHHH------------HHHHH
Q psy10459 224 SPEILKGVPY--------------------T-PQQSDIWSMGVVLFAMVYGRL-PFDDTNYSE------------LLKQV 269 (335)
Q Consensus 224 aPE~~~~~~~--------------------~-~~~~Di~slG~~~~~l~~g~~-p~~~~~~~~------------~~~~i 269 (335)
|||.+..... . +.+.|+||+||++|+|+++.. ||....... .....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 9998754321 1 124699999999999999875 765421111 01111
Q ss_pred HccccCCCCCCCCHHHHHHHHHhc-CCC---CCCCCHHHHhcCCCcCC
Q psy10459 270 QKRVVFPESPRLSSSCKALISNIL-SPV---KFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~L-~~p---~~Rps~~~ll~hp~~~~ 313 (335)
...+.++....++...++|+.+|| .+| .+|+|++|+|+||||..
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 123445555678999999999999 765 68999999999999964
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=286.42 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=210.4
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC------CCCeeeece
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK------HPNLIRFLQ 118 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~ 118 (335)
+..+...+|.+....|+|-|++|.+|.+..-|..||||+|+.... ..+.=..|+++|++|+ .-|++.++.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 344567789999999999999999999999999999999987533 2344458999999995 358999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEec
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSD 194 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~D 194 (335)
.|...+++|+|+|.+. .+|.+++++.+ .+....+..++.|++.||..|-.+||+|.||||+|||+..+. .+||||
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 9999999999999994 59999998754 377889999999999999999999999999999999999765 579999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cc
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RV 273 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~ 273 (335)
||.|...+.+.. ..+.-+-.|.|||++.+.+|. ...|+||+||++|||.||+..|.+....+++...-. ..
T Consensus 581 fGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 581 FGSASFASENEI-------TPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred Cccccccccccc-------cHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999977654332 123346689999999999999 889999999999999999999998776666543311 11
Q ss_pred cCCCC---------------------------------------------------C-------CCCHHHHHHHHHhc-C
Q psy10459 274 VFPES---------------------------------------------------P-------RLSSSCKALISNIL-S 294 (335)
Q Consensus 274 ~~~~~---------------------------------------------------~-------~~~~~l~~li~~~L-~ 294 (335)
.+|.. . .+-..+++|+..|| .
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 11100 0 11236889999999 9
Q ss_pred CCCCCCCHHHHhcCCCcCC
Q psy10459 295 PVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 295 ~p~~Rps~~~ll~hp~~~~ 313 (335)
||++|.|.+++|.||||++
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 9999999999999999975
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=301.28 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=198.6
Q ss_pred CeEEeeeecccCceE-EEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEEE
Q psy10459 52 GYSLGDVVGMGSYAT-VKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~-V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~iv 129 (335)
-|...+.+|.|+.|+ ||+|. -.|+.||||++-.. .-..+.+|+..|+.. .|||||++++.-.+....||.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 355668899999988 69998 56899999987542 245677999999998 599999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---C--CCEEEeccccccc
Q psy10459 130 MEYAKNGSLLEVIRKER-Y---IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---K--YNIKLSDFGFARK 200 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~---~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~--~~~~l~Dfg~~~~ 200 (335)
.|.|.. +|.+++.... . ......+.++.|++.||++||+.+||||||||.||||+. + .+++|+|||+++.
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999976 9999997741 1 112456888999999999999999999999999999986 3 3589999999999
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcc-ccCCC-
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPE- 277 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~-~~~~~- 277 (335)
+..+...+.. ..+..||.+|+|||++...... .+.|||||||++|+.++ |.+||.+.-..+. +|..+ +....
T Consensus 661 l~~~~sS~~r--~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L 735 (903)
T KOG1027|consen 661 LAGGKSSFSR--LSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHL 735 (903)
T ss_pred cCCCcchhhc--ccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeee
Confidence 9876665544 5567899999999999988777 78999999999999998 5999976544332 22221 11110
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
.+.-..+..+||.+|+ .+|..||+|.++|.||+|=.
T Consensus 736 ~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 736 EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0111128999999999 99999999999999999844
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=253.78 Aligned_cols=255 Identities=26% Similarity=0.501 Sum_probs=204.3
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETT 123 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 123 (335)
+..-..++|++.+++|+|-|+.||.|....+++.+++|+++... .+.+.+|+.+|+.|. ||||+++++...+.
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 34456789999999999999999999999999999999997543 567889999999997 99999999998664
Q ss_pred --CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccc
Q psy10459 124 --HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARK 200 (335)
Q Consensus 124 --~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~ 200 (335)
....+++||+.+.+...+... ++.-.+..++.+++.||.|+|+.||.|||+||.|++|+... .++|+|+|++..
T Consensus 106 ~SktpaLiFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 106 ESKTPSLIFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred cccCchhHhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 457799999988776666544 77888999999999999999999999999999999999654 699999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHH---------
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQV--------- 269 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~--~~~~~~~~~i--------- 269 (335)
..+... +. ..+.+..|.-||.+..-......-|+|||||++..|+..+.||.. .+.+++.+-.
T Consensus 183 YHp~~e-Yn-----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 183 YHPGKE-YN-----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred cCCCce-ee-----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 754332 22 123466788899998776665889999999999999999999853 2333332111
Q ss_pred ---Hc-c---------------------ccCCCC-CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 270 ---QK-R---------------------VVFPES-PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 270 ---~~-~---------------------~~~~~~-~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+ . +..+.. ..++++..+|+.++| .|-.+|+|+.|++.||||.--
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 00 0 000111 236799999999999 999999999999999999654
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=289.94 Aligned_cols=203 Identities=29% Similarity=0.457 Sum_probs=172.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------CC
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------TH 124 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 124 (335)
.-+...+.||+|+||.||+++++.+|+.||||.++....... .+...+|++++++++|+|||++.+.-+. .+
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 456778899999999999999999999999999987554333 5566799999999999999999887543 33
Q ss_pred eEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC--CC--EEEecccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK---ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YN--IKLSDFGF 197 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~--~~--~~l~Dfg~ 197 (335)
...++||||.||+|...+++ ...+++..++.++.++..||.|||.+||+||||||.||++-.. |+ .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999965 3469999999999999999999999999999999999999533 43 69999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~ 261 (335)
|+.++.+.. ....+||..|.+||......+++..+|.|||||++|+++||..||-...
T Consensus 171 Arel~d~s~------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNSL------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCCe------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 998876542 3456899999999999864444478999999999999999999997543
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=266.36 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=210.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----eEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-----RVY 127 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 127 (335)
.+..+.||.|+||.||.++|..+|+.||+|.+......... .+.+.+|+.+|.-++|.|++..++...-.+ .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s-~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLAS-CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHH-HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 44567899999999999999999999999988765444333 344559999999999999999888764432 457
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
.++|.+. .+|..++-+-..++...++-+++||+.||.|||+.+|.||||||.|.|+++|..+||||||+++....+...
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 7888885 488888877778999999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC---------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--------- 278 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------- 278 (335)
.++ .-+-|..|+|||++.+...++.+.||||+||++.||+..+..|...++-+..+.|.+.+..|..
T Consensus 213 ---hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 213 ---NMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred ---hhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 111 2245889999999998877778999999999999999999999998888877777543333311
Q ss_pred ------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 279 ------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 279 ------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
..-..+...++..|+ .||..|.+.++++.|++.....-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 112346678888899 99999999999999999987743
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=261.30 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=210.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC---
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--- 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 123 (335)
.....+|.-++.+|.|.- .|..+-|.-.++.||+|.+...... ........+|..++..++|+||++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 455678999999999998 7778888888999999988765333 22355667999999999999999999988433
Q ss_pred ---CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 124 ---HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 124 ---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
...|+|||++.. +|...+.. .++...+..++.|++.|+.+||+.||+||||||+||++..++.+||.|||+++.
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 357999999965 99998873 368889999999999999999999999999999999999999999999999976
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC--
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-- 278 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-- 278 (335)
-... .....++.+..|+|||++.+-.+. ..+||||+||++.||++|...|.+.+.-+.+.++.+.+..|+.
T Consensus 168 e~~~------~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 EDTD------FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred cCcc------cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 5433 223456778999999999888877 7899999999999999999999988776666555433322211
Q ss_pred --------------------------------------C-CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 279 --------------------------------------P-RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 279 --------------------------------------~-~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
. .=+...++++.+|| .+|++|.|++++|+||||+
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1 12346889999999 9999999999999999998
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.34 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=218.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
..+..++||+|+||+||+|.+.-.|+ +||+|++........ ...+.+|+-.+..++|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45567899999999999999966555 689998876554433 556779999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||++|+++|+|.++++.. ..+-....+.|+.||++||.|||.++++||||-..|||+..-..+|+.|||+++.+..+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999764 4588889999999999999999999999999999999999999999999999999887776
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
.+... ...-.+-|+|-|.+....++ .++||||+|+++||++| |..||.+...+++-+.+..+.+.+.++.++.++
T Consensus 854 ey~~~---~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDV 929 (1177)
T KOG1025|consen 854 EYSAP---GGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDV 929 (1177)
T ss_pred ccccc---ccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHH
Confidence 65432 22335679999999998888 88999999999999998 999999999999999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHh
Q psy10459 286 KALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll 306 (335)
..++.+|| .|+..||+++++.
T Consensus 930 y~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHH
Confidence 99999999 9999999998875
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=280.66 Aligned_cols=258 Identities=27% Similarity=0.417 Sum_probs=216.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeee
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRF 116 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 116 (335)
...+..++..+.+.||+|.||.|++|.-.. ....||||..+..... ...+.+..|+++++.+ +|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence 455566667788899999999999986421 1457999998765554 3377888999999999 69999999
Q ss_pred ceeEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q psy10459 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCE 180 (335)
Q Consensus 117 ~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~ 180 (335)
++++...+.+++|+||+..|+|.++++..+ .++...++.++.||+.|++||++.+++||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999988899999999999999999997765 3888999999999999999999999999999999
Q ss_pred CEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy10459 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDD 259 (335)
Q Consensus 181 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~ 259 (335)
|||+..+..+||+|||+++.......-........ -...|||||.+....++ .++||||+|+++||+++ |..||.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~--LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT--LPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCc--cceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999986543322110100000 13459999999997777 89999999999999998 9999998
Q ss_pred CC-HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 260 TN-YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 260 ~~-~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.. ..++++.+..+.....+..++.++.++++.|| .+|.+||+..++.+
T Consensus 525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 65 67778888999888888889999999999999 99999999998864
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=280.34 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=223.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|+.+.++|.|+||.||+++++.+++..|+|+++...... .+-+++|+-+++.++|+||+.+++.+...+.++|.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 457999999999999999999999999999999997654332 44566899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||||.||+|.+.-+-.+++++.++..+++..+++|.|||+.|-+|||||-.||++++.|.+++.|||.+..+..--
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati---- 166 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI---- 166 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccccccccc---CCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC----CCCCCC
Q psy10459 210 QNLSETFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----ESPRLS 282 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~---~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----~~~~~~ 282 (335)
..+..+.||+.|||||+. ....|. ..+|+|++|+...|+.--..|-.+..+......+.+....| +....+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 123456899999999986 344566 89999999999999999999988888877777766543332 335689
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+.+.+|++.+| ++|.+||+++.+|+|||..+.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999 999999999999999998764
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=260.89 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=196.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC--CCCCeeeeceeEEeCC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL--KHPNLIRFLQAIETTH 124 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~ 124 (335)
..+.....+.+.||+|.||.||+|+. +++.||||++... ..+.+.+|.+++... +|+||++++++-....
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 34566778899999999999999995 4699999998542 256677888877654 7999999998876655
Q ss_pred ----eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCCEeecCCCCEE
Q psy10459 125 ----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK---------KSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 125 ----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~---------~~i~H~dikp~Nili~~~~~~~ 191 (335)
.++||++|.+.|+|.+++..+. +++.....++..+++||+|||. ..|+|||||..||||..++.++
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 8999999999999999997654 8999999999999999999995 3599999999999999999999
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCC-----CCchhHHHHHHHHHHHHhCC------------
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT-----PQQSDIWSMGVVLFAMVYGR------------ 254 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-----~~~~Di~slG~~~~~l~~g~------------ 254 (335)
|+|||++..+...... ......+||.+|||||++.+..-- ..+.||||+|.++|||++.-
T Consensus 357 IaDFGLAl~~~p~~~~---~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQ---GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred eeccceeEEecCCCCC---cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 9999999988643322 123347899999999999764322 24689999999999998742
Q ss_pred CCCC-----CCCHHHHHHHHHccccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHH------HhcCCCc
Q psy10459 255 LPFD-----DTNYSELLKQVQKRVVFPES------PRLSSSCKALISNIL-SPVKFRIQMED------IRQDPWL 311 (335)
Q Consensus 255 ~p~~-----~~~~~~~~~~i~~~~~~~~~------~~~~~~l~~li~~~L-~~p~~Rps~~~------ll~hp~~ 311 (335)
.||. ....+++...+......|.. ......+++.+..|| .|++-|.|+.= -+.|.|=
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 2332 23345555555443333332 123467889999999 99999999863 3566663
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.43 Aligned_cols=236 Identities=21% Similarity=0.315 Sum_probs=185.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|...+.||+|+||.||+|.+..++..||+|.+...... ...|++.+++++||||+++++++...+..++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 466778999999999999999889999999988653321 1256888999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH---KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH---~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+++|+|.++++. +++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999964 789999999999999999999 6699999999999999998887765 554432211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcc-----ccCCC-
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-----YSELLKQVQKR-----VVFPE- 277 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-----~~~~~~~i~~~-----~~~~~- 277 (335)
.....++..|+|||++.+..++ .++|||||||++|||++|+.||.... ..+........ ...+.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ----CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 1122578899999999888777 78999999999999999999985421 11111111000 00010
Q ss_pred --C----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 278 --S----PRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 278 --~----~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
. .....++.+++.+|| .||++||++.|+++.
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 011235778899999 999999999999976
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.47 Aligned_cols=249 Identities=22% Similarity=0.418 Sum_probs=188.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHc--CCCCCeeeeceeEEeC---
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG--LKHPNLIRFLQAIETT--- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~--- 123 (335)
...+..+.+.||+|.||.||+|.+. |+.||||++.... .....+|.++++. |+|+||+.++..-..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3557889999999999999999975 8999999996543 2233367777765 4999999999765332
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEeecCCCCEEEec
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK--------SVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~i~H~dikp~Nili~~~~~~~l~D 194 (335)
..+++|++|.+.|||+||+.+ ..++.+..++++..++.||++||.. .|.|||||..|||+..++.+.|.|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 268999999999999999988 5689999999999999999999953 499999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCC----C-CCCchhHHHHHHHHHHHHhC----------CCCCCC
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP----Y-TPQQSDIWSMGVVLFAMVYG----------RLPFDD 259 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~-~~~~~Di~slG~~~~~l~~g----------~~p~~~ 259 (335)
+|++........ ...-.....+||.+|||||++...- + +...+||||||.++||++.. ++||.+
T Consensus 360 LGLAv~h~~~t~-~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 360 LGLAVRHDSDTD-TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred ceeeEEecccCC-cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999987765432 2222345568999999999986431 1 11458999999999999842 677754
Q ss_pred C-----CHHHHHHHHHccccCCCCC-CC--C---HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 260 T-----NYSELLKQVQKRVVFPESP-RL--S---SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 260 ~-----~~~~~~~~i~~~~~~~~~~-~~--~---~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
. ..++..+-+......|..+ .. . ..+-++|+.|| .+|.-|.|+-.|.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 2 3344443333222222221 11 1 35667899999 99999999877653
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=231.20 Aligned_cols=213 Identities=25% Similarity=0.383 Sum_probs=173.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (335)
..+....+..||+|++|.|-+.++..+|...|+|.+...-. ....+++.+|+.+..+. .+|.+|.+++....+...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34455667899999999999999999999999999975433 23356666888877666 6999999999999999999
Q ss_pred EEEeccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 128 IIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 128 iv~e~~~~~sL~~~l----~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
|.||.|.. ||..+- ..++.++|..+-+|+..++.||.|||++ .++|||+||+||||+..|++|+||||++-.+.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 99999964 887665 4567799999999999999999999976 89999999999999999999999999987654
Q ss_pred cCCcccccccccccccccccccccccCC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKG----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQK 271 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~ 271 (335)
.+-.. ....|-..|+|||.+.. ..|+ -++||||||++++||.+++.||..- .+.+.++++.+
T Consensus 201 dSiAk------t~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIAK------TMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhHH------HHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 32211 11346778999999753 3455 8999999999999999999999753 45555555544
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=263.66 Aligned_cols=204 Identities=31% Similarity=0.538 Sum_probs=180.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHH-----HhhHHHHHHHHHcCC---CCCeeeeceeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL-----KKFLPREIEVVKGLK---HPNLIRFLQAI 120 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~ 120 (335)
...+|..++.+|+|+||.|++|+++.+...|++|.+.+.+...+.. ...+..|+.+|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999999999999999998765544332 234667999999997 99999999999
Q ss_pred EeCCeEEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 121 ETTHRVYIIMEYA-KNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 121 ~~~~~~~iv~e~~-~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
++++++||+||.- +|.+|.++|.....++|.++..|++|++.|+++||+.||+|||||-+||.++.+|-++|+|||.+.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999965 567999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~ 259 (335)
..... ....++||..|.|||++.+..|-...-|||+||+++|-+.....||..
T Consensus 719 ~~ksg-------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSG-------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCC-------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 54322 233568999999999999999988889999999999999998888853
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=252.03 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=203.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC---CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 124 (335)
....|..+++||+|+|++||++.+.. .++.||+|.+.....+ ..+.+|+++|..+. +.||+++.+.+..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44679999999999999999998877 6889999999776654 34779999999995 899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~~ 203 (335)
...+|+||++..+..++... ++...+..++..++.||.++|..|||||||||.|+|++.. +.-.|+|||++.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999999988888876 6788999999999999999999999999999999999864 5679999999972211
Q ss_pred CC-----cc---------------------------c-------ccccccccccccccccccccCCCCCCCCchhHHHHH
Q psy10459 204 NN-----TD---------------------------Y-------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244 (335)
Q Consensus 204 ~~-----~~---------------------------~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG 244 (335)
.. .. + .........||++|+|||++...+-.+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00 0 000111235999999999998877666899999999
Q ss_pred HHHHHHHhCCCCCCCCCHH-HHHHHH---------------------------------Hccc-----------------
Q psy10459 245 VVLFAMVYGRLPFDDTNYS-ELLKQV---------------------------------QKRV----------------- 273 (335)
Q Consensus 245 ~~~~~l~~g~~p~~~~~~~-~~~~~i---------------------------------~~~~----------------- 273 (335)
+++..++++..||.....+ ..+..+ ...+
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999999532110 000000 0000
Q ss_pred cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 274 VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.......++..+.+|+.+|| .||.+|.|++++|+||||...
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00011235668999999999 999999999999999999864
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=241.21 Aligned_cols=254 Identities=19% Similarity=0.295 Sum_probs=215.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
+...+++....+-+|.||.||.|.+.+. .+.|-+|.++....+. ....+..|.-.+..+.|||+.++.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4566888999999999999999977543 3456777775544433 36677889999999999999999988744
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEe
Q psy10459 123 -THRVYIIMEYAKNGSLLEVIRKE--------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLS 193 (335)
Q Consensus 123 -~~~~~iv~e~~~~~sL~~~l~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~ 193 (335)
....+.++.++.-|+|..++.-. ..++..++..++.|++.|++|||+.|++|.||-..|.+|++.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 56778899999889999999721 236778889999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcc
Q psy10459 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR 272 (335)
Q Consensus 194 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~ 272 (335)
|-.+++.+.+....... .+--....||+||.+.+..|+ .++|+||||+++|||+| |..||...++.++...++++
T Consensus 439 DsaLSRDLFP~DYhcLG---DnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLG---DNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred cchhccccCcccccccC---CCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99999987654433211 111235579999999999998 89999999999999998 99999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 273 VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 273 ~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++...+.++|.++..++..|| .+|++||+.+|+..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 999988899999999999999 99999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=227.73 Aligned_cols=212 Identities=36% Similarity=0.656 Sum_probs=184.2
Q ss_pred ecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCH
Q psy10459 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 59 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL 138 (335)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999988889999999997654422 246678999999999999999999999998999999999998999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEeccccccccccCCccccccccccc
Q psy10459 139 LEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETF 216 (335)
Q Consensus 139 ~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 216 (335)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~ 153 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LLKTI 153 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----hhhcc
Confidence 9999775 46899999999999999999999999999999999999999 89999999999976644321 11223
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CC
Q psy10459 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SP 295 (335)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~ 295 (335)
.+...|++||........+.+.|+|++|+++++| ..+.+++..|+ .+
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCC
Confidence 4678899999998762333789999999999999 67999999999 99
Q ss_pred CCCCCCHHHHhcCC
Q psy10459 296 VKFRIQMEDIRQDP 309 (335)
Q Consensus 296 p~~Rps~~~ll~hp 309 (335)
|.+||++.++++|+
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=225.03 Aligned_cols=214 Identities=35% Similarity=0.610 Sum_probs=181.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
|.+.+.||.|++|+||+|....+++.+|+|.+...... .....+.+|+..+..++|+|++++++.+...+..++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56889999999999999999888999999999764432 2356788999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 133 AKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999988766 899999999999999999999999999999999999999999999999998776543210
Q ss_pred ccccccccccccccccc-CCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHccc
Q psy10459 212 LSETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQVQKRV 273 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~-~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~--~~~~~~~~~i~~~~ 273 (335)
......++..|++||.+ ....++ .++|+|+||+++++|++|+.||.. .....+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 12234567889999998 555555 589999999999999999999977 34445666665543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=222.77 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=194.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeece-eEEeCCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQ-AIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~-~~~~~~~~~ 127 (335)
.+.|.|.+.||+|.||.+.+|.+..++..+|+|.+.+.... ...|.+|...--.| .|.||+.-++ .|+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 35699999999999999999999999999999999776543 56677888876666 4899998665 577888999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC--CCCEEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~ 205 (335)
+++||++.|+|..-+...+ +-|.....++.|++.||.|||++++||||||.+||||-+ ..++||||||..+..+.-.
T Consensus 99 F~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999999998886644 789999999999999999999999999999999999953 3479999999987654321
Q ss_pred cccccccccccccccccccccccCCCC---C-CCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHccc--cC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVP---Y-TPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRV--VF 275 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~---~-~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~~~--~~ 275 (335)
. ..--+..|.+||...... + ....+|+|.||+++|.+++|..||..... --.+.+...+. ..
T Consensus 178 ~--------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 178 K--------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred h--------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 1 111255789999874321 1 12458999999999999999999974321 11233333332 22
Q ss_pred CC-CCCCCHHHHHHHHHhc-CCCCCC---CCHHHHhcCCCcCCC
Q psy10459 276 PE-SPRLSSSCKALISNIL-SPVKFR---IQMEDIRQDPWLKED 314 (335)
Q Consensus 276 ~~-~~~~~~~l~~li~~~L-~~p~~R---ps~~~ll~hp~~~~~ 314 (335)
|. ...+++.+..+.++-| .++++| -++......-|....
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 22 1357888889999999 889999 566666666776544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=266.28 Aligned_cols=200 Identities=16% Similarity=0.229 Sum_probs=142.8
Q ss_pred CCeeeeceeE-------EeCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 111 PNLIRFLQAI-------ETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 111 ~~iv~~~~~~-------~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
.||+.+++++ .....++.++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4666666665 2234567788888 5699999965 34589999999999999999999999999999999999
Q ss_pred eecCCCCEE-------------------EeccccccccccCCc----cc---c----cccccccccccccccccccCCCC
Q psy10459 183 LLDDKYNIK-------------------LSDFGFARKYSVNNT----DY---K----QNLSETFCGSYAYASPEILKGVP 232 (335)
Q Consensus 183 li~~~~~~~-------------------l~Dfg~~~~~~~~~~----~~---~----~~~~~~~~g~~~y~aPE~~~~~~ 232 (335)
||+..+.++ ++|||+++....... .. . .......+||+.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996655554 555555433210000 00 0 00011246888999999998888
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 233 ~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
++ .++|||||||++|||++|..|+.... .....+......+..........+++.+|| .+|.+||++.|+|+||||
T Consensus 192 ~~-~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 SN-CASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred CC-chhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 87 89999999999999999988875322 222222222211111122456778999999 999999999999999999
Q ss_pred CCC
Q psy10459 312 KED 314 (335)
Q Consensus 312 ~~~ 314 (335)
.+.
T Consensus 269 ~~~ 271 (793)
T PLN00181 269 NEP 271 (793)
T ss_pred hhh
Confidence 764
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=201.79 Aligned_cols=240 Identities=22% Similarity=0.304 Sum_probs=191.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 125 (335)
.+...+|.++++||.|+||.+|+|....+|+.||+|+-+.... ...+..|..+++.|+ ..+|..+..++...++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 4667889999999999999999999999999999999865433 345668999999996 5678888888888888
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEecccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKY 201 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~~~~~ 201 (335)
-.+||+.+ |.||.++..- ...++..+++-++-|++.-++|+|..+++||||||+|+|+.-+ ..+.|+|||+++.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 89999999 8899998864 4569999999999999999999999999999999999999754 35899999999887
Q ss_pred ccCCccccc--ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHcc-ccC
Q psy10459 202 SVNNTDYKQ--NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL---LKQVQKR-VVF 275 (335)
Q Consensus 202 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~---~~~i~~~-~~~ 275 (335)
-........ .......||.+|.+-..+.+...+ .+.|+-|+|.++.++..|.+||.+...... +++|.+. ...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 554432221 122356799999998877776666 789999999999999999999998765443 4444331 111
Q ss_pred C---CCCCCCHHHHHHHHHhc
Q psy10459 276 P---ESPRLSSSCKALISNIL 293 (335)
Q Consensus 276 ~---~~~~~~~~l~~li~~~L 293 (335)
+ -..++|.++...+..|-
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHh
Confidence 2 23567778777777665
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=217.67 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=196.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCC-CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC----CCCeeeeceeE-EeCCe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK----HPNLIRFLQAI-ETTHR 125 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~iv~~~~~~-~~~~~ 125 (335)
+|.+.+.||+|+||.||.|.+..++ +.+|+|+........ ...+..|..++..+. ..++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 689999887643321 114667888888886 36899999888 47778
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-----CCEEEeccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-----YNIKLSDFGFA 198 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-----~~~~l~Dfg~~ 198 (335)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999988654 469999999999999999999999999999999999999865 35899999999
Q ss_pred c--ccccCCccc-cccc--ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H
Q psy10459 199 R--KYSVNNTDY-KQNL--SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---Q 270 (335)
Q Consensus 199 ~--~~~~~~~~~-~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i---~ 270 (335)
+ .+....... .... .....||..|.++..+.+.... .+.|+||++.++.+++.|..||...........+ .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 433222211 1111 2345699999999999999888 8999999999999999999999776643333333 2
Q ss_pred ccccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 271 KRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 271 ~~~~~~-~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...... .....+.++..+...+- .+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 222222 22345677877777777 788999988877654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=206.09 Aligned_cols=212 Identities=21% Similarity=0.317 Sum_probs=179.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 124 (335)
..+..-.|+++++||+|+||.++.|...-+++.||||.-..... .-++..|+..++.|. .++|..++.+...+.
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 34666789999999999999999999999999999998754332 445778999999884 789999998888888
Q ss_pred eEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-----CEEEeccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKLSDFGFA 198 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-----~~~l~Dfg~~ 198 (335)
+..+|+|.+ |.||.++..- +..|+..++..++.|++.-++++|.+.+|.|||||+|+||..-+ .+.++|||++
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 889999999 8899999865 45699999999999999999999999999999999999997533 3899999999
Q ss_pred cccccCCcccccccc--cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy10459 199 RKYSVNNTDYKQNLS--ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~ 264 (335)
+.+....+....+-. ....||.+||+=....+...+ .+.|+-|||-++++.+.|.+||.+...+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 988665544332222 245799999999988888888 88999999999999999999998865443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=243.36 Aligned_cols=262 Identities=25% Similarity=0.412 Sum_probs=206.5
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecC---CCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKV---QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
....++|.|++|.|+.+......+.++.|.++.. ..........+..|+.+-..+.|+|++..+..+.......-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4678999999998888887777777777765421 1111112222556777778889999988777666555555559
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|||++ +|..++.+.+.+....+-.+++|++.|+.|+|..|+.|||+|++|+++..+|.++|+|||.+..+....... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~-~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN-I 478 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh-h
Confidence 99999 999999888778999999999999999999999999999999999999999999999999998775443321 1
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHc--cc-----cCCCCCCCC
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQVQK--RV-----VFPESPRLS 282 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~-~~i~~--~~-----~~~~~~~~~ 282 (335)
......+|+..|+|||++.+..|.+...||||.|++++.|.+|+.||.-....+.. ..... .. .......++
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp 558 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP 558 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence 34567789999999999999999999999999999999999999999765544332 11111 11 111123578
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
...+.+|.+|| .+|.+|.|+++|++.+||+.-..+
T Consensus 559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred hhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 89999999999 999999999999999999875443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=203.80 Aligned_cols=159 Identities=19% Similarity=0.218 Sum_probs=127.7
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 136 GSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 136 ~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
|+|.+++.. ...+++..++.++.|++.||.|||+.+ ||+|||++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999976 456999999999999999999999998 999999999999999 9988755321
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccccCC------CCCCCCH--HH
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFP------ESPRLSS--SC 285 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~------~~~~~~~--~l 285 (335)
...|+..|+|||++.+..++ .++|||||||++|+|++|..||..... ......+....... ....++. ++
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cCCCcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 12578999999999988887 789999999999999999999976543 23333333221111 1112333 69
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
.++|.+|| .+|.+||++.++++|+|+..
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999 99999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=210.58 Aligned_cols=173 Identities=17% Similarity=0.204 Sum_probs=133.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-CCCeEEEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
...++|.+.+.||+|+||+||+|.+.. ++..||||++..... ..+.....+.+|+.+++.++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 446779999999999999999998876 677889998753311 123346678899999999999999853322 24
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI-KCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~di-kp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..|+||||++|++|... .. .. ...++.+++++|.|||+.||+|||| ||+|||++.++.++|+|||++..+..
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 57999999999999632 11 11 1567899999999999999999999 99999999999999999999987765
Q ss_pred CCccccc---ccccccccccccccccccCC
Q psy10459 204 NNTDYKQ---NLSETFCGSYAYASPEILKG 230 (335)
Q Consensus 204 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~ 230 (335)
.+..... .......++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4422211 11135678889999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-26 Score=200.17 Aligned_cols=263 Identities=30% Similarity=0.484 Sum_probs=210.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC-CeeeeceeEEeCCeEEEEEe
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP-NLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~iv~e 131 (335)
|.+.+.||.|+||.||++.+. ..+++|++.............+.+|...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999976 78999999765554433466777999999999988 79999999977777899999
Q ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccCCcc
Q psy10459 132 YAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 207 (335)
++.++++.+++.... .++......++.|++.++.++|..+++|||+||+||+++..+ .++++|||.+..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887664 689999999999999999999999999999999999999998 6999999999755433322
Q ss_pred ccc-ccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHccccC--C--
Q psy10459 208 YKQ-NLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVF--P-- 276 (335)
Q Consensus 208 ~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~~~~~--~-- 276 (335)
... .......|+..|+|||...+. .......|+||+|++++++++|..||..... ......+...... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 111 124566899999999999874 3444789999999999999999999887763 4555555443321 1
Q ss_pred CCCCC----CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 277 ESPRL----SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 277 ~~~~~----~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
..... ...+.+++..++ .+|..|.+..+...++|........
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~ 285 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccccc
Confidence 11111 157899999999 9999999999999997766654433
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=220.84 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=187.6
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCC--CChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ--APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
-..++.. .|...+.||.+.|=.|.+|++. .|. |+||++-+.. ...+...+++ .|++ ...+++||++++..+..
T Consensus 17 yfsd~~~-e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 17 YFSDLSV-ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred HhhcCcc-ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHH
Confidence 3334443 6889999999999999999964 455 8999986544 3334444444 3334 56679999999998877
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc-
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK- 200 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~- 200 (335)
.+...|+|-+|... +|+|.+..+..+...+.+.|+.|++.||..+|..||+|||||.+||||+....+.|+||..-+.
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCc
Confidence 78888899999976 9999998888888899999999999999999999999999999999999999999999987542
Q ss_pred -cccCCcccccccccccccccccccccccCCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCCC---------
Q psy10459 201 -YSVNNTDYKQNLSETFCGSYAYASPEILKGV----------PYTPQQSDIWSMGVVLFAMVY-GRLPFDD--------- 259 (335)
Q Consensus 201 -~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~~Di~slG~~~~~l~~-g~~p~~~--------- 259 (335)
+..+++........+-..-.+|.|||.+... +.-+.+.||||+||++.||++ |++||.-
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~ 250 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSG 250 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhcc
Confidence 2233332222222233345579999987431 112367899999999999998 8888842
Q ss_pred --CCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 260 --TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 260 --~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+.+.++|. +..+++||..|+ .||++|.++++.|+-
T Consensus 251 ~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 12222222221 236999999999 999999999999986
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=215.68 Aligned_cols=239 Identities=29% Similarity=0.511 Sum_probs=198.4
Q ss_pred eecccCceEEEEEEE---cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEEecc
Q psy10459 58 VVGMGSYATVKLATS---ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
++|.|+||.|+++.. ...|..+|+|+..+......... .-..|..++..++ ||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998753 34577899999876544332222 3346888888887 999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccc
Q psy10459 134 KNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213 (335)
Q Consensus 134 ~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 213 (335)
.||.|...+.....+.+.....+...++-+++++|+.+++|+|+|++||+++.+|++++.|||.++..-....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------- 152 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------- 152 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc
Q psy10459 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293 (335)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L 293 (335)
.|||.-|||||+..+ .. .+.|.||+|+++++|++|..||.. ++...|.+ ..++.+..++...++++..|+
T Consensus 153 --~cgt~eymApEI~~g--h~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~-~~~~~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIING--HL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILK-AELEMPRELSAEARSLFRQLF 222 (612)
T ss_pred --cccchhhhhhHhhhc--cC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-hccCCchhhhHHHHHHHHHHH
Confidence 189999999999993 33 579999999999999999999988 44444443 223344568899999999999
Q ss_pred -CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 294 -SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 294 -~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
.+|.+|. -+.|+++|+||+..
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheee
Confidence 9999998 45899999999875
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=189.74 Aligned_cols=249 Identities=18% Similarity=0.312 Sum_probs=199.4
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.....+......+..+|.+...|..|+|+++ |..+++|++.-... ...+...|..|+-.|+.+.||||+++++.|..
T Consensus 182 sr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacns 258 (448)
T KOG0195|consen 182 SRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNS 258 (448)
T ss_pred ccccCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccC
Confidence 3445566667778889999999999999976 55677787754333 23446678889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCEEEe--ccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLS--DFG 196 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~~l~--Dfg 196 (335)
...+.++..|++.|+|+.+++.... ++..++.+++.+++.|++|||+.. |.---++...++||++-+.+|+ |--
T Consensus 259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence 9999999999999999999987653 678899999999999999999974 4445688899999998776654 322
Q ss_pred cccccccCCcccccccccccccccccccccccCCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-ccc
Q psy10459 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT--PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ-KRV 273 (335)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~--~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~-~~~ 273 (335)
++ +...+ ..-.+.|++||.+...+-. -.++|+|||++++|||.|...||.+..+.+.-.++. +++
T Consensus 339 fs--fqe~g----------r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl 406 (448)
T KOG0195|consen 339 FS--FQEVG----------RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL 406 (448)
T ss_pred ee--eeccc----------cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc
Confidence 22 11111 1236789999999765433 357899999999999999999999998888776664 566
Q ss_pred cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh
Q psy10459 274 VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 306 (335)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll 306 (335)
....+++++..+..|+.-|+ .||.+||.++.|.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 67777899999999999999 9999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=181.46 Aligned_cols=142 Identities=19% Similarity=0.224 Sum_probs=111.2
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHH-----------------------HHhhHHHHHHHHHcCCCCC
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDY-----------------------LKKFLPREIEVVKGLKHPN 112 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~ 112 (335)
...||+|+||.||+|.+. +|+.||+|+++........ .......|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999764321110 1123345999999998777
Q ss_pred eeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEeecCCCCEE
Q psy10459 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC-HKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 113 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~i~H~dikp~Nili~~~~~~~ 191 (335)
+........ . ..+|||||+.|+++.........++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644333222 2 2389999999877766544456789999999999999999999 799999999999999998 47899
Q ss_pred Eecccccccc
Q psy10459 192 LSDFGFARKY 201 (335)
Q Consensus 192 l~Dfg~~~~~ 201 (335)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=189.48 Aligned_cols=234 Identities=20% Similarity=0.270 Sum_probs=153.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC----------CCeeeeceeE-
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH----------PNLIRFLQAI- 120 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~- 120 (335)
.+..+..||.|+++.||.+++..+|+.+|+|+............+.+.+|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678999999999999999999999999999876665544445566566554444322 1222222221
Q ss_pred --------EeC---C-----eEEEEEeccCCCCHHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q psy10459 121 --------ETT---H-----RVYIIMEYAKNGSLLEVIRK---ERY----IDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177 (335)
Q Consensus 121 --------~~~---~-----~~~iv~e~~~~~sL~~~l~~---~~~----~~~~~~~~i~~~i~~~L~~LH~~~i~H~di 177 (335)
... + ..+++|+-+. ++|.+++.- ... +.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 2477888885 488887642 221 223344566699999999999999999999
Q ss_pred CCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCC-------CCCCCchhHHHHHHHHHHH
Q psy10459 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-------PYTPQQSDIWSMGVVLFAM 250 (335)
Q Consensus 178 kp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~Di~slG~~~~~l 250 (335)
+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... ...+.+.|.|+||+++|.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999887655432211 1234678999976432 1223788999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCC
Q psy10459 251 VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFR 299 (335)
Q Consensus 251 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~R 299 (335)
+++..||........... .+.....+|+.++.||+.|| .+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999986543222111 34444579999999999999 999887
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-25 Score=182.41 Aligned_cols=177 Identities=14% Similarity=0.140 Sum_probs=135.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhh------HHHHHHHHHcCCCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF------LPREIEVVKGLKHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~ 119 (335)
..+...+|++.++||.|+||.||++.+ ++..+|+|+++......+..... +.+|+..+.++.|++|..+..+
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 445678999999999999999999764 46689999997654443333222 6789999999999999998887
Q ss_pred EEeC--------CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 120 IETT--------HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 120 ~~~~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
+... ...+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||++|+||+++++| ++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 6533 35789999999999988742 333 3456999999999999999999999999999988 99
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHH
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 251 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~ 251 (335)
|+|||........... ..+.....+. .++|+||||+++..+.
T Consensus 175 liDfg~~~~~~e~~a~-----------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-----------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-----------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9999987654221110 0133344556 6899999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=175.06 Aligned_cols=144 Identities=15% Similarity=0.216 Sum_probs=113.1
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh-----------------------HHHHhhHHHHHHHHHcCCCC
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI-----------------------DYLKKFLPREIEVVKGLKHP 111 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~ 111 (335)
+...||+|++|+||+|.+. +|+.||||+++...... ......+..|...+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999976 89999999998642210 01123346789999999988
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCE
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNI 190 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~ 190 (335)
++.....+... ..++||||++|+++.........++......++.|++.+|.++|. .||+|+||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 87544433332 247999999987654433334567889999999999999999999 9999999999999999 7899
Q ss_pred EEeccccccccc
Q psy10459 191 KLSDFGFARKYS 202 (335)
Q Consensus 191 ~l~Dfg~~~~~~ 202 (335)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=184.30 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=177.3
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCC-----------------------------------eEEEEEEecCC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ-----------------------------------DVAIKIISKVQ 88 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----------------------------------~vavK~~~~~~ 88 (335)
..+.|..++|+|++.||+|+.+.||.+.-..+|. +.|+|.+-...
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 3455778899999999999999999886543111 23566553322
Q ss_pred --CChHHHHhhHHHHHH------H--------HHc--------CCCCCeeeeceeEEe----------------------
Q psy10459 89 --APIDYLKKFLPREIE------V--------VKG--------LKHPNLIRFLQAIET---------------------- 122 (335)
Q Consensus 89 --~~~~~~~~~~~~E~~------~--------l~~--------l~h~~iv~~~~~~~~---------------------- 122 (335)
.....+.+.+.+|.. . .+. -+|||||+++.+|.+
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 122223333333321 1 111 259999999887632
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec--CCC--CEEEe
Q psy10459 123 -----THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD--DKY--NIKLS 193 (335)
Q Consensus 123 -----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~--~~~--~~~l~ 193 (335)
+..+|+||..++. +|..++-.+. .+.....-++.|+++|+.|||++||.|||+|.+|||+. +++ .+++.
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 2358999999976 9999997654 56777888999999999999999999999999999994 333 47899
Q ss_pred ccccccccccCCc--ccccccccccccccccccccccCCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy10459 194 DFGFARKYSVNNT--DYKQNLSETFCGSYAYASPEILKGVP-----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 266 (335)
Q Consensus 194 Dfg~~~~~~~~~~--~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~ 266 (335)
|||++-.-..-+- .+.. ..-...|...-||||+....+ ....++|.|+.|.+.||++....||.......+.
T Consensus 388 DFGCcLAd~~hGlqlpy~S-~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~ 466 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYES-DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD 466 (598)
T ss_pred ccceeeecccccccccccc-ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec
Confidence 9999853322110 1100 011234677899999985432 1225799999999999999999999874332221
Q ss_pred HH-HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHH
Q psy10459 267 KQ-VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 304 (335)
Q Consensus 267 ~~-i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ 304 (335)
.. .++....+....+++.+++++..+| .||++|+++.-
T Consensus 467 ~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 467 TRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred hhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 11 2222223344579999999999999 99999997653
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=203.78 Aligned_cols=198 Identities=23% Similarity=0.366 Sum_probs=161.2
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIET 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 122 (335)
..+....|.|.+.||+|+||+||+|...+ |+.||+|+-+......-++- .+++.+|+ -+.|..+..++..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHcc
Confidence 44667789999999999999999999765 99999999876544322222 23333443 3456666667777
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-------CCCEEEecc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------KYNIKLSDF 195 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-------~~~~~l~Df 195 (335)
.+..++|++|.+.|||.++++..+.+++..+..++.|++..++.||..+||||||||+|+||.. +.-++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 8888999999999999999998888999999999999999999999999999999999999953 345899999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCC
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~ 254 (335)
|.+..+...... ......++|..+-.+|+..+.+++ .+.|.|.|+.+++-|+.|.
T Consensus 846 G~siDm~lfp~~---~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG---TKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC---cEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHH
Confidence 999755322111 123345789999999999999999 8999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=166.99 Aligned_cols=195 Identities=13% Similarity=0.116 Sum_probs=139.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHH-HHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDY-LKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+.+...|++|+||+|+.+.. .+..++.+.+......... ....+.+|+++|++|. +++++.++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998774 6777777766554432221 1335789999999995 5788888775 3468999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEeecCCCCEEEeccccccccccCCccc-
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDI-KCENLLLDDKYNIKLSDFGFARKYSVNNTDY- 208 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~di-kp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~- 208 (335)
+|+.|.+|...... ....++.|++.+|.++|+.||+|||| ||+|||++.++.++|+|||++..........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999888754421 12457889999999999999999999 7999999999999999999998654333110
Q ss_pred --c-ccc----ccccccccccccccccCCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy10459 209 --K-QNL----SETFCGSYAYASPEILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDT 260 (335)
Q Consensus 209 --~-~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~p~~~~ 260 (335)
. ... ..-...++.|++|+...-- ..+-...+.++.|+.+|.++|+..+..+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 000 0011246667777764332 12213467889999999999998887543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-24 Score=200.25 Aligned_cols=225 Identities=26% Similarity=0.474 Sum_probs=171.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|..++.|..|+||.||+++++.+.+.+|+|+= +.. .+.+. ++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~--------lilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN--------LILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccc--------hhhhc--cccccCCccee--------------
Confidence 345799999999999999999999999999999532 211 11111 22222233322
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc--
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT-- 206 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 206 (335)
|+=...++..+.++.. ++.+++|||+.||+|+|+||+|.+|..-|++|++|||+++.-.....
T Consensus 136 -------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3333444444444433 27899999999999999999999999999999999999864321111
Q ss_pred --------ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccCCC
Q psy10459 207 --------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPE 277 (335)
Q Consensus 207 --------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~ 277 (335)
..........|||+.|.|||++....|. ..+|.|++|+++|+.+-|..||.+..+++++..+.. .+.+|+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 1111223456999999999999998898 789999999999999999999999999999888765 334444
Q ss_pred C-CCCCHHHHHHHHHhc-CCCCCCC---CHHHHhcCCCcCCC
Q psy10459 278 S-PRLSSSCKALISNIL-SPVKFRI---QMEDIRQDPWLKED 314 (335)
Q Consensus 278 ~-~~~~~~l~~li~~~L-~~p~~Rp---s~~~ll~hp~~~~~ 314 (335)
. ..++++.+++|.++| .+|..|. .+-++.+|+||+..
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 3 468899999999999 9999997 78889999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=167.45 Aligned_cols=145 Identities=16% Similarity=0.213 Sum_probs=114.6
Q ss_pred CeEEeeeecccCceEEEEEE-EcCCCCeEEEEEEecCCCCh---------------------HHHHhhHHHHHHHHHcCC
Q psy10459 52 GYSLGDVVGMGSYATVKLAT-SARHSQDVAIKIISKVQAPI---------------------DYLKKFLPREIEVVKGLK 109 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 109 (335)
-|.+.+.||+|++|.||+|. +..+|+.||+|+++...... ......+..|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 66789999999997543210 112234678999999997
Q ss_pred CCC--eeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEeecC
Q psy10459 110 HPN--LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS-VVHRDIKCENLLLDD 186 (335)
Q Consensus 110 h~~--iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-i~H~dikp~Nili~~ 186 (335)
+.+ +++++. .. ..++||||+.|.+|.........+....+..++.|++.+|.+||+.| ++|+||||+||+++
T Consensus 109 ~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 333333 22 34899999999888766544455667778899999999999999999 99999999999999
Q ss_pred CCCEEEecccccccc
Q psy10459 187 KYNIKLSDFGFARKY 201 (335)
Q Consensus 187 ~~~~~l~Dfg~~~~~ 201 (335)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 789999999988643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=159.54 Aligned_cols=135 Identities=21% Similarity=0.230 Sum_probs=106.3
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-----CCCCeeeeceeEEeCC---eE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-----KHPNLIRFLQAIETTH---RV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~ 126 (335)
-.+.||+|+||.||. +..++.. +||++...... ....+.+|+.+++.+ .||||++++++++++. ..
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 457899999999995 5666555 68988654322 245678999999999 5799999999998863 43
Q ss_pred E-EEEec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCEeecCC----CCEEEeccccc
Q psy10459 127 Y-IIMEY--AKNGSLLEVIRKERYIDEDKGRRWFSQLADAI-DYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFA 198 (335)
Q Consensus 127 ~-iv~e~--~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~i~H~dikp~Nili~~~----~~~~l~Dfg~~ 198 (335)
+ +|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+.+|+||||||+|||++.+ +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 5578999999764 46665 35678888777 99999999999999999999743 37999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-20 Score=154.64 Aligned_cols=137 Identities=18% Similarity=0.225 Sum_probs=113.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH-----HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+.|++++....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999986 677899998654322111 123457789999999999998877777767778899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
|++|++|.+++..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 7889999999999999999999999999999999 78899999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=151.65 Aligned_cols=140 Identities=21% Similarity=0.279 Sum_probs=109.3
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH-------------------HHHhhHHHHHHHHHcCCCCC-
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-------------------YLKKFLPREIEVVKGLKHPN- 112 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~~- 112 (335)
|.+.+.||+|+||.||++... +|+.||||+++....... ........|+..+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999864 799999999865331100 11223567888888887764
Q ss_pred -eeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 113 -LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 113 -iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
++..++ ....+++|||++|++|..+... .....++.+++.++.++|..|++|+||+|.||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 333332 2455899999999998765431 34567889999999999999999999999999999999999
Q ss_pred Eecccccccccc
Q psy10459 192 LSDFGFARKYSV 203 (335)
Q Consensus 192 l~Dfg~~~~~~~ 203 (335)
|+|||.+..+..
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=165.36 Aligned_cols=200 Identities=25% Similarity=0.445 Sum_probs=157.7
Q ss_pred HHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCCE
Q psy10459 105 VKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSV-VHRDIKCENL 182 (335)
Q Consensus 105 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i-~H~dikp~Ni 182 (335)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... -.++.-....++++|+.||.|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35788999999999999999999999999999999999773 457888888999999999999999876 9999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCC------CCCchhHHHHHHHHHHHHhCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY------TPQQSDIWSMGVVLFAMVYGRLP 256 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~~Di~slG~~~~~l~~g~~p 256 (335)
+++..-.+||+|||+...... .. ............-|.|||.+..... .+.+.|+||+|++++|+++...|
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~-~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE-TA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeEEEEechhhhcccccc-cc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999876532 00 0011112224567999999876421 24679999999999999999999
Q ss_pred CCC----CCHHHHHHHHHccccC---CCC---CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 257 FDD----TNYSELLKQVQKRVVF---PES---PRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 257 ~~~----~~~~~~~~~i~~~~~~---~~~---~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
|.. ....+++..+...... |.. ..+++++..+++.|+ .+|..||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 975 2335566666552222 211 145668999999999 99999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=149.80 Aligned_cols=133 Identities=17% Similarity=0.233 Sum_probs=106.9
Q ss_pred eecccCceEEEEEEEcCCCCeEEEEEEecCCCC-----hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
.||+|++|.||+|. .+|..|++|+....... .......+.+|+.++..+.++++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 45788999986543211 111235677899999999888765555555566677899999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 8899999999999999999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-19 Score=165.26 Aligned_cols=139 Identities=17% Similarity=0.226 Sum_probs=111.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCC-C----ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ-A----PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..|...+.||+|+||+||+|.+.. ..+++|+..... . ........+.+|+.++..++|++++....++...+.
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999998643 344555432211 1 111224567899999999999999887777767777
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
.++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 346789999999999999999999999999999 577899999999854
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-21 Score=181.83 Aligned_cols=260 Identities=29% Similarity=0.507 Sum_probs=206.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (335)
...|.+.+.||+|+|+.|-.+....+ ...+|+|.+...... ......+..|..+-..+. |.|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~-~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS-EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc-cchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 45578888899999999988876433 345677766554311 112333445777667776 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCEeecCCC-CEEEecccccccccc
Q psy10459 128 IIMEYAKNGSLLEVI-RKER-YIDEDKGRRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSV 203 (335)
Q Consensus 128 iv~e~~~~~sL~~~l-~~~~-~~~~~~~~~i~~~i~~~L~~LH-~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~ 203 (335)
+++++..|+++.+.+ .... ..+......++.|+..++.|+| ..++.|+|+||+|.+++.++ .+++.|||++..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999888 5554 5777888999999999999999 99999999999999999999 999999999988766
Q ss_pred -CCccccccccccccc-ccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH-H--ccccCCC
Q psy10459 204 -NNTDYKQNLSETFCG-SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQV-Q--KRVVFPE 277 (335)
Q Consensus 204 -~~~~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~-~~i-~--~~~~~~~ 277 (335)
.+.. ......+| +..|.|||...+..+.....|+||.|+++..+++|..||......... ... . .......
T Consensus 178 ~~g~~---~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 178 KNGAE---RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred cCCcc---eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 3322 22344567 999999999998766667899999999999999999999765443321 111 1 1112344
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+..++....+++.++| .+|..|.+.+++-.++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 5678899999999999 89999999999999999998
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=166.16 Aligned_cols=178 Identities=24% Similarity=0.432 Sum_probs=135.0
Q ss_pred eEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
++||.|++|...+|.+++.+.. ..+....+.++.|++.+++| +|.+|+|+||.||++..+..++|.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5889999999999999997543 35677889999999999999 99999999999999999999999999998776
Q ss_pred ccCCcccc-cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCC-C-
Q psy10459 202 SVNNTDYK-QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP-E- 277 (335)
Q Consensus 202 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~-~- 277 (335)
........ ........||..||+||.+.+..|. .++||||||++++||+. -...+.. ......+..+ .+| .
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g-~ip~~~ 481 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDG-IIPPEF 481 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcC-CCChHH
Confidence 54431110 1112346799999999999999999 89999999999999996 2222211 1112222222 233 1
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...+ ++-.+|+.+|| ..|.+||++.+.--|.|.
T Consensus 482 ~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1223 33458999999 999999988888888775
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=142.18 Aligned_cols=139 Identities=20% Similarity=0.324 Sum_probs=98.5
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhh---------------------HHHHHHHHHcCCCCC--
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF---------------------LPREIEVVKGLKHPN-- 112 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~~-- 112 (335)
.+.||+|+||+||+|.+. +|..||||++............. ...|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999976 79999999987643221111111 134555565554432
Q ss_pred eeeeceeEEeCCeEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCE
Q psy10459 113 LIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNI 190 (335)
Q Consensus 113 iv~~~~~~~~~~~~~iv~e~~~~~sL~~-~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~ 190 (335)
+.+.++. ...+++|||++++++.. .+.... . ......++.+++.++.++|. .|++|+||+|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 3333332 24589999999854321 111111 1 16678999999999999999 9999999999999999 8899
Q ss_pred EEeccccccccc
Q psy10459 191 KLSDFGFARKYS 202 (335)
Q Consensus 191 ~l~Dfg~~~~~~ 202 (335)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=140.14 Aligned_cols=137 Identities=19% Similarity=0.238 Sum_probs=103.1
Q ss_pred eeec-ccCceEEEEEEEcCCCCeEEEEEEecCCC----------ChHHHHhhHHHHHHHHHcCCCCCe--eeeceeEEeC
Q psy10459 57 DVVG-MGSYATVKLATSARHSQDVAIKIISKVQA----------PIDYLKKFLPREIEVVKGLKHPNL--IRFLQAIETT 123 (335)
Q Consensus 57 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~ 123 (335)
..|| .|+.|+||.+.. .+..++||.+..... ........+.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3566 777888888874 377899998864321 011224567789999999988775 5566554332
Q ss_pred -C---eEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 124 -H---RVYIIMEYAKN-GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 124 -~---~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
. ..++|||+++| .+|.+++... .+++.. +.+++.+|.+||+.||+|+||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 6898888653 455543 568999999999999999999999999999889999999987
Q ss_pred cc
Q psy10459 199 RK 200 (335)
Q Consensus 199 ~~ 200 (335)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-18 Score=155.98 Aligned_cols=260 Identities=22% Similarity=0.233 Sum_probs=197.0
Q ss_pred cccCCeEEeeeecc--cCceEEEEEEE--cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGM--GSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 122 (335)
+....+-+.+.+|. |.+|.||.+.- ..++..+|+|.-......... ...=.+|+.....+ .|++.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCccccc
Confidence 34556788899999 99999999887 778899999985443322111 11222566666666 49999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCEeecCC-CCEEEeccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLAD----AIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFG 196 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~----~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg 196 (335)
.+.+|+-+|+| +.+|..+...... +++..++..+.+... ||.++|..+++|.|+||.||++..+ ..++++|||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 99999999999 5688888876544 889999999999999 9999999999999999999999999 789999999
Q ss_pred cccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC
Q psy10459 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 276 (335)
+...++..+............|...|++||...+... ..+|+|+||.++.+..++..+........ +..+...+...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~--~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~ip~ 345 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT--FASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGYIPL 345 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccc--hHhhhcchhhhhHhhHhhcccccCCCCCC-ccccccccCch
Confidence 9988876654333322334457888999999887543 57999999999999988766654331111 11111222111
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 277 -ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 277 -~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
.....+.++...+..|+ .+|..|++...++.|+++.
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 12346677777899999 8999999999999999886
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.3e-17 Score=126.83 Aligned_cols=131 Identities=23% Similarity=0.296 Sum_probs=109.5
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC--CCeeeeceeEEeCCeEEEEEec
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
+++.||.|.++.||++... +..+++|....... ...+.+|+..+..+.+ .++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999964 47899998865432 3456789999999976 5888888888777889999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK---SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~---~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+.|+++..+ +......++.+++.+|..||.. +++|+|++|+||++++.+.++++|||.+.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 998777654 4556678899999999999985 69999999999999998899999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-15 Score=139.65 Aligned_cols=216 Identities=16% Similarity=0.265 Sum_probs=154.3
Q ss_pred EEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCC
Q psy10459 69 LATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI 148 (335)
Q Consensus 69 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~ 148 (335)
.|..+.++.+|.|++++.... .....+.+-++.|+.++||||+++++.++..+..|+|+|.+. .|..+++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 466678899999999876544 223445677889999999999999999999999999999994 788888764
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccc
Q psy10459 149 DEDKGRRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227 (335)
Q Consensus 149 ~~~~~~~i~~~i~~~L~~LH-~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 227 (335)
....+..-+.||+.||.||| +.+++|++|.-+.|+|+..|.++|++|.++......+. ......-...|..|+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPEE 176 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----ccccchhhhcccChhh
Confidence 36677788899999999997 56899999999999999999999999998765433221 1111222345667766
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHH---
Q psy10459 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME--- 303 (335)
Q Consensus 228 ~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~--- 303 (335)
+.... ...|.|.|||++++++.|..+- ... ......+|.....+..+.+ ..+..||...
T Consensus 177 ~~~s~---~s~D~~~Lg~li~el~ng~~~~--~~~------------~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~ 239 (690)
T KOG1243|consen 177 IDPSE---WSIDSWGLGCLIEELFNGSLLT--KTD------------LSNTGKIPKALIELYCKKLGATELKRPNKLRFI 239 (690)
T ss_pred cCccc---cchhhhhHHHHHHHHhCcccCc--chh------------hhccCccchhHHHHHHHHhccccccccchhhHH
Confidence 55443 3479999999999999983221 110 0111234545555554444 5566666432
Q ss_pred --HHhcCCCcCCC
Q psy10459 304 --DIRQDPWLKED 314 (335)
Q Consensus 304 --~ll~hp~~~~~ 314 (335)
-.+-|+||++.
T Consensus 240 ~~~~~~~gff~n~ 252 (690)
T KOG1243|consen 240 LECRLLGGFFRND 252 (690)
T ss_pred HHHHhccccccch
Confidence 22348888775
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=140.76 Aligned_cols=143 Identities=17% Similarity=0.284 Sum_probs=94.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------------------------------hHHHHhhH--
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------------------------------IDYLKKFL-- 98 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------~~~~~~~~-- 98 (335)
.|.. +.||+|++|+||+|+.+.+|+.||||+++..... .+.....+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 7899999999999998877999999999753210 00112222
Q ss_pred ----HHHHHHHHcC----CCCCeeeeceeE-EeCCeEEEEEeccCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHHH
Q psy10459 99 ----PREIEVVKGL----KHPNLIRFLQAI-ETTHRVYIIMEYAKNGSLLEVI--RKER----YIDEDKGRRWFSQLADA 163 (335)
Q Consensus 99 ----~~E~~~l~~l----~h~~iv~~~~~~-~~~~~~~iv~e~~~~~sL~~~l--~~~~----~~~~~~~~~i~~~i~~~ 163 (335)
.+|+..+.++ .+.+.+.+-..+ +.....++||||+.|+++.++. ...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence 2333333333 233333333333 2245668999999999998753 3322 1333333333444
Q ss_pred HHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 164 IDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 164 L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
+...|++|+|++|.||+++.++ +++++|||++..+.
T Consensus 276 ---if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ---VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4468999999999999999988 89999999986553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-14 Score=132.25 Aligned_cols=142 Identities=19% Similarity=0.218 Sum_probs=96.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh-------------------------------HHHHh------hHH
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI-------------------------------DYLKK------FLP 99 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~------~~~ 99 (335)
+.||.|++|+||+|+. .+|+.||||+.+..-... +.... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 479999999986431100 00000 233
Q ss_pred HHHHHHHcC----CCCCeeeeceeE-EeCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q psy10459 100 REIEVVKGL----KHPNLIRFLQAI-ETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLAD-AIDYCHKKSV 172 (335)
Q Consensus 100 ~E~~~l~~l----~h~~iv~~~~~~-~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~-~L~~LH~~~i 172 (335)
+|+..+..+ ++.+-+.+-..+ ......++||||++|++|.++.... ... ....++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 445444444 222222222222 3344568999999999998876432 112 23456666665 4788999999
Q ss_pred eeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 173 ~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+|+|++|.||+++.++.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=150.34 Aligned_cols=283 Identities=19% Similarity=0.309 Sum_probs=208.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...+.+.+.+-+-.|+++.++.+.-..+|...+.|+......-.....+.+..+-.++-...+|-++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35667888999999999999988876777666666654322111100111222222222234555555544444566789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC--
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN-- 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 205 (335)
++++|..+++|...++..+..+.+-....+..+.+++++||...+.|+|++|.|.++..++...+.|||.....+.-.
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999999999999888878888888888999999999999999999999999999999999999998443221100
Q ss_pred -------------------cc--cc---cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy10459 206 -------------------TD--YK---QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261 (335)
Q Consensus 206 -------------------~~--~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~ 261 (335)
.. .. ........||..|.+||...+.... ..+|.|++|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 00 0112345789999999999888777 67999999999999999999999999
Q ss_pred HHHHHHHHHcc-ccCCCCC-CCCHHHHHHHHHhc-CCCCCCCCHH---HHhcCCCcCCCCCCCCCCCCCCcccccCC
Q psy10459 262 YSELLKQVQKR-VVFPESP-RLSSSCKALISNIL-SPVKFRIQME---DIRQDPWLKEDSNPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 262 ~~~~~~~i~~~-~~~~~~~-~~~~~l~~li~~~L-~~p~~Rps~~---~ll~hp~~~~~~~~~~~~~~~~~~~~~~~ 332 (335)
...+++.+... ..+|..+ ..+.+.++++..+| .+|.+|..+. ++-.|+||+...... .-+.+.+++|..+
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~-l~~q~~~~~p~~~ 1115 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN-LALQKAEFVPQPE 1115 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc-cccccCccCCCCC
Confidence 99999888764 3344433 57899999999999 9999999888 999999998743221 2335555665544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-14 Score=115.67 Aligned_cols=141 Identities=13% Similarity=0.242 Sum_probs=101.2
Q ss_pred eeeecccCceEEEEEEEcC------CCCeEEEEEEecCCC-----------------------ChHHHHhhHHHHHHHHH
Q psy10459 56 GDVVGMGSYATVKLATSAR------HSQDVAIKIISKVQA-----------------------PIDYLKKFLPREIEVVK 106 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~ 106 (335)
...||.|--+.||.|.... .+..+|||+.+.... +........++|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 357999999853110 01112223448999999
Q ss_pred cCCC--CCeeeeceeEEeCCeEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCE
Q psy10459 107 GLKH--PNLIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYC-HKKSVVHRDIKCENL 182 (335)
Q Consensus 107 ~l~h--~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~-~l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~i~H~dikp~Ni 182 (335)
++.. -+++.++.+ ...++||||+.+..+.. .++ ...+++.....+..+++.+|..| |+.|++|+||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8853 345555543 45579999996643322 222 22356667788889999999988 899999999999999
Q ss_pred eecCCCCEEEeccccccccc
Q psy10459 183 LLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~ 202 (335)
++.+ +.+.|+|||.+....
T Consensus 157 L~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEC-CcEEEEECCCceeCC
Confidence 9974 679999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.4e-15 Score=124.94 Aligned_cols=204 Identities=18% Similarity=0.311 Sum_probs=141.2
Q ss_pred HHHHHcCCCCCeeeeceeEEeCC-----eEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--
Q psy10459 102 IEVVKGLKHPNLIRFLQAIETTH-----RVYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKK-- 170 (335)
Q Consensus 102 ~~~l~~l~h~~iv~~~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~-- 170 (335)
+..|.++-|.|||+++.++.+.. ...+++||+..|++..++++. ..+......+|+.||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 44566677999999998886533 478899999999999999753 4578888999999999999999998
Q ss_pred CceeccCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHH
Q psy10459 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 250 (335)
Q Consensus 171 ~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l 250 (335)
.++|+++..+.|++..+|-+++.--........-+.. ...-...-.+.++|.|||.=...... -++|||++|+...+|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~-~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNST-REAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhh-hHhhhhccccCCccccCCcCcccccc-cchhhhhhhHHHHHH
Confidence 5999999999999999987776532221111000000 00001112356788999876555544 679999999999999
Q ss_pred HhCCCCC-CCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 251 VYGRLPF-DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 251 ~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+..-- .+...-.....+.... +.. -...-++++++|| ..|..||++.++|.||-+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i-~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVI-IGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHheeccCCCcceeehhhhhhhhe-eec---cCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 8775542 2222222222222211 110 1123457889999 899999999999999965
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-15 Score=134.47 Aligned_cols=252 Identities=20% Similarity=0.216 Sum_probs=184.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA-RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (335)
-..+|..+..||.|.|+.|+.+... .++..|++|...+.-..... ...-..|+.+...+ .|.+++.+...|...+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-hhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457889999999999999987754 57788999987654433222 22233566666666 488888888777777777
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~ 205 (335)
|+-.|||.++++...+.....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||+...+....
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 8999999999888777555557888999999999999999999999999999999999986 678999999986543222
Q ss_pred cccccccccccccccccc--cccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYA--SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.. .....++. +++......+. .+.|+||||.-+.+.+++...-........ ......+..+....
T Consensus 422 ~~--------~~~~~r~~p~~~~~~e~~~~~-~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----i~~~~~p~~~~~~~ 488 (524)
T KOG0601|consen 422 GV--------FHHIDRLYPIAEILLEDYPHL-SKADIFSLGLSVDEAITGSPLSESGVQSLT----IRSGDTPNLPGLKL 488 (524)
T ss_pred cc--------ccccccccccchhhccccccc-cccccccccccccccccCcccCccccccee----eecccccCCCchHH
Confidence 11 11233444 44444555555 789999999999999987544332222111 12233444455567
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+..+.+.|+ .++..||.+.++..|.=|...
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 7888888898 999999999999999866543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.2e-14 Score=114.25 Aligned_cols=127 Identities=17% Similarity=0.103 Sum_probs=94.4
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeee-eceeEEeCCeEEEEEeccC
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR-FLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~iv~e~~~ 134 (335)
++.|+.|.++.||++... +..|++|+....... ...+..|+.+++.+.+.++++ ++... ....++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467889999999999853 788999987554321 223467899998886555543 44332 234579999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCEeecCCCCEEEecccccc
Q psy10459 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV-----VHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 135 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i-----~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
|.++.... .....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876430 1123456789999999999885 9999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-13 Score=106.36 Aligned_cols=134 Identities=17% Similarity=0.232 Sum_probs=101.6
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEec-----CCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISK-----VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
..+++|+-+.++.+.+ -|..+++|.=.. ......-......+|+.++..+.--+|...+-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4678999999999965 355566664322 222222335566789999999976666655555567777789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
|++|..|.+++... ...++..+-..+.-||..||+|+|+.++||++...+ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998999898765 255667777778889999999999999999998774 99999999863
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-12 Score=115.02 Aligned_cols=211 Identities=18% Similarity=0.231 Sum_probs=154.9
Q ss_pred CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE----eCCeEEEEEeccCC-CC
Q psy10459 63 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE----TTHRVYIIMEYAKN-GS 137 (335)
Q Consensus 63 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~iv~e~~~~-~s 137 (335)
--.+.|++....+|..|++|++.-.+... ......-+++++++.|.|+|++.++|. .+..+++|++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34578999999999999999993222111 111225688999999999999998876 24568999999986 47
Q ss_pred HHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 138 LLEVIRK---------------ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 138 L~~~l~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
|.++.-. +...+|+.+|.++.|+..||.++|+.|+..+-|.+.+|+++.+.+++|+..|+.-.+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7775521 1236789999999999999999999999999999999999999899999888775554
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHccccCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~--~~~~~~~~~i~~~~~~~~~~~ 280 (335)
.+.. |.+.+ . .+-|.=.||.++..|.+|..--.. .........+. ..
T Consensus 445 ~d~~-------------------~~le~---~-Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~--------~~ 493 (655)
T KOG3741|consen 445 EDPT-------------------EPLES---Q-QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT--------TT 493 (655)
T ss_pred CCCC-------------------cchhH---H-hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------hh
Confidence 3321 01111 1 568999999999999999654222 22222233333 34
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.+++++|..+. ..+++ -++.+++.|
T Consensus 494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 7889999999888 66776 788888765
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=101.92 Aligned_cols=144 Identities=17% Similarity=0.175 Sum_probs=108.8
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEE-----EecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKI-----ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~-----~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.+..|-+|+-+.|+++. ..|+.++||. ++.......-.+.+..+|+..|.++.--+|.-..-++.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 66788999999999998 4588777774 2333333444567788999999988755655444455566667899
Q ss_pred EeccCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEeccccccc
Q psy10459 130 MEYAKN-GSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARK 200 (335)
Q Consensus 130 ~e~~~~-~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~~~ 200 (335)
|||++| .++.+++.... .........++..|-+.+.-||..+++|+||..+||++.+++. +.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47888886542 2333444788999999999999999999999999999987653 48999999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.6e-12 Score=104.56 Aligned_cols=139 Identities=17% Similarity=0.215 Sum_probs=99.8
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeeceeEEeC---CeEEEEEe
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQAIETT---HRVYIIME 131 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~---~~~~iv~e 131 (335)
+.||.|..+.||++... +|+.+++|+....... .....+..|+.++..+.+.+ +++++.+.... +..+++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999863 4688999997654321 12445678999999997544 45566655443 25689999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK------------------------------------------ 169 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------ 169 (335)
+++|.++...+.. ..++......++.+++++|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999877664421 235555566666666666666662
Q ss_pred --------------CCceeccCCCCCEeecC--CCCEEEecccccc
Q psy10459 170 --------------KSVVHRDIKCENLLLDD--KYNIKLSDFGFAR 199 (335)
Q Consensus 170 --------------~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~ 199 (335)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34699999999999998 5668999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.3e-12 Score=120.49 Aligned_cols=154 Identities=21% Similarity=0.355 Sum_probs=114.1
Q ss_pred HHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccCC----cccccccccccccccccccccccCCCCC
Q psy10459 159 QLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN----TDYKQNLSETFCGSYAYASPEILKGVPY 233 (335)
Q Consensus 159 ~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 233 (335)
+++.||.|+|+. ++||++|.|++|.++.++.+||+.|+++....... ..+.............|.|||++.....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344999999976 89999999999999999999999999886443311 1122222222335678999999988555
Q ss_pred CCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHc---cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 234 TPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 234 ~~~~~Di~slG~~~~~l~-~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
. .++|+||+|+++|.+. .|..-+.............. ...+-....+|+++++-+.++| .++.-||++.++++.
T Consensus 187 ~-~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 T-PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred c-ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 5 7899999999999998 46555554433332222221 1122233579999999999999 999999999999999
Q ss_pred CCcCC
Q psy10459 309 PWLKE 313 (335)
Q Consensus 309 p~~~~ 313 (335)
|||.+
T Consensus 266 ~ff~D 270 (700)
T KOG2137|consen 266 PFFSD 270 (700)
T ss_pred cccCC
Confidence 99987
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.4e-11 Score=96.52 Aligned_cols=128 Identities=23% Similarity=0.325 Sum_probs=84.6
Q ss_pred EEEEEEEcCCCCeEEEEEEecCC-----------------------CChHHHHhhHHHHHHHHHcCCCCC--eeeeceeE
Q psy10459 66 TVKLATSARHSQDVAIKIISKVQ-----------------------APIDYLKKFLPREIEVVKGLKHPN--LIRFLQAI 120 (335)
Q Consensus 66 ~V~~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~ 120 (335)
.||.|.. .+|..+|+|+.+... ...........+|+..|..+...+ +++++.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4888986 467899999985311 122334556789999999997664 4555533
Q ss_pred EeCCeEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 121 ETTHRVYIIMEYAK--NGSLLEVIRKERYIDEDKGRRWFSQLADAIDY-CHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 121 ~~~~~~~iv~e~~~--~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
. ..+|||||+. |..+..+.... ++......++.+++..+.. +|..|++|||+.+.||+++++ .+.++|||.
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred -e--CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2 2369999998 65555544322 1234567778888885444 689999999999999999988 899999998
Q ss_pred cccc
Q psy10459 198 ARKY 201 (335)
Q Consensus 198 ~~~~ 201 (335)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 8654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.7e-11 Score=99.17 Aligned_cols=139 Identities=19% Similarity=0.293 Sum_probs=105.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------------------hHHHHhhHHHHHHHHHcCCCC--
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------------------IDYLKKFLPREIEVVKGLKHP-- 111 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~h~-- 111 (335)
+.++..||.|--+.||.|.+. .|..+|||.=+..... ..-.+...++|+++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999975 6889999976432111 112244577999999999654
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
.+++.+++ +...+|||+++|..|...- ++.+....++..|++-+..+-..|++|+|+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 66666544 5668999999986665433 23455667777777777777799999999999999999999999
Q ss_pred Eecccccccc
Q psy10459 192 LSDFGFARKY 201 (335)
Q Consensus 192 l~Dfg~~~~~ 201 (335)
++||-.+...
T Consensus 243 vIDwPQ~v~~ 252 (304)
T COG0478 243 VIDWPQAVPI 252 (304)
T ss_pred EEeCcccccC
Confidence 9999876543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-10 Score=97.71 Aligned_cols=132 Identities=17% Similarity=0.080 Sum_probs=94.3
Q ss_pred eEEEEEEEcCCCCeEEEEEEecCCCChHHH---------HhhHHHHHHHHHcCCCCCee--eeceeEEe-----CCeEEE
Q psy10459 65 ATVKLATSARHSQDVAIKIISKVQAPIDYL---------KKFLPREIEVVKGLKHPNLI--RFLQAIET-----THRVYI 128 (335)
Q Consensus 65 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv--~~~~~~~~-----~~~~~i 128 (335)
..|+++. -.|+.|.||........ ... ...+.+|+..+..|...+|. .++.++.. ....++
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 3455655 35778999977433211 000 11366888888888544443 33444432 235789
Q ss_pred EEeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-------CCCEEEeccccc
Q psy10459 129 IMEYAKNG-SLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------KYNIKLSDFGFA 198 (335)
Q Consensus 129 v~e~~~~~-sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-------~~~~~l~Dfg~~ 198 (335)
|||++++. +|.+++.. ....+......++.+++..+..||..||+|+|+++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999876 79998864 234566778899999999999999999999999999999985 467899999987
Q ss_pred c
Q psy10459 199 R 199 (335)
Q Consensus 199 ~ 199 (335)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.1e-10 Score=97.59 Aligned_cols=237 Identities=16% Similarity=0.172 Sum_probs=152.3
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee------E-EeCCe
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA------I-ETTHR 125 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~------~-~~~~~ 125 (335)
..+..||+|+-+.+|-.-.. +.. +.|++......-. . +-+..|... .||-+-.-+.+ . .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hch-hheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 35678999999999965422 233 4588866443221 1 223334333 45543221111 1 12233
Q ss_pred EEEEEeccCCC-CHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 126 VYIIMEYAKNG-SLLEVIR------KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 126 ~~iv~e~~~~~-sL~~~l~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
..++|+.++|- .+..+.. +...+.+..++..+..++.+.+.||..|.+-+|++++|+|+++++.+.|.|-+.-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 67888888764 3333332 1233678899999999999999999999999999999999999999999986543
Q ss_pred cccccCCcccccccccccccccccccccccCCC-----CCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------HHH-
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-----PYTPQQSDIWSMGVVLFAMVYG-RLPFDDTN-------YSE- 264 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~~Di~slG~~~~~l~~g-~~p~~~~~-------~~~- 264 (335)
... .++ ......+|...|.+||...-. .-+ ...|.|.||+++++++.| ++||.+.. +-+
T Consensus 165 qi~-~ng-----~~~~cpVg~~eftPPElQ~~~sf~g~~r~-~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 165 QIN-ANG-----TLHLCPVGVSEFTPPELQTLPSFVGFERT-ANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred eec-cCC-----ceEecccCccccCCHHHhccccccccCCC-ccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 322 111 123355789999999987522 222 458999999999999885 99997632 111
Q ss_pred HHH--------HHHccccCC----CCCCCCHHHHHHHHHhcCC---CCCCCCHHHHh
Q psy10459 265 LLK--------QVQKRVVFP----ESPRLSSSCKALISNILSP---VKFRIQMEDIR 306 (335)
Q Consensus 265 ~~~--------~i~~~~~~~----~~~~~~~~l~~li~~~L~~---p~~Rps~~~ll 306 (335)
.+. +-..++..+ ....+++++..|..+|..+ +.-|||++..+
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~ 294 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV 294 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence 110 001122211 1234788999999999833 56899987543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-09 Score=89.61 Aligned_cols=106 Identities=22% Similarity=0.279 Sum_probs=83.7
Q ss_pred HhhHHHHHHHHHcCCCCCe--eeeceeEEeC----CeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q psy10459 95 KKFLPREIEVVKGLKHPNL--IRFLQAIETT----HRVYIIMEYAKNG-SLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167 (335)
Q Consensus 95 ~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~----~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L 167 (335)
.....+|...+..|...+| ++.+.+.... ...++|+|++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4456688888877754333 3344444332 2458999999874 7999998755577788899999999999999
Q ss_pred HhCCceeccCCCCCEeecCCC---CEEEeccccccc
Q psy10459 168 HKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARK 200 (335)
Q Consensus 168 H~~~i~H~dikp~Nili~~~~---~~~l~Dfg~~~~ 200 (335)
|..||+|+|+++.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.2e-09 Score=84.22 Aligned_cols=138 Identities=12% Similarity=0.155 Sum_probs=99.6
Q ss_pred cccCceEEEEEEEcCCCCeEEEEEEecCC--C-ChHHHHhhHHHHHHHHHcCCCCC--eeeeceeEE-e----CCeEEEE
Q psy10459 60 GMGSYATVKLATSARHSQDVAIKIISKVQ--A-PIDYLKKFLPREIEVVKGLKHPN--LIRFLQAIE-T----THRVYII 129 (335)
Q Consensus 60 g~G~~g~V~~~~~~~~~~~vavK~~~~~~--~-~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~-~----~~~~~iv 129 (335)
|+||-+.|+.... .|+.+-+|.....- . ........+.+|+..|..|...+ +++.. ++. . .-..+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888988763 35568888765210 0 00123667889999999885333 44444 222 1 1246899
Q ss_pred EeccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC--EEEeccccccc
Q psy10459 130 MEYAKN-GSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARK 200 (335)
Q Consensus 130 ~e~~~~-~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~--~~l~Dfg~~~~ 200 (335)
+|-+.| .+|.+++... .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998854 4888888653 34577778899999999999999999999999999999987677 99999986643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.7e-09 Score=85.62 Aligned_cols=143 Identities=19% Similarity=0.192 Sum_probs=94.5
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHH-Hh-----hHHHHHHHHHcCCCCCe---eee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL-KK-----FLPREIEVVKGLKHPNL---IRF 116 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~-----~~~~E~~~l~~l~h~~i---v~~ 116 (335)
..+...+|.+.+++-......|.+.. -+|+.+++|..+......+.. .. ...+++..+..+...++ ..+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 34567789999999888777776665 568899999886533221111 11 12234444444432222 222
Q ss_pred ce-----eEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 117 LQ-----AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 117 ~~-----~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
+- .+......+++|||++|..|.++.. +++ .++..+.+++..||+.|++|+|.+|.|+++++++ ++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence 21 2223346679999999988876542 222 2446677889999999999999999999998664 99
Q ss_pred Eecccccc
Q psy10459 192 LSDFGFAR 199 (335)
Q Consensus 192 l~Dfg~~~ 199 (335)
++||+...
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.4e-09 Score=95.22 Aligned_cols=142 Identities=22% Similarity=0.251 Sum_probs=93.3
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------------------------------hHHHHhh------HH
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------------------------------IDYLKKF------LP 99 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------~~~~~~~------~~ 99 (335)
+-|+.++-|+||+|+.+ +|+.||||+.+..-.. .+...+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 68899999999999965 5999999998542110 0111122 22
Q ss_pred HHHHHHHcC----C-CCCeeeeceeEEeCCeEEEEEeccCCCCHHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q psy10459 100 REIEVVKGL----K-HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKGRRWFSQLADA-IDYCHKKS 171 (335)
Q Consensus 100 ~E~~~l~~l----~-h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l--~~~~~~~~~~~~~i~~~i~~~-L~~LH~~~ 171 (335)
+|...+.++ + .+++.-..-+++....-.++|||++|..+.++. +. ..++.. .++..++.+ +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 333333333 1 333322222334456678999999999998874 33 335533 333333332 33444589
Q ss_pred ceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 172 i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
++|.|.+|.||+++.+|++.+.|||+...++.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.3e-08 Score=79.58 Aligned_cols=139 Identities=16% Similarity=0.213 Sum_probs=92.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh---------------------HHHHhhHHHHHHHHHcCCCC--Ce
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI---------------------DYLKKFLPREIEVVKGLKHP--NL 113 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--~i 113 (335)
..|+.|--+.||+|.. .++..+|+|+++...... .........|+.-|.++... .+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3667788889999984 568899999996432211 11222345677777777433 33
Q ss_pred eeeceeEEeCCeEEEEEeccCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEE
Q psy10459 114 IRFLQAIETTHRVYIIMEYAKNGSL-LEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 114 v~~~~~~~~~~~~~iv~e~~~~~sL-~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~ 191 (335)
++.+.+. ...+|||++..... .-.++. -++.......+..++++.+.-|-. .++||+||+.-|||+. ++.+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 4444332 23699999943210 001111 112333677788889999988877 8999999999999999 77899
Q ss_pred Eeccccccccc
Q psy10459 192 LSDFGFARKYS 202 (335)
Q Consensus 192 l~Dfg~~~~~~ 202 (335)
++|||.+....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999986554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.80 E-value=9.1e-08 Score=80.20 Aligned_cols=133 Identities=14% Similarity=0.131 Sum_probs=82.6
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
..||+|..+.||+. .|..+++|+...... ...+.+|.++++.+..-+ +.+.+.+....+...++|++++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 245678898764332 234568999998886443 3566777777777889999999
Q ss_pred CCC-HHHHH---------------------Hhc--CCCCHHHHH-HHHH----------HHHHH-HHHHH----hCCcee
Q psy10459 135 NGS-LLEVI---------------------RKE--RYIDEDKGR-RWFS----------QLADA-IDYCH----KKSVVH 174 (335)
Q Consensus 135 ~~s-L~~~l---------------------~~~--~~~~~~~~~-~i~~----------~i~~~-L~~LH----~~~i~H 174 (335)
|.+ +...+ +.- ......... .+.. .+... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11111 000 011111111 1100 11111 12222 124789
Q ss_pred ccCCCCCEeecCCCCEEEecccccc
Q psy10459 175 RDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 175 ~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+|+.|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.8e-07 Score=72.08 Aligned_cols=130 Identities=16% Similarity=0.207 Sum_probs=93.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
.+..+.||+|.+|.||+|.+. |..+|+|+-+.... +..++.|+++|..+...++.+=+..+. .-++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhh
Confidence 445689999999999999964 67899998876443 667889999999998777655332222 22466999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC-CCEeecCCCCEEEecccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKC-ENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp-~Nili~~~~~~~l~Dfg~~~ 199 (335)
+.|..|.+.-... + .+-+..+++.-.-|-..||-|+.|+- ..+++..++.+.|+||..++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9998888766432 1 23334556665667788999999874 44444444489999999886
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.1e-07 Score=87.73 Aligned_cols=203 Identities=16% Similarity=0.194 Sum_probs=140.3
Q ss_pred hhHHHHHHHHHcCCCCCeeeeceeEEeCCeE----EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy10459 96 KFLPREIEVVKGLKHPNLIRFLQAIETTHRV----YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171 (335)
Q Consensus 96 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 171 (335)
.....|...+..+.|+|++.++.+....... .+..+++...++...+..-..++..+++.+..++++||.++|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3344567778888999999998876543322 234578888899999988888999999999999999999999986
Q ss_pred ceeccCCCC---CEeecCCCCEEEe--ccccccccccCCcccccccccccccccccccccccCCCCCCC-CchhHHHHHH
Q psy10459 172 VVHRDIKCE---NLLLDDKYNIKLS--DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP-QQSDIWSMGV 245 (335)
Q Consensus 172 i~H~dikp~---Nili~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~Di~slG~ 245 (335)
..|.-+..+ +.-++..+...++ ||+.+..+......... .....+.++|......... ...|+|.+|.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~------~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD------LLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhh------cCccccccccccccccchhhhhhHHHHHHH
Confidence 666555544 4444555556666 88888776554432211 1244567777776555441 3469999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 246 VLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 246 ~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+...+..|..+-.-. .....+.. .....++.+++.+|+ .++++|+++.+++.|+|.+-.
T Consensus 381 l~~~~~~~~~i~~~~---~~~~~~l~-------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS---AVPVSLLD-------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHhhhhhcCcccccc---cchhhhhc-------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999998775442211 11111110 112226778889999 899999999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.1e-07 Score=74.58 Aligned_cols=137 Identities=20% Similarity=0.228 Sum_probs=80.4
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeeceeE---EeCCeEEEEE
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQAI---ETTHRVYIIM 130 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~---~~~~~~~iv~ 130 (335)
++.|+.|..+.||++.... ..+++|+.... .....+..|..+++.+...+ +..++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999999643 58999987553 23566778888888885333 44555433 2234578999
Q ss_pred eccCCCCHHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-HHH
Q psy10459 131 EYAKNGSLLE----------------VIR---KE----RYIDEDK---------GRRW------------FSQLAD-AID 165 (335)
Q Consensus 131 e~~~~~sL~~----------------~l~---~~----~~~~~~~---------~~~i------------~~~i~~-~L~ 165 (335)
++++|.++.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0011000 0000 011122 233
Q ss_pred HHH-------hCCceeccCCCCCEeec-CCCCEEEecccccc
Q psy10459 166 YCH-------KKSVVHRDIKCENLLLD-DKYNIKLSDFGFAR 199 (335)
Q Consensus 166 ~LH-------~~~i~H~dikp~Nili~-~~~~~~l~Dfg~~~ 199 (335)
.++ ...++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 23599999999999999 55666799998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.5e-07 Score=83.94 Aligned_cols=141 Identities=23% Similarity=0.326 Sum_probs=90.6
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCC----------------------------hHHHHhhHHHHHHHH---
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAP----------------------------IDYLKKFLPREIEVV--- 105 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~~~~~~E~~~l--- 105 (335)
+.||..+.|+||+|+.+ +|+.||||+.+..-.. .++....+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 68999999999999965 5999999998542111 122222333333322
Q ss_pred -------HcCCCCC------eeeeceeEEeCCeEEEEEeccCCCCHHHH--HHhcCCCCHHHHHHHHHHHHHH-HHHHHh
Q psy10459 106 -------KGLKHPN------LIRFLQAIETTHRVYIIMEYAKNGSLLEV--IRKERYIDEDKGRRWFSQLADA-IDYCHK 169 (335)
Q Consensus 106 -------~~l~h~~------iv~~~~~~~~~~~~~iv~e~~~~~sL~~~--l~~~~~~~~~~~~~i~~~i~~~-L~~LH~ 169 (335)
+.+.|-+ |++++- .......++|||++|..+.++ +.+.+ ++... ++..+.++ +..|=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence 2223444 333332 234456899999999887664 44443 55543 33333333 233446
Q ss_pred CCceeccCCCCCEeecC----CCCEEEeccccccccccC
Q psy10459 170 KSVVHRDIKCENLLLDD----KYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~----~~~~~l~Dfg~~~~~~~~ 204 (335)
.|++|+|=+|.||++.+ ++.+.+.|||+...+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 78999999999999994 568999999998766543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-06 Score=74.99 Aligned_cols=75 Identities=17% Similarity=0.108 Sum_probs=50.7
Q ss_pred eecccCc-eEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEEeccCC
Q psy10459 58 VVGMGSY-ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 58 ~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~ 135 (335)
.|..|.. +.||++.. .+..+++|+..... ...+.+|+.++..+. +--+++++.+....+..++||++++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444554 78898874 34678888875432 223557888888774 33455677766666678899999999
Q ss_pred CCHHH
Q psy10459 136 GSLLE 140 (335)
Q Consensus 136 ~sL~~ 140 (335)
.++..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 77764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.2e-08 Score=92.17 Aligned_cols=242 Identities=16% Similarity=0.119 Sum_probs=161.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC-eeeeceeEEeCCeEEEEEe
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~iv~e 131 (335)
|...+-+++|+++.+++.+...+...+ .+++... ....-++++|.+++||| .+..++.++.++..++.++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 445577899999999999866555444 6766543 22335889999999999 7777777888889999999
Q ss_pred ccCCC-CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 132 YAKNG-SLLEVI-RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 132 ~~~~~-sL~~~l-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
++.++ +..... ...-.+.+-+...++..-+++++++|+.--+|+| ||+..+ +..+..||+....+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc----
Confidence 99876 221111 1111133334455556667889999998778888 776655 578999999886654321
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC---CCCCHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---PRLSSSCK 286 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~l~ 286 (335)
......+++.++|||+.....+. .+.|.|++|.-..++.-|..|-... ......+-.+..-+.. ...+....
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccc
Confidence 23456789999999999888888 7899999998777777777665431 0000000000000000 00111122
Q ss_pred -HHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 287 -ALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 287 -~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++...|+ ..|..|+..-+++-|.+|+.....
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 4667788 789999999999999999776443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.3e-06 Score=66.49 Aligned_cols=136 Identities=18% Similarity=0.273 Sum_probs=94.5
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------------hHHHHhhHHHHHHHHHcCC------CCCeeee
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------------IDYLKKFLPREIEVVKGLK------HPNLIRF 116 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------h~~iv~~ 116 (335)
...||+|+.=.||.- .+.....||+....... .........+|+..+..+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999998843 34556788998765500 0011334456666655554 7889999
Q ss_pred ceeEEeCCeEEEEEeccC------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC--
Q psy10459 117 LQAIETTHRVYIIMEYAK------NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-- 188 (335)
Q Consensus 117 ~~~~~~~~~~~iv~e~~~------~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-- 188 (335)
+|+.+++-...+|+|.+. ..||.+++.... ++. .+...+-+-..+|-..+|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999988999998764 247888885543 554 3334444556678899999999999999997532
Q ss_pred --CEEEec-ccccc
Q psy10459 189 --NIKLSD-FGFAR 199 (335)
Q Consensus 189 --~~~l~D-fg~~~ 199 (335)
.+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 478887 66543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.43 E-value=8.4e-06 Score=65.99 Aligned_cols=128 Identities=20% Similarity=0.183 Sum_probs=90.4
Q ss_pred CCeEEeeeecccCc-eEEEEEEEcCCCCeEEEEEEecC---CC-------C--------hHHHHhhHHHHHHHHHcCC--
Q psy10459 51 HGYSLGDVVGMGSY-ATVKLATSARHSQDVAIKIISKV---QA-------P--------IDYLKKFLPREIEVVKGLK-- 109 (335)
Q Consensus 51 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~---~~-------~--------~~~~~~~~~~E~~~l~~l~-- 109 (335)
.+++.++.||.|.- |.||++. -.|+.||+|+.+.- .. . ......-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999998 46889999994320 00 0 0123456778888877774
Q ss_pred -CCCe--eeeceeEEeC------------------CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy10459 110 -HPNL--IRFLQAIETT------------------HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168 (335)
Q Consensus 110 -h~~i--v~~~~~~~~~------------------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH 168 (335)
+.++ |+.+|+..-. ....||.||.+... .+.. .-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8888876322 12356777776533 1222 33456777778899
Q ss_pred hCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 169 ~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 3589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=72.46 Aligned_cols=74 Identities=11% Similarity=0.053 Sum_probs=44.6
Q ss_pred eeeecccCce-EEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC---CeeeeceeEEeC---CeEEE
Q psy10459 56 GDVVGMGSYA-TVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP---NLIRFLQAIETT---HRVYI 128 (335)
Q Consensus 56 ~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~i 128 (335)
++.|+.|+.. .||+.. ..+++|+..... ....+.+|..++..+... .+..++...... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567766666 488752 357788754321 134577899999887532 233344333222 23478
Q ss_pred EEeccCCCCHH
Q psy10459 129 IMEYAKNGSLL 139 (335)
Q Consensus 129 v~e~~~~~sL~ 139 (335)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.5e-06 Score=82.12 Aligned_cols=81 Identities=15% Similarity=0.177 Sum_probs=55.5
Q ss_pred EeeeecccCceEEEEEEEcCCC--CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCe--eeeceeEEeC---CeE
Q psy10459 55 LGDVVGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNL--IRFLQAIETT---HRV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~ 126 (335)
.++.++.|.+..+|+......+ ..+++|+......... ...+.+|+.+++.+. |.++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4678899999999998764332 4677777543322111 345779999999995 6654 6666666543 457
Q ss_pred EEEEeccCCCC
Q psy10459 127 YIIMEYAKNGS 137 (335)
Q Consensus 127 ~iv~e~~~~~s 137 (335)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.7e-06 Score=74.24 Aligned_cols=142 Identities=19% Similarity=0.269 Sum_probs=100.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------hHH------------HHhhHHHHHHHHHcCCCC--
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------IDY------------LKKFLPREIEVVKGLKHP-- 111 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~------------~~~~~~~E~~~l~~l~h~-- 111 (335)
+.++..||-|--+.||.+.+ ..|.+.++|+-+..... .++ .+-...+|+..++.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66789999999999999986 46889999965422111 110 122345788888877432
Q ss_pred CeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 112 ~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
-+++.++ .+..++|||++.|.+|...-+-. .+..+...+...+--|-..|+||+|++-=||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2333333 35668999999998877654321 2345556666677788899999999999999999999999
Q ss_pred EeccccccccccCC
Q psy10459 192 LSDFGFARKYSVNN 205 (335)
Q Consensus 192 l~Dfg~~~~~~~~~ 205 (335)
++||-.+...+..+
T Consensus 243 vIDFPQmvS~sh~n 256 (465)
T KOG2268|consen 243 VIDFPQMVSTSHPN 256 (465)
T ss_pred EeechHhhccCCCc
Confidence 99998765544433
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.7e-05 Score=68.17 Aligned_cols=80 Identities=9% Similarity=0.030 Sum_probs=56.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC---CCeeeeceeEEe---CCe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH---PNLIRFLQAIET---THR 125 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~ 125 (335)
.-.-.+.||.|..+.||..... ++ .+++|+.+. ..+ ...+..|...|+.+.. -.++++++.+.. .+.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARS-FST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecc-ccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 4445678999999999998732 23 577787543 111 3467789999988853 356777776654 356
Q ss_pred EEEEEeccCCCCH
Q psy10459 126 VYIIMEYAKNGSL 138 (335)
Q Consensus 126 ~~iv~e~~~~~sL 138 (335)
.++|||+++|.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=65.02 Aligned_cols=75 Identities=13% Similarity=0.147 Sum_probs=47.1
Q ss_pred eeeecccCceEEEEEEEcC-CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeEEEEEecc
Q psy10459 56 GDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~e~~ 133 (335)
++.|..|-...+|++.... +++.|++|+....... .-...+|+.++..+...+++ +++..+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567778888999987433 3578999977542111 11223688888888544443 3433322 2 4899999
Q ss_pred CCCCH
Q psy10459 134 KNGSL 138 (335)
Q Consensus 134 ~~~sL 138 (335)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1e-05 Score=65.61 Aligned_cols=98 Identities=16% Similarity=0.167 Sum_probs=78.8
Q ss_pred HHHHHHHcCCC-CCeeeeceeEEeCCeEEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q psy10459 100 REIEVVKGLKH-PNLIRFLQAIETTHRVYIIMEYAKNGSLLEV---IRKERYIDEDKGRRWFSQLADAIDYCHK---KSV 172 (335)
Q Consensus 100 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~---l~~~~~~~~~~~~~i~~~i~~~L~~LH~---~~i 172 (335)
+|.-+++.+.+ +++++++|+|-. +++.||...+++... +......++..+.+++.++++.+.+|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 68888888875 699999999832 579999976655421 1111235899999999999999999987 358
Q ss_pred eeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 173 VHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 173 ~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...|++++|+-++++++++++|.+.+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.06 E-value=7e-05 Score=65.64 Aligned_cols=144 Identities=20% Similarity=0.253 Sum_probs=99.7
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecC-----------------------CCChHHHHhhHHHHHHHHHcCCC
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-----------------------QAPIDYLKKFLPREIEVVKGLKH 110 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------------~~~~~~~~~~~~~E~~~l~~l~h 110 (335)
.+..+|..|--+.||.|. ..+|..+|||+++.. ..+.....-..+.|+.-|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 355788899999999998 467889999998521 12233344556688888888877
Q ss_pred CCeeeeceeEEeCCeEEEEEeccCCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEeecCCC
Q psy10459 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEV-IRKERYIDEDKGRRWFSQLADAIDYC-HKKSVVHRDIKCENLLLDDKY 188 (335)
Q Consensus 111 ~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~-l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~i~H~dikp~Nili~~~~ 188 (335)
.+|...--.... ...|||+++- .+=+-. .-+.-.++...+..+-.+++.-+.-| |.+++||.||+--|+|+-+ |
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G 301 (520)
T ss_pred cCCCCCCceeee--cceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C
Confidence 665433222222 3369999993 321111 01223467777888888888888877 5679999999999999965 4
Q ss_pred CEEEeccccccccc
Q psy10459 189 NIKLSDFGFARKYS 202 (335)
Q Consensus 189 ~~~l~Dfg~~~~~~ 202 (335)
.+.++|.+.+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 79999999886543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.5e-05 Score=65.41 Aligned_cols=132 Identities=13% Similarity=0.166 Sum_probs=75.9
Q ss_pred eecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeEEEEEeccCCC
Q psy10459 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
.+..|-...+|+.. .++..+++|+........ .-...+|..+++.+...++. +++... . -++|++|++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 35567778899887 457788898764322111 01235788888888654443 333322 2 26899999986
Q ss_pred CHHH-----------H---HH---hcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccC
Q psy10459 137 SLLE-----------V---IR---KER----YIDE-DKGRRWFSQL---------ADAIDYCHK--------KSVVHRDI 177 (335)
Q Consensus 137 sL~~-----------~---l~---~~~----~~~~-~~~~~i~~~i---------~~~L~~LH~--------~~i~H~di 177 (335)
++.. + +. ... +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6532 1 11 111 1111 1111211111 112222221 25899999
Q ss_pred CCCCEeecCCCCEEEecccccc
Q psy10459 178 KCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 178 kp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00013 Score=63.87 Aligned_cols=136 Identities=19% Similarity=0.182 Sum_probs=80.3
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeecee------EEeCCeEE
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQA------IETTHRVY 127 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~~~~ 127 (335)
.+.|..|....+|++.. ++..+++|+... . . ...+..|+.++..+.+.+ +++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~-~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-V-S----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-C-C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56777788789998863 345789998764 1 1 233556777777774332 3343321 23345678
Q ss_pred EEEeccCCCCHHH----H-------H---Hh-cCCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q psy10459 128 IIMEYAKNGSLLE----V-------I---RK-ERYID--------EDKGR------------RWFSQLADAIDYCHK--- 169 (335)
Q Consensus 128 iv~e~~~~~sL~~----~-------l---~~-~~~~~--------~~~~~------------~i~~~i~~~L~~LH~--- 169 (335)
+++++++|.++.. . + +. ...+. ..... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998866421 1 1 10 00000 00000 011112233444443
Q ss_pred ----CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 ----KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ----~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998767899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00017 Score=63.67 Aligned_cols=141 Identities=17% Similarity=0.162 Sum_probs=80.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeecee------EEeC
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQA------IETT 123 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~ 123 (335)
.....+.++.|....+|++.. . +..+++|+...... ...+..|.+++..|...+ +++++.. ....
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEe-C-CCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 344567778888889998873 3 34688898755322 122345667676664222 3333321 1224
Q ss_pred CeEEEEEeccCCCCHH-----------HHH---Hh-cCCC--------CHHHHH---------------HHHHHHHHHHH
Q psy10459 124 HRVYIIMEYAKNGSLL-----------EVI---RK-ERYI--------DEDKGR---------------RWFSQLADAID 165 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~-----------~~l---~~-~~~~--------~~~~~~---------------~i~~~i~~~L~ 165 (335)
+..+++++|++|.++. ..+ +. ...+ ...... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885431 111 11 0111 000000 00111233444
Q ss_pred HHH-------hCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 166 YCH-------KKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 166 ~LH-------~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
++. ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 453 2589999999999999998767899999863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00023 Score=62.57 Aligned_cols=75 Identities=16% Similarity=0.127 Sum_probs=45.6
Q ss_pred eeecccCceEEEEEEEcC------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeEEEE
Q psy10459 57 DVVGMGSYATVKLATSAR------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYII 129 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~iv 129 (335)
+.|..|-...+|++.... .++.+++|+....... .....+|..++..+...++. +++..+. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 455556667888887432 2578999997553221 12344788888888544443 3444432 2 368
Q ss_pred EeccCCCCHH
Q psy10459 130 MEYAKNGSLL 139 (335)
Q Consensus 130 ~e~~~~~sL~ 139 (335)
++|++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 8998886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00085 Score=59.49 Aligned_cols=30 Identities=30% Similarity=0.468 Sum_probs=25.6
Q ss_pred CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976556899999873
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0013 Score=59.65 Aligned_cols=81 Identities=12% Similarity=0.027 Sum_probs=52.3
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecC----CCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCeEE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKV----QAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 127 (335)
-.+.||.|.+..||++.+...++.|+||..... ...-.....+...|.+.|..+. ..++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 456899999999999997543358999975311 0000111345567888887763 2345666655 445678
Q ss_pred EEEeccCCCC
Q psy10459 128 IIMEYAKNGS 137 (335)
Q Consensus 128 iv~e~~~~~s 137 (335)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00017 Score=65.89 Aligned_cols=159 Identities=22% Similarity=0.334 Sum_probs=105.0
Q ss_pred HHHHHHHHHcCCCCCeeeeceeEEe-CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy10459 98 LPREIEVVKGLKHPNLIRFLQAIET-THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 98 ~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
+.--+.+++.+.|+|...++++-.. .....+|+|++ +.+|++++..+. +-..... ..|+.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~- 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL- 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee-
Confidence 4456788899999999998887654 23578899999 569999987654 2111111 2222222
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCC
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 256 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p 256 (335)
|+ +..+| -++ .. | |- +.. .|+||||+|.++.++..|...
T Consensus 92 ----~~-------~~~td-~~~----t~-----------------~--~~-----~~~-pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 92 ----NI-------IYITD-HFL----TK-----------------Y--PS-----PIG-PKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ----hh-------hhccc-ccc----cc-----------------C--CC-----CCC-cchhhhhHHHHHHHHHHhhHH
Confidence 22 22233 000 00 0 00 001 389999999999999999988
Q ss_pred CCCCCHHHHHHHHHccccCCCC-----------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 257 FDDTNYSELLKQVQKRVVFPES-----------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 257 ~~~~~~~~~~~~i~~~~~~~~~-----------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|......+....+.+-+..+.. ..++..+.++..+|+ ..|..||...++.+++-|.+.
T Consensus 131 ~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 8777766666666554433322 235667778888999 899999999999999988653
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.67 E-value=2.2e-06 Score=86.53 Aligned_cols=250 Identities=16% Similarity=0.048 Sum_probs=155.0
Q ss_pred eEEEEEEEcCCCCeE-EEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE--eCCeEEEEEeccCCCCHH
Q psy10459 65 ATVKLATSARHSQDV-AIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEYAKNGSLL 139 (335)
Q Consensus 65 g~V~~~~~~~~~~~v-avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~iv~e~~~~~sL~ 139 (335)
+.-+++.+....... .+|+.+.... -.+-.++....|...++...|+++.....-.. .....+..++++.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 344455554333222 4555543211 11223445556666667778888766543332 233567899999999999
Q ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-----CceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 140 EVIRKER----YIDEDKGRRWFSQLADAIDYCHKK-----SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 140 ~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~-----~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+.+-++- .+...-+.....+.+....-+|.. -.+|+++++-|.+|..+.++++.++|+.+..... .
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-----~ 1394 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-----L 1394 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-----H
Confidence 9886542 233333333333335555555543 2689999999999999999999999998732211 1
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
...+...+++.|++|++...-.++ .++|+|..|+.+|....|..+|-..........+.....+......|.+......
T Consensus 1395 sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~ 1473 (2724)
T KOG1826|consen 1395 SFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEAL 1473 (2724)
T ss_pred hhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHH
Confidence 123445677889999988776766 5699999999999999888776543333333233333223332333444444444
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
.+| ..-..||.-...+.-+.|--...+.+.
T Consensus 1474 ~~Ll~K~~~rp~q~isls~d~~a~~~~d~~k 1504 (2724)
T KOG1826|consen 1474 HRLLWKYMERPGQYISLSRDHFAVGLRDICK 1504 (2724)
T ss_pred HHHHHHhhhcchhhhhcccccccccccCcch
Confidence 455 555678999999988888777666664
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00091 Score=57.92 Aligned_cols=29 Identities=28% Similarity=0.450 Sum_probs=24.7
Q ss_pred CceeccCCCCCEeecCCCC-EEEecccccc
Q psy10459 171 SVVHRDIKCENLLLDDKYN-IKLSDFGFAR 199 (335)
Q Consensus 171 ~i~H~dikp~Nili~~~~~-~~l~Dfg~~~ 199 (335)
.++|+|++|.||++++++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0038 Score=55.06 Aligned_cols=28 Identities=29% Similarity=0.618 Sum_probs=25.0
Q ss_pred CCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999988 57899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0028 Score=56.35 Aligned_cols=74 Identities=16% Similarity=0.121 Sum_probs=46.0
Q ss_pred eecccCceEEEEEEEcCCCCeEEEEEEec------CCCChHHHHhhHHHHHHHHHcCC--CCC-eeeeceeEEeCCeEEE
Q psy10459 58 VVGMGSYATVKLATSARHSQDVAIKIISK------VQAPIDYLKKFLPREIEVVKGLK--HPN-LIRFLQAIETTHRVYI 128 (335)
Q Consensus 58 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~~~~~E~~~l~~l~--h~~-iv~~~~~~~~~~~~~i 128 (335)
.||.|-...||++.+...++.|+||.-.. ...+.+ ..+..-|...|+... .|. +++++. + +.....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~--~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT--LDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC--ccHHHHHHHHHHHhhccCccccCeEEE-E-cccccee
Confidence 47889999999999754446899996431 122222 334446777777663 344 444433 2 4455679
Q ss_pred EEeccCC
Q psy10459 129 IMEYAKN 135 (335)
Q Consensus 129 v~e~~~~ 135 (335)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0046 Score=55.40 Aligned_cols=136 Identities=15% Similarity=0.208 Sum_probs=77.1
Q ss_pred eeeecccCceEEEEEEEcC----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeEEEEE
Q psy10459 56 GDVVGMGSYATVKLATSAR----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYIIM 130 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~iv~ 130 (335)
...|-.|-.-.+|++.... .++.|++|+...... ....+ .+|..+++.+...++. ++++.+.. . .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3455457777899886432 246789998754321 11222 4788888888655554 34444422 2 578
Q ss_pred eccCCCCHHHH--------------H---HhcC-C----C-CHHHHHHHHHHH-----------------HHHHHHH---
Q psy10459 131 EYAKNGSLLEV--------------I---RKER-Y----I-DEDKGRRWFSQL-----------------ADAIDYC--- 167 (335)
Q Consensus 131 e~~~~~sL~~~--------------l---~~~~-~----~-~~~~~~~i~~~i-----------------~~~L~~L--- 167 (335)
+|+++.++... + +... + . ....+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 88877665311 1 1101 0 1 112222332211 1111111
Q ss_pred -H----hCCceeccCCCCCEeecC-CCCEEEecccccc
Q psy10459 168 -H----KKSVVHRDIKCENLLLDD-KYNIKLSDFGFAR 199 (335)
Q Consensus 168 -H----~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~ 199 (335)
. ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4679999999874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0039 Score=55.57 Aligned_cols=140 Identities=14% Similarity=0.237 Sum_probs=76.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~ 126 (335)
+...+.. |..|=...+|++..... +..|++|+...... .... -.+|..+++.+...++. ++++.+. ++
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G-- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG-- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence 3444444 43366677888864322 34788998754321 1111 13788888888665554 3444442 22
Q ss_pred EEEEeccCCCCHHH-------HH-------H---hcC-C----C-CHHHHHHHHHHH-----------------------
Q psy10459 127 YIIMEYAKNGSLLE-------VI-------R---KER-Y----I-DEDKGRRWFSQL----------------------- 160 (335)
Q Consensus 127 ~iv~e~~~~~sL~~-------~l-------~---~~~-~----~-~~~~~~~i~~~i----------------------- 160 (335)
+|.+|++|.++.. .+ + ... + . ....+..+..++
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5888887765421 11 1 111 0 1 112222222111
Q ss_pred --HHHHHHHH-hC----CceeccCCCCCEeecC-CCCEEEecccccc
Q psy10459 161 --ADAIDYCH-KK----SVVHRDIKCENLLLDD-KYNIKLSDFGFAR 199 (335)
Q Consensus 161 --~~~L~~LH-~~----~i~H~dikp~Nili~~-~~~~~l~Dfg~~~ 199 (335)
+..+..+. .. -++|+|+.+.|||+++ ++.++++||..+.
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11111121 11 2799999999999975 4689999999874
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0017 Score=57.90 Aligned_cols=61 Identities=16% Similarity=0.172 Sum_probs=46.4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEeecC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC-HKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~i~H~dikp~Nili~~ 186 (335)
...++-+|..|.++..++...+ .++.....++.-.+.||-.+ --.+++|.|++|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3457778999999999986544 46667777777777776544 4568999999999999953
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0052 Score=53.84 Aligned_cols=145 Identities=15% Similarity=0.193 Sum_probs=79.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC--CCeeeeceeEEeCC--eEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTH--RVY 127 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~ 127 (335)
...+++.+..|..-.+|...+. ++.+++. ......... ......+|+.+++.+.. --+...++.+..+. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~-~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVE-SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccch-hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 3445555544444445555533 7778888 322112211 24445578888888753 22334455554444 668
Q ss_pred EEEeccCCCCHH------------------HHHHhc-----------CC---CCHHHHHHHHHHH--------------H
Q psy10459 128 IIMEYAKNGSLL------------------EVIRKE-----------RY---IDEDKGRRWFSQL--------------A 161 (335)
Q Consensus 128 iv~e~~~~~sL~------------------~~l~~~-----------~~---~~~~~~~~i~~~i--------------~ 161 (335)
.||+|+.|..+. +++..- +. ....++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 999999873221 111100 00 0111111111111 2
Q ss_pred HHHHHHHh--------CCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 162 DAIDYCHK--------KSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 162 ~~L~~LH~--------~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
....+|+. ..++|||+.+.|+++++++-+-+.||+.+..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22334432 2589999999999999998899999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0038 Score=54.20 Aligned_cols=76 Identities=14% Similarity=0.177 Sum_probs=49.2
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCeEEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~iv 129 (335)
..-.+.++.|....+|+.. .+++.+.||+-.... ...+..|++-|+.|. .-.+++++.+....+..|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 4456788889999999988 678899999876321 456778888888883 44577888888777777999
Q ss_pred EeccCCC
Q psy10459 130 MEYAKNG 136 (335)
Q Consensus 130 ~e~~~~~ 136 (335)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.013 Score=51.66 Aligned_cols=29 Identities=21% Similarity=0.295 Sum_probs=26.7
Q ss_pred CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 171 SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 171 ~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+++|+|+.++||++++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.02 Score=52.00 Aligned_cols=75 Identities=19% Similarity=0.097 Sum_probs=48.6
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC------ChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCe
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA------PIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHR 125 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~ 125 (335)
..+.||.|....||++.+ .+..++||.-..... +.+ ..+...|...|+.+. ...+++++.++. +.
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~--~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMT--KERAYFEATALREHGRLCPDHVPEVYHFDR--TM 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCC--ccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC
Confidence 467889999999999886 345689997642111 111 233335666666653 246677776655 45
Q ss_pred EEEEEeccCC
Q psy10459 126 VYIIMEYAKN 135 (335)
Q Consensus 126 ~~iv~e~~~~ 135 (335)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 6788999976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.049 Score=48.41 Aligned_cols=71 Identities=10% Similarity=0.005 Sum_probs=41.8
Q ss_pred cCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeec---e--eEEeCCeEEEEEeccC
Q psy10459 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFL---Q--AIETTHRVYIIMEYAK 134 (335)
Q Consensus 62 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~---~--~~~~~~~~~iv~e~~~ 134 (335)
+.-..||++.. .+|..+++|+.+..... ...+..|...+..|.... ++... + ....++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44567898874 45778999998644333 334456777766663211 22211 1 2233567788999988
Q ss_pred CCC
Q psy10459 135 NGS 137 (335)
Q Consensus 135 ~~s 137 (335)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.013 Score=52.93 Aligned_cols=77 Identities=13% Similarity=0.093 Sum_probs=49.2
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEec-----CCCChHHHHhhHHHHHHHHHcCC--CCC-eeeeceeEEeCCeE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISK-----VQAPIDYLKKFLPREIEVVKGLK--HPN-LIRFLQAIETTHRV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~--h~~-iv~~~~~~~~~~~~ 126 (335)
..+.||.|--..||++.+...++.|+||--.. ...+.+ ..+..-|.+.|+... .|. +++++.+ +....
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~--~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~ 108 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLS--TNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMN 108 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCC--hHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHh
Confidence 36788999999999999744456799985421 122333 444556778777663 454 4444433 44556
Q ss_pred EEEEeccCC
Q psy10459 127 YIIMEYAKN 135 (335)
Q Consensus 127 ~iv~e~~~~ 135 (335)
.+|||+++.
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 788888853
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.012 Score=53.39 Aligned_cols=29 Identities=31% Similarity=0.397 Sum_probs=24.5
Q ss_pred CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
..++|.|+-+.||+.+++ .+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 468999999999997654 69999998874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.008 Score=53.07 Aligned_cols=73 Identities=23% Similarity=0.361 Sum_probs=55.6
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+.+.|++|++- |++|.- +. .-..+++..++.+.+..+.-+... .+-|||+.-.||+|+ +|++.|+||-+++.-
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34567777776 555542 21 134677888888888888777765 789999999999999 999999999999843
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.16 Score=52.27 Aligned_cols=30 Identities=40% Similarity=0.520 Sum_probs=25.7
Q ss_pred CCceeccCCCCCEeecCCC--CEE-Eecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKY--NIK-LSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~--~~~-l~Dfg~~~ 199 (335)
.++||+|+++.||+++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 555 99999874
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.033 Score=46.16 Aligned_cols=75 Identities=13% Similarity=0.170 Sum_probs=51.6
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
+.+.-|..-..|... .....+.||+-... ....+..|+.-|+.|. .-.+.+++.+....+..|+|++|+
T Consensus 22 ~~v~gG~inea~~v~--dg~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLR--DGTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEee--cCCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 444445555566555 23457888875432 2566778888777774 345778888888899999999999
Q ss_pred CCCCHH
Q psy10459 134 KNGSLL 139 (335)
Q Consensus 134 ~~~sL~ 139 (335)
+.+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.039 Score=45.49 Aligned_cols=116 Identities=14% Similarity=0.176 Sum_probs=70.0
Q ss_pred cCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccCCCCHHHH
Q psy10459 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV 141 (335)
Q Consensus 62 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~ 141 (335)
++.++.-.+... -|- ..+|.++....... ...+.+++.++.++. +|+++..- ..-.+.++.|+|-....
T Consensus 73 ~gNsTl~~~kt~-iG~-L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTK-IGP-LFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEeccc-cch-hhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 444554444422 243 34454433222111 334567888888775 36776632 34456789999853211
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 142 IRKERYIDEDKGRRWFSQLADAIDYCHKK--SVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 142 l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
. ...++.-=+.+|.-.|+. +.+|||-.|+|||-|..|.+||.|=+..
T Consensus 142 ---------~-~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 ---------N-FSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ---------c-hhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 111222224567778854 7999999999999999999999998764
|
The function of this family is unknown. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.031 Score=47.50 Aligned_cols=75 Identities=16% Similarity=0.141 Sum_probs=52.5
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHH---HHHHcCCCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI---EVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
..+..|..+.|+.++ ..+|..+++|+....... ..|. ..|+..+..+.|+++..- ...-.+++|.+
T Consensus 8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~~--------~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl 76 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAEA--------EHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERL 76 (253)
T ss_pred CCCCCCcceEEEEEE-cCCCCeEEEEecCCcccc--------hhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhc
Confidence 445678889999998 467999999998643321 1233 558888888899998764 33446888988
Q ss_pred -CCCCHHHHH
Q psy10459 134 -KNGSLLEVI 142 (335)
Q Consensus 134 -~~~sL~~~l 142 (335)
++.+|.++.
T Consensus 77 ~~g~~L~~~~ 86 (253)
T PF04655_consen 77 DPGRSLASLP 86 (253)
T ss_pred cCCCchhhcc
Confidence 445676544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.14 Score=47.51 Aligned_cols=76 Identities=17% Similarity=0.105 Sum_probs=44.8
Q ss_pred EeeeecccCceEEEEEEEcCC--------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCe
Q psy10459 55 LGDVVGMGSYATVKLATSARH--------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHR 125 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~ 125 (335)
-++.|..|-.-.+|++..... ++.|++++...... .... -.+|..++..+...+|- ++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lId-R~~E~~v~~~ls~~gi~P~l~~~f~-g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYN-PISEFEVYKTMSKYRIAPQLLNTFS-G-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeC-HHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence 455666676777888874321 46788888754321 1111 23678887777655554 3444432 2
Q ss_pred EEEEEeccCCCCH
Q psy10459 126 VYIIMEYAKNGSL 138 (335)
Q Consensus 126 ~~iv~e~~~~~sL 138 (335)
+.+.+|++|.+|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 457899887643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 335 | ||||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-51 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-51 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-50 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-50 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-50 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-50 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-50 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-49 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-49 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-49 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-48 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-46 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-46 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-45 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-43 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-43 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-43 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-43 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-43 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-37 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-36 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-36 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-36 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-36 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-36 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-36 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-36 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-36 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-36 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-36 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-36 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-36 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-36 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-36 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-36 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-36 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-36 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-36 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-36 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-36 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-36 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-35 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-35 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-35 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-34 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-34 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-34 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-33 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-33 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-33 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-33 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-33 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-33 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-33 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-33 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-32 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-32 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-32 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-32 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-32 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-31 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-31 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-31 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-31 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-31 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-31 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-31 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-31 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-30 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-29 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-29 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-29 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-29 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-29 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-29 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-29 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-29 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-29 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-29 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-28 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-28 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-28 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-28 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-28 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-28 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-28 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-28 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-28 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-27 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-27 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-26 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-26 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-25 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-24 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-24 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-23 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-23 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-23 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-23 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-23 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-23 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-23 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-23 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-23 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-22 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-22 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-22 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-22 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-22 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-22 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-22 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-22 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-22 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-22 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-22 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-22 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-21 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-21 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-21 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-21 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-21 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-21 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-21 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-21 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-21 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-21 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-21 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-21 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-21 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-21 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-21 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-21 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-21 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-21 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-21 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-21 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-21 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-21 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-21 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-21 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-21 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-21 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-21 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-20 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-20 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-20 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-20 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-20 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-20 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-20 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-20 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-20 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-20 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-20 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-20 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-20 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-19 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-19 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 |
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-102
Identities = 101/267 (37%), Positives = 154/267 (57%), Gaps = 11/267 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L +G G++A VKLA ++VAIKII K Q L+K L RE+ ++K L HPN
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPN 75
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++ + IET +Y+IMEYA G + + + + E + R F Q+ A+ YCH+K +
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD+K ENLLLD NIK++DFGF+ +++ + FCG+ YA+PE+ +G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFT------VGGKLDAFCGAPPYAAPELFQGKK 189
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292
Y + D+WS+GV+L+ +V G LPFD N EL ++V R + +S+ C+ L+
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRGKYRIPFYMSTDCENLLKRF 248
Query: 293 LS--PVKFRIQMEDIRQDPWLKEDSNP 317
L P+K R +E I +D W+
Sbjct: 249 LVLNPIK-RGTLEQIMKDRWINAGHEE 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 8e-98
Identities = 97/267 (36%), Positives = 151/267 (56%), Gaps = 10/267 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y LGD +G+G++ VK+ VA+KI+++ + + + REI+ +K +HP+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+I+ Q I T +++MEY G L + I K ++E + RR F Q+ A+DYCH+ V
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD+K EN+LLD N K++DFG + S T CGS YA+PE++ G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNYAAPEVISGRL 186
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292
Y + DIWS GV+L+A++ G LPFDD + L K++ + VF L+ S L+ ++
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPEYLNRSVATLLMHM 245
Query: 293 L--SPVKFRIQMEDIRQDPWLKEDSNP 317
L P+K R ++DIR+ W K+D
Sbjct: 246 LQVDPLK-RATIKDIREHEWFKQDLPS 271
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-96
Identities = 85/266 (31%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L +G G+Y V+LA + + VA+KI+ +A +D + + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPEN-IKKEICINKMLNHEN 66
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++F + Y+ +EY G L + I + + E +R+F QL + Y H +
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
HRDIK ENLLLD++ N+K+SDFG A + NN + L CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER---LLNKMCGTLPYVAPELLKRRE 183
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVF-PESPRLSSSCKALIS 290
+ + D+WS G+VL AM+ G LP+D ++ + +++ + ++ S+ AL+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 291 NIL--SPVKFRIQMEDIRQDPWLKED 314
IL +P RI + DI++D W +
Sbjct: 244 KILVENPSA-RITIPDIKKDRWYNKP 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 2e-96
Identities = 67/321 (20%), Positives = 138/321 (42%), Gaps = 12/321 (3%)
Query: 11 RPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLA 70
P +A + P ++ + Y G +G G +A
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR--YVRGRFLGKGGFAKCFEI 60
Query: 71 TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130
+ A + A KI+ K + ++ + EI + + L H +++ F E V++++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI 190
E + SLLE+ ++ + + E + R + Q+ Y H+ V+HRD+K NL L++ +
Sbjct: 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 180
Query: 191 KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 250
K+ DFG A +Y + CG+ Y +PE+L ++ + D+WS+G +++ +
Sbjct: 181 KIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTL 234
Query: 251 VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQD 308
+ G+ PF+ + E ++ K+ + ++ +LI +L P R + ++ D
Sbjct: 235 LVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAASLIQKMLQTDPTA-RPTINELLND 292
Query: 309 PWLKEDSNPVGKSKSAPEVIP 329
+ P + + P
Sbjct: 293 EFFTSGYIPARLPITCLTIPP 313
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 5e-96
Identities = 64/279 (22%), Positives = 130/279 (46%), Gaps = 10/279 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y G +G G +A + A + A KI+ K + ++ + EI + + L H +
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ F E V++++E + SLLE+ ++ + + E + R + Q+ Y H+ V
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K NL L++ +K+ DFG A +Y + CG+ Y +PE+L
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292
++ + D+WS+G +++ ++ G+ PF+ + E ++ K+ + ++ +LI +
Sbjct: 192 HSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAASLIQKM 249
Query: 293 LS--PVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIP 329
L P R + ++ D + P + + P
Sbjct: 250 LQTDPTA-RPTINELLNDEFFTSGYIPARLPITCLTIPP 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 2e-95
Identities = 85/266 (31%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L +G G+Y V+LA + + VA+KI+ +A +D + + +EI + K L H N
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPEN-IKKEICINKMLNHEN 66
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++F + Y+ +EY G L + I + + E +R+F QL + Y H +
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
HRDIK ENLLLD++ N+K+SDFG A + NN + L CG+ Y +PE+LK
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER---LLNKMCGTLPYVAPELLKRRE 183
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVF-PESPRLSSSCKALIS 290
+ + D+WS G+VL AM+ G LP+D ++ + +++ + ++ S+ AL+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 291 NIL--SPVKFRIQMEDIRQDPWLKED 314
IL +P RI + DI++D W +
Sbjct: 244 KILVENPSA-RITIPDIKKDRWYNKP 268
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-94
Identities = 101/264 (38%), Positives = 158/264 (59%), Gaps = 11/264 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G GS+ VKLAT + Q VA+K IS+ + + REI +K L+HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+I+ I T + +++EYA G L + I +++ + ED+GRR+F Q+ AI+YCH+ +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD+K ENLLLDD N+K++DFG + + N +T CGS YA+PE++ G
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDG------NFLKTSCGSPNYAAPEVINGKL 183
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292
Y + D+WS G+VL+ M+ GRLPFDD L K+V V+ LS ++LI +
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPDFLSPGAQSLIRRM 242
Query: 293 L--SPVKFRIQMEDIRQDPWLKED 314
+ P++ RI +++IR+DPW +
Sbjct: 243 IVADPMQ-RITIQEIRRDPWFNVN 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 5e-94
Identities = 84/274 (30%), Positives = 134/274 (48%), Gaps = 20/274 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G G++ +L + VA+K I + A + ++ REI + L+HPN
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPN 77
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++RF + I T + IIMEYA G L E I ED+ R +F QL + YCH +
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 173 VHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
HRD+K EN LLD +K+ DFG++ + + ++ G+ AY +PE+L
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-----FPESPRLSSSC 285
Y + +D+WS GV L+ M+ G PF+D ++ +R++ P+ R+S C
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251
Query: 286 KALISNIL--SPVKFRIQMEDIRQDPWLKEDSNP 317
LIS I P RI + +I+ W ++
Sbjct: 252 CHLISRIFVADPAT-RISIPEIKTHSWFLKNLPA 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 1e-93
Identities = 80/290 (27%), Positives = 145/290 (50%), Gaps = 37/290 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP------------- 99
Y+L D +G GSY VKLA + + A+K++SK + P
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 100 ----------REIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERY 147
+EI ++K L HPN+++ ++ ++ +Y++ E G ++EV +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL 134
Query: 148 IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207
ED+ R +F L I+Y H + ++HRDIK NLL+ + +IK++DFG + ++ ++
Sbjct: 135 -SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192
Query: 208 YKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
L G+ A+ +PE L ++ + D+W+MGV L+ V+G+ PF D L
Sbjct: 193 ----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 266 LKQVQK-RVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLK 312
+++ + FP+ P ++ K LI+ +L +P RI + +I+ PW+
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES-RIVVPEIKLHPWVT 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 2e-93
Identities = 76/274 (27%), Positives = 132/274 (48%), Gaps = 13/274 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G+++G GS+A V A S +VAIK+I K + + + E+++ LKHP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKS 171
++ E ++ VY+++E NG + ++ + + E++ R + Q+ + Y H
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
++HRD+ NLLL NIK++DFG A T CG+ Y SPEI
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALIS 290
+ +SD+WS+G + + ++ GR PFD L +V P LS K LI
Sbjct: 188 AHGL-ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF--LSIEAKDLIH 244
Query: 291 NILS--PVKFRIQMEDIRQDPWLKEDSNPVGKSK 322
+L P R+ + + P++ +S+ K +
Sbjct: 245 QLLRRNPAD-RLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 3e-93
Identities = 98/268 (36%), Positives = 154/268 (57%), Gaps = 12/268 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ-APIDYLKKFLPREIEVVKGLKHP 111
Y LGD +G+G++ VK+ VA+KI+++ + +D + K + REI+ +K +HP
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHP 76
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
++I+ Q I T ++++MEY G L + I K +DE + RR F Q+ +DYCH+
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
VVHRD+K EN+LLD N K++DFG + N T CGS YA+PE++ G
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYAAPEVISGR 190
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 291
Y + DIWS GV+L+A++ G LPFDD + L K++ +F L+ S +L+ +
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI-CDGIFYTPQYLNPSVISLLKH 249
Query: 292 IL--SPVKFRIQMEDIRQDPWLKEDSNP 317
+L P+K R ++DIR+ W K+D
Sbjct: 250 MLQVDPMK-RATIKDIREHEWFKQDLPK 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 5e-93
Identities = 80/283 (28%), Positives = 135/283 (47%), Gaps = 18/283 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKH 110
Y +GD++G GSY VK + A+KI+ K ++ + + +EI++++ L+H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRH 65
Query: 111 PNLIRFLQAI--ETTHRVYIIMEYAKNGS--LLEVIRKERYIDEDKGRRWFSQLADAIDY 166
N+I+ + + E ++Y++MEY G +L+ + ++R + +F QL D ++Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEY 124
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
H + +VH+DIK NLLL +K+S G A D + T GS A+ PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD---DTCRTSQGSPAFQPPE 181
Query: 227 ILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSS 284
I G+ ++ + DIWS GV L+ + G PF+ N +L + + K P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD--CGPP 239
Query: 285 CKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPVGKSKSAP 325
L+ +L P K R + IRQ W ++ P P
Sbjct: 240 LSDLLKGMLEYEPAK-RFSIRQIRQHSWFRKKHPPAEAPVPIP 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 1e-91
Identities = 83/335 (24%), Positives = 149/335 (44%), Gaps = 31/335 (9%)
Query: 10 HRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKL 69
H L H A N + K+ E Y +G ++G G + +V
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYS 61
Query: 70 ATSARHSQDVAIKIISKVQ----APIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETT 123
+ VAIK + K + + + +P E+ ++K + +IR L E
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 124 HRVYIIMEYAKN-GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182
+I+E + L + I + + E+ R +F Q+ +A+ +CH V+HRDIK EN+
Sbjct: 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180
Query: 183 LLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIW 241
L+D ++ +KL DFG K + F G+ Y+ PE ++ Y + + +W
Sbjct: 181 LIDLNRGELKLIDFGSGALL-------KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 242 SMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFR 299
S+G++L+ MV G +PF+ + ++ +V F R+SS C+ LI L+ P R
Sbjct: 234 SLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--QRVSSECQHLIRWCLALRPSD-R 285
Query: 300 IQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
E+I+ PW+++ P ++ + S+
Sbjct: 286 PTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 3e-90
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 22/287 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----LPREIEVVKG 107
YS +G G++ V A +++V +K I K + D + + EI ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGS-LLEVIRKERYIDEDKGRRWFSQLADAIDY 166
++H N+I+ L E ++ME +G L I + +DE F QL A+ Y
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGY 145
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
K ++HRDIK EN+++ + + IKL DFG A + L TFCG+ Y +PE
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE------RGKLFYTFCGTIEYCAPE 199
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286
+L G PY + ++WS+GV L+ +V+ PF + L++ + +S
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEA-AIHPPYLVSKELM 252
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKK 332
+L+S +L P + R +E + DPW+ + N + EV K
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD--YTWEEVFRVNK 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 2e-88
Identities = 80/273 (29%), Positives = 145/273 (53%), Gaps = 14/273 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G +G G + V LA + +A+K++ K Q ++ L RE+E+ L+HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R RVY+I+EYA G++ ++K DE + + ++LA+A+ YCH K V
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK ENLLL +K++DFG++ + CG+ Y PE+++G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISN 291
+ + D+WS+GV+ + + G+ PF+ Y E K++ + FP ++ + LIS
Sbjct: 184 HDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DFVTEGARDLISR 240
Query: 292 IL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSK 322
+L +P + R + ++ + PW+ +S+ +
Sbjct: 241 LLKHNPSQ-RPMLREVLEHPWITANSSKPSNCQ 272
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 2e-88
Identities = 86/269 (31%), Positives = 152/269 (56%), Gaps = 14/269 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G +G G + V LA ++ +A+K++ K Q + ++ L REIE+ L+HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R R+Y+++E+A G L + ++K DE + + +LADA+ YCH++ V
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK ENLL+ K +K++DFG+ SV+ ++ T CG+ Y PE+++G
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRRR---TMCGTLDYLPPEMIEGKT 188
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISN 291
+ + D+W GV+ + + G PFD +++E +++ + FP P LS K LIS
Sbjct: 189 HDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISK 245
Query: 292 IL--SPVKFRIQMEDIRQDPWLKEDSNPV 318
+L P + R+ ++ + + PW+K +S V
Sbjct: 246 LLRYHPPQ-RLPLKGVMEHPWVKANSRRV 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-87
Identities = 81/278 (29%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ----APIDYLKKFLPREIEVVK-- 106
Y LG ++G G + TV VAIK+I + + +P+ P E+ ++
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 107 --GLKHPNLIRFLQAIETTHRVYIIMEYAKNGS-LLEVIRKERYIDEDKGRRWFSQLADA 163
G HP +IR L ET +++E L + I ++ + E R +F Q+ A
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
I +CH + VVHRDIK EN+L+D + KL DFG F G+ Y
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-------HDEPYTDFDGTRVY 204
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282
+ PE + Y + +WS+G++L+ MV G +PF+ + ++ + FP +S
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEAELHFP--AHVS 257
Query: 283 SSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPV 318
C ALI L+ P R +E+I DPW++ + V
Sbjct: 258 PDCCALIRRCLAPKPSS-RPSLEEILLDPWMQTPAEDV 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 6e-85
Identities = 69/318 (21%), Positives = 136/318 (42%), Gaps = 26/318 (8%)
Query: 23 HSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIK 82
H ++ G D ++ + ++ YS+ +G G + V + Q AIK
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSM--SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIK 58
Query: 83 IISKVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFLQAIETTHRVYIIMEYAKNGSLLE 140
++ +A L + EI + L+ + IR T +Y++ME N L
Sbjct: 59 YVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 141 VIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200
++K++ ID + + ++ + +A+ H+ +VH D+K N L+ D +KL DFG A +
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQ 175
Query: 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ----------SDIWSMGVVLFAM 250
+ T + ++ G+ Y PE +K + + + SD+WS+G +L+ M
Sbjct: 176 MQPDTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 251 VYGRLPFDD--TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIR 306
YG+ PF S+L + + ++ L P + RI + ++
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELL 291
Query: 307 QDPWLKEDSNPVGKSKSA 324
P+++ ++PV +
Sbjct: 292 AHPYVQIQTHPVNQMAKG 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-82
Identities = 75/339 (22%), Positives = 141/339 (41%), Gaps = 28/339 (8%)
Query: 4 RPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGS 63
R +K K ER H + D ++ +SV + YS+ +G G
Sbjct: 13 RGSGMKETAAA---KFERQHMDSPDLGTDDDDKASSSANECISV-KGRIYSILKQIGSGG 68
Query: 64 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFLQAIE 121
+ V + Q AIK ++ +A L + EI + L+ + IR
Sbjct: 69 SSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYEI 126
Query: 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181
T +Y++ME N L ++K++ ID + + ++ + +A+ H+ +VH D+K N
Sbjct: 127 TDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185
Query: 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ---- 237
L+ D +KL DFG A + + T + ++ G+ Y PE +K + + +
Sbjct: 186 FLIVDG-MLKLIDFGIANQMQPDTTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSK 241
Query: 238 ------SDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQVQKRVVFPESPRLSSSCKALI 289
SD+WS+G +L+ M YG+ PF S+L + + ++
Sbjct: 242 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 301
Query: 290 SNIL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPE 326
L P + RI + ++ P+++ ++PV +
Sbjct: 302 KCCLKRDPKQ-RISIPELLAHPYVQIQTHPVNQMAKGTT 339
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-82
Identities = 66/328 (20%), Positives = 118/328 (35%), Gaps = 59/328 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLP------------ 99
Y + + G + + L + A+K K
Sbjct: 33 YRIIRTLNQGKFNKIILC---EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 100 --REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYID-------- 149
E++++ +K+ + I VYII EY +N S+L+ +D
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 150 EDKGRRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
+ + ++ Y H +K++ HRD+K N+L+D +KLSDFG S D
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE----SEYMVD- 204
Query: 209 KQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELL 266
+ G+Y + PE Y + DIWS+G+ L+ M Y +PF + EL
Sbjct: 205 --KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 267 KQVQK-RVVFPESPR-----------------LSSSCKALISNILS--PVKFRIQMEDIR 306
++ + +P LS+ + L P + RI ED
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE-RITSEDAL 321
Query: 307 QDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
+ WL + + + + + K+ +
Sbjct: 322 KHEWLAD--TNIEDLREFSKELYKKRKK 347
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 2e-81
Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 24/290 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
YS+ +G G + V + Q AIK ++ +A L + EI + L+ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHS 68
Query: 113 L--IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
IR T +Y++ME N L ++K++ ID + + ++ + +A+ H+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+VH D+K N L+ D +KL DFG A + + T + ++ G+ Y PE +K
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS---VVKDSQVGTVNYMPPEAIKD 183
Query: 231 VPYTPQQ----------SDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQVQKRVVFPES 278
+ + + SD+WS+G +L+ M YG+ PF S+L +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 279 PRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPE 326
+ ++ L P + RI + ++ P+++ ++PV +
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTHPVNQMAKGTT 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-78
Identities = 65/287 (22%), Positives = 127/287 (44%), Gaps = 33/287 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ V+G G++ V A +A S+ AIK I + + + E+ ++ L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQY 63
Query: 113 LIRF-------------LQAIETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFS 158
++R+ + A++ ++I MEY +NG+L ++I E D+ R F
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE---- 214
Q+ +A+ Y H + ++HRD+K N+ +D+ N+K+ DFG A+ + K +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 215 -----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
+ G+ Y + E+L G + ++ D++S+G++ F M+Y +LK++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 270 QK-RVVFPE--SPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 312
+ + FP K +I ++ R + WL
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-76
Identities = 63/312 (20%), Positives = 113/312 (36%), Gaps = 55/312 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L D++G G+ A V + AIK+ + + RE EV+K L H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68
Query: 113 LIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERY---IDEDKGRRWFSQLADAIDYC 167
+++ E TT +IME+ GSL V+ + + E + + +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 168 HKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223
+ +VHR+IK N++ D + KL+DFG AR+ + + G+ Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD------EQFVSLYGTEEYL 182
Query: 224 SPEILKGVPYTPQQS-------DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-- 274
P++ + D+WS+GV + G LPF K+V +++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 275 ----------------------FPESPRLSSSCKALISNILS------PVKFRIQMEDIR 306
P S LS + L++ +L+ K +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK-CWGFDQFF 301
Query: 307 QDPWLKEDSNPV 318
+
Sbjct: 302 AETSDILHRGNS 313
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-76
Identities = 63/284 (22%), Positives = 122/284 (42%), Gaps = 20/284 (7%)
Query: 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
Y +G G ++ V L A+K I D ++ RE ++ + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQD--REEAQREADMHRLFNH 85
Query: 111 PNLIRFLQAI----ETTHRVYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLAD 162
PN++R + H ++++ + K G+L I K ++ ED+ +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE----TFCG 218
++ H K HRD+K N+LL D+ L D G + ++ +Q L+
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 219 SYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ--VQKRVV 274
+ +Y +PE+ + +++D+WS+G VL+AM++G P+D VQ ++
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 275 FPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
P+SPR SS+ L++++++ R + + + P
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-74
Identities = 81/274 (29%), Positives = 138/274 (50%), Gaps = 21/274 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G GSY + + + K + + K+ L E+ +++ LKHPN
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPN 66
Query: 113 LIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDY 166
++R+ I T +YI+MEY + G L VI K Y+DE+ R +QL A+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 167 CHKK-----SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
CH++ +V+HRD+K N+ LD K N+KL DFG AR + + + ++TF G+
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-----SFAKTFVGTPY 181
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
Y SPE + + Y ++SDIWS+G +L+ + PF + EL ++++ R
Sbjct: 182 YMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 282 SSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 313
S +I+ +L+ R +E+I ++P + E
Sbjct: 241 SDELNEIITRMLNLKDYH-RPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-74
Identities = 73/301 (24%), Positives = 138/301 (45%), Gaps = 23/301 (7%)
Query: 17 LKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHS 76
+ HHS+ + + Q + Y +G GS+ L S
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSME-----------KYVRLQKIGEGSFGKAILVKSTEDG 49
Query: 77 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 136
+ IK I+ + ++ RE+ V+ +KHPN++++ ++ E +YI+M+Y + G
Sbjct: 50 RQYVIKEINISRMSSKEREESR-REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 137 SLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194
L + I ++ ED+ WF Q+ A+ + H + ++HRDIK +N+ L ++L D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
Query: 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
FG AR + + + + G+ Y SPEI + PY +SDIW++G VL+ + +
Sbjct: 169 FGIARVLN-STVELAR----ACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLK 222
Query: 255 LPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLK 312
F+ + L+ ++ P S S ++L+S + P R + I + ++
Sbjct: 223 HAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRD-RPSVNSILEKGFIA 281
Query: 313 E 313
+
Sbjct: 282 K 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-73
Identities = 83/272 (30%), Positives = 136/272 (50%), Gaps = 20/272 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+L + +G GS+ VK+A A K I K ++ + +F +EIE++K L HPN
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFK-QEIEIMKSLDHPN 67
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+IR + E +Y++ME G L E + +R E R + A+ YCHK +V
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 173 VHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
HRD+K EN L +KL DFG A ++ + + T G+ Y SP++L+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-----KMMR-TKVGTPYYVSPQVLE 181
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
G Y P + D WS GV+++ ++ G PF SE++ ++++ FPE +S +
Sbjct: 182 G-LYGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 287 ALISNIL--SPVKFRIQMEDIRQDPWLKEDSN 316
+LI +L SP + RI + W ++ +
Sbjct: 240 SLIRRLLTKSPKQ-RITSLQALEHEWFEKQLS 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-72
Identities = 83/348 (23%), Positives = 139/348 (39%), Gaps = 56/348 (16%)
Query: 23 HSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIK 82
H ++ G + + +L Y L +G GSY V++A + AIK
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLEL----QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 83 IISKVQAPIDYLKKF--LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLE 140
I++K + K + E+ ++K L HPN+ R + E + ++ME G LL+
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 141 VIRKE----------------------------------------RYIDEDKGRRWFSQL 160
+ E Q+
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 161 ADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
A+ Y H + + HRDIK EN L + IKL DFG ++++ N ++ T G
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT-TKAG 236
Query: 219 SYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVF 275
+ + +PE+L Y P + D WS GV+L ++ G +PF N ++ + QV ++ F
Sbjct: 237 TPYFVAPEVLNTTNESYGP-KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295
Query: 276 PESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 320
LS + L+SN+L+ V R Q PW+ + S+ + K
Sbjct: 296 ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-72
Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 20/271 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G G++ V L + IK I+K ++ + + + EIEV+K L HPN
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPN 81
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLADAIDYCH 168
+I+ + E H +YI+ME + G LLE I + + + E Q+ +A+ Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 169 KKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
+ VVH+D+K EN+L D IK+ DFG A + + ++ + G+ Y +P
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-----EHST-NAAGTALYMAP 195
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPR-LSS 283
E+ K T + DIWS GVV++ ++ G LPF T+ E+ ++ + R L+
Sbjct: 196 EVFKR-DVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLKE 313
L+ +L+ + R + W K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-71
Identities = 76/270 (28%), Positives = 131/270 (48%), Gaps = 15/270 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G+++ V+ + A KII+ + +K RE + + L+HPN
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPN 66
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R +I+ Y++ + G L E I + E Q+ ++I YCH +
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 173 VHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHR++K ENLLL K +KL+DFG A + + + + F G+ Y SPE+LK
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----EAWH-GFAGTPGYLSPEVLK 180
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
PY+ DIW+ GV+L+ ++ G PF D + L Q++ +P ++ K
Sbjct: 181 KDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+LI ++L+ K RI + + PW+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-71
Identities = 63/304 (20%), Positives = 112/304 (36%), Gaps = 55/304 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L D++G G+ A V + AIK+ + + RE EV+K L H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68
Query: 113 LIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRK---ERYIDEDKGRRWFSQLADAIDYC 167
+++ E TT +IME+ GSL V+ + + E + + +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 168 HKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223
+ +VHR+IK N++ D + KL+DFG AR+ + G+ Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------DDEQFVSLYGTEEYL 182
Query: 224 SPEILKGVPYTPQQS-------DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-- 274
P++ + D+WS+GV + G LPF K+V +++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 275 ----------------------FPESPRLSSSCKALISNILS------PVKFRIQMEDIR 306
P S LS + L++ +L+ K +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK-CWGFDQFF 301
Query: 307 QDPW 310
+
Sbjct: 302 AETS 305
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-71
Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 24/279 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----LPREIEVVKG 107
Y + +G G+ VKLA + + VAIKIISK + I ++ + EIE++K
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
L HP +I+ + YI++E + G L + + + + E + +F Q+ A+ Y
Sbjct: 72 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 168 HKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
H+ ++HRD+K EN+LL + IK++DFG ++ + +L T CG+ Y +
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------ETSLMRTLCGTPTYLA 184
Query: 225 PEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQK-RVVFPESP- 279
PE+L V + D WS+GV+LF + G PF + L Q+ + F
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244
Query: 280 -RLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDS 315
+S L+ +L P R E+ + PWL+++
Sbjct: 245 AEVSEKALDLVKKLLVVDPKA-RFTTEEALRHPWLQDED 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 1e-70
Identities = 68/278 (24%), Positives = 128/278 (46%), Gaps = 22/278 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK------VQAPIDYLKKFLPREIEVVK 106
Y +++G G + V+ ++ A+KII + L++ +E+++++
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 107 GLK-HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
+ HPN+I+ ET +++ + K G L + + ++ + E + R+ L + I
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
HK ++VHRD+K EN+LLDD NIKL+DFGF+ + CG+ +Y +P
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD------PGEKLREVCGTPSYLAP 192
Query: 226 EILKGVPYTPQQS-----DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP 279
EI++ D+WS GV+++ ++ G PF +L+ + F
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 280 --RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED 314
S + K L+S L + R E+ P+ ++
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-70
Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----LPREIEVVKG 107
Y + +G G+ VKLA + + VAI+IISK + I ++ + EIE++K
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
L HP +I+ + YI++E + G L + + + + E + +F Q+ A+ Y
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 168 HKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
H+ ++HRD+K EN+LL + IK++DFG ++ + +L T CG+ Y +
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG------ETSLMRTLCGTPTYLA 309
Query: 225 PEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVV-FPESP 279
PE+L V Y D WS+GV+LF + G PF + L Q+ F
Sbjct: 310 PEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 280 --RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED 314
+S L+ +L K R E+ + PWL+++
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-69
Identities = 72/323 (22%), Positives = 139/323 (43%), Gaps = 23/323 (7%)
Query: 5 PDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSY 64
+ + + + P ++ D + Y DV+G G
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK--YDPKDVIGRGVS 107
Query: 65 ATVKLATSARHSQDVAIKIISK-----VQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQ 118
+ V+ + A+KI+ ++ +++ RE +++ + HP++I +
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIK 178
+ E++ ++++ + + G L + + ++ + E + R L +A+ + H ++VHRD+K
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227
Query: 179 CENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQS 238
EN+LLDD I+LSDFGF+ CG+ Y +PEILK
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLE------PGEKLRELCGTPGYLAPEILKCSMDETHPG 281
Query: 239 -----DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCKALIS 290
D+W+ GV+LF ++ G PF +L+ + + + F SS+ K LIS
Sbjct: 282 YGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLIS 341
Query: 291 NILSP-VKFRIQMEDIRQDPWLK 312
+L + R+ E Q P+ +
Sbjct: 342 RLLQVDPEARLTAEQALQHPFFE 364
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-69
Identities = 82/271 (30%), Positives = 137/271 (50%), Gaps = 16/271 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y++ ++G GS+ V Q+ A+K+I+K A L RE+E++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++ + +E + YI+ E G L + I K + E R Q+ I Y HK ++
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 173 VHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+K EN+LL+ K +IK+ DFG + + N + G+ Y +PE+L+
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-----TKMK-DRIGTAYYIAPEVLR 196
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
G Y + D+WS GV+L+ ++ G PF N ++LK+V+ + F +S K
Sbjct: 197 G-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSN 316
LI +L+ RI + PW+++ S+
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-69
Identities = 59/273 (21%), Positives = 117/273 (42%), Gaps = 22/273 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + + +G G + V + VAIK + +P + ++ EI+++K L HPN
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPN 73
Query: 113 LIRFLQAIET------THRVYIIMEYAKNGSLLEVIRK---ERYIDEDKGRRWFSQLADA 163
++ + + + MEY + G L + + + + E R S ++ A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 164 IDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
+ Y H+ ++HRD+K EN++L + K+ D G+A++ + L F G+
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD------QGELCTEFVGTL 187
Query: 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVVFPESP 279
Y +PE+L+ YT D WS G + F + G PF + + +V+++
Sbjct: 188 QYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 280 RLSSSCKALISNILSPVKFRIQMEDIRQDPWLK 312
+ S++L + + + WL+
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-68
Identities = 86/317 (27%), Positives = 135/317 (42%), Gaps = 22/317 (6%)
Query: 22 HHSAKTNAEGSDPNEQDKDTERKLSVLETHG------YSLGDVVGMGSYATVKLATSARH 75
HH ++ + Q + + Y +G G+Y V L
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 76 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 135
+ AIKII K K L E+ V+K L HPN+++ E Y++ME K
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLL-EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 136 GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKL 192
G L + I +E Q+ + Y HK ++VHRD+K ENLLL+ K IK+
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY 252
DFG + + + G+ Y +PE+L+ Y + D+WS+GV+LF ++
Sbjct: 181 VDFGLSAVFENQKK------MKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLA 232
Query: 253 GRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQD 308
G PF E+L++V+K + F +S K LI +L + RI + +
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
Query: 309 PWLKEDSNPVGKSKSAP 325
PW+KE + P
Sbjct: 293 PWIKEMCSKKESGIELP 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-68
Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 16/280 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y++ ++G GS+ V Q+ A+K+I+K A L RE+E++K L HPN
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPN 82
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++ + +E + YI+ E G L + I K + E R Q+ I Y HK ++
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 173 VHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+K EN+LL+ K +IK+ DFG + + N + G+ Y +PE+L+
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK------MKDRIGTAYYIAPEVLR 196
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
G Y + D+WS GV+L+ ++ G PF N ++LK+V+ + F +S K
Sbjct: 197 G-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAP 325
LI +L+ RI + PW+++ S+ P
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-68
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 18/272 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +V+G G+++ V L + A+K I K A L EI V+K +KH N
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHEN 67
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ E+T Y++M+ G L + I + E Q+ A+ Y H+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 173 VHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+K ENLL ++ I ++DFG ++ + + T CG+ Y +PE+L
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM-------EQNGIMSTACGTPGYVAPEVLA 180
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
PY+ D WS+GV+ + ++ G PF + S+L +++++ F +S S K
Sbjct: 181 QKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
I ++L R E PW+ ++
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-68
Identities = 84/271 (30%), Positives = 134/271 (49%), Gaps = 15/271 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y V+G GS+ V L Q+ A+K+ISK Q K+ L RE++++K L HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++ + E Y++ E G L + I + E R Q+ I Y HK +
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 173 VHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+K ENLLL+ K NI++ DFG + + + + G+ Y +PE+L
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK------MKDKIGTAYYIAPEVLH 201
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
G Y + D+WS GV+L+ ++ G PF+ N ++LK+V+K + F ++S S K
Sbjct: 202 G-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSN 316
LI +L+ RI D W++ +
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-67
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 14/270 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y L + +G G+++ V+ Q+ A II+ + +K RE + + LKHPN
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPN 71
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R +I Y+I + G L E I Y E Q+ +A+ +CH+ V
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 173 VHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHR++K ENLLL K +KL+DFG A + + F G+ Y SPE+L+
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF-----GFAGTPGYLSPEVLR 186
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
PY D+W+ GV+L+ ++ G PF D + L +Q++ FP ++ K
Sbjct: 187 KDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
LI+ +L+ RI + + PW+ S
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISHRS 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-67
Identities = 76/270 (28%), Positives = 131/270 (48%), Gaps = 15/270 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G+++ V+ + A KII+ + +K RE + + L+HPN
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPN 89
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R +I+ Y++ + G L E I + E Q+ ++I YCH +
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 173 VHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHR++K ENLLL K +KL+DFG A + + + + F G+ Y SPE+LK
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH------GFAGTPGYLSPEVLK 203
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
PY+ DIW+ GV+L+ ++ G PF D + L Q++ +P ++ K
Sbjct: 204 KDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+LI ++L+ K RI + + PW+
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRE 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 4e-67
Identities = 69/330 (20%), Positives = 130/330 (39%), Gaps = 33/330 (10%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP 90
G D + L + V+ G +A V A ++ A+K +
Sbjct: 8 GGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL-SNEE 66
Query: 91 IDYLKKFLPREIEVVKGLK-HPNLIRFLQA-------IETTHRVYIIMEYAKNGSLLEVI 142
+ + +E+ +K L HPN+++F A +T ++++ G L+E +
Sbjct: 67 EK--NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 143 RKER---YIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGF 197
+K + D + F Q A+ + H++ ++HRD+K ENLLL ++ IKL DFG
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184
Query: 198 ARKYSVNNTDYKQNLSE-------TFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVL 247
A S T + Y +PEI+ P + DIW++G +L
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE-KQDIWALGCIL 243
Query: 248 FAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDI 305
+ + + + PF+D L+ V + P + +LI +L +P + R+ + ++
Sbjct: 244 YLLCFRQHPFEDGA---KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE-RLSIAEV 299
Query: 306 RQDPWLKEDSNPVGKSKSAPEVIPFKKSRN 335
+ V E++
Sbjct: 300 VHQLQEIAAARNVNPKSPITELLEQNGGYG 329
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-66
Identities = 57/291 (19%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +++G G + V A + IK + Y + RE++ + L H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVN 65
Query: 113 LIRFLQAIE----------------TTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKGR 154
++ + + T ++I ME+ G+L + I R+ +D+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214
F Q+ +DY H K +++RD+K N+ L D +K+ DFG + N +
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKRT---- 179
Query: 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274
G+ Y SPE + Y ++ D++++G++L +++ +T+ + ++ ++
Sbjct: 180 RSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII 236
Query: 275 FPESPRLSSSCKALISNILSPV-KFRIQMEDIRQDPWLKEDSNPVGKSKSA 324
S K L+ +LS + R +I + + + S + +A
Sbjct: 237 ---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-66
Identities = 88/324 (27%), Positives = 143/324 (44%), Gaps = 28/324 (8%)
Query: 17 LKQERHHSAKTNAEGSDPNEQDKDT--ERKLSVLETHGYSLGDVVGMGSYATVKLATSAR 74
+ HHS+ + +K + Y +G G+Y V L
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGES-YFKVRKLGSGAYGEVLLCKEKN 59
Query: 75 HSQDVAIKIISK----------VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124
+ AIK+I K I+ + + EI ++K L HPN+I+ E
Sbjct: 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119
Query: 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184
Y++ E+ + G L E I DE Q+ I Y HK ++VHRDIK EN+LL
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILL 179
Query: 185 DDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIW 241
++K NIK+ DFG + +S + G+ Y +PE+LK Y + D+W
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYK------LRDRLGTAYYIAPEVLKK-KYNE-KCDVW 231
Query: 242 SMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VK 297
S GV+++ ++ G PF N +++K+V+K + F + +S K LI +L+
Sbjct: 232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYN 291
Query: 298 FRIQMEDIRQDPWLKEDSNPVGKS 321
R E+ W+K+ +N + KS
Sbjct: 292 KRCTAEEALNSRWIKKYANNINKS 315
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-65
Identities = 72/300 (24%), Positives = 129/300 (43%), Gaps = 16/300 (5%)
Query: 23 HSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIK 82
S + K + + + +G G ++ V A VA+K
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63
Query: 83 IISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI 142
+ + +EI+++K L HPN+I++ + + + I++E A G L +I
Sbjct: 64 KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 123
Query: 143 ----RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198
+++R I E ++F QL A+++ H + V+HRDIK N+ + +KL D G
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF- 257
R +S T + + G+ Y SPE + Y +SDIWS+G +L+ M + PF
Sbjct: 184 RFFSSKTT-----AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFY 237
Query: 258 -DDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 313
D N L K++++ P S S + L++ ++ P K R + +
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK-RPDVTYVYDVAKRMH 296
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-64
Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 19/284 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLK 109
Y +G+ +G G +A V+ ++ A K I K + ++ + RE+ +++ ++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HPN+I E V +I+E G L + + ++ + ED+ ++ Q+ D + Y H
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 170 KSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
K + H D+K EN++L DK IKL DFG A K ++K G+ + +P
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFK-----NIFGTPEFVAP 180
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLS 282
EI+ P ++D+WS+GV+ + ++ G PF E L + F E S
Sbjct: 181 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLKED-SNPVGKSKSA 324
K I +L K R+ + + W+K V S
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 75/320 (23%), Positives = 139/320 (43%), Gaps = 26/320 (8%)
Query: 10 HRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG------YSLGDVVGMGS 63
H V L E + ++ + + ++ + + +G G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 64 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123
+ V + A+K++ K KK + EI V+ L HPN+I+ + ET
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLL 183
+ +++E G L + I ++ Y E Q+ +A+ Y H+ +VHRD+K ENLL
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 184 LDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDI 240
+K++DFG ++ Q L +T CG+ Y +PEIL+G Y P + D+
Sbjct: 181 YATPAPDAPLKIADFGLSKIVE------HQVLMKTVCGTPGYCAPEILRGCAYGP-EVDM 233
Query: 241 WSMGVVLFAMVYGRLPF-DDTNYSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP- 295
WS+G++ + ++ G PF D+ + +++ F +S + K L+ ++
Sbjct: 234 WSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293
Query: 296 VKFRIQMEDIRQDPWLKEDS 315
K R+ Q PW+ +
Sbjct: 294 PKKRLTTFQALQHPWVTGKA 313
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-64
Identities = 68/286 (23%), Positives = 127/286 (44%), Gaps = 18/286 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLK 109
Y +G+ +G G +A VK + A K I K + ++ + RE+ +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
H N+I E V +I+E G L + + ++ + E++ + Q+ D ++Y H
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 170 KSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
K + H D+K EN++L +IKL DFG A + + ++K G+ + +P
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFK-----NIFGTPEFVAP 187
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLS 282
EI+ P ++D+WS+GV+ + ++ G PF E L + F E S
Sbjct: 188 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 327
K I +L + R+ +++ + PW+ N + V
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVV 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-64
Identities = 72/277 (25%), Positives = 121/277 (43%), Gaps = 20/277 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKH 110
Y L +V+G G ++ V+ + Q A+KI+ + + L RE + LKH
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLADAIDY 166
P+++ L+ + +Y++ E+ L I E + Q+ +A+ Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 167 CHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223
CH +++HRD+K +LL K N +KL FG A + + G+ +
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG-----GRVGTPHFM 200
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--R 280
+PE++K PY D+W GV+LF ++ G LPF T L + + K +
Sbjct: 201 APEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258
Query: 281 LSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 316
+S S K L+ +L RI + + PWLKE
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-64
Identities = 74/293 (25%), Positives = 132/293 (45%), Gaps = 25/293 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHP 111
Y + + +G+GSY+ K + + A+KII K K+ EIE++ + +HP
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEILLRYGQHP 76
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
N+I + VY++ E K G LL+ I ++++ E + + ++Y H +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 172 VVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
VVHRD+K N+L + +I++ DFGFA++ N T C + + +PE+
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-----TPCYTANFVAPEV 191
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD---DTNYSELLKQVQK-RVVFPESP--RL 281
L+ Y DIWS+GV+L+ M+ G PF D E+L ++ + +
Sbjct: 192 LERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 282 SSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKS 333
S + K L+S +L R+ + + PW+ + + K
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKG 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-63
Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 32/290 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G G + V A + + AIK I + ++ + RE++ + L+HP
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPG 64
Query: 113 LIRFLQAIETTHR------------VYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWF 157
++R+ A + +YI M+ + +L + + + F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-------YSVNNTDYKQ 210
Q+A+A+++ H K ++HRD+K N+ +K+ DFG +V
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQV 269
G+ Y SPE + G Y+ + DI+S+G++LF ++Y PF L V
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240
Query: 270 QKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 317
+ P + ++ ++LS P++ R + +I ++ ++ P
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPME-RPEAINIIENAVFEDLDFP 289
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-63
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 18/276 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLK 109
Y G+ +G G +A VK A K I K + ++ + RE+ ++K ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HPN+I + E V +I+E G L + + ++ + E++ + Q+ + + Y H
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 170 KSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
+ H D+K EN++L D+ IK+ DFG A K ++K G+ + +P
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFK-----NIFGTPEFVAP 186
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLS 282
EI+ P ++D+WS+GV+ + ++ G PF E L V F + S
Sbjct: 187 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
+ K I +L K R+ ++D Q PW+K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-63
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 18/286 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLK 109
Y +G+ +G G +A VK + A K I K + ++ + RE+ +++ +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HPN+I E V +I+E G L + + ++ + E++ + Q+ D ++Y H
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 170 KSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
K + H D+K EN++L DK +IKL DFG A + + ++K G+ + +P
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFK-----NIFGTPEFVAP 187
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLS 282
EI+ P ++D+WS+GV+ + ++ G PF E L + F E + S
Sbjct: 188 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 327
K I +L + R+ +++ + PW+ + V
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 202 bits (514), Expect = 3e-62
Identities = 44/373 (11%), Positives = 100/373 (26%), Gaps = 77/373 (20%)
Query: 2 TIRPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVL------------- 48
+ R + P V +++ + + N + Q + L
Sbjct: 9 SGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESEL 68
Query: 49 --ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI---- 102
G V+G AT + + + + P K + E+
Sbjct: 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 103 ---------------------EVVKGLKHPNLIRFLQAIETTH--RVYIIMEYAKN---- 135
++VK + +IR + + ++
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 136 --GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLS 193
LL + + + Q+ + H +VH ++ +++LD + + L+
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK-----------GVPYTPQQSDIWS 242
F + S + PE+ T D W+
Sbjct: 249 GFEHLV---------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF-SFDAWA 298
Query: 243 MGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRI 300
+G+V++ + LP + +F + +AL+ L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKED-RL 352
Query: 301 QMEDIRQDPWLKE 313
+ P ++
Sbjct: 353 LPLQAMETPEYEQ 365
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-62
Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 27/278 (9%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
+G GS++ + + +Q A+KIISK + +EI +K + HP
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHP 66
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
N+++ + +++ME G L E I+K+++ E + +L A+ + H
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 172 VVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
VVHRD+K ENLL D+ IK+ DFGFAR +N K T C + YA+PE+L
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK-----TPCFTLHYAAPELL 181
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-------YSELLKQVQK-RVVFPESP- 279
Y D+WS+GV+L+ M+ G++PF + E++K+++K F
Sbjct: 182 NQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 280 -RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+S K LI +L+ R++M +R + WL++ S
Sbjct: 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-61
Identities = 51/277 (18%), Positives = 117/277 (42%), Gaps = 18/277 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G + V + K + +K +EI ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRN 62
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
++ ++ E+ + +I E+ + E + ++E + + Q+ +A+ + H +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 172 VVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+ H DI+ EN++ + + IK+ +FG AR+ +++ + Y +PE+ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFR-----LLFTAPEYYAPEVHQ 176
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCK 286
+ +D+WS+G +++ ++ G PF ++++ + F E +S
Sbjct: 177 HDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSK 322
+ +L K R+ + Q PWLK+ V
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-60
Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 33/293 (11%)
Query: 53 YSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-H 110
Y L DV+G G++A V+ + SQ+ A+KII K I + + RE+E++ + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGH 70
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
N++ ++ E R Y++ E + GS+L I K R+ +E + +A A+D+ H K
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 171 SVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNN--TDYKQNLSETFCGSYAYASP 225
+ HRD+K EN+L + +K+ DF +N + T CGS Y +P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 226 EILKGVPYTPQ----QSDIWSMGVVLFAMVYGRLPFDDTNYS---------------ELL 266
E+++ + D+WS+GV+L+ ++ G PF S L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 267 KQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+ +Q+ + FP+ +S + K LIS +L K R+ + Q PW++ +
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 75/333 (22%), Positives = 141/333 (42%), Gaps = 28/333 (8%)
Query: 18 KQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG-----------YSLGDVVGMGSYAT 66
+ +G N+ DK E Y + + +G G++
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 67 VKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126
V + K I+ P+D K + EI ++ L HP LI A E + +
Sbjct: 67 VHRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 127 YIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD 185
+I+E+ G L + + ++ + E + + Q + + + H+ S+VH DIK EN++ +
Sbjct: 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183
Query: 186 DK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSM 243
K ++K+ DFG A K + + K + +A+PEI+ P +D+W++
Sbjct: 184 TKKASSVKIIDFGLATKLN-PDEIVK-----VTTATAEFAAPEIVDREPVGF-YTDMWAI 236
Query: 244 GVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKFR 299
GV+ + ++ G PF + E L+ V++ F E +S K I N+L + R
Sbjct: 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
Query: 300 IQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKK 332
+ + D + PWLK D + + + ++
Sbjct: 297 LTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-59
Identities = 71/337 (21%), Positives = 137/337 (40%), Gaps = 20/337 (5%)
Query: 9 KHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETH---GYSLGDVVGMGSYA 65
+ D+ + +N + + + + + + H Y + + +G G++
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171
Query: 66 TVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125
V T + A K + D K+ + +EI+ + L+HP L+ A E +
Sbjct: 172 VVHRVTERATGNNFAAKFVMT-PHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 126 VYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184
+ +I E+ G L E + E + ED+ + Q+ + + H+ + VH D+K EN++
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288
Query: 185 DDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWS 242
K +KL DFG + + G+ +A+PE+ +G P +D+WS
Sbjct: 289 TTKRSNELKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPEVAEGKPVGY-YTDMWS 341
Query: 243 MGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKF 298
+GV+ + ++ G PF N E L+ V+ +S +S K I +L
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 299 RIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSRN 335
R+ + + PWL + P S+ +
Sbjct: 402 RMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 438
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-59
Identities = 66/316 (20%), Positives = 117/316 (37%), Gaps = 19/316 (6%)
Query: 3 IRPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQ-DKDTERKLSVLETHGYSLGDVVGM 61
D + Q + E S+ + D R S + + +G
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-FQRLSRLGH 67
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120
GSY V S + A+K + L E+ + + +HP +R QA
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAW 126
Query: 121 ETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKC 179
E +Y+ E SL + + E + + A+ + H + +VH D+K
Sbjct: 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKP 185
Query: 180 ENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSD 239
N+ L + KL DFG + E G Y +PE+L+G Y +D
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELG------TAGAGEVQEGDPRYMAPELLQG-SYGT-AAD 237
Query: 240 IWSMGVVLFAMVYGR-LPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSP-VK 297
++S+G+ + + LP + +L Q + + LSS ++++ +L P K
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQL---RQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294
Query: 298 FRIQMEDIRQDPWLKE 313
R E + P L++
Sbjct: 295 LRATAEALLALPVLRQ 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 9e-59
Identities = 47/348 (13%), Positives = 88/348 (25%), Gaps = 57/348 (16%)
Query: 12 PDQVKLKQERHHSAKTNAEGSDPNEQDKDTERK-LSVLETHGYSLGDVVGMGSYATVKLA 70
+ + + +A A + Q+ +T L L + + +G + V L
Sbjct: 22 IGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV 81
Query: 71 TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI---------- 120
+D A+K+ + + L L +
Sbjct: 82 RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141
Query: 121 ----------------ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG-------RRWF 157
++M A L + ++ +G
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT 200
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
+QL K +VH +NL + + L D K
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG--------TRGPASS 252
Query: 218 GSYAYASPEIL--KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--------ELLK 267
YA E L +T + W +G+ ++ + LPF L
Sbjct: 253 VPVTYAPREFLNASTATFTH-ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 268 QVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKE 313
+ F L K LI L + R+ + + P +
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR-RLLPLEAMETPEFLQ 358
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-58
Identities = 77/333 (23%), Positives = 127/333 (38%), Gaps = 43/333 (12%)
Query: 21 RHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLG-DVVGMGSYATVKLATSARHSQDV 79
HHS+ P + Y L V+G+G V R Q
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDD--------YQLSKQVLGLGVNGKVLECFHRRTGQKC 57
Query: 80 AIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR----VYIIMEYAK 134
A+K++ +E++ P+++ L E H + IIME +
Sbjct: 58 ALKLLYD--------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109
Query: 135 NGSLLEVI--RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---N 189
G L I R ++ E + + AI + H ++ HRD+K ENLL K
Sbjct: 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV 169
Query: 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249
+KL+DFGFA++ QN +T C + Y +PE+L Y D+WS+GV+++
Sbjct: 170 LKLTDFGFAKE-------TTQNALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYI 221
Query: 250 MVYGRLPFDDTNYSELLKQVQKRVV-----FPESP--RLSSSCKALISNILSP-VKFRIQ 301
++ G PF + +++R+ FP +S K LI +L R+
Sbjct: 222 LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
Query: 302 MEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
+ PW+ + V+ K
Sbjct: 282 ITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-58
Identities = 71/303 (23%), Positives = 128/303 (42%), Gaps = 22/303 (7%)
Query: 22 HHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSL-GDVVGMGSYATVKLATSARHSQDVA 80
HH + + + Y L +G G +A V+ S Q+ A
Sbjct: 2 HHHHH--HSSGVDLGTENLYFQSMENFNNF-YILTSKELGRGKFAVVRQCISKSTGQEYA 58
Query: 81 IKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRVYIIMEYAKNGSLL 139
K + K + D + L EI V++ K P +I + E T + +I+EYA G +
Sbjct: 59 AKFLKKRRRGQDCRAEIL-HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 140 EVI--RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSD 194
+ + E+ R Q+ + + Y H+ ++VH D+K +N+LL Y +IK+ D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
FG +RK + + + G+ Y +PEIL P T +D+W++G++ + ++
Sbjct: 178 FGMSRKIG-HACELR-----EIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHT 230
Query: 255 LPFDDTNYSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPW 310
PF + E + + V + E +S I ++L + R E W
Sbjct: 231 SPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290
Query: 311 LKE 313
L++
Sbjct: 291 LQQ 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-57
Identities = 77/301 (25%), Positives = 143/301 (47%), Gaps = 23/301 (7%)
Query: 28 NAEGSDPNEQDKDTERKLSVLETHGYSLGD-----VVGMGSYATVKLATSARHSQDVAIK 82
+ ++P + + D ++G GS++TV LA S++ AIK
Sbjct: 2 DGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 83 IISKVQAPIDYLKK--FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLE 140
I+ K I K ++ RE +V+ L HP ++ + ++Y + YAKNG LL+
Sbjct: 62 ILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 141 VIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200
IRK DE R + +++ A++Y H K ++HRD+K EN+LL++ +I+++DFG A+
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 260
S + + N +F G+ Y SPE+L SD+W++G +++ +V G PF
Sbjct: 180 LSPESKQARAN---SFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAG 235
Query: 261 NYSELLKQ-VQKRVVFPESPRLSSSCKALISNILSP-------VKFRIQMEDIRQDPWLK 312
N + ++ ++ FP + + L+ +L + ++ P+ +
Sbjct: 236 NEYLIFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 313 E 313
Sbjct: 294 S 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 50/300 (16%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
++G GS TV S + VA+K + D+ L EI+++ HP
Sbjct: 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLI-----DFCDIAL-MEIKLLTESDDHP 69
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG-------RRWFSQLADAI 164
N+IR+ + T +YI +E N +L +++ + DE+ Q+A +
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 165 DYCHKKSVVHRDIKCENLLLDDK-------------YNIKLSDFGFARKYSVNNTDYKQN 211
+ H ++HRD+K +N+L+ I +SDFG +K + ++ N
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 212 LSETFCGSYAYASPEILKGV-------PYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYS 263
L+ G+ + +PE+L+ T DI+SMG V + ++ G+ PF D
Sbjct: 189 LN-NPSGTSGWRAPELLEESNNLQTKRRLTR-SIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 264 ELLKQVQK------RVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDS 315
E + + + L + LIS ++ P+K R + + P S
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK-RPTAMKVLRHPLFWPKS 303
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-57
Identities = 70/272 (25%), Positives = 126/272 (46%), Gaps = 19/272 (6%)
Query: 53 YSLG--DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
Y++ +++G G + V +A KII + D K+ + EI V+ L H
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKD--KEEVKNEISVMNQLDH 145
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYCHK 169
NLI+ A E+ + + ++MEY G L + +I + + E + Q+ + I + H+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 170 KSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
++H D+K EN+L ++ IK+ DFG AR+Y K G+ + +PE+
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLK-----VNFGTPEFLAPEV 259
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPES--PRLSSS 284
+ + +D+WS+GV+ + ++ G PF N +E L + R + +S
Sbjct: 260 VNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318
Query: 285 CKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
K IS +L +RI + + PWL +
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHK 350
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-56
Identities = 62/300 (20%), Positives = 121/300 (40%), Gaps = 25/300 (8%)
Query: 31 GSDPNEQ--DKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQ 88
GS P+ + D D E + ++ + DV+G G+ T+ ++DVA+K I
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPEC 60
Query: 89 APIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKER 146
F RE+++++ +HPN+IR+ + YI +E +L E + +K+
Sbjct: 61 F------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDF 113
Query: 147 YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-----YNIKLSDFGFARKY 201
+ Q + + H ++VHRD+K N+L+ +SDFG +K
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAM-VYGRLPFD 258
+V + + G+ + +PE+L DI+S G V + + G PF
Sbjct: 174 AVGRHSFSR--RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 259 DTNYSELLKQVQKRVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+ + + + P + LI +++ + R + + + P+
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-56
Identities = 74/349 (21%), Positives = 139/349 (39%), Gaps = 34/349 (9%)
Query: 4 RPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGS 63
P P + + + +K ++++ + V+G+G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY-KVTSQVLGLGI 74
Query: 64 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 122
V + R + A+K++ RE+E+ + P+++R + E
Sbjct: 75 NGKVLQIFNKRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHIVRIVDVYEN 126
Query: 123 T----HRVYIIMEYAKNGSLLEVI--RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ I+ME G L I R ++ E + + +AI Y H ++ HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 177 IKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
+K ENLL K +KL+DFGFA++ + +N+ T C + Y +PE+L Y
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT------TPCYTPYYVAPEVLGPEKY 240
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQK-RVVFPESP--RLSSSCK 286
D+WS+GV+++ ++ G PF + + +++ + FP +S K
Sbjct: 241 DK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 299
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
LI N+L R+ + + PW+ + + V+ K R
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 348
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-54
Identities = 61/243 (25%), Positives = 122/243 (50%), Gaps = 12/243 (4%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G +G GS+ TV DVA+K+++ L+ F E+ V++ +H N++
Sbjct: 28 VGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNIL 83
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
F+ T ++ I+ ++ + SL + E + K Q A +DY H KS++
Sbjct: 84 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII 142
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
HRD+K N+ L + +K+ DFG A + + E GS + +PE+++
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 234 TP--QQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSCKALIS 290
P QSD+++ G+VL+ ++ G+LP+ + N ++++ V + + P+ ++ S+C +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 291 NIL 293
++
Sbjct: 260 RLM 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 181 bits (459), Expect = 8e-54
Identities = 38/345 (11%), Positives = 95/345 (27%), Gaps = 50/345 (14%)
Query: 8 VKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATV 67
+ + + + + + Q E +L G V+G
Sbjct: 36 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE-RPRTLVRGTVLGQEDPYAY 94
Query: 68 KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL------------------- 108
AT + + + + P K + E+ ++ L
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 109 ---KHPNLIRFLQAIETTHRVYIIMEYAKN-----------GSLLEVIRKERYIDEDKGR 154
K P + ++ ++++ + LL + +
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 155 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214
+ Q+ + H +VH ++ +++LD + + L+ F + +
Sbjct: 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ASAVSPIG 270
Query: 215 TFCGSYAYASPEILKGVPYTPQQ----SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 270
+ +L + P D W++G+ ++ + LP D
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS---- 326
Query: 271 KRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 313
+F + +AL+ L R+ + P ++
Sbjct: 327 -EWIFRSCKNIPQPVRALLEGFLRYPKED-RLLPLQAMETPEYEQ 369
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 75/290 (25%), Positives = 138/290 (47%), Gaps = 31/290 (10%)
Query: 17 LKQERHHS-------AKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKL 69
+K HH T D + L + + +G GS+ TV
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLN-----IKEKIGAGSFGTVHR 55
Query: 70 ATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129
A H DVA+KI+ + + + +FL RE+ ++K L+HPN++ F+ A+ + I+
Sbjct: 56 AEW--HGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112
Query: 130 MEYAKNGSLLEVIRKE---RYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLL 184
EY GSL ++ K +DE + +A ++Y H ++ +VHR++K NLL+
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244
D KY +K+ DFG +R + S++ G+ + +PE+L+ P ++SD++S G
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLS-----SKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFG 226
Query: 245 VVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL 293
V+L+ + + P+ + N + QV V F + + + ++ I+
Sbjct: 227 VILWELATLQQPWGNLNPA----QVVAAVGFKCKRLEIPRNLNPQVAAII 272
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-52
Identities = 50/227 (22%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G+++G G + V +VAI++I + D LK F RE+ + +H N++
Sbjct: 37 IGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENVV 92
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVV 173
F+ A + + II K +L V+R + +D +K R+ ++ + Y H K ++
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-- 231
H+D+K +N+ D+ + ++DFG V +++ G + +PEI++ +
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 232 -------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271
P++ + SD++++G + + + PF ++ Q+
Sbjct: 212 DTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 174 bits (441), Expect = 1e-51
Identities = 44/297 (14%), Positives = 108/297 (36%), Gaps = 35/297 (11%)
Query: 53 YSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
+ ++G G++A V AT A++ Q +K+ P ++ + +E +K
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEF--YIGTQLMERLKP 123
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLAD 162
++F A + ++ E G+LL I E+ + + + ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKY-----------NIKLSDFGFARKYSVNNTDYKQN 211
I+ H ++H DIK +N +L + + + L D G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG---T 240
Query: 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQ 270
+ C + + E+L P+ Q D + + ++ M++G + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 271 KRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQ--DPWLKEDSNPVGKSKSAP 325
+R+ + + + ++ NI ++ +RQ ++ ++
Sbjct: 300 RRLPHLD---MWNEFFHVMLNIPDCHH-LPSLDLLRQKLKKVFQQHYTNKIRALRNR 352
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-51
Identities = 73/321 (22%), Positives = 121/321 (37%), Gaps = 27/321 (8%)
Query: 18 KQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ 77
K +R + EG E+ K + + E H + VG GS+ V +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYRE-EVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 78 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 137
A+K + L+ F E+ GL P ++ A+ V I ME + GS
Sbjct: 85 QCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 138 LLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFG 196
L ++I++ + ED+ + Q + ++Y H + ++H D+K +N+LL L DFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 256
A + + G+ + +PE++ G P + DIWS ++ M+ G P
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHP 255
Query: 257 FDDTN-YSELLKQVQKRVVFPESP-RLSSSCKALISNILS--PVK------------FRI 300
+ LK + E P + I L PV +
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315
Query: 301 QMEDIRQDPWLKEDSNPVGKS 321
Q + PW E P G S
Sbjct: 316 QEVGGLKSPWKGEYKEPRGNS 336
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 27/246 (10%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+ +VVG G++ V A ++DVAIK I K F+ E+ + + HPN++
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVAIKQIE----SESERKAFI-VELRQLSRVNHPNIV 64
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHK-- 169
+ A + V ++MEYA+ GSL V+ Y W Q + + Y H
Sbjct: 65 KLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 170 -KSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
K+++HRD+K NLLL +K+ DFG A Q GS A+ +PE+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--------IQTHMTNNKGSAAWMAPEV 174
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287
+G Y+ ++ D++S G++L+ ++ R PFD+ ++ V P L +
Sbjct: 175 FEGSNYS-EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 288 LISNIL 293
I +++
Sbjct: 232 PIESLM 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-50
Identities = 62/252 (24%), Positives = 119/252 (47%), Gaps = 28/252 (11%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKII--SKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L +++G+G + V A +VA+K + ++ +E ++ LKHPN
Sbjct: 11 LEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHPN 67
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-- 170
+I + ++ME+A+ G L V+ +R I D W Q+A ++Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 171 -SVVHRDIKCENLLLDDKY--------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
++HRD+K N+L+ K +K++DFG AR + T + G+YA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKM-----SAAGAYA 179
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
+ +PE+++ ++ + SD+WS GV+L+ ++ G +PF + + V + P
Sbjct: 180 WMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP-- 236
Query: 282 SSSCKALISNIL 293
S+C + ++
Sbjct: 237 -STCPEPFAKLM 247
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-50
Identities = 67/319 (21%), Positives = 124/319 (38%), Gaps = 55/319 (17%)
Query: 34 PNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDY 93
P+ + +K ++++ + V+G+G V + R + A+K++
Sbjct: 2 PHVKSGLQIKKNAIIDDY-KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK---- 56
Query: 94 LKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR----VYIIMEYAKNGSLLEVI--RKER 146
RE+E+ + P+++R + E + + I+ME G L I R ++
Sbjct: 57 ----ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 147 YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSV 203
E + + +AI Y H ++ HRD+K ENLL K +KL+DFGFA
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY- 262
E Y D+WS+GV+++ ++ G PF +
Sbjct: 168 ---------------------KETTGE-KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGL 204
Query: 263 ---SELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+ +++ + FP +S K LI N+L R+ + + PW+ + +
Sbjct: 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264
Query: 316 NPVGKSKSAPEVIPFKKSR 334
V+ K R
Sbjct: 265 KVPQTPLHTSRVLKEDKER 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-47
Identities = 51/255 (20%), Positives = 107/255 (41%), Gaps = 30/255 (11%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKII-----SKVQAPIDYLKKFLPREIEVVKGLK 109
+G G + V + VAIK + I+ ++F RE+ ++ L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMSNLN 81
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCH 168
HPN+++ + ++ME+ G L + K I R +A I+Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 169 KKS--VVHRDIKCENLLLDDK-----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
++ +VHRD++ N+ L K++DFG +++ + G++
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------SVHSVSGLLGNFQ 191
Query: 222 YASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ES 278
+ +PE + YT +++D +S ++L+ ++ G PFD+ +Y ++ + +
Sbjct: 192 WMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEGLR 248
Query: 279 PRLSSSCKALISNIL 293
P + C + N++
Sbjct: 249 PTIPEDCPPRLRNVI 263
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-47
Identities = 40/247 (16%), Positives = 93/247 (37%), Gaps = 26/247 (10%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+ + + D+ +K++ + F E ++ HPN+
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNV 69
Query: 114 IRFLQAIET--THRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCH- 168
+ L A ++ +I + GSL V+ + +D+ + ++ +A + + H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 169 -KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
+ + + ++++D+ ++S + S + A+ +PE
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----------SPGRMYAPAWVAPEA 179
Query: 228 LKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLS 282
L+ P + +D+WS V+L+ +V +PF D + E+ +V R P +S
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG--IS 237
Query: 283 SSCKALI 289
L+
Sbjct: 238 PHVSKLM 244
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 54/300 (18%), Positives = 129/300 (43%), Gaps = 24/300 (8%)
Query: 30 EGSDPNEQDKDTERKLSVLET----HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIIS 85
+ +QD E + + +G GS+ TV + +VA +
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 86 KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL----QAIETTHRVYIIMEYAKNGSLLEV 141
+ ++F E E++KGL+HPN++RF ++ + ++ E +G+L
Sbjct: 61 DRKLTKSERQRFK-EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 142 IRKERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKY-NIKLSDFGFA 198
+++ + + R W Q+ + + H ++ ++HRD+KC+N+ + ++K+ D G A
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 258
+ ++ G+ + +PE+ + Y D+++ G+ + M P+
Sbjct: 180 TLKR-------ASFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYS 230
Query: 259 D-TNYSELLKQVQKRVVFPESPRLSSS-CKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+ N +++ ++V V +++ K +I + R ++D+ + +E++
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 3e-46
Identities = 69/267 (25%), Positives = 129/267 (48%), Gaps = 18/267 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDV-AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G G++ V+L + ++ V A+K++SK + F E +++ P +++
Sbjct: 76 VIGRGAFGEVQLVRH-KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A + +Y++MEY G L+ ++ + E R + +++ A+D H +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRD 193
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP---- 232
+K +N+LLD ++KL+DFG K + +T G+ Y SPE+LK
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMV----RCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALI 289
Y + D WS+GV L+ M+ G PF + ++ + + FP+ +S K LI
Sbjct: 250 YGR-ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308
Query: 290 SNILSPVKFRI---QMEDIRQDPWLKE 313
L+ + R+ +E+I++ + K
Sbjct: 309 CAFLTDREVRLGRNGVEEIKRHLFFKN 335
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-46
Identities = 72/293 (24%), Positives = 131/293 (44%), Gaps = 27/293 (9%)
Query: 35 NEQDKDTERKLSVLETHGYSLGD-----VVGMGSYATVKLATSARHSQDVAIKIISKVQA 89
+ +D +K + L +G GS+ V L A+KI+ K
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK--Q 77
Query: 90 PIDYLKKF--LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY 147
+ LK+ E +++ + P L++ + + +Y++MEY G + +R+
Sbjct: 78 KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR 137
Query: 148 IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207
E R + +Q+ +Y H +++RD+K ENLL+D + I+++DFGFA++ V
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT 195
Query: 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
+ T CG+ +PEI+ Y + D W++GV+++ M G PF ++ +
Sbjct: 196 W------TLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 268 Q-VQKRVVFPESPRLSSSCKALISNILSP-VKFRI-----QMEDIRQDPWLKE 313
+ V +V FP SS K L+ N+L + R + DI+ W
Sbjct: 249 KIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-46
Identities = 50/215 (23%), Positives = 103/215 (47%), Gaps = 14/215 (6%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
G+V+G G + T + + +K + + + + FL +E++V++ L+HPN++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFL-KEVKVMRCLEHPNVL 70
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+F+ + R+ I EY K G+L +I+ + + + +A + Y H +++
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK---------QNLSETFCGSYAYAS 224
HRD+ N L+ + N+ ++DFG AR T + + T G+ + +
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
PE++ G Y ++ D++S G+VL ++ D
Sbjct: 191 PEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-46
Identities = 52/286 (18%), Positives = 101/286 (35%), Gaps = 40/286 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHP 111
+ + +G G + +V AIK K A + L RE+ L +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQHS 71
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVI----RKERYIDEDKGRRWFSQLADAIDYC 167
+++R+ A + I EY GSL + I R Y E + + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 168 HKKSVVHRDIKCENLLLD-------------------DKYNIKLSDFGFARKYSVNNTDY 208
H S+VH DIK N+ + +K K+ D G + S
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--- 188
Query: 209 KQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
G + + E+L+ + P ++DI+++ + + + +
Sbjct: 189 ------VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRN---GDQWH 238
Query: 268 QVQKRVVFPESPRLSSSCKALISNILSPV-KFRIQMEDIRQDPWLK 312
++++ + LS L+ ++ P + R + + L
Sbjct: 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 46/231 (19%), Positives = 93/231 (40%), Gaps = 18/231 (7%)
Query: 95 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI---DED 151
+I + N + LQ +YI M+ + +L + + + + +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 152 KGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-------SVN 204
F Q+A+A+++ H K ++HRD+K N+ +K+ DFG +V
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYS 263
G+ Y SPE + G Y+ + DI+S+G++LF ++Y F
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLY---SFSTQMERV 280
Query: 264 ELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLK 312
++ V+ + ++ ++LS P + R + DI ++ +
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE-RPEATDIIENAIFE 330
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 32/300 (10%)
Query: 32 SDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI 91
E D +++ E V+G G+Y V + +AIK I + +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-- 60
Query: 92 DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER---YI 148
Y + L EI + K LKH N++++L + + I ME GSL ++R +
Sbjct: 61 RYSQP-LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTD 207
+E + Q+ + + Y H +VHRDIK +N+L++ +K+SDFG +++ + N
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178
Query: 208 YKQNLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265
+ETF G+ Y +PEI+ P Y +DIWS+G + M G+ P + EL
Sbjct: 179 ----CTETFTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPP-----FYEL 228
Query: 266 LKQVQKRVVF--------PESP-RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
+ +F PE P +S+ KA I P R D+ D +LK S
Sbjct: 229 GEPQA--AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 74/242 (30%), Positives = 119/242 (49%), Gaps = 11/242 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y + D +G G +TV LA + VAIK I + + LK+F RE+ L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-REVHNSSQLSHQ 71
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
N++ + E Y++MEY + +L E I + D + +Q+ D I + H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+VHRDIK +N+L+D +K+ DFG A+ +++ T Q + G+ Y SPE KG
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQ--TNHVLGTVQYFSPEQAKGE 187
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQKRVVFPES---PRLSSSCKA 287
+DI+S+G+VL+ M+ G PF+ +T S +K +Q V + + S
Sbjct: 188 ATDE-CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 288 LI 289
+I
Sbjct: 247 VI 248
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (393), Expect = 6e-45
Identities = 74/275 (26%), Positives = 143/275 (52%), Gaps = 32/275 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-------VV 105
+ + +G GS+ V L S + + A+K++ K ++ +++E ++
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV----VRL---KQVEHTNDERLML 60
Query: 106 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
+ HP +IR + ++++IM+Y + G L ++RK + + + +++ A++
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
Y H K +++RD+K EN+LLD +IK++DFGFA KY + T T CG+ Y +P
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-KYVPDVTY-------TLCGTPDYIAP 172
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSS 284
E++ PY + D WS G++++ M+ G PF D+N + ++ + + FP P +
Sbjct: 173 EVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNED 229
Query: 285 CKALISNILSP-VKFRI-----QMEDIRQDPWLKE 313
K L+S +++ + R+ ED++ PW KE
Sbjct: 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 52/241 (21%), Positives = 99/241 (41%), Gaps = 9/241 (3%)
Query: 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKH 110
Y L +VG G V A + VA+K++ + + + + RE L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-REARTAGRLQE 93
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK 170
P+++ E ++Y+ M L ++R++ + + Q+ A+D H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
HRD+K EN+L+ L DFG A + + Q G+ Y +PE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQ--LGNTVGTLYYMAPERFSE 209
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--PRLSSSCKAL 288
T ++DI+++ VL+ + G P+ S + + + + P + P + + A+
Sbjct: 210 SHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268
Query: 289 I 289
I
Sbjct: 269 I 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-44
Identities = 58/270 (21%), Positives = 128/270 (47%), Gaps = 28/270 (10%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNL 113
+G GS+ V + + A+K ++K + + + +E+++++GL+HP L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF----KELQIMQGLEHPFL 77
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+ + + ++++++ G L +++ + E+ + + +L A+DY + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL---KG 230
HRD+K +N+LLD+ ++ ++DF A T G+ Y +PE+ KG
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT------TMAGTKPYMAPEMFSSRKG 191
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPF---DDTNYSELLKQVQK-RVVFPESPRLSSSCK 286
Y+ D WS+GV + ++ GR P+ T+ E++ + V +P S
Sbjct: 192 AGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMV 248
Query: 287 ALISNILS--PVKFRIQ-MEDIRQDPWLKE 313
+L+ +L P + R + D++ P++ +
Sbjct: 249 SLLKKLLEPNPDQ-RFSQLSDVQNFPYMND 277
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 62/245 (25%), Positives = 118/245 (48%), Gaps = 12/245 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y LG+++G G + V LA R +DVA+K++ + + + +F RE + L HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHP 72
Query: 112 NLIRFL----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
++ YI+MEY +L +++ E + + + A+++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H+ ++HRD+K N+++ +K+ DFG AR + + Q + G+ Y SPE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGTAQYLSPEQ 190
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQKRVVFPES--PRLSSS 284
+G +SD++S+G VL+ ++ G PF D+ S + V++ + P + LS+
Sbjct: 191 ARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 285 CKALI 289
A++
Sbjct: 250 LDAVV 254
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 18/270 (6%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
V+G G+++ V + + Q A+KI++K E +V+ + +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
A + + +Y++MEY G LL ++ K I + R + +++ AID H+ VHRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
IK +N+LLD +I+L+DFG K + T S G+ Y SPEIL+ V P
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVR----SLVAVGTPDYLSPEILQAVGGGPG 243
Query: 237 QS------DIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPR-LSSSCK 286
D W++GV + M YG+ PF + +E ++ ++ + P + +
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303
Query: 287 ALISNILSPVKFRI---QMEDIRQDPWLKE 313
I +L P + R+ D R P+
Sbjct: 304 DFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 9e-43
Identities = 59/273 (21%), Positives = 114/273 (41%), Gaps = 42/273 (15%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L + VG G Y V + ++VA+KI S D F E+ L+H N++
Sbjct: 12 LLECVGKGRYGEVWRGS--WQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENIL 65
Query: 115 RFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-- 168
F+ + T+ ++++I Y + GSL + ++ +D R +A + + H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIE 124
Query: 169 ------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
K ++ HRD+K +N+L+ ++D G A +S +T+ + G+ Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-QSTNQLDVGNNPRVGTKRY 183
Query: 223 ASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYG----------RLPFDDTNYSEL-L 266
+PE+L ++ DIW+ G+VL+ + + PF D ++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 267 KQVQKRVVF----PESPR--LSSSCKALISNIL 293
+ ++K V P P S ++ ++
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 73/270 (27%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 58 VVGMGSYATVKLATSARHSQDV-AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
V+G G++ V + +++ V A+KI++K + E +V+ +
Sbjct: 81 VIGRGAFGEVAVVKL-KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
A + + +Y++M+Y G LL ++ K E + E+ R + +++ AID H+ VHR
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP--- 232
DIK +N+L+D +I+L+DFG K + S G+ Y SPEIL+ +
Sbjct: 200 DIKPDNILMDMNGHIRLADFGSCLK----LMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 233 --YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFP-ESPRLSSSCK 286
Y P + D WS+GV ++ M+YG PF + E ++ ++R FP + +S + K
Sbjct: 256 GRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 287 ALISNILSPVKFRI---QMEDIRQDPWLKE 313
LI ++ + R+ +ED ++ P+
Sbjct: 315 DLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-42
Identities = 77/273 (28%), Positives = 139/273 (50%), Gaps = 35/273 (12%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNL 113
++G G++ V L + A+KI+ K + + + E V++ +HP L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT----ESRVLQNTRHPFL 67
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
A +T R+ +MEYA G L + +ER E++ R + +++ A++Y H + VV
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEIL 228
+RDIK ENL+LD +IK++DFG K+ +S+ TFCG+ Y +PE+L
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLC----------KEGISDGATMKTFCGTPEYLAPEVL 177
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKA 287
+ Y + D W +GVV++ M+ GRLPF + ++ L + + + + FP LS K+
Sbjct: 178 EDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAKS 234
Query: 288 LISNILS--PVKFRI-----QMEDIRQDPWLKE 313
L++ +L P + R+ +++ + +
Sbjct: 235 LLAGLLKKDPKQ-RLGGGPSDAKEVMEHRFFLS 266
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-42
Identities = 63/247 (25%), Positives = 133/247 (53%), Gaps = 25/247 (10%)
Query: 58 VVGMGSYATVKLA--TSARHSQDV-AIKIISKVQAPIDYLKKFLPREIE-------VVKG 107
V+G G Y V + ++ + A+K++ K A I ++ ++ +++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK--AMI--VRN--AKDTAHTKAERNILEE 77
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+KHP ++ + A +T ++Y+I+EY G L + +E ED + ++++ A+ +
Sbjct: 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H+K +++RD+K EN++L+ + ++KL+DFG K S+++ ++ TFCG+ Y +PEI
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-KESIHDGT----VTHTFCGTIEYMAPEI 192
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCK 286
L + + D WS+G +++ M+ G PF N + + + ++ ++ P P L+ +
Sbjct: 193 LMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP--PYLTQEAR 249
Query: 287 ALISNIL 293
L+ +L
Sbjct: 250 DLLKKLL 256
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 84/319 (26%), Positives = 145/319 (45%), Gaps = 48/319 (15%)
Query: 19 QERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGD-----VVGMGSYATVKLATSA 73
+ NA + P + S D V+G GS+ V LA
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPS--SNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 74 RHSQDVAIKIISKVQAPIDYLKKFLPREIE--------VVKGLKHPNLIRFLQAIETTHR 125
A+K++ K I LKK +E + ++K +KHP L+ + +T +
Sbjct: 61 AEEVFYAVKVLQK--KAI--LKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113
Query: 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD 185
+Y +++Y G L +++ER E + R + +++A A+ Y H ++V+RD+K EN+LLD
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 186 DKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEILKGVPYTPQQSDI 240
+ +I L+DFG K+N+ TFCG+ Y +PE+L PY + D
Sbjct: 174 SQGHIVLTDFGLC----------KENIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 222
Query: 241 WSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKALISNILS--PVK 297
W +G VL+ M+YG PF N +E+ + K + P +++S + L+ +L K
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTK 280
Query: 298 FRI----QMEDIRQDPWLK 312
R+ +I+ +
Sbjct: 281 -RLGAKDDFMEIKSHVFFS 298
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 5e-41
Identities = 67/251 (26%), Positives = 131/251 (52%), Gaps = 35/251 (13%)
Query: 58 VVGMGSYATVKLA--TSARHSQDV-AIKIISKVQAPIDYLKKFLPREIE------VVKGL 108
V+G GS+ V L S ++ + A+K++ K LK + ++ +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKV--RDRVRTKMERDILVEV 83
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
HP +++ A +T ++Y+I+++ + G L + KE E+ + + ++LA A+D+ H
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYA 223
+++RD+K EN+LLD++ +IKL+DFG + K+++ +FCG+ Y
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLS----------KESIDHEKKAYSFCGTVEYM 193
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLS 282
+PE++ +T Q +D WS GV++F M+ G LPF + E + ++ ++ P LS
Sbjct: 194 APEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP--QFLS 250
Query: 283 SSCKALISNIL 293
++L+ +
Sbjct: 251 PEAQSLLRMLF 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 89/347 (25%), Positives = 163/347 (46%), Gaps = 35/347 (10%)
Query: 4 RPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGD-----V 58
R + +++ + GS + + H ++ + +
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL 155
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G G++ V L + A+KI+ K + + + E V++ +HP L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT----ENRVLQNSRHPFLT 211
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-KKSVV 173
+ +T R+ +MEYA G L + +ER ED+ R + +++ A+DY H +K+VV
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 271
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY 233
+RD+K ENL+LD +IK++DFG K + + +TFCG+ Y +PE+L+ Y
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLC-KEGIKDGA----TMKTFCGTPEYLAPEVLEDNDY 326
Query: 234 TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKALISNI 292
+ D W +GVV++ M+ GRLPF + ++ +L + + + + FP + L K+L+S +
Sbjct: 327 G-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LGPEAKSLLSGL 383
Query: 293 LS--PVKFRI-----QMEDIRQDPWLKE-DSNPVGKSKSAPEVIPFK 331
L P + R+ ++I Q + V + K +P PFK
Sbjct: 384 LKKDPKQ-RLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSP---PFK 426
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 77/273 (28%), Positives = 123/273 (45%), Gaps = 38/273 (13%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE--------VVKGLK 109
++G GS+ V LA + +Q AIK + K D + ++E + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKK-----DVVLM--DDDVECTMVEKRVLSLAWE 76
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HP L +T ++ +MEY G L+ I+ D + + +++ + + H
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYAS 224
K +V+RD+K +N+LLD +IK++DFG K+N+ TFCG+ Y +
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMC----------KENMLGDAKTNTFCGTPDYIA 186
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSS 283
PEIL G Y D WS GV+L+ M+ G+ PF + EL +P L
Sbjct: 187 PEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--RWLEK 243
Query: 284 SCKALISNILS--PVKFRI-QMEDIRQDPWLKE 313
K L+ + P K R+ DIRQ P +E
Sbjct: 244 EAKDLLVKLFVREPEK-RLGVRGDIRQHPLFRE 275
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 65/263 (24%), Positives = 111/263 (42%), Gaps = 11/263 (4%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 116
+G G+ V + +A K+I P + + RE++V+ P ++ F
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNSPYIVGF 96
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-KKSVVHR 175
A + + I ME+ GSL +V++K I E + + + Y K ++HR
Sbjct: 97 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 156
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+K N+L++ + IKL DFG + + +++ +F G+ +Y SPE L+G Y+
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERLQGTHYS- 208
Query: 236 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSP 295
QSDIWSMG+ L M GR P + EL +V +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 296 VKFRIQMEDIRQDPWLKEDSNPV 318
+ R M ++ + P
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPK 291
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 72/332 (21%), Positives = 152/332 (45%), Gaps = 52/332 (15%)
Query: 18 KQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG----YSLGD-----VVGMGSYATVK 68
+A T+A+G D EQ + +L G + + V+G G+Y V
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 69 LA--TSARHSQDV-AIKIISKVQAPIDYLKKFLPREIEVV-----------KGLKHPNLI 114
L S + + A+K++ K + ++ + + P L+
Sbjct: 72 LVRKISGHDTGKLYAMKVLKK---------ATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
A +T ++++I++Y G L + + E + + + ++ A+++ HK +++
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 182
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RDIK EN+LLD ++ L+DFG + K V + + FCG+ Y +P+I++G
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLS-KEFVADETERAY---DFCGTIEYMAPDIVRGGDSG 238
Query: 235 PQQS-DIWSMGVVLFAMVYGRLPF----DDTNYSELLKQ-VQKRVVFPESPRLSSSCKAL 288
++ D WS+GV+++ ++ G PF + + +E+ ++ ++ +P +S+ K L
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDL 296
Query: 289 ISNILS--PVKFRI-----QMEDIRQDPWLKE 313
I +L P K R+ ++I++ + ++
Sbjct: 297 IQRLLMKDPKK-RLGCGPRDADEIKEHLFFQK 327
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 78/307 (25%), Positives = 139/307 (45%), Gaps = 49/307 (15%)
Query: 34 PNEQDKDTERKLSVLETHGYSLGD-----VVGMGSYATVKLATSARHSQDVAIKIISKVQ 88
P E K+ + V ++ + + V+G GS+ V LA A+K++ K
Sbjct: 2 PKESSKEGN-GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-- 58
Query: 89 APIDYLKKFLPR-EIE--------VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLL 139
L ++E + HP L + +T R++ +ME+ G L+
Sbjct: 59 ------DVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM 112
Query: 140 EVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199
I+K R DE + R + +++ A+ + H K +++RD+K +N+LLD + + KL+DFG
Sbjct: 113 FHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC- 171
Query: 200 KYSVNNTDYKQNLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
K+ + TFCG+ Y +PEIL+ + Y D W+MGV+L+ M+ G
Sbjct: 172 ---------KEGICNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGH 221
Query: 255 LPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKALISNILS--PVK-----FRIQMEDIR 306
PF+ N +L + + VV+P L ++ + ++ P + I
Sbjct: 222 APFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL 279
Query: 307 QDPWLKE 313
+ P+ KE
Sbjct: 280 RHPFFKE 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 53/272 (19%), Positives = 105/272 (38%), Gaps = 45/272 (16%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+ +G G Y V + + VA+K+ + F EI ++H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFF----TTEEASWFRETEIYQTVLMRHENIL 94
Query: 115 RFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-- 168
F+ A ++Y+I +Y +NGSL + ++ +D + + + H
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 169 ------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
K ++ HRD+K +N+L+ ++D G A K+ ++T+ T G+ Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI-SDTNEVDIPPNTRVGTKRY 212
Query: 223 ASPEILKG------VPYTPQQSDIWSMGVVL---------------FAMVYGRLPFDDTN 261
PE+L +D++S G++L + + Y L D +
Sbjct: 213 MPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 262 YSELLKQV---QKRVVFPESPRLSSSCKALIS 290
Y ++ + V + R FP + +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGK 303
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 31/253 (12%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISK 86
G PN+ ++ V+G G++ TV + VAIK + +
Sbjct: 1 GEAPNQALLRILKETEF------KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-R 53
Query: 87 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 146
K+ L E V+ + +P++ R L I T V +I + G LL+ +R+ +
Sbjct: 54 EATSPKANKEIL-DEAYVMASVDNPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHK 111
Query: 147 Y-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205
I W Q+A ++Y + +VHRD+ N+L+ ++K++DFG A+
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 206 TDYKQNLSETFCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFD 258
+Y G A E + YT QSD+WS GV ++ M +G P+D
Sbjct: 172 KEYHAE------GGKVPIKWMA---LESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYD 221
Query: 259 DTNYSELLKQVQK 271
SE+ ++K
Sbjct: 222 GIPASEISSILEK 234
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-39
Identities = 53/259 (20%), Positives = 102/259 (39%), Gaps = 37/259 (14%)
Query: 21 RHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVA 80
HH ++ + L +V G + V A ++ VA
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMP---------LQLLEVKARGRFGCVWKAQ--LLNEYVA 51
Query: 81 IKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV----YIIMEYAKNG 136
+KI D E+ + G+KH N+++F+ A + V ++I + + G
Sbjct: 52 VKIFP----IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCH----------KKSVVHRDIKCENLLLDD 186
SL + ++ + ++ +A + Y H K ++ HRDIK +N+LL +
Sbjct: 108 SLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166
Query: 187 KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP----QQSDIWS 242
++DFG A K+ + + G+ Y +PE+L+G + D+++
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTH---GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 243 MGVVLFAMVYGRLPFDDTN 261
MG+VL+ + D
Sbjct: 224 MGLVLWELASRCTAADGPV 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 57/267 (21%), Positives = 116/267 (43%), Gaps = 42/267 (15%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L + +G G + V ++VA+KI S + F EI L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENIL 99
Query: 115 RFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-- 168
F+ A + +++++ +Y ++GSL + + + + + + A + + H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 158
Query: 169 ------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
K ++ HRD+K +N+L+ ++D G A ++ + TD G+ Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTIDIAPNHRVGTKRY 217
Query: 223 ASPEILKG------VPYTPQQSDIWSMGVVLFAMVYG----------RLPFDDTNYSEL- 265
+PE+L +++DI++MG+V + + +LP+ D S+
Sbjct: 218 MAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 266 LKQVQKRVVF----PESPRLSSSCKAL 288
+++++K V P P SC+AL
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEAL 303
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 76/332 (22%), Positives = 147/332 (44%), Gaps = 40/332 (12%)
Query: 5 PDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG-YSLGD-----V 58
+ + +++ AK P E+ +T K L D V
Sbjct: 289 VPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV 348
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+G GS+ V L+ + A+KI+ K ++ + + + + K P L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM--VEKRV-LALPGKPPFLT 405
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
+ +T R+Y +MEY G L+ I++ E + +++A + + K +++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEILK 229
RD+K +N++LD + +IK++DFG K+N+ + TFCG+ Y +PEI+
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMC----------KENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKAL 288
PY + D W+ GV+L+ M+ G+ PF+ + EL + ++ V +P +S A+
Sbjct: 516 YQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVAI 572
Query: 289 ISNILS--PVKFRI-----QMEDIRQDPWLKE 313
+++ P K R+ DI++ + +
Sbjct: 573 CKGLMTKHPGK-RLGCGPEGERDIKEHAFFRY 603
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 63/246 (25%), Positives = 121/246 (49%), Gaps = 26/246 (10%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNL 113
V+G GS+ V L+ + A+KI+ K ++ + + + + K P L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM--VEKRV-LALPGKPPFL 83
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVV 173
+ +T R+Y +MEY G L+ I++ E + +++A + + K ++
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 174 HRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEIL 228
+RD+K +N++LD + +IK++DFG K+N+ + TFCG+ Y +PEI+
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMC----------KENIWDGVTTKTFCGTPDYIAPEII 193
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-VQKRVVFPESPRLSSSCKA 287
PY + D W+ GV+L+ M+ G+ PF+ + EL + ++ V +P +S A
Sbjct: 194 AYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--KSMSKEAVA 250
Query: 288 LISNIL 293
+ ++
Sbjct: 251 ICKGLM 256
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 8e-38
Identities = 75/279 (26%), Positives = 140/279 (50%), Gaps = 36/279 (12%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNLIRF 116
V+G GSYA V L + + A+K++ K D ++ E V + HP L+
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 117 LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+T R++ ++EY G L+ ++++R + E+ R + ++++ A++Y H++ +++RD
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEILKGV 231
+K +N+LLD + +IKL+D+G K+ L TFCG+ Y +PEIL+G
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMC----------KEGLRPGDTTSTFCGTPNYIAPEILRGE 185
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPF---------DDTNYSELLKQ-VQKRVVFPESPRL 281
Y D W++GV++F M+ GR PF D L + ++K++ P L
Sbjct: 186 DYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 242
Query: 282 SSSCKALISNILS--PVK-----FRIQMEDIRQDPWLKE 313
S +++ + L+ P + + DI+ P+ +
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 55/252 (21%), Positives = 118/252 (46%), Gaps = 22/252 (8%)
Query: 22 HHSAKTNAEGSDPNEQ-------DKDTERKLSVLETHG-----YSLGDVVGMGSYATVKL 69
HH + + N + + L ++ G +G GS V L
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCL 63
Query: 70 ATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129
A + VA+K++ + ++ L E+ +++ +H N++ ++ ++++
Sbjct: 64 AREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189
ME+ + G+L +++ + ++E++ + A+ Y H + V+HRDIK +++LL
Sbjct: 121 MEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179
Query: 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA 249
+KLSDFGF + ++ K+ + G+ + +PE++ Y + DIWS+G+++
Sbjct: 180 VKLSDFGFCAQ--ISKDVPKRK---SLVGTPYWMAPEVISRSLYAT-EVDIWSLGIMVIE 233
Query: 250 MVYGRLPFDDTN 261
MV G P+ +
Sbjct: 234 MVDGEPPYFSDS 245
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 84/340 (24%), Positives = 156/340 (45%), Gaps = 49/340 (14%)
Query: 6 DTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGD-----VVG 60
H + A GS E+ + + S + L D V+G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 61 MGSYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEV-VKGLKHPNLIR 115
GSYA V L + + A++++ K ID+++ E V + HP L+
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ----TEKHVFEQASNHPFLVG 117
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+T R++ ++EY G L+ ++++R + E+ R + ++++ A++Y H++ +++R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE-----TFCGSYAYASPEILKG 230
D+K +N+LLD + +IKL+D+G K+ L TFCG+ Y +PEIL+G
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMC----------KEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPF---------DDTNYSELLKQ-VQKRVVFPESPR 280
Y D W++GV++F M+ GR PF D L + ++K++ P S
Sbjct: 228 EDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-- 284
Query: 281 LSSSCKALISNILS--PVK-----FRIQMEDIRQDPWLKE 313
LS +++ + L+ P + + DI+ P+ +
Sbjct: 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-38
Identities = 63/209 (30%), Positives = 114/209 (54%), Gaps = 10/209 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ + +G G+ TV A Q+VAI+ ++ Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPN 78
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +L + ++++MEY GSL +V+ E +DE + + A+++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK +N+LL ++KL+DFGF + + K++ T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRS---TMVGTPYWMAPEVVTRKA 192
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y P + DIWS+G++ M+ G P+ + N
Sbjct: 193 YGP-KVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 62/290 (21%), Positives = 121/290 (41%), Gaps = 36/290 (12%)
Query: 48 LETHGYSLGD-----VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK-----F 97
LE V+G G + V + A K ++K LKK
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNK-----KRLKKRKGYQG 231
Query: 98 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL----LEVIRKERYIDEDKG 153
E +++ + ++ A ET + ++M G + V E +
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 154 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213
+ +Q+ +++ H++++++RD+K EN+LLDD N+++SD G A + T +
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-----KT 346
Query: 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273
+ + G+ + +PE+L G Y D +++GV L+ M+ R PF K++++RV
Sbjct: 347 KGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
Query: 274 VFPE---SPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 313
+ + S + K +L P K R+ + +R P ++
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEK-RLGFRDGSCDGLRTHPLFRD 454
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 55/286 (19%), Positives = 113/286 (39%), Gaps = 55/286 (19%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK--GLKHP 111
L +++G G Y V + + VA+K+ S + F+ E + + ++H
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFI-NEKNIYRVPLMEHD 67
Query: 112 NLIRFLQAIETTHRV-----YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
N+ RF+ E ++MEY NGSL + + D R + + Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAY 126
Query: 167 CH---------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN---TDYKQNLSE 214
H K ++ HRD+ N+L+ + +SDFG + + + N + N +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 215 TFCGSYAYASPEILKGVPYTP------QQSDIWSMGVVL------------------FAM 250
+ G+ Y +PE+L+G +Q D++++G++ + M
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 251 VYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNIL 293
+ + + ++ V ++R FPE+ + +S + +
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 59/276 (21%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK-------FLPREI-EVVKGLK 109
++G G + V A + A+K + K +K R + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETLALNERIMLSLVSTGD 250
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
P ++ A T ++ I++ G L + + E R + +++ +++ H
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL- 228
+ VV+RD+K N+LLD+ ++++SD G A +S G++ Y +PE+L
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------HASVGTHGYMAPEVLQ 363
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQV-QKRVVFPESPRLSSS 284
KGV Y +D +S+G +LF ++ G PF E+ + V P+S S
Sbjct: 364 KGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPE 420
Query: 285 CKALISNILS--PVKFRI-----QMEDIRQDPWLKE 313
++L+ +L + R+ +++++ P+ +
Sbjct: 421 LRSLLEGLLQRDVNR-RLGCLGRGAQEVKESPFFRS 455
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 69/247 (27%), Positives = 113/247 (45%), Gaps = 17/247 (6%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATV---KLATSARHSQDVAIKIISK- 86
G P + L L + +G GS+ V + + + VA+K +
Sbjct: 4 GEGPLQSLT-CLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 87 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 146
V + + + F+ RE+ + L H NLIR L + T + ++ E A GSLL+ +RK +
Sbjct: 58 VLSQPEAMDDFI-REVNAMHSLDHRNLIR-LYGVVLTPPMKMVTELAPLGSLLDRLRKHQ 115
Query: 147 Y-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205
R+ Q+A+ + Y K +HRD+ NLLL + +K+ DFG R N+
Sbjct: 116 GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 264
Y +A+ +PE LK ++ SD W GV L+ M YG+ P+ N S+
Sbjct: 176 DHYVMQEHRKV--PFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
Query: 265 LLKQVQK 271
+L ++ K
Sbjct: 233 ILHKIDK 239
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 12/210 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + + +G GSY +V A Q VAIK + + +K EI +++ P+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPH 85
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKS 171
++++ + ++I+MEY GS+ ++IR + + + ED+ ++Y H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRDIK N+LL+ + + KL+DFG A + + +T K+N T G+ + +PE+++ +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRN---TVIGTPFWMAPEVIQEI 200
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y +DIWS+G+ M G+ P+ D +
Sbjct: 201 GYNC-VADIWSLGITAIEMAEGKPPYADIH 229
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 8/220 (3%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
LG+ +G G++ V + VA+K + P D KFL +E ++K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSV 172
+R + +YI+ME + G L +R E + + A ++Y K
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+ N L+ +K +K+SDFG +R+ + Y + + +PE L
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQV-PVKWTAPEALNYGR 291
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
Y+ +SD+WS G++L+ G P+ + + + + V+K
Sbjct: 292 YSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 31/253 (12%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISK 86
G PN+ ++ V+G G++ TV + VAIK + +
Sbjct: 1 GEAPNQALLRILKETEF------KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-R 53
Query: 87 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 146
K+ L E V+ + +P++ R L I T V +I + G LL+ +R+ +
Sbjct: 54 EATSPKANKEIL-DEAYVMASVDNPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVREHK 111
Query: 147 Y-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205
I W Q+A ++Y + +VHRD+ N+L+ ++K++DFG A+
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 206 TDYKQNLSETFCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFD 258
+Y G A E + YT QSD+WS GV ++ M +G P+D
Sbjct: 172 KEYHAE------GGKVPIKWMA---LESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYD 221
Query: 259 DTNYSELLKQVQK 271
SE+ ++K
Sbjct: 222 GIPASEISSILEK 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 63/298 (21%), Positives = 126/298 (42%), Gaps = 35/298 (11%)
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK-----FLPREIEVVKGLKHPN 112
V+G G + V + A K + K +KK E ++++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKK 170
++ A ET + +++ G L I + E + + +++ ++ H++
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+V+RD+K EN+LLDD +I++SD G A T + G+ Y +PE++K
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------IKGRVGTVGYMAPEVVKN 359
Query: 231 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-----FPESPRLSSSC 285
YT D W++G +L+ M+ G+ PF ++V++ V + E S
Sbjct: 360 ERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQA 416
Query: 286 KALISNILS--PVKFRI-----QMEDIRQDPWLKE-DSNPVGKSKSAPEVIPFKKSRN 335
++L S +L P + R+ ++++ P K+ + +G P P ++
Sbjct: 417 RSLCSQLLCKDPAE-RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 9/209 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
++ + +G GS+ V R + VAIKII +A + + + +EI V+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPY 81
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+ ++ + +++IIMEY GS L+++ + +DE + ++ +DY H +
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK N+LL + +KL+DFG A + + +T K+N TF G+ + +PE++K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRN---TFVGTPFWMAPEVIKQSA 195
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
Y ++DIWS+G+ + G P + +
Sbjct: 196 YDS-KADIWSLGITAIELARGEPPHSELH 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-35
Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G GSY V + Q VAIK +KK REI ++K LKHPN
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLADAIDYCHKKS 171
L+ L+ R++++ EY + ++L + R +R + E + Q A+++CHK +
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YASPEI 227
+HRD+K EN+L+ IKL DFGFAR + + Y Y SPE+
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY------D---DEVATRWYRSPEL 173
Query: 228 LKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
L G Y P D+W++G V ++ G
Sbjct: 174 LVGDTQYGP-PVDVWAIGCVFAELLSGV 200
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 35/234 (14%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
L ++G G + V +VA+K K +D +KF+ E ++K L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
P++++ L I +IIME G L + + + + + Q+ A+ Y
Sbjct: 73 PHIVK-LIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS----- 224
+ VHRDI N+L+ +KL DFG +R + + DY Y +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDY-------------YKASVTRL 176
Query: 225 ------PEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
PE + +T SD+W V ++ ++ +G+ PF +++ ++K
Sbjct: 177 PIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 18/219 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIIS--KVQAPIDYLKKFLPREIEVVKGLKH 110
Y L +V+G G+ A V+ A A + VAIK I+ K Q +D L K EI+ + H
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK----EIQAMSQCHH 72
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------QLA 161
PN++ + + ++++M+ GS+L++I K + ++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVL 131
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
+ ++Y HK +HRD+K N+LL + +++++DFG + + + + +TF G+
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 222 YASPE-ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 259
+ +PE + + Y ++DIWS G+ + G P+
Sbjct: 192 WMAPEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHK 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 44/234 (18%), Positives = 96/234 (41%), Gaps = 26/234 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y + + G + LA + + V +K + + + E + + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAM-AERQFLAEVVHP 139
Query: 112 NLIRFLQAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
++++ +E T R YI+MEY SL ++ + + + ++ A+ Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSY 197
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
H +V+ D+K EN++L ++ +KL D G +N+ G+ + +PE
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFG-------YLYGTPGFQAPE 247
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 280
I++ P T +DI+++G L A+ + + + + ++
Sbjct: 248 IVRTGP-TV-ATDIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDPVLKTYD 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y +VG GSY V + + VAIK K + REI+++K L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLKQL 81
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLADAIDYC 167
+H NL+ L+ + R Y++ E+ + ++L+ + +D +++ Q+ + I +C
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN---TDYKQNLSETFCGSYAYAS 224
H +++HRDIK EN+L+ +KL DFGFAR + D Y +
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--------WYRA 192
Query: 225 PEILKG-VPYTPQQSDIWSMGVVLFAMVYGR 254
PE+L G V Y D+W++G ++ M G
Sbjct: 193 PELLVGDVKYGK-AVDVWAIGCLVTEMFMGE 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
LG +G G + V + + VAIK K +KFL +E ++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 75
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
P++++ L + T + V+IIME G L ++ +Y +D + QL+ A+ Y
Sbjct: 76 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS----- 224
K VHRDI N+L+ +KL DFG +R + ++ Y Y +
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTY-------------YKASKGKL 179
Query: 225 ------PEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
PE + +T SD+W GV ++ ++ +G PF ++++ +++
Sbjct: 180 PIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 53/217 (24%), Positives = 106/217 (48%), Gaps = 8/217 (3%)
Query: 58 VVGMGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G G++ TVK + + VA+KI+ + L E V++ L +P ++R
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIVR 82
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+ I ++ME A+ G L + +++ R++ + Q++ + Y + + VHR
Sbjct: 83 -MIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+ N+LL ++ K+SDFG ++ + YK + + +PE + ++
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPECINYYKFS- 198
Query: 236 QQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
+SD+WS GV+++ A YG+ P+ SE+ ++K
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 49/229 (21%), Positives = 97/229 (42%), Gaps = 25/229 (10%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
V+G G + TV V IK+I + ++ + + + L H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIGSLDH 74
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
+++R L + + ++ +Y GSLL+ +R+ R + W Q+A + Y +
Sbjct: 75 AHIVR-LLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS------YAYA 223
+VHR++ N+LL ++++DFG A ++ + + A
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS------EAKTPIKWMA-- 185
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
E + YT QSD+WS GV ++ ++ +G P+ +E+ ++K
Sbjct: 186 -LESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 51/216 (23%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 60 GMGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
G G++ +V+ + DVAIK++ K ++ + RE +++ L +P ++R L
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR-L 75
Query: 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+ + ++ME A G L + + +R I Q++ + Y +K+ VHRD
Sbjct: 76 IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ 236
+ N+LL +++ K+SDFG ++ +++ Y + + + +PE + ++
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPECINFRKFS-S 192
Query: 237 QSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
+SD+WS GV ++ A+ YG+ P+ E++ +++
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 14/219 (6%)
Query: 53 YSLGDVVGMG--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
Y L V+G G TV LA + V ++ I+ + + FL E+ V K H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNH 85
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWFSQLADAIDYCH 168
PN++ + + ++++ + GS ++I ++E + A+DY H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YAS 224
VHR +K ++L+ + LS S+ + +Q + F + S
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 225 PEILK--GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
PE+L+ Y +SDI+S+G+ + G +PF D
Sbjct: 204 PEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMP 241
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 58/220 (26%), Positives = 113/220 (51%), Gaps = 12/220 (5%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
+ +G G Y V ++S VA+K + K +++FL +E V+K +KHPNL+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTM--EVEEFL-KEAAVMKEIKHPNLV 279
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSV 172
+ L YII E+ G+LL+ +R+ + +Q++ A++Y KK+
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HR++ N L+ + + +K++DFG +R + Y + F + +PE L
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF--PIKWTAPESLAYNK 395
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+W+ GV+L+ + YG P+ + S++ + ++K
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 53/215 (24%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + +G G++ V A + A K+I + EIE++ HP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPY 77
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKS 171
+++ L A +++I++E+ G++ ++ + +R + E + + Q+ +A+++ H K
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI---- 227
++HRD+K N+L+ + +I+L+DFG + K T K++ +F G+ + +PE+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRD---SFIGTPYWMAPEVVMCE 192
Query: 228 -LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261
+K PY ++DIWS+G+ L M P + N
Sbjct: 193 TMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELN 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 25/240 (10%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIR 115
+G G+ V + +A+K + + + K + +++VV K P +++
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHDCPYIVQ 88
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-KKSVVH 174
T V+I ME + R + I E + + A+ Y K V+H
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARK--YSVNNTDYKQNLSETFCGSYAYASPEILK--- 229
RD+K N+LLD++ IKL DFG + + G AY +PE +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--------RSAGCAAYMAPERIDPPD 200
Query: 230 --GVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSCK 286
Y ++D+WS+G+ L + G+ P+ + E+L + V+ E P L
Sbjct: 201 PTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTK----VLQEEPPLLPGHMG 255
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 81/324 (25%), Positives = 132/324 (40%), Gaps = 59/324 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGL 108
Y D +G G+YATV S VA+K I +++ P + RE+ ++K L
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAI-----REVSLLKDL 57
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
KH N++ I T + ++ EY L+ I+ + + QL + Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD--DCGNIINMHNVKLFLFQLLRGLAY 115
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---LSETFCGSYAYA 223
CH++ V+HRD+K +NLL++++ +KL+DFG AR S+ Y L Y
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL--------WYR 167
Query: 224 SPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQ----------- 270
P+IL G Y+ Q D+W +G + + M GR F T +L +
Sbjct: 168 PPDILLGSTDYST-QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 271 --------KRVVFPES---------PRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 311
K +P+ PRL S L++ +L RI ED + P+
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN-RISAEDAMKHPFF 285
Query: 312 KEDSNPVGKSKSAPEVIPFKKSRN 335
+ K + K+ +
Sbjct: 286 LSLGERIHKLPDTTSIFALKEIQL 309
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 23/238 (9%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIR 115
+G G+Y V+ Q +A+K I + +K L ++++ + + P +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVT 70
Query: 116 FLQAIETTHRVYIIMEYAKNGSLL----EVIRKERYIDEDKGRRWFSQLADAIDYCHKK- 170
F A+ V+I ME + SL +VI K + I ED + + A+++ H K
Sbjct: 71 FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
SV+HRD+K N+L++ +K+ DFG + + + K + G Y +PE +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAK----DIDAGCKPYMAPERINP 183
Query: 231 VPYTPQ---QSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSS 284
+SDIWS+G+ + + R P+D + LKQ VV SP+L +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEPSPQLPAD 237
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 58/246 (23%), Positives = 95/246 (38%), Gaps = 46/246 (18%)
Query: 55 LGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
+ +G GS+ K VAIK + A + +FL E V+K
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL-NEASVMKEFN 86
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFS---------Q 159
+++R L + +IME G L +R R + + S +
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 219
+AD + Y + VHRD+ N ++ + + +K+ DFG R + TDY
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDY----------- 193
Query: 220 YAYA------------SPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 266
Y SPE LK +T SD+WS GVVL+ + P+ + ++L
Sbjct: 194 --YRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 267 KQVQKR 272
+ V +
Sbjct: 251 RFVMEG 256
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 22 HHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAI 81
HH A+ P + ++ Y +G G+Y V A ++ VAI
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPSATSIDR--YRRITKLGEGTYGEVYKAIDTVTNETVAI 64
Query: 82 KIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 137
K I +++ ++ +P RE+ ++K L+H N+I I HR+++I EYA+N
Sbjct: 65 KRIR-----LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118
Query: 138 LLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKL 192
L + + K + + + QL + +++CH + +HRD+K +NLLL +K+
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
Query: 193 SDFGFARKYSVNNTDYKQN---LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLF 248
DFG AR + + + L Y PEIL G Y+ DIWS+ +
Sbjct: 179 GDFGLARAFGIPIRQFTHEIITL--------WYRPPEILLGSRHYST-SVDIWSIACIWA 229
Query: 249 AMVYGR 254
M+
Sbjct: 230 EMLMKT 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 13/223 (5%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
LG +G G + V + + VAIK K +KFL +E ++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDH 450
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
P++++ L + T + V+IIME G L ++ ++ +D + QL+ A+ Y
Sbjct: 451 PHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
K VHRDI N+L+ +KL DFG +R + ++ Y + + +PE +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKL--PIKWMAPESIN 565
Query: 230 GVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T SD+W GV ++ ++ +G PF ++++ +++
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 66/303 (21%), Positives = 130/303 (42%), Gaps = 52/303 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y + +G G+Y TV A + + VA+K + +D + +P REI ++K L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKEL 58
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
KH N++R + + ++ ++ E+ + + +D + + + QL + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
CH ++V+HRD+K +NLL++ +KL++FG AR + + Y + + Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW-----YRPPD 171
Query: 227 ILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPF---------------------DDT---- 260
+L G Y+ D+WS G + + P ++
Sbjct: 172 VLFGAKLYST-SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 261 ----NYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKED 314
+Y + P+L+++ + L+ N+L PV+ RI E+ Q P+ +
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ-RISAEEALQHPYFSDF 289
Query: 315 SNP 317
P
Sbjct: 290 CPP 292
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 57/275 (20%), Positives = 127/275 (46%), Gaps = 11/275 (4%)
Query: 2 TIRPDTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVV-G 60
T+ D P ++ + + P ++ + K L+ + D+ G
Sbjct: 286 TLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELG 345
Query: 61 MGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118
G++ +V+ + DVAIK++ K ++ + RE +++ L +P ++R L
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR-LI 402
Query: 119 AIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177
+ + ++ME A G L + + +R I Q++ + Y +K+ VHR++
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
N+LL +++ K+SDFG ++ +++ Y + + + +PE + ++ +
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPECINFRKFS-SR 519
Query: 238 SDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
SD+WS GV ++ A+ YG+ P+ E++ +++
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 59/221 (26%), Positives = 115/221 (52%), Gaps = 14/221 (6%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
L + +G G + V + VA+K + + D FL E ++K L+H L
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPD---AFL-AEANLMKQLQHQRL 70
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR--RWFSQLADAIDYCHKKS 171
+R L A+ T +YII EY +NGSL++ ++ I + +Q+A+ + + +++
Sbjct: 71 VR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD++ N+L+ D + K++DFG AR + + +Y F + +PE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKF--PIKWTAPEAINYG 185
Query: 232 PYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T +SD+WS G++L +V +GR+P+ E+++ +++
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 14/220 (6%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L +G G + V + T + VAIK + + FL +E +V+K L+H L+
Sbjct: 188 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKLV 242
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSV 172
+ + + +YI+ EY GSLL+ ++ E Y+ + +Q+A + Y + +
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD++ N+L+ + K++DFG AR + + +Y F + +PE
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF--PIKWTAPEAALYGR 357
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T +SD+WS G++L + GR+P+ E+L QV++
Sbjct: 358 FT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 49/245 (20%), Positives = 102/245 (41%), Gaps = 43/245 (17%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+LG ++G G + +V +L VA+K++ +++FL RE +K H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKEFDH 84
Query: 111 PNLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG------RRWFS 158
P++ + + +A +I+ + K+G L + R + R+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+A ++Y ++ +HRD+ N +L + + ++DFG +RK + + DY
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--IYSGDY---------- 192
Query: 219 SYAYAS----------PE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 266
Y E + + YT SD+W+ GV ++ ++ G+ P+ +E+
Sbjct: 193 -YRQGCASKLPVKWLALESLADNL-YTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 267 KQVQK 271
+
Sbjct: 250 NYLIG 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 67/313 (21%), Positives = 127/313 (40%), Gaps = 64/313 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGL 108
+ + +G G+YATV + VA+K + K+ + P + REI ++K L
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAI-----REISLMKEL 60
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLE---VIRKERYIDEDKGRRWFSQLADA 163
KH N++R I T +++ ++ E+ N ++ V R ++ + + + QL
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---LSETFCGSY 220
+ +CH+ ++HRD+K +NLL++ + +KL DFG AR + + + L
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL-------- 172
Query: 221 AYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLK----------- 267
Y +P++L G Y+ DIWS G +L M+ G+ F + +L
Sbjct: 173 WYRAPDVLMGSRTYST-SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 268 ---------------------QVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMED 304
+++ + L + + +L P R+ +
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM-RLSAKQ 290
Query: 305 IRQDPWLKEDSNP 317
PW E +
Sbjct: 291 ALHHPWFAEYYHH 303
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 59/283 (20%), Positives = 113/283 (39%), Gaps = 47/283 (16%)
Query: 17 LKQERHHSAKTNAEGSDPNEQDKDTERKLSVLET--HGYSLGDVVGMGSYATV---KLAT 71
+ HH ++ G P ++ + KL + + LG ++G G + +V L
Sbjct: 1 MGSSHHHH--HHSSGLVP-RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57
Query: 72 SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL-----QAIETTHRV 126
S VA+K + + +++FL E +K HPN+IR L + + +
Sbjct: 58 EDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116
Query: 127 YIIMEYAKNGSLLEVIRKERYIDEDKG------RRWFSQLADAIDYCHKKSVVHRDIKCE 180
+I+ + K G L + R K ++ +A ++Y ++ +HRD+
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176
Query: 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS----------PE-ILK 229
N +L D + ++DFG ++K + + DY Y E +
Sbjct: 177 NCMLRDDMTVCVADFGLSKK--IYSGDY-----------YRQGRIAKMPVKWIAIESLAD 223
Query: 230 GVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
V YT + SD+W+ GV ++ + G P+ E+ +
Sbjct: 224 RV-YTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 14/220 (6%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L +G G + V + T + VAIK + + FL +E +V+K L+H L+
Sbjct: 271 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE---AFL-QEAQVMKKLRHEKLV 325
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSV 172
+ + + +YI+ EY GSLL+ ++ E Y+ + +Q+A + Y + +
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
VHRD++ N+L+ + K++DFG AR + + +Y F + +PE
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF--PIKWTAPEAALYGR 440
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T +SD+WS G++L + GR+P+ E+L QV++
Sbjct: 441 FT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 59/221 (26%), Positives = 114/221 (51%), Gaps = 12/221 (5%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
++ +G G Y V ++S VA+K + K +++FL +E V+K +KHPNL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTM--EVEEFL-KEAAVMKEIKHPNL 71
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR--RWFSQLADAIDYCHKKS 171
++ L YII E+ G+LL+ +R+ + +Q++ A++Y KK+
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD+ N L+ + + +K++DFG +R + Y + F + +PE L
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF--PIKWTAPESLAYN 187
Query: 232 PYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+W+ GV+L+ + YG P+ + S++ + ++K
Sbjct: 188 KFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 59/220 (26%), Positives = 117/220 (53%), Gaps = 14/220 (6%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L +G G + V +AT VA+K + K + ++ FL E V+K L+H L+
Sbjct: 192 LEKKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSM--SVEAFL-AEANVMKTLQHDKLV 246
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR--RWFSQLADAIDYCHKKSV 172
+ L A+ T +YII E+ GSLL+ ++ + + + + +Q+A+ + + +++
Sbjct: 247 K-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD++ N+L+ K++DFG AR + + +Y F + +PE +
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFP--IKWTAPEAINFGS 361
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T +SD+WS G++L +V YGR+P+ + E+++ +++
Sbjct: 362 FT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 32/233 (13%)
Query: 55 LGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
+ ++G G V +L + VAIK + K + FL E ++ HP
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHP 110
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKK 170
N+IR + I+ EY +NGSL +R + + + Y
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS------ 224
VHRD+ N+L+D K+SDFG +R + AY +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-------------DAAYTTTGGKIP 217
Query: 225 -----PEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
PE + ++ SD+WS GVV++ + YG P+ + +++ V++
Sbjct: 218 IRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+L +G G + VKL + DVA+K+I K + + +F +E + + L HP L
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMI-KEGSMSE--DEFF-QEAQTMMKLSHPKL 65
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSV 172
++F + +YI+ EY NG LL +R ++ + + + + +
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+ N L+D +K+SDFG R V + Y ++ F +++PE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKF--PVKWSAPEVFHYFK 181
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
Y+ +SD+W+ G++++ + G++P+D SE++ +V +
Sbjct: 182 YS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 55/263 (20%), Positives = 111/263 (42%), Gaps = 21/263 (7%)
Query: 9 KHRPDQVKLKQERHHSAKTNAEGSDPNEQ-DKDTERKLSVLETHG-----YSLGDVVGMG 62
H + + + + + + ++ L +S +G G
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65
Query: 63 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122
S+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN I++
Sbjct: 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125
Query: 123 THRVYIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181
H +++MEY GS +++ ++ + E + + Y H +++HRD+K N
Sbjct: 126 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 184
Query: 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI---LKGVPYTPQQS 238
+LL + +KL DFG A + N +F G+ + +PE+ + Y +
Sbjct: 185 ILLSEPGLVKLGDFGSASIMA------PAN---SFVGTPYWMAPEVILAMDEGQYDG-KV 234
Query: 239 DIWSMGVVLFAMVYGRLPFDDTN 261
D+WS+G+ + + P + N
Sbjct: 235 DVWSLGITCIELAERKPPLFNMN 257
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+V+G G + V L + A+K + I + +FL E ++K H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85
Query: 111 PNLIRFLQAI-ETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCH 168
PN++ L + +++ Y K+G L IR E + + Q+A + Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA----- 223
K VHRD+ N +LD+K+ +K++DFG AR + + +Y ++T A
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKT------GAKLPVK 197
Query: 224 --SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+ E + +T +SD+WS GV+L+ ++ G P+ D N ++ + +
Sbjct: 198 WMALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (297), Expect = 3e-31
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y + +G G+Y V A + + + A+K I ++ + +P REI ++K L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR-----LEKEDEGIPSTTIREISILKEL 57
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
KH N+++ I T R+ ++ E+ LL+V ++ + + QL + I Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAY 115
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---LSETFCGSYAYA 223
CH + V+HRD+K +NLL++ + +K++DFG AR + + Y L Y
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL--------WYR 167
Query: 224 SPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
+P++L G Y+ DIWS+G + MV G
Sbjct: 168 APDVLMGSKKYST-TIDIWSVGCIFAEMVNGT 198
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 60/246 (24%), Positives = 115/246 (46%), Gaps = 28/246 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHP 111
+ L ++VG G+Y V + Q AIK++ + +K+ EI ++K H
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 81
Query: 112 NLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIR--KERYIDEDKGRRWFSQLADA 163
N+ + +++++ME+ GS+ ++I+ K + E+ ++
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 223
+ + H+ V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF G+ +
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFIGTPYWM 196
Query: 224 SPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278
+PE++ Y +SD+WS+G+ M G P D + L + + +
Sbjct: 197 APEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----PA 251
Query: 279 PRLSSS 284
PRL S
Sbjct: 252 PRLKSK 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 12/220 (5%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+ +G G + V L + VAIK I + A + F+ E EV+ L HP L
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI-REGAM--SEEDFI-EEAEVMMKLSHPKL 65
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSV 172
++ + ++ E+ ++G L + +R +R + + + + Y + V
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+ N L+ + IK+SDFG R V + Y + F +ASPE+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKF--PVKWASPEVFSFSR 181
Query: 233 YTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
Y+ +SD+WS GV+++ + G++P+++ + SE+++ +
Sbjct: 182 YS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 28/241 (11%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIR 115
+G G+Y +V Q +A+K I + +K L +++VV + P +++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSDCPYIVQ 85
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLADAIDYCH-K 169
F A+ +I ME + S + + + I E+ + A+++
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARK--YSVNNTDYKQNLSETFCGSYAYASPEI 227
++HRDIK N+LLD NIKL DFG + + S+ T G Y +PE
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT--------RDAGCRPYMAPER 196
Query: 228 LKGVPYTPQ---QSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPESPRLSS 283
+ +SD+WS+G+ L+ + GR P+ + + L QV K + P+LS+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG----DPPQLSN 252
Query: 284 S 284
S
Sbjct: 253 S 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+G G++ +V+L VA+K + + P D + F REI+++K L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGP-DQQRDFQ-REIQILKALHS 83
Query: 111 PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYC 167
++++ R + ++MEY +G L + +++ R +D + + SQ+ ++Y
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS------YA 221
+ VHRD+ N+L++ + ++K++DFG A+ ++ Y YA
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE-----PGQSPIFWYA 198
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF 257
PE L ++ +QSD+WS GVVL+ + Y
Sbjct: 199 ---PESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSC 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-31
Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 52/270 (19%)
Query: 31 GSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISK 86
GSDP + ++ + L L G G++ +V++ + VA+K + +
Sbjct: 1 GSDPTQFEERHLKFLQQL-----------GKGNFGSVEMCRYDPLQDNTGEVVAVKKL-Q 48
Query: 87 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRK 144
++L+ F REIE++K L+H N++++ + R + +IMEY GSL + ++K
Sbjct: 49 HSTE-EHLRDFE-REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 106
Query: 145 ERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203
+ ID K ++ SQ+ ++Y K +HRD+ N+L++++ +K+ DFG +
Sbjct: 107 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 204 NNTDYKQNLSETFCGS------YAYASPEILKGVPYTPQQSDIWSMGVVL---------- 247
+ +K YA PE L ++ SD+WS GVVL
Sbjct: 167 DKEFFKVKE-----PGESPIFWYA---PESLTESKFS-VASDVWSFGVVLYELFTYIEKS 217
Query: 248 ------FAMVYGRLPFDDTNYSELLKQVQK 271
F + G L++ ++
Sbjct: 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKN 247
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-31
Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
+ +G G + VK R DVAIK+I K + +F+ E +V+ L H L
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSM--SEDEFI-EEAKVMMNLSHEKL 81
Query: 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------ADAIDY 166
++ ++II EY NG LL +R+ R R QL +A++Y
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEY 135
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
K +HRD+ N L++D+ +K+SDFG +R V + +Y ++ F ++ PE
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKF--PVRWSPPE 191
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+L ++ +SDIW+ GV+++ + G++P++ SE + + +
Sbjct: 192 VLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y + VG G+Y V A + VA+K I +D + +P REI ++K L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKEL 76
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
HPN++ + I + + ++ E+ + +L+ + + + + + + QL + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAH 134
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---LSETFCGSYAYA 223
CH+ ++HRD+K +NLL++ +KL+DFG AR + + Y L Y
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL--------WYR 186
Query: 224 SPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQ----------- 270
+P++L G Y+ DIWS+G + M+ G+ F T+ +L K
Sbjct: 187 APDVLMGSKKYST-SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 271 --------KRVVFPES---------PRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 311
K+ F P L+SN+L P K RI D P+
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK-RISARDAMNHPYF 304
Query: 312 KE 313
K+
Sbjct: 305 KD 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 57/285 (20%), Positives = 112/285 (39%), Gaps = 40/285 (14%)
Query: 10 HRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLET----HGYSLGDVVGMGSYA 65
K E + N D + + + + + + +V+G G +
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 66 TV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-E 121
V L + A+K + I + +FL E ++K HPN++ L
Sbjct: 104 CVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICLR 161
Query: 122 TTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCE 180
+ +++ Y K+G L IR E + + Q+A + + K VHRD+
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221
Query: 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA------------SPE-I 227
N +LD+K+ +K++DFG AR + + ++ + + E +
Sbjct: 222 NCMLDEKFTVKVADFGLARD--MYDKEF-----------DSVHNKTGAKLPVKWMALESL 268
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+T +SD+WS GV+L+ ++ G P+ D N ++ + +
Sbjct: 269 QTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 35/235 (14%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
V+G G + V S + VAIK + K FL E ++ H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFL-GEAGIMGQFSH 105
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
N+IR I + II EY +NG+L + +R++ + +A + Y
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS----- 224
+ VHRD+ N+L++ K+SDFG +R + Y +
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-------------YTTSGGKI 212
Query: 225 ------PE-ILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
PE I +T SD+WS G+V++ M YG P+ + + E++K +
Sbjct: 213 PIRWTAPEAISYRK-FTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 25/228 (10%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+G G + V+L + VA+K + K ++ +++ +EIE+++ L H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLK-KEIEILRNLYH 82
Query: 111 PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYC 167
N++++ + +IME+ +GSL E + K + I+ + ++ Q+ +DY
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS------YA 221
+ VHRD+ N+L++ ++ +K+ DFG + + Y YA
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD-----DRDSPVFWYA 197
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQ 268
PE L + SD+WS GV L ++ Y +
Sbjct: 198 ---PECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 40/230 (17%), Positives = 69/230 (30%), Gaps = 38/230 (16%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y L G A + VA+ + + P D L++ L + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKP 91
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+ R L + T ++ E+ + GSL EV R LA A D H+
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
V + + ++ L+ A+P+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM----------------------PDANPQ----- 182
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPR 280
DI +G L+A++ R P + L ++ P P
Sbjct: 183 ------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 53/236 (22%), Positives = 107/236 (45%), Gaps = 36/236 (15%)
Query: 55 LGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
V+G G + V + A++ AIK + + ++ FL RE +++GL HP
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRGLNHP 82
Query: 112 NLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHK 169
N++ + + ++++ Y +G LL+ IR + + Q+A ++Y +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA------ 223
+ VHRD+ N +LD+ + +K++DFG AR + + +Y Y+
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREY-----------YSVQQHRHAR 189
Query: 224 ------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+ E + +T +SD+WS GV+L+ ++ G P+ + +L + +
Sbjct: 190 LPVKWTALESLQTYR-FT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 53/244 (21%), Positives = 102/244 (41%), Gaps = 39/244 (15%)
Query: 55 LGDVVGMGSYATVKLA----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+G G + V L T+ + VA+K + K A + + +EI++++ L H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWK-QEIDILRTLYH 92
Query: 111 PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
++I++ E + ++MEY GSL + + + I + + Q+ + + Y H
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS------YAY 222
+ +HRD+ N+LLD+ +K+ DFG A+ + Y+ YA
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE-----DGDSPVFWYA- 205
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR--------------LPFDDTNYSELLK 267
PE LK + SD+WS GV L+ ++ + + L +
Sbjct: 206 --PECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 268 QVQK 271
+++
Sbjct: 263 LLER 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 10/223 (4%)
Query: 54 SLGDVVGMGSYATV---KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
S+ VVG G + V +L ++ VAIK + KV + FL E ++ H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 111 PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHK 169
PN+IR + + V I+ EY +NGSL +RK + +A + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+ N+L++ K+SDFG R + + SPE +
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSPEAIA 223
Query: 230 GVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 271
+T SD+WS G+VL+ M YG P+ + + +++K V +
Sbjct: 224 YRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 68/256 (26%), Positives = 113/256 (44%), Gaps = 57/256 (22%)
Query: 54 SLGDVVGMGSYATVKLAT-------SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK 106
+LG +G G++ V +A + + VA+K++ K A L + E+E++K
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 107 GL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS------- 158
+ KH N+I L A +Y+I+EYA G+L E +R R +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 159 ---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
QLA ++Y + +HRD+ N+L+ + +K++DFG AR +NN DY
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDY- 212
Query: 210 QNLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRL 255
Y +PE + V YT QSD+WS GV+++ + G
Sbjct: 213 ------------YKKTTNGRLPVKWMAPEALFDRV-YTH-QSDVWSFGVLMWEIFTLGGS 258
Query: 256 PFDDTNYSELLKQVQK 271
P+ EL K +++
Sbjct: 259 PYPGIPVEELFKLLKE 274
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL 113
L +G G + V L VA+K I + FL E V+ L+H NL
Sbjct: 24 KLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA----QAFL-AEASVMTQLRHSNL 76
Query: 114 IRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------QLAD 162
++ L + + +YI+ EY GSL++ +R +GR + +
Sbjct: 77 VQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDVCE 128
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
A++Y + VHRD+ N+L+ + K+SDFG ++ S K +
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------L--PVKW 180
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
+PE L+ ++ +SD+WS G++L+ + +GR+P+ +++ +V+K
Sbjct: 181 TAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 59/246 (23%), Positives = 110/246 (44%), Gaps = 41/246 (16%)
Query: 55 LGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 110
+G G++ +V++ + VA+K + + ++L+ F REIE++K L+H
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFE-REIEILKSLQH 101
Query: 111 PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYC 167
N++++ + R + +IMEY GSL + ++K + ID K ++ SQ+ ++Y
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS------YA 221
K +HRD+ N+L++++ +K+ DFG + + YK YA
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE-----PGESPIFWYA 216
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVL----------------FAMVYGRLPFDDTNYSEL 265
PE L ++ SD+WS GVVL F + G L
Sbjct: 217 ---PESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 266 LKQVQK 271
++ ++
Sbjct: 273 IELLKN 278
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 64/260 (24%), Positives = 103/260 (39%), Gaps = 62/260 (23%)
Query: 55 LGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
LG +G G + V AT VA+K++ K A L+ L E V+K +
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLL-SEFNVLKQVN 84
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS----------- 158
HP++I+ A + +I+EYAK GSL +R+ R + S
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 159 -------------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205
Q++ + Y + +VHRD+ N+L+ + +K+SDFG +R V
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYE 202
Query: 206 TDYKQNLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV- 251
D Y + E + + YT QSD+WS GV+L+ +V
Sbjct: 203 EDS-------------YVKRSQGRIPVKWMAIESLFDHI-YTT-QSDVWSFGVLLWEIVT 247
Query: 252 YGRLPFDDTNYSELLKQVQK 271
G P+ L ++
Sbjct: 248 LGGNPYPGIPPERLFNLLKT 267
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 41/271 (15%)
Query: 8 VKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG----------YSLGD 57
+ RP + + +A GS +DKD + +V+ T G Y+
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 58 VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 117
V+G GS+ V A + VAIK KV D K+F RE+++++ L H N++R
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIK---KV--LQD--KRFKNRELQIMRKLDHCNIVRLR 113
Query: 118 QAIETTHR------VYIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDYC 167
++ + ++++Y ++ V R + + + QL ++ Y
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 168 HKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGSYAYAS 224
H + HRDIK +NLLLD D +KL DFG A++ N Y C Y Y +
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-------ICSRY-YRA 224
Query: 225 PEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
PE++ G YT D+WS G VL ++ G+
Sbjct: 225 PELIFGATDYTS-SIDVWSAGCVLAELLLGQ 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 54/254 (21%)
Query: 54 SLGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
+ +G + + +Q VAIK + K +A ++F E + L
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFR-HEAMLRARL 69
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------- 158
+HPN++ L + + +I Y +G L E + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 159 ------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
Q+A ++Y VVH+D+ N+L+ DK N+K+SD G R+ V DY
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADY---- 183
Query: 213 SETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFD 258
Y +PE I+ G ++ SDIWS GVVL+ + YG P+
Sbjct: 184 ---------YKLLGNSLLPIRWMAPEAIMYGK-FS-IDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 259 DTNYSELLKQVQKR 272
+ ++++ ++ R
Sbjct: 233 GYSNQDVVEMIRNR 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 65/243 (26%), Positives = 109/243 (44%), Gaps = 34/243 (13%)
Query: 33 DPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATS--ARHSQDVAIKIISKVQAP 90
D + + K + + V + Y G VG G+Y V A + +D A+K I
Sbjct: 4 DYDFKVKLSSERERVEDLFEY-EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 91 IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---RVYIIMEYAKNGSLLEVIRKERY 147
+ REI +++ LKHPN+I LQ + +H +V+++ +YA++ L +I+ R
Sbjct: 63 MSAC-----REIALLRELKHPNVIS-LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRA 115
Query: 148 IDEDKGRRWFS---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYN----IKLSD 194
+K Q+ D I Y H V+HRD+K N+L+ + +K++D
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
Query: 195 FGFARKYSVNNTDYKQNLSE--TFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMV 251
GFAR ++ TF Y +PE+L G YT DIW++G + ++
Sbjct: 176 MGFARLFNSPLKPLADLDPVVVTFW----YRAPELLLGARHYTK-AIDIWAIGCIFAELL 230
Query: 252 YGR 254
Sbjct: 231 TSE 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 38/223 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y +G+G+Y TV A VA+K + +V P RE+ +++ L
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGL-PISTVREVALLRRL 68
Query: 109 K---HPNLIRFLQAIETTH-----RVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFS 158
+ HPN++R + T+ +V ++ E+ + L+ + + +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMR 127
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q +D+ H +VHRD+K EN+L+ +KL+DFG AR YS
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA------------ 175
Query: 219 SYA-------YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
Y +PE+L Y D+WS+G + M +
Sbjct: 176 -LTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGL 108
Y D +G G +ATV A +Q VAIK I K+ K + REI++++ L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR-SEAKDGINRTALREIKLLQEL 69
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
HPN+I L A + ++ ++ + +++ + + + ++Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---LSETFCGSYAYA 223
H+ ++HRD+K NLLLD+ +KL+DFG A+ + N Y Y
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR--------WYR 179
Query: 224 SPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
+PE+L G Y D+W++G +L ++
Sbjct: 180 APELLFGARMYGV-GVDMWAVGCILAELLLRV 210
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 68/255 (26%), Positives = 111/255 (43%), Gaps = 57/255 (22%)
Query: 55 LGDVVGMGSYATVKLAT-------SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
LG +G G + V +A + + VA+K++ K A L + E+E++K
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMKM 142
Query: 108 L-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS-------- 158
+ KH N+I L A +Y+I+EYA G+L E +R R +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 159 --------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
QLA ++Y + +HRD+ N+L+ + +K++DFG AR +NN DY
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDY-- 258
Query: 211 NLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLP 256
Y +PE + V YT QSD+WS GV+++ + G P
Sbjct: 259 -----------YKKTTNGRLPVKWMAPEALFDRV-YTH-QSDVWSFGVLMWEIFTLGGSP 305
Query: 257 FDDTNYSELLKQVQK 271
+ EL K +++
Sbjct: 306 YPGIPVEELFKLLKE 320
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 42/224 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD-VAIKIISKVQAPIDYLKKFLP----REIEVVKG 107
Y +G G+Y V A ++ VA+K + + ++ +P RE+ V++
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIREVAVLRH 67
Query: 108 LK---HPNLIRFL-----QAIETTHRVYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWF 157
L+ HPN++R + ++ ++ E+ + L+ + E + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMM 126
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
QL +D+ H VVHRD+K +N+L+ IKL+DFG AR YS
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----------- 175
Query: 218 GSYA-------YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 254
Y +PE+L Y D+WS+G + M +
Sbjct: 176 --LTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRK 216
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 48/237 (20%), Positives = 91/237 (38%), Gaps = 31/237 (13%)
Query: 54 SLGDVVGMGSYATVKLAT-------SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK 106
+ +G G++ + H +V +K++ K A +Y + F ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFF-EAASMMS 67
Query: 107 GLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAID 165
L H +L+ ++ E+ K GSL ++K + I+ QLA A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 166 YCHKKSVVHRDIKCENLLLDDKYN--------IKLSDFGFARKYSVNNTDYKQNLSETFC 217
+ + +++H ++ +N+LL + + IKLSD G + +V D Q
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDILQ------- 178
Query: 218 GSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 272
+ PE I +D WS G L+ + G P + L+ + R
Sbjct: 179 ERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 114
L +G G + V L VA+K I K A + FL E V+ L+H NL+
Sbjct: 197 LLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDAT---AQAFL-AEASVMTQLRHSNLV 249
Query: 115 RFLQAIETTHR--VYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKK 170
+ L + + +YI+ EY GSL++ +R + D ++ + +A++Y
Sbjct: 250 Q-LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ VHRD+ N+L+ + K+SDFG ++ S K + T +PE L+
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------APEALRE 360
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 271
++ +SD+WS G++L+ + +GR+P+ +++ +V+K
Sbjct: 361 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 55/255 (21%)
Query: 54 SLGDVVGMGSYATVKLAT-------SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK 106
LG +G G++ V LA VA+K++ K A L + E+E++K
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129
Query: 107 GL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWF-------- 157
+ KH N+I L A +Y+I+EYA G+L E ++ R +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 158 --------SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR +++ DY
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDY- 246
Query: 210 QNLSETFCGSYAYA------------SPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLP 256
Y +PE L YT QSD+WS GV+L+ + G P
Sbjct: 247 ------------YKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSP 293
Query: 257 FDDTNYSELLKQVQK 271
+ EL K +++
Sbjct: 294 YPGVPVEELFKLLKE 308
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 55 LGDVVGMGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHP 111
DV+G G++ V A D AIK + K A D + F E+EV+ L HP
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLGHHP 86
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS------------- 158
N+I L A E +Y+ +EYA +G+LL+ +RK R ++ D +
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 159 ---QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE- 214
+A +DY +K +HRD+ N+L+ + Y K++DFG +R + +
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMG 201
Query: 215 ------TFCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 266
+ E + V YT SD+WS GV+L+ +V G P+ +EL
Sbjct: 202 RLPVRWM--------AIESLNYSV-YT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 267 KQVQK 271
+++ +
Sbjct: 252 EKLPQ 256
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 56/254 (22%)
Query: 54 SLGDVVGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
G +G G++ V AT+ ++ VA+K++ K A D + + E++++ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHL 106
Query: 109 -KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS--------- 158
+H N++ L A V +I EY G LL +R++ + E +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 159 -----QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213
Q+A + + K+ +HRD+ N+LL + + K+ DFG AR + N
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--IMNDSN----- 219
Query: 214 ETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF-- 257
Y +PE I V YT QSD+WS G++L+ + G P+
Sbjct: 220 --------YIVKGNARLPVKWMAPESIFDCV-YTV-QSDVWSYGILLWEIFSLGLNPYPG 269
Query: 258 DDTNYSELLKQVQK 271
N S+ K V+
Sbjct: 270 ILVN-SKFYKLVKD 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 53/247 (21%), Positives = 88/247 (35%), Gaps = 48/247 (19%)
Query: 54 SLGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
+L +G G++ V + VA+K + FL E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 90
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------A 161
H N++R + + +I+ME G L +R+ R L A
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 162 DAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Y + +HRDI N LL K+ DFG AR + Y
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASY---------- 198
Query: 219 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 264
Y PE ++G+ +T ++D WS GV+L+ + G +P+ + E
Sbjct: 199 ---YRKGGCAMLPVKWMPPEAFMEGI-FTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
Query: 265 LLKQVQK 271
+L+ V
Sbjct: 254 VLEFVTS 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/253 (22%), Positives = 98/253 (38%), Gaps = 54/253 (21%)
Query: 54 SLGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
L +G G++ A + VA+K + + A + F RE E++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQ-REAELLTML 100
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------- 158
+H +++RF + ++ EY ++G L +R +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 159 -----QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213
Q+A + Y VHRD+ N L+ +K+ DFG +R + +TDY
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYSTDY----- 213
Query: 214 ETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD 259
Y PE IL +T +SD+WS GVVL+ + YG+ P+
Sbjct: 214 --------YRVGGRTMLPIRWMPPESILYRK-FTT-ESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 260 TNYSELLKQVQKR 272
+ +E + + +
Sbjct: 264 LSNTEAIDCITQG 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 63/257 (24%), Positives = 104/257 (40%), Gaps = 58/257 (22%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
S G +G G++ V AT + + VA+K++ K A + + + E++V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM-SELKVLSYL 83
Query: 109 -KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER----------YIDEDKGR--- 154
H N++ L A +I EY G LL +R++R I ED
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 155 -----RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
+ Q+A + + K+ +HRD+ N+LL K+ DFG AR + N
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKNDSN- 200
Query: 210 QNLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRL 255
Y +PE I V YT +SD+WS G+ L+ + G
Sbjct: 201 ------------YVVKGNARLPVKWMAPESIFNCV-YT-FESDVWSYGIFLWELFSLGSS 246
Query: 256 PFDD-TNYSELLKQVQK 271
P+ S+ K +++
Sbjct: 247 PYPGMPVDSKFYKMIKE 263
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
Y L +G G Y+ V A + +++ V +KI+ V+ KK REI++++ L+ P
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIK-REIKILENLRGGP 91
Query: 112 NLIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
N+I + + ++ E+ N ++ + + + R + ++ A+DYCH
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 148
Query: 170 KSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNN--TDYKQNLSETFCGSYAYASPE 226
++HRD+K N+++D + ++L D+G A Y S + PE
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPE 200
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
+L D+WS+G +L +M++ + PF
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 57/256 (22%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
LG +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 87
Query: 109 -KHPNLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKER-------YIDEDKGRRWFS- 158
H N++ L A + + +I+E+ K G+L +R +R ED + + +
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 159 --------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
Q+A +++ + +HRD+ N+LL +K +K+ DFG AR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPD-- 203
Query: 211 NLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLP 256
Y +PE I V YT QSD+WS GV+L+ + G P
Sbjct: 204 -----------YVRKGDARLPLKWMAPETIFDRV-YTI-QSDVWSFGVLLWEIFSLGASP 250
Query: 257 F-DDTNYSELLKQVQK 271
+ E +++++
Sbjct: 251 YPGVKIDEEFCRRLKE 266
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ V+G GS+ V A S +VAIK KV K+F RE+++++ +KHPN
Sbjct: 42 YTNCKVIGNGSFGVVFQAKL-VESDEVAIK---KVLQD----KRFKNRELQIMRIVKHPN 93
Query: 113 LIRFLQAIETT------HRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLAD 162
++ + + +++EY ++ R ++ + + + QL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 163 AIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGS 219
++ Y H + HRDIK +NLLLD +KL DFG A+ N Y C
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY-------ICSR 205
Query: 220 YAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
Y Y +PE++ G YT DIWS G V+ ++ G+
Sbjct: 206 Y-YRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQ 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 57/254 (22%), Positives = 102/254 (40%), Gaps = 55/254 (21%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
L +G G++ V LA + VA+K + + K F RE E++ L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKDFQ-REAELLTNL 74
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------- 158
+H ++++F + ++ EY K+G L + +R
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 159 ------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212
Q+A + Y + VHRD+ N L+ +K+ DFG +R V +TDY
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDY---- 188
Query: 213 SETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFD 258
Y PE I+ +T +SD+WS GV+L+ + YG+ P+
Sbjct: 189 ---------YRVGGHTMLPIRWMPPESIMYRK-FTT-ESDVWSFGVILWEIFTYGKQPWF 237
Query: 259 DTNYSELLKQVQKR 272
+ +E+++ + +
Sbjct: 238 QLSNTEVIECITQG 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 56/262 (21%), Positives = 96/262 (36%), Gaps = 62/262 (23%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
+G G++ V A VA+K++ K +A D F RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEF 107
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------- 158
+PN+++ L + ++ EY G L E +R
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 159 --------------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204
Q+A + Y ++ VHRD+ N L+ + +K++DFG +R +
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN--IY 225
Query: 205 NTDYKQNLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV 251
+ DY Y PE I YT +SD+W+ GVVL+ +
Sbjct: 226 SADY-------------YKADGNDAIPIRWMPPESIFYNR-YTT-ESDVWAYGVVLWEIF 270
Query: 252 -YGRLPFDDTNYSELLKQVQKR 272
YG P+ + E++ V+
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDG 292
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 77 QDVAIKIISKVQAPIDY--LKKFLPREIEVVKGLKHPNLIRFL-QAIETTHR--VYIIME 131
VA+K ++ + ++F +EI+V+ +H NL+ L + + VY
Sbjct: 55 TTVAVKKLAAMVDITTEELKQQFD-QEIKVMAKCQHENLVELLGFSSDGDDLCLVY---V 110
Query: 132 YAKNGSLLEVIRKERYIDEDKGRR---WFSQLADAID------YCHKKSVVHRDIKCENL 182
Y NGSL + G W + A + H+ +HRDIK N+
Sbjct: 111 YMPNGSL------LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164
Query: 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWS 242
LLD+ + K+SDFG AR + ++ G+ AY +PE L+G +SDI+S
Sbjct: 165 LLDEAFTAKISDFGLARASEKFA---QTVMTSRIVGTTAYMAPEALRGEITP--KSDIYS 219
Query: 243 MGVVLFAMVYGRLPFDDTNYSELL 266
GVVL ++ G D+ +LL
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLL 243
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 28/265 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y +G G+ V A A ++VAIK +S+ Q + + RE+ ++K + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 112 NLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
N+I L + +E VY++ME + +L +VI+ E +D ++ Q+ I
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIK 178
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSETFCGSYAYA 223
+ H ++HRD+K N+++ +K+ DFG AR + T Y + Y
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VVTRYYR 230
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP---R 280
+PE++ G+ Y + DIWS+G ++ MV ++ F +Y + +V +++ P +
Sbjct: 231 APEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 281 LSSSCKALISNILSPVKFRIQMEDI 305
L + + + N P + +
Sbjct: 290 LQPTVRNYVENR--PKYAGLTFPKL 312
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 66/265 (24%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y +G G+ V A A ++VAIK +S+ Q + + RE+ ++K + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 112 NLIRFLQAI------ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
N+I L E VYI+ME + +L +VI+ E +D ++ Q+ I
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIK 141
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSETFCGSYAYA 223
+ H ++HRD+K N+++ +K+ DFG AR + T Y + Y
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VVTRYYR 193
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP---R 280
+PE++ G+ Y + DIWS+G ++ M+ G + F T++ + +V +++ P +
Sbjct: 194 APEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 281 LSSSCKALISNILSPVKFRIQMEDI 305
L + + + N P E +
Sbjct: 253 LQPTVRTYVENR--PKYAGYSFEKL 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 48/247 (19%)
Query: 54 SLGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
+L +G G++ V + VA+K + FL E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKF 131
Query: 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL-------A 161
H N++R + + +I++E G L +R+ R L A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 162 DAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Y + +HRDI N LL K+ DFG AR + Y
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGY---------- 239
Query: 219 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 264
Y PE ++G+ +T ++D WS GV+L+ + G +P+ + E
Sbjct: 240 ---YRKGGCAMLPVKWMPPEAFMEGI-FTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
Query: 265 LLKQVQK 271
+L+ V
Sbjct: 295 VLEFVTS 301
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 60/262 (22%), Positives = 107/262 (40%), Gaps = 63/262 (24%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
G V+G G++ V AT S VA+K++ K +A + + E++++ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALM-SELKMMTQL 105
Query: 109 -KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS--------- 158
H N++ L A + +Y+I EY G LL +R +R + + +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 159 --------------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204
Q+A +++ KS VHRD+ N+L+ +K+ DFG AR +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IM 223
Query: 205 NTDYKQNLSETFCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV 251
+ Y +PE + +G+ YT +SD+WS G++L+ +
Sbjct: 224 SDSN-------------YVVRGNARLPVKWMAPESLFEGI-YTI-KSDVWSYGILLWEIF 268
Query: 252 -YGRLPF-DDTNYSELLKQVQK 271
G P+ + K +Q
Sbjct: 269 SLGVNPYPGIPVDANFYKLIQN 290
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y VG G+Y +V A R + VAIK +S+ Q+ I + + RE+ ++K ++H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 112 NLIRFLQAIETTHR------VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
N+I L Y++M + L +++ + E+K + Q+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGLK 140
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
Y H VVHRD+K NL +++ +K+ DFG AR T Y + Y +P
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--------VVTRWYRAP 192
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
E++ + Q DIWS+G ++ M+ G+ F +Y + L Q+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 32/215 (14%)
Query: 59 VGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLI 114
+G G++ V A + Q VA+K KV ++ K+ P REI++++ LKH N++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK---KVL--MENEKEGFPITALREIKILQLLKHENVV 79
Query: 115 RFLQAIETTHR---------VYIIMEYAKN--GSLLEVIRKERYIDEDKGRRWFSQLADA 163
L I T +Y++ ++ ++ LL + +R L +
Sbjct: 80 N-LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNG 136
Query: 164 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE---TFCGSY 220
+ Y H+ ++HRD+K N+L+ +KL+DFG AR +S+ + T
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW--- 193
Query: 221 AYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 254
Y PE+L G Y P D+W G ++ M
Sbjct: 194 -YRPPELLLGERDYGP-PIDLWGAGCIMAEMWTRS 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 60/226 (26%), Positives = 111/226 (49%), Gaps = 23/226 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y VG G+Y +V A + VA+K +S+ Q+ I + + RE+ ++K +KH
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 112 NLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS-QLADAI 164
N+I L +++E + VY++ L +++ ++ D+ ++ Q+ +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHV--QFLIYQILRGL 145
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y H ++HRD+K NL +++ +K+ DFG AR + T Y + Y +
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--------VATRWYRA 197
Query: 225 PEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
PEI+ Y Q DIWS+G ++ ++ GR F T++ + LK +
Sbjct: 198 PEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 57/224 (25%), Positives = 110/224 (49%), Gaps = 19/224 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y VG G+Y V A R VAIK + + Q+ + + + RE+ ++K ++H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 112 NLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
N+I L + ++ Y++M + L ++++ E+ + ED+ + Q+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLR 142
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
Y H ++HRD+K NL +++ +K+ DFG AR+ T Y + Y +P
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--------VVTRWYRAP 194
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
E++ Q DIWS+G ++ M+ G+ F +++ + LK++
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 19/219 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ +G G+Y V A + VAIK IS + + REI+++ +H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 113 LIRFL-----QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+I IE VYI+ + + L ++++ + + D + Q+ + Y
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH-LSNDHICYFLYQILRGLKYI 144
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----YA 223
H +V+HRD+K NLLL+ ++K+ DFG AR + D+ L+E Y Y
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-PDHDHTGFLTE-----YVATRWYR 198
Query: 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
+PEI+ + DIWS+G +L M+ R F +Y
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 53/271 (19%), Positives = 100/271 (36%), Gaps = 39/271 (14%)
Query: 10 HRPDQVKLKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHG--------YSLGDVVGM 61
H + + ++ + + + + + Y + ++G
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 62 GSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121
GSY V A + VAIK I +V + K+ L REI ++ L H ++++ L +
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLDIVI 122
Query: 122 TTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176
+Y+++E A + ++ R Y+ E + L + Y H ++HRD
Sbjct: 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA--------------- 221
+K N L++ ++K+ DFG AR Q
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 222 -------YASPEILKGVP-YTPQQSDIWSMG 244
Y +PE++ YT + D+WS+G
Sbjct: 242 GHVVTRWYRAPELILLQENYT-EAIDVWSIG 271
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 82/361 (22%), Positives = 141/361 (39%), Gaps = 82/361 (22%)
Query: 23 HSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIK 82
NA + K+ +R + + + G G++ TV+L VAIK
Sbjct: 4 SMMSLNAAAAADERSRKEMDR---------FQVERMAGQGTFGTVQLGKEKSTGMSVAIK 54
Query: 83 IISKV-QAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHR-------VYIIME 131
KV Q P + RE+++++ L HPN+++ T + ++ME
Sbjct: 55 ---KVIQDPRF--RN---RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106
Query: 132 YAKNGSLLEVIR---KERYIDEDKGRRWFS-QLADAIDYCHKKS--VVHRDIKCENLLLD 185
Y +L R + + + F QL +I H S V HRDIK N+L++
Sbjct: 107 YV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN 165
Query: 186 -DKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIW 241
+KL DFG A+K S + N Y C Y Y +PE++ G YT DIW
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAY-------ICSRY-YRAPELIFGNQHYTT-AVDIW 216
Query: 242 SMGVVLFAMVYGR--------------------------LPFDDTNYSEL----LKQVQK 271
S+G + M+ G L + +++++ K +
Sbjct: 217 SVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPW 276
Query: 272 RVVFPE-SPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVI 328
VF + S + + L+S +L P + R++ + P+ E +P K + ++
Sbjct: 277 SNVFSDHSLKDAKEAYDLLSALLQYLPEE-RMKPYEALCHPYFDELHDPATKLPNNKDLP 335
Query: 329 P 329
Sbjct: 336 E 336
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 18/222 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L ++G G+Y V AT + VAIK I P+ L+ REI+++K KH N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 113 LIRFLQAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS-QLADAIDY 166
+I VYII E + L VI + D+ ++F Q A+
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHI--QYFIYQTLRAVKV 127
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET-FCGSYA---- 221
H +V+HRD+K NLL++ ++K+ DFG AR + D + + +
Sbjct: 128 LHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 222 YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
Y +PE++ Y+ + D+WS G +L + R F +Y
Sbjct: 188 YRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDY 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-24
Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 32/229 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLP--------REI 102
Y++ + GSY V + S VAIK + + + REI
Sbjct: 24 YTVQRFISSGSYGAV---CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 103 EVVKGLKHPNLIRFLQAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWF 157
++ HPN++ +Y++ E + L +VI +R + + ++F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 158 S-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSE 214
+ + H+ VVHRD+ N+LL D +I + DF AR+ + + T Y
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY------ 193
Query: 215 TFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
Y +PE++ +T + D+WS G V+ M + F + +
Sbjct: 194 --VTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTF 239
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-24
Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 52/271 (19%)
Query: 21 RHHSAKTNAEGSDPNEQD--KDTERKLSVLE----THGYSLGDVVGMGSYATV---KLAT 71
+S TN+ + ++ +++ T+ + ++G G + V L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-- 60
Query: 72 SARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIRFL-QAIETTHR--V 126
R VA+K + Q +++F EIE + +HP+L+ + E +
Sbjct: 61 --RDGAKVALKRRTPESSQG----IEEFE-TEIETLSFCRHPHLVSLIGFCDERNEMILI 113
Query: 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRR---WFSQL------ADAIDYCHKKSVVHRDI 177
Y +Y +NG+L K D W +L A + Y H ++++HRD+
Sbjct: 114 Y---KYMENGNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165
Query: 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQ 237
K N+LLD+ + K++DFG ++K + + + LS G+ Y PE + +
Sbjct: 166 KSINILLDENFVPKITDFGISKKGTELDQTH---LSTVVKGTLGYIDPEY-----FIKGR 217
Query: 238 ----SDIWSMGVVLFAMVYGRLPFDDTNYSE 264
SD++S GVVLF ++ R + E
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHP 111
Y + ++G GSY V LA ++VAIK ++++ + ID K+ L REI ++ LK
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKRIL-REITILNRLKSD 85
Query: 112 NLIRFLQAIETTHR-----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
+IR I +YI++E A + L ++ + ++ E+ + L ++
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA----- 221
H+ ++HRD+K N LL+ ++K+ DFG AR + N E
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 222 ------------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLP 256
Y +PE++ YT + DIWS G + ++
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQS 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 32/237 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G G V A + VAIK I + P REI++++ L H N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQSVKHAL--REIKIIRRLDHDN 69
Query: 113 LIRFLQAIETTHR--------------VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS 158
+++ + + + VYI+ EY + L V+ + + E+ R +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP-LLEEHARLFMY 127
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
QL + Y H +V+HRD+K NL ++ + +K+ DFG AR + +K +LSE
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHLSE--- 183
Query: 218 GSYA----YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269
Y SP +L YT + D+W+ G + M+ G+ F + E ++ +
Sbjct: 184 --GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 63/248 (25%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
YSLG +G GS+ V + A+K KV ++ RE++++K L H N
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQD----PRYKNRELDIMKVLDHVN 61
Query: 113 LIRFLQAIETTHR--------------------------------------VYIIMEYAK 134
+I+ + TT + +IMEY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 135 NGSLLEVIR---KERYIDEDKGRRWFS-QLADAIDYCHKKSVVHRDIKCENLLLD-DKYN 189
+ +L +V++ + + QL A+ + H + HRDIK +NLL++
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 190 IKLSDFGFARKYSVN--NTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVV 246
+KL DFG A+K + + Y C + Y +PE++ G YTP D+WS+G V
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAY-------ICSRF-YRAPELMLGATEYTP-SIDLWSIGCV 231
Query: 247 LFAMVYGR 254
++ G+
Sbjct: 232 FGELILGK 239
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-22
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 47/238 (19%)
Query: 50 THGYSLGDVVGMGSYATV---KLATSARHSQDVAIKIIS--KVQAPIDYLKKFLPREIEV 104
+ +S +++G G + V +LA VA+K + + Q +F E+E+
Sbjct: 29 SDNFSNKNILGRGGFGKVYKGRLADG----TLVAVKRLKEERTQGG---ELQFQ-TEVEM 80
Query: 105 VKGLKHPNLIRFLQA--IETTHR--VYIIMEYAKNGS----LLEVIRKERYIDEDKGRRW 156
+ H NL+R L+ + T R VY Y NGS L E + +D W
Sbjct: 81 ISMAVHRNLLR-LRGFCMTPTERLLVY---PYMANGSVASCLRERPESQPPLD------W 130
Query: 157 FSQL------ADAIDYCHKKS---VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207
+ A + Y H ++HRD+K N+LLD+++ + DFG A+ +T
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT- 189
Query: 208 YKQNLSETFCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264
+++ G+ + +PE + G + +++D++ GV+L ++ G+ FD +
Sbjct: 190 ---HVTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 28/232 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLK-H 110
Y L +G G+Y V + R + VA+K I Q D + F REI ++ L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 111 PNLIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS-QLADAIDYC 167
N++ L + + VY++ +Y + L VIR K ++ QL I Y
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHK--QYVVYQLIKVIKYL 125
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA------ 221
H ++HRD+K N+LL+ + ++K++DFG +R + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 222 ----------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262
Y +PEIL G YT + D+WS+G +L ++ G+ F ++
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSST 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV-----QAP--IDYLKKFLPREIEVV 105
Y L +G G ++TV LA ++ VA+KI+ A I L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 106 KGLKHPNLIRFL-----QAIETTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFS 158
+ ++++ L + H V ++ E +LL +I+K + I ++
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVV-MVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 159 QLADAIDYCHKK-SVVHRDIKCENLLLDD------KYNIKLSDFGFARKYSVNNTDYKQN 211
QL +DY H++ ++H DIK EN+L++ IK++D G A Y + T+ Q
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ- 197
Query: 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 258
+ Y SPE+L G P+ +DIWS ++F ++ G F+
Sbjct: 198 -------TREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 36/231 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-- 110
Y + V+G GS+ V A + Q VA+K++ + + ++ EI +++ L+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAA-EEIRILEHLRKQD 154
Query: 111 ----PNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKG------RRWFS 158
N+I L+ R + + E +L E+I+K ++ +G R++
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSM-NLYELIKKNKF----QGFSLPLVRKFAH 207
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 216
+ +D HK ++H D+K EN+LL + IK+ DFG + Y Q
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ------ 261
Query: 217 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
S Y +PE++ G Y D+WS+G +L ++ G + + L
Sbjct: 262 --SRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 45/290 (15%), Positives = 98/290 (33%), Gaps = 53/290 (18%)
Query: 53 YSLGDVVGMGSYATVKLAT--------SARHSQDVAIKIISKVQAPIDYLKKFLPREIEV 104
+ L + + A S Q ++K+ +K + + F R +
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-DGRLFNEQNFFQRAAKP 102
Query: 105 --------VKGLKH---PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG 153
+ P + F + +R ++++ G L+
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGF-GVHQDKYR-FLVLPSL--GRSLQSALDVS------P 152
Query: 154 RRWFS---------QLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYS 202
+ S +L DA+++ H+ VH ++ EN+ + +D+ + L+ +GFA +Y
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 203 VNNT--DYKQNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLPF 257
+ Y + G + S ++ KG S D+ S+G + +YG LP+
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGC----GPSRRSDLQSLGYCMLKWLYGFLPW 268
Query: 258 DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQ 307
+ + QK+ + C I + ++ +
Sbjct: 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIR---PSETLQKYLKVVMA 315
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-- 110
Y LG +G GS+ + L T ++VAIK + L E ++ K ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGV 65
Query: 111 --PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------Q 159
P + E + ++ME G LE + R+ FS Q
Sbjct: 66 GIPTIRWCGA--EGDYN-VMVMELL--GPSLEDLFNF------CSRK-FSLKTVLLLADQ 113
Query: 160 LADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT----DYKQNL 212
+ I+Y H K+ +HRD+K +N L+ + + DFG A+KY T Y++N
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 213 SETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 256
+ G+ YAS G+ +QS D+ S+G VL G LP
Sbjct: 174 N--LTGTARYASINTHLGI----EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 48/229 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-- 110
+ +G +G G++ ++L + ++ VAIK+ P+ L E K L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 111 --PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------Q 159
P + F + +++E G LE + R FS Q
Sbjct: 66 GIPQVYYFGP--CGKYN-AMVLELL--GPSLEDLFDL------CDRT-FSLKTVLMIAIQ 113
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTD----YKQ 210
L ++Y H K++++RD+K EN L+ N I + DF A++Y T Y++
Sbjct: 114 LISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 256
+ S G+ Y S G +QS D+ ++G + + G LP
Sbjct: 174 HKS--LTGTARYMSINTHLGK----EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 59/263 (22%), Positives = 111/263 (42%), Gaps = 32/263 (12%)
Query: 21 RHHSAKTNAEGSDPNEQDKDTERKLSVLE--THGYSLGDVVGMGSYATVKLATSARHSQD 78
S K + + D + + + E Y + ++G GS+ V A +
Sbjct: 22 SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEW 81
Query: 79 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP------NLIRFLQAIETTHR--VYIIM 130
VAIKII +A +L + E+ +++ + ++ + R + ++
Sbjct: 82 VAIKIIKNKKA---FLNQAQ-IEVRLLELMNKHDTEMKYYIVHLKRHFM--FRNHLCLVF 135
Query: 131 EYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCH--KKSVVHRDIKCENLLL-- 184
E +L +++R + + + R++ Q+ A+ + + S++H D+K EN+LL
Sbjct: 136 EMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194
Query: 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244
+ IK+ DFG + + Y Q S Y SPE+L G+PY D+WS+G
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQ--------SRFYRSPEVLLGMPYD-LAIDMWSLG 245
Query: 245 VVLFAMVYGRLPFDDTNYSELLK 267
+L M G F N + +
Sbjct: 246 CILVEMHTGEPLFSGANEVDQMN 268
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 48/229 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-- 110
Y +G +G GS+ + T+ ++Q VAIK P L E K L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 111 --PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------Q 159
PN+ F Q E H ++++ G LE + GR+ FS Q
Sbjct: 67 GIPNVYYFGQ--EGLHN-VLVIDLL--GPSLEDLLDL------CGRK-FSVKTVAMAAKQ 114
Query: 160 LADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNT----DYKQ 210
+ + H+KS+V+RDIK +N L+ + I + DFG + Y T Y++
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 256
+ G+ Y S G +QS D+ ++G V + G LP
Sbjct: 175 KKN--LSGTARYMSINTHLGR----EQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 46/227 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-- 110
+ LG +G GS+ + L T+ + +++VAIK + L E ++ + L+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQGGT 63
Query: 111 --PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFS---------Q 159
PN+ F E + ++M+ G LE + R+ S Q
Sbjct: 64 GIPNVRWFGV--EGDYN-VLVMDLL--GPSLEDLFNF------CSRK-LSLKTVLMLADQ 111
Query: 160 LADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT----DYKQNL 212
+ + +++ H KS +HRDIK +N L+ + + DFG A+KY +T Y++N
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 213 SETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 256
+ G+ YAS G+ +QS D+ S+G VL + G LP
Sbjct: 172 N--LTGTARYASVNTHLGI----EQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 55/290 (18%), Positives = 103/290 (35%), Gaps = 56/290 (19%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII---SKVQAPIDYLKKFLPR--------- 100
+ LG +G G + + LA + A ++ + P+ KF R
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 101 --EIEVVKGLKHPNLIRF--LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRW 156
E + + L P + ++R ++ME G L+ I +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRF-MVMERL--GIDLQKISGQN--------GT 147
Query: 157 FS---------QLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNN 205
F ++ D ++Y H+ VH DIK NLLL + + L+D+G + +Y N
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 206 T--DYKQNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLPFDDT 260
Y++N + G+ + S + KGV S D+ +G + + G+LP++
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLDAHKGV----ALSRRSDVEILGYCMLRWLCGKLPWEQN 263
Query: 261 NYSELLKQVQKRVVFPESPRLSSS---CKALISNILSPVKFRIQMEDIRQ 307
+ Q K + E P+ + + +
Sbjct: 264 LKDPVAVQTAKTNLLDELPQSVLKWAPSGSS------CCEIAQFLVCAHS 307
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 48/238 (20%)
Query: 53 YSLGDVVGMGSY-----ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFL-----PREI 102
+ +G +G G + A + + S +K+ P+ KF P +I
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 103 EVVKGLKH------PNLIRF--LQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGR 154
+ + P ++R +IM+ GS L+ I + +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRF-MIMDRF--GSDLQKIYEAN------AK 147
Query: 155 RWFS---------QLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSV 203
R FS ++ D ++Y H+ VH DIK NLLL+ + + L D+G A +Y
Sbjct: 148 R-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 204 NNT--DYKQNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 256
Y + G+ + S + GV S D+ +G + + G LP
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGV----APSRRGDLEILGYCMIQWLTGHLP 260
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 55/280 (19%), Positives = 109/280 (38%), Gaps = 40/280 (14%)
Query: 17 LKQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHS 76
+ HHS+ +++ K +L + + + +G G++ V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK 60
Query: 77 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIET-THR--VYIIME 131
+ A+K++ ++ Y + E +++K +++ N ++ + + +I E
Sbjct: 61 KYYAVKVVRNIKK---YTRSAK-IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 132 -YAKNGSLLEVIRKERYIDEDKG------RRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184
+ L E+I + Y G + + ++ A++Y K S+ H D+K EN+LL
Sbjct: 117 PLGPS--LYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSE---------TFCGSYAYA--------SPEI 227
DD Y K Y+ + TF Y + +PE+
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEV 230
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 267
+ + + SD+WS G VL + G L F + E L
Sbjct: 231 ILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 56/271 (20%), Positives = 99/271 (36%), Gaps = 80/271 (29%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--- 109
Y + +G G ++TV L+ + + VA+K++ + + EI ++K ++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLKSVRNSD 94
Query: 110 --HPNLIRFLQAIET--------THRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWF 157
PN +Q ++ TH ++ E + LL+ I K Y + ++
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKII 152
Query: 158 SQLADAIDYCHKK-SVVHRDIKCENLLL-------------------------------- 184
Q+ +DY H K ++H DIK EN+LL
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 185 -----------------DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
+K +K++D G A + T+ Q + Y S E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--------TRQYRSLEV 264
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 258
L G Y +DIWS + F + G F+
Sbjct: 265 LIGSGYNT-PADIWSTACMAFELATGDYLFE 294
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 56/250 (22%)
Query: 53 YSLGDVVGMGSYATVKLAT-SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y + +G G++ V AR VA+KII V Y + EI V+K +K
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAAR-LEINVLKKIKEK 76
Query: 112 ------NLIRFLQAIETTHR--VYIIME-YAKNGSLLEVIRKERYIDEDKG------RRW 156
+ + I E KN E +++ + + R
Sbjct: 77 DKENKFLCVLMSDWFN--FHGHMCIAFELLGKN--TFEFLKENNF----QPYPLPHVRHM 128
Query: 157 FSQLADAIDYCHKKSVVHRDIKCENLLLDD-------------------KYNIKLSDFGF 197
QL A+ + H+ + H D+K EN+L + +I+++DFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
A T ++ + T + Y PE++ + + Q D+WS+G +LF G F
Sbjct: 189 A-------TFDHEHHT-TIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLF 239
Query: 258 DDTNYSELLK 267
E L
Sbjct: 240 QTHENREHLV 249
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 49/243 (20%), Positives = 95/243 (39%), Gaps = 42/243 (17%)
Query: 53 YSLGDVVGMGSYATVKLAT-SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 111
Y + D +G G++ V + VA+KI+ V Y + EI+V++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR---YCEAAR-SEIQVLEHLNTT 71
Query: 112 ------NLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKG------RRWF 157
++ L+ E H + I+ E S + I++ + R+
Sbjct: 72 DPNSTFRCVQMLEWFE--HHGHICIVFELLGL-STYDFIKENGF----LPFRLDHIRKMA 124
Query: 158 SQLADAIDYCHKKSVVHRDIKCEN-LLLDDKYNIKLSDFGFARKYSVNNTDYKQNL---- 212
Q+ ++++ H + H D+K EN L + Y + + ++ N D K +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK--VVDFG 182
Query: 213 SETFCGSYAYA--------SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 264
S T+ + +PE++ + ++ Q D+WS+G +L G F + E
Sbjct: 183 SATYDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 265 LLK 267
L
Sbjct: 242 HLA 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q+A +++ + +HRD+ N+LL +K +K+ DFG AR + +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGDARL- 257
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD-TNYSELLKQVQK 271
+ +PE + YT QSD+WS GV+L+ + G P+ E +++++
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 23/100 (23%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 54 SLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 108
LG +G G++ V A + VA+K++ K A + + E++++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHI 82
Query: 109 -KHPNLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKER 146
H N++ L A + + +I+E+ K G+L +R +R
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 2e-11
Identities = 33/209 (15%), Positives = 62/209 (29%), Gaps = 48/209 (22%)
Query: 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKII----------------SKVQA 89
L T + +G G + V + VAIKII ++
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 90 PIDYLKKFLP---------------REIEVVKGLKHPNLIRFLQ-------------AIE 121
I K+ + V+G P L++
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCE 180
+++I++E+ G LE +R + + QL ++ HRD+
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191
Query: 181 NLLLDDKYNIKLSDFGFARKYSVNNTDYK 209
N+LL KL + ++ + +
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTIPSCGLQ 220
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 56/364 (15%), Positives = 111/364 (30%), Gaps = 99/364 (27%)
Query: 4 RPDTVKHRPDQVKLKQERHHSAKTNAEG-------SDPNEQDK-DTERKLSVLETHGYSL 55
+K R ++ + R +K + + + K+ + T +
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLT-TRFKQV 277
Query: 56 GDVVGMGSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVV--------- 105
D + + + L + + D ++ K +D + LPRE+
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY---LDCRPQDLPREVLTTNPRRLSIIA 334
Query: 106 ----------KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK-GR 154
KH N + IE++ V EY K L V +I
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394
Query: 155 RWF----SQLADAIDYCHKKSVVHRD----------------IKCENLL-----LDDKYN 189
WF S + ++ HK S+V + +K EN + D YN
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYN 454
Query: 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY---TPQQSDIWSMGVV 246
I + + ++ L + F Y++ + + + + +
Sbjct: 455 IP-------KTFD-SDDLIPPYLDQYF---YSH--------IGHHLKNIEHPERMT---- 491
Query: 247 LFAMVYGRLPF-------DDTNYS------ELLKQVQ--KRVVFPESPRLSSSCKALISN 291
LF MV+ F D T ++ L+Q++ K + P+ A++
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 292 ILSP 295
+
Sbjct: 552 LPKI 555
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 7e-04
Identities = 40/329 (12%), Positives = 98/329 (29%), Gaps = 75/329 (22%)
Query: 6 DTVKHRPDQVKLKQERHHSAKTNAEGSDPNEQDKDT---ERKLSVLETHGYSLGD----- 57
+K Q + + + D K + L L
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYN-DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154
Query: 58 VVGM-GSYATVKLATSARHSQDVAIKIISKVQAPIDYL---KKFLPREI-EVVKGLKHPN 112
+ G+ GS T +A K+ K+ I +L P + E+++ L +
Sbjct: 155 IDGVLGSGKTW-VALDV--CLS--YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY------IDEDKGRRWFSQLADAIDY 166
+ + + + + + + L +++ + Y + +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQA-ELRRLLKSKPYENCLLVLL---------------NV 253
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDF-GFARKYSVNNTDYKQNL----SETFCGSYA 221
+ K+ ++ C+ LL +++DF A ++ + L ++ Y
Sbjct: 254 QNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 222 YAS-----PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 276
E+L P +++ D + K V
Sbjct: 312 DCRPQDLPREVLTTNP-------------RRLSII-AESIRDGLATWDNWKHVNC----- 352
Query: 277 ESPRLSSSCKALISNILSPVKFRIQMEDI 305
+L++ ++ + N+L P ++R + +
Sbjct: 353 --DKLTTIIESSL-NVLEPAEYRKMFDRL 378
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.52 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.61 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.65 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.28 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.76 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.23 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 88.56 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.88 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-66 Score=457.10 Aligned_cols=257 Identities=23% Similarity=0.435 Sum_probs=230.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
..|++.++||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997644322 456779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC----
Confidence 99999999999976 4599999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~l 288 (335)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+..... .+....+|+++++|
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred -cccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 23467899999999999988887 899999999999999999999999999999888877543 23345789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
|.+|| .||++|||++|+|+||||++...+
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 99999 999999999999999999986544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-67 Score=454.42 Aligned_cols=259 Identities=29% Similarity=0.570 Sum_probs=231.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++|||||+++++|.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999999764322222256688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~-- 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-- 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC--
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc--
Confidence 999999999999998889999999999999999999999999999999999999999999999999999877543221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKAL 288 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~l 288 (335)
......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++..++... +.+| ..+++++++|
T Consensus 189 -~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p--~~~s~~~~dl 264 (311)
T 4aw0_A 189 -ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP--EKFFPKARDL 264 (311)
T ss_dssp -CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--TTCCHHHHHH
T ss_pred -ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--cccCHHHHHH
Confidence 234567899999999999988887 7999999999999999999999999999998888764 3333 4699999999
Q ss_pred HHHhc-CCCCCCCCHHH------HhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQMED------IRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~------ll~hp~~~~~ 314 (335)
|++|| .||++|||++| |++||||++-
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999 99999999988 6899999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-66 Score=445.20 Aligned_cols=256 Identities=36% Similarity=0.677 Sum_probs=216.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999998765544444667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-----
Confidence 999 67999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 290 (335)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...+.+.+.... .+.+..+|+++++||+
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHH
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence 23356899999999999998887689999999999999999999999999998888887643 2333569999999999
Q ss_pred Hhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 291 NIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 291 ~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+|| .||++|||++|+|+||||+..
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 999 999999999999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=459.51 Aligned_cols=259 Identities=27% Similarity=0.493 Sum_probs=228.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|++..+|+.||||++........ ..+.+.+|+.+++.++|||||++++++.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH-HHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999987665443 366788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 130 MEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||||+||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 9999999999999754 347999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++...+......+....+|.++++
T Consensus 180 ---~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~ 255 (350)
T 4b9d_A 180 ---ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255 (350)
T ss_dssp ---HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ---ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 123356899999999999998888 7999999999999999999999999999999998877655666789999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
||.+|| .||.+|||++|+|+||||++..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 999999 9999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-65 Score=458.78 Aligned_cols=257 Identities=23% Similarity=0.435 Sum_probs=231.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
..|+++++||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.+++.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654332 556789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
|||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 302 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 302 (423)
T ss_dssp ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC----
T ss_pred eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc----
Confidence 999999999999764 599999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~l 288 (335)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+..... .+....+|+++++|
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred -cccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 23467899999999999998888 899999999999999999999999999999888877543 33446799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
|.+|| .||.+|||++|+|+||||++...+
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 99999 999999999999999999986544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-66 Score=448.76 Aligned_cols=273 Identities=26% Similarity=0.485 Sum_probs=226.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..++|++++.||+|+||+||+|++. .+++.||+|++.+....... ...+.+|+.+++.++|||||++++++.+++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3467999999999999999999874 46789999999754322111 3356789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+.... .+.+..+|+++
T Consensus 181 ~-----~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 253 (304)
T 3ubd_A 181 K-----KAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEA 253 (304)
T ss_dssp C-----CCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred c-----cccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHH
Confidence 1 23456899999999999998888 79999999999999999999999999999988887643 23335699999
Q ss_pred HHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC-CCCCCCCCCCCcccc
Q psy10459 286 KALISNIL-SPVKFRIQ-----MEDIRQDPWLKED-SNPVGKSKSAPEVIP 329 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~-~~~~~~~~~~~~~~~ 329 (335)
++||++|| .||.+||| ++|+++||||++- ++....+...|+++|
T Consensus 254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 99999999 99999998 5899999999873 222223444555554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-65 Score=447.85 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=225.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..+.|.+.++||+|+||+||+|++..+|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34579999999999999999999999999999999976432 2379999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 207 (335)
|||||+||+|.++++..+.+++..+..++.||+.||.|||++||+||||||+|||++.+| .+||+|||+++.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999888899999999999999999999999999999999999999987 6999999999877544332
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCCCCCHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSC 285 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l 285 (335)
.........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+...... ..++.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 222223456899999999999998888 7999999999999999999999988777777776654321 1245799999
Q ss_pred HHHHHHhc-CCCCCCCCHHHH-------------hcCCCcCCCCCCCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDI-------------RQDPWLKEDSNPVGK 320 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~l-------------l~hp~~~~~~~~~~~ 320 (335)
.+||.+|| .||.+|||+.|+ |+|||+.+..+|-+.
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~n 335 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN 335 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC-
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCCC
Confidence 99999999 999999999998 679999998777553
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=431.84 Aligned_cols=254 Identities=20% Similarity=0.458 Sum_probs=217.8
Q ss_pred CCe-EEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----CCe
Q psy10459 51 HGY-SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THR 125 (335)
Q Consensus 51 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 125 (335)
.+| ++.++||+|+||+||+|.+..++..||+|++........ ..+.+.+|+.+++.++|||||+++++|.. ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 355 788899999999999999999999999999987655433 35678899999999999999999999865 356
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecC-CCCEEEeccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDD-KYNIKLSDFGFARKYS 202 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~ 202 (335)
+|||||||+||+|.+++.+.+.+++..+..|+.||+.||.|||++| |+||||||+|||++. ++.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999999889999999999999999999999998 999999999999984 7899999999997533
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHccccCCC-CCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPE-SPR 280 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~-~~~ 280 (335)
. ......+||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+. +...+...+......+. ...
T Consensus 184 ~-------~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 184 A-------SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp T-------TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred C-------CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 2 12345689999999999875 466 8999999999999999999999764 45566666665543322 245
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+++++++||.+|| .||.+|||++|+|+||||++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 7899999999999 999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-62 Score=439.44 Aligned_cols=267 Identities=25% Similarity=0.436 Sum_probs=227.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 123 (335)
.++|++++.||+|+||+||+|.+..+|+.||||++........ ....+.+|+.+|+.++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT-NAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH-HHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH-HHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4689999999999999999999999999999999976554433 34567799999999999999999998753 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.+|||||||. |+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67899999996 58999998888999999999999999999999999999999999999999999999999999987644
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------ 277 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 277 (335)
.... ........+||+.|+|||++.+..+.+.++||||+||++|+|++|..||.+.+..+....+......|.
T Consensus 211 ~~~~-~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 211 SPAE-HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred Cccc-cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 3221 122345678999999999998876655899999999999999999999999998888887754322211
Q ss_pred ------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 ------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 ------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.++.++.+||++|| .||.+|||++|+|+||||++...+..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence 1357899999999999 99999999999999999998765443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=415.92 Aligned_cols=257 Identities=22% Similarity=0.400 Sum_probs=200.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-------
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH------- 124 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 124 (335)
+|++++.||+|+||+||+|.+..+|+.||||+++.... +...+.+.+|+.+++.++|||||+++++|...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 59999999999999999999999999999999976543 333567889999999999999999999987544
Q ss_pred -----eEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccc
Q psy10459 125 -----RVYIIMEYAKNGSLLEVIRKERY---IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG 196 (335)
Q Consensus 125 -----~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg 196 (335)
.+|+|||||+||+|.+++..... .++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 37999999999999999987654 3456789999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccc-------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Q psy10459 197 FARKYSVNNTDYK-------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQ 268 (335)
Q Consensus 197 ~~~~~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~ 268 (335)
+++.+........ .......+||+.|+|||++.+..|+ .++|||||||++|||++ ||.+.... .....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9987754332111 1122346899999999999998888 89999999999999996 77653221 22233
Q ss_pred HHccccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 269 VQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 269 i~~~~~~~-~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+.. ..+| .....++.+.+||++|| .||.+|||+.|+|+||||++..
T Consensus 240 ~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 240 VRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred Hhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 332 2232 22345677889999999 9999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=412.01 Aligned_cols=260 Identities=22% Similarity=0.383 Sum_probs=225.2
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..+..++|.+.+.||+|+||+||+|.+. .++..||||+++... +...+.+.+|+.++++++|||||++++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3466788999999999999999999864 357889999996532 33467788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE-------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~ 187 (335)
.+++.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999764 358999999999999999999999999999999999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL 266 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~ 266 (335)
+.+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..++.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CcEEECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999865432211 122345689999999999988888 89999999999999998 89999999999999
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+..+...+.+..+|.++.+||.+|| .||++|||+++| |+|+++.
T Consensus 241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 999887776666789999999999999 999999999999 4577653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-60 Score=412.24 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=225.2
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 119 (335)
...+...++++.++||+|+||+||+|.+. .+++.||||+++..... ...+.|.+|+.++.+++|||||+++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 34566778999999999999999999863 45789999999754332 225678899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEe
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLL 183 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nil 183 (335)
+..++.++||||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+|+||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 99999999999999999999999643 35899999999999999999999999999999999999
Q ss_pred ecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q psy10459 184 LDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNY 262 (335)
Q Consensus 184 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~ 262 (335)
+++++.+||+|||+++.+..... .......+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred ECCCCCEEECCcccceeccCCCc---eeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999986643321 1223456799999999999988888 89999999999999998 8999999999
Q ss_pred HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 263 SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++...+..+...|.+..+|.++.+||.+|| .||.+|||+.||+++
T Consensus 254 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 254 QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999988777777789999999999999 999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=413.00 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=217.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..+..++|.+.++||+|+||+||+|.+. .+++.||||+++.. .....+.|.+|+.++++++|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3456678999999999999999999864 36789999999653 233467788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE---------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD 185 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~ 185 (335)
.+.+.+|||||||++|+|.++++.. .++++..+..|+.||+.||.|||+.+|+||||||+|||++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999753 3589999999999999999999999999999999999999
Q ss_pred CCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy10459 186 DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE 264 (335)
Q Consensus 186 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~ 264 (335)
.++.+||+|||+++.+...... ......+||+.|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TTTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CCCcEEEcccccceeccCCCcc---eecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999866433211 123345789999999999998888 89999999999999999 899999999999
Q ss_pred HHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 265 LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+...+..+...+.+..+|+++.+||.+|| .||++|||+.||+++
T Consensus 269 ~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 269 AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99999888777777789999999999999 999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-60 Score=445.60 Aligned_cols=275 Identities=21% Similarity=0.369 Sum_probs=225.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHH---HHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP---REIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|+++++||+|+||+||+|++..+|+.||||++.+...........+. .++.++..++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 45677899999999999999999999999999999999753221111122223 345667778999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.+|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|..+..
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccccccccccccccccCCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHccccCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~ 279 (335)
. .....+||+.|+|||++... .|+ .++|+|||||++|+|++|..||.+. +...+...+... ....+.
T Consensus 345 ~-------~~~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~ 415 (689)
T 3v5w_A 345 K-------KPHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPD 415 (689)
T ss_dssp C-------CCCSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCT
T ss_pred C-------CCCCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCc
Confidence 2 23456899999999999754 566 8999999999999999999999763 334444444332 222335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC-CCCCCCCCCCCccccc
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQ-----MEDIRQDPWLKED-SNPVGKSKSAPEVIPF 330 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~ 330 (335)
.+|+++++||.+|| .||.+|++ ++||++||||++- +.........|+++|.
T Consensus 416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence 69999999999999 99999998 7999999999873 1222233445555553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=415.06 Aligned_cols=257 Identities=22% Similarity=0.391 Sum_probs=208.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+++++.+ +||||+++++++...+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 467999999999999999999875 3578899999865433 34566899999988 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~ 204 (335)
+|+||||++|++|.+++. .+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999999984 48999999999999999999999999999999999999877 78999999999765432
Q ss_pred Ccccc-----------------------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q psy10459 205 NTDYK-----------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT- 260 (335)
Q Consensus 205 ~~~~~-----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~- 260 (335)
..... .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 21110 011234589999999999988765548999999999999999999999543
Q ss_pred CHHHHHHHHHcc-----------------------------------------------------ccCCCCCCCCHHHHH
Q psy10459 261 NYSELLKQVQKR-----------------------------------------------------VVFPESPRLSSSCKA 287 (335)
Q Consensus 261 ~~~~~~~~i~~~-----------------------------------------------------~~~~~~~~~~~~l~~ 287 (335)
+..+....+... ...+.+..+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 333333332110 011123568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
||++|| .||.+|+|++|+|+||||++-
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999 999999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=400.21 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=207.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
+.+..+++.+.++||+|+||+||+|++. ..||||+++...... ...+.+.+|+.++++++|||||++++++. ++.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence 4577788999999999999999999854 359999997654443 34667889999999999999999999875 456
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||||+||+|.+++... ..+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999764 56999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccccCCC---
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPE--- 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~--- 277 (335)
... ......+||+.|+|||++.+. .++ .++|||||||++|||+||..||.+.+. ......+......|.
T Consensus 186 ~~~---~~~~~~~GT~~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~ 261 (307)
T 3omv_A 186 SGS---QQVEQPTGSVLWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK 261 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred Ccc---eeecccccCCCccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 211 123456899999999998643 355 799999999999999999999987654 444555555554443
Q ss_pred -CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 278 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 278 -~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+|.++.+||.+|| .||++|||+.||++
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 3468999999999999 99999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=431.94 Aligned_cols=259 Identities=25% Similarity=0.478 Sum_probs=230.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.+.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 358999999999999999999999999999999997643 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC--CCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~--~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 999999999999864 4579999999999999999999999999999999999999854 7899999999987754322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCC--CCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFP--ESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~ 283 (335)
....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+.... .++ ....+|.
T Consensus 313 ------~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 313 ------VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ------eeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2345899999999999998887 78999999999999999999999999999998887643 332 2357999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
++++||++|| .||.+|||+.|+|+||||+....+.
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 9999999999 9999999999999999999865544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=402.79 Aligned_cols=257 Identities=20% Similarity=0.346 Sum_probs=219.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC-CCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~ 119 (335)
..+..++|++++.||+|+||+||+|.+... ++.||||++...... ...+.+.+|+.++.++.| ||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 457778999999999999999999987654 357999999764432 235678899999999965 899999999
Q ss_pred EEe-CCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 120 IET-THRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 120 ~~~-~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
|.. ++.++||||||++|+|.++++.. ..+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 45789999999999999999753 3488999999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
|++.++.+||+|||+++.+...... ......+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+..
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999876443221 123356789999999999988888 89999999999999998 999998865
Q ss_pred -HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 262 -YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 262 -~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+...+..+...+.+..+++++.+||.+|| .||.+|||+.+|++|
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 45566667777766666789999999999999 999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=387.74 Aligned_cols=261 Identities=37% Similarity=0.687 Sum_probs=232.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|++.+.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.+++.++||||+++++++...+..|+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45689999999999999999999999999999999987654433 35567799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--- 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--- 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+..+....+..... .....++.++.+|
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 244 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENL 244 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHH
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHH
Confidence 123557999999999999888776789999999999999999999999999988888876432 2334689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
|++|| .||.+|||++|+++||||+.....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 99999 999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=396.67 Aligned_cols=279 Identities=27% Similarity=0.484 Sum_probs=230.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|+++++||+|+||+||+|++..+|+.||+|++.+...........+.+|..++..+ +||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 46678999999999999999999999999999999999764322222345567899999988 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
......+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+...... ....++.++
T Consensus 179 -----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~~~~~ 251 (353)
T 3txo_A 179 -----VTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-YPTWLHEDA 251 (353)
T ss_dssp ------------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-CCTTSCHHH
T ss_pred -----ccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCHHH
Confidence 123456899999999999887777 7999999999999999999999999999988888764322 224589999
Q ss_pred HHHHHHhc-CCCCCCCCH------HHHhcCCCcCCCC-CCCCCCCCCCcccccCC
Q psy10459 286 KALISNIL-SPVKFRIQM------EDIRQDPWLKEDS-NPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~------~~ll~hp~~~~~~-~~~~~~~~~~~~~~~~~ 332 (335)
.+||++|| .||.+||++ +++++||||++.. .....+...|+++|..+
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 99999999 999999998 9999999998742 22222334455555433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=388.38 Aligned_cols=259 Identities=29% Similarity=0.533 Sum_probs=227.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997532111112445678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999875432221
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~ 286 (335)
.....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.......+... ..+| ..++.++.
T Consensus 161 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~ 233 (337)
T 1o6l_A 161 ----TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--RTLSPEAK 233 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred ----cccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHH
Confidence 23456899999999999988877 7899999999999999999999999988888777653 3333 46899999
Q ss_pred HHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 287 ALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 287 ~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
+||++|| .||.+|| +++++++||||++-
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999 9999999 99999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=394.76 Aligned_cols=279 Identities=27% Similarity=0.510 Sum_probs=229.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 124 (335)
..+..++|+++++||+|+||+||+|++..+++.||+|++.+...........+.+|..++..+ +||||+++++++...+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456778999999999999999999999999999999999876554444456678899999877 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+|+||||++||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999753222
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHccccC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------NYSELLKQVQKRVVF 275 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---------~~~~~~~~i~~~~~~ 275 (335)
. ......+||+.|+|||++.+..++ .++|+|||||++|+|++|..||... ......+.+... ..
T Consensus 207 ~-----~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~ 279 (396)
T 4dc2_A 207 G-----DTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI 279 (396)
T ss_dssp T-----CCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CC
T ss_pred C-----CccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-cc
Confidence 1 123456899999999999998887 8999999999999999999999642 233344444432 22
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhcCCCcCCCC-CCCCCCCCCCcccccC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQM------EDIRQDPWLKEDS-NPVGKSKSAPEVIPFK 331 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~------~~ll~hp~~~~~~-~~~~~~~~~~~~~~~~ 331 (335)
.....++.++++||++|| .||.+||++ ++|++||||++-. .........|+++|..
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~ 343 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 343 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCC
Confidence 233469999999999999 999999985 8999999998641 1122234455555544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=397.87 Aligned_cols=279 Identities=26% Similarity=0.443 Sum_probs=238.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|.++++||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 55678999999999999999999999999999999997532111111345778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++||+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999999999999764 5899999999999999999999999999999999999999999999999999766433211
Q ss_pred cccccccccccccccccccccCCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccCCCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPR 280 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~ 280 (335)
.....+||+.|+|||++.+.. ++ .++|+|||||++|+|++|..||.+.+.......+... ..+|....
T Consensus 225 ----~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 225 ----RCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp ----ECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred ----cccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 133568999999999997654 44 7899999999999999999999999999988888653 56777678
Q ss_pred CCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC-CCCCCCCCCCCcccccCC
Q psy10459 281 LSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED-SNPVGKSKSAPEVIPFKK 332 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~~ 332 (335)
++.++++||++|| .+|.+ |++++||++||||++. +.....+...++++|...
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~ 355 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 355 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCS
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCC
Confidence 9999999999999 88888 9999999999999885 344444556666766544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=387.23 Aligned_cols=278 Identities=24% Similarity=0.426 Sum_probs=232.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|.+++.||+|+||+||+|.+..+|+.||+|++.............+..|..++..+ +||+|+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 46678899999999999999999999989999999999764221111245567899999888 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
......+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..++...+.... ......++.++
T Consensus 176 -----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 248 (353)
T 2i0e_A 176 -----VTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEA 248 (353)
T ss_dssp -----CCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHH
T ss_pred -----cccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHH
Confidence 123456899999999999988887 89999999999999999999999999988888877642 22234699999
Q ss_pred HHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCCC-CCCCCCCCCCcccccC
Q psy10459 286 KALISNIL-SPVKFRI-----QMEDIRQDPWLKEDS-NPVGKSKSAPEVIPFK 331 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~-~~~~~~~~~~~~~~~~ 331 (335)
.+||++|| .||.+|| ++++|++||||+.-. .........|+++|..
T Consensus 249 ~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp HHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 99999999 9999999 479999999998631 1122234455555544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=388.43 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=225.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.......+.....+..|..++..+ +||||+++++++...+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999763211111234566888888876 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
. .....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+..... .....++.++
T Consensus 173 ~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 245 (345)
T 1xjd_A 173 A-----KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEA 245 (345)
T ss_dssp C-----CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHH
T ss_pred C-----cccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHH
Confidence 1 23456899999999999988877 899999999999999999999999999888888876432 2224589999
Q ss_pred HHHHHHhc-CCCCCCCCHH-HHhcCCCcCCC
Q psy10459 286 KALISNIL-SPVKFRIQME-DIRQDPWLKED 314 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~-~ll~hp~~~~~ 314 (335)
.+||.+|| .||.+||++. +|++||||++.
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999 9999999998 99999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=380.78 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=225.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++..+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35667899999999999999999999999999999999876555455566788999999988 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHccccCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD---------TNYSELLKQVQKRVVFP 276 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~---------~~~~~~~~~i~~~~~~~ 276 (335)
......+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.. .........+... ...
T Consensus 165 -----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~ 237 (345)
T 3a8x_A 165 -----DTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIR 237 (345)
T ss_dssp -----CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCC
T ss_pred -----CcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCC
Confidence 123456899999999999988877 899999999999999999999975 2334444444432 222
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCH------HHHhcCCCcCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQM------EDIRQDPWLKED 314 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~------~~ll~hp~~~~~ 314 (335)
....++.++.+||++|| .||.+||++ +++++||||++.
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 23468999999999999 999999985 899999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=383.16 Aligned_cols=258 Identities=27% Similarity=0.504 Sum_probs=227.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999986543211 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
++||||++|++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888899999999999999999999999999999999999998877 79999999998764
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCCC--CC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPE--SP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~~ 279 (335)
... .....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+.... .++. +.
T Consensus 171 ~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 171 DGV------EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp TTC------CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCC------ccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 322 12345799999999999988877 89999999999999999999999999988888887643 2221 25
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++.++++||++|| .||.+|||++|+|+||||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 68999999999999 999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=388.29 Aligned_cols=261 Identities=28% Similarity=0.531 Sum_probs=220.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHH-HHcCCCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..+ ++.++||||+++++++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3566789999999999999999999999999999999987554333334455567766 467899999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++.......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997543221
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
......+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+.... ......++.++
T Consensus 194 -----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 266 (373)
T 2r5t_A 194 -----STTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSA 266 (373)
T ss_dssp -----CCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHH
T ss_pred -----CccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHH
Confidence 123456899999999999988887 89999999999999999999999999988888887642 22235699999
Q ss_pred HHHHHHhc-CCCCCCCCH----HHHhcCCCcCCC
Q psy10459 286 KALISNIL-SPVKFRIQM----EDIRQDPWLKED 314 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~----~~ll~hp~~~~~ 314 (335)
++||++|| .||.+||++ +++++||||+.-
T Consensus 267 ~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999 999999986 699999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=378.46 Aligned_cols=257 Identities=27% Similarity=0.532 Sum_probs=226.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|..+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45678999999999999999999999999999999997532111112455678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999765321
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.......+.... ......++.++.+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ 232 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKD 232 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred -----cccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHH
Confidence 2345799999999999988877 78999999999999999999999999888887776542 2223468999999
Q ss_pred HHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
||++|| .||.+|| +++++++||||++-
T Consensus 233 li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999 9999999 99999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=384.27 Aligned_cols=257 Identities=24% Similarity=0.453 Sum_probs=228.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999997532211112456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..+....+.... ......++.++.+
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ 267 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKD 267 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHH
T ss_pred -----cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHH
Confidence 2345799999999999988877 89999999999999999999999999988888887643 2233568999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
||.+|| .||.+||+ +++|++||||++.
T Consensus 268 li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999 99999998 9999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=373.38 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=225.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+|++.+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3468999999999999999999999999999999997544332 4557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||+.+++|.+++... .+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 99999999999999765 589999999999999999999999999999999999999999999999999876643322
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCK 286 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~ 286 (335)
.....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... .......++..+.
T Consensus 172 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 172 ---KRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp ---CBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred ---ccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence 13345789999999999888887 79999999999999999999999988877766665432 2233456899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+||.+|| .||.+|||++|+|+||||+....
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 9999999 99999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-54 Score=392.41 Aligned_cols=263 Identities=28% Similarity=0.466 Sum_probs=227.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|+++++||+|+||+||+|.+..+++.||+|++.+...........+.+|..++..++||||+++++++.+.+.+
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999753221111234477999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999987 4679999999999999999999999999999999999999999999999999997664432
Q ss_pred cccccccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPE 277 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~ 277 (335)
.. .....+||+.|+|||++. ...++ .++|||||||++|+|++|..||.+.+..+....+.. ...+|.
T Consensus 230 ~~----~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 230 TV----QSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CE----ECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred Cc----ccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 21 123457999999999986 34455 799999999999999999999999999888888864 344454
Q ss_pred C-CCCCHHHHHHHHHhc-CCCCC--CCCHHHHhcCCCcCCC
Q psy10459 278 S-PRLSSSCKALISNIL-SPVKF--RIQMEDIRQDPWLKED 314 (335)
Q Consensus 278 ~-~~~~~~l~~li~~~L-~~p~~--Rps~~~ll~hp~~~~~ 314 (335)
. ..++.++++||++|| .+|++ |++++|+++||||++-
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 3 468999999999999 78887 9999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=389.27 Aligned_cols=258 Identities=31% Similarity=0.535 Sum_probs=227.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45799999999999999999999999999999999875543 33356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec---CCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+.||+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999888899999999999999999999999999999999999998 457899999999976643322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-C--CCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-F--PESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~ 283 (335)
. ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..+.. + +.+..+++
T Consensus 169 ~-----~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 169 A-----WFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp B-----CCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred e-----eecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 1 2345799999999999988887 799999999999999999999999999998888876432 2 33457899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++.+||.+|| .||.+|||+.|+|+||||++.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999 999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=368.94 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=216.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 57999999999999999999999999999999998654432 23456779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+.+ ++.+++. ..+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 156 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---
Confidence 99976 6665554 467799999999999999999999999999999999999999999999999999986643222
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHccccCC------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQKRVVFP------------ 276 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p-~~~~~~~~~~~~i~~~~~~~------------ 276 (335)
......||..|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+......+
T Consensus 157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 123456899999999998776444899999999999999987777 56667777666664422111
Q ss_pred ----------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 ----------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 ----------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+.++.++++||++|| .||++|||++|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11357899999999999 999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=395.92 Aligned_cols=281 Identities=29% Similarity=0.482 Sum_probs=228.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34566789999999999999999999999999999999975422222224556689999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+++||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999999888889999999999999999999998 99999999999999999999999999998754322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... ......++++
T Consensus 303 ~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~ 375 (446)
T 4ejn_A 303 GA-----TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPE 375 (446)
T ss_dssp ---------CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHH
T ss_pred Cc-----ccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHH
Confidence 21 13346799999999999888887 89999999999999999999999999888887776533 2223468999
Q ss_pred HHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCCC-CCCCCCCCCCcccccCCC
Q psy10459 285 CKALISNIL-SPVKFRI-----QMEDIRQDPWLKEDS-NPVGKSKSAPEVIPFKKS 333 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~~-~~~~~~~~~~~~~~~~~~ 333 (335)
+.+||.+|| .||.+|| +++++++||||++.. .........|+++|...+
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~ 431 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTS 431 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSS
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCC
Confidence 999999999 9999999 999999999998752 222234555666665543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=377.43 Aligned_cols=261 Identities=33% Similarity=0.573 Sum_probs=221.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999999754332 2246678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence 999999999999988778999999999999999999999999999999999999999999999999999766433221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-ccccCCCCCCCCHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQ-KRVVFPESPRLSSSCKA 287 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~-~~~~~~~~~~~~~~l~~ 287 (335)
......+||..|+|||++.+..+.+.++|||||||++|+|++|..||...... .....+. .....+....++.++.+
T Consensus 162 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 162 -RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp -CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred -cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 12335678999999999988776557899999999999999999999875543 2222322 33333444678999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
||.+|| .||.+|||++|+++||||++..
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999 9999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=384.54 Aligned_cols=261 Identities=20% Similarity=0.430 Sum_probs=222.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34667889999999999999999999999999999999975322111224567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||+.||+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998664322
Q ss_pred cccccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHccccCCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~ 279 (335)
.....+||+.|+|||++... .++ .++|+|||||++|+|++|..||... ........+... ..+...
T Consensus 170 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~p~ 241 (384)
T 4fr4_A 170 ------QITTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPS 241 (384)
T ss_dssp ------CBCCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-CCCCCT
T ss_pred ------ceeccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-ccCCCC
Confidence 23456799999999998743 355 7899999999999999999999743 344444444432 223335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCC-HHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQ-MEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps-~~~ll~hp~~~~~ 314 (335)
.++.++.+||.+|| .||.+||+ ++++++||||++.
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 68999999999999 99999998 9999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=385.63 Aligned_cols=277 Identities=27% Similarity=0.421 Sum_probs=231.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.++||+|+||+||+|.+..+|+.||+|++.+...........+.+|..++..++|+||+++++++.+.+.+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999753322222345678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999775 479999999999999999999999999999999999999999999999999998764432
Q ss_pred cccccccccccccccccccccccC-------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---ccC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILK-------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVF 275 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~---~~~ 275 (335)
.. .....+||+.|+|||++. ...++ .++|+|||||++|+|++|..||.+.+..+....+... ..+
T Consensus 217 ~~----~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 217 TV----RSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CE----ECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred cc----ccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 21 123458999999999986 34455 8899999999999999999999999998888887642 334
Q ss_pred CC-CCCCCHHHHHHHHHhcCCCCCC---CCHHHHhcCCCcCCC-CCCCCCCCCCCccccc
Q psy10459 276 PE-SPRLSSSCKALISNILSPVKFR---IQMEDIRQDPWLKED-SNPVGKSKSAPEVIPF 330 (335)
Q Consensus 276 ~~-~~~~~~~l~~li~~~L~~p~~R---ps~~~ll~hp~~~~~-~~~~~~~~~~~~~~~~ 330 (335)
|. ...+|.++++||++||.+|.+| |+++++++||||++- +... ....|+++|.
T Consensus 292 p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l--~~~~~p~~p~ 349 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL--RDSVPPFTPD 349 (412)
T ss_dssp C----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS--TTSCCSCCCC
T ss_pred CccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH--hhcCCCCCCc
Confidence 43 2469999999999999878777 699999999999874 2222 2345555554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=375.50 Aligned_cols=257 Identities=19% Similarity=0.377 Sum_probs=226.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 468999999999999999999999999999999986432 2245678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC--CCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||++|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++. ++.++|+|||++..+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999999765 36999999999999999999999999999999999999997 78999999999987643221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---CCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~ 283 (335)
.....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+........ ...++.
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 160 ------FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ------EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ------cccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 2234689999999999887766 789999999999999999999999998888888876443222 247899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++.+||.+|| .||.+|||+.|+|+||||++....
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~ 267 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccCccc
Confidence 9999999999 999999999999999999986544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=383.31 Aligned_cols=259 Identities=39% Similarity=0.713 Sum_probs=221.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|.+.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45689999999999999999999999999999999975322111223467899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--- 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--- 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---
Confidence 99999 67999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+... .......+++++.+|
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 238 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSL 238 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHH
T ss_pred ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHH
Confidence 2334579999999999998877557899999999999999999999876554443333222 122334689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
|++|| .||.+|||++|+++||||+...
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999 9999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=373.06 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=193.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----eE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 126 (335)
.+|.+.++||+|+||+||+|.+ +|+.||||++.... ......+.|+..+..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 58999999986532 11223345666667889999999999997654 58
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK--------SVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
|||||||++|+|.++++.. .++++.+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999765 489999999999999999999987 9999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCC--------------
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY-----TPQQSDIWSMGVVLFAMVYGRLPFDD-------------- 259 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~Di~slG~~~~~l~~g~~p~~~-------------- 259 (335)
+......... .......+||+.|+|||++.+... .+.++|||||||++|||+||..||..
T Consensus 156 ~~~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 156 VRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEEETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccccCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 8765433221 112334689999999999976531 12689999999999999999766532
Q ss_pred -CCHHHHHHHHHccccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 260 -TNYSELLKQVQKRVVFPESP------RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 260 -~~~~~~~~~i~~~~~~~~~~------~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.........+......|..+ ..+..+.+|+.+|| .||.+|||+.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12344444444333223221 13357899999999 999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=372.19 Aligned_cols=261 Identities=25% Similarity=0.488 Sum_probs=218.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+..++|++.+.||+|+||.||+|.+. .+|+.||+|++...... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 466788999999999999999999985 68999999999764322 12224556789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... .....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+.......+.... ......++
T Consensus 173 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~ 245 (327)
T 3a62_A 173 HDGT-----VTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLT 245 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSC
T ss_pred cCCc-----cccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCC
Confidence 2221 23345789999999999888777 89999999999999999999999999888887776532 22335689
Q ss_pred HHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
.++.+||.+|| .||.+|| +++++++||||++.
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999 9999999 89999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=377.91 Aligned_cols=257 Identities=30% Similarity=0.565 Sum_probs=227.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4579999999999999999999999999999999987655433 356688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---CEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+.|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999999999998888899999999999999999999999999999999999998654 59999999997664321
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCC--CCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFP--ESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~ 283 (335)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... .++ .+..++.
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 186 -----AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp -----SCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred -----ccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 12345789999999999988877 79999999999999999999999999888888887643 222 2246899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++.+||.+|| .||.+||++.++|+||||.+.
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999999999 999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=378.11 Aligned_cols=258 Identities=32% Similarity=0.599 Sum_probs=213.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++...+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4567899999999999999999999999999999999765433 345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC--EEEeccccccccccCC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNN 205 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~ 205 (335)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988888999999999999999999999999999999999999987765 9999999987432211
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHc-cccCCCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQK-RVVFPESPR 280 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~----~~~~~~i~~-~~~~~~~~~ 280 (335)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+... ......+.. ....+....
T Consensus 173 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 173 ------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred ------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 123456899999999998888775569999999999999999999987543 344444333 445566667
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++.++.+||.+|| .||.+|||+.|+++||||.+..
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 9999999999999 9999999999999999997653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=370.72 Aligned_cols=259 Identities=27% Similarity=0.506 Sum_probs=226.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3569999999999999999999999999999999976543211 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++ .++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999999887 79999999998764
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCCC--CC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPE--SP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~--~~ 279 (335)
.... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+.... .++. ..
T Consensus 170 ~~~~------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 170 FGNE------FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp TTSC------CCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCCc------cccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 3221 2345689999999999888777 79999999999999999999999998888877776532 2221 24
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.++..+.+||++|| .||.+|||++++|+||||+...
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 68999999999999 9999999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=391.96 Aligned_cols=263 Identities=35% Similarity=0.659 Sum_probs=231.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 44667889999999999999999999999999999999975422111224567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+..+.. .....++.++
T Consensus 171 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 243 (476)
T 2y94_A 171 ------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSV 243 (476)
T ss_dssp ------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHH
T ss_pred ------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHH
Confidence 123457999999999999887765789999999999999999999999888888888876542 3335689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.+||++|| .||.+|||++++++||||++..
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 99999999 9999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=370.29 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=206.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+|+.||+|++....... ....+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999999999999999997644221 135567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 130 MEYAKNGSLLEVIRKE------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999998653 3589999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------- 276 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 276 (335)
... .....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 161 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 161 PVN-----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp CCC-----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred Ccc-----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence 221 12344689999999999775433489999999999999999999999998887777664421111
Q ss_pred --------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 --------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 --------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
....++.++.+||.+|| .||.+|||++|+|+||||++...+-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 11257899999999999 99999999999999999998765543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=368.62 Aligned_cols=260 Identities=30% Similarity=0.583 Sum_probs=218.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh-----------------------HHHHhhHHHHHHH
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI-----------------------DYLKKFLPREIEV 104 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~ 104 (335)
+..++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45678999999999999999999999999999999997643211 1123567899999
Q ss_pred HHcCCCCCeeeeceeEEe--CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 105 VKGLKHPNLIRFLQAIET--THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 105 l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
++.++||||+++++++.. .+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+.|++||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 568999999999999987653 45699999999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY--TPQQSDIWSMGVVLFAMVYGRLPFDDT 260 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~Di~slG~~~~~l~~g~~p~~~~ 260 (335)
|++.++.++|+|||++..+...... .....||..|+|||++.+... .+.++|||||||++|+|++|..||...
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDAL-----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCE-----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEecCCCcccccccccc-----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999876533221 234578999999999977653 246799999999999999999999998
Q ss_pred CHHHHHHHHHc-cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 261 NYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 261 ~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
........+.. ...++....++.++.+||.+|| .||++|||+.|+++||||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 88777776655 3445555679999999999999 99999999999999999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=358.90 Aligned_cols=263 Identities=29% Similarity=0.548 Sum_probs=230.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|++......... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH-HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 57899999999999999999999999999999999876554333 46678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~ 206 (335)
|||+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999987655 99999999976543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc---CCCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~ 283 (335)
.....|+..|+|||++.+..++ .++||||||+++|+|++|..||.+.........+..... .+....++.
T Consensus 164 ------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 164 ------WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ------CCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ------ccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2235689999999999988777 799999999999999999999999999888888776432 223357899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
++.+||.+|| .||.+|||++++|+||||++.......
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 9999999999 999999999999999999886554443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=368.89 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=214.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
-..++|++++.||+|+||+||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++..++..+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 44578999999999999999999985 5899999999754332 223456779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999975 888888664 4599999999999999999999999999999999999999999999999999987643222
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------- 277 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 277 (335)
. ....+||..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+.
T Consensus 175 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 175 S-----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred c-----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 1 22346799999999997754444899999999999999999999988776666655543221111
Q ss_pred --------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 278 --------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 278 --------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.+.++.++.+||.+|| .||.+|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1347889999999999 9999999999999999998743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=373.96 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=214.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
.....++|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 344567899999999999999999999999999999999755432 2234556689999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-----CCCCEEEeccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-----DKYNIKLSDFGFARK 200 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-----~~~~~~l~Dfg~~~~ 200 (335)
.++||||+.+ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999999888899999999999999999999999999999999999995 445599999999976
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCC-
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP- 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~- 279 (335)
+...... ....+||..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+...
T Consensus 187 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 187 FGIPIRQ-----FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cCCcccc-----cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 6432211 2334679999999999876544489999999999999999999999998888777775543322211
Q ss_pred ----------------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 ----------------------------RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ----------------------------~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++.++.+||.+|| .||.+|||++|+|+||||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 16899999999999 999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=365.77 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=218.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 3679999999999999999999999999999999866543 334466778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-- 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999999766432221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc----------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---------------- 273 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---------------- 273 (335)
....+|+..|+|||++.+....+.++||||||+++|+|++|..||.+....+....+....
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 159 ---YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ---cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2344689999999999774444489999999999999999999999988777766554321
Q ss_pred ----cCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 274 ----VFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 274 ----~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
..+. .+.++.++.+||.+|| .||.+|||++++|+||||++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 1111 1458899999999999 9999999999999999999865443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=364.55 Aligned_cols=262 Identities=30% Similarity=0.599 Sum_probs=227.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+..++..||+|++.............+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678899999999999999999999999999999999654322222355678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999885443221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.....|+..|+|||++.+..++ .++||||||+++|+|++|..||......+....+.... .+....++.++.
T Consensus 164 ------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (279)
T 3fdn_A 164 ------RTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGAR 235 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHH
T ss_pred ------ccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHH
Confidence 2244689999999999887777 78999999999999999999999999888887776533 233356899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
+||.+|| .||.+||+++++++||||++....
T Consensus 236 ~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 236 DLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 9999999 999999999999999999886543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=372.60 Aligned_cols=257 Identities=27% Similarity=0.515 Sum_probs=208.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++.+.||+|+||+||+|.+..+++.||+|++..... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 345679999999999999999999999999999999976432 455778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccccccccC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~ 204 (335)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++. ++.++|+|||++......
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988888999999999999999999999999999999999999975 889999999998765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcccc-C--CCCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQKRVV-F--PESPR 280 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~-~~~~i~~~~~-~--~~~~~ 280 (335)
. .....+||..|+|||++.+..++ .++|||||||++|+|++|..||....... ....+..... + +....
T Consensus 205 ~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 205 V------LMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT
T ss_pred c------ccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh
Confidence 1 12345789999999999988777 79999999999999999999998765443 5555554322 2 22357
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
++.++.+||++|| .||++|||+.++|+||||++...
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 8999999999999 99999999999999999987544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=364.16 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=213.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5799999999999999999998 67899999999654322 122355678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+.+ +|.+++... +.+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 99975 999998764 56999999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------- 276 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 276 (335)
.....||..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+......+
T Consensus 157 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 ---YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ---cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 2234679999999999765544489999999999999999999999988777766664321110
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 ---------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 ---------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....++.++.+||++|| .||.+|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01357899999999999 999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=370.79 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=217.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|.+++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 5799999999999999999999999999999999654322 11234457999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 156 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 156 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence 99974 999888764 45899999999999999999999999999999999999999999999999998765432221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC------------
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------ 277 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------------ 277 (335)
....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 157 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 ---YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ---cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 23346799999999998754444899999999999999999999999998888777755322221
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCCCC
Q psy10459 278 -----------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKSKS 323 (335)
Q Consensus 278 -----------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~~~ 323 (335)
.+.++.++.+||.+|| .||.+|||++|+|+||||.+.........+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 297 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD 297 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence 1357899999999999 999999999999999999987766554333
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=376.23 Aligned_cols=268 Identities=25% Similarity=0.411 Sum_probs=213.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCC--e
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH--R 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~ 125 (335)
..++|++++.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.++..+. |+||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChH-HHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35689999999999999999999999999999999975443333 3556679999999997 999999999997544 7
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.+....
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 899999997 599999876 468999999999999999999999999999999999999999999999999998654311
Q ss_pred cc----------------cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy10459 206 TD----------------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 269 (335)
Q Consensus 206 ~~----------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i 269 (335)
.. .........+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 10 01112344689999999999987444448999999999999999999999999888887777
Q ss_pred HccccCCC----------------------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCH
Q psy10459 270 QKRVVFPE----------------------------------------------SPRLSSSCKALISNIL-SPVKFRIQM 302 (335)
Q Consensus 270 ~~~~~~~~----------------------------------------------~~~~~~~l~~li~~~L-~~p~~Rps~ 302 (335)
......|. ...++.++.+||.+|| .||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 65433332 1267899999999999 999999999
Q ss_pred HHHhcCCCcCCCCCCCC
Q psy10459 303 EDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 303 ~~ll~hp~~~~~~~~~~ 319 (335)
+|+|+||||+....+..
T Consensus 324 ~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 324 NDALKHPFVSIFHNPNE 340 (388)
T ss_dssp HHHTTSTTTTTTCCGGG
T ss_pred HHHhCCHHHHHhcCCcc
Confidence 99999999988654433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=402.55 Aligned_cols=279 Identities=24% Similarity=0.424 Sum_probs=235.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 124 (335)
..+..++|+++++||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +|++|+.+++++...+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 345677899999999999999999999999999999999753221122245566899999888 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999754322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. .....+||+.|+|||++.+..++ .++|+||||+++|||++|..||.+.+..++...+.... ......++.+
T Consensus 496 ~~-----~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 568 (674)
T 3pfq_A 496 GV-----TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKE 568 (674)
T ss_dssp TC-----CBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHH
T ss_pred Cc-----ccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHH
Confidence 21 23456899999999999988887 89999999999999999999999999999988887643 2223469999
Q ss_pred HHHHHHHhc-CCCCCCCCH-----HHHhcCCCcCCC-CCCCCCCCCCCcccccC
Q psy10459 285 CKALISNIL-SPVKFRIQM-----EDIRQDPWLKED-SNPVGKSKSAPEVIPFK 331 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~-----~~ll~hp~~~~~-~~~~~~~~~~~~~~~~~ 331 (335)
+.+||++|| .||.+||++ ++|++||||++- +.........|+++|..
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence 999999999 999999997 999999999873 22233344556666654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=383.53 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=201.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-----C
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----T 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 123 (335)
..++|++++.||+|+||+||+|.+..+|+.||||++...... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 357899999999999999999999999999999999764433 2335667899999999999999999999843 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5789999998 569999998888899999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccc----------------------cccccccccccccccccccCC-CCCCCCchhHHHHHHHHHHHHh--------
Q psy10459 204 NNTDYK----------------------QNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVY-------- 252 (335)
Q Consensus 204 ~~~~~~----------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~-------- 252 (335)
...... .......+||..|+|||++.. ..++ .++|||||||++|||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC-THHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC-cHhHHHHHHHHHHHHHHhccccccc
Confidence 221100 012345678999999998754 4455 89999999999999998
Q ss_pred ---CCCCCCCCCH--------------------HHHHHHHHcccc---------------------CC---------CCC
Q psy10459 253 ---GRLPFDDTNY--------------------SELLKQVQKRVV---------------------FP---------ESP 279 (335)
Q Consensus 253 ---g~~p~~~~~~--------------------~~~~~~i~~~~~---------------------~~---------~~~ 279 (335)
|..+|.+... .+....+..... ++ ..+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777765431 112222211100 00 124
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
.++.++.+||++|| .||.+|||++|+|+||||++...+.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 56999999999999 9999999999999999999875443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=375.96 Aligned_cols=267 Identities=21% Similarity=0.326 Sum_probs=219.5
Q ss_pred cccCCeEEeeeeccc--CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 48 LETHGYSLGDVVGMG--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
....+|++++.||+| +||+||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 356689999999999 99999999999999999999998755443 346778899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||.+.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6699999999999999999999999999999999999999999999999999876543
Q ss_pred CCccc--ccccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc------
Q psy10459 204 NNTDY--KQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------ 273 (335)
Q Consensus 204 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~------ 273 (335)
..... ........+||..|+|||++.+ ..++ .++|||||||++|+|++|..||.+.+.......+....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 22111 1112233478999999999987 4555 79999999999999999999998765443332221110
Q ss_pred ---------------------------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 274 ---------------------------------------VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 274 ---------------------------------------~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
..+....++.++.+||++|| .||.+|||++|+|+||||++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 01122457899999999999 99999999999999999987
Q ss_pred CCC
Q psy10459 314 DSN 316 (335)
Q Consensus 314 ~~~ 316 (335)
...
T Consensus 340 ~~~ 342 (389)
T 3gni_B 340 IKR 342 (389)
T ss_dssp C--
T ss_pred Hhh
Confidence 654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=364.04 Aligned_cols=258 Identities=22% Similarity=0.427 Sum_probs=224.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|...+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999998899999999997644322 4557799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998865 4599999999999999999999999999999999999999999999999999876643322
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCCCCCHHHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALI 289 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li 289 (335)
......||..|+|||++.+..++ .++||||||+++|+|++|..||......+....+...... .....++.++.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence 12345789999999999887777 7899999999999999999999999888887777654322 22345899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+|| .||.+|||++++++||||.+...+.+
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 306 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTGLPEC 306 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCCCGGG
T ss_pred HHHccCChhhCcCHHHHhcChhhccCCCccc
Confidence 9999 99999999999999999987655443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=374.32 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=224.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999975432 2245678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC--CCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+.|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++........
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999997553 6999999999999999999999999999999999999974 46799999999987643221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-C--CCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-F--PESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~ 283 (335)
....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..... + +....++.
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 207 ------VKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ------eeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 2234689999999999988777 789999999999999999999999988888877766432 2 22346899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
++.+||.+|| .||.+|||+.++|+||||++...
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999 99999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=367.69 Aligned_cols=265 Identities=23% Similarity=0.472 Sum_probs=233.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++...+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44568999999999999999999999999999999998765544555677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999976643221
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......|+..|+|||++.+..++ .++||||||+++|+|++|..||......+....+.... ......++.++.+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 270 (335)
T 2owb_A 197 ----RKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAAS 270 (335)
T ss_dssp ----CBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHH
T ss_pred ----cccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHH
Confidence 12345689999999999887776 79999999999999999999999988877777666532 2233468999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
||++|| .||.+||+++++++||||+....+..
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~ 303 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 303 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCcccc
Confidence 999999 99999999999999999988765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=359.73 Aligned_cols=265 Identities=23% Similarity=0.472 Sum_probs=233.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
....+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++|+||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45568999999999999999999999999999999998765544455677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999976643222
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
......|+..|+|||++.+..++ .++|+||||+++|+|++|..||......+....+.... .+....++..+.+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (294)
T 2rku_A 171 ----RKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAAS 244 (294)
T ss_dssp ----CBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHH
T ss_pred ----ccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHH
Confidence 12345689999999999887776 79999999999999999999999988887777766542 2333568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+|.+|| .||++|||++++++||||+....+..
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~ 277 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPAR 277 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence 999999 99999999999999999988765554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=375.33 Aligned_cols=260 Identities=28% Similarity=0.517 Sum_probs=217.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
+..++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345679999999999999999999999999999999964211 000114567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEeccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFA 198 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~ 198 (335)
+|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999998877542 35899999999999999999999999999999999999987655 999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCC-
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFP- 276 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~- 276 (335)
........ .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.. ......+... ...+
T Consensus 181 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 181 IQLGESGL-----VAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp EECCTTSC-----BCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred eEecCCCe-----eecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence 87654321 12345789999999999988777 89999999999999999999998864 4444444443 2222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 -ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 -~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....++.++.+||++|| .||.+|||+.++|+||||++.
T Consensus 254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 12468999999999999 999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=392.97 Aligned_cols=260 Identities=22% Similarity=0.359 Sum_probs=222.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.++||+|+||.||+|.+..+|+.||+|++.............+.+|+.++..++||||+++++++...+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 36678899999999999999999999999999999999753221111244567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
|+||||++||+|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++......
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999997754 3999999999999999999999999999999999999999999999999999766432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHccccCCCCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~ 280 (335)
.. ....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.. ...+...+... .......
T Consensus 340 ~~------~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~ 411 (576)
T 2acx_A 340 QT------IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSER 411 (576)
T ss_dssp CC------EECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTT
T ss_pred cc------ccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCcc
Confidence 21 2235799999999999988777 89999999999999999999998753 44455444432 2222356
Q ss_pred CCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
++.++++||++|| .||.+|| +++||++||||++.
T Consensus 412 ~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 412 FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999 9999999 89999999999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=363.87 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=212.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh--HHHHhhHHHHHHHHHcC---CCCCeeeeceeEE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGL---KHPNLIRFLQAIE 121 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~ 121 (335)
.+..++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 455779999999999999999999999999999999997433211 11122345677776666 5999999999997
Q ss_pred eCC-----eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEec
Q psy10459 122 TTH-----RVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 122 ~~~-----~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~D 194 (335)
... ..+++||++. ++|.+++..... +++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 755 5899999996 599999987654 89999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
||++....... .....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 164 fg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 164 FGLARIYSYQM------ALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp CSCTTTSTTCC------CSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CccccccCCCc------ccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99997654322 12345789999999999888877 789999999999999999999999998888877755322
Q ss_pred CCC--------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 275 FPE--------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 275 ~~~--------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+. .+.++.++.+||.+|| .||.+|||+.|+|+||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 211 1357899999999999 99999999999999999988543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=364.11 Aligned_cols=258 Identities=26% Similarity=0.476 Sum_probs=225.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999976443211 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888899999999999999999999999999999999999999887 79999999997664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---CC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~ 279 (335)
.... .....||..|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+........ ..
T Consensus 171 ~~~~------~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 171 DGVE------FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp TTCC------CCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cccc------ccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 3221 2345689999999999888777 799999999999999999999999988888877766432211 14
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++..+.+||.+|| .||.+|||++++++||||+..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 68999999999999 999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=385.38 Aligned_cols=262 Identities=31% Similarity=0.527 Sum_probs=225.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH----------HHHhhHHHHHHHHHcCCCCCeeeece
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID----------YLKKFLPREIEVVKGLKHPNLIRFLQ 118 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~ 118 (335)
..++|.+++.||+|+||+||+|.+..+++.||+|++........ .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999976443211 22456789999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---CEEEecc
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDF 195 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---~~~l~Df 195 (335)
++...+.+++||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998888899999999999999999999999999999999999999876 6999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
|++....... .....+||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 194 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 194 GLSSFFSKDY------KLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp TTCEECCTTS------CBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCCEEcCCCC------ccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998664322 1234578999999999875 455 7999999999999999999999999999998888775432
Q ss_pred C---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 276 P---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 276 ~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
. .+..++.++++||++|| .||.+|||++|+|+||||++.....
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 312 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc
Confidence 2 23578999999999999 9999999999999999998865543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=360.53 Aligned_cols=263 Identities=31% Similarity=0.605 Sum_probs=228.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++...+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45667899999999999999999999999999999999753221122245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
.....|+..|+|||++.+..++ .++|+||||+++|+|++|..||......+....+.... ......++.++.
T Consensus 169 ------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 240 (284)
T 2vgo_A 169 ------RRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSK 240 (284)
T ss_dssp ------BCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHH
T ss_pred ------cccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHH
Confidence 2345689999999999987777 78999999999999999999999988887777665532 223356899999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
+||.+|| .||.+||+++++++||||+......
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 9999999 9999999999999999998765444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=367.98 Aligned_cols=257 Identities=32% Similarity=0.561 Sum_probs=201.1
Q ss_pred CeEEe---eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEE
Q psy10459 52 GYSLG---DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 52 ~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (335)
+|.+. +.||+|+||+||+|.+..+|+.||||++.... ...+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 46664 78999999999999999999999999996531 455668999999997 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---CEEEeccccccccccC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 204 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---~~~l~Dfg~~~~~~~~ 204 (335)
+||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999988899999999999999999999999999999999999998765 7999999999765433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHccccCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-------YSELLKQVQKRVVFPE 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~~~ 277 (335)
.. .....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+ ..+....+..+.....
T Consensus 163 ~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 163 NQ-----PLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp --------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC-----cccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 22 12345689999999999888877 78999999999999999999998644 3455555554332211
Q ss_pred ---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 278 ---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 278 ---~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
+..++.++++||.+|| .||.+|||++++++||||++.......
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~ 283 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence 1358999999999999 999999999999999999987655444
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=357.75 Aligned_cols=259 Identities=30% Similarity=0.535 Sum_probs=226.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||+||+|.+..++..||+|++....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 357999999999999999999999999999999997643322 45677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999999999999888889999999999999999999999999999999999999 7888999999999976643221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC---CCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---PRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~ 283 (335)
.....||..|+|||++.+. ++ .++||||||+++|+|++|..||......+....+......... ..++.
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 165 ------MRTKVGTPYYVSPQVLEGL-YG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ------BCCCCSCTTTCCHHHHTTC-BC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ------hhccCCCCCccChHHhccc-CC-chhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2344689999999998765 45 7899999999999999999999999988888887765433221 36899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.+||.+|| .||.+|||+.++|+||||++.....+
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~~ 273 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCSG
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhccccccc
Confidence 9999999999 99999999999999999987655443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=387.20 Aligned_cols=261 Identities=21% Similarity=0.338 Sum_probs=222.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++...+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35668899999999999999999999999999999999753221111235577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999763 369999999999999999999999999999999999999999999999999998764
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHccccCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELLKQVQKRVVFPES 278 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~----~~~~~~~~i~~~~~~~~~ 278 (335)
.... .....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+. ....+...+.... ....
T Consensus 341 ~~~~-----~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p 413 (543)
T 3c4z_A 341 AGQT-----KTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYP 413 (543)
T ss_dssp TTCC-----CBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCC
T ss_pred CCCc-----ccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCC
Confidence 3321 12345899999999999988877 8999999999999999999999875 3455555554432 2223
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
..++.++.+||++|| .||.+||+ +++|++||||++.
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 568999999999999 99999995 5899999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=367.89 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=218.1
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-----CCCeeeec
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----HPNLIRFL 117 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~ 117 (335)
.....+..++|.+.++||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+. |+||++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344556678999999999999999999999999999999999642 223455668999999986 99999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---------
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--------- 186 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--------- 186 (335)
+++...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 889999997754 4899999999999999999999999999999999999975
Q ss_pred ----------------CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHH
Q psy10459 187 ----------------KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 250 (335)
Q Consensus 187 ----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l 250 (335)
++.++|+|||++...... ....+||..|+|||++.+..++ .++|||||||++|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el 252 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAEL 252 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHH
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHH
Confidence 788999999999754321 2345689999999999988887 789999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHccccCCC---------------------------C------------------CCCCHHH
Q psy10459 251 VYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------S------------------PRLSSSC 285 (335)
Q Consensus 251 ~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------------------~------------------~~~~~~l 285 (335)
++|..||...+..+....+........ . ...+..+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999999888777766654221110 0 0124778
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
.+||.+|| .||.+|||++|+|+||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 89999999 9999999999999999996
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=356.00 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=214.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||+||+|.+..++..||+|++........ ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 4579999999999999999999999999999999976543322 45677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEeccccccccc
Q psy10459 130 MEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~ 202 (335)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998854 3679999999999999999999999999999999999999 456789999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPR 280 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~ 280 (335)
.... .....|+..|+|||++.+ .++ .++||||||+++|+|++|..||.+....+....+...... .....
T Consensus 179 ~~~~------~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 179 SDEH------STNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp --------------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred Cccc------CcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 3221 234568999999999864 455 7899999999999999999999999888877766543222 12235
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
+++++.+||.+|| .||++|||+.|+|+||||++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 8999999999999 99999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=357.72 Aligned_cols=263 Identities=36% Similarity=0.650 Sum_probs=221.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34567889999999999999999999998999999999975322111224567799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
......|+..|+|||++.+..+.+.++|+||||+++|+|++|..||...........+..... +....++.++
T Consensus 166 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 238 (276)
T 2h6d_A 166 ------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSV 238 (276)
T ss_dssp -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHH
T ss_pred ------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cCchhcCHHH
Confidence 122346899999999998877655789999999999999999999999988888877766432 2334689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.++|.+|| .||.+|||++++++||||++..
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999 9999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=355.97 Aligned_cols=263 Identities=32% Similarity=0.561 Sum_probs=222.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 56999999999999999999999999999999997544322 2566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999987778999999999999999999999999999999999999999999999999999765433221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc-cccCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQK-RVVFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~-~~~~~~~~~~~~~l~~l 288 (335)
.......|+..|+|||++.+..+.+.++|+||||+++|+|++|..||...... .....+.. ....+....++..+.+|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence 12334578999999999988776547899999999999999999999876542 22333332 22233345689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
|.+|| .||.+|||++++++||||++.....
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 272 (276)
T 2yex_A 242 LHKILVENPSARITIPDIKKDRWYNKPLKKG 272 (276)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred HHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence 99999 9999999999999999998865443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=373.83 Aligned_cols=281 Identities=23% Similarity=0.375 Sum_probs=215.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 357899999999999999999999999999999999765433 33356778999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999996 59999999888899999999999999999999999999999999999999999999999999987643
Q ss_pred CCccc-----------------ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-----------CC
Q psy10459 204 NNTDY-----------------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-----------RL 255 (335)
Q Consensus 204 ~~~~~-----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-----------~~ 255 (335)
..... ........+||..|+|||++......+.++|||||||++|+|++| .+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 32110 001234568999999999875444344899999999999999984 44
Q ss_pred CCCCCC-----------------HHHHHHHHHccccCC------------------------------CCCCCCHHHHHH
Q psy10459 256 PFDDTN-----------------YSELLKQVQKRVVFP------------------------------ESPRLSSSCKAL 288 (335)
Q Consensus 256 p~~~~~-----------------~~~~~~~i~~~~~~~------------------------------~~~~~~~~l~~l 288 (335)
+|.+.+ ..+....+......| ..+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 443332 111111111111000 014589999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC-CCCCCcccccC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK-SKSAPEVIPFK 331 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~-~~~~~~~~~~~ 331 (335)
|++|| .||.+|||++|+|+||||++...+... ....+...||.
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~ 386 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh
Confidence 99999 999999999999999999987555443 22233344444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=368.56 Aligned_cols=252 Identities=30% Similarity=0.561 Sum_probs=216.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~i 128 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ..+|++++..+ +||||+++++++.+.+..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 45799999999999999999999999999999999765432 33688888777 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC----CCEEEeccccccccccC
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVN 204 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~----~~~~l~Dfg~~~~~~~~ 204 (335)
||||+.||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+.++ +.++|+|||++......
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999988889999999999999999999999999999999999998543 24999999999866433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcccc-CC--CC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD---TNYSELLKQVQKRVV-FP--ES 278 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~---~~~~~~~~~i~~~~~-~~--~~ 278 (335)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+ ....++...+..... ++ .+
T Consensus 174 ~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 174 NG-----LLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp TC-----CBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CC-----ceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 22 23345789999999999877666 789999999999999999999986 456667777665332 22 23
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..++.++++||++|| .||.+||++.++++||||.+.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 568999999999999 999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=367.53 Aligned_cols=256 Identities=28% Similarity=0.536 Sum_probs=222.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-----hHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCC
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 124 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 124 (335)
++|.+.+.||+|+||.||+|.+..+|+.||||++...... .+.....+.+|+.++..+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999889999999999764321 123355678999999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..++||||++|++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998766532
Q ss_pred CcccccccccccccccccccccccCCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGV------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-- 276 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-- 276 (335)
.. ....+||+.|+|||++.+. .++ .++|||||||++|+|++|..||...........+.......
T Consensus 254 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 254 EK------LRELCGTPGYLAPEILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CC------BCCCCSCGGGCCHHHHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cc------cccCCCCCCccChhhccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 21 2345789999999998532 344 78999999999999999999999988888777776543222
Q ss_pred -CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 277 -ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 277 -~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
.+..++..+.+||.+|| .||.+|||++++|+||||++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22468899999999999 99999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=386.66 Aligned_cols=261 Identities=32% Similarity=0.559 Sum_probs=229.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++.+.||+|+||+||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44568999999999999999999999999999999997654433333566789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEeccccccccccC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999988889999999999999999999999999999999999999 46788999999999766433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc---CCCCCCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRL 281 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~ 281 (335)
.. ....+||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+.+..+....+..... .+.+..+
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 183 KK------MKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CS------HHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc------cccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 21 223468999999999876 455 799999999999999999999999999998888876532 2334578
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+.++++||++|| .||.+|||+.++|+||||+....
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999 99999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=366.70 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=212.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 124 (335)
..++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 357899999999999999999999999999999999664433 334566789999999999999999999987653
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 7899999976 468999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----- 276 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----- 276 (335)
.. ....++|..|+|||++.+ ..++ .++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 180 ~~--------~~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 180 SE--------MTGYVVTRWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp SS--------CCSSCSCGGGCCTHHHHTTTCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cc--------cCcCcCCCCcCCHHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 22 234568999999999887 4455 88999999999999999999999988877766654321111
Q ss_pred -------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 -------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 -------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
..+.+++++.+||.+|| .||.+|||++++|+||||++...+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 319 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence 11457899999999999 99999999999999999998765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=382.46 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=212.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|++++.||+|+||+||+|.+..+|+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3578999999999999999999999999999999997653332 3355677999999999999999999998654
Q ss_pred -CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999976 67776643 48999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----- 277 (335)
... .....+||..|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+......|.
T Consensus 216 ~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 216 TSF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -CC------CC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred CCc------ccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 321 23346789999999999998887 789999999999999999999999988877777654322221
Q ss_pred ---------------CCC---------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 278 ---------------SPR---------------------LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 278 ---------------~~~---------------------~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
... .+.++.+||++|| .||.+|||++|+|+||||+....+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 000 1567999999999 999999999999999999875443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=359.35 Aligned_cols=262 Identities=30% Similarity=0.529 Sum_probs=210.5
Q ss_pred cCCeEEe-eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEE
Q psy10459 50 THGYSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (335)
.+.|++. +.||+|+||+||+|.+..+++.||||++...... ....+.+|+.++.++ +||||+++++++...+.++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679885 7899999999999999999999999999765332 145677899999885 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEeccccccccccC
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 204 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~ 204 (335)
+||||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988888999999999999999999999999999999999999998776 999999998765432
Q ss_pred Cccc--ccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------------H
Q psy10459 205 NTDY--KQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---------------Y 262 (335)
Q Consensus 205 ~~~~--~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---------------~ 262 (335)
.... ........+||..|+|||++.. ..++ .++|||||||++|+|++|..||.+.. .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 2110 1111234568999999999864 3345 78999999999999999999998754 2
Q ss_pred HHHHHHHHccc-cCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 263 SELLKQVQKRV-VFPE--SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 263 ~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
......+.... .++. ...++.++.+||++|| .||.+|||+.++|+||||++..
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 33445554432 2221 1468999999999999 9999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=359.62 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=206.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHH-HcCCCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++.++||+|+||+||+|.+..+|+.||||++.............+ .|+..+ ...+|+||+++++++...+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHH-HHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHH-HHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3445689999999999999999999999999999999876555444434444 444444 44599999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999999 66999888664 45999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~ 283 (335)
.. .....||..|+|||++.+ .++ .++|||||||++|+|++|..|+.... ....+......+ ....++.
T Consensus 211 ~~------~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 279 (311)
T 3p1a_A 211 GA------GEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSS 279 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCH
T ss_pred CC------CcccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCH
Confidence 21 234468999999999886 555 79999999999999999977665432 223333322111 1246899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
++.+||.+|| .||.+|||++++|+||||++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999 99999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=365.29 Aligned_cols=265 Identities=26% Similarity=0.420 Sum_probs=221.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 124 (335)
..+|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.++..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 4689999999999999999999999999999999975332 33356778999999999999999999998654 3
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..|+|||++. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 6899999997 4999999764 5999999999999999999999999999999999999999999999999999866433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------- 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 277 (335)
... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 182 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 182 HDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11223457899999999876555334899999999999999999999998877666665543211111
Q ss_pred -----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 278 -----------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 278 -----------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
.+.++.++.+||.+|| .||.+|||++++|+||||++...+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~ 326 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccc
Confidence 1457899999999999 999999999999999999998665543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=357.52 Aligned_cols=259 Identities=28% Similarity=0.535 Sum_probs=197.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999999999999999999753221112245678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 168 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK- 168 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence 9999999999999875 56999999999999999999999999999999999999999999999999999765432211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.....|+..|+|||++.+..++ .++|+||||+++|+|++|..||...........+... .......++.++.+|
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 169 ----HYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDL 242 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHH
T ss_pred ----ceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHH
Confidence 2234689999999999887776 7899999999999999999999876654444333221 122334689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
|.+|| .||.+|||++++++||||.+..
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999 9999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=383.86 Aligned_cols=259 Identities=31% Similarity=0.570 Sum_probs=223.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+++.||||++........ ....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4579999999999999999999999999999999964321111 145677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec---CCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+|||++..+.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99999999999998888899999999999999999999999999999999999995 456799999999976543221
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~ 283 (335)
....+||+.|+|||++.+. ++ .++|||||||++|+|++|..||.+.+..+....+.... ..+.+..+|.
T Consensus 180 ------~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 180 ------MKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp --------CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ------cCCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 2345789999999999763 55 78999999999999999999999999988888887643 2233457899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++++||.+|| .||.+|||+.++|+||||++....
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 9999999999 999999999999999999886544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=371.37 Aligned_cols=251 Identities=27% Similarity=0.521 Sum_probs=204.6
Q ss_pred cCCeEEe-eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHH-HcCCCCCeeeeceeEEe----C
Q psy10459 50 THGYSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIET----T 123 (335)
Q Consensus 50 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~ 123 (335)
.++|.+. +.||+|+||+||+|.+..+|+.||||++.. ...+.+|+.++ +..+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4567776 799999999999999999999999999964 23455788876 45589999999999875 5
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFA 198 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~ 198 (335)
+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67899999999999999998653 5999999999999999999999999999999999999997 788999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHc-cc
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE----LLKQVQK-RV 273 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~----~~~~i~~-~~ 273 (335)
....... .....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+..... ....+.. .+
T Consensus 212 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 212 KETTSHN------SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred cccCCCC------ccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 7654221 12345789999999999888887 89999999999999999999997654321 2233332 22
Q ss_pred cC--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 274 VF--PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 274 ~~--~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.+ +.+..++.++.+||++|| .||.+|||++++++||||.+..
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 22 234579999999999999 9999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=367.73 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=214.0
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEecc
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 133 (335)
...+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 336789999999999999999999999999976432 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee--cCCCCEEEeccccccccccCCccccc
Q psy10459 134 KNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 134 ~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---- 244 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---- 244 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB----
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc----
Confidence 999999988654 469999999999999999999999999999999999999 5667899999999987643221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-CC--CCCCCCHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKA 287 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~ 287 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..... .+ ....++.++.+
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred --cccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence 2234689999999999887777 789999999999999999999999998888877765432 22 22568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
||.+|| .||.+|||++++|+||||++..
T Consensus 322 li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 999999 9999999999999999998763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=355.55 Aligned_cols=255 Identities=28% Similarity=0.512 Sum_probs=223.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 45799999999999999999999999999999999754322 245677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999999888889999999999999999999999999999999999999 77889999999998654321
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC---CCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~ 283 (335)
.....+|+..|+|||++.+..++ .++||||||+++|+|++|..||...........+...... +....++.
T Consensus 163 -----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 163 -----IMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp -----TTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred -----ccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 12234689999999999888777 7899999999999999999999999988888888765422 22356899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++.+||.+|| .||.+||+++++|+||||++..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999 9999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=382.11 Aligned_cols=255 Identities=32% Similarity=0.536 Sum_probs=218.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|.+..++..||+|++......... ...+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999765432221 456779999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEeccccccccccCCcc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.. +.++|+|||++..+....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999999999999888889999999999999999999999999999999999999764 459999999997664322
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC---CCCCCCCHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSSS 284 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 284 (335)
.....+||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+....+....+...... +.+..++.+
T Consensus 194 ----~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 194 ----KMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ----CBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ----cccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 1234578999999999874 455 7999999999999999999999999999988888765332 233578999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+++||++|| .||.+|||+.++|+||||++.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999 999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=363.87 Aligned_cols=268 Identities=22% Similarity=0.339 Sum_probs=220.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 122 (335)
..++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 3568999999999999999999999999999999986544322 123456689999999999999999999876
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 123 --THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 123 --~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4468999999975 787777654 569999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC-
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES- 278 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~- 278 (335)
.+...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.........+......+..
T Consensus 173 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccc-cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 76533222 1122334578999999999977554348999999999999999999999999888877777552221111
Q ss_pred --CC----------------------------CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 279 --PR----------------------------LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 279 --~~----------------------------~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
+. .++++.+||.+|| .||.+|||++|+|+||||+....+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 11 2678999999999 99999999999999999988766554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=364.09 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=216.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh--HHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++....... +.....+.+|+.+++.++||||+++++++...+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 467999999999999999999999999999999987533221 222456779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999976 898888664 3589999999999999999999999999999999999999999999999999987643322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------- 277 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------- 277 (335)
.....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 168 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 168 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 123456899999999997655444789999999999999999999999988877777654322111
Q ss_pred ------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 ------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 ------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
...++.++.+||++|| .||.+|||++|+|+||||++...+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 0346789999999999 99999999999999999998755543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=363.42 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=218.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
-..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 3567899999999999999999999999999999999765443 334566779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 9999999989998888777899999999999999999999999999999999999999999999999999976543222
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--------------- 272 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~--------------- 272 (335)
......|+..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+...
T Consensus 180 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 180 ----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 1234468999999999987644448999999999999999999999988877665554321
Q ss_pred -----ccCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 273 -----VVFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 273 -----~~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
...+. .+.++.++.+||.+|| .||.+|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 11111 1357999999999999 999999999999999999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=364.98 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=217.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH-----HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
.++|++.+.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4679999999999999999999999999999999986543221 12445668999999999999999999999999
Q ss_pred eEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNG-SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..++||||+.+| +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 999999998766 9999999888899999999999999999999999999999999999999999999999999976643
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... ....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... .. .........++.
T Consensus 183 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~--~~~~~~~~~~~~ 249 (335)
T 3dls_A 183 GKL------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TV--EAAIHPPYLVSK 249 (335)
T ss_dssp TCC------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GT--TTCCCCSSCCCH
T ss_pred CCc------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HH--hhccCCCcccCH
Confidence 221 23456899999999999887755789999999999999999999976321 11 112223345899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++.+||.+|| .||.+|||++++++||||++..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999 9999999999999999998743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=360.86 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=221.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
..|.+.+.||+|+||+||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999998765555555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||+. |+|.+++. ....+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 58888775 4567999999999999999999999999999999999999999999999999998765321
Q ss_pred cccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC-CCCCCCCHHH
Q psy10459 210 QNLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-PESPRLSSSC 285 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l 285 (335)
...+||+.|+|||++. ...++ .++|||||||++|+|++|..||.+.+.......+...... .....++..+
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ----CcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 2346899999999984 34455 7899999999999999999999988877766666554322 2235689999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+||.+|| .||.+|||++++++||||.....
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 99999999 99999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=350.20 Aligned_cols=256 Identities=20% Similarity=0.440 Sum_probs=216.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----CC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----TH 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 124 (335)
....|.+.+.||+|+||+||+|.+..++..||+|++........ ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 44569999999999999999999999999999999986555433 36678899999999999999999998865 35
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeec-CCCCEEEecccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLD-DKYNIKLSDFGFARKY 201 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~-~~~~~~l~Dfg~~~~~ 201 (335)
.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.| ++|+||||+||+++ .++.++|+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999998888999999999999999999999999 99999999999998 7889999999998654
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHccccCC-CCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFP-ESP 279 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~-~~~ 279 (335)
... ......|+..|+|||++.+. ++ .++||||||+++|+|++|..||... ........+....... ...
T Consensus 183 ~~~-------~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 183 RAS-------FAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp CTT-------SBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred ccc-------ccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC
Confidence 322 12344689999999988753 55 7999999999999999999999874 4555555555543322 224
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..++++.+||.+|| .||.+|||++++++||||++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 57799999999999 999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=363.07 Aligned_cols=257 Identities=22% Similarity=0.386 Sum_probs=206.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC------
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH------ 124 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 124 (335)
++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4699999999999999999999999999999999765432 23567889999999999999999999885543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCCHHHHHHhcCC---CCH
Q psy10459 125 ---------------------------------------------------RVYIIMEYAKNGSLLEVIRKERY---IDE 150 (335)
Q Consensus 125 ---------------------------------------------------~~~iv~e~~~~~sL~~~l~~~~~---~~~ 150 (335)
..++||||+++++|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987543 556
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc-------cccccccccccccc
Q psy10459 151 DKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-------QNLSETFCGSYAYA 223 (335)
Q Consensus 151 ~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~-------~~~~~~~~g~~~y~ 223 (335)
..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++........... .......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999987754432111 11233457999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-CCCCCCHHHHHHHHHhc-CCCCCCCC
Q psy10459 224 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQ 301 (335)
Q Consensus 224 aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~L-~~p~~Rps 301 (335)
|||++.+..++ .++|||||||++|+|++|..|+.. .......+... ..+ .....++++.+||.+|| .||.+|||
T Consensus 244 aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 244 SPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp CHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred ChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 99999888877 899999999999999998766421 12222222222 222 12346788999999999 99999999
Q ss_pred HHHHhcCCCcCC
Q psy10459 302 MEDIRQDPWLKE 313 (335)
Q Consensus 302 ~~~ll~hp~~~~ 313 (335)
++++|+||||++
T Consensus 320 ~~~~l~~~~f~~ 331 (332)
T 3qd2_B 320 ATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHSTTCCC
T ss_pred HHHHhhchhhhc
Confidence 999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=360.08 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=224.2
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
...+...+|++.+.||+|+||+||+|.+..++. .||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355778899999999999999999999976655 499999975433 333567889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999754 5799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 279 (335)
........ .......+|..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+......+...
T Consensus 201 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 201 LEDDPDAA--YTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277 (325)
T ss_dssp CC----CC--EECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccCccce--eeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCC
Confidence 65432211 112233467789999999877777 78999999999999999 999999999999999999888888778
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++.++.+||.+|| .||.+|||+.+|++.
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999 999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=366.00 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=223.4
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.....+..++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 34456778899999999999999999999999999999999976532 3346678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+. |++|+||||+|||++.++.++|+|||++...
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999999999888899999999999999999999996 9999999999999999999999999998655
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV------------ 269 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i------------ 269 (335)
... ......||..|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+
T Consensus 183 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 183 IDS-------MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp HHH-------C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ccc-------cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 321 12345689999999999988777 7899999999999999999999887765543322
Q ss_pred ------------------------------HccccC-CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 270 ------------------------------QKRVVF-PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 270 ------------------------------~~~~~~-~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
...... .....++.++.+||.+|| .||.+|||++++|+||||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111111 112347899999999999 999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=365.03 Aligned_cols=267 Identities=28% Similarity=0.465 Sum_probs=219.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC--ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++...+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 4579999999999999999999999999999999975321 11223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q psy10459 128 IIMEYAKNGSLLEVIRK----------------------------------------ERYIDEDKGRRWFSQLADAIDYC 167 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~----------------------------------------~~~~~~~~~~~i~~~i~~~L~~L 167 (335)
+||||++|++|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 11135778899999999999999
Q ss_pred HhCCceeccCCCCCEeecCCC--CEEEeccccccccccCCcccccccccccccccccccccccCC--CCCCCCchhHHHH
Q psy10459 168 HKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSM 243 (335)
Q Consensus 168 H~~~i~H~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~sl 243 (335)
|+.|++|+||||+||+++.++ .++|+|||++..+...... .........||+.|+|||++.+ ..++ .++|||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Diwsl 262 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG-EYYGMTTKAGTPYFVAPEVLNTTNESYG-PKCDAWSA 262 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSSCCC-THHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc-ccccccccCCCccccCchhhccCCCCCC-cHHHHHHH
Confidence 999999999999999998776 8999999999866432211 1111234568999999999875 4455 79999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 244 GVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 244 G~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
||++|+|++|..||.+....+....+....... ....++.++.+||.+|| .||.+||++.++|+||||++.....
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 999999999999999998888877776543322 22348999999999999 9999999999999999999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=362.75 Aligned_cols=265 Identities=24% Similarity=0.414 Sum_probs=221.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC---
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--- 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 124 (335)
...++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34578999999999999999999999999999999998765555555677889999999999999999999987654
Q ss_pred -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 -RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..|+||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 3499999999999999998888899999999999999999999999999999999999999999999999999976644
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---CCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPR 280 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 280 (335)
..... ......+||..|+|||++.+..++ .++||||||+++|+|++|..||.+................+. ...
T Consensus 169 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 169 SGNSV--TQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccc--ccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 32211 122345689999999999888777 789999999999999999999999988777666655433332 246
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++.++.+||.+|| .||.+||++.+++.|+|++...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 8999999999999 9999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=366.16 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=204.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC----
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT---- 123 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 123 (335)
-..++|.+++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 3457899999999999999999999999999999999764433 23356677999999999999999999998653
Q ss_pred --CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 --HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 --~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5679999999 6799998876 56999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC----
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---- 277 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 277 (335)
... ....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......|.
T Consensus 183 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 ADE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccc--------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 321 22456899999999998743334889999999999999999999999888777666644221110
Q ss_pred --------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 --------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 --------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.+++++.+||++|| .||.+|||++++|+||||++...+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 1346889999999999 99999999999999999998766554
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=350.39 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=220.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 44567899999999999999999999999999999999977655555567788899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
.++||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999997664322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC----CCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----ESPRL 281 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----~~~~~ 281 (335)
.. .....+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+................. ....+
T Consensus 166 ~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 166 LT----QTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cc----ccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 11 12345689999999999888777 78999999999999999999999988777655554432211 23568
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
|..+.++|.+|| .||.+||+..+.+.+.|..
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999 9999999666666666544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=350.83 Aligned_cols=260 Identities=27% Similarity=0.516 Sum_probs=224.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC------hHHHHhhHHHHHHHHHcCC-CCCeeeeceeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP------IDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 121 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 121 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999999999999999999765321 1233566789999999995 999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
..+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCcccccccccccccccccccccccC------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILK------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV- 274 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~- 274 (335)
..... .....|+..|+|||++. ...++ .++||||||+++|+|++|..||...........+.....
T Consensus 175 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 175 DPGEK------LREVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CTTCC------BCCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCcc------cccccCCccccCHHHhccccccccccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 43221 23456899999999985 33344 789999999999999999999999888887777765432
Q ss_pred C--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 F--PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 ~--~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
+ +....++..+.+||.+|| .||.+|||++++++||||++..
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 2 222468999999999999 9999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=351.78 Aligned_cols=258 Identities=27% Similarity=0.499 Sum_probs=222.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3579999999999999999999999999999999976533211 1245678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||.+....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998877 79999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---CC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~ 279 (335)
.... .....|+..|+|||++.+..++ .++|+||||+++|+|++|..||.+....+....+........ ..
T Consensus 164 ~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 164 AGNE------FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp --------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCCc------ccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 3221 2234689999999999887777 799999999999999999999999988888777765332211 24
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++..+.+||.+|| .||.+||++.++++||||++.
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 68999999999999 999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=351.96 Aligned_cols=258 Identities=25% Similarity=0.431 Sum_probs=227.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..+.|.+.+.||+|+||.||+|.+..+++.||+|++........ ...+.+|+.++..++||||+++++++...+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 44679999999999999999999999999999999976543322 5667899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence 9999999999999865 5689999999999999999999999999999999999999999999999999976643221
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
......|+..|+|||++.+..++ .++||||||+++|+|++|..||...........+...........++..+.+|
T Consensus 175 ---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 175 ---KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred ---ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 12345689999999999888777 78999999999999999999999988888877776655444456789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
|.+|| .||.+|||++++++||||.+..
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999 9999999999999999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=347.74 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=210.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~i 128 (335)
.++|++.+.||+|+||+||+|.+..+++.||+|++......... ...+.+|+..+..+ +||||+++++++...+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35799999999999999999999999999999999865443332 45666899999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-----------------
Q psy10459 129 IMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----------------- 187 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~----------------- 187 (335)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999764 669999999999999999999999999999999999999844
Q ss_pred --CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy10459 188 --YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 265 (335)
Q Consensus 188 --~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~ 265 (335)
..++|+|||.+....... ...|+..|+|||++.+....+.++|||||||++|+|++|..++.... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred CceEEEEcccccccccCCcc---------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 479999999987654321 23589999999999876444468999999999999999988775543 2
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
...+...........++.++.+||.+|| .||.+|||+.++++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 3344444333344578999999999999 9999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=359.45 Aligned_cols=268 Identities=23% Similarity=0.431 Sum_probs=197.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.++..++||||+++++++...+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 456778999999999999999999998889999999988654322 224567789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRK--------ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999964 35589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC-
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF- 275 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~- 275 (335)
+...................|+..|+|||++.+. .++ .++||||||+++|+|++|..||..................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 8766443221112223345789999999998753 444 7899999999999999999999887765555444332211
Q ss_pred --------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 276 --------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 276 --------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.....++.++.+||.+|| .||.+||++.++++||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 112468899999999999 99999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=360.34 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=212.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC--CCeeeeceeEEeCC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETTH 124 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 124 (335)
.+..++|++.+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.++..++| +||+++++++...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 35677899999999999999999997 468899999997655443 335677899999999976 99999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..++|||+ .+++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++..+...
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99999995 4789999999988899999999999999999999999999999999999997 568999999999876433
Q ss_pred CcccccccccccccccccccccccCC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc-
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKG-----------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK- 271 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~- 271 (335)
... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++|..||.... .......+..
T Consensus 161 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 161 TTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccc---ccCCCCcCCcCcCCHHHHhhccccccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 221 12234578999999999854 3444 78999999999999999999998743 3333333332
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
..........+.++.+||.+|| .||.+|||+.++|+||||+....+.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~ 284 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC--
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCcc
Confidence 3333333457789999999999 9999999999999999998766554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=365.32 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=213.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC--CCCeeeeceeEEeCC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETTH 124 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 124 (335)
.+...+|.+.+.||+|+||.||+|.+.. ++.||||++....... .....+.+|+.++..+. |+||+++++++...+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3445679999999999999999999764 8999999997655433 33567889999999996 599999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.+|+||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++..+...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999999 45789999999888899999999999999999999999999999999999995 578999999999876433
Q ss_pred CcccccccccccccccccccccccCC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc-
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKG-----------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK- 271 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~- 271 (335)
... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++|..||.... .......+..
T Consensus 208 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 208 TTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred Ccc---ccCCCCCcCCCccChHHhhhccccccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 221 11234579999999999865 2344 78999999999999999999998753 3344444443
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
....+.....+.++.+||.+|| .||.+||++.++|+||||+....+.
T Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~~ 331 (390)
T 2zmd_A 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331 (390)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC---
T ss_pred cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCccc
Confidence 3333333456899999999999 9999999999999999998765543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=364.49 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=210.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-----
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----- 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 122 (335)
...++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345789999999999999999999999999999999875432 22379999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q psy10459 123 ---------------------------------THRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAID 165 (335)
Q Consensus 123 ---------------------------------~~~~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~L~ 165 (335)
...+++||||+++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348999999975 8777664 3567999999999999999999
Q ss_pred HHHhCCceeccCCCCCEeec-CCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHH
Q psy10459 166 YCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMG 244 (335)
Q Consensus 166 ~LH~~~i~H~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG 244 (335)
|||+.||+||||||+|||++ .++.++|+|||++..+..... .....||..|+|||++.+....+.++||||||
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP------SVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC------CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 99999999999999999998 678999999999986643322 23446799999999988766444899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccccC------------------C----------CCCCCCHHHHHHHHHhc-CC
Q psy10459 245 VVLFAMVYGRLPFDDTNYSELLKQVQKRVVF------------------P----------ESPRLSSSCKALISNIL-SP 295 (335)
Q Consensus 245 ~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------------~----------~~~~~~~~l~~li~~~L-~~ 295 (335)
|++|+|++|..||.+.+..+....+...... + ....++.++.+||.+|| .|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999998887777666532111 1 12347899999999999 99
Q ss_pred CCCCCCHHHHhcCCCcCCC
Q psy10459 296 VKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 296 p~~Rps~~~ll~hp~~~~~ 314 (335)
|.+|||+.|+|+||||++.
T Consensus 310 P~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp GGGSCCHHHHHTSGGGHHH
T ss_pred hhhCCCHHHHhcCHHHHHH
Confidence 9999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=368.92 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=209.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3447999999999999999999999999999999986542 2233799999999999999999988542
Q ss_pred -CeEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEecccc
Q psy10459 124 -HRVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGF 197 (335)
Q Consensus 124 -~~~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~ 197 (335)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999975 7776654 34679999999999999999999999999999999999999965 5689999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-----
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR----- 272 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~----- 272 (335)
++.+..... ....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 204 a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 204 AKQLVRGEP------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp CEECCTTCC------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred hhhcccCCC------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 986543221 224568999999999977643338999999999999999999999998876666555432
Q ss_pred -------------ccCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 273 -------------VVFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 273 -------------~~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
+.++. ...++.++.+||++|| .||.+||++.|+|+||||++...+
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 11221 1356899999999999 999999999999999999876443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=370.87 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=205.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-----hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
.++|.+.+.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 56899999999999999999999999999999999764321 12223457899999999999999999999754 5
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---CEEEecccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKY 201 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~---~~~l~Dfg~~~~~ 201 (335)
..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++ .++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6799999999999999998888899999999999999999999999999999999999997654 4999999999876
Q ss_pred ccCCcccccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHccccCC-
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFP- 276 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~- 276 (335)
.... .....+||+.|+|||++.+ ..++ .++|||||||++|+|++|..||...... .....+.......
T Consensus 293 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 293 GETS------LMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp C-----------------CTTCCTTTTC----CTTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred CCCc------cccccCCCCCccCceeeecCCCCCCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 4322 2234678999999999864 3444 6899999999999999999999765432 2333333322111
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 277 --ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 277 --~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
....++..+.+||.+|| .||.+|||++++|+||||++
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12468999999999999 99999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=366.41 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=214.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC------CCCCeeeeceeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL------KHPNLIRFLQAIE 121 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 121 (335)
....+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ .|+||+.+++.+.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3456899999999999999999999999999999999653 22345566788887776 5779999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC--EEEecccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGF 197 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~--~~l~Dfg~ 197 (335)
..+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999996 59999997654 4899999999999999999999999999999999999999887 99999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
+...... ....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 249 a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 249 SCYEHQR--------VYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CEETTCC--------CCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ceecCCc--------ccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 8654321 2345789999999999988887 899999999999999999999999988877766654221111
Q ss_pred ----------------------------------------------------------CCCCCHHHHHHHHHhc-CCCCC
Q psy10459 278 ----------------------------------------------------------SPRLSSSCKALISNIL-SPVKF 298 (335)
Q Consensus 278 ----------------------------------------------------------~~~~~~~l~~li~~~L-~~p~~ 298 (335)
....++++.+||++|| .||.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0123788999999999 99999
Q ss_pred CCCHHHHhcCCCcCCCCC
Q psy10459 299 RIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 299 Rps~~~ll~hp~~~~~~~ 316 (335)
|||++|+|+||||++...
T Consensus 400 Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp SCCHHHHHTSTTTC----
T ss_pred CCCHHHHhCChhhccCCC
Confidence 999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=350.88 Aligned_cols=259 Identities=23% Similarity=0.420 Sum_probs=217.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
....++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.++..++||||+++++++...+..
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3456789999999999999999999999999999999976433 34567899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+.+++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999996 45679999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 283 (335)
. ......|+..|+|||++.+..++ .++||||||+++|+|++|..||...........+..... +.....++.
T Consensus 180 ~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 180 A-----KRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp S-----CBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred c-----ccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence 1 12344689999999999888777 789999999999999999999998887766655544321 222345799
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+.+||.+|| .||.+|||+.++++||||++...
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999999999 99999999999999999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=364.63 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=210.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 124 (335)
..++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 357899999999999999999999999999999999765433 333566779999999999999999999987654
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 8888885 348999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----- 277 (335)
... .....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 179 ~~~------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 179 TSF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccc------ccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 321 12345789999999999988777 789999999999999999999999988777777655332211
Q ss_pred ---------------CC---------------------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 278 ---------------SP---------------------RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 278 ---------------~~---------------------~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
.. ..+.++++||++|| .||.+|||++|+|+||||+....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 329 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 329 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence 00 01567999999999 9999999999999999998765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=349.69 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=223.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 127 (335)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.. .+..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 467999999999999999999999999999999998655443 336678899999999999999999998754 56899
Q ss_pred EEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKE----RYIDEDKGRRWFSQLADAIDYCHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~-----i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999653 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
......... .....|+..|+|||++.+..++ .++||||||+++|+|++|..||...+..+....+......+..
T Consensus 164 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 164 RILNHDTSF-----AKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp HHC---CHH-----HHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred eeecccccc-----ccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 765432211 1234679999999999887777 7899999999999999999999999988888888776554455
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
..++.++.++|.+|| .||.+||++++|++|+|+.+.-
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 678999999999999 9999999999999999998743
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=357.17 Aligned_cols=254 Identities=22% Similarity=0.429 Sum_probs=209.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEe--C
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET--T 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~ 123 (335)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++++.. .
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 345678999999999999999999999999999999986432 456779999999997 9999999999987 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~ 202 (335)
...++||||+.+++|.+++.. +++..+..++.||+.||.|||+.|++||||||+|||++.++ .++|+|||++....
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred CceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 678999999999999998854 89999999999999999999999999999999999999777 89999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcc---------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKR--------- 272 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~~--------- 272 (335)
.... .....|+..|+|||++.+....+.++|||||||++|+|++|..||... ...+....+...
T Consensus 183 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 183 PGQE------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp TTCC------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCCc------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 3221 233468999999999987444448999999999999999999999543 222222222110
Q ss_pred -----c----------------------cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 273 -----V----------------------VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 273 -----~----------------------~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
. .......++.++.+||.+|| .||.+|||++|+|+||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0 00011237999999999999 9999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=358.07 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=216.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE--
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV-- 126 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 126 (335)
..++|.+.+.||+|+||+||+|.+..+|+.||+|++...... +.....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 457899999999999999999999999999999999765433 34456778999999999999999999999876654
Q ss_pred ----EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 127 ----YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 127 ----~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58888773 348999999999999999999999999999999999999999999999999997553
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC------
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------ 276 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------ 276 (335)
.. ....+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 196 ~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 196 AE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cC--------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 22 2234679999999999874434488999999999999999999999988877776664422111
Q ss_pred ------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 ------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 ------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
..+.++.++.+||.+|| .||.+|||++|+|+||||+....+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 335 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 335 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccc
Confidence 01357899999999999 99999999999999999998655544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=355.45 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=219.1
Q ss_pred cCCeEEe-eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEE
Q psy10459 50 THGYSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 50 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (335)
.++|.+. +.||+|+||.||+|.+..+|+.||+|++........ ....+.+|+.++..+. ||||+++++++...+..+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-CRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 4467777 899999999999999999999999999976443322 2456778999999994 699999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYS 202 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~~~~~ 202 (335)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++. ++.++|+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998543 56999999999999999999999999999999999999998 7899999999998664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc---cCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~ 279 (335)
.... ....+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+..+....+.... ..+...
T Consensus 186 ~~~~------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 186 HACE------LREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp --------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred Cccc------cccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 3221 2235689999999999888877 79999999999999999999999998888877776532 222335
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.++..+.+||.+|| .||.+|||++++|+||||++.
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 78999999999999 999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=349.05 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=215.6
Q ss_pred hhhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 42 ERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
......+...+|++.+.||+|+||+||+|.+ +|..||||++........ ....+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3344456778999999999999999999985 588999999976554433 3556779999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCEEEeccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKERY---IDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFG 196 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~~l~Dfg 196 (335)
..+..++||||+++++|.+++..... +++..++.++.||+.||.|||+.| ++||||||+||+++.++.++|+|||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 99999999999999999999987553 899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-cccC
Q psy10459 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVF 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~-~~~~ 275 (335)
++........ ......||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.. ....
T Consensus 185 ~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 185 LSRLKASTFL-----SSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCcccccccc-----ccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9875432211 12345789999999999988877 789999999999999999999999998888777753 3333
Q ss_pred CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc--CCCcCCC
Q psy10459 276 PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ--DPWLKED 314 (335)
Q Consensus 276 ~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~--hp~~~~~ 314 (335)
+....++.++.+||.+|| .||.+|||+.++++ .++++..
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 444579999999999999 99999999999998 5666553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=354.79 Aligned_cols=267 Identities=27% Similarity=0.416 Sum_probs=217.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT----- 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 123 (335)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc--chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 45789999999999999999999999999999999964332 33355677999999999999999999987653
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
...+++|||+. ++|.+++.. +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67899999996 599999876 4599999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccc-----cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-
Q psy10459 204 NNTDYK-----QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE- 277 (335)
Q Consensus 204 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 277 (335)
...... .......+||..|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 322111 01123457899999999876543334889999999999999999999999887666555432111110
Q ss_pred ------------------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 ------------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 ------------------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.++.++.+||.+|| .||.+|||++++|+||||+....+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 1368899999999999 99999999999999999998765544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=348.63 Aligned_cols=259 Identities=22% Similarity=0.378 Sum_probs=216.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
-..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++..++||||+++++++...+..+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3457899999999999999999999999999999998654322 1456778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999998865 4569999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--CCCC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESP 279 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~ 279 (335)
.......|+..|+|||++. ...++ .++||||||+++|+|++|..||...+.......+...... ....
T Consensus 172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 172 ----QKRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp ----HC-----CCGGGCCHHHHHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred ----cccccccCChhhcCCeeeccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcc
Confidence 1122346899999999983 44455 7999999999999999999999998887777666554322 2234
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.++.++.+||.+|| .||.+|||+.++++||||++..
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 68999999999999 9999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=349.32 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=203.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.++...++.++||||+++++++...+..+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 556789999999999999999999999999999999975433 2333445555666688889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999975 88777653 46799999999999999999999998 99999999999999999999999999997654
Q ss_pred cCCccccccccccccccccccccccc----CCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHH-HccccCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEIL----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQV-QKRVVFP 276 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i-~~~~~~~ 276 (335)
.... .....|+..|+|||++ .+..++ .++|||||||++|+|++|..||.. .......... .......
T Consensus 162 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 162 DDVA------KDIDAGCKPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred cccc------ccccCCCccccChhhcChhhcCcCCC-cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 3221 2233689999999996 344455 789999999999999999999986 3333333333 3333333
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
....++.++.+||.+|| .||.+|||+.++++||||+...
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 34578999999999999 9999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=349.62 Aligned_cols=266 Identities=28% Similarity=0.503 Sum_probs=219.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh-HHHHhhHHHHHHHHHcCCCCCeeeeceeEE--eCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI-DYLKKFLPREIEVVKGLKHPNLIRFLQAIE--TTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 126 (335)
.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++|+||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999999999999999997532110 122566889999999999999999999984 45688
Q ss_pred EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||+.++ |.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999875 7777765 356999999999999999999999999999999999999999999999999999766432
Q ss_pred CcccccccccccccccccccccccCCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... .......|+..|+|||++.+... .+.++||||||+++|+|++|..||.+.+.......+.... .+....++.
T Consensus 163 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~ 238 (305)
T 2wtk_C 163 AAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGP 238 (305)
T ss_dssp CSS---CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCH
T ss_pred ccc---cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCH
Confidence 211 11234468999999999976443 2368999999999999999999999998888887776643 233456899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
.+.+||.+|| .||.+|||++++++||||++...+...
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 276 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEA 276 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCC
Confidence 9999999999 999999999999999999987655444
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=350.81 Aligned_cols=257 Identities=23% Similarity=0.424 Sum_probs=213.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe-----
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET----- 122 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----- 122 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 467899999999999999999999999999999999764432 34567899999998 79999999999976
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 123 -THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 123 -~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 46899999999999999999764 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
....... ......|+..|+|||++. +..++ .++|||||||++|+|++|..||...........+.....
T Consensus 178 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (326)
T 2x7f_A 178 QLDRTVG-----RRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251 (326)
T ss_dssp ------------------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred ecCcCcc-----ccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 6543211 123446899999999986 34455 789999999999999999999998887777666654332
Q ss_pred C-CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 275 F-PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 275 ~-~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
. .....++..+.+||.+|| .||.+||+++++++||||++..
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 2 223568999999999999 9999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=359.29 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=221.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-------CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeece
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSA-------RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQ 118 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 118 (335)
.+..++|.+.+.||+|+||+||+|.+. .++..||+|++..... ......+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 456678999999999999999999874 2455799999975432 33356788999999999 8999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999997643 478999999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
|++.++.++|+|||++......... .......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+..
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999865432211 112234567899999999888777 78999999999999999 999999999
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+....+......+....++.++.+||.+|| .||.+||++.+++++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888888877666666789999999999999 999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=347.06 Aligned_cols=259 Identities=31% Similarity=0.562 Sum_probs=223.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
....++|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+++++++...+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3345689999999999999999999998999999999975433211 145677999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEecccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSV 203 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~~~~~~~ 203 (335)
++||||+.+++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999887889999999999999999999999999999999999999764 4699999999876543
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc---CCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPR 280 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~ 280 (335)
... .....|+..|+|||++.+. ++ .++|+||||+++|+|++|..||.+.+..+....+..... .+....
T Consensus 177 ~~~------~~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 177 NTK------MKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp CSS------CSCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred CCc------cccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 221 2234579999999998764 55 789999999999999999999999998888877766432 223357
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
++.++.+||++|| .||.+|||+.++|+||||++.
T Consensus 249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 8999999999999 999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=360.38 Aligned_cols=262 Identities=25% Similarity=0.371 Sum_probs=205.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe--
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-- 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 125 (335)
...++|.+.+.||+|+||+||+|.+..+|+.||||++...... .....+++..+..++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4567899999999999999999999999999999998654332 2344577888888999999999999865433
Q ss_pred -----EEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEeecC-CCCEEEe
Q psy10459 126 -----VYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCH--KKSVVHRDIKCENLLLDD-KYNIKLS 193 (335)
Q Consensus 126 -----~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH--~~~i~H~dikp~Nili~~-~~~~~l~ 193 (335)
+++||||+.+ +|...+. ....+++..++.++.|++.||.||| +.||+||||||+|||++. ++.++|+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999976 6555443 4566899999999999999999999 999999999999999997 8899999
Q ss_pred ccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc
Q psy10459 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273 (335)
Q Consensus 194 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~ 273 (335)
|||++........ .....||..|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 175 Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 175 DFGSAKKLSPSEP------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp CCTTCBCCCTTSC------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eCCCceecCCCCC------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999986653322 2244689999999999766644489999999999999999999999998887777765422
Q ss_pred cCC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 274 VFP-------------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 274 ~~~-------------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
..+ .....+.++.+||.+|| .||.+|||+.|+|+||||++...+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 111 11225689999999999 999999999999999999987665553
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=373.05 Aligned_cols=249 Identities=14% Similarity=0.179 Sum_probs=201.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH---HHHcCCCCCeeeec-------ee
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE---VVKGLKHPNLIRFL-------QA 119 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~~ 119 (335)
.++|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+. .+..++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999998899999999998654433344677889995 45555799999998 55
Q ss_pred EEeCC-----------------eEEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q psy10459 120 IETTH-----------------RVYIIMEYAKNGSLLEVIRKERYIDE-------DKGRRWFSQLADAIDYCHKKSVVHR 175 (335)
Q Consensus 120 ~~~~~-----------------~~~iv~e~~~~~sL~~~l~~~~~~~~-------~~~~~i~~~i~~~L~~LH~~~i~H~ 175 (335)
+...+ ..|++|||+ +|+|.+++...+.+++ ..++.++.||+.||.|||+.||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 278999999 6799999987554555 7888899999999999999999999
Q ss_pred cCCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCC-----------CCCCCchhHHHHH
Q psy10459 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-----------PYTPQQSDIWSMG 244 (335)
Q Consensus 176 dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~~Di~slG 244 (335)
||||+|||++.++.++|+|||++..... .....+| ..|+|||++.+. .++ .++||||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG 300 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALG 300 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHH
Confidence 9999999999999999999999975322 1224467 899999999876 666 899999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 245 VVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 245 ~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|++|+|++|..||.+.........+. .....++.++.+||.+|| .||.+||++.++++||||++.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999999998765443332222 223578999999999999 999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=362.16 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=226.6
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEE-----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeece
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 118 (335)
....+..++|.+.+.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..++||||+++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34556778999999999999999999994 45677899999865433 223456778999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC---
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER-------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--- 188 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~--- 188 (335)
++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence 9999999999999999999999997643 489999999999999999999999999999999999999555
Q ss_pred CEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy10459 189 NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLK 267 (335)
Q Consensus 189 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~ 267 (335)
.++|+|||++......... .......||..|+|||++.+..++ .++|||||||++|+|++ |..||......+...
T Consensus 222 ~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~ 297 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYY---RKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297 (367)
T ss_dssp CEEECCCHHHHHHHHHSSC---TTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred eEEECCCcccccccccccc---ccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 4999999999755332211 122345678899999999887777 79999999999999998 999999999999999
Q ss_pred HHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 268 QVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 268 ~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+......+....++..+.+||.+|| .||.+||++.+|+++.|+-..
T Consensus 298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 99887777667789999999999999 999999999999999877554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=358.54 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=208.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC---
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--- 124 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 124 (335)
....+|.+.+.||+|+||+||+|.+..+++ ||+|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 345679999999999999999999877665 88887754322 2237999999999999999999986543
Q ss_pred ---eEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-CCCCEEEeccc
Q psy10459 125 ---RVYIIMEYAKNGSLLEVIR----KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFG 196 (335)
Q Consensus 125 ---~~~iv~e~~~~~sL~~~l~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-~~~~~~l~Dfg 196 (335)
.+++||||+++ ++...+. ....+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 38899999976 5544432 356799999999999999999999999999999999999999 78999999999
Q ss_pred cccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--
Q psy10459 197 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-- 274 (335)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 274 (335)
++..+..... .....||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 188 ~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 188 SAKILIAGEP------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp TCEECCTTCC------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CcccccCCCC------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9987643222 22456799999999997765444899999999999999999999999887776666544211
Q ss_pred ----------------CCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 275 ----------------FPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 275 ----------------~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
++. ...+++++.+||.+|| .||.+|||+.|+|+||||++.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 111 1348899999999999 9999999999999999999865543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=352.29 Aligned_cols=266 Identities=19% Similarity=0.344 Sum_probs=205.5
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
..+..++|++.+.||+|+||+||+|.+..++. .||+|++........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH-HHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH-HHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34667889999999999999999999877665 899999976433222 25677899999999999999999999987
Q ss_pred CCeE------EEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCE
Q psy10459 123 THRV------YIIMEYAKNGSLLEVIRKER------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI 190 (335)
Q Consensus 123 ~~~~------~iv~e~~~~~sL~~~l~~~~------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~ 190 (335)
.+.. +++|||+.+++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 6655 99999999999999996532 58999999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy10459 191 KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQV 269 (335)
Q Consensus 191 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i 269 (335)
+|+|||++......... .......++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+
T Consensus 177 kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp EECCCCC--------------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EEeeccccccccccccc---cccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 99999999766433211 112233457789999999887777 89999999999999999 99999999988888888
Q ss_pred HccccCCCCCCCCHHHHHHHHHhc-CCCCCCCC-------HHHHhcCCCcCCCCC
Q psy10459 270 QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ-------MEDIRQDPWLKEDSN 316 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps-------~~~ll~hp~~~~~~~ 316 (335)
......+....++.++.+||.+|| .||.+||| ++++++|||+.....
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 253 IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 887777777789999999999999 99999999 899999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=340.50 Aligned_cols=253 Identities=21% Similarity=0.379 Sum_probs=222.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3467789999999999999999999976 5778999999765443 3457799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999764 45899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.. .......++..|+|||++.+..++ .++|+||||+++|+|++ |..||......+....+...........++.
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T 4hcu_A 160 QY----TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234 (269)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cc----ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCH
Confidence 21 112234567889999999877777 78999999999999999 9999999999999999988777666677899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.++|.+|| .||.+||++.++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 235 HVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999 999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=357.77 Aligned_cols=262 Identities=24% Similarity=0.478 Sum_probs=216.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 122 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 122 (335)
+..++|++.+.||+|+||+||+|.+. .+++.||||++...... .......+.+|+.++..+ +|+||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 45578999999999999999999984 47899999998643210 011134456799999999 69999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+..++||||+++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHccccCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELLKQVQKRVVFPE 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~----~~~~~~~~i~~~~~~~~ 277 (335)
..... .....+||..|+|||++.+.. ..+.++|||||||++|+|++|..||... ....+...+... ..+.
T Consensus 211 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 285 (355)
T 1vzo_A 211 ADETE----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPY 285 (355)
T ss_dssp GGGGG----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCC
T ss_pred cCCCC----cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCC
Confidence 32211 123457899999999998632 2337899999999999999999999743 334444444332 2233
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
...++..+.+||.+|| .||.+|| +++++++||||++.
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 4568999999999999 9999999 99999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=361.91 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=195.8
Q ss_pred CCeEE-eeeecccCceEEEEEEEc--CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCe
Q psy10459 51 HGYSL-GDVVGMGSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THR 125 (335)
Q Consensus 51 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 125 (335)
+.|.+ +++||+|+||+||+|.+. .+++.||+|++...... ..+.+|+.+++.++||||+++++++.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34776 558999999999999965 56889999999765442 346689999999999999999999954 678
Q ss_pred EEEEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee----cCCCCEEE
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE---------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKL 192 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili----~~~~~~~l 192 (335)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999999964 888887532 248999999999999999999999999999999999999 67789999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--------- 263 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~--------- 263 (335)
+|||++..+...... .......+||..|+|||++.+....+.++|||||||++|+|++|..||.+....
T Consensus 174 ~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp CCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EECCCceecCCCCcc--cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999876432211 112334678999999999987654448999999999999999999999765542
Q ss_pred HHHHHHHccccCCCC-------------------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHH
Q psy10459 264 ELLKQVQKRVVFPES-------------------------------------PRLSSSCKALISNIL-SPVKFRIQMEDI 305 (335)
Q Consensus 264 ~~~~~i~~~~~~~~~-------------------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~l 305 (335)
+....+......|.. ...+..+.+||++|| .||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 333333332222211 122678999999999 999999999999
Q ss_pred hcCCCcCCCCCCCC
Q psy10459 306 RQDPWLKEDSNPVG 319 (335)
Q Consensus 306 l~hp~~~~~~~~~~ 319 (335)
|+||||++...+..
T Consensus 332 L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 332 MQDPYFLEDPLPTS 345 (405)
T ss_dssp HTSGGGTSSSCCCS
T ss_pred hcChhhccCCCCcc
Confidence 99999988655443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=352.79 Aligned_cols=257 Identities=30% Similarity=0.543 Sum_probs=209.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-----hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45799999999999999999999999999999999754321 1122445779999999999999999999987665
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEecccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKY 201 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~~~~~ 201 (335)
.++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987665 999999999765
Q ss_pred ccCCcccccccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcccc-CC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVV-FP 276 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~~~-~~ 276 (335)
..... .....|+..|+|||++. ...++ .++|||||||++|+|++|..||...... .....+..... ..
T Consensus 168 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 168 GETSL------MRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CCCHH------HHHHHSCCTTCCHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ccccc------cccccCCcCccCchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 43211 12346899999999973 34455 7899999999999999999999765432 22333333221 11
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 --ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 --~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....++.++.+||.+|| .||.+||+++++|+||||++.
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 12468999999999999 999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=342.48 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=220.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|++.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++..++|+||+++++++...+.
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 4577889999999999999999999875 6778999999765443 3457799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999976 456999999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||...........+...........++.
T Consensus 174 ~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T 3gen_A 174 EYT----SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 248 (283)
T ss_dssp HHH----STTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccc----cccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCH
Confidence 211 12233467889999999877776 78999999999999998 9999999999999999988877766677899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+||.+|| .||.+|||++++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999 999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=354.72 Aligned_cols=265 Identities=23% Similarity=0.395 Sum_probs=212.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC--------hHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP--------IDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..++|.+.+.||+|+||.||+|.+.. |+.||||++...... .....+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45789999999999999999999754 999999998653322 122346788999999999999999999998
Q ss_pred Ee-----CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEec
Q psy10459 121 ET-----THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 121 ~~-----~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~D 194 (335)
.. ...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 54 346899999997 5888888654 3699999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 274 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~ 274 (335)
||++........ .....|+..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+.....
T Consensus 178 fg~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADAN------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp TTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cCcccccccccc------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999975432221 23456899999999998744344899999999999999999999999888777766643221
Q ss_pred CC-------------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCCC
Q psy10459 275 FP-------------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKS 321 (335)
Q Consensus 275 ~~-------------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~~ 321 (335)
.+ ..+.+++.+.+||.+|| .||.+|||++++|+||||+....+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 330 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT 330 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc
Confidence 11 01356889999999999 9999999999999999999987666543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=338.61 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=221.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++..++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 466788999999999999999999865 5678999999765443 34577999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997653 59999999999999999999999999999999999999999999999999997664432
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. ......++..|+|||++.+..++ .++||||||+++|+|++ |..||...........+...........++..
T Consensus 159 ~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 159 YV----SSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDT 233 (268)
T ss_dssp EE----ECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred hh----cccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHH
Confidence 21 12233467789999999877777 78999999999999999 99999999999988888887766666778999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++|.+|| .||.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=346.27 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=217.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEE---
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA-RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIE--- 121 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~--- 121 (335)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3478999999999999999999985 6788999999875432211 123455777777666 8999999999987
Q ss_pred --eCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 122 --TTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 122 --~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
.....++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 4567899999997 59999997753 489999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP- 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~- 276 (335)
+....... ......|+..|+|||++.+..++ .++||||||+++|+|++|..||.+....+....+......+
T Consensus 167 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 167 ARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp CCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccCCC------CccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 97654321 12345689999999999888777 79999999999999999999999988887777765422111
Q ss_pred -------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 -------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 -------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
....++..+.+||.+|| .||.+||++.++++||||++......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 308 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 308 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhh
Confidence 11458899999999999 99999999999999999988655443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=352.13 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=214.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 125 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 125 (335)
..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 46899999999999999999999999999999999764433 3345667899999999999999999999977653
Q ss_pred --EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 --VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 --~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+|++|||+. ++|.+++.. .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 588877743 489999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC--------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-------- 275 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------- 275 (335)
. .....||..|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 179 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 179 E--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred C--------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 2 223467999999999887443448899999999999999999999998877766655432111
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 276 ----------------------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 276 ----------------------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
...+.++.++.+||.+|| .||.+|||++++|+||||+....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 317 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEE 317 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccc
Confidence 112467999999999999 99999999999999999998765544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=358.21 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=219.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH--------------HHHhhHHHHHHHHHcCCCCC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID--------------YLKKFLPREIEVVKGLKHPN 112 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~ 112 (335)
....++|.+.+.||+|+||.||+|.+ +|+.||+|++........ .....+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34567899999999999999999997 899999999975321110 01167889999999999999
Q ss_pred eeeeceeEEeCCeEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEe
Q psy10459 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEV------IRK--ERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLL 183 (335)
Q Consensus 113 iv~~~~~~~~~~~~~iv~e~~~~~sL~~~------l~~--~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nil 183 (335)
|+++++++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 655 5679999999999999999999999 99999999999999
Q ss_pred ecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy10459 184 LDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262 (335)
Q Consensus 184 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~ 262 (335)
++.++.++|+|||.+...... ......|+..|+|||++.+. .+.+.++|||||||++|+|++|..||.....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999765432 12345689999999999877 4443389999999999999999999988766
Q ss_pred -HHHHHHHHcc-ccCCCC-----------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 263 -SELLKQVQKR-VVFPES-----------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 263 -~~~~~~i~~~-~~~~~~-----------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+....+... ..++.. ..++.++.+||.+|| .||.+|||++++++||||++.
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 6666666543 222311 568999999999999 999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=357.70 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=223.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 45677899999999999999999999998999999999875422 3335667799999999999999999999999899
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999764 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... .......++..|+|||++.+..++ .++|||||||++|||++ |..||.+....+....+..+...+....++.
T Consensus 267 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 267 VYA---ASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPD 342 (377)
T ss_dssp EEE---CCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cee---ecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 111 111222357789999999877776 78999999999999998 9999999999999888888877777778999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.+||.+|| .||.+|||++++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999 99999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=348.26 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=214.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEE-cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC------Ceeeece
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATS-ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP------NLIRFLQ 118 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~ 118 (335)
.....++|++.+.||+|+||+||+|.+ ..+++.||+|++... +.....+.+|+.+++.++|+ +++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 345567999999999999999999998 557899999999643 23356677899999888654 5999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC----------
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---------- 186 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---------- 186 (335)
++...+..++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 789999998765 5899999999999999999999999999999999999987
Q ss_pred ---------CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy10459 187 ---------KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257 (335)
Q Consensus 187 ---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~ 257 (335)
++.++|+|||++...... .....||..|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCC
Confidence 668999999998754321 2345689999999999988877 8999999999999999999999
Q ss_pred CCCCHHHHHHHHHccccC-C------------------------------------------CCCCCCHHHHHHHHHhc-
Q psy10459 258 DDTNYSELLKQVQKRVVF-P------------------------------------------ESPRLSSSCKALISNIL- 293 (335)
Q Consensus 258 ~~~~~~~~~~~i~~~~~~-~------------------------------------------~~~~~~~~l~~li~~~L- 293 (335)
...+..+....+...... | .....+.++.+||.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 998877766555332110 0 01123577999999999
Q ss_pred CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 294 SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 294 ~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.||.+|||+.|+++||||+...
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGG
T ss_pred cCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999998743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=362.24 Aligned_cols=255 Identities=17% Similarity=0.158 Sum_probs=196.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC--CCCCeeeec-------eeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL--KHPNLIRFL-------QAI 120 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~ 120 (335)
...|.+.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.++..+ +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999887665566677788885544444 699988755 344
Q ss_pred EeC-----------------CeEEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecc
Q psy10459 121 ETT-----------------HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKG------RRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 121 ~~~-----------------~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~------~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
... ..+|+||||+. ++|.+++... ..+++... ..++.||+.||.|||+.||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 332 34899999998 7999999763 33455555 67779999999999999999999
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCC
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGR 254 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~ 254 (335)
|||+|||++.++.++|+|||++....... ....+|..|+|||++.+ ..++ .++|||||||++|+|++|.
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG--------PASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE--------EGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc--------cCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999997654211 12346799999999987 5566 8999999999999999999
Q ss_pred CCCCCCCHHHHH--H------HHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 255 LPFDDTNYSELL--K------QVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 255 ~p~~~~~~~~~~--~------~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.||.+....... . .......++....++..+.+||.+|| .||++|||+.++|+||||++.
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 999876432110 0 00112334444578999999999999 999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=346.69 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=209.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE-------
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE------- 121 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------- 121 (335)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4578999999999999999999999999999999987532 233566789999999999999999998873
Q ss_pred -------eCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-CCCCEEEe
Q psy10459 122 -------TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLS 193 (335)
Q Consensus 122 -------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-~~~~~~l~ 193 (335)
..+..++||||+. ++|.+++.. +.+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3468899999997 599999864 5689999999999999999999999999999999999997 56689999
Q ss_pred ccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc
Q psy10459 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 273 (335)
Q Consensus 194 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~ 273 (335)
|||++......... ........++..|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....
T Consensus 164 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 164 DFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred cCccccccCCCccc--ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999866432111 1112334578899999998764334488999999999999999999999988777766654432
Q ss_pred cCC-----------------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 274 VFP-----------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 274 ~~~-----------------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
... ..+.++.++.+||.+|| .||.+|||++++|+||||+....+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 111 01358999999999999 9999999999999999999765554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=340.99 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=210.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..+.|.....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 344455556699999999999999999999999999976532 22456779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-CCCEEEecccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSV 203 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-~~~~~l~Dfg~~~~~~~ 203 (335)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999999997652 4678999999999999999999999999999999999997 88999999999976543
Q ss_pred CCcccccccccccccccccccccccCCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-H-HHHHHccccCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-L-LKQVQKRVVFPESP 279 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~-~-~~~i~~~~~~~~~~ 279 (335)
... ......|+..|+|||++.+.. ++ .++||||||+++|+|++|..||....... . ..............
T Consensus 176 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 176 INP-----CTETFTGTLQYMAPEIIDKGPRGYG-KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp ----------CCCCCCGGGCCHHHHHHGGGGCS-HHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred CCC-----cccccCCCccccChhhhcCCCCCCC-cHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 221 123456899999999987543 44 78999999999999999999997643322 2 22212222223345
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.++.++.+||.+|| .||.+||+++++|+||||+...
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 68999999999999 9999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=349.42 Aligned_cols=270 Identities=30% Similarity=0.506 Sum_probs=206.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcC----CCCCeeeecee
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGL----KHPNLIRFLQA 119 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~~~~~ 119 (335)
....++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++..+ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999976443211 1234455789999888 89999999999
Q ss_pred EEeCCeEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-CCCCEEEecccc
Q psy10459 120 IETTHRVYIIMEY-AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGF 197 (335)
Q Consensus 120 ~~~~~~~~iv~e~-~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-~~~~~~l~Dfg~ 197 (335)
+...+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++ .++.++|+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9988899999999 78899999998888899999999999999999999999999999999999999 788999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 277 (335)
+....... .....|+..|+|||++.+..+.+.++||||||+++|+|++|..||.... . .......+
T Consensus 187 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~---~~~~~~~~-- 252 (312)
T 2iwi_A 187 GALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E---ILEAELHF-- 252 (312)
T ss_dssp CEECCSSC-------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHTCCCC--
T ss_pred hhhcccCc-------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H---HhhhccCC--
Confidence 97664322 2244689999999998876665468999999999999999999997532 1 12222222
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC--CCCCCccccc
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK--SKSAPEVIPF 330 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~ 330 (335)
...++..+.+||.+|| .||++||+++++++||||++..+..+. .+..|..++|
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~~~~~~p~~~~~ 308 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAW 308 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-------------------
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccccccCCcccccc
Confidence 3568999999999999 999999999999999999998776664 4444544444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=347.04 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=222.8
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..+..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 4566788999999999999999999873 4558899999975432 33356788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKERY------------------------IDEDKGRRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~~~------------------------~~~~~~~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
...+..++||||+++++|.+++..... +++..++.++.||+.||.|||+.|++|+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986543 88999999999999999999999999999
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCC
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRL 255 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~ 255 (335)
|||+||+++.++.++|+|||++.......... ......++..|+|||++.+..++ .++|||||||++|+|++ |..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYV---KRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEE---CSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCC
T ss_pred cchheEEEcCCCCEEEccccccccccccccce---eccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999997664432211 12234567889999999877777 78999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 256 PFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 256 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
||.+.........+......+....++.++.++|.+|| .||.+||++.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999888888888877666666789999999999999 999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=352.18 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=224.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCC-------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeec
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARH-------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 117 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 117 (335)
..+..++|.+.+.||+|+||+||+|.+... +..||+|++..... ......+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 456778999999999999999999997533 35799999976533 23356778999999999 899999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+++...+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 48999999999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
||++.++.++|+|||++......... .......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT---CCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEcCCCcEEEcccCccccccccccc---ccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999866432211 112334578899999999887777 78999999999999999 99999999
Q ss_pred CHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 261 NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+....+...........++.++.+||.+|| .||.+|||+++++++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999887777777789999999999999 999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=354.10 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=212.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
...+...+|.+.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+.++..++||||+++++++.
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34567789999999999999999999876 4577899999975432 333667889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
..+..++||||+++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999999997754 699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 279 (335)
........ .......++..|+|||++.+..++ .++||||||+++|+|++ |..||......+....+......+...
T Consensus 197 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 273 (373)
T 2qol_A 197 LEDDPEAA--YTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCT
T ss_pred cccCCccc--eeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 64332111 111223457789999999887777 78999999999999998 999999999999999988887777777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.++..+.+||.+|| .||.+||+++++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 89999999999999 99999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.15 Aligned_cols=257 Identities=19% Similarity=0.292 Sum_probs=222.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..+..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3566789999999999999999999986 3458899999975432 33466788999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE------------------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 5689999999999999999999999999999
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCC
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRL 255 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~ 255 (335)
|||+|||++.++.++|+|||++......... .......++..|+|||++.+..++ .++||||||+++|+|++ |..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccc---cccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999765432211 112344678899999999877777 79999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 256 PFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 256 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
||.+....+....+......+....++.++.+||.+|| .||.+||++.+++++
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999999988888877655556679999999999999 999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=353.71 Aligned_cols=259 Identities=20% Similarity=0.353 Sum_probs=216.7
Q ss_pred hccccccCCeEEeeeecccCceEEEEEE-----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeec
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 117 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 117 (335)
....+..++|.+.+.||+|+||.||+|. +..+++.||||++..... ......+.+|+.++..+ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3345677899999999999999999998 455678999999975433 22356688999999999 789999999
Q ss_pred eeEEeCC-eEEEEEeccCCCCHHHHHHhcCC-------------------------------------------------
Q psy10459 118 QAIETTH-RVYIIMEYAKNGSLLEVIRKERY------------------------------------------------- 147 (335)
Q Consensus 118 ~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~------------------------------------------------- 147 (335)
+++...+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987754 48999999999999999976533
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 148 -----------------IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 148 -----------------~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--- 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--- 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC---
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc---
Confidence 889999999999999999999999999999999999999999999999999866433221
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHHccccCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~l 288 (335)
.......||..|+|||++.+..++ .++|||||||++|+|++ |..||.+... ......+......+....+++++.++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 112345678899999999887777 79999999999999998 9999988764 44445555555555556799999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~h 308 (335)
|.+|| .||.+|||+.++++|
T Consensus 329 i~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHH
Confidence 99999 999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=352.87 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=211.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CC-----CeeeeceeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP-----NLIRFLQAIE 121 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~ 121 (335)
...++|++.+.||+|+||+||+|.+..+++.||||++... ......+..|+.++..++ |+ +|+.+++.+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3457899999999999999999999999999999999643 223455667888888774 44 4999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEeec--CCCCEEEecc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCH--KKSVVHRDIKCENLLLD--DKYNIKLSDF 195 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH--~~~i~H~dikp~Nili~--~~~~~~l~Df 195 (335)
..+..++||||+.+ +|.+++... ..+++..+..++.|++.||.||| ..||+||||||+|||++ .++.++|+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999964 999999765 45899999999999999999999 57999999999999995 4778999999
Q ss_pred ccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 275 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 275 (335)
|++...... ....+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......
T Consensus 206 G~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 206 GSSCQLGQR--------IYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp TTCEETTCC--------CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred cCceecccc--------cccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999766422 2245689999999999988877 8999999999999999999999998888777766543221
Q ss_pred CCC-----------------------------------C---C-------------------------CCHHHHHHHHHh
Q psy10459 276 PES-----------------------------------P---R-------------------------LSSSCKALISNI 292 (335)
Q Consensus 276 ~~~-----------------------------------~---~-------------------------~~~~l~~li~~~ 292 (335)
+.. + . .+.++.+||++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 100 0 0 013789999999
Q ss_pred c-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 293 L-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 293 L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
| .||.+|||++|+|+||||++..
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC--
T ss_pred cCCChhhCCCHHHHhcCcccccCC
Confidence 9 9999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=348.25 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=206.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC--e
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--R 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 125 (335)
...++|.+.+.||+|+||+||+|.+..+|+.||||++........ ...+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456789999999999999999999999999999999975432211 455678999999999999999999987755 7
Q ss_pred EEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee----cCCCCEEEeccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERY---IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFA 198 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili----~~~~~~~l~Dfg~~ 198 (335)
.++||||+++++|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999976433 8999999999999999999999999999999999999 77778999999999
Q ss_pred cccccCCcccccccccccccccccccccccC--------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHH
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILK--------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELL 266 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~----~~~~~ 266 (335)
........ .....||..|+|||++. +..++ .++|||||||++|+|++|..||.... ..+..
T Consensus 164 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 164 RELEDDEQ------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp EECCTTCC------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred eecCCCCc------eeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 87644321 22356899999999985 34455 78999999999999999999997432 23333
Q ss_pred HHHHcccc--------------------CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 267 KQVQKRVV--------------------FPES----PRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 267 ~~i~~~~~--------------------~~~~----~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
..+..... .+.. ..++..+.+||++|| .||++|||++|+|+||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 33332211 1111 124568899999999 9999999999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=343.49 Aligned_cols=254 Identities=20% Similarity=0.365 Sum_probs=210.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++..++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 46678999999999999999999999999999999988542 233466788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999987 5679999999999999999999999999999999999999999999999999998764433
Q ss_pred cccc---------cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHc
Q psy10459 206 TDYK---------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL-----LKQVQK 271 (335)
Q Consensus 206 ~~~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~-----~~~i~~ 271 (335)
.... .......+||+.|+|||++.+..++ .++||||||+++|+|++|..||........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2110 0111245789999999999988877 799999999999999999999865322110 111111
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
......++..+.++|.+|| .||.+|||+.++++
T Consensus 242 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 ---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1123468889999999999 99999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=348.06 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=214.0
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeE----EEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDV----AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
...+..++|++.+.||+|+||+||+|.+..+++.+ |+|.+..... ......+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34567788999999999999999999988877765 6666643222 12246678999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
...+ .+++++++.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 8764 7899999999999999977 4569999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
.+....... ......+|..|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+......+..
T Consensus 166 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3poz_A 166 LLGAEEKEY---HAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp HHTTTCC----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred EccCCcccc---cccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC
Confidence 765433221 12234568899999999887777 79999999999999999 99999999888888888887777777
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..++.++.+++.+|| .||.+||++.+++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 889999999999999 999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=348.37 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=186.2
Q ss_pred cccCCeEEee-eecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----
Q psy10459 48 LETHGYSLGD-VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET---- 122 (335)
Q Consensus 48 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 122 (335)
...++|.+.+ .||+|+||+||+|.+..+|+.||+|++... ..........++.+.|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 4567899965 699999999999999999999999999652 1112223344677799999999999876
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC---CCEEEecccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGF 197 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~---~~~~l~Dfg~ 197 (335)
....++||||++|++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.+ +.++|+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999998753 59999999999999999999999999999999999999864 4599999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK------ 271 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~------ 271 (335)
+....... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||..............
T Consensus 178 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 178 AKETTQNA-------LQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CEEC-----------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ceeccccc-------cccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 97554221 2344679999999999877777 789999999999999999999987665444222211
Q ss_pred -cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 272 -RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 272 -~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
....+....++.++.+||.+|| .||.+|||++++|+||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 2223334578999999999999 99999999999999999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=339.13 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=208.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|++.+.||+|+||+||+|.+..+ +..||+|++.... .+...+.+.+|+.+++.++||||+++++++. +
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 46678899999999999999999998654 4569999886543 2344667889999999999999999999874 5
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67889999999999999997654 69999999999999999999999999999999999999999999999999997664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
..... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+......+....+
T Consensus 168 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (281)
T 1mp8_A 168 DSTYY----KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred ccccc----ccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCC
Confidence 32211 12233467889999999877777 78999999999999996 99999998888888888877666666789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+..+.++|.+|| .||.+|||+.+++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999 999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=355.73 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=207.0
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC--------CCCeeee
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--------HPNLIRF 116 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~ 116 (335)
...+..++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ |+||+++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 3445568899999999999999999999999999999999643 233566779999998885 7889999
Q ss_pred ceeEE----eCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCC-
Q psy10459 117 LQAIE----TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKY- 188 (335)
Q Consensus 117 ~~~~~----~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~- 188 (335)
++.+. ....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 456899999999 56777766554 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------------CEEEeccccccccccCCccccccccccccccc
Q psy10459 189 ------------------------------------------------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220 (335)
Q Consensus 189 ------------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~ 220 (335)
.++|+|||.+...... ....+||.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~ 257 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTR 257 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCG
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCC
Confidence 7999999999765432 22346899
Q ss_pred ccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHccccC-------------------
Q psy10459 221 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN------YSELLKQVQKRVVF------------------- 275 (335)
Q Consensus 221 ~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~------~~~~~~~i~~~~~~------------------- 275 (335)
.|+|||++.+..++ .++|||||||++|+|++|..||.+.+ .......+......
T Consensus 258 ~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 258 QYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred cccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 99999999988877 79999999999999999999997654 22222222211000
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 276 ----------------------PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 276 ----------------------~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
......+.++.+||.+|| .||.+|||++|+|+||||++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 001123467889999999 99999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=339.46 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=210.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 44578999999999999999999999999999999997654444445677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
++|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--CCCCCCHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--ESPRLSSSC 285 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~l 285 (335)
......|+..|+|||++.+..++ .++||||||+++|+|++|..||.+.........+......+ ....+|.++
T Consensus 191 ----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 191 ----QLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred ----cccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 12244689999999999887777 78999999999999999999999887776655555443322 235689999
Q ss_pred HHHHHHhc-CCCCCCC-CHHHHhcC
Q psy10459 286 KALISNIL-SPVKFRI-QMEDIRQD 308 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rp-s~~~ll~h 308 (335)
.++|.+|| .||++|| +++++++.
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHH
Confidence 99999999 9999999 88888753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=339.37 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=224.3
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|.+.+.||+|+||+||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34677889999999999999999999999999999999975432 24567799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
.++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999864 3489999999999999999999999999999999999999999999999999976653
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||...+.......+......+....++
T Consensus 164 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 3kfa_A 164 DTYT----AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238 (288)
T ss_dssp SSSE----EETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred Cccc----cccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCC
Confidence 3221 12234567889999999877777 78999999999999999 999999999888888888877777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+.+||.+|| .||.+|||++++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999 99999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=346.72 Aligned_cols=256 Identities=19% Similarity=0.336 Sum_probs=217.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCe----EEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
..+..++|++.+.||+|+||+||+|.+..+++. ||+|++....... ....+.+|+.++..++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 346778999999999999999999999888876 6677664332211 1345668999999999999999999886
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
++..++||||+.+++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45688999999999999999764 5689999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 279 (335)
....... .......|+..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+......+...
T Consensus 165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 165 LPPDDKQ---LLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240 (325)
T ss_dssp SCCCTTC---CC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred cCccccc---ccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence 6543321 122345678899999999877777 79999999999999999 999999988888888888776666666
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++.++.++|.+|| .||.+||++.++++|
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999 999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=341.02 Aligned_cols=267 Identities=24% Similarity=0.389 Sum_probs=211.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC--CCCeeeeceeEEeC
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETT 123 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 123 (335)
..+..++|++.+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++..++ |+||+++++++...
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 4456778999999999999999999975 58899999997655433 33567789999999997 59999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+..+++||+ .+++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||++++ +.++|+|||++.....
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred CEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 999999994 57899999998888999999999999999999999999999999999999965 7899999999986643
Q ss_pred CCcccccccccccccccccccccccCC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKG-----------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK 271 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~-~~~~~~~i~~ 271 (335)
.... .......|+..|+|||++.+ ..++ .++||||||+++|+|++|..||.... .......+..
T Consensus 179 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 179 DTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccc---ccccCCCCCCCcCCHHHHhhcccccccccccccCC-chHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 3221 11234568999999999875 2344 78999999999999999999998653 3333333333
Q ss_pred -cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 272 -RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 272 -~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
..........+.++.+||.+|| .||.+||++.++|+||||+....+...
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~~ 305 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC------
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchhh
Confidence 2233333457899999999999 999999999999999999987666553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=336.52 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=218.2
Q ss_pred cccccCCeEEee-eecccCceEEEEEEE--cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 46 SVLETHGYSLGD-VVGMGSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 46 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
..+...+|.+.+ .||+|+||+||+|.+ ..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 345677899999 999999999999954 556789999999764332 23356788999999999999999999998 5
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
.+..++||||+.+++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 66789999999999999999988889999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
....... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+......+....+
T Consensus 169 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYK--AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245 (291)
T ss_dssp TTCSEEE--C----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred cCCCccc--ccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 4332211 12223457889999999877766 78999999999999999 99999999999888888877666666789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..+.++|.+|| .||.+||++.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999 99999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=349.30 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=217.1
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCC--CCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK--HPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~~ 120 (335)
......+|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++ |+||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34456789999999999999999999999999999999976433210 11345568999999996 59999999999
Q ss_pred EeCCeEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec-CCCCEEEeccccc
Q psy10459 121 ETTHRVYIIMEYAKN-GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFA 198 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~-~~~~~~l~Dfg~~ 198 (335)
...+..++++|++.+ ++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+|||++ .++.++|+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999976 89999998888899999999999999999999999999999999999999 7789999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
....... .....||..|+|||++.+..+.+.++||||||+++|+|++|..||..... ...... ...
T Consensus 198 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~--~~~ 263 (320)
T 3a99_A 198 ALLKDTV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIRGQV--FFR 263 (320)
T ss_dssp EECCSSC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHHCCC--CCS
T ss_pred ccccccc-------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhcccc--ccc
Confidence 7664321 22346899999999998776655789999999999999999999975321 122222 223
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
..++.++.+||.+|| .||.+|||++++++||||++...+.
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence 568999999999999 9999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=344.19 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=221.2
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-------CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeec
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-------RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 117 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 117 (335)
..+..++|.+.+.||+|+||+||+|.+. .++..||+|++..... ......+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 4567789999999999999999999975 4577899999975432 23356678999999999 899999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999997653 38899999999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
|+++.++.++|+|||++......... .......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+.
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999766433211 112233567889999999877766 78999999999999999 99999999
Q ss_pred CHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 261 NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+....+......+....++.++.++|.+|| .||.+||++.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999988888877666666789999999999999 999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=339.81 Aligned_cols=256 Identities=22% Similarity=0.398 Sum_probs=209.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
..+..++|++++.||+|+||+||+|. +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35778899999999999999999998 56688999999986432 333567889999999999999999999885
Q ss_pred e--CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 122 T--THRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 122 ~--~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
. ...+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 356899999999999999997754 4999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--------------- 263 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~--------------- 263 (335)
.......... .......++..|+|||++.+..++ .++||||||+++|+|++|..||......
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 162 KVLPQDKEFF--KVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp C---------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccCCccee--eeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 8764432211 112234567789999999887777 7999999999999999999998653222
Q ss_pred -HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 264 -ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 264 -~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.....+......+....++.++.+||.+|| .||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 334444555566666789999999999999 99999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=332.13 Aligned_cols=252 Identities=21% Similarity=0.382 Sum_probs=220.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 356778999999999999999999975 6778999999765443 34577999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987653321
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
. .......++..|+|||++.+..++ .++|+||||+++|+|++ |..||......+....+...........++..
T Consensus 159 ~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 159 Y----TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 233 (267)
T ss_dssp H----HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred c----cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHH
Confidence 1 112234567889999999877776 78999999999999999 99999999999998888887666666678999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++|.+|| .||.+||++.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999 999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=340.80 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=216.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCC----CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
..+...+|.+.+.||+|+||+||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4567789999999999999999999876543 3599999975432 233556889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 5699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCC
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESP 279 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~ 279 (335)
........ .......++..|+|||++.+..++ .++||||||+++|+|++ |..||......+....+......+...
T Consensus 197 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 197 LEDDPEAT--YTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hccccccc--cccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcc
Confidence 64332111 112233457889999999887777 78999999999999998 999999999999988888877777777
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++..+.++|.+|| .||.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999 999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=342.72 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=213.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeE----EEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDV----AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
...+..++|++.+.||+|+||+||+|.+..+++.| |+|.+....... ....+.+|+.+++.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 34567789999999999999999999998888766 555554332221 255677999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
...+ .+++++++.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8765 78999999999999999764 569999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
......... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+......+..
T Consensus 166 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T 3lzb_A 166 LLGAEEKEY---HAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 241 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred EccCccccc---cccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 764433221 12234567889999999887777 79999999999999999 99999999988888888888777777
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..++.++.+||++|| .||.+||++.++++
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 889999999999999 99999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=336.61 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=203.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--------
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-------- 122 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------- 122 (335)
++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5699999999999999999999999999999999642 2335677899999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccc
Q psy10459 123 -----THRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG 196 (335)
Q Consensus 123 -----~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg 196 (335)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 457899999999999999998643 57889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccc---------ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHH
Q psy10459 197 FARKYSVNNTDY---------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELL 266 (335)
Q Consensus 197 ~~~~~~~~~~~~---------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~ 266 (335)
++.......... .........|+..|+|||++.+....+.++|||||||++|+|++ ||... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 997654221100 01112345689999999999865434489999999999999998 55432 333444
Q ss_pred HHHHcc-ccCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 267 KQVQKR-VVFPE--SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 267 ~~i~~~-~~~~~--~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
..+... ..++. ....+..+.+||++|| .||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 444432 22222 2457788999999999 999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=343.85 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=219.7
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeE--EEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDV--AIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
....+..++|.+.+.||+|+||.||+|.+..++..+ |+|.+..... ......+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 344577789999999999999999999998888865 9998875332 22356688999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL 184 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili 184 (335)
...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence 99999999999999999999997654 68999999999999999999999999999999999999
Q ss_pred cCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy10459 185 DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS 263 (335)
Q Consensus 185 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~ 263 (335)
+.++.++|+|||++....... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp CGGGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cCCCeEEEcccCcCccccccc------cccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 999999999999986432211 11233467889999999877766 78999999999999998 99999999999
Q ss_pred HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 264 ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+....+......+....++..+.+||.+|| .||.+||++++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988888877666666789999999999999 999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=344.24 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=212.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCC-CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC------eeeece
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN------LIRFLQ 118 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~ 118 (335)
.....++|++.+.||+|+||+||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 4455789999999999999999999998776 68999999642 233566778999999887655 889999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee------------
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL------------ 184 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili------------ 184 (335)
++...+..++||||+ ++++.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 56787777654 369999999999999999999999999999999999999
Q ss_pred -------cCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy10459 185 -------DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257 (335)
Q Consensus 185 -------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~ 257 (335)
+.++.++|+|||++...... .....||..|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCC
Confidence 66789999999999754322 2345689999999999988877 7999999999999999999999
Q ss_pred CCCCHHHHHHHHHccccC-C------------------------------------------CCCCCCHHHHHHHHHhc-
Q psy10459 258 DDTNYSELLKQVQKRVVF-P------------------------------------------ESPRLSSSCKALISNIL- 293 (335)
Q Consensus 258 ~~~~~~~~~~~i~~~~~~-~------------------------------------------~~~~~~~~l~~li~~~L- 293 (335)
......+....+...... | .....+.++.+||++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 998877665555432111 0 01112457899999999
Q ss_pred CCCCCCCCHHHHhcCCCcCCC
Q psy10459 294 SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 294 ~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.||.+|||+.++|+||||++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGC
T ss_pred CChhhCcCHHHHhcChhhcCC
Confidence 999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=345.00 Aligned_cols=265 Identities=19% Similarity=0.257 Sum_probs=221.3
Q ss_pred hccccccCCeEEeeeecccCceEEEEEE-----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeece
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 118 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 118 (335)
....+...+|.+.+.||+|+||.||+|. +..++..||+|++..... ......+.+|+.+++.++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--hhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3445778899999999999999999998 556788999999965433 233556779999999999999999999
Q ss_pred eEEeCCeEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CC
Q psy10459 119 AIETTHRVYIIMEYAKNGSLLEVIRKER-------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KY 188 (335)
Q Consensus 119 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~-------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~ 188 (335)
++...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+|||++. +.
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 9999999999999999999999998653 4889999999999999999999999999999999999984 44
Q ss_pred CEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy10459 189 NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLK 267 (335)
Q Consensus 189 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~ 267 (335)
.++|+|||++......... .......|+..|+|||++.+..++ .++||||||+++|+|++ |..||......+...
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYY---RKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp CEEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred eEEECcccccccccccccc---ccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 6999999998755332211 112334578899999999877777 79999999999999998 999999999988888
Q ss_pred HHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 268 QVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 268 ~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+......+....++..+.++|.+|| .||.+||++.++++|.|+-..
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 88877666666789999999999999 999999999999999987554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=334.85 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=205.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++|+||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34556899999999999999999999999999999999865444455567788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 4568999999999999999999999999999999999999999999999999987654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHccccCC-CCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--NYSELLKQVQKRVVFP-ESP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~--~~~~~~~~i~~~~~~~-~~~ 279 (335)
.... ......|+..|+|||++.+..++ .++||||||+++|+|++|..||.+. ........+......+ ...
T Consensus 188 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T 2wqm_A 188 SKTT-----AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTT
T ss_pred CCCc-----cccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccc
Confidence 3221 12234689999999999887777 7899999999999999999999764 3444555554432222 225
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++.++.+||.+|| .||.+||++.+++++
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 68999999999999 999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=338.51 Aligned_cols=258 Identities=21% Similarity=0.357 Sum_probs=213.8
Q ss_pred ccccccCCeEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
...+...+|++.+.||+|+||.||+|. +..+++.||+|++...... .....+.+|+.+++.++|+||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 345677789999999999999999998 5678999999999754322 1245678999999999999999999999
Q ss_pred EeC--CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 121 ETT--HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 121 ~~~--~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
... +.+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 678999999999999999954 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CH
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------------NY 262 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---------------~~ 262 (335)
+.......... .......||..|+|||++.+..++ .++||||||+++|+|++|..|+... ..
T Consensus 173 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 173 TKAIETDKEYY--TVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CEECCTTCCEE--ECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred cccccCCCcce--eccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 98765433211 123345678889999999887777 7899999999999999998876422 23
Q ss_pred HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 263 SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
......+......+....++.++.+||.+|| .||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3444555556666666789999999999999 99999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=345.86 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=215.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|.+.+.||+|+||+||+|.+. .++..||+|++..... ......+.+|+.++..+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4567789999999999999999999973 3566899999975432 22356788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKER-----------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
+...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997643 278999999999999999999999999999
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCC
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRL 255 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~ 255 (335)
|||+|||++.++.++|+|||++......... .......||..|+|||++.+..++ .++||||||+++|+|++ |..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999866443221 112344578899999999877777 78999999999999998 999
Q ss_pred CCCCCCHHH-HHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 256 PFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 256 p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
||.+..... ....+......+....++.++.+||.+|| .||.+|||+.++++|-
T Consensus 274 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 998876443 44444555555555678999999999999 9999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=339.42 Aligned_cols=260 Identities=19% Similarity=0.309 Sum_probs=211.0
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcC---CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
....+..++|.+.+.||+|+||+||+|.+.. ++..||+|++........ ....+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH-HHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh-HHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3344667899999999999999999998765 445899999976544433 355678999999999999999999998
Q ss_pred EeCC-----eEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC
Q psy10459 121 ETTH-----RVYIIMEYAKNGSLLEVIRK------ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 121 ~~~~-----~~~iv~e~~~~~sL~~~l~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~ 189 (335)
...+ ..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 35999999999999999843 346999999999999999999999999999999999999999999
Q ss_pred EEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy10459 190 IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQ 268 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~ 268 (335)
++|+|||++......... .......++..|+|||.+.+..++ .++||||||+++|+|++ |..||...........
T Consensus 186 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp EEECSCSCC-------------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred EEEeecCcceeccccccc---CcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999766432211 112233567889999999887777 78999999999999999 9999999888888888
Q ss_pred HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 269 VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 269 i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+......+....++..+.++|.+|| .||.+||++.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8777666666789999999999999 999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=349.06 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=207.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-----------CCCeee
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----------HPNLIR 115 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~ 115 (335)
.+...+|.+.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+. |+||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 45677899999999999999999999999999999999642 223556778999988876 789999
Q ss_pred eceeEEeCC----eEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecC--
Q psy10459 116 FLQAIETTH----RVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDD-- 186 (335)
Q Consensus 116 ~~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~-- 186 (335)
+++++...+ .++++||++ +++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999987654 789999999 88999999763 4599999999999999999999998 9999999999999953
Q ss_pred ----CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q psy10459 187 ----KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 262 (335)
Q Consensus 187 ----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~ 262 (335)
.+.++|+|||++...... .....||..|+|||++.+..++ .++|||||||++|+|++|..||.+...
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CCcCcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 347999999999765432 2234689999999999988877 899999999999999999999986542
Q ss_pred ------HHHHHHHHccc-c----------------------------------------CCCCCCCCHHHHHHHHHhc-C
Q psy10459 263 ------SELLKQVQKRV-V----------------------------------------FPESPRLSSSCKALISNIL-S 294 (335)
Q Consensus 263 ------~~~~~~i~~~~-~----------------------------------------~~~~~~~~~~l~~li~~~L-~ 294 (335)
......+.... . ......++.++.+||.+|| .
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 22222222100 0 0011234678999999999 9
Q ss_pred CCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 295 PVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 295 ~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
||.+|||++|+|+||||++......
T Consensus 321 dP~~Rpt~~ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWLKDTLGMEE 345 (373)
T ss_dssp STTTCBCHHHHHTCGGGTTCTTCTT
T ss_pred CccccCCHHHHhhChhhhcccCccc
Confidence 9999999999999999998654433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=340.92 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=224.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
.+..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.++|+||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 456678999999999999999999876 3578899999875433 223556789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKE----------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999999652 3568999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQ 270 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~ 270 (335)
|+|||++......... .......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+.
T Consensus 179 l~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp ECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999765432211 112234568899999999877777 78999999999999999 999999999998888888
Q ss_pred ccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC------CCcCC
Q psy10459 271 KRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD------PWLKE 313 (335)
Q Consensus 271 ~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h------p~~~~ 313 (335)
.....+....++..+.+||.+|| .||.+|||+.++++| +||+.
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 76666666789999999999999 999999999999987 66654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=340.19 Aligned_cols=253 Identities=18% Similarity=0.271 Sum_probs=210.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+...+|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +|+||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 3456789999999999999999999999999999999876433 34577899999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC-----EEEecccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFAR 199 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~-----~~l~Dfg~~~ 199 (335)
.++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8999999986 467999999999999999999999999999999999999998887 9999999998
Q ss_pred ccccCCccccc--ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHccc-
Q psy10459 200 KYSVNNTDYKQ--NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRV- 273 (335)
Q Consensus 200 ~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~- 273 (335)
.+......... ......+||..|+|||++.+..++ .++|||||||++|+|++|..||.+. ...+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 76543321111 112456799999999999988877 7999999999999999999999874 3444444443211
Q ss_pred cCCC---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 274 VFPE---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 274 ~~~~---~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+. ...+| ++.++|..|| .||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111 12345 9999999999 99999999999886
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=331.84 Aligned_cols=255 Identities=18% Similarity=0.211 Sum_probs=213.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.++..+ +|+|++.+++++.....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4567789999999999999999999999999999999875433 34567899999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC-----EEEecccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFAR 199 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~-----~~l~Dfg~~~ 199 (335)
.++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 899999998754 5999999999999999999999999999999999999987766 9999999998
Q ss_pred ccccCCccccc--ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcccc
Q psy10459 200 KYSVNNTDYKQ--NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVV 274 (335)
Q Consensus 200 ~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~---~~~~~~~~i~~~~~ 274 (335)
........... .......||..|+|||++.+..++ .++||||||+++|+|++|..||.+. ........+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 76543321111 123456789999999999888877 7999999999999999999999874 34444444433211
Q ss_pred -CC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 275 -FP---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 275 -~~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+ ....++.++.+||.+|| .||.+||++++|++.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11 12468999999999999 999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=360.28 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=223.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+...+|.+.+.||+|+||.||+|.+..++..||||++...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456677899999999999999999999988999999999765433 4567799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999864 4589999999999999999999999999999999999999999999999999986643
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... ......++..|+|||++....++ .++|||||||++|+|++ |..||.+.+..++.+.+......+....++
T Consensus 371 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (495)
T 1opk_A 371 DTYT----AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445 (495)
T ss_dssp CCEE----CCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred Ccee----ecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 2211 12233467889999999877777 78999999999999999 999999999888888888887777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+.+||.+|| .||.+|||+.+|++
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999999 99999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=334.73 Aligned_cols=257 Identities=21% Similarity=0.379 Sum_probs=219.6
Q ss_pred ccccCCeEEee-eecccCceEEEEEEEc--CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGD-VVGMGSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|.+.+ .||+|+||+||+|.+. .++..||+|++..... ....+.+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 35667888887 9999999999999864 4677899999976532 33466788999999999999999999998 45
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 6789999999999999999654 459999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
...... .......++..|+|||++.+..++ .++||||||+++|+|++ |..||......+....+......+....+
T Consensus 162 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 162 ADDSYY--TARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp TCSCEE--CCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred cCccee--eccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 433221 112334568899999999877776 78999999999999998 99999998888888888776655556789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
+.++.++|.+|| .||.+||++.+++++.
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999 9999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=338.57 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=217.7
Q ss_pred cccccCCeEEeeeecccCceEEEEEEE-----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|.+.+.||+|+||+||+|.+ ..+++.||+|++..... ....+.+.+|+.++..+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 356678899999999999999999985 45678999999975443 22356788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKER------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+...+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.|++|+||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997653 38999999999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
|+++.++.++|+|||++......... .......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+.
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred EEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999766543221 112334578899999999877777 88999999999999998 99999877
Q ss_pred CHH-HHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 261 NYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 261 ~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
... .....+...........++.++.++|.+|| .||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 643 344444455555555679999999999999 999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=337.23 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=200.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
....++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.++..+++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 45567899999999999999999999999999999999765432 33344555566678888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 5566666644 56799999999999999999999995 9999999999999999999999999998765432
Q ss_pred CcccccccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHccc--cCC
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRV--VFP 276 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~~~--~~~ 276 (335)
.. .....|+..|+|||++. ...++ .++||||||+++|+|++|..||... ...+....+.... ..+
T Consensus 179 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 179 KA------KDRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp --------------CCTTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred cc------ccccCCCccccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 21 22346899999999985 33444 7899999999999999999999873 4555555554432 233
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....++.++.+||.+|| .||.+||+++++++||||++.
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 252 GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 33468999999999999 999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=352.23 Aligned_cols=247 Identities=24% Similarity=0.430 Sum_probs=216.7
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
...+..++|.+.+.||+|+||.||+|.+. |+.||||+++.... .+.+.+|+.+++.++||||+++++++...+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 34577889999999999999999999864 77999999976432 456779999999999999999999987655
Q ss_pred -eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 125 -RVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 125 -~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
..++||||+++|+|.+++...+. +++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999987543 799999999999999999999999999999999999999999999999998754
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
... .....++..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+..+...+....
T Consensus 340 ~~~--------~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~ 410 (450)
T 1k9a_A 340 SST--------QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410 (450)
T ss_dssp C--------------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTT
T ss_pred ccc--------ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 321 1122467889999999888877 79999999999999998 9999999888888888888877777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.++.+||.+|| .||.+|||+.++++
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 99999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=341.77 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=193.1
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHH-HHHcCCCCCeeeeceeEEeC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~ 123 (335)
...+..++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ... ...+..|+. +++.++||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 345777899999999999999999999999999999999976533 222 333445555 77778999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEeecCCCCEEEecccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~-~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
+..++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999975 88888763 56789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccC----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcc
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILK----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKR 272 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~ 272 (335)
+........ .....|+..|+|||++. +..++ .++|||||||++|+|++|..||...... +....+...
T Consensus 173 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 173 SGQLVDSIA------KTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp SCC------------------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred ceecccccc------cccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 976543221 12336899999999983 44455 7899999999999999999999875422 222111111
Q ss_pred cc--C--CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 273 VV--F--PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 273 ~~--~--~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.. . .....++..+.+||.+|| .||.+||++.++++||||.+..
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 11 1 112358999999999999 9999999999999999997653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=330.48 Aligned_cols=251 Identities=24% Similarity=0.459 Sum_probs=204.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh-HHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI-DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++.+.||+|+||+||+|.+. |+.||+|++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356788999999999999999999964 8899999987543322 2224567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEeecC--------CCCEEEec
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS---VVHRDIKCENLLLDD--------KYNIKLSD 194 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---i~H~dikp~Nili~~--------~~~~~l~D 194 (335)
.++||||+++++|.+++. .+.+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999885 456999999999999999999999999 899999999999986 67899999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-c
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-V 273 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~ 273 (335)
||.+....... .....|+..|+|||.+.+..++ .++||||||+++|+|++|..||.+.+.......+... .
T Consensus 160 fg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (271)
T 3dtc_A 160 FGLAREWHRTT-------KMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231 (271)
T ss_dssp CCC--------------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC
T ss_pred CCccccccccc-------ccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC
Confidence 99997654322 1234689999999999887776 7899999999999999999999998887776666543 3
Q ss_pred cCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 274 VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 274 ~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+....++..+.++|.+|| .||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 34445678999999999999 999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.67 Aligned_cols=253 Identities=23% Similarity=0.408 Sum_probs=220.4
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
....+..++|.+.+.||+|+||+||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++. .
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 335677789999999999999999999975 4678999999764432 456779999999999999999999886 5
Q ss_pred CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 6789999999999999999753 35899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
..... .......++..|+|||++....++ .++|||||||++|+|++ |..||.+.+..++...+..+...+....
T Consensus 335 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 335 EDNEY----TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp CCHHH----HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCCce----eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 43211 112233467889999999877777 79999999999999999 9999999999999999988888887788
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.++.+||.+|| .||.+|||+++|++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999 99999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=327.83 Aligned_cols=249 Identities=16% Similarity=0.272 Sum_probs=214.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC--
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-- 123 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 123 (335)
..+..++|.+.+.||+|+||+||+|.+. ++.||+|++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHH-HHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHH-HHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567788999999999999999999974 88999999987554433 356688999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765 4899999999999999999999999 9999999999999999999999998875
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCC--CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc-ccCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFP 276 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~ 276 (335)
.... ....||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.........+... ...+
T Consensus 162 ~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T 3kmu_A 162 SFQS----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231 (271)
T ss_dssp TTSC----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eecc----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC
Confidence 4321 2335789999999998765552 2799999999999999999999998888776666543 3344
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....++.++.++|.+|| .||.+|||++++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 44679999999999999 99999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=335.87 Aligned_cols=247 Identities=19% Similarity=0.310 Sum_probs=210.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC-------CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHS-------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 119 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 119 (335)
.+..++|.+.+.||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 466788999999999999999999988777 4699999865332 224667899999999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC--------E
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--------I 190 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~--------~ 190 (335)
+...+..++||||+.+++|.+++..... +++..++.++.||+.||.|||+.|++||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999998887 9
Q ss_pred EEeccccccccccCCcccccccccccccccccccccccCC-CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy10459 191 KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQ 268 (335)
Q Consensus 191 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~ 268 (335)
+|+|||++...... ....|+..|+|||++.+ ..++ .++|||||||++|+|++ +..||...........
T Consensus 161 kl~Dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EECCCCSCTTTSCH---------HHHHHTTTTSCHHHHHCGGGCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeccCcccccccCc---------cccCCcCcccCHHHhCCCCCCC-chhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999998654321 12357889999999987 4445 89999999999999999 5667777777666666
Q ss_pred HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 269 VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 269 i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.......+ ...+.++.+||.+|| .||.+|||+.++++|
T Consensus 231 ~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 231 YEDRHQLP--APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHTTCCCC--CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhccCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544444 346888999999999 999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=331.01 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=214.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|.+.+.||+|+||+||+|.+... +..||+|++..... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 45678899999999999999999987543 34699999876432 23356788999999999999999999998654
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 568999999999999999765 459999999999999999999999999999999999999999999999999997664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
..... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||...........+......+....+
T Consensus 165 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 165 DEDYY----KASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTC
T ss_pred ccccc----ccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCC
Confidence 32211 12234567889999999877777 78999999999999998 99999988877777777777666666789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
++.+.++|.+|| .||.+||++.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999 999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.32 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=215.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.-.|.+.++||+|+||+||+|.+..++. .||+|++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 3457788999999999999999765554 799999865332 33356778999999999999999999999776654
Q ss_pred -EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 -YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 -~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
+++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999999976 456899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... .........++..|+|||.+.+..++ .++||||||+++|+|++ +.+||...+..+....+......+....++.
T Consensus 178 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3pls_A 178 EYY-SVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD 255 (298)
T ss_dssp GGG-CSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred ccc-ccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchH
Confidence 211 11223345678999999999988877 78999999999999999 6666777777788888887777777778999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+.+||.+|| .||.+|||++++++.
T Consensus 256 ~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 256 SLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999 999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=338.63 Aligned_cols=263 Identities=21% Similarity=0.378 Sum_probs=218.0
Q ss_pred ccccccCCeEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
...+..++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 345788899999999999999999998 56788999999986542 23356688999999999999999999988
Q ss_pred E--eCCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 121 E--TTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 121 ~--~~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
. ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+|||++.++.++|+|||+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 6 45678999999999999999976 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---------------
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY--------------- 262 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~--------------- 262 (335)
+.......... .......|+..|+|||++.+..++ .++||||||+++|+|++|..||.....
T Consensus 174 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 174 AKLLPLDKDYY--VVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp CEECCTTCSEE--ECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred ceecccCCccc--eeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 98765433221 122344678889999999877776 789999999999999999999865432
Q ss_pred HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHh---cCCCcCC
Q psy10459 263 SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR---QDPWLKE 313 (335)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll---~hp~~~~ 313 (335)
......+......+....++.++.+||.+|| .||.+|||+.+++ +..|...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 3444555556666666789999999999999 9999999999995 4444443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=328.77 Aligned_cols=250 Identities=22% Similarity=0.407 Sum_probs=216.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++. .+..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 456678999999999999999999964 5678999999765433 456779999999999999999999876 4568
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 89999999999999996542 6899999999999999999999999999999999999999999999999999876533
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... ......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+....+....+...........++.
T Consensus 163 ~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 163 EYT----AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp CEE----CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccc----cccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 211 12234567889999999877766 78999999999999999 9999999999998888888776666678999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.++|.+|| .||++|||++++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999 99999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=328.53 Aligned_cols=252 Identities=20% Similarity=0.383 Sum_probs=208.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHH----HhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYL----KKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
...+..++|++.+.||+|+||+||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 44577889999999999999999999999999999999986544322211 15678999999999999999999998
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCC-----EEE
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYN-----IKL 192 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~-----~~l 192 (335)
.... ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| ++|+||||+||+++.++. ++|
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6655 6999999999999888654 46999999999999999999999999 999999999999988776 999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL--LKQ 268 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~--~~~ 268 (335)
+|||++...... .....|+..|+|||++.. ..++ .++|||||||++|+|++|..||........ ...
T Consensus 171 ~Dfg~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVHS--------VSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CCCTTCBCCSSC--------EECCCCCCTTSCGGGSSCSSCEEC-HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CCCCcccccccc--------ccccCCCccccCchhhccCCCCcC-chhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 999998743321 223568999999999843 3344 789999999999999999999987553332 333
Q ss_pred HHc-cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 269 VQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 269 i~~-~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.. .........++.++.+||.+|| .||.+|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 333 3333444678999999999999 99999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=337.81 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=215.5
Q ss_pred cccccCCeEEeeeecccCceEEEEEEE-----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|++.+.||+|+||+||+|.+ ..+++.||+|++..... ......+.+|+.++..+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 346678999999999999999999985 34678999999976433 23355678999999999 79999999999
Q ss_pred EEeCC-eEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q psy10459 120 IETTH-RVYIIMEYAKNGSLLEVIRKERY----------------IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENL 182 (335)
Q Consensus 120 ~~~~~-~~~iv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Ni 182 (335)
+...+ .+++||||+++++|.+++..... +++..++.++.||+.||.|||+.|++|+||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 58999999999999999987543 88999999999999999999999999999999999
Q ss_pred eecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy10459 183 LLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTN 261 (335)
Q Consensus 183 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~ 261 (335)
+++.++.++|+|||++......... .......|+..|+|||++.+..++ .++||||||+++|+|++ |..||.+..
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999766433221 112234578899999999887777 79999999999999998 999998765
Q ss_pred H-HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 262 Y-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 262 ~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
. ......+......+....++..+.++|.+|| .||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 4445555555555555678999999999999 999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=337.65 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=209.6
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe---
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--- 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 122 (335)
..+..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3466778999999999999999999999999999999986532 2335678899999999999999999999863
Q ss_pred -CCeEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 123 -THRVYIIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 123 -~~~~~iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
....++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 4478999999999999999975 46699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccc----cccccccccccccccccccCCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q psy10459 198 ARKYSVNNTDYK----QNLSETFCGSYAYASPEILKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQ 268 (335)
Q Consensus 198 ~~~~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~p~~~~~--~~~~~~~ 268 (335)
+........... ........|+..|+|||++.+.. ++ .++||||||+++|+|++|..||.... .......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID-ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEEC-THHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCC-chhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 875432111000 00012335689999999987654 34 78999999999999999999995321 1122333
Q ss_pred HHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 269 VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 269 i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
+......+....++.++.+||.+|| .||.+||++++++++-
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 4445556666789999999999999 9999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=337.29 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=204.6
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.....+..++|++.++||+|+||+||+|.+. ++.||||++.... ........|+.++..++||||+++++++..
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 3445678889999999999999999999864 7899999996532 223445568888999999999999999977
Q ss_pred CC----eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCEeecCCC
Q psy10459 123 TH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK----------SVVHRDIKCENLLLDDKY 188 (335)
Q Consensus 123 ~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~----------~i~H~dikp~Nili~~~~ 188 (335)
.. .+++||||+++++|.+++... .+++..++.++.|++.||.|||+. |++||||||+|||++.++
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 44 479999999999999999765 489999999999999999999999 999999999999999999
Q ss_pred CEEEeccccccccccCCcccccccccccccccccccccccCCCCCC----CCchhHHHHHHHHHHHHhCCCCCCCC----
Q psy10459 189 NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT----PQQSDIWSMGVVLFAMVYGRLPFDDT---- 260 (335)
Q Consensus 189 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~----~~~~Di~slG~~~~~l~~g~~p~~~~---- 260 (335)
.++|+|||++..+...... ......+||..|+|||++.+.... +.++|||||||++|+|++|..||.+.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSA---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp CEEECCCTTCEEECTTSCC---CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred eEEEccCCcccccccccCc---cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999776543221 112345789999999999864222 25789999999999999999999753
Q ss_pred ------------CHHHHHHHHHccccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 261 ------------NYSELLKQVQKRVVFPESP------RLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 261 ------------~~~~~~~~i~~~~~~~~~~------~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
........+......+... ..+.++.+||.+|| .||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2333333343333333221 12456999999999 99999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.78 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=212.6
Q ss_pred CCeEEe-eeecccCceEEEEEEE--cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 51 HGYSLG-DVVGMGSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 51 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
..+.+. +.||+|+||.||+|.+ ..+++.||||+++...... ...+.+.+|+.++..++||||+++++++.. +..+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEE
Confidence 344443 4899999999999955 4567899999997643322 224668899999999999999999999865 4578
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+......
T Consensus 446 lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
. .......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..++...+......+....++.++.
T Consensus 526 ~--~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 602 (635)
T 4fl3_A 526 Y--KAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 602 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred c--ccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 112233567889999999887777 79999999999999998 9999999999999999988877777778999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhc
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+||..|| .||++||++++|++
T Consensus 603 ~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 603 DLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999 99999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=343.09 Aligned_cols=262 Identities=16% Similarity=0.274 Sum_probs=203.5
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCC-----CCeEEEEEEecCCCChHHH--------HhhHHHHHHHHHcCCC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYL--------KKFLPREIEVVKGLKH 110 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h 110 (335)
.+..+..++|++.+.||+|+||+||+|.+..+ ++.||+|++.......... ...+..|+..+..++|
T Consensus 28 ~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (364)
T 3op5_A 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKY 107 (364)
T ss_dssp EEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred EeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence 34446677999999999999999999998664 5889999987643211100 1122345556777889
Q ss_pred CCeeeeceeEEeC----CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec
Q psy10459 111 PNLIRFLQAIETT----HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD 185 (335)
Q Consensus 111 ~~iv~~~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~ 185 (335)
+||+++++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186 (364)
T ss_dssp CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEe
Confidence 9999999998764 4589999999 99999999775 6799999999999999999999999999999999999999
Q ss_pred --CCCCEEEeccccccccccCCccc--ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy10459 186 --DKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261 (335)
Q Consensus 186 --~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~ 261 (335)
.++.++|+|||++..+....... ........+||..|+|||++.+..++ .++|||||||++|+|++|..||.+..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999998765433211 11122445699999999999988877 89999999999999999999998532
Q ss_pred H-HHHHHHHHcccc---------CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 262 Y-SELLKQVQKRVV---------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 262 ~-~~~~~~i~~~~~---------~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
. ............ ......++.++.++|..|| .+|.+||++.+|++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2 121111111000 0012468999999999999 99999999999885
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=336.48 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=216.5
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCC-----eEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQ-----DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|.+.+.||+|+||.||+|.+..++. .||+|++..... ......+.+|+.++..+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45677899999999999999999999876654 799999976443 23356788999999999 89999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKE--------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD 185 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~ 185 (335)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999999652 3579999999999999999999999999999999999999
Q ss_pred CCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy10459 186 DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE 264 (335)
Q Consensus 186 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~ 264 (335)
.++.++|+|||++......... .......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCeEEECccccccccccccce---eecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 9999999999999866433221 112334568899999999877777 78999999999999998 999998766444
Q ss_pred H-HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 265 L-LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 265 ~-~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
. ...+......+....++..+.+||.+|| .||.+|||+.+++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 3 3444445555555678999999999999 999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.14 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=211.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCC---CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE-EeCC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTH 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 124 (335)
...+|++.+.||+|+||+||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3457999999999999999999975433 3589998865332 33356778999999999999999999985 4566
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 889999999999999999763 4589999999999999999999999999999999999999999999999999986643
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... .........++..|+|||.+.+..++ .++||||||+++|+|++ +.+||......+....+...........++
T Consensus 181 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T 3f66_A 181 KEYY-SVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258 (298)
T ss_dssp GGGC-BC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCC
T ss_pred cchh-ccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCC
Confidence 3221 11223344678899999999887777 78999999999999999 778888877777777777766666667789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
..+.++|.+|| .||.+|||+.++++
T Consensus 259 ~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 259 DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999 99999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=349.16 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=218.2
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
...+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345677889999999999999999999764 567999999765433 3457799999999999999999998865 6
Q ss_pred eEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++....
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999964 3568999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
..... ......++..|+|||++....++ .++||||||+++|+|++ |..||.+....+....+..+...+....+
T Consensus 332 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 332 DNEYT----ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred CCcee----cccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 32211 12233467889999999877777 79999999999999999 99999999999999999888877777889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC--CCcCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD--PWLKE 313 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h--p~~~~ 313 (335)
+..+.+||.+|| .||.+|||+++|++. .++..
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 999999999999 999999999999873 55544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=329.62 Aligned_cols=246 Identities=24% Similarity=0.443 Sum_probs=208.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-C
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-H 124 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 124 (335)
..+..++|++.+.||+|+||+||+|.+ +|+.||+|++..... .+.+.+|+.+++.++||||+++++++... +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 346678999999999999999999986 488999999875432 45677999999999999999999986544 4
Q ss_pred eEEEEEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~--~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..++||||+++++|.+++..... +++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 78999999999999999976543 8999999999999999999999999999999999999999999999999987543
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
... ....++..|+|||++.+..++ .++||||||+++|+|++ |..||......+....+......+....+
T Consensus 169 ~~~--------~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (278)
T 1byg_A 169 STQ--------DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239 (278)
T ss_dssp ---------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTC
T ss_pred ccc--------cCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccC
Confidence 221 123467889999999877777 78999999999999998 99999998888888888777666666789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..+.++|.+|| .||.+||++.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999 99999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=339.88 Aligned_cols=265 Identities=20% Similarity=0.296 Sum_probs=205.9
Q ss_pred hhhccccccCCeEEeeeecccCceEEEEEEEcC---CCCeEEEEEEecCCCChHH--------HHhhHHHHHHHHHcCCC
Q psy10459 42 ERKLSVLETHGYSLGDVVGMGSYATVKLATSAR---HSQDVAIKIISKVQAPIDY--------LKKFLPREIEVVKGLKH 110 (335)
Q Consensus 42 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h 110 (335)
......+..++|.+.+.||+|+||+||+|.+.. ++..||+|++......... ....+.+|+..+..++|
T Consensus 28 g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h 107 (345)
T 2v62_A 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY 107 (345)
T ss_dssp TCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred CCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence 334455667899999999999999999999987 7889999999765432111 12235578888999999
Q ss_pred CCeeeeceeEEe----CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC
Q psy10459 111 PNLIRFLQAIET----THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 111 ~~iv~~~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~ 186 (335)
+||+++++++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence 999999999987 67899999999 9999999987778999999999999999999999999999999999999998
Q ss_pred CC--CEEEeccccccccccCCcc--cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC--C
Q psy10459 187 KY--NIKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--T 260 (335)
Q Consensus 187 ~~--~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~--~ 260 (335)
++ .++|+|||++..+...... ..........||..|+|||++.+..++ .++|||||||++|+|++|..||.+ .
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCcccccc
Confidence 87 9999999999876543211 111122455789999999999987777 899999999999999999999965 2
Q ss_pred CHHHHHHHHHc-cccCC-------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 261 NYSELLKQVQK-RVVFP-------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 261 ~~~~~~~~i~~-~~~~~-------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
........... ....+ ....++.++.++|.+|| .||.+||++++|++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 33222221111 11111 11268999999999999 999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=357.75 Aligned_cols=261 Identities=20% Similarity=0.366 Sum_probs=215.7
Q ss_pred ccccCCeEEee-eecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGD-VVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..+++.+.+ .||+|+||.||+|.+.. ++..||||+++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556677777 89999999999998753 45679999997643322 25667899999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+.+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 5689999999999999999654 459999999999999999999999999999999999999999999999999998764
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
....... ......++..|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+...+....+
T Consensus 488 ~~~~~~~--~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYT--ARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 564 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTC
T ss_pred CCCceee--eccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 3322111 11223456889999999877777 79999999999999998 99999999999999999888777777789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHh---cCCCcCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIR---QDPWLKE 313 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll---~hp~~~~ 313 (335)
+.++.+||..|| .||.+||++++|+ ++.|+.-
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999 9999999999984 5555543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=327.00 Aligned_cols=247 Identities=21% Similarity=0.364 Sum_probs=209.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 122 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 122 (335)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 457999999999999999999999899999999997542 345689999999999999999998754
Q ss_pred ---------CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEE
Q psy10459 123 ---------THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIK 191 (335)
Q Consensus 123 ---------~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~ 191 (335)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 44689999999999999999754 5699999999999999999999999999999999999999999999
Q ss_pred EeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q psy10459 192 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 192 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~ 271 (335)
|+|||++........ .....|+..|+|||++.+..++ .++||||||+++|+|++|..|+.. .......+..
T Consensus 163 l~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~ 233 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK------RTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD 233 (284)
T ss_dssp ECCCTTCEESSCCSC------CCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT
T ss_pred ECcchhheecccccc------ccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc
Confidence 999999877644321 2234689999999999888777 799999999999999999988743 2223333333
Q ss_pred cccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 272 RVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 272 ~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.. ....++..+.+||.+|| .||.+||++.++++|.|.-+..
T Consensus 234 ~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 234 GI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp TC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred cc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 22 22458999999999999 9999999999999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=348.24 Aligned_cols=259 Identities=22% Similarity=0.348 Sum_probs=198.9
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEE
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 121 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 121 (335)
.....+...+|.+.+.||+|+||+|+.. ...+|+.||||++.... ...+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3445566678999999999999997643 34679999999986532 23355899999999 7999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-----CCCEEEecc
Q psy10459 122 TTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-----KYNIKLSDF 195 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-----~~~~~l~Df 195 (335)
..+..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ...++|+||
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 9999999999996 59999997654 3556677899999999999999999999999999999953 235789999
Q ss_pred ccccccccCCcccccccccccccccccccccccCC---CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q psy10459 196 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG---VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK 271 (335)
Q Consensus 196 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~ 271 (335)
|++..+....... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++ |..||...........+..
T Consensus 168 G~a~~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~t-~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~ 244 (432)
T 3p23_A 168 GLCKKLAVGRHSF--SRRSGVPGTEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244 (432)
T ss_dssp TEEECC--------------CCSCTTSCCGGGTSCC---CCC-THHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTC
T ss_pred cceeeccCCCcce--eeccccCCCcCccChhhhhcccccCCC-cHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhcc
Confidence 9998765432211 12334679999999999974 3344 68999999999999999 9999976655444332222
Q ss_pred cccCC---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 272 RVVFP---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 272 ~~~~~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
...+ .....+..+.+||.+|| .||.+|||++++++||||..
T Consensus 245 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 245 -CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1111 11224566899999999 99999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.41 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=199.0
Q ss_pred hccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 44 KLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 44 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
....+..++|++.+.||+|+||+||+|.+. ..||+|++...... ....+.+.+|+.+++.++|+||++++++. ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 345678889999999999999999999853 35999999765443 33356788999999999999999999964 55
Q ss_pred CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 678999999999999999954 3568999999999999999999999999999999999999999999999999987554
Q ss_pred cCCcccccccccccccccccccccccC---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHccccCCC-
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPE- 277 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~- 277 (335)
..... .......||..|+|||++. +..++ .++||||||+++|+|++|..||..... ......+......+.
T Consensus 172 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 172 RWSGS---HQFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred ccccc---ccccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 32211 1123456899999999986 44444 689999999999999999999987554 444444444333332
Q ss_pred ---CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 278 ---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 278 ---~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...++..+.+||.+|| .||.+|||+.++++
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2368899999999999 99999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=327.89 Aligned_cols=232 Identities=25% Similarity=0.502 Sum_probs=190.3
Q ss_pred cCCeEEe-eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHH-HcCCCCCeeeeceeEEe----C
Q psy10459 50 THGYSLG-DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIET----T 123 (335)
Q Consensus 50 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~ 123 (335)
.++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567777 789999999999999999999999999964 23455788887 66699999999999877 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFA 198 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~ 198 (335)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998754 5999999999999999999999999999999999999998 788999999998
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE- 277 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~- 277 (335)
..... ..++ .++|||||||++|+|++|..||.+.........+........
T Consensus 168 ~~~~~---------------------------~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 168 KETTG---------------------------EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp EECTT---------------------------CGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccccc---------------------------ccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 64321 1233 689999999999999999999987665544332222221111
Q ss_pred ------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 278 ------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 278 ------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
...++.++.+||.+|| .||.+|||++++++||||++....
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 1468999999999999 999999999999999999886543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=329.85 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=208.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcC-CCC--eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSAR-HSQ--DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
..+..++|++.+.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 45667899999999999999999998643 333 689999876544333446778899999999999999999999877
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
++ .++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 78999999999999999764 56899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcc-ccCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPESP 279 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~-~~~~~~~ 279 (335)
....... .......++..|+|||++.+..++ .++||||||+++|+|++ |..||.+.+..+....+... ...+...
T Consensus 172 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 172 PQNDDHY--VMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248 (291)
T ss_dssp CC-CCEE--EC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred cccccch--hhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCc
Confidence 5433211 112234567889999999877766 78999999999999999 99999999988888877653 3445556
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.++.++.++|.+|| .||.+||++.+++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 79999999999999 999999999999973
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.93 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=210.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEE----cCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATS----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+....|++++.||+|+||+||++.. ..+++.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 35555569999999999999988754 44788999999976532 3336678899999999999999999999987
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 123 --THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 123 --~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
...+++||||+++++|.+++.... +++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 467899999999999999997654 89999999999999999999999999999999999999999999999999987
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HH
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------------EL 265 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---------------~~ 265 (335)
........ .......++..|+|||++.+..++ .++||||||+++|+|++|..||...... ..
T Consensus 184 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 184 VPEGHEYY--RVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CCTTCSEE--EC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccc--ccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 65433211 123344578889999999887777 7899999999999999999999754322 23
Q ss_pred HHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 266 LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
...+......+....++.++.+||++|| .||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3444455556666789999999999999 99999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=340.33 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=203.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCC---CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE-eCCeE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHRV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 126 (335)
..|.+.+.||+|+||+||+|.+..++ ..||+|.+...... .....+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999875433 36899988654332 23567889999999999999999999864 45678
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458899999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (335)
.. .........++..|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+......+....++..
T Consensus 247 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 247 FD-SVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred cc-cccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 11 11112234567889999999887777 79999999999999999 78899887776777777766655556679999
Q ss_pred HHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 285 CKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 285 l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++|.+|| .||.+||++.+++++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=327.75 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=205.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++. +..
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence 456778999999999999999999864 7889999986422 2566789999999999999999999876 347
Q ss_pred EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCEeecCCCC-EEEecccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHK---KSVVHRDIKCENLLLDDKYN-IKLSDFGFAR 199 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~---~~i~H~dikp~Nili~~~~~-~~l~Dfg~~~ 199 (335)
++||||+++++|.+++.... .++...++.++.|+++||.|||+ .|++||||||+||+++.++. ++|+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 89999999999999998654 37899999999999999999999 89999999999999998887 7999999987
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHccccCCC
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPE 277 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~ 277 (335)
..... .....||..|+|||++.+..++ .++||||||+++|+|++|..||.... .......+......+.
T Consensus 155 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 155 DIQTH--------MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp ------------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred ccccc--------cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 54321 1233589999999999888777 79999999999999999999998543 3344444455544555
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc-----CCCcCCCCCC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ-----DPWLKEDSNP 317 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~-----hp~~~~~~~~ 317 (335)
...++..+.++|.+|| .||.+|||++++++ ..++.....+
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 5679999999999999 99999999999998 4555554433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=337.32 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=206.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 457899999999999999999996 46899999988654332 25567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 129 IMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986543 4899999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHccccC---
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL------KQVQKRVVF--- 275 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~------~~i~~~~~~--- 275 (335)
... .......||..|+|||++.+..++ .++|||||||++|+|++|..||......+.. .........
T Consensus 193 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 193 DQT---HLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp SCC---CCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred ccc---ccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 211 122345689999999999877777 8999999999999999999999764322111 111111000
Q ss_pred --C-----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 276 --P-----ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 276 --~-----~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
+ ..+.++..+.+++.+|| .||++|||+.+++++-
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 11234567999999999 9999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=352.67 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=222.4
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
...+..++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+++.++|+||+++++++.. +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 355777889999999999999999999764 567999999765433 3457799999999999999999998865 6
Q ss_pred eEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999964 3568999999999999999999999999999999999999999999999999997654
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
.... .......++..|+|||++....++ .++|||||||++|+|++ |..||.+....++...+..+...+....+
T Consensus 415 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 489 (535)
T 2h8h_A 415 DNEY----TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489 (535)
T ss_dssp CHHH----HTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCce----ecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 3211 112233467889999999877777 79999999999999999 99999999999999999888877777789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC--CCcCC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD--PWLKE 313 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h--p~~~~ 313 (335)
+.++.+||.+|| .||++|||+++|++. .+|..
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999 999999999999874 45543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=334.04 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=204.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC--------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeee----
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSAR--------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR---- 115 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~---- 115 (335)
...++|.+.+.||+|+||.||+|.+.. +++.||+|++... ..+.+|+.+++.++||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhh
Confidence 345789999999999999999999887 4889999999753 45678999999999999887
Q ss_pred -----------eceeEEe-CCeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 116 -----------FLQAIET-THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 116 -----------~~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+++++.. ++..++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 5666665 67899999999 89999999875 679999999999999999999999999999999999
Q ss_pred EeecCCC--CEEEeccccccccccCCccc--ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy10459 182 LLLDDKY--NIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257 (335)
Q Consensus 182 ili~~~~--~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~ 257 (335)
||++.++ .++|+|||++..+....... .........||..|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCc
Confidence 9999998 89999999998765432211 11122345789999999999988777 7999999999999999999999
Q ss_pred CCC--CHHHHHHHHHccc----cCC----CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 258 DDT--NYSELLKQVQKRV----VFP----ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 258 ~~~--~~~~~~~~i~~~~----~~~----~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
... ............. .+. ....++.++.+||.+|| .||.+||++++|++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 875 3333333332111 111 11257999999999999 999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=323.21 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=205.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE-EeCCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 127 (335)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999876443 34567899999999988776665554 5677889
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEecccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~ 203 (335)
+||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8899999974 4569999999999999999999999999999999999999 4788999999999987654
Q ss_pred CCccccc--ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc-cccCC-
Q psy10459 204 NNTDYKQ--NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQK-RVVFP- 276 (335)
Q Consensus 204 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~---~~~~~~i~~-~~~~~- 276 (335)
....... .......||..|+|||++.+..++ .++|||||||++|+|++|..||.+... ......+.. ....+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 3321111 112455789999999999988877 799999999999999999999986432 222222222 11122
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 277 --ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 277 --~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
....+|.++.+||.+|| .||.+||+++++++.
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 12468999999999999 999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=322.37 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=202.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE-EeCCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 127 (335)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 35689999999999999999999999999999998765432 34577899999999988777666555 6677889
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEecccccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~ 203 (335)
++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999975 4569999999999999999999999999999999999999 7889999999999987654
Q ss_pred CCcccc--cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc-cccCC-
Q psy10459 204 NNTDYK--QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQK-RVVFP- 276 (335)
Q Consensus 204 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~---~~~~~i~~-~~~~~- 276 (335)
...... ........||..|+|||++.+..++ .++|||||||++|+|++|..||.+.... .....+.. ....+
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 332111 1123356789999999999988877 7999999999999999999999864321 22222211 11122
Q ss_pred --CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 277 --ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 277 --~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....+|.++.+||.+|| .||.+||+++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 12468999999999999 99999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=326.02 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=197.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHc--CCCCCeeeeceeEEe--
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG--LKHPNLIRFLQAIET-- 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~-- 122 (335)
....++|++.+.||+|+||+||+|.+ +|+.||||++.... ...+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999986 68999999986531 2334456666665 799999999998654
Q ss_pred --CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEeecCCCCEEE
Q psy10459 123 --THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH--------KKSVVHRDIKCENLLLDDKYNIKL 192 (335)
Q Consensus 123 --~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~i~H~dikp~Nili~~~~~~~l 192 (335)
....++||||+++++|.++++. ..+++..++.++.|++.||.||| +.|++||||||+|||++.++.++|
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3468999999999999999954 46899999999999999999999 999999999999999999999999
Q ss_pred eccccccccccCCcccccccccccccccccccccccCCCCCC-----CCchhHHHHHHHHHHHHhC----------CCCC
Q psy10459 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT-----PQQSDIWSMGVVLFAMVYG----------RLPF 257 (335)
Q Consensus 193 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-----~~~~Di~slG~~~~~l~~g----------~~p~ 257 (335)
+|||++.......... .......+||..|+|||++.+.... +.++|||||||++|+|++| ..||
T Consensus 155 ~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CCCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred eeCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999997654433221 1122344789999999999876322 1579999999999999999 8888
Q ss_pred CCC-----CHHHHHHHHHccccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 258 DDT-----NYSELLKQVQKRVVFPESP------RLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 258 ~~~-----~~~~~~~~i~~~~~~~~~~------~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
... ........+......+..+ .++.++.+||.+|| .||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 543 2333333333222222221 24578999999999 99999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=340.44 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=193.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (335)
..+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.++..+ +||||+++++++...+..|
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 34567788999999999998654 4679999999986531 34466899999876 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-------------
Q psy10459 128 IIMEYAKNGSLLEVIRKERYID-------EDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK------------- 187 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~-------~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~------------- 187 (335)
+||||+. ++|.+++....... +..++.++.||+.||.|||+.||+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999996 59999997654322 23457899999999999999999999999999999754
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCC-------CCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG-------VPYTPQQSDIWSMGVVLFAMVY-GRLPFDD 259 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slG~~~~~l~~-g~~p~~~ 259 (335)
+.++|+|||++........... ......+||+.|+|||++.+ ..++ .++|||||||++|+|++ |..||..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFR-TNLNNPSGTSGWRAPELLEESNNLQTKRRLT-RSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCC-THHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred eEEEEcccccceecCCCCccce-eeecCCCCCCCccCHHHhccccccccccCcc-hhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 4799999999987654322111 11234579999999999875 3344 89999999999999999 9999976
Q ss_pred CCHHHHHHHHHccccCCCCC-----CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 260 TNYSELLKQVQKRVVFPESP-----RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 260 ~~~~~~~~~i~~~~~~~~~~-----~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
..... ...+......+... .++.++.+||.+|| .||.+|||+.++++||||..
T Consensus 243 ~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 65433 22222222222221 24578999999999 99999999999999999964
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.87 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=206.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+ .+|+.||+|++........ ...+.+|+.++..++||||+++++++...+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 45678899999999999999999984 4689999999876433211 33577999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDYCHKK---SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~----~~~~~~~~~i~~~i~~~L~~LH~~---~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHc---
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQK--- 271 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-----~~~~~~~~i~~--- 271 (335)
........ ......||..|+|||++.+..++ .++|||||||++|+|++|..||... ........+..
T Consensus 183 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 183 LMDYKDTH----VTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp ECCSSSSC----EECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccCccccc----ccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 76433221 12344689999999999877776 7899999999999999999999521 11111111111
Q ss_pred cccCCC----------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 272 RVVFPE----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 272 ~~~~~~----------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
...... ....+..+.+++.+|| .||.+|||+.+|++|-+-..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 110000 0123368999999999 99999999999999875433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=330.74 Aligned_cols=260 Identities=19% Similarity=0.335 Sum_probs=211.0
Q ss_pred hhccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 43 RKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 43 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.....+..++|++.+.||+|+||.||+|.+.. .||+|++........ ..+.+.+|+.+++.++|+||+++++++..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-QLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-CCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-HHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34455778899999999999999999998753 599999875433211 13456689999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
.+..+++|||+++++|.+++...+ .+++..++.++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++...
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999997654 689999999999999999999999999999999999998 679999999998765
Q ss_pred ccCCcccccccccccccccccccccccCCC---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcc
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGV---------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 272 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~ 272 (335)
................|+..|+|||++... .++ .++||||||+++|+|++|..||...........+...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCC-HHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 432222222223345689999999998752 234 7899999999999999999999999988888777765
Q ss_pred ccCCC-CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 273 VVFPE-SPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 273 ~~~~~-~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..... ...++.++.++|.+|| .||.+|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 44332 2368899999999999 999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=330.27 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=192.4
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEE--
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE-- 121 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-- 121 (335)
...+...+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34466678999999999999999999999999999999985542 233556779999999996 999999999984
Q ss_pred ------eCCeEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeecCCCCE
Q psy10459 122 ------TTHRVYIIMEYAKNGSLLEVIRK---ERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNI 190 (335)
Q Consensus 122 ------~~~~~~iv~e~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~~~~~~ 190 (335)
....++++|||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| ++|+||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3446899999996 699998865 456999999999999999999999999 9999999999999999999
Q ss_pred EEeccccccccccCCcccc-------ccccccccccccccccccc---CCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy10459 191 KLSDFGFARKYSVNNTDYK-------QNLSETFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 260 (335)
Q Consensus 191 ~l~Dfg~~~~~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~---~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~ 260 (335)
+|+|||++........... ........||..|+|||++ .+..++ .++|||||||++|+|++|..||...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999987654322110 0111244689999999998 344455 7899999999999999999999865
Q ss_pred CHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 261 NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
...... ......+.....+..+.+||.+|| .||.+||++.++++|-+-
T Consensus 257 ~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 257 AKLRIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 544332 233444555678889999999999 999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=343.48 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=203.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC--e
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--R 125 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 125 (335)
...++|.+.+.||+|+||+||+|.+..+|+.||||++........ ...+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 446789999999999999999999999999999999975432111 455668999999999999999999988755 7
Q ss_pred EEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee----cCCCCEEEeccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFA 198 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili----~~~~~~~l~Dfg~~ 198 (335)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997543 38999999999999999999999999999999999999 77778999999999
Q ss_pred cccccCCcccccccccccccccccccccccCC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHH
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKG--------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELL 266 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~~Di~slG~~~~~l~~g~~p~~~~----~~~~~~ 266 (335)
........ ....+||..|+|||++.+ ..++ .++|||||||++|+|++|..||... ...+..
T Consensus 164 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 164 RELEDDEQ------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp EECCCGGG------SSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred eEccCCCc------cccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 86643221 224568999999999864 2334 6899999999999999999999642 223444
Q ss_pred HHHHcccc--------------------CCCC----CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 267 KQVQKRVV--------------------FPES----PRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 267 ~~i~~~~~--------------------~~~~----~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
..+..... .+.. ..++..+.++|++|| .||++||++++++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 44433221 1111 124567889999999 999999999998543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=328.77 Aligned_cols=256 Identities=22% Similarity=0.395 Sum_probs=210.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEE----EcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 121 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 121 (335)
..+..++|++++.||+|+||.||+|. +..+|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 45677889999999999999999998 45678999999997532 223567889999999999999999999886
Q ss_pred eCC--eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 122 TTH--RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 122 ~~~--~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
..+ ..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 543 789999999999999999875 45999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH----------------
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------------- 262 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~---------------- 262 (335)
.......... .......++..|+|||++.+..++ .++||||||+++|+|++|..||.....
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp EECCSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred hhcccccccc--ccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 8765433211 112234567789999999877766 789999999999999999999864311
Q ss_pred HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 263 SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
....+.+......+....++.++.+||++|| .||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223334444455556679999999999999 99999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.54 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=215.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC---CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|.+.+.||+|+||+||+|.+..+ +..||+|.+..... +.....+.+|+.+++.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45567899999999999999999998653 45689998865332 334567889999999999999999999884 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 56899999999999999997654 68999999999999999999999999999999999999999999999999998664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
..... ......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....+....+......+....+
T Consensus 543 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 617 (656)
T 2j0j_A 543 DSTYY----KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617 (656)
T ss_dssp C--------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTC
T ss_pred CCcce----eccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 32211 12234567899999999877777 78999999999999997 99999999999999888887767777789
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+..+.+||.+|| .||.+||++.++++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999 999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=336.63 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=206.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC-CCeeeeceeEEeCCeE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRV 126 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 126 (335)
...++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| +++..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 345789999999999999999999999999999999876443 3446789999999986 5555666666778889
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEee---cCCCCEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili---~~~~~~~l~Dfg~~~~~~ 202 (335)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||| +.++.++|+|||++..+.
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 4569999999999999999999999999999999999999 688899999999998765
Q ss_pred cCCcccc--cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHccccC--
Q psy10459 203 VNNTDYK--QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRVVF-- 275 (335)
Q Consensus 203 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---~~~~~~~i~~~~~~-- 275 (335)
....... .......+||..|+|||++.+..++ .++|||||||++|+|++|..||.+.. ..+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 4332211 1122356799999999999988877 89999999999999999999998744 33333333321111
Q ss_pred --CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 276 --PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 276 --~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.....++.++.+||..|| .+|.+||++++|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111468999999999999 99999999998765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.79 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=206.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 123 (335)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC--HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 4689999999999999999999999999999999865432 3336678899999999999999999988754 6
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC---EEEecccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGF 197 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~---~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---~~l~Dfg~ 197 (335)
+..++||||++|++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||.
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999998754 5899999999999999999999999999999999999997765 89999999
Q ss_pred ccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Q psy10459 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-------- 269 (335)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i-------- 269 (335)
+........ .....|+..|+|||++.+..++ .++|||||||++|+|++|..||.+......+...
T Consensus 171 a~~~~~~~~------~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL------CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC------CCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccc------cccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 986643221 2345789999999999888887 7899999999999999999999876443221100
Q ss_pred -------HccccC----CC----CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 270 -------QKRVVF----PE----SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 270 -------~~~~~~----~~----~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.....+ +. ...++..+.+||.+|| .||++|||+.++++||||+..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000011 11 1235789999999999 999999999999999999764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.16 Aligned_cols=251 Identities=20% Similarity=0.372 Sum_probs=196.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC--CCCCeeeeceeEEeC--
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL--KHPNLIRFLQAIETT-- 123 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~-- 123 (335)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ......|.+++..+ +|+||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33468999999999999999999864 8999999986432 22233455555554 899999999999877
Q ss_pred --CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEeecCCCCEEEe
Q psy10459 124 --HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK--------SVVHRDIKCENLLLDDKYNIKLS 193 (335)
Q Consensus 124 --~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~i~H~dikp~Nili~~~~~~~l~ 193 (335)
...++||||+++++|.+++... .+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999765 589999999999999999999998 99999999999999999999999
Q ss_pred ccccccccccCCcccccccccccccccccccccccCCCCCCCC-----chhHHHHHHHHHHHHhC----------CCCCC
Q psy10459 194 DFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYG----------RLPFD 258 (335)
Q Consensus 194 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-----~~Di~slG~~~~~l~~g----------~~p~~ 258 (335)
|||++..+....... .......+||..|+|||++.+...... ++|||||||++|+|++| ..||.
T Consensus 185 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 185 DLGLAVKFISDTNEV-DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eCCCceeeccccccc-cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999997664433221 111234578999999999987766632 38999999999999999 77775
Q ss_pred CC-----CHHHHHHHHHccccCCCC------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 259 DT-----NYSELLKQVQKRVVFPES------PRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 259 ~~-----~~~~~~~~i~~~~~~~~~------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.. ........+......+.. ..++.++.+||.+|| .||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 43 223333333222222221 245678999999999 999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=329.84 Aligned_cols=247 Identities=17% Similarity=0.260 Sum_probs=197.2
Q ss_pred cccccCCeEEeeeecccCceEEEEE-----EEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeec
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLA-----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFL 117 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~ 117 (335)
..+..++|.+.+.||+|+||+||+| .+..+++.||+|++.... ...+..|+.++..++ |+||+.++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3466788999999999999999999 466789999999996532 334567888888886 89999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC------
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD------ 186 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~------ 186 (335)
+++...+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred -----CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy10459 187 -----KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 261 (335)
Q Consensus 187 -----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~ 261 (335)
++.++|+|||++..+...... ......+||..|+|||++.+..++ .++|||||||++|+|++|..||....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKG---TIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTT---EEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCC---ceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCC
Confidence 899999999999765422111 123345799999999999988877 89999999999999999999996542
Q ss_pred HHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 262 YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.... .....++. ...+..+.+++..|| .+|.+|++..+.+.
T Consensus 290 ~~~~----~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 290 GGEC----KPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp TTEE----EECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CCce----eechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 2110 00011111 134678999999999 89888865444333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=324.56 Aligned_cols=263 Identities=21% Similarity=0.353 Sum_probs=195.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHH--HHcCCCCCeeeeceeEEe-
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV--VKGLKHPNLIRFLQAIET- 122 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~- 122 (335)
..+..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++|+||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346778999999999999999999975 68999999997532 2223334444 445899999999975532
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCEeecCCCC
Q psy10459 123 ----THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK---------SVVHRDIKCENLLLDDKYN 189 (335)
Q Consensus 123 ----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------~i~H~dikp~Nili~~~~~ 189 (335)
...+++||||+++++|.+++.... .++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 336789999999999999997655 58999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccccCCcc---cccccccccccccccccccccCCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy10459 190 IKLSDFGFARKYSVNNTD---YKQNLSETFCGSYAYASPEILKGV-------PYTPQQSDIWSMGVVLFAMVYGRLPFDD 259 (335)
Q Consensus 190 ~~l~Dfg~~~~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~~Di~slG~~~~~l~~g~~p~~~ 259 (335)
++|+|||++..+...... .........+||..|+|||++.+. .++ .++|||||||++|+|++|..||..
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccc-cccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999876533211 011122345789999999999863 233 579999999999999999777643
Q ss_pred C------------------CHHHHHHHHHccccCCCC-------CCCCHHHHHHHHHhc-CCCCCCCCHHHH------hc
Q psy10459 260 T------------------NYSELLKQVQKRVVFPES-------PRLSSSCKALISNIL-SPVKFRIQMEDI------RQ 307 (335)
Q Consensus 260 ~------------------~~~~~~~~i~~~~~~~~~-------~~~~~~l~~li~~~L-~~p~~Rps~~~l------l~ 307 (335)
. ........+......+.. ..++.++.+||.+|| .||++|||+.|+ +-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2 112222222222222221 114457999999999 999999999999 66
Q ss_pred CCCcCCCCCCC
Q psy10459 308 DPWLKEDSNPV 318 (335)
Q Consensus 308 hp~~~~~~~~~ 318 (335)
++|-++.....
T Consensus 318 ~~~~~~~~~~~ 328 (336)
T 3g2f_A 318 MIWERNKSVSP 328 (336)
T ss_dssp HCCCC------
T ss_pred HHHHhcccCCC
Confidence 89988865443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=321.06 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=200.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC-ChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA-PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
|...+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44558999999999999985 688999999875432 223346678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 132 YAKNGSLLEVIRK---ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 132 ~~~~~sL~~~l~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999974 345899999999999999999999999999999999999999999999999998765432211
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcc----------cc
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL----LKQVQKR----------VV 274 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~----~~~i~~~----------~~ 274 (335)
.......|+..|+|||++.+. ++ .++||||||+++|+|++|..||........ ...+... ..
T Consensus 190 --~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 190 --VMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp --EECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred --ccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 112345689999999998764 44 789999999999999999999986543222 1222111 00
Q ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 275 FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 275 ~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
......++..+.+++.+|| .||.+|||+++++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111234577999999999 999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=339.71 Aligned_cols=248 Identities=15% Similarity=0.190 Sum_probs=193.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC-CCeee--------------
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIR-------------- 115 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~-------------- 115 (335)
..|...+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.++..+.| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999985544443345678899999999976 22111
Q ss_pred -------eceeEEe-----CCeEEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q psy10459 116 -------FLQAIET-----THRVYIIMEYAKNGSLLEVIRK-------ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRD 176 (335)
Q Consensus 116 -------~~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~-------~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~d 176 (335)
+...+.. ...++++|+++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 12467788877 5799998852 23367888999999999999999999999999
Q ss_pred CCCCCEeecCCCCEEEeccccccccccCCccccccccccccccccccccccc----------CCCCCCCCchhHHHHHHH
Q psy10459 177 IKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL----------KGVPYTPQQSDIWSMGVV 246 (335)
Q Consensus 177 ikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~~Di~slG~~ 246 (335)
|||+|||++.++.+||+|||++...... ....+| ..|+|||++ ....++ .++|||||||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvi 306 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLA 306 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHH
Confidence 9999999999999999999998765432 234467 999999998 444455 78999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 247 LFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 247 ~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+|+|++|..||...+.......+ +.....+|.++.+||.+|| .||++||++.++++||||++.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999999876544332222 2334578999999999999 999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=318.57 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=202.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHc--CCCCCeeeeceeEEeCC--
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG--LKHPNLIRFLQAIETTH-- 124 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~-- 124 (335)
..++|.+.+.||+|+||.||+|.+ +|+.||+|++.... ...+.+|.+++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 356899999999999999999996 58999999986431 3445678888877 78999999999998776
Q ss_pred --eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEeecCCCCEEEec
Q psy10459 125 --RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH--------KKSVVHRDIKCENLLLDDKYNIKLSD 194 (335)
Q Consensus 125 --~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~i~H~dikp~Nili~~~~~~~l~D 194 (335)
..++||||+++++|.+++... .+++..++.++.|++.||.||| +.|++|+||||+|||++.++.++|+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 799999999999999999764 5899999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCcccccccccccccccccccccccCCCCCCC-----CchhHHHHHHHHHHHHhC----------CCCCCC
Q psy10459 195 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYG----------RLPFDD 259 (335)
Q Consensus 195 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-----~~~Di~slG~~~~~l~~g----------~~p~~~ 259 (335)
||++........... .......||..|+|||++.+..... .++|||||||++|+|++| ..||..
T Consensus 191 fg~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 191 LGLAVRHDSATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CTTCEEEETTTTEEE-ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeccccccccc-cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999976654332111 1233457899999999997653321 579999999999999999 889876
Q ss_pred C-----CHHHHHHHHHccccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 260 T-----NYSELLKQVQKRVVFPESP------RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 260 ~-----~~~~~~~~i~~~~~~~~~~------~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
. ........+......+..+ .++..+.+||.+|| .||.+|||+.++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4 3444455444333222221 23468999999999 999999999999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=331.32 Aligned_cols=245 Identities=18% Similarity=0.238 Sum_probs=191.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-----hHHHHhhHHHHHHHHHcCC---------CCCe
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLK---------HPNL 113 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~i 113 (335)
+..++|++.+.||+|+||+||+|.+ +|+.||||++...... .....+.+.+|+.+++.++ |+||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4567899999999999999999997 6899999999865321 1111356778998888875 5555
Q ss_pred eeecee-----------------EEe-------------CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHH
Q psy10459 114 IRFLQA-----------------IET-------------THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADA 163 (335)
Q Consensus 114 v~~~~~-----------------~~~-------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~ 163 (335)
+++.+. +.. .+.+|+||||+++|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 555544 433 6789999999999977666644 568999999999999999
Q ss_pred HHHHH-hCCceeccCCCCCEeecCCC--------------------CEEEeccccccccccCCccccccccccccccccc
Q psy10459 164 IDYCH-KKSVVHRDIKCENLLLDDKY--------------------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222 (335)
Q Consensus 164 L~~LH-~~~i~H~dikp~Nili~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y 222 (335)
|.||| +.||+||||||+|||++.++ .+||+|||+++..... ..+||+.|
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCCCT
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEeecc
Confidence 99999 99999999999999999887 8999999999865421 33789999
Q ss_pred ccccccCCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHccccCCCC------CCCCHHHHHHHHHhc-
Q psy10459 223 ASPEILKGVPYTPQQSDIWSMGVV-LFAMVYGRLPFDDTNY-SELLKQVQKRVVFPES------PRLSSSCKALISNIL- 293 (335)
Q Consensus 223 ~aPE~~~~~~~~~~~~Di~slG~~-~~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~------~~~~~~l~~li~~~L- 293 (335)
+|||++.+.. + .++|||||+++ .+++++|..||..... ......+......+.. ..+++++++||++||
T Consensus 244 ~aPE~~~g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 244 MDEDLFTGDG-D-YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp TCSGGGCCCS-S-HHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred cChhhhcCCC-c-cceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 9999998766 4 78999998777 7778889999854321 2233333322222211 247889999999999
Q ss_pred CCCCCCCCHHHHh-cCCCcC
Q psy10459 294 SPVKFRIQMEDIR-QDPWLK 312 (335)
Q Consensus 294 ~~p~~Rps~~~ll-~hp~~~ 312 (335)
.| |++|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 66 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.85 Aligned_cols=225 Identities=16% Similarity=0.139 Sum_probs=187.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+..+..++|+||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55678999999999999999999999999999999998765554555677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++|++|.+++... .....+..++.|++.||.|||+.||+||||||+|||++.++.++|+++|..
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~--------- 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM--------- 176 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC---------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc---------
Confidence 999999999999999543 466678999999999999999999999999999999999999999855432
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHccccC--CCCCCC
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK----QVQKRVVF--PESPRL 281 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~----~i~~~~~~--~~~~~~ 281 (335)
+| ++ .++|||||||++|+|++|..||.+.+...... .+...... .....+
T Consensus 177 ----------------~~-------~~-~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 177 ----------------PD-------AN-PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ----------------TT-------CC-HHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ----------------CC-------CC-chhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 21 33 78999999999999999999998765432110 00000000 012468
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++.+||.+|| .||.+| |+.++++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999 999999 99999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.32 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=199.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
.+..++|++.+.||+|+||+||+|.+.. +|+.||||++..... ......+.+|+.++..++||||+++++++...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 3456899999999999999999999976 789999999865432 3335667899999999999999999999987665
Q ss_pred -----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 126 -----VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 126 -----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||+.||+||||||+|||++.+ .++|+|||++..
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988755 68999999999999999999999999999999999999986 899999999976
Q ss_pred cccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC--
Q psy10459 201 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-- 278 (335)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-- 278 (335)
.... ...+||+.|+|||++.+.. + .++|||||||++|+|++|..||.+.... ..+..
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~-~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~ 289 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-T-VATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPEDDP 289 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-C-HHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTTCH
T ss_pred cccC---------CccCCCccccCHHHHcCCC-C-CceehhhhHHHHHHHHhCCCCCcccccc----------ccccccc
Confidence 5432 3446899999999987654 4 7899999999999999999988752110 01110
Q ss_pred -CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 279 -PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 279 -~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
..++..+.+||.+|| .||.+||+..+.+.|+|+.-
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 124678999999999 99999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=282.98 Aligned_cols=189 Identities=16% Similarity=0.117 Sum_probs=137.3
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC-------hHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeCCeE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP-------IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (335)
.....+.|++|.+..++....|+.||+|++...... .+...+.+.+|+++|+++ .|+||+++++++++++.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 344567788888887777778999999999764321 223356788999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||||++|++|.+++...+++++. .|+.||+.||.|+|++|||||||||+|||++.+|.+||+|||+++.+.....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 9999999999999999998888775 4789999999999999999999999999999999999999999987654322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG 253 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g 253 (335)
.....+||+.|+|||++.+.. . .++|+||+|++++++.++
T Consensus 395 -----~~~t~vGTp~YmAPE~l~g~~-~-~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 395 -----WPTNLVQSFFVFVNELFAENK-S-WNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp -----CSHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred -----cccCceechhhccHHHhCCCC-C-Ccccccccccchhhhccc
Confidence 234568999999999998753 3 579999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-30 Score=239.15 Aligned_cols=192 Identities=19% Similarity=0.202 Sum_probs=146.1
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH-----HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID-----YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
...+.||+|+||+||+|. ..+..+++|.......... ...+.+.+|+.+++.++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456799999999999995 5678899998755333211 124557899999999999999976666667777899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||||++|++|.+++.. +..++.|++.||.|||+.||+||||||+|||++. .++|+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999865 5789999999999999999999999999999999 99999999998765422110
Q ss_pred c--cccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy10459 209 K--QNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFD 258 (335)
Q Consensus 209 ~--~~~~~~~~g~~~y~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~p~~ 258 (335)
. .......+||+.|+|||++.. ..|. ..+|+||..+-..+...++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 0 001235679999999999976 4555 56899999988888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.8e-27 Score=202.10 Aligned_cols=136 Identities=15% Similarity=0.219 Sum_probs=110.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---------------HHHhhHHHHHHHHHcCCCCCeee
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---------------YLKKFLPREIEVVKGLKHPNLIR 115 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~ 115 (335)
..|.+++.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+++.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3456669999999999999998 7899999999964322111 13556789999999999 5 67
Q ss_pred eceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecc
Q psy10459 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 195 (335)
Q Consensus 116 ~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Df 195 (335)
+.+.+.. +..|+||||++|++|.+ +. . .....++.|++.||.+||+.||+||||||+|||++ ++.++|+||
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 7776544 45699999999999988 42 1 23457999999999999999999999999999999 999999999
Q ss_pred cccc
Q psy10459 196 GFAR 199 (335)
Q Consensus 196 g~~~ 199 (335)
|++.
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-23 Score=175.78 Aligned_cols=141 Identities=18% Similarity=0.251 Sum_probs=109.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCe--EEEEEEecCCCC---------------------hHHHHhhHHHHHHHHHcC
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQD--VAIKIISKVQAP---------------------IDYLKKFLPREIEVVKGL 108 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l 108 (335)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... .......+.+|+..+..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778989 999997643211 111224677999999999
Q ss_pred CCCCe--eeeceeEEeCCeEEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCC
Q psy10459 109 KHPNL--IRFLQAIETTHRVYIIMEYAKN-G----SLLEVIRKERYIDEDKGRRWFSQLADAIDYCH-KKSVVHRDIKCE 180 (335)
Q Consensus 109 ~h~~i--v~~~~~~~~~~~~~iv~e~~~~-~----sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~i~H~dikp~ 180 (335)
.|+++ +.++.. +..++||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87764 223321 355899999932 3 67766432 234567899999999999999 999999999999
Q ss_pred CEeecCCCCEEEecccccccc
Q psy10459 181 NLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 181 Nili~~~~~~~l~Dfg~~~~~ 201 (335)
|||++. .++|+|||++...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999998 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.4e-20 Score=163.86 Aligned_cols=141 Identities=16% Similarity=0.222 Sum_probs=101.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC---------------hH----HHHhhHHHHHHHHHcCCCCCe
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP---------------ID----YLKKFLPREIEVVKGLKHPNL 113 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~----~~~~~~~~E~~~l~~l~h~~i 113 (335)
|+++..||.|++|.||+|.+ .+|+.||||+++..... .. ..+-....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999997 46999999998632110 00 011123356677777754443
Q ss_pred eeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCC----
Q psy10459 114 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---- 189 (335)
Q Consensus 114 v~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~---- 189 (335)
... ..+... ..+|||||+.|++|..+. ..+....++.||+.+|.+||+.|||||||||.|||+++++.
T Consensus 176 ~vp-~p~~~~-~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVP-EPIAQS-RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCC-CEEEEE-TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCC-eeeecc-CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 222 222222 237999999998876543 12345678899999999999999999999999999998773
Q ss_pred ------EEEeccccccccc
Q psy10459 190 ------IKLSDFGFARKYS 202 (335)
Q Consensus 190 ------~~l~Dfg~~~~~~ 202 (335)
+.|+||+.+....
T Consensus 248 ~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TSEEEEEEECCCTTCEETT
T ss_pred cccccceEEEEeCCcccCC
Confidence 8999999886544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=7.8e-14 Score=118.94 Aligned_cols=139 Identities=17% Similarity=0.116 Sum_probs=110.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv 129 (335)
..|.+...++.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3588999999999999999983 46899999986532111 345778999999884 66778889888888899999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK---------------------------------------- 169 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~---------------------------------------- 169 (335)
||+++|.+|.+... +......++.++.++|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999887531 222345788899999999998
Q ss_pred -------------------CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 -------------------KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 -------------------~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-12 Score=109.34 Aligned_cols=133 Identities=18% Similarity=0.130 Sum_probs=97.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeeceeEEeCCeEEEE
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQAIETTHRVYII 129 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~iv 129 (335)
+|.+....+.|..+.||++.. .+|..+++|+..... ...+..|+.+++.+.+.+ +++++.+....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 466655555677799999964 567889999976531 245678999998885444 45578887777789999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS-------------------------------------- 171 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 171 (335)
||+++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998874 1 1112 2356677777777777643
Q ss_pred --------------------ceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 172 --------------------VVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 172 --------------------i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
++|+|++|.||++++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877556799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=7.1e-12 Score=111.75 Aligned_cols=142 Identities=15% Similarity=0.194 Sum_probs=104.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEe--cCCCChHHHHhhHHHHHHHHHcCCC--CCeeeeceeEEeC---Ce
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIIS--KVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETT---HR 125 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~ 125 (335)
...++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+.. ..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 34577899999999999884 35678889775 32211 113467789999999874 4567777777665 34
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK------------------------------------ 169 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------ 169 (335)
.|+|||+++|.++.+. ....++......++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 7899999998777431 12236788888999999999999997
Q ss_pred ----------------------CCceeccCCCCCEeecCCCC--EEEeccccccc
Q psy10459 170 ----------------------KSVVHRDIKCENLLLDDKYN--IKLSDFGFARK 200 (335)
Q Consensus 170 ----------------------~~i~H~dikp~Nili~~~~~--~~l~Dfg~~~~ 200 (335)
.+++|+|+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 58999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.8e-11 Score=106.63 Aligned_cols=186 Identities=15% Similarity=0.247 Sum_probs=117.7
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCC--eeeeceeEEeCC---eEEEE
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPN--LIRFLQAIETTH---RVYII 129 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~iv 129 (335)
++.++.|....||++. ..+++|+.... .....+.+|+.+++.+. +.. +..++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999763 46899986432 23566789999998873 333 333433332222 34789
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK---------------------------------------- 169 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~---------------------------------------- 169 (335)
|++++|.++..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865432 236777778888888888888885
Q ss_pred ------------------CCceeccCCCCCEeecC--CCCEEEeccccccccccCCccccccccc----------ccccc
Q psy10459 170 ------------------KSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNTDYKQNLSE----------TFCGS 219 (335)
Q Consensus 170 ------------------~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~----------~~~g~ 219 (335)
..++|+|++|.||++++ +..+.|+||+.+..-.. ..+....... .....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHH
Confidence 23799999999999998 45578999998754321 1110000000 00000
Q ss_pred ccccc-ccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy10459 220 YAYAS-PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257 (335)
Q Consensus 220 ~~y~a-PE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~ 257 (335)
..... |+...... ...+.|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 22211111 1258999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=3.7e-08 Score=83.88 Aligned_cols=131 Identities=18% Similarity=0.189 Sum_probs=93.3
Q ss_pred ecccCce-EEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEEEeccCCC
Q psy10459 59 VGMGSYA-TVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAKNG 136 (335)
Q Consensus 59 lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~~ 136 (335)
+..|..| .||+......+..+++|+-... ....+..|...|+.+. +-.+.+++.++.+.+..++||++++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3445444 6999887777888999987542 1456778999998874 334667888888888999999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q psy10459 137 SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK----------------------------------------------- 169 (335)
Q Consensus 137 sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~----------------------------------------------- 169 (335)
++.+...... .....++.++...|..||.
T Consensus 106 ~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 8877654321 1223344455555555552
Q ss_pred ----C-------CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 ----K-------SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ----~-------~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
. .++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0 27899999999999987767799999774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=6.8e-08 Score=83.90 Aligned_cols=133 Identities=17% Similarity=0.156 Sum_probs=90.4
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC---CeeeeceeEE-eCCeEEEEEe
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP---NLIRFLQAIE-TTHRVYIIME 131 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~iv~e 131 (335)
++.++.|....||+. |..+++|+... ......+..|+.+++.+.+. .+..++.+.. ..+..+++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788998899987 56789998532 22356788999999998642 2455555553 3456789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKK----------------------------------------- 170 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 170 (335)
+++|.++....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 1234444444444444444444432
Q ss_pred -------------------CceeccCCCCCEeecC---CCCE-EEeccccccc
Q psy10459 171 -------------------SVVHRDIKCENLLLDD---KYNI-KLSDFGFARK 200 (335)
Q Consensus 171 -------------------~i~H~dikp~Nili~~---~~~~-~l~Dfg~~~~ 200 (335)
.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999997 4554 7999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.4e-07 Score=83.50 Aligned_cols=80 Identities=16% Similarity=0.077 Sum_probs=48.8
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCC-ChH---HHHhhHHHHHHHHHcCCC--CCe-eeeceeEEeCCeEE
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQA-PID---YLKKFLPREIEVVKGLKH--PNL-IRFLQAIETTHRVY 127 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~~i-v~~~~~~~~~~~~~ 127 (335)
..+.||.|..+.||++....+++.+++|....... ..+ .....+..|..++..+.. +.. ++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997655678899998653211 000 013345678888887732 333 344433 344567
Q ss_pred EEEeccCCC
Q psy10459 128 IIMEYAKNG 136 (335)
Q Consensus 128 iv~e~~~~~ 136 (335)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.45 E-value=2.1e-06 Score=75.39 Aligned_cols=30 Identities=23% Similarity=0.316 Sum_probs=27.1
Q ss_pred CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.2e-07 Score=82.41 Aligned_cols=84 Identities=14% Similarity=0.216 Sum_probs=53.5
Q ss_pred EEeeee-cccCceEEEEEEEc--C----CCCeEEEEEEecCCC-ChHHHHhhHHHHHHHHHcCCC---CCeeeeceeEEe
Q psy10459 54 SLGDVV-GMGSYATVKLATSA--R----HSQDVAIKIISKVQA-PIDYLKKFLPREIEVVKGLKH---PNLIRFLQAIET 122 (335)
Q Consensus 54 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~ 122 (335)
...+.| +.|....+|++... . ++..+++|+...... .. .....+..|+.+++.+.. -.+.+++.+...
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 345778 88889999988743 1 256789998654220 00 002346688888887742 345666666554
Q ss_pred C---CeEEEEEeccCCCCH
Q psy10459 123 T---HRVYIIMEYAKNGSL 138 (335)
Q Consensus 123 ~---~~~~iv~e~~~~~sL 138 (335)
. +..|+|||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 346899999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.9e-05 Score=68.46 Aligned_cols=77 Identities=13% Similarity=0.140 Sum_probs=59.8
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC---CCCeeeeceeEEeCCeEEEEE
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.-.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.|. ...+++++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467889999999999983 5778999987642 1456778988888873 356777888877778899999
Q ss_pred eccCCCCH
Q psy10459 131 EYAKNGSL 138 (335)
Q Consensus 131 e~~~~~sL 138 (335)
|+++|.++
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.07 E-value=7.5e-05 Score=60.15 Aligned_cols=121 Identities=17% Similarity=0.161 Sum_probs=80.4
Q ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 135 NGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 135 ~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
..||.+++.. +.+++++++|.++.|.+.+|..+-. ..-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 3489999975 4679999999999999999887622 2212334557889999999888774 1110
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHh
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 292 (335)
.....+.|||... ...+.+.-|||||+++|..+--..| ......+|+.+.+||..|
T Consensus 98 ----~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHM 153 (229)
T ss_dssp -------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHH
T ss_pred ----ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHH
Confidence 0133466888764 2223678999999999998853322 112356999999999999
Q ss_pred c
Q psy10459 293 L 293 (335)
Q Consensus 293 L 293 (335)
.
T Consensus 154 t 154 (229)
T 2yle_A 154 A 154 (229)
T ss_dssp T
T ss_pred H
Confidence 8
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.9e-05 Score=71.61 Aligned_cols=32 Identities=13% Similarity=0.315 Sum_probs=27.7
Q ss_pred HhCCceeccCCCCCEeecCCCCEEEeccccccc
Q psy10459 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 200 (335)
Q Consensus 168 H~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~ 200 (335)
+...++|+|++|.|||++.++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999999876 99999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.6e-05 Score=65.29 Aligned_cols=85 Identities=8% Similarity=0.022 Sum_probs=58.5
Q ss_pred ccccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC---CeeeeceeEE
Q psy10459 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP---NLIRFLQAIE 121 (335)
Q Consensus 45 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~ 121 (335)
...+......-++.+|.|..+.||++.. .+|+.|++|+........ ...+..|+..|+.|... .+++++..
T Consensus 9 ~~~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-- 82 (288)
T 3f7w_A 9 VTELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW-- 82 (288)
T ss_dssp HHHHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--
T ss_pred HHHhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--
Confidence 3344556677889999999999999984 678999999865433221 34577899999888422 23344433
Q ss_pred eCCeEEEEEeccCCCC
Q psy10459 122 TTHRVYIIMEYAKNGS 137 (335)
Q Consensus 122 ~~~~~~iv~e~~~~~s 137 (335)
.. .+++||+++++.
T Consensus 83 ~~--~~lv~e~l~~~~ 96 (288)
T 3f7w_A 83 DD--RTLAMEWVDERP 96 (288)
T ss_dssp ET--TEEEEECCCCCC
T ss_pred cC--ceEEEEeecccC
Confidence 22 368999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.97 E-value=3e-05 Score=66.86 Aligned_cols=71 Identities=13% Similarity=0.023 Sum_probs=44.3
Q ss_pred eeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCeEEEEEecc-
Q psy10459 56 GDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVYIIMEYA- 133 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~- 133 (335)
.+.|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ .+++.. ..+.-+++++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 678888999999998 56889988643111 1122467877777743333 344433 333346899999
Q ss_pred CCCCH
Q psy10459 134 KNGSL 138 (335)
Q Consensus 134 ~~~sL 138 (335)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.88 E-value=5.7e-05 Score=65.67 Aligned_cols=140 Identities=17% Similarity=0.133 Sum_probs=77.7
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeecee------EEeCC
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQA------IETTH 124 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~------~~~~~ 124 (335)
..-.+.|+.|....+|++... +| .+++|+...... ...+..|+.++..+...+ +.+++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 344567788888999998743 34 688998865211 234556777776663222 2333311 12345
Q ss_pred eEEEEEeccCCCCHH-----H------H---HHh-cCCC--------CHHHHHHH---------------HHHHHHHHHH
Q psy10459 125 RVYIIMEYAKNGSLL-----E------V---IRK-ERYI--------DEDKGRRW---------------FSQLADAIDY 166 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~-----~------~---l~~-~~~~--------~~~~~~~i---------------~~~i~~~L~~ 166 (335)
..++++++++|.++. . . ++. ...+ ........ ...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 678999999886431 1 1 111 1111 11100000 0113334455
Q ss_pred HHh-------CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 167 CHK-------KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 167 LH~-------~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
+.. .+++|+|+++.||++++++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 542 369999999999999987556899998774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00017 Score=62.89 Aligned_cols=135 Identities=11% Similarity=0.089 Sum_probs=76.9
Q ss_pred eeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCC--eeeecee-----EEeCCeEEEE
Q psy10459 57 DVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN--LIRFLQA-----IETTHRVYII 129 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~-----~~~~~~~~iv 129 (335)
..++ |....||++.. .+|+.+++|+....... ...+..|..++..+...+ +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 78889998763 45678999998643222 234556777777664222 3334332 2235567889
Q ss_pred EeccCCCCHH-----H------HH---Hh---cC------CCCHHHH----H------------------HHHHHHHHHH
Q psy10459 130 MEYAKNGSLL-----E------VI---RK---ER------YIDEDKG----R------------------RWFSQLADAI 164 (335)
Q Consensus 130 ~e~~~~~sL~-----~------~l---~~---~~------~~~~~~~----~------------------~i~~~i~~~L 164 (335)
|++++|.++. . .+ +. .. ..+.... . ..+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874421 1 11 11 00 1111110 0 1111222222
Q ss_pred HHH----HhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 165 DYC----HKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 165 ~~L----H~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
..+ ....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 224589999999999999 4 89999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00017 Score=63.04 Aligned_cols=31 Identities=32% Similarity=0.401 Sum_probs=26.7
Q ss_pred CCceeccCCCCCEeecCC----CCEEEeccccccc
Q psy10459 170 KSVVHRDIKCENLLLDDK----YNIKLSDFGFARK 200 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~----~~~~l~Dfg~~~~ 200 (335)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6789999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00024 Score=64.48 Aligned_cols=74 Identities=12% Similarity=0.086 Sum_probs=47.9
Q ss_pred EeeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCeE
Q psy10459 55 LGDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~ 126 (335)
-++.|+.|....||++.... ++..+++|+.... .. ...+..|..+++.+...++ +++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET----ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 45678888889999998642 2578999988432 11 1233368888887754344 45555432 2
Q ss_pred EEEEeccCCCC
Q psy10459 127 YIIMEYAKNGS 137 (335)
Q Consensus 127 ~iv~e~~~~~s 137 (335)
.+|++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00012 Score=65.11 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=78.5
Q ss_pred eeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCeEE
Q psy10459 56 GDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVY 127 (335)
Q Consensus 56 ~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~ 127 (335)
++.|..|-...+|++.... ++..|++|+....... ...+.+|..+++.+...++ .++++.+. + .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~----~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG----VDSLVLESVMFAILAERSLGPQLYGVFP--E--G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC----HHHHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch----HHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--c
Confidence 4567778888899988532 3578999986332111 2334488988888753333 44555443 2 2
Q ss_pred EEEeccCCCCHH--------------HHH---Hhc-----CCCC--HHHHHHHHHHHHH-------------------HH
Q psy10459 128 IIMEYAKNGSLL--------------EVI---RKE-----RYID--EDKGRRWFSQLAD-------------------AI 164 (335)
Q Consensus 128 iv~e~~~~~sL~--------------~~l---~~~-----~~~~--~~~~~~i~~~i~~-------------------~L 164 (335)
+||||++|.+|. ..+ +.. +... ..++..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999875542 111 111 1111 3455555544321 12
Q ss_pred HHH----Hh----CCceeccCCCCCEeecCC----CCEEEecccccc
Q psy10459 165 DYC----HK----KSVVHRDIKCENLLLDDK----YNIKLSDFGFAR 199 (335)
Q Consensus 165 ~~L----H~----~~i~H~dikp~Nili~~~----~~~~l~Dfg~~~ 199 (335)
..| .. ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 333 22 258999999999999876 689999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.0015 Score=57.27 Aligned_cols=30 Identities=23% Similarity=0.364 Sum_probs=26.9
Q ss_pred CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 369999999999999988889999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0003 Score=62.43 Aligned_cols=75 Identities=16% Similarity=0.032 Sum_probs=43.3
Q ss_pred EeeeecccCceEEEEEEEcC--------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCe
Q psy10459 55 LGDVVGMGSYATVKLATSAR--------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHR 125 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~ 125 (335)
-.+.|+.|....+|++.... .+..+++|+..... +. ......|..+++.+...++ +++++.. .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cc-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 34677788888999998543 13678889875421 11 1123578888887753343 3555433 22
Q ss_pred EEEEEeccCCCC
Q psy10459 126 VYIIMEYAKNGS 137 (335)
Q Consensus 126 ~~iv~e~~~~~s 137 (335)
++||+|++|.+
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=59.73 Aligned_cols=76 Identities=13% Similarity=0.045 Sum_probs=47.6
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCeEEEEEecc
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRVYIIMEYA 133 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~iv~e~~ 133 (335)
-++.|+.|-...+|++.....+..+++|+....... .-.-.+|..++..|...++ +++++.+ .+ .+|++|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 456788888899999986543578999987542111 0011478999988875555 4555554 23 2599999
Q ss_pred CCCCH
Q psy10459 134 KNGSL 138 (335)
Q Consensus 134 ~~~sL 138 (335)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0059 Score=55.01 Aligned_cols=75 Identities=12% Similarity=0.041 Sum_probs=46.7
Q ss_pred EeeeecccCceEEEEEEEcCC-------CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe-eeeceeEEeCCeE
Q psy10459 55 LGDVVGMGSYATVKLATSARH-------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL-IRFLQAIETTHRV 126 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~ 126 (335)
-++.|..|-...+|++..... +..|++++...... . .-...+|..+++.+...++ .++++. ..+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~-~idR~~E~~~l~~L~~~gi~P~l~~~--~~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---K-FYDSKVELDVFRYLSNINIAPNIIAD--FPE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEE--ETT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---h-hcCHHHHHHHHHHHHhcCCCCCEEEE--cCC--
Confidence 456677788889999986421 57899998644211 1 1122478888887753333 344442 223
Q ss_pred EEEEeccCCCC
Q psy10459 127 YIIMEYAKNGS 137 (335)
Q Consensus 127 ~iv~e~~~~~s 137 (335)
++|++|++|.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.07 E-value=0.085 Score=47.12 Aligned_cols=28 Identities=32% Similarity=0.576 Sum_probs=24.2
Q ss_pred ceeccCCCCCEee------cCCCCEEEecccccc
Q psy10459 172 VVHRDIKCENLLL------DDKYNIKLSDFGFAR 199 (335)
Q Consensus 172 i~H~dikp~Nili------~~~~~~~l~Dfg~~~ 199 (335)
++|+|+.+.|||+ +++..+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999999885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.75 E-value=0.89 Score=36.56 Aligned_cols=113 Identities=13% Similarity=0.136 Sum_probs=77.2
Q ss_pred CCCCeeeeceeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCEeecCC
Q psy10459 109 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID-YCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 109 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~i~H~dikp~Nili~~~ 187 (335)
.||++ -...-..++.+.+.++.-+++.=...++. ++....++++..|+.... ++ ..-+|--|+|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 57887 33444677777777777654433334433 688888999888888655 33 456788899999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHH-HHHHHHHHHHhCCCCC
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIW-SMGVVLFAMVYGRLPF 257 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~-slG~~~~~l~~g~~p~ 257 (335)
+.+++.=.|+-.. ++|. .....|.| ++=|++..++.++..|
T Consensus 121 ~~p~i~hRGi~~~----------------------lpP~-------e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 121 LEPFFLHVGVKES----------------------LPPD-------EWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCEEESCCEETTT----------------------BSSC-------SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred CcEEEEEcCCccc----------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999987776422 2221 11345665 5778888888887766
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.23 E-value=0.59 Score=37.48 Aligned_cols=115 Identities=10% Similarity=0.150 Sum_probs=79.1
Q ss_pred CCCCCeeeeceeEEeCCeEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC
Q psy10459 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNG-SLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD 186 (335)
Q Consensus 108 l~h~~iv~~~~~~~~~~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~ 186 (335)
..||++++. .+-..++.+.+.++.-..+ ++.. ++ .++....+.++..|+....++ ..-+|--|+|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence 368888876 5566677777777665432 3333 32 267888899999998877443 33477889999999999
Q ss_pred CCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHH-HHHHHHHHHHhCCCCCC
Q psy10459 187 KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIW-SMGVVLFAMVYGRLPFD 258 (335)
Q Consensus 187 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~-slG~~~~~l~~g~~p~~ 258 (335)
++.+++.=.|+...+ +|. .....|.| .+=|++..+++++..|.
T Consensus 115 ~~~p~i~~RGik~~l----------------------~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGLPIAKTRGLQNVV----------------------DPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSCEEESCCEETTTB----------------------SCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCCEEEEEccCccCC----------------------CCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999877753221 221 11345665 57889999999988774
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=88.56 E-value=2 Score=36.80 Aligned_cols=135 Identities=13% Similarity=0.123 Sum_probs=75.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeecee-------------
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA------------- 119 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~------------- 119 (335)
+..++..-.|.. .||.+.. ++..|+||-.. ....+.+..++...-.+..|+..-+...
T Consensus 71 v~~I~~s~~Gst-gvff~~t--d~~~~VVK~s~------~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 71 FKGIERSEKGTE-GLFFVET--ESGVFIVKRST------NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp EEEEEECCSTTS-CEEEEEE--SSCEEEEECCT------THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred eeEEEeccCCCC-CeEEEEe--CCCEEEEeCcH------HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 667777777765 4555553 47789999431 2235555566666667777764332211
Q ss_pred E---------EeCCeEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHHhCC-----ceeccCCCCC
Q psy10459 120 I---------ETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQL--ADAIDYCHKKS-----VVHRDIKCEN 181 (335)
Q Consensus 120 ~---------~~~~~~~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i--~~~L~~LH~~~-----i~H~dikp~N 181 (335)
. ...+.++++|+|.+|..|.+.-.. ...+.... +.++ +-++..+..++ +.+.--.++|
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhh
Confidence 0 012256799999987665532110 01123333 2332 33445555442 2223468899
Q ss_pred EeecCCCC-EEEeccccccc
Q psy10459 182 LLLDDKYN-IKLSDFGFARK 200 (335)
Q Consensus 182 ili~~~~~-~~l~Dfg~~~~ 200 (335)
||++.++. +.++|-+++..
T Consensus 218 IL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 218 IMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EEEESBTTCEEECSCCCCCC
T ss_pred eEEeCCCCeEEEEcCCcccc
Confidence 99987554 88999988743
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.88 E-value=0.084 Score=48.11 Aligned_cols=63 Identities=13% Similarity=0.097 Sum_probs=17.4
Q ss_pred EEeeeecccCceEEEEEEEcCCCCeEEE------EEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 54 SLGDVVGMGSYATVKLATSARHSQDVAI------KIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
.+.+.|| ||.||++........||+ |.........+. ...+.+|..+...++|+|+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~-~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR-LTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccc-cccccccccccccccccccCCCcceE
Confidence 3456666 999999998655568888 655433322222 34456788888889999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 335 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-69 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-69 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-64 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-49 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-42 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-73
Identities = 81/265 (30%), Positives = 142/265 (53%), Gaps = 10/265 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G +G G + V LA + +A+K++ K Q ++ L RE+E+ L+HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R RVY+I+EYA G++ ++K DE + + ++LA+A+ YCH K V
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK ENLLL +K++DFG++ + T CG+ Y PE+++G
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-------TLCGTLDYLPPEMIEGRM 180
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 292
+ + D+WS+GV+ + + G+ PF+ Y E K++ RV F ++ + LIS +
Sbjct: 181 HDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-SRVEFTFPDFVTEGARDLISRL 238
Query: 293 LSP-VKFRIQMEDIRQDPWLKEDSN 316
L R + ++ + PW+ +S+
Sbjct: 239 LKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 6e-72
Identities = 87/265 (32%), Positives = 139/265 (52%), Gaps = 8/265 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ L +G G+Y V+LA + + VA+KI+ +A +D + +EI + K L H N
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIK-KEICINKMLNHEN 64
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++F + Y+ +EY G L + I + + E +R+F QL + Y H +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
HRDIK ENLLLD++ N+K+SDFG A + NN + L CG+ Y +PE+LK
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRE---RLLNKMCGTLPYVAPELLKRRE 181
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--ELLKQVQKRVVFPESPRLSSSCKALIS 290
+ + D+WS G+VL AM+ G LP+D + S E +K+ ++ S+ AL+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 291 NILSP-VKFRIQMEDIRQDPWLKED 314
IL RI + DI++D W +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKP 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-69
Identities = 78/271 (28%), Positives = 133/271 (49%), Gaps = 19/271 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G GSY + + + K + + + E+ +++ LKHPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPN 64
Query: 113 LIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKER----YIDEDKGRRWFSQLADAIDY 166
++R+ I T +YI+MEY + G L VI K Y+DE+ R +QL A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 167 CHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
CH++S V+HRD+K N+ LD K N+KL DFG AR + + + ++ F G+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-----FAKAFVGTPY 179
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
Y SPE + + Y + SDIWS+G +L+ + PF + EL ++++ R
Sbjct: 180 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 282 SSSCKALISNILSP-VKFRIQMEDIRQDPWL 311
S +I+ +L+ R +E+I ++P +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-69
Identities = 70/273 (25%), Positives = 130/273 (47%), Gaps = 18/273 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + +G G++ V A + S A K+I + L+ ++ EI+++ HPN
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYM-VEIDILASCDHPN 70
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+++ L A + ++I++E+ G++ V+ ER + E + + Q DA++Y H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL--- 228
++HRD+K N+L +IKL+DFG + K + +F G+ + +PE++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-----SFIGTPYWMAPEVVMCE 185
Query: 229 --KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--RVVFPESPRLSSS 284
K PY ++D+WS+G+ L M P + N +L ++ K + R SS+
Sbjct: 186 TSKDRPYDY-KADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 285 CKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 316
K + L V R + Q P++ DSN
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-68
Identities = 79/263 (30%), Positives = 139/263 (52%), Gaps = 8/263 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ G ++G GS++TV LA S++ AIKI+ K + ++ RE +V+ L HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ + ++Y + YAKNG LL+ IRK DE R + +++ A++Y H K +
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K EN+LL++ +I+++DFG A+ S + + N +F G+ Y SPE+L
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN---SFVGTAQYVSPELLTEKS 186
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISN 291
SD+W++G +++ +V G PF N + +++ K FPE + + L+
Sbjct: 187 ACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEK 243
Query: 292 ILSP-VKFRIQMEDIRQDPWLKE 313
+L R+ E++ LK
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-67
Identities = 73/284 (25%), Positives = 135/284 (47%), Gaps = 17/284 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ + +G G+ TV A Q+VAI+ ++ Q P K+ + EI V++ K+PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPN 78
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ +L + ++++MEY GSL +V+ + DE + + A+++ H V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQV 137
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRDIK +N+LL ++KL+DFGF + + + T G+ + +PE++
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-----TMVGTPYWMAPEVVTRKA 192
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALIS 290
Y P + DIWS+G++ M+ G P+ + N L + +LS+ + ++
Sbjct: 193 YGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 291 NILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKS 333
L V+ R +++ Q +LK S +I K
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKPL----SSLTPLIAAAKE 291
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (537), Expect = 4e-67
Identities = 58/269 (21%), Positives = 117/269 (43%), Gaps = 13/269 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+S +G GS+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
I++ H +++MEY + + ++ + E + + Y H ++
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K N+LL + +KL DFG A + N +F G+ + +PE++ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------SFVGTPYWMAPEVILAMD 187
Query: 233 YTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALI 289
+ D+WS+G+ + + P + N L + Q +S S + +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 290 SNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
+ L + R E + + ++ + P
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-66
Identities = 66/264 (25%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
++G +G GS+ TV + DVA+K+++ L+ F E+ V++ +H N
Sbjct: 10 ITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVN 65
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKS 171
++ F+ T ++ I+ ++ + SL + + K Q A +DY H KS
Sbjct: 66 ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
++HRD+K N+ L + +K+ DFG A S + ++ E GS + +PE+++
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ---FEQLSGSILWMAPEVIRMQ 181
Query: 232 PYTP--QQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSC--- 285
P QSD+++ G+VL+ ++ G+LP+ + N +++ V + + P+ ++ S+C
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 286 -KALISNILSP-VKFRIQMEDIRQ 307
K L++ L R I
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILA 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 206 bits (525), Expect = 1e-65
Identities = 69/277 (24%), Positives = 130/277 (46%), Gaps = 22/277 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP------IDYLKKFLPREIEVVK 106
Y +++G G + V+ ++ A+KII + L++ +E+++++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 107 GLK-HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAID 165
+ HPN+I+ ET +++ + K G L + + ++ + E + R+ L + I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 166 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
HK ++VHRD+K EN+LLDD NIKL+DFGF+ + CG+ +Y +P
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR------EVCGTPSYLAP 178
Query: 226 EILKGVPYTPQQ-----SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPE 277
EI++ D+WS GV+++ ++ G PF +L+ + + PE
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 278 SPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 313
S + K L+S L + R E+ P+ ++
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-65
Identities = 52/270 (19%), Positives = 120/270 (44%), Gaps = 20/270 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+G GS+ TV + +VA + + ++F E E++KGL+HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPN 69
Query: 113 LIRFLQAIETT----HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
++RF + E+T + ++ E +G+L +++ + + R W Q+ + + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 169 KKS--VVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
++ ++HRD+KC+N+ + ++K+ D G A + + ++ G+ + +P
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAP 182
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPESPR-LSS 283
E+ + Y D+++ G+ + M P+ + N +++ ++V V +
Sbjct: 183 EMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 284 SCKALISNILSP-VKFRIQMEDIRQDPWLK 312
K +I + R ++D+ + +
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 206 bits (526), Expect = 7e-65
Identities = 67/284 (23%), Positives = 123/284 (43%), Gaps = 17/284 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G++ V T + A K + P + K+ + +EI+ + L+HP
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPT 84
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKS 171
L+ A E + + +I E+ G L E + E + ED+ + Q+ + + H+ +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 172 VVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VH D+K EN++ K + +KL DFG + G+ +A+PE+ +
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK------VTTGTAEFAAPEVAE 198
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCK 286
G P +D+WS+GV+ + ++ G PF N E L+ V+ + +S K
Sbjct: 199 GKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIP 329
I +L R+ + + PWL + P S+
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 2e-64
Identities = 85/270 (31%), Positives = 137/270 (50%), Gaps = 16/270 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y DV+G G+++ V LA R + VAIK I+K ++ + + EI V+ +KHPN
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK--KALEGKEGSMENEIAVLHKIKHPN 68
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++ E+ +Y+IM+ G L + I ++ + E R Q+ DA+ Y H +
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 173 VHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
VHRD+K ENLL D+ I +SDFG ++ + T CG+ Y +PE+L
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV------LSTACGTPGYVAPEVLA 182
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR---LSSSCK 286
PY+ D WS+GV+ + ++ G PF D N ++L +Q+ K +SP +S S K
Sbjct: 183 QKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
I +++ + R E Q PW+ D+
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 205 bits (522), Expect = 3e-64
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 17/273 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G++ V + K I+ P+D K + EI ++ L HP
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPK 87
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKS 171
LI A E + + +I+E+ G L + I E Y + E + + Q + + + H+ S
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 172 VVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+VH DIK EN++ + K +K+ DFG A K + + + + +A+PEI+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLN------PDEIVKVTTATAEFAAPEIVD 201
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPES--PRLSSSCK 286
P D+W++GV+ + ++ G PF + E L+ V++ F E +S K
Sbjct: 202 REPVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPV 318
I N+L + R+ + D + PWLK D + +
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-63
Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 13/286 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHP 111
+ L ++G GS+ V LA + +Q AIK + K +D + E V+ +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 112 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
L +T ++ +MEY G L+ I+ D + + +++ + + H K
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+V+RD+K +N+LLD +IK++DFG ++ + + TFCG+ Y +PEIL G
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-----TFCGTPDYIAPEILLGQ 178
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALIS 290
Y D WS GV+L+ M+ G+ PF + EL ++ +P L K L+
Sbjct: 179 KYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLV 235
Query: 291 NILSP-VKFRIQME-DIRQDPWLKE-DSNPVGKSKSAPEVIPFKKS 333
+ + R+ + DIRQ P +E + + + + P P KS
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-63
Identities = 68/311 (21%), Positives = 119/311 (38%), Gaps = 55/311 (17%)
Query: 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
L+ + +G G+ V + +A K+I P + + RE++V+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQII-RELQVLHE 60
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
P ++ F A + + I ME+ GSL +V++K I E + + + Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 168 H-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
K ++HRD+K N+L++ + IKL DFG + + +++ +F G+ +Y SPE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPE 173
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---------- 276
L+G Y+ QSDIWSMG+ L M GR P + EL +V
Sbjct: 174 RLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 277 ---------------------------------ESPRLSSSCKALISNILSP-VKFRIQM 302
S S + ++ L R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 303 EDIRQDPWLKE 313
+ + ++K
Sbjct: 293 KQLMVHAFIKR 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 52/289 (17%), Positives = 119/289 (41%), Gaps = 19/289 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + + +G G + V + K + + + +EI ++ +H N
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRN 62
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKS 171
++ ++ E+ + +I E+ + E I + ++E + + Q+ +A+ + H +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 172 VVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+ H DI+ EN++ + IK+ +FG AR+ + + Y +PE+ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR------LLFTAPEYYAPEVHQ 176
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPES--PRLSSSCK 286
+ +D+WS+G +++ ++ G PF ++++ + F E +S
Sbjct: 177 HDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
+ +L K R+ + Q PWLK+ V +K + +
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERV-STKVIRTLKHRRYYH 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-59
Identities = 75/292 (25%), Positives = 129/292 (44%), Gaps = 23/292 (7%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK 109
Y G+ +G G +A VK A K I K + ++ + RE+ ++K ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
HPN+I + E V +I+E G L + + ++ + E++ + Q+ + + Y H
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 170 KSVVHRDIKCENLLLDD----KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 225
+ H D+K EN++L D K IK+ DFG A K N G+ + +P
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN------IFGTPEFVAP 185
Query: 226 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---PRLS 282
EI+ P ++D+WS+GV+ + ++ G PF E L V E S
Sbjct: 186 EIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 283 SSCKALISNILSP-VKFRIQMEDIRQDPWLK--EDSNPVGKSKSAPEVIPFK 331
+ K I +L K R+ ++D Q PW+K + + + S P F+
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP---QFE 293
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (478), Expect = 1e-58
Identities = 68/265 (25%), Positives = 121/265 (45%), Gaps = 12/265 (4%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y LG+++G G + V LA R +DVA+K++ A RE + L HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 113 LIRFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
++ E YI+MEY +L +++ E + + + A+++ H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+ ++HRD+K N+++ +K+ DFG AR + + Q + G+ Y SPE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGTAQYLSPEQA 186
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR---LSSSC 285
+G +SD++S+G VL+ ++ G PF + + Q + P S R LS+
Sbjct: 187 RGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 286 KALISNILSP-VKFRIQ-MEDIRQD 308
A++ L+ + R Q ++R D
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 7e-58
Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 24/274 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP----IDYLKKFLPREIEVVKGL 108
Y +G ++G G + +V + VAIK + K + + + E+ ++K +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP-MEVVLLKKV 64
Query: 109 K--HPNLIRFLQAIETTHRVYIIMEYAKNGSLL-EVIRKERYIDEDKGRRWFSQLADAID 165
+IR L E +I+E + L + I + + E+ R +F Q+ +A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 166 YCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
+CH V+HRDIK EN+L+D ++ +KL DFG K + F G+ Y+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-------KDTVYTDFDGTRVYSP 177
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
PE ++ Y + + +WS+G++L+ MV G +PF+ + ++ +V F R+SS
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFR--QRVSSE 230
Query: 285 CKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
C+ LI L+ R E+I+ PW+++ P
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-57
Identities = 60/260 (23%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L +G G + V L VA+K I + FL E V+ L+H N
Sbjct: 9 LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDAT----AQAFL-AEASVMTQLRHSN 61
Query: 113 LIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHK 169
L++ L +E +YI+ EY GSL++ +R + D ++ + +A++Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+ VHRD+ N+L+ + K+SDFG ++ S T + +PE L+
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWTAPEALR 173
Query: 230 GVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 288
++ +SD+WS G++L+ + +GR+P+ +++ +V+K + +
Sbjct: 174 EKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
Query: 289 ISNILSP-VKFRIQMEDIRQ 307
+ N R +R+
Sbjct: 233 MKNCWHLDAAMRPSFLQLRE 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 186 bits (474), Expect = 2e-57
Identities = 71/285 (24%), Positives = 135/285 (47%), Gaps = 19/285 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + +G GS+ V L S + + A+K++ K + E ++ + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+IR + ++++IM+Y + G L ++RK + + + +++ A++Y H K +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
++RD+K EN+LLD +IK++DFGFA+ T CG+ Y +PE++ P
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--------TLCGTPDYIAPEVVSTKP 177
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISN 291
Y D WS G++++ M+ G PF D+N + +++ + FP P + K L+S
Sbjct: 178 YNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSR 234
Query: 292 ILS------PVKFRIQMEDIRQDPWLKE-DSNPVGKSKSAPEVIP 329
+++ + ED++ PW KE + P
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 186 bits (473), Expect = 7e-57
Identities = 59/295 (20%), Positives = 126/295 (42%), Gaps = 19/295 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPRE---IEVVKGLK 109
+S+ ++G G + V A + A+K + K + + + E + +V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
P ++ A T ++ I++ G L + + E R + +++ +++ H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 229
+ VV+RD+K N+LLD+ ++++SD G A +S G++ Y +PE+L+
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-------SVGTHGYMAPEVLQ 178
Query: 230 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--PRLSSSCKA 287
+D +S+G +LF ++ G PF + + + + S ++
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 288 LISNILSP-VKFRIQM-----EDIRQDPWLKE-DSNPVGKSKSAPEVIPFKKSRN 335
L+ +L V R+ +++++ P+ + D V K P +IP + N
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-57
Identities = 61/288 (21%), Positives = 128/288 (44%), Gaps = 16/288 (5%)
Query: 43 RKLSVLETHGYSLGDVV-GMGSYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLP 99
+KL L+ + D+ G G++ +V+ + DVAIK++ + D ++ +
Sbjct: 1 KKL-FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMM- 57
Query: 100 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKGRRWFS 158
RE +++ L +P ++R + + + ++ME A G L + + +R I
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116
Query: 159 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
Q++ + Y +K+ VHRD+ N+LL +++ K+SDFG ++ +++ Y
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA--RSAGKW 174
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPE 277
+ +PE + ++ +SD+WS GV ++ + YG+ P+ E++ +++
Sbjct: 175 PLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 278 SPRLSSSCKALISNILSP-VKFRIQMEDIRQ---DPWLKEDSNPVGKS 321
P AL+S+ + R + Q + S G
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-56
Identities = 71/298 (23%), Positives = 129/298 (43%), Gaps = 33/298 (11%)
Query: 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNL 113
V+G+G V + R + A+K++ RE+E+ + + P++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHI 67
Query: 114 IRFLQAIETTHR----VYIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYC 167
+R + E + + I+ME G L I+ ++ E + + +AI Y
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 168 HKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
H ++ HRD+K ENLL K +KL+DFGFA++ + +N+ T C + Y +
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT------TPCYTPYYVA 181
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------FPE 277
PE+L Y D+WS+GV+++ ++ G PF + + ++ R+ PE
Sbjct: 182 PEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 278 SPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334
+S K LI N+L R+ + + PW+ + + V+ K R
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 9e-55
Identities = 56/265 (21%), Positives = 114/265 (43%), Gaps = 11/265 (4%)
Query: 58 VVGMGSYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 115
+G G++ TVK + VA+KI+ + L E V++ L +P ++R
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIVR 72
Query: 116 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHR 175
+ E ++ME A+ G L + +++ R++ + Q++ + Y + + VHR
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 176 DIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP 235
D+ N+LL ++ K+SDFG ++ + YK + +PE + ++
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKA--QTHGKWPVKWYAPECINYYKFSS 189
Query: 236 QQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS 294
+SD+WS GV+++ YG+ P+ SE+ ++K L++ +
Sbjct: 190 -KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 295 P-VKFRIQMEDIRQ--DPWLKEDSN 316
V+ R + + + N
Sbjct: 249 YDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (451), Expect = 2e-54
Identities = 57/261 (21%), Positives = 107/261 (40%), Gaps = 9/261 (3%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
+ V+G G + V + VAIK + + FL E ++
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFL-SEASIMGQFD 85
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCH 168
HPN+I + + V II E+ +NGSL +R+ + +A + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+ VHRD+ N+L++ K+SDFG +R + +D + + +PE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 229 KGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287
+ +T SD+WS G+V++ ++ YG P+ D +++ +++ P S+
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 288 LISNILSP-VKFRIQMEDIRQ 307
L+ + R + I
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-54
Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 16/285 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ ++G G++ V L + A+KI+ K E V++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
L A +T R+ +MEYA G L + +ER E++ R + +++ A++Y H + V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
V+RDIK ENL+LD +IK++DFG ++ + K FCG+ Y +PE+L+
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYLAPEVLEDND 181
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISN 291
Y D W +GVV++ M+ GRLPF + ++ L + + + FP + LS K+L++
Sbjct: 182 YGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAG 238
Query: 292 ILSP-VKFRIQM-----EDIRQDPWLKE-DSNPVGKSKSAPEVIP 329
+L K R+ +++ + + + V + K P P
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 35/291 (12%)
Query: 57 DVVGMGSYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLI 114
D +G G +ATV A +Q VAIK I D + + REI++++ L HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 115 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVH 174
L A + ++ ++ + + + + + + ++Y H+ ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 175 RDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYT 234
RD+K NLLLD+ +KL+DFG A+ + N Y + Y +PE+L G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-----QVVTRWYRAPELLFGARMY 178
Query: 235 PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---------------- 278
D+W++G +L ++ + + L ++ + + P
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 279 -----------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
LI + RI + + P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-53
Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 17/271 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L +G G + V + T + VAIK + + +E +V+K L+H
Sbjct: 19 LRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 73
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKK 170
L++ A+ + +YI+ EY GSLL+ ++ E +Y+ + +Q+A + Y +
Sbjct: 74 LVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ VHRD++ N+L+ + K++DFG AR D + + + +PE
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEAALY 188
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289
+T +SD+WS G++L + GR+P+ E+L QV++ P P S L+
Sbjct: 189 GRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247
Query: 290 SNILSP-VKFRIQMEDIRQ--DPWLKEDSNP 317
+ R E ++ + +
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-53
Identities = 59/259 (22%), Positives = 112/259 (43%), Gaps = 13/259 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G G + VK R DVAIK+I + D E +V+ L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 60
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCHKKS 171
L++ ++II EY NG LL +R+ R+ + + +A++Y K
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
+HRD+ N L++D+ +K+SDFG +R D + S ++ PE+L
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 232 PYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290
++ +SDIW+ GV+++ + G++P++ SE + + + + S ++
Sbjct: 177 KFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 291 NILSP-VKFRIQMEDIRQD 308
+ R + + +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-53
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 13/268 (4%)
Query: 53 YSLGDVVGMGSYATVKLAT---SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
L + +G GS+ V+ + + VA+K + RE+ + L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLE-VIRKERYIDEDKGRRWFSQLADAIDYCH 168
H NLIR + T + ++ E A GSLL+ + + + + R+ Q+A+ + Y
Sbjct: 70 HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K +HRD+ NLLL + +K+ DFG R N+ Y + E +A+ +PE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV--MQEHRKVPFAWCAPESL 186
Query: 229 KGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCK 286
K ++ SD W GV L+ M YG+ P+ N S++L ++ K P
Sbjct: 187 KTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245
Query: 287 ALISNILSP-VKFRIQMEDIRQDPWLKE 313
++ + + R +R +L E
Sbjct: 246 NVMVQCWAHKPEDRPTFVALRD--FLLE 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (438), Expect = 1e-52
Identities = 59/269 (21%), Positives = 118/269 (43%), Gaps = 15/269 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
++ +G G Y V ++S VA+K + + ++ +E V+K +KHPN
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPN 74
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKGRRWFSQLADAIDYCHKK 170
L++ L YII E+ G+LL+ + + + +Q++ A++Y KK
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ +HRD+ N L+ + + +K++DFG +R + + + +PE L
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKWTAPESLAY 190
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289
++ +SD+W+ GV+L+ + YG P+ + S++ + ++K L+
Sbjct: 191 NKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249
Query: 290 SNILSP-VKFRIQMEDIRQ--DPWLKEDS 315
R +I Q + +E S
Sbjct: 250 RACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-52
Identities = 59/259 (22%), Positives = 118/259 (45%), Gaps = 15/259 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L + +G G + V + VA+K + + D E ++K L+H
Sbjct: 15 LKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKGRRWFSQLADAIDYCHKK 170
L+R A+ T +YII EY +NGSL++ ++ + +K +Q+A+ + + ++
Sbjct: 70 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 171 SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 230
+ +HRD++ N+L+ D + K++DFG AR D + E + +PE +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKWTAPEAINY 184
Query: 231 VPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289
+T +SD+WS G++L +V +GR+P+ E+++ +++ L+
Sbjct: 185 GTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 290 SNILSP-VKFRIQMEDIRQ 307
+ R + +R
Sbjct: 244 RLCWKERPEDRPTFDYLRS 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-52
Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 40/308 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ +G G+Y V A + VAIK IS + Y ++ L REI+++ +H N
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTL-REIKILLRFRHEN 67
Query: 113 LIRFLQAIET----THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
+I I + ++ + L ++++ + + D + Q+ + Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 126
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
+V+HRD+K NLLL+ ++K+ DFG AR ++ + + Y +PEI+
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 184
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------- 277
+ DIWS+G +L M+ R F +Y + L + + P
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 278 -------------------SPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
P S L+ +L+ RI++E P+L++ +P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 318 VGKSKSAP 325
+ +
Sbjct: 305 SDEPIAEA 312
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-52
Identities = 55/258 (21%), Positives = 114/258 (44%), Gaps = 13/258 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ +G G + V L + VAIK I + + F+ E EV+ L HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFI-EEAEVMMKLSHPK 61
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI-DEDKGRRWFSQLADAIDYCHKKS 171
L++ + ++ E+ ++G L + +R +R + + + + + Y +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
V+HRD+ N L+ + IK+SDFG R D + S +ASPE+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 232 PYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALIS 290
Y+ +SD+WS GV+++ + G++P+++ + SE+++ + + S+ +++
Sbjct: 178 RYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 291 NILSP-VKFRIQMEDIRQ 307
+ + R + +
Sbjct: 237 HCWKERPEDRPAFSRLLR 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (432), Expect = 9e-52
Identities = 68/290 (23%), Positives = 122/290 (42%), Gaps = 36/290 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G G+Y V A + + + A+K I + + REI ++K LKH N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSN 61
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
+++ I T R+ ++ E+ + E ++ + + QL + I YCH + V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K +NLL++ + +K++DFG AR + + Y + Y +P++L G
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-----HEIVTLWYRAPDVLMGSK 176
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-------------- 278
DIWS+G + MV G F + ++ L ++ + + P S
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 279 --------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 313
L S L+S +L RI + + + KE
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-51
Identities = 60/269 (22%), Positives = 116/269 (43%), Gaps = 10/269 (3%)
Query: 45 LSVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKV--QAPIDYLKKFLPREI 102
L +L+ + V+G G++ TV + V I + K +A K + E
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 103 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVI-RKERYIDEDKGRRWFSQLA 161
V+ + +P++ R L T V +I + G LL+ + + I W Q+A
Sbjct: 63 YVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 221
++Y + +VHRD+ N+L+ ++K++DFG A+ +Y +E
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKVPIK 178
Query: 222 YASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPR 280
+ + E + YT QSD+WS GV ++ ++ +G P+D SE+ ++K P+ P
Sbjct: 179 WMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237
Query: 281 LSSSCKALISNILSP-VKFRIQMEDIRQD 308
+ ++ R + ++ +
Sbjct: 238 CTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 4e-51
Identities = 69/319 (21%), Positives = 129/319 (40%), Gaps = 17/319 (5%)
Query: 18 KQERHHSAKTNAEGSDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ 77
K S K + + K + + + +G GS+ V L
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 78 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 137
A+KI+ K + + E +++ + P L++ + + +Y++MEY G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 138 LLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197
+ +R+ E R + +Q+ +Y H +++RD+K ENLL+D + I+++DFGF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 198 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 257
A++ T CG+ +PEI+ Y D W++GV+++ M G PF
Sbjct: 188 AKRVKGRTW--------TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPF 238
Query: 258 DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS------PVKFRIQMEDIRQDPWL 311
++ +++ SS K L+ N+L + + DI+ W
Sbjct: 239 FADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 312 KE-DSNPVGKSKSAPEVIP 329
D + + K IP
Sbjct: 298 ATTDWIAIYQRKVEAPFIP 316
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-51
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
+ + +G G+Y V A + + VA+K I + REI ++K L HPN
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPN 62
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEV-IRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
+++ L I T +++Y++ E+ + I + + QL + +CH
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 172 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 231
V+HRD+K +NLL++ + IKL+DFG AR + V Y + Y +PEIL G
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-----HEVVTLWYRAPEILLGC 177
Query: 232 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES------------- 278
Y DIWS+G + MV R F + + L ++ + + P+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 279 ---------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPV 318
P L ++L+S +L RI + P+ ++ + PV
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-50
Identities = 60/287 (20%), Positives = 116/287 (40%), Gaps = 38/287 (13%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKG 107
G V+G G++ V AT+ S+ VA+K++ + +A + + E++++
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALM-SELKMMTQ 96
Query: 108 L-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-------------------- 146
L H N++ L A + +Y+I EY G LL +R +R
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 147 ---YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203
+ + + Q+A +++ KS VHRD+ N+L+ +K+ DFG AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-- 214
Query: 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNY 262
+D + + +PE L YT +SD+WS G++L+ + G P+
Sbjct: 215 -MSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 263 SELL-KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 307
K +Q + + ++ + + + R ++
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-50
Identities = 56/306 (18%), Positives = 107/306 (34%), Gaps = 44/306 (14%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G G++ V A + Q VA+K + + L REI++++ LKH N
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHEN 70
Query: 113 LIRFLQAIETT--------HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAI 164
++ ++ T +Y++ ++ ++ + + +R L + +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 165 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 224
Y H+ ++HRD+K N+L+ +KL+DFG AR +S+ + + Y
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRP 189
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-------- 276
PE+L G D+W G ++ M L + +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 277 -----------------------ESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 311
++ LI +L P + RI +D +
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ-RIDSDDALNHDFF 308
Query: 312 KEDSNP 317
D P
Sbjct: 309 WSDPMP 314
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 6e-50
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 39/297 (13%)
Query: 44 KLSVLE--THGYSLGDVVGMGSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKK 96
KL LE + +G G++ V A + VA+K++ + +A D
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQAD 62
Query: 97 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY--------- 147
F RE ++ +PN+++ L + ++ EY G L E +R
Sbjct: 63 FQ-REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 148 ---------------IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKL 192
+ + Q+A + Y ++ VHRD+ N L+ + +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 193 SDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV- 251
+DFG +R + + PE + YT +SD+W+ GVVL+ +
Sbjct: 182 ADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFS 237
Query: 252 YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 307
YG P+ + E++ V+ + L+ S R I +
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-50
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 32/289 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-K 109
DV+G G++ V A + D AIK + + + D + F E+EV+ L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFA-GELEVLCKLGH 69
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKG---------------- 153
HPN+I L A E +Y+ +EYA +G+LL+ +RK R ++ D
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 154 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 213
+ + +A +DY +K +HRD+ N+L+ + Y K++DFG +R V
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK------K 183
Query: 214 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 272
+ + E L YT SD+WS GV+L+ +V G P+ +EL +++ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 273 VVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSNPV 318
+ L+ R I + L+E V
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-50
Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 14/262 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLK 109
LG +G G + V VAIK + +KFL +E ++
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFL-QEALTMRQFD 66
Query: 110 HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY-IDEDKGRRWFSQLADAIDYCH 168
HP++++ + I T + V+IIME G L ++ +Y +D + QL+ A+ Y
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 169 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
K VHRDI N+L+ +KL DFG +R D + + +PE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAPESI 181
Query: 229 KGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287
+T SD+W GV ++ + ++G PF ++++ +++ P P + +
Sbjct: 182 NFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 288 LISNILSP-VKFRIQMEDIRQD 308
L++ + R + +++
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-49
Identities = 65/293 (22%), Positives = 140/293 (47%), Gaps = 20/293 (6%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD---VAIKIISKVQAPIDY-LKKFLPREIEVVKGL 108
+ L V+G G+Y V L A+K++ K + E +V++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 109 KH-PNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+ P L+ A +T ++++I++Y G L + + E + + + ++ A+++
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
HK +++RDIK EN+LLD ++ L+DFG ++++ + T+ + FCG+ Y +P+I
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGTIEYMAPDI 201
Query: 228 LKGVPYTP-QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRLSS 283
++G + D WS+GV+++ ++ G PF ++ +R++ P +S+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 284 SCKALISNILSP-VKFRIQM-----EDIRQDPWLKE-DSNPVGKSKSAPEVIP 329
K LI +L K R+ ++I++ + ++ + + + K P
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-48
Identities = 65/295 (22%), Positives = 123/295 (41%), Gaps = 36/295 (12%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y + +G G+Y TV A + + VA+K + L REI ++K LKH N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKN 62
Query: 113 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSV 172
++R + + ++ ++ E+ +D + + + QL + +CH ++V
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 173 VHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVP 232
+HRD+K +NLL++ +KL++FG AR + + Y + Y P++L G
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-----EVVTLWYRPPDVLFGAK 177
Query: 233 YTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQKRVVFPES------------- 278
D+WS G + + P F + + LK++ + + P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 279 ---------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 317
P+L+++ + L+ N+L RI E+ Q P+ + P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-48
Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y+ V+G GS+ V A + VAIK + + K+F RE+++++ L H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCN 74
Query: 113 LIRFLQAIETTHR------VYIIMEYAKNG---SLLEVIRKERYIDEDKGRRWFSQLADA 163
++R ++ + ++++Y R ++ + + + QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 164 IDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
+ Y H + HRDIK +NLLLD D +KL DFG A++ + ++ S Y
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV------SYICSRYY 188
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---- 278
+PE++ G D+WS G VL ++ G+ F + + L ++ K + P
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 279 ------------------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 313
PR AL S +L R+ + + E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
Query: 314 DSNP 317
+P
Sbjct: 309 LRDP 312
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 60/283 (21%), Positives = 117/283 (41%), Gaps = 14/283 (4%)
Query: 32 SDPNEQDKDTERKLSVLETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQ 88
+ + + S L H +V+G G + V T + A+K ++++
Sbjct: 11 PELVQAVQHVVIGPSSLIVH---FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 89 APIDYLKKFLPREIEVVKGLKHPNLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKERY 147
+ +FL E ++K HPN++ L + + +++ Y K+G L IR E +
Sbjct: 68 DI-GEVSQFL-TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 148 -IDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206
+ Q+A + + K VHRD+ N +LD+K+ +K++DFG AR
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSEL 265
D N + + E L+ +T +SD+WS GV+L+ ++ G P+ D N ++
Sbjct: 186 DSVHN-KTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 266 LKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 307
+ + + ++ P + R ++
Sbjct: 244 TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-47
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 45/298 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-- 109
Y +G G+Y V A ++ + VA+K + + RE+ V++ L+
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 67
Query: 110 -HPNLIRFLQAIETTH-----RVYIIMEYAKNGSL-LEVIRKERYIDEDKGRRWFSQLAD 162
HPN++R + ++ ++ E+ E + + + QL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
+D+ H VVHRD+K +N+L+ IKL+DFG AR YS + + Y
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT------SVVVTLWY 181
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---- 278
+PE+L Y D+WS+G + M + F ++ + L ++ + P
Sbjct: 182 RAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 279 ----------------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 313
+ K L+ L+ RI P+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-47
Identities = 59/267 (22%), Positives = 106/267 (39%), Gaps = 12/267 (4%)
Query: 48 LETHGYSLGDVVGMGSYATVKLA----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIE 103
+ + V+G G + V +S + VAIK + FL E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFL-GEAG 61
Query: 104 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV-IRKERYIDEDKGRRWFSQLAD 162
++ H N+IR I + II EY +NG+L + K+ + +A
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 163 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 222
+ Y + VHRD+ N+L++ K+SDFG +R + + + +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR--VLEDDPEATYTTSGGKIPIRW 179
Query: 223 ASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRL 281
+PE + +T SD+WS G+V++ ++ YG P+ + + E++K + P
Sbjct: 180 TAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 282 SSSCKALISNILSP-VKFRIQMEDIRQ 307
S+ L+ R + DI
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-47
Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD-------VAIKIISKVQAPIDYLKKFLPREIEVV 105
LG +G G++ V LA + +D VA+K++ D L + E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLI-SEMEMM 72
Query: 106 KGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR----------------KERYI 148
K + KH N+I L A +Y+I+EYA G+L E ++ E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLK 267
K + + +PE L YT QSD+WS GV+L+ + G P+ EL K
Sbjct: 193 K---TTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 268 QVQKRVVFPESPRLSSSCKALISNILSPV-KFRIQMEDIRQD 308
+++ + ++ ++ + V R + + +D
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 6e-47
Identities = 55/282 (19%), Positives = 101/282 (35%), Gaps = 23/282 (8%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y LG +G GS+ + L T ++VAIK+ L E ++ K ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 113 LIRFLQAIETT-HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
I ++ ++ME R Q+ I+Y H K+
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 172 VVHRDIKCENLL---LDDKYNIKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAYASPE 226
+HRD+K +N L + + DFG A+KY T ++ G+ YAS
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-------P 279
G+ + + D+ S+G VL G LP+ + ++ ++ S
Sbjct: 184 THLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 280 RLSSSCKALISNILSP-VKFRIQMEDIRQ---DPWLKEDSNP 317
S ++ S + +RQ + + ++ +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-45
Identities = 57/294 (19%), Positives = 117/294 (39%), Gaps = 47/294 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
L + +G G + V ++VA+KI S + F EI L+H N
Sbjct: 5 IVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREER----SWFREAEIYQTVMLRHEN 58
Query: 113 LIRFLQAIE----TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH 168
++ F+ A T +++++ +Y ++GSL + + + + + + A + + H
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 117
Query: 169 --------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 220
K ++ HRD+K +N+L+ ++D G A ++ + TD G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTIDIAPNHRVGTK 176
Query: 221 AYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYGRLPFD---------------DT 260
Y +PE+L +++DI++MG+V + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 261 NYSELLKQVQKRVVFPESPRLSSSCKA------LISNILSP-VKFRIQMEDIRQ 307
+ E+ K V ++ + P P SC+A ++ R+ I++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 2e-44
Identities = 47/244 (19%), Positives = 86/244 (35%), Gaps = 14/244 (5%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G +G GS+ + T+ ++Q VAIK + L E K L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 113 LIRFLQAI-ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS 171
I + + ++++ + R Q+ + H+KS
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 172 VVHRDIKCENLLLDDKY-----NIKLSDFGFARKY--SVNNTDYKQNLSETFCGSYAYAS 224
+V+RDIK +N L+ I + DFG + Y V + G+ Y S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 225 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSS 284
G + + D+ ++G V + G LP+ + ++ ++ +S L
Sbjct: 182 INTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 285 CKAL 288
C
Sbjct: 241 CAGF 244
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-44
Identities = 59/293 (20%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 53 YSLGDVVGMGSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
S G +G G++ V AT+ + VA+K++ + ++ L E++V+
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSY 82
Query: 108 LK-HPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY------------------I 148
L H N++ L A +I EY G LL +R++R +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 149 DEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208
D + + Q+A + + K+ +HRD+ N+LL K+ DFG AR ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELL 266
+ + +PE + YT +SD+WS G+ L+ + S+
Sbjct: 203 ---VKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 267 KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSN 316
K +++ + ++ R + I Q + + E +N
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-44
Identities = 58/286 (20%), Positives = 105/286 (36%), Gaps = 29/286 (10%)
Query: 53 YSLGDVVGMGSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 107
++ +G GS+ V VAIK +++ + + + E V+K
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMKE 79
Query: 108 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY----------IDEDKGRRWF 157
+++R L + +IME G L +R R K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 158 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 217
++AD + Y + VHRD+ N ++ + + +K+ DFG R + K
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG---KGL 196
Query: 218 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 276
+ SPE LK +T D+WS GVVL+ + P+ + ++L+ V + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 277 ESPRLSSSCKALISNILSP-VKFRIQMEDIRQ------DPWLKEDS 315
+ L+ K R +I +P +E S
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-44
Identities = 64/302 (21%), Positives = 119/302 (39%), Gaps = 48/302 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y VG G+Y V A R VAIK + + + K+ RE+ ++K ++H N
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHEN 78
Query: 113 LIRFLQAIETTHR------VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
+I L Y++M + G+ L + K + ED+ + Q+ + Y
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
H ++HRD+K NL +++ +K+ DFG AR+ T + + Y +PE
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--------GYVVTRWYRAPE 188
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-------- 278
++ Q DIWS+G ++ M+ G+ F +++ + LK++ K P +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 279 ----------------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 315
S L+ +L + R+ + P+ +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 316 NP 317
+
Sbjct: 309 DT 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-42
Identities = 65/317 (20%), Positives = 123/317 (38%), Gaps = 50/317 (15%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y VG G+Y +V A + VA+K +S+ I + K+ RE+ ++K +KH N
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHEN 78
Query: 113 LIRFLQAIETTHRV-----YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYC 167
+I L + ++ + L +++ ++ D+ + Q+ + Y
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-QFLIYQILRGLKYI 137
Query: 168 HKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 227
H ++HRD+K NL +++ +K+ DFG AR T + + Y +PEI
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--------GYVATRWYRAPEI 189
Query: 228 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--------- 278
+ + Q DIWS+G ++ ++ GR F T++ + LK + + V P +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 279 ---------------------PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 316
+ L+ +L RI + + +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
Query: 317 PVGKSKSAPEVIPFKKS 333
P P P+ +S
Sbjct: 310 P----DDEPVADPYDQS 322
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 143 bits (362), Expect = 5e-41
Identities = 59/303 (19%), Positives = 124/303 (40%), Gaps = 57/303 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP 111
Y L +G G Y+ V A + +++ V +KI+ V+ KK + REI++++ L+ P
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGP 90
Query: 112 NLIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK 169
N+I ++ + ++ E+ N ++ + + + R + ++ A+DYCH
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHS 147
Query: 170 KSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 228
++HRD+K N+++D + ++L D+G A Y S + PE+L
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV------RVASRYFKGPELL 201
Query: 229 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFD------------------------------ 258
D+WS+G +L +M++ + PF
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 259 --DTNYSELL-----KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPW 310
D ++++L K+ ++ V +S + +L + R+ + + P+
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 311 LKE 313
Sbjct: 322 FYT 324
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-39
Identities = 53/280 (18%), Positives = 110/280 (39%), Gaps = 30/280 (10%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKG 107
LG +G G++ V A + + VA+K++ + A + + ++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHI 73
Query: 108 LKHPNLIRFLQAI-ETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDE 150
H N++ L A + + +I+E+ K G+L +R +R ++
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 151 DKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210
+ + Q+A +++ + +HRD+ N+LL +K +K+ DFG AR + ++
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQV 269
+ +PE + YT QSD+WS GV+L+ + P+ E +
Sbjct: 194 G---DARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 270 QKRVVFPESPR-LSSSCKALISNILSP-VKFRIQMEDIRQ 307
K +P + + + R ++ +
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-38
Identities = 68/328 (20%), Positives = 130/328 (39%), Gaps = 61/328 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 112
Y +G G+ V A A ++VAIK +S+ + K+ RE+ ++K + H N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 77
Query: 113 LIRFLQA------IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDY 166
+I L +E VY++ME + + +D ++ Q+ I +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKH 134
Query: 167 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 226
H ++HRD+K N+++ +K+ DFG AR + + + Y +PE
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------YVVTRYYRAPE 188
Query: 227 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---------- 276
++ G+ Y DIWS+G ++ MV ++ F +Y + +V +++ P
Sbjct: 189 VILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 277 -------------------------------ESPRLSSSCKALISNILS--PVKFRIQME 303
+ +S + L+S +L P K RI ++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK-RISVD 306
Query: 304 DIRQDPWLKEDSNPVGKSKSAPEVIPFK 331
D Q P++ +P P++ +
Sbjct: 307 DALQHPYINVWYDPAEVEAPPPQIYDKQ 334
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 1e-27
Identities = 60/328 (18%), Positives = 105/328 (32%), Gaps = 68/328 (20%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISK-------VQAPIDYLKKFLPREIEVV 105
Y L +G G ++TV LA ++ VA+KI+ + I L++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 106 KGLKHPNLIRFLQAIET-----THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQL 160
+ ++++ L H V + +N L + R I ++ QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 161 ADAIDYC-HKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 218
+DY + ++H DIK EN+L++ L A + N +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD---LGNACWYDEHYTNSIQ 191
Query: 219 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---- 274
+ Y SPE+L G P+ +DIWS ++F ++ G F+ K
Sbjct: 192 TREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 275 -------------------------------------------FPESPRLSSSCKALISN 291
+ S + +S
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 292 ILS--PVKFRIQMEDIRQDPWLKEDSNP 317
+L P K R + PWLK+
Sbjct: 311 MLQLDPRK-RADAGGLVNHPWLKDTLGM 337
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 1e-21
Identities = 27/206 (13%), Positives = 60/206 (29%), Gaps = 39/206 (18%)
Query: 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKII-------SKVQAPIDYLKKFLPREIEVV 105
++G ++G G + V S + + +K KV+ DY
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 106 KGLKHPNLIRFLQAIETTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLA 161
+ L + ++ME + + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMIL 113
Query: 162 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY-----KQNLSETF 216
+ + + + +VH D+ N+L+ + I + DF + + +N+ F
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 217 CGSYAYASPEILKGVPYTPQQSDIWS 242
+Y + DI S
Sbjct: 173 SRTYRT--------------EKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.31 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-65 Score=433.64 Aligned_cols=256 Identities=30% Similarity=0.616 Sum_probs=228.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999754322222356678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+++|+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... .+.+..+|+++++||
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 235 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLI 235 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 2345799999999999998887 78999999999999999999999999998888876643 223356899999999
Q ss_pred HHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
.+|| .||.+|||++|+|+||||+.+
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 9999 999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-65 Score=434.40 Aligned_cols=259 Identities=32% Similarity=0.578 Sum_probs=221.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 5799999999999999999999999999999999765432 22456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~--- 159 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 159 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc---
Confidence 99999999999988888999999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc-cccCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQK-RVVFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~-~~~~~~~~~~~~~l~~l 288 (335)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... .....+.. ....+....+|.++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 22345689999999999988887657899999999999999999999765432 23333333 23333345789999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|.+|| .||++|||++|+|+||||++.
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999 999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-63 Score=428.23 Aligned_cols=254 Identities=27% Similarity=0.476 Sum_probs=225.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
.+|++.+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 47999999999999999999999999999999997654332 456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 97 Ey~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 999999999988664 599999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--cCCCCCCCCHHHHHH
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKAL 288 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l~~l 288 (335)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... ..+....+|.++++|
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred -cccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 23455799999999999998887 79999999999999999999999988877766665432 233345689999999
Q ss_pred HHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 289 ISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 289 i~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
|.+|| .||.+|||++|+|+||||+..
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999 999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-63 Score=435.10 Aligned_cols=260 Identities=28% Similarity=0.502 Sum_probs=230.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++++.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45578999999999999999999999999999999997543222222456779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999986543222
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
.....+||+.|+|||++.+..++ .++|+|||||++|+|++|..||.+.+..++.+.+.... .+.+..+|+++++
T Consensus 161 ----~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~d 234 (337)
T d1o6la_ 161 ----TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKS 234 (337)
T ss_dssp ----CBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHH
T ss_pred ----ccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHH
Confidence 23456899999999999999887 79999999999999999999999999999888887643 2333569999999
Q ss_pred HHHHhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 288 LISNIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 288 li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
||++|| .||.+|++ ++++++||||++-
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999 99999994 9999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-63 Score=428.37 Aligned_cols=260 Identities=28% Similarity=0.552 Sum_probs=226.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.....+.....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999753322222245688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||+++++.++|+|||+++.+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-- 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-- 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc--
Confidence 999999999999998889999999999999999999999999999999999999999999999999999876533221
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+.... ...+..+++++++||
T Consensus 165 -~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 165 -ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHH
T ss_pred -cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 123356799999999999988887 79999999999999999999999999999888887643 222346999999999
Q ss_pred HHhc-CCCCCCCCHHH------HhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRIQMED------IRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~~------ll~hp~~~~~ 314 (335)
++|| .||++|||++| +++||||++-
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 9999 99999999998 6899999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-62 Score=428.09 Aligned_cols=257 Identities=32% Similarity=0.556 Sum_probs=213.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.+.|++.+.||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 466999999999999999999999999999999997654432 245677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec---CCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||+||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+. +++.+||+|||++.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999999888899999999999999999999999999999999999995 47889999999997654322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC---CCCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~ 283 (335)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+....+....+...... +..+.+|+
T Consensus 165 -----~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 165 -----VLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred -----eeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 12346799999999999998887 7999999999999999999999999998888888764322 33457999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++++||.+|| .||.+|||++|+|+||||++..
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999 9999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-63 Score=421.64 Aligned_cols=255 Identities=31% Similarity=0.540 Sum_probs=216.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe--CCeEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 127 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 127 (335)
.++|++++.||+|+||+||+|++..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH-HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH-HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3579999999999999999999999999999999987655433 36678899999999999999999999864 45689
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 128 IIMEYAKNGSLLEVIRK----ERYIDEDKGRRWFSQLADAIDYCHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~-----i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 457999999999999999999999876 999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 278 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 278 (335)
..+..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+......+.+
T Consensus 162 ~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~ 235 (269)
T d2java1 162 RILNHDTS-----FAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235 (269)
T ss_dssp HHC----------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC
T ss_pred eecccCCC-----ccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 87643221 23356789999999999988887 7999999999999999999999999999999888876555555
Q ss_pred CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCc
Q psy10459 279 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 311 (335)
Q Consensus 279 ~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~ 311 (335)
..+|+++.+||++|| .||.+|||++|||+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 679999999999999 999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=423.82 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=222.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
+.|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++.+++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4699999999999999999999999999999999764322 2566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 131 EYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 131 e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--- 165 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 165 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH---
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc---
Confidence 99999999998765 45699999999999999999999999999999999999999999999999999976532211
Q ss_pred cccccccccccccccccccC-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc--CCCCCCCC
Q psy10459 210 QNLSETFCGSYAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLS 282 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~ 282 (335)
.....+||+.|+|||++. ...++ .++|||||||++|+|++|..||.+.+..+....+..... .+....+|
T Consensus 166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 242 (288)
T d2jfla1 166 --RRDSFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242 (288)
T ss_dssp --HHTCCCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSC
T ss_pred --cccccccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCC
Confidence 123467999999999984 33445 789999999999999999999999888888877776432 23335789
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+++++||++|| .||.+|||++|+|+||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999 999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-62 Score=424.56 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=228.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 131 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 131 (335)
.|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987766666667778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccccc
Q psy10459 132 YAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 211 (335)
Q Consensus 132 ~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 211 (335)
||.+|+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888899999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-CCCCCCCCHHHHH
Q psy10459 212 LSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKA 287 (335)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~ 287 (335)
....+||+.|+|||++.+. .++ .++|||||||++|+|++|..||.+.+..+....+..... ......+|+++++
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 2245799999999998643 344 789999999999999999999999888887777765443 3334568999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
||.+|| .||.+|||++|+|+||||.+...+
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 999999 999999999999999999875543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-62 Score=425.78 Aligned_cols=255 Identities=27% Similarity=0.536 Sum_probs=228.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999753222222245678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+.||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----
Confidence 999999999999999988999999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... .+..+.+|++++++|
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLL 232 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Confidence 2346899999999999988888 78999999999999999999999999999988887643 233356999999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
.+|| .||.+|+ |++++|+||||++-
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 9999 9999996 99999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-61 Score=416.42 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=227.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.++|++++.||+|+||+||+|.+..+|+.||||++.+...... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999976433221 1256688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC----CEEEeccccccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYS 202 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~----~~~l~Dfg~~~~~~ 202 (335)
|+|||||+||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998888899999999999999999999999999999999999998776 49999999998764
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccC-C--CCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-P--ESP 279 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~--~~~ 279 (335)
.... .....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+...... + ..+
T Consensus 169 ~~~~------~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 169 FGNE------FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TSCB------CSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCcc------ccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 3322 2345789999999999988777 8999999999999999999999999999988888764322 2 125
Q ss_pred CCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+|.++++||++|| .||.+|||++|+|+||||++...
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 68999999999999 99999999999999999986433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-61 Score=409.94 Aligned_cols=250 Identities=20% Similarity=0.453 Sum_probs=215.7
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe----CCeEEE
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THRVYI 128 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~i 128 (335)
|++.++||+|+||+||+|.+..+++.||+|++........ ..+.+.+|++++++++||||+++++++.. ++.+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4678899999999999999999999999999987655433 35678899999999999999999999865 356899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEeec-CCCCEEEeccccccccccCC
Q psy10459 129 IMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKS--VVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--i~H~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~ 205 (335)
||||+++|+|.+++.+...+++..+..++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||+++.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999998888999999999999999999999998 99999999999996 4789999999999754322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHccccCCC-CCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPE-SPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~-~~~~~~ 283 (335)
.....+||+.|+|||++.+ .++ .++|||||||++|+|++|..||.+. +...+...+..+...+. ...+++
T Consensus 169 ------~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 169 ------FAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240 (270)
T ss_dssp ------SBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ------ccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence 2335679999999999876 466 8999999999999999999999764 45666666665543322 245789
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLK 312 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~ 312 (335)
++++||.+|| .||++|||++|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999 9999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-62 Score=428.04 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=217.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++++.||+|+||+||+|.+..+|+.||+|+++..... .....+.+|+.+++.++|||||+++++|.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4567899999999999999999999999999999999765433 23567789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999988889999999999999999999997 59999999999999999999999999999865422
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK------------------- 267 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~------------------- 267 (335)
.....+||..|+|||++.+..++ .++|||||||++|||++|+.||.+.+......
T Consensus 159 -----~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 -----MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp -----TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred -----ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 23356899999999999998888 78999999999999999999997654322111
Q ss_pred -----------------------HHHccccCC-CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 268 -----------------------QVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 268 -----------------------~i~~~~~~~-~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
.+....... ....+|.++++||.+|| .||.+|||++|+|+||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 001000000 11246899999999999 99999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-61 Score=426.27 Aligned_cols=259 Identities=24% Similarity=0.477 Sum_probs=227.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 358999999999999999999999999999999996543 22356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC--CCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||+||+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999999854 457999999999999999999999999999999999999964 57899999999987654322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-CCC--CCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~--~~~~~~ 283 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..... .+. ...+|.
T Consensus 182 ------~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 182 ------VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ------EEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ------cceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2345789999999999988887 789999999999999999999999999988888876432 222 246899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 318 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~ 318 (335)
++++||.+|| .||++|||++|+|+||||++...+.
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 9999999999 9999999999999999999875543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-61 Score=425.70 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=227.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999976432 2256678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeec--CCCCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~--~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||+||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999999887654 4699999999999999999999999999999999999998 568999999999987654322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cCC--CCCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFP--ESPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~~ 283 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.... .++ ....+|+
T Consensus 185 ------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 185 ------VKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ------eeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2345789999999999998887 79999999999999999999999999998888887643 222 2357999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
++++||.+|| .||.+|||++|+|+||||++....
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 9999999999 999999999999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-60 Score=407.84 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=227.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCCh------HHHHhhHHHHHHHHHcCC-CCCeeeeceeEEe
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPI------DYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 122 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 122 (335)
.++|++.+.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997654321 233456789999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
++..||||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccccccccccccccccccCC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-cC-
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VF- 275 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-~~- 275 (335)
.... ....+||..|+|||++.+ ....+.++||||+||++|+|++|..||.+.+.......+.... ..
T Consensus 162 ~~~~------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 162 PGEK------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp TTCC------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCc------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 4322 234578999999999853 2222478999999999999999999999999988888776643 22
Q ss_pred -CCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 276 -PESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 276 -~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
+....+|+++++||.+|| .||.+|||++|||+||||++.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 233479999999999999 999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-61 Score=427.59 Aligned_cols=259 Identities=20% Similarity=0.355 Sum_probs=216.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHH---HHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP---REIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..++|++.+.||+|+||+||+|++..+|+.||||++.+...........+. .++.+++.++||||+++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467899999999999999999999999999999999753322111122233 44667778889999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998664322
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--cccCCCCCCCCH
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--RVVFPESPRLSS 283 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~ 283 (335)
....+||+.|+|||++......+.++|||||||++|+|++|..||.+............ ....+.+..+|+
T Consensus 162 -------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 162 -------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp -------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred -------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 23457999999999997654333899999999999999999999987654333332222 222333457999
Q ss_pred HHHHHHHHhc-CCCCCCCC-----HHHHhcCCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQ-----MEDIRQDPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps-----~~~ll~hp~~~~~ 314 (335)
++++||.+|| .||.+||| ++|+++||||++-
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999 99999999 8999999999873
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-61 Score=424.34 Aligned_cols=255 Identities=25% Similarity=0.460 Sum_probs=227.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999999999999999999753221122245677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||+.||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..... .....+++++.+||
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLL 269 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHH
T ss_pred ---cccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHH
Confidence 2345799999999999998887 799999999999999999999999999988888876542 23357999999999
Q ss_pred HHhc-CCCCCCC-----CHHHHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRI-----QMEDIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rp-----s~~~ll~hp~~~~~ 314 (335)
++|| .||.+|+ |+++|++||||++-
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 9999 9999995 99999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-61 Score=420.54 Aligned_cols=257 Identities=29% Similarity=0.498 Sum_probs=223.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHH-HcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
++|.+++.||+|+||+||+|.+..+|+.||||++++.....+.....+..|..++ +.++||||+++++++.+.+.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999753221111133444666655 478999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcccc
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 209 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 209 (335)
|||++||+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--- 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--- 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999986543322
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHH
Q psy10459 210 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALI 289 (335)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 289 (335)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..++...+.... .+....+|+++.+||
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 159 --KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLL 234 (320)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred --cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHH
Confidence 23345799999999999998888 79999999999999999999999999999988887543 223346899999999
Q ss_pred HHhc-CCCCCCCCHH-HHhcCCCcCCC
Q psy10459 290 SNIL-SPVKFRIQME-DIRQDPWLKED 314 (335)
Q Consensus 290 ~~~L-~~p~~Rps~~-~ll~hp~~~~~ 314 (335)
++|| .||.+||++. ++++||||++-
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999 9999999996 89999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-60 Score=413.27 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=218.6
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC--hHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEec
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 132 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 132 (335)
.+++||+|+||+||+|.+..+|+.||||+++..... .+.....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999999999999999998754332 122345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccc
Q psy10459 133 AKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 212 (335)
Q Consensus 133 ~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 212 (335)
+.++++..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-----~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-----A 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----C
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----c
Confidence 99877777776677799999999999999999999999999999999999999999999999999976644322 1
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC---------------
Q psy10459 213 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------------- 277 (335)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------------- 277 (335)
....+||+.|+|||++......+.++|||||||++|+|++|..||.+.+..+....+.+....+.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 23457899999999987665544899999999999999999999999998888777754321111
Q ss_pred ------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCCC
Q psy10459 278 ------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGK 320 (335)
Q Consensus 278 ------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~~ 320 (335)
...+++++.+||++|| .||++|||++|+|+||||++...+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~ 292 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence 1246889999999999 999999999999999999987666554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-60 Score=413.55 Aligned_cols=255 Identities=20% Similarity=0.419 Sum_probs=225.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEE
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv 129 (335)
.++|.+++.||+|+||+||+|.+..+|+.||||+++.... + ...+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--D--QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--H--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--c--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976432 2 45577999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC--CCEEEeccccccccccCCc
Q psy10459 130 MEYAKNGSLLEVIRKER-YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~--~~~~l~Dfg~~~~~~~~~~ 206 (335)
||||+||+|.+++...+ .+++.+++.++.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++........
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999999997654 69999999999999999999999999999999999999854 4799999999987643322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcccc-CCC--CCCCCH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSS 283 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~--~~~~~~ 283 (335)
....+|++.|+|||...+..++ .++|||||||++|+|++|..||.+.+..+....+..... ++. .+.+|.
T Consensus 160 ------~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 160 ------FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ------EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ------ccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 2345689999999999988887 799999999999999999999999999999888876432 222 246899
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
++++||++|| .||.+|||++|+|+||||++..
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 9999999999 9999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-58 Score=402.86 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=219.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|.+..+|+.||||++...... +.....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 6899999999999999999999999999999999654322 223566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 131 EYAKNGSLLEVIR-K-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 131 e~~~~~sL~~~l~-~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
||+.+ ++..++. . .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||.+........
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 99976 5555543 3 45699999999999999999999999999999999999999999999999999976543222
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-----------
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------- 277 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 277 (335)
......||+.|+|||++....+.+.++|+|||||++|+|++|+.||.+.+..+....+......+.
T Consensus 158 ---~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 ---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp ---CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ---cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 233457899999999988877766899999999999999999999999887776666543211110
Q ss_pred -----------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 -----------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 -----------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
.+.++.++++||++|| .||.+|||++|+|+||||++-..|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 1357899999999999 99999999999999999998776655
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-58 Score=399.94 Aligned_cols=259 Identities=21% Similarity=0.343 Sum_probs=212.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC---eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|++.++||+|+||+||+|.+..+++ .||||.+..... +...+.+.+|+.++++++|||||++++++..+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566789999999999999999999877665 578888755433 33356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+.+++||||+++|+|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988774 469999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
...............||+.|+|||++.+..++ .++|||||||++|||+| |..||.+....++...+..+...+....+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 44332222223345678999999999888877 78999999999999998 89999999999999999988888887889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+.++.+||.+|| .||++|||+.||+++
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 999999999998865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-58 Score=396.79 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=216.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|+++++||+|+||+||+|++. +|+.||||++..... .+.....+.+|+.+++.++||||+++++++..++..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999985 789999999976533 2223566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+++.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc----
Confidence 9998877777777678899999999999999999999999999999999999999999999999999976643322
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC--------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-------------- 276 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------- 276 (335)
......|++.|+|||.+.+..+.+.++|+|||||++|+|++|+.||.+.+..+....+......+
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 12334678999999999877665689999999999999999999999988887777664321111
Q ss_pred --------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCC
Q psy10459 277 --------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 313 (335)
Q Consensus 277 --------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~ 313 (335)
....+++++.+||++|| .||++|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 01357899999999999 99999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-58 Score=397.38 Aligned_cols=253 Identities=29% Similarity=0.508 Sum_probs=213.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChH---HHHhhHHHHHHHHHcCC--CCCeeeeceeEEeCC
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK--HPNLIRFLQAIETTH 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~ 124 (335)
.++|++.+.||+|+||+||+|++..+|+.||||++........ .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3579999999999999999999999999999999975432211 11234568999999986 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC-CCEEEeccccccccc
Q psy10459 125 RVYIIMEYAKN-GSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYS 202 (335)
Q Consensus 125 ~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~-~~~~l~Dfg~~~~~~ 202 (335)
..++||||+.+ +++.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 5888899888889999999999999999999999999999999999999854 789999999997653
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.. .....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+ . .+.....+ ...+|
T Consensus 163 ~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~---i~~~~~~~--~~~~s 228 (273)
T d1xwsa_ 163 DT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---IIRGQVFF--RQRVS 228 (273)
T ss_dssp SS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHCCCCC--SSCCC
T ss_pred cc-------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H---HhhcccCC--CCCCC
Confidence 22 23356799999999999877776577999999999999999999997632 1 12222333 34699
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
+++++||++|| .||++|||++|+|+||||++...
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 99999999999 99999999999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=406.22 Aligned_cols=251 Identities=27% Similarity=0.523 Sum_probs=208.4
Q ss_pred cCCeEEee-eecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHH-cCCCCCeeeeceeEEe----C
Q psy10459 50 THGYSLGD-VVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK-GLKHPNLIRFLQAIET----T 123 (335)
Q Consensus 50 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~ 123 (335)
.++|.+.. .||+|+||+||+|.+..+|+.||||+++. ...+.+|+.++. .++||||++++++|.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 45799875 59999999999999999999999999975 344668998865 4589999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFA 198 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~ 198 (335)
+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6789999999999999999764 36999999999999999999999999999999999999985 457999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc-----
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV----- 273 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~----- 273 (335)
+....... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 162 KETTSHNS------LTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp EECCCCCC------CCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred eeccCCCc------cccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 87654322 2345799999999999988888 79999999999999999999998766544444443322
Q ss_pred cCCC--CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 274 VFPE--SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 274 ~~~~--~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
.+|. ...+|+++++||++|| .||++|||++|+|+||||++..
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 2222 1358999999999999 9999999999999999997643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-57 Score=393.83 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=222.4
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCe
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 125 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 125 (335)
..+..++|++.+.||+|+||+||+|.+..+|+.||||+++..... .+.+.+|+.+++.++|||||++++++..++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 346678899999999999999999999999999999998765443 4457799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999764 4689999999999999999999999999999999999999999999999999987654
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR-LPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~-~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
.... ......|+..|+|||++.+..++ .++|||||||++|||++|. +||.+.+...+.+.+..+...+....+|
T Consensus 168 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (287)
T d1opja_ 168 DTYT----AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242 (287)
T ss_dssp SSSE----EETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCce----eeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccch
Confidence 3221 12234578899999999888887 8999999999999999954 5566777888888888877777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
.++.+||.+|| .||++|||+++|++
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999 99999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=387.14 Aligned_cols=251 Identities=21% Similarity=0.381 Sum_probs=212.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEE
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 127 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (335)
+..++|++.+.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.+++.++||||+++++++..++..+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45678999999999999999999975 5678999999765443 345779999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998765 5589999999999999999999999999999999999999999999999999976643322
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHH
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSC 285 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 285 (335)
. ......||..|+|||++.+..++ .++|||||||++|||++ |.+||...+..++...+..+...+.+..+++++
T Consensus 157 ~----~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 231 (263)
T d1sm2a_ 157 T----SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred e----eecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence 1 12345689999999999988887 79999999999999999 688888888888999998887777767889999
Q ss_pred HHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 286 KALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 286 ~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.+||.+|| .||++|||+++|++|
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999 999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=391.63 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=213.7
Q ss_pred eeecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEEeccC
Q psy10459 57 DVVGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 57 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
++||+|+||+||+|.+.. +++.||||+++..... ....+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 469999999999998643 4578999999754332 33356788999999999999999999998654 5789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccccccc
Q psy10459 135 NGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 214 (335)
Q Consensus 135 ~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 214 (335)
+|+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.+....... ....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~--~~~~ 168 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQT 168 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--EC--
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc--cccc
Confidence 99999999998889999999999999999999999999999999999999999999999999998765433221 1233
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc
Q psy10459 215 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 293 (335)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L 293 (335)
...||+.|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+...+.+..+|.++.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence 45689999999999887777 79999999999999998 89999999999999999888777777789999999999999
Q ss_pred -CCCCCCCCHHHH---hcCCCc
Q psy10459 294 -SPVKFRIQMEDI---RQDPWL 311 (335)
Q Consensus 294 -~~p~~Rps~~~l---l~hp~~ 311 (335)
.||.+|||+++| |+|+|+
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999998 567665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=392.34 Aligned_cols=260 Identities=20% Similarity=0.374 Sum_probs=223.8
Q ss_pred cccCCeEEeee-ecccCceEEEEEEEcC--CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC
Q psy10459 48 LETHGYSLGDV-VGMGSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 124 (335)
Q Consensus 48 ~~~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 124 (335)
+..++|.+.+. ||+|+||+||+|.+.. ++..||||+++.... ....+.+.+|+.++++++|||||++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 55678889885 9999999999998754 345799999976433 2335678899999999999999999999865 4
Q ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 678999999999999998653 5699999999999999999999999999999999999999999999999999987754
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
..... ......+||+.|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+...+.++.+|
T Consensus 162 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 238 (285)
T d1u59a_ 162 DDSYY--TARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238 (285)
T ss_dssp CSCEE--CCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccc--ccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 33221 223345689999999999887777 79999999999999998 999999999889999998887777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHH---hcCCCcCC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDI---RQDPWLKE 313 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~l---l~hp~~~~ 313 (335)
+++.+||.+|| .||++|||+.+| |+|+|+.-
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999 999999999888 67888753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=389.11 Aligned_cols=255 Identities=22% Similarity=0.406 Sum_probs=221.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+. ++..||||+++..... .+.+.+|+.++++++|||||++++++. ++..
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~ 82 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCe
Confidence 466778999999999999999999975 5778999999765443 345789999999999999999999875 4567
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 8999999999999977433 35899999999999999999999999999999999999999999999999999876543
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
... ......||..|+|||++.+..++ .++|||||||++|||+| |.+||......+....+..+...+.+..++.
T Consensus 163 ~~~----~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 163 EYT----AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp CEE----CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccc----cccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 221 23345689999999999887777 79999999999999999 5667778888888999988877777778999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc--CCCcC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ--DPWLK 312 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~--hp~~~ 312 (335)
++.+||.+|| .||++|||+++|++ |+||.
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999 99999999999998 78875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-57 Score=382.45 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=223.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 128 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~i 128 (335)
..++|+++++||+|+||+||+|++ .++..||||+++..... .+.+.+|+.++..++||||+++++++..++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 456899999999999999999997 47789999999875544 3457799999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCcc
Q psy10459 129 IMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 207 (335)
Q Consensus 129 v~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 207 (335)
||||+.+|+|..++.. ...+++..++.++.|+++||.|||+.||+||||||+|||++.++.+||+|||++..+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998765 456899999999999999999999999999999999999999999999999999766443221
Q ss_pred cccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCHHHH
Q psy10459 208 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCK 286 (335)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 286 (335)
......||..|+|||++.+..++ .++|||||||++|||+| |..||.+.+..++...+..+...+.+..++.++.
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ----eecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence 12345689999999999988887 79999999999999998 8999999999999999998887777778999999
Q ss_pred HHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 287 ALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 287 ~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+||++|| .||++|||+++|++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999 999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-57 Score=388.20 Aligned_cols=259 Identities=24% Similarity=0.437 Sum_probs=215.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----e
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----R 125 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 125 (335)
.++|++.+.||+|+||+||+|.+..+|+.||||+++............+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998766555555677889999999999999999999987654 4
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++..+++|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC---CCCCCC
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---ESPRLS 282 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~ 282 (335)
.. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......+ ....+|
T Consensus 166 ~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 166 NS--VTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cc--ccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 21 1223456799999999999988887 78999999999999999999999998888777666543332 235799
Q ss_pred HHHHHHHHHhc-CCCCCCC-CHHHHhcCCCcC
Q psy10459 283 SSCKALISNIL-SPVKFRI-QMEDIRQDPWLK 312 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rp-s~~~ll~hp~~~ 312 (335)
+++.+||.+|| .||.+|| |++++ .|+|++
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 99999999999 9999999 55555 456553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=391.22 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=211.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-CCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC---CCCCeeeeceeEEe---
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIET--- 122 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~--- 122 (335)
.++|++++.||+|+||+||+|++..+ ++.||||+++....... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999665 66799999975433221 133455777776655 79999999998853
Q ss_pred --CCeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 123 --THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 123 --~~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
....+++||++.++.+...... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3478999999988666544433 3568999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC---
Q psy10459 200 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--- 276 (335)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 276 (335)
...... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 165 ~~~~~~------~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 165 IYSFQM------ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCGGG------GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhcccc------cCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 553322 23456799999999999998888 89999999999999999999999999888877764321111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 277 -----------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 277 -----------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
....+++++++||++|| .||++|||++|+|+||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 11357899999999999 999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-56 Score=384.47 Aligned_cols=259 Identities=24% Similarity=0.420 Sum_probs=221.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeEEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 130 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 130 (335)
++|++++.||+|+||+||+|++..+|+.||||+++..... +.....+.+|+.+++.++|+||+++++++...+..++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 5899999999999999999999999999999999765443 334667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccccc
Q psy10459 131 EYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 210 (335)
Q Consensus 131 e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 210 (335)
+++.+++|..++...+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||.+.........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999998888888999999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHccccCC-------------
Q psy10459 211 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVVFP------------- 276 (335)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~------------- 276 (335)
.....++..|+|||++....+.+.++|||||||++|+|++|..|| .+.+..+....+......+
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 223356788999999987776558999999999999999999985 5556666665553311111
Q ss_pred ---------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 277 ---------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 277 ---------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
....+++++.+||++|| .||++|||++|+|+||||++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 11357889999999999 9999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=391.50 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=215.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----eE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 126 (335)
++|++++.||+|+||+||+|.+..+|+.||||+++.... ....+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 579999999999999999999999999999999976443 333567789999999999999999999986543 23
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 206 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 206 (335)
+++++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 4444556689999999765 599999999999999999999999999999999999999999999999999987644332
Q ss_pred ccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC----------
Q psy10459 207 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---------- 276 (335)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 276 (335)
. .......+||+.|+|||++......+.++||||+||++|+|++|..||.+.+..+...........+
T Consensus 165 ~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 165 H--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp B--CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred c--ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 1223456799999999998766555589999999999999999999999887766655543321111
Q ss_pred --------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 277 --------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 277 --------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
..+.++.++++||.+|| .||.+|||++|+|+||||++...+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~ 306 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGG
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCcc
Confidence 12457889999999999 99999999999999999997766544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=385.20 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=207.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|.+.+.||+|+||+||+|+.. ..||||+++....... ..+.+.+|+.++++++||||+++++++. ++.+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTT-HHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 466788999999999999999999843 3699999976544333 3567889999999999999999999864 4568
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCC
Q psy10459 127 YIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 205 (335)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999997664322
Q ss_pred cccccccccccccccccccccccCCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHccccCCC----
Q psy10459 206 TDYKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE---- 277 (335)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~---- 277 (335)
.. .......||+.|+|||++.+. .++ .++|||||||++|||++|..||.+.+.. .....+......|.
T Consensus 159 ~~---~~~~~~~gt~~y~APE~l~~~~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 159 GS---HQFEQLSGSILWMAPEVIRMQDKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred Cc---ccccccccCcccCCHHHHhcccCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 21 123356789999999998643 344 7899999999999999999999886644 44455555544432
Q ss_pred CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 278 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 278 ~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
...+|+++.+||.+|| .||.+|||+++|+++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3468999999999999 999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=393.30 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=215.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC-----eEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ-----DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|+++++||+|+||+||+|++...++ .||+|.+...... .....+.+|+.++.++ +|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4666889999999999999999999876544 6899988654332 2256678999999988 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKER-----------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDI 177 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~~-----------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~di 177 (335)
...+.+++|||||++|+|.++++... .+++..++.++.||+.||.|||+.||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999999999999997542 4789999999999999999999999999999
Q ss_pred CCCCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q psy10459 178 KCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLP 256 (335)
Q Consensus 178 kp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p 256 (335)
||+|||++.++.+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||++|||++ |..|
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCS
T ss_pred chhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999765443221 112345689999999999888887 79999999999999997 8999
Q ss_pred CCCCCHHH-HHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 257 FDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 257 ~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
|.+.+..+ ..+.+......+.+..+|+++++||.+|| .||++|||++||++|
T Consensus 267 f~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98866544 44455556666666789999999999999 999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=389.83 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=213.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-------
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 122 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------- 122 (335)
.++|++++.||+|+||+||+|++..+|+.||||++...... +.....+.+|+.+++.++|+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 47899999999999999999999999999999998654432 2224556799999999999999999998754
Q ss_pred -CCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 -THRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 -~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
++..|++|||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999987666655555677999999999999999999999999999999999999999999999999999776
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCCC---
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--- 278 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 278 (335)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 168 ~~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccc-ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 543322 1122344579999999999987644448999999999999999999999998888877776553221111
Q ss_pred ----------------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 279 ----------------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 279 ----------------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
...++++.+||.+|| .||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 013678899999999 999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=381.11 Aligned_cols=257 Identities=24% Similarity=0.422 Sum_probs=217.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCCeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 126 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (335)
.+..++|++.+.||+|+||+||+|.+.. +..||||++...... .+.+.+|+.+++.++|+|||++++++. ++.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCe
Confidence 4667889999999999999999999864 467999999765443 356789999999999999999999985 4567
Q ss_pred EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 127 YIIMEYAKNGSLLEVIRK--ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 899999999999988854 456999999999999999999999999999999999999999999999999999766432
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCCH
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSS 283 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (335)
.. .......||+.|+|||++....++ .++|||||||++|||++ |.+|+......+....+......+....++.
T Consensus 167 ~~----~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 167 EY----TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred Cc----eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence 22 122345689999999999888887 79999999999999999 5666677888888888888887787788999
Q ss_pred HHHHHHHHhc-CCCCCCCCHHHHhc--CCCcCCC
Q psy10459 284 SCKALISNIL-SPVKFRIQMEDIRQ--DPWLKED 314 (335)
Q Consensus 284 ~l~~li~~~L-~~p~~Rps~~~ll~--hp~~~~~ 314 (335)
++++||.+|| .||++|||+++|++ ++||...
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999 99999999999998 8999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=391.94 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=211.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC-----
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 124 (335)
.++|++++.||+|+||+||+|.+..+|+.||||+++..... +...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 57899999999999999999999999999999999765443 334567789999999999999999999997654
Q ss_pred -eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 125 -RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 125 -~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
.+|+||||+ +.+|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 6678777754 5699999999999999999999999999999999999999999999999999976543
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCC-------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------- 276 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------- 276 (335)
. .....||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+......+
T Consensus 174 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 174 E--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp S--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred c--------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 2 2345789999999999876665589999999999999999999999888776655543311110
Q ss_pred -----------------------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCC
Q psy10459 277 -----------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 315 (335)
Q Consensus 277 -----------------------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~ 315 (335)
....+++++.+||++|| .||.+|||++|||+||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11457899999999999 9999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=391.75 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=209.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------CCe
Q psy10459 52 GYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------THR 125 (335)
Q Consensus 52 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 125 (335)
+|..+++||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++|+||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999976432 23379999999999999999999854 235
Q ss_pred EEEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEecccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVI---RKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKY 201 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~ 201 (335)
+++||||++++.+..+. .....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 79999999765333332 3455799999999999999999999999999999999999999775 8999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccc--------
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-------- 273 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~-------- 273 (335)
..... ....+|+..|+|||.+.+....+.++|||||||++|+|++|..||...+..+....+.+..
T Consensus 174 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGEP------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CTTSC------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCcc------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 43322 2345789999999998766544489999999999999999999999888777766654211
Q ss_pred ----------cCC----------CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCC
Q psy10459 274 ----------VFP----------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 317 (335)
Q Consensus 274 ----------~~~----------~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~ 317 (335)
.++ ..+.+++++.+||.+|| .||.+|||+.|+|+||||++...+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 111 12357899999999999 999999999999999999876443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=377.93 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=213.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC----CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+....|++.++||+|+||+||+|.+..++ ..||||++..... +.....+.+|+.+++.++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 456678999999999999999999876554 3699999865433 2235567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
.+..++||||+.++++.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999988654 56999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
...... ........||..|+|||++.+..++ .++|||||||++|||++ |.+|+......++...+..+...+....
T Consensus 161 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEA--TYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCCCcc--ceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchh
Confidence 443221 1123345689999999999888887 79999999999999998 5666777788888888888887777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
++.++.+||.+|| .||++|||+.+|++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999 99999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=391.69 Aligned_cols=261 Identities=24% Similarity=0.474 Sum_probs=217.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc---CCCCeEEEEEEecCCCC-hHHHHhhHHHHHHHHHcCCC-CCeeeeceeEEeC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 123 (335)
..++|++++.||+|+||+||+|.+. .+|+.||||++.+.... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 3477999999999999999999873 46889999998653221 11124566789999999976 8999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.++++|||+.+++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---cccCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESP 279 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~ 279 (335)
.... ......|++.|+|||.+.+.. +.+.++|||||||++|+|++|..||.+....+....+.. ....+...
T Consensus 182 ~~~~----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 182 DETE----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp GGGG----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred cccc----cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 3222 133457899999999997654 334789999999999999999999987654433333322 22333345
Q ss_pred CCCHHHHHHHHHhc-CCCCCCC-----CHHHHhcCCCcCC
Q psy10459 280 RLSSSCKALISNIL-SPVKFRI-----QMEDIRQDPWLKE 313 (335)
Q Consensus 280 ~~~~~l~~li~~~L-~~p~~Rp-----s~~~ll~hp~~~~ 313 (335)
.+|+++.+||.+|| .||.+|| +++|+|+||||++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 79999999999999 9999999 5899999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=378.83 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=210.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC---CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|++++.||+|+||+||+|.+..++ ..||||.++... .+.....+.+|+.+++.++||||+++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 355678999999999999999999986543 457888775433 3444677889999999999999999999985 5
Q ss_pred CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998765 4568999999999999999999999999999999999999999999999999998664
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRL 281 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 281 (335)
..... ......||+.|+|||++.+..++ .++|||||||++|||++ |..||.+.+..++...+..+...+.++.+
T Consensus 160 ~~~~~----~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~ 234 (273)
T d1mp8a_ 160 DSTYY----KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred CCcce----eccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 32221 22345689999999999888887 79999999999999998 89999999999999999888877777889
Q ss_pred CHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 282 SSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 282 ~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
|.++.+||.+|| .||.+|||++||++|
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999 999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=389.48 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=217.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC-----C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 124 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 124 (335)
.++|++++.||+|+||+||+|++..+|+.||||+++........ ...+.+|+.+++.++|+||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH-HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH-HHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 57899999999999999999999999999999999865544333 45677999999999999999999998643 2
Q ss_pred eEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccC
Q psy10459 125 RVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 204 (335)
Q Consensus 125 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 204 (335)
..+++++++.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 34566777789999999855 46999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC-------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------- 277 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------- 277 (335)
.....|+..|+|||+..+..+.+.++|||||||++|+|++|..||.+.+.......+......+.
T Consensus 175 --------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 175 --------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp --------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred --------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 23457899999999988877666899999999999999999999999888777776654322211
Q ss_pred -----------------------CCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCCCCC
Q psy10459 278 -----------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 319 (335)
Q Consensus 278 -----------------------~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~~~~ 319 (335)
...+++++++||++|| .||.+|||++|+|+||||++...+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 1357899999999999 99999999999999999998755443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=381.89 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=214.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCC----eEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQ----DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 122 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 122 (335)
.+...+|+++++||+|+||+||+|.+..+|+ .||+|.+...... ...+.+.+|+.+++.++|||||++++++..
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3455679999999999999999999988776 4777777543222 225567899999999999999999999976
Q ss_pred CCeEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccc
Q psy10459 123 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 201 (335)
Q Consensus 123 ~~~~~iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~ 201 (335)
+ ..+++++++.+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+
T Consensus 83 ~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 83 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 5 567888999999999887654 56999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCC
Q psy10459 202 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPR 280 (335)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 280 (335)
...... .......||..|+|||++.+..++ .++|||||||++|||+| |..||.+.+..++...+..+...+.+..
T Consensus 162 ~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 162 GAEEKE---YHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237 (317)
T ss_dssp TTTCC-----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred cccccc---ccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 543322 112344689999999999888877 89999999999999998 8999999988888888888887777778
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhcCC
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQDP 309 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~hp 309 (335)
++.++.+||.+|| .||.+|||+.+|++|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999 9999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-54 Score=380.84 Aligned_cols=251 Identities=23% Similarity=0.439 Sum_probs=206.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEe--CCe
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET--THR 125 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~ 125 (335)
..++|+++++||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999996532 345778999999995 9999999999874 456
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCC-CEEEeccccccccccC
Q psy10459 126 VYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVN 204 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~ 204 (335)
+++||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++......
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999987653 4599999999999999999999999999999999999999765 5899999999866433
Q ss_pred CcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcc-----------
Q psy10459 205 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKR----------- 272 (335)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~-~~~~~~i~~~----------- 272 (335)
.. ....++|..|+|||.+.+....+.++|+||+||++|+|++|..||..... ......+...
T Consensus 184 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 184 QE------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CC------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred Cc------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 21 23457899999999988766545899999999999999999999976542 2221111100
Q ss_pred -------------------------ccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCC
Q psy10459 273 -------------------------VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 314 (335)
Q Consensus 273 -------------------------~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~ 314 (335)
...+....+++++.+||++|| .||++|||++|+|+||||+.-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 000111347899999999999 999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=371.38 Aligned_cols=246 Identities=24% Similarity=0.450 Sum_probs=210.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-CCe
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THR 125 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 125 (335)
.+..++|+++++||+|+||.||+|.+ .|+.||||+++.... .+.+.+|++++++++||||+++++++.. .+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 46778899999999999999999997 478999999975432 4567899999999999999999998854 456
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 126 VYIIMEYAKNGSLLEVIRKE--RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 126 ~~iv~e~~~~~sL~~~l~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+++||||||+|||++.++.++|+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 89999999999999999654 3489999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHccccCCCCCCCC
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLS 282 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (335)
. .....++..|+|||++.+..++ .++|||||||++|||++ |..||...+..++...+..+...+....++
T Consensus 156 ~--------~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (262)
T d1byga_ 156 T--------QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred C--------CccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 2 2234578899999999887777 79999999999999998 899999999999999998887777777899
Q ss_pred HHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 283 SSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 283 ~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
+++.+||++|| .||.+|||+.+|+++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999 999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=371.76 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=208.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC-C--CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARH-S--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
.+..++|++.+.||+|+||+||+|....+ + ..||||++.......+...+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 45677899999999999999999986433 3 3689999877655555556778899999999999999999999965
Q ss_pred CeEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 202 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~ 202 (335)
+..++||||++++++.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 467899999999999987754 4569999999999999999999999999999999999999999999999999998775
Q ss_pred cCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcc-ccCCCCCC
Q psy10459 203 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPESPR 280 (335)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~~~~~~~~~i~~~-~~~~~~~~ 280 (335)
...... .......|+..|+|||++.+..++ .++||||||+++|||++ |..||.+.+..+....+... ...+....
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 163 QNDDHY--VMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp C-CCEE--EC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cCCCcc--eecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 443321 223345678899999999988777 78999999999999998 89999999999998888654 44555678
Q ss_pred CCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 281 LSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 281 ~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+|.++.+||.+|| .||++|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999 99999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=377.19 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=221.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCCe--EEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeEEeC
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSARHSQD--VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 123 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 123 (335)
.+..++|++.++||+|+||+||+|.+..+|.. ||||.+..... +...+.+.+|+.++..+ +||||+++++++..+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 46678999999999999999999999888774 66777654332 22356788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK 187 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~ 187 (335)
+.+++||||+++|+|.++++.. ..+++..+..++.||+.||.|||+.|++||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999653 468999999999999999999999999999999999999999
Q ss_pred CCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q psy10459 188 YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELL 266 (335)
Q Consensus 188 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~p~~~~~~~~~~ 266 (335)
+.+||+|||+++....... .....||..|+|||.+.+..++ .++|||||||++|||++| ..||.+.+..++.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~------~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK------KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp GCEEECCTTCEESSCEECC------C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CceEEcccccccccccccc------ccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999976543221 2244689999999999888877 789999999999999996 5689999999999
Q ss_pred HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC--CCcCCCC
Q psy10459 267 KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD--PWLKEDS 315 (335)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h--p~~~~~~ 315 (335)
..+..+...+.+..+++++.+||.+|| .||++|||+++|++| .++++.+
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 998887777777789999999999999 999999999999997 4555443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=383.84 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=205.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe------C
Q psy10459 50 THGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------T 123 (335)
Q Consensus 50 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~ 123 (335)
.++|+++++||+|+||+||+|++..+|+.||||++....... .....+.+|+.+++.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 367999999999999999999999999999999998765543 335578899999999999999999999853 3
Q ss_pred CeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccccccccc
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 203 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 203 (335)
+.+|+||||+.+ ++...+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++++|||++.....
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 688999999976 555544 34589999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHccccCCC------
Q psy10459 204 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------ 277 (335)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~------ 277 (335)
.. .....+||..|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+......+.
T Consensus 172 ~~------~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 172 SF------MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cc------ccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 22 23345789999999999988777 789999999999999999999998887776665543221110
Q ss_pred --------------C---------------------CCCCHHHHHHHHHhc-CCCCCCCCHHHHhcCCCcCCCCC
Q psy10459 278 --------------S---------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 278 --------------~---------------------~~~~~~l~~li~~~L-~~p~~Rps~~~ll~hp~~~~~~~ 316 (335)
. ...++++++||++|| .||++||||+|||+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 0 113568899999999 99999999999999999987544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-54 Score=373.64 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=219.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeC
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 123 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 123 (335)
-.++|++.+.||+|+||+||+|++. .+++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 4567999999999999999999875 3567899999865433 33466788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q psy10459 124 HRVYIIMEYAKNGSLLEVIRKER------------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKC 179 (335)
Q Consensus 124 ~~~~iv~e~~~~~sL~~~l~~~~------------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp 179 (335)
+..+++|||+.+|+|.+++.... .+++..++.++.|++.||+|||+.+++||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999996432 378899999999999999999999999999999
Q ss_pred CCEeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-CCCCC
Q psy10459 180 ENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFD 258 (335)
Q Consensus 180 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~p~~ 258 (335)
+|||++.++.+||+|||+++........ ......+|++.|+|||.+.+..++ .++|||||||++|||++| ..||.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cceEECCCCcEEEccchhheeccCCccc---cccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999765433221 123456788999999999988888 799999999999999998 47899
Q ss_pred CCCHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 259 DTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 259 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+.+..++...+..+...+....+++++.+||.+|| .+|.+|||+.||++
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999887766666789999999999999 99999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=371.07 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=218.5
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcCCC-------CeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeec
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSARHS-------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 117 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 117 (335)
..+..++|.+++.||+|+||.||+|++..++ ..||||++..... +.....+.+|...+.++ +||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4577889999999999999999999876544 3799999875443 22245677888888777 799999999
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+++..++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999754 248999999999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
||++.++.+||+|||++......... ......+|++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999999877543322 123445789999999999888887 89999999999999998 79999999
Q ss_pred CHHHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 261 NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..++...+..+...+....+++++.+||.+|| .||++|||+.||++
T Consensus 242 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999888877777789999999999999 99999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=370.86 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=227.9
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeE
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 120 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 120 (335)
..+..++|.+++.||+|+||+||+|.+.. ++..||||+++.... ......+.+|+.++++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 45777899999999999999999998752 357899999975433 23356688999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCE
Q psy10459 121 ETTHRVYIIMEYAKNGSLLEVIRKE----------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI 190 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL~~~l~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~ 190 (335)
..++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999998642 236889999999999999999999999999999999999999999
Q ss_pred EEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q psy10459 191 KLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQV 269 (335)
Q Consensus 191 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~p~~~~~~~~~~~~i 269 (335)
||+|||+++.+...... .......||+.|+|||.+.+..++ .++|||||||++|||++| ..||.+.+..+....+
T Consensus 173 Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp EECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEeecccceeccCCcce---eeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999876543322 123345689999999999988887 789999999999999997 6899999999999999
Q ss_pred HccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc------CCCcCC
Q psy10459 270 QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ------DPWLKE 313 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~------hp~~~~ 313 (335)
.++...+....++..+.+||.+|| .+|++|||+++|++ +|+|++
T Consensus 249 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 887777777789999999999999 99999999999998 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=371.14 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=203.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-----CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeeceeE
Q psy10459 47 VLETHGYSLGDVVGMGSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAI 120 (335)
Q Consensus 47 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 120 (335)
.+..++|++++.||+|+||+||+|.+.. +++.||||++....... ....+.+|...+.++ +|+||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 4666889999999999999999999754 34689999986543322 244556777777666 689999999987
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEe
Q psy10459 121 ETT-HRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLL 183 (335)
Q Consensus 121 ~~~-~~~~iv~e~~~~~sL~~~l~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nil 183 (335)
... +.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 4689999999999999999653 24889999999999999999999999999999999999
Q ss_pred ecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCH
Q psy10459 184 LDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNY 262 (335)
Q Consensus 184 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~p~~~~~~ 262 (335)
++.++.+||+|||+++........ ......+||+.|+|||++.+..++ .++|||||||++|||++| ..||.+...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS---CCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ECCCCcEEEccCcchhhccccccc---cccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999865433221 123456799999999999888877 899999999999999986 568877654
Q ss_pred -HHHHHHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 263 -SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 263 -~~~~~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
......+..+...+....+++++.+||.+|| .||.+|||++||++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4455556666666666679999999999999 999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=360.23 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=212.9
Q ss_pred EEeeeecccCceEEEEEEEcCCC---CeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEe-CCeEEEE
Q psy10459 54 SLGDVVGMGSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYII 129 (335)
Q Consensus 54 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~iv 129 (335)
.+.++||+|+||+||+|.+..++ ..||||+++.... ....+.+.+|++++.+++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986543 2589999865332 3335778899999999999999999999765 5689999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEeccccccccccCCccc
Q psy10459 130 MEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 208 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 208 (335)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 9999999999998754 35778889999999999999999999999999999999999999999999999876543322
Q ss_pred ccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHccccCCCCCCCCHHHHH
Q psy10459 209 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSCKA 287 (335)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 287 (335)
.........||..|+|||.+.+..++ .++||||||+++|||++|..||.. .+..+....+..+...+....++.++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHH
Confidence 12223345689999999999887777 899999999999999997666654 4455566667766666666778999999
Q ss_pred HHHHhc-CCCCCCCCHHHHhcC------CCcCCCCCCCC
Q psy10459 288 LISNIL-SPVKFRIQMEDIRQD------PWLKEDSNPVG 319 (335)
Q Consensus 288 li~~~L-~~p~~Rps~~~ll~h------p~~~~~~~~~~ 319 (335)
||.+|| .||++||++.||++| .|+.++..+..
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~~~ 304 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCC
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchhcc
Confidence 999999 999999999999998 77766544443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=363.46 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=217.0
Q ss_pred cccccCCeEEeeeecccCceEEEEEEEc-----CCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcC-CCCCeeeecee
Q psy10459 46 SVLETHGYSLGDVVGMGSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 119 (335)
Q Consensus 46 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 119 (335)
..+..++|+++++||+|+||.||+|++. .+++.||||+++..... .....+.+|+.++..+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3467789999999999999999999863 45678999999765442 2356688999999998 69999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q psy10459 120 IETTHRVYIIMEYAKNGSLLEVIRKER------------------YIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCEN 181 (335)
Q Consensus 120 ~~~~~~~~iv~e~~~~~sL~~~l~~~~------------------~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~N 181 (335)
+...+..+++||||++|+|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999997543 48899999999999999999999999999999999
Q ss_pred EeecCCCCEEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy10459 182 LLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDT 260 (335)
Q Consensus 182 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~p~~~~ 260 (335)
|+++.++.++++|||.++........ ......+||+.|+|||++.+..++ .++|||||||++|||++ |.+||...
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999876543322 123346789999999999887777 79999999999999998 67777666
Q ss_pred CHHHHH-HHHHccccCCCCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 261 NYSELL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 261 ~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+..+.+ +.+..+........+|.++.+||.+|| .||++|||+++|++
T Consensus 252 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 654444 445555655555678999999999999 99999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-51 Score=357.09 Aligned_cols=275 Identities=21% Similarity=0.265 Sum_probs=211.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~iv 129 (335)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+..|+++++.++|++++ .+..++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999876433 34567899999999876655 455566778899999
Q ss_pred EeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC---CCCEEEeccccccccccCC
Q psy10459 130 MEYAKNGSLLEVIR-KERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNN 205 (335)
Q Consensus 130 ~e~~~~~sL~~~l~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~~ 205 (335)
|||+ ++++...+. ..+.+++..+..++.|++.||+|||+.||+||||||+|||++. +..++|+|||+++.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 457766654 4567999999999999999999999999999999999999864 4579999999998775433
Q ss_pred cccc--cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----cccCC---
Q psy10459 206 TDYK--QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK----RVVFP--- 276 (335)
Q Consensus 206 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~~~~~~i~~----~~~~~--- 276 (335)
.... .......+||+.|+|||++.+..++ .++|||||||++|||++|..||...........+.. ....+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2211 1223456799999999999998887 899999999999999999999987665544333321 11111
Q ss_pred CCCCCCHHHHHHHHHhc-CCCCCCCCHH---HHhcCCCcCCCCCCCCCCCCCCcccccCCCC
Q psy10459 277 ESPRLSSSCKALISNIL-SPVKFRIQME---DIRQDPWLKEDSNPVGKSKSAPEVIPFKKSR 334 (335)
Q Consensus 277 ~~~~~~~~l~~li~~~L-~~p~~Rps~~---~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (335)
....+|+++.+||..|| .+|.+||++. ++|+|+|.++......+ --.+.+.+++||
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~--~Dw~~~~~~~~~ 299 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV--FDWNMLKFGASR 299 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCC--CHHHHGGGTCCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCC--cCchhhcCCCCC
Confidence 12468999999999999 9999999987 55788877554333211 113566666665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-49 Score=340.50 Aligned_cols=252 Identities=18% Similarity=0.224 Sum_probs=207.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCC-CCeeeeceeEEeCCeEE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRVY 127 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 127 (335)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.+..+.| +|++.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 35789999999999999999999999999999999866433 3456789999999965 89999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecC-----CCCEEEecccccccc
Q psy10459 128 IIMEYAKNGSLLEVIRKE-RYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-----KYNIKLSDFGFARKY 201 (335)
Q Consensus 128 iv~e~~~~~sL~~~l~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~-----~~~~~l~Dfg~~~~~ 201 (335)
+||||+ +++|.+++... ..++...+..++.|++.||.|||+.||+||||||+|||++. ++.++|+|||+++.+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 67999998765 46999999999999999999999999999999999999974 567999999999877
Q ss_pred ccCCcccc--cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcccc-C
Q psy10459 202 SVNNTDYK--QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRVV-F 275 (335)
Q Consensus 202 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~---~~~~~~~i~~~~~-~ 275 (335)
........ .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.. .......+..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 54332211 1223456899999999999988887 88999999999999999999997543 3333333322111 1
Q ss_pred C---CCCCCCHHHHHHHHHhc-CCCCCCCCHHHHhc
Q psy10459 276 P---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 307 (335)
Q Consensus 276 ~---~~~~~~~~l~~li~~~L-~~p~~Rps~~~ll~ 307 (335)
+ ....+|+++.+++..|+ .+|++||+++.+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 12468999999999999 99999998877754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=343.34 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=192.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCeeeeceeEEeCC----eE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 126 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 126 (335)
++|.+.+.||+|+||+||+|+. +|+.||||+++... ......+.|+..+..++||||+++++++..++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5688999999999999999985 68899999986432 11222334555666789999999999987654 68
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCEeecCCCCEEEeccccc
Q psy10459 127 YIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHK--------KSVVHRDIKCENLLLDDKYNIKLSDFGFA 198 (335)
Q Consensus 127 ~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~--------~~i~H~dikp~Nili~~~~~~~l~Dfg~~ 198 (335)
|+||||+++|+|.+++++. .+++..++.++.|++.||.|||. .||+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999875 58999999999999999999996 59999999999999999999999999999
Q ss_pred cccccCCcccccccccccccccccccccccCCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCC--------------
Q psy10459 199 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPY-----TPQQSDIWSMGVVLFAMVYGRLPFDD-------------- 259 (335)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-----~~~~~Di~slG~~~~~l~~g~~p~~~-------------- 259 (335)
......... ........+||+.|+|||++.+... .+.++|||||||++|||++|..||..
T Consensus 156 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 156 VRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 877543322 1222345679999999999876532 12578999999999999999887632
Q ss_pred -CCHHHHHHHHHccccCCCCC------CCCHHHHHHHHHhc-CCCCCCCCHHHHhcC
Q psy10459 260 -TNYSELLKQVQKRVVFPESP------RLSSSCKALISNIL-SPVKFRIQMEDIRQD 308 (335)
Q Consensus 260 -~~~~~~~~~i~~~~~~~~~~------~~~~~l~~li~~~L-~~p~~Rps~~~ll~h 308 (335)
.........+......|..+ ..+..+.+|+.+|| .||++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12333333333322222211 12346899999999 999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.3e-47 Score=337.46 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=194.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-----------CCCeeee
Q psy10459 48 LETHGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----------HPNLIRF 116 (335)
Q Consensus 48 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~ 116 (335)
+...+|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++
T Consensus 10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 34467999999999999999999999999999999997532 22455678888887774 5789999
Q ss_pred ceeEEe--CCeEEEEEeccCCCCH-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEeecCCCC-
Q psy10459 117 LQAIET--THRVYIIMEYAKNGSL-LEVIR--KERYIDEDKGRRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYN- 189 (335)
Q Consensus 117 ~~~~~~--~~~~~iv~e~~~~~sL-~~~l~--~~~~~~~~~~~~i~~~i~~~L~~LH~-~~i~H~dikp~Nili~~~~~- 189 (335)
++++.. ....++++.++..+.. ..... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 988754 4566667666655433 33332 23568999999999999999999998 89999999999999987653
Q ss_pred -----EEEeccccccccccCCcccccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-
Q psy10459 190 -----IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS- 263 (335)
Q Consensus 190 -----~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p~~~~~~~- 263 (335)
++++|||.+...... ....+||+.|+|||++....++ .++|+||+||++++|++|+.||......
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cccceeeEeecccccccccc--------cccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 899999998755322 2345789999999999988887 7999999999999999999999754321
Q ss_pred -----HHHHHHHccc-------------------------c----------------CCCCCCCCHHHHHHHHHhc-CCC
Q psy10459 264 -----ELLKQVQKRV-------------------------V----------------FPESPRLSSSCKALISNIL-SPV 296 (335)
Q Consensus 264 -----~~~~~i~~~~-------------------------~----------------~~~~~~~~~~l~~li~~~L-~~p 296 (335)
+......... . .......++++.+||.+|| .||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 1111110000 0 0001124678999999999 999
Q ss_pred CCCCCHHHHhcCCCcCCCCC
Q psy10459 297 KFRIQMEDIRQDPWLKEDSN 316 (335)
Q Consensus 297 ~~Rps~~~ll~hp~~~~~~~ 316 (335)
.+|||++|+|+||||++...
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred hHCcCHHHHhcCcccCCCCC
Confidence 99999999999999996533
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=8.4e-27 Score=188.14 Aligned_cols=138 Identities=14% Similarity=0.165 Sum_probs=107.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCC---------------hHHHHhhHHHHHHHHHcCCCCCeeeec
Q psy10459 53 YSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAP---------------IDYLKKFLPREIEVVKGLKHPNLIRFL 117 (335)
Q Consensus 53 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 117 (335)
+.++++||+|+||+||+|.+. +|+.||||+++..... ..........|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999974 6899999987532111 011133455788899999999988876
Q ss_pred eeEEeCCeEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEeecCCCCEEEecccc
Q psy10459 118 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 197 (335)
Q Consensus 118 ~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i~H~dikp~Nili~~~~~~~l~Dfg~ 197 (335)
++. . .+++|||+++..+.. ++...+..++.|++.+|.+||+.||+||||||+|||+++++ ++|+|||.
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 542 2 269999998765432 45566788999999999999999999999999999999764 89999999
Q ss_pred cccccc
Q psy10459 198 ARKYSV 203 (335)
Q Consensus 198 ~~~~~~ 203 (335)
+.....
T Consensus 149 a~~~~~ 154 (191)
T d1zara2 149 SVEVGE 154 (191)
T ss_dssp CEETTS
T ss_pred cccCCC
Confidence 976543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.5e-08 Score=83.93 Aligned_cols=139 Identities=16% Similarity=0.112 Sum_probs=90.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCC-CCCeeeeceeEEeCCeEEEE
Q psy10459 51 HGYSLGDVVGMGSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYII 129 (335)
Q Consensus 51 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~iv 129 (335)
..|+..+..+.++.+.||++. .++..+++|+........ ...+.+|...+..+. +--+.+++.+...++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 357777776666678999887 456778889876432211 334567888887774 33356677777788899999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q psy10459 130 MEYAKNGSLLEVIRKERYIDEDKGRRWFSQLADAIDYCH----------------------------------------- 168 (335)
Q Consensus 130 ~e~~~~~sL~~~l~~~~~~~~~~~~~i~~~i~~~L~~LH----------------------------------------- 168 (335)
|++++|.++........ ....++.++...+..||
T Consensus 89 ~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999877754331110 01112222222222222
Q ss_pred ------------hC------CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 169 ------------KK------SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 169 ------------~~------~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.. .++|+|+.|.||++++++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11 37999999999999987666799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.38 E-value=7.9e-07 Score=72.76 Aligned_cols=135 Identities=14% Similarity=0.103 Sum_probs=81.1
Q ss_pred eecccC-ceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCC--CeeeeceeEEeCCeEEEEEeccC
Q psy10459 58 VVGMGS-YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP--NLIRFLQAIETTHRVYIIMEYAK 134 (335)
Q Consensus 58 ~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~iv~e~~~ 134 (335)
.+..|. .+.||+... .++..+++|...... ...+..|...++.+... .+.+++.+..+++..+++|++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 334444 468998874 457778999865432 23466788888777433 35567777778888999999998
Q ss_pred CCCHHH--------------HHHhcC-------CC--CHHHHHHHHH--------------------HHHHHHHHHHhC-
Q psy10459 135 NGSLLE--------------VIRKER-------YI--DEDKGRRWFS--------------------QLADAIDYCHKK- 170 (335)
Q Consensus 135 ~~sL~~--------------~l~~~~-------~~--~~~~~~~i~~--------------------~i~~~L~~LH~~- 170 (335)
|.++.+ .+..-. .+ .......-.. .....+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 765422 111100 00 0000000000 012223333322
Q ss_pred ------CceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 171 ------SVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 171 ------~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667799999763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.34 E-value=1.3e-06 Score=76.29 Aligned_cols=80 Identities=16% Similarity=0.105 Sum_probs=48.5
Q ss_pred EeeeecccCceEEEEEEEcCCCCeEEEEEEecC------CCChHHHHhhHHHHHHHHHcCC--CC-CeeeeceeEEeCCe
Q psy10459 55 LGDVVGMGSYATVKLATSARHSQDVAIKIISKV------QAPIDYLKKFLPREIEVVKGLK--HP-NLIRFLQAIETTHR 125 (335)
Q Consensus 55 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~ 125 (335)
..+.||.|....||++.+..+++.++||..... ..+.. ..+...|.+.|+.+. .| .+++++.+ +.+.
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~--~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLT--IDRARIESSALIRQGEHVPHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCC--TTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCC--HHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC
Confidence 456789999999999998777889999965321 11111 233456888777663 23 34444433 4445
Q ss_pred EEEEEeccCCCCH
Q psy10459 126 VYIIMEYAKNGSL 138 (335)
Q Consensus 126 ~~iv~e~~~~~sL 138 (335)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 6789999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.78 E-value=5.3e-05 Score=64.02 Aligned_cols=69 Identities=6% Similarity=-0.003 Sum_probs=44.2
Q ss_pred CceEEEEEEEcCCCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCe--eeec-----eeEEeCCeEEEEEeccCC
Q psy10459 63 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFL-----QAIETTHRVYIIMEYAKN 135 (335)
Q Consensus 63 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~-----~~~~~~~~~~iv~e~~~~ 135 (335)
.--.||++.. .+|..|++|+.+..... ...+..|...+..|...++ +..+ ..+......+.+++++.|
T Consensus 34 ~EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 34 YENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ccceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3458999984 67899999999765444 3345567777776642222 1111 123456678899999876
Q ss_pred C
Q psy10459 136 G 136 (335)
Q Consensus 136 ~ 136 (335)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.57 E-value=0.00011 Score=61.54 Aligned_cols=30 Identities=30% Similarity=0.347 Sum_probs=26.7
Q ss_pred CCceeccCCCCCEeecCCCCEEEecccccc
Q psy10459 170 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 199 (335)
Q Consensus 170 ~~i~H~dikp~Nili~~~~~~~l~Dfg~~~ 199 (335)
.|+||+|+.++||+++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.31 E-value=0.00062 Score=58.88 Aligned_cols=80 Identities=13% Similarity=0.130 Sum_probs=49.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC-------CCCeEEEEEEecCCCChHHHHhhHHHHHHHHHcCCCCCee-eeceeE
Q psy10459 49 ETHGYSLGDVVGMGSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAI 120 (335)
Q Consensus 49 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~ 120 (335)
..+.+++ +.|+.|-.-.+|++.... ..+.|++++...... . -...+|..+++.+.-.++. ++++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~---idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E---SHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H---HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--h---hHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3445544 677778888899988643 245677777653222 1 1234788888888544554 555554
Q ss_pred EeCCeEEEEEeccCCCCH
Q psy10459 121 ETTHRVYIIMEYAKNGSL 138 (335)
Q Consensus 121 ~~~~~~~iv~e~~~~~sL 138 (335)
. + ++|++|++|.++
T Consensus 115 ~--~--g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 S--G--GRLEEYIPSRPL 128 (395)
T ss_dssp T--T--EEEECCCCEEEC
T ss_pred C--C--ceEEEEeccccC
Confidence 3 2 588999987543
|